drugbank-id,description,name
DB06605,Apixaban may increase the anticoagulant activities of Lepirudin.,Apixaban
DB06695,Dabigatran etexilate may increase the anticoagulant activities of Lepirudin.,Dabigatran etexilate
DB01254,The risk or severity of bleeding and hemorrhage can be increased when Dasatinib is combined with Lepirudin.,Dasatinib
DB01609,The risk or severity of gastrointestinal bleeding can be increased when Lepirudin is combined with Deferasirox.,Deferasirox
DB01586,The risk or severity of bleeding and bruising can be increased when Lepirudin is combined with Ursodeoxycholic acid.,Ursodeoxycholic acid
DB02123,The risk or severity of bleeding and bruising can be increased when Lepirudin is combined with Glycochenodeoxycholic Acid.,Glycochenodeoxycholic Acid
DB02659,The risk or severity of bleeding and bruising can be increased when Lepirudin is combined with Cholic Acid.,Cholic Acid
DB02691,The risk or severity of bleeding and bruising can be increased when Lepirudin is combined with Glycocholic acid.,Glycocholic acid
DB03619,The risk or severity of bleeding and bruising can be increased when Lepirudin is combined with Deoxycholic acid.,Deoxycholic acid
DB04348,The risk or severity of bleeding and bruising can be increased when Lepirudin is combined with Taurocholic acid.,Taurocholic acid
DB05990,The risk or severity of bleeding and bruising can be increased when Lepirudin is combined with Obeticholic acid.,Obeticholic acid
DB06777,The risk or severity of bleeding and bruising can be increased when Lepirudin is combined with Chenodeoxycholic acid.,Chenodeoxycholic acid
DB08833,The risk or severity of bleeding and bruising can be increased when Lepirudin is combined with Taurochenodeoxycholic acid.,Taurochenodeoxycholic acid
DB08834,The risk or severity of bleeding and bruising can be increased when Lepirudin is combined with Tauroursodeoxycholic acid.,Tauroursodeoxycholic acid
DB08857,The risk or severity of bleeding and bruising can be increased when Lepirudin is combined with Bamet-UD2.,Bamet-UD2
DB11622,The risk or severity of bleeding and bruising can be increased when Lepirudin is combined with Dehydrocholic acid.,Dehydrocholic acid
DB11789,The risk or severity of bleeding and bruising can be increased when Lepirudin is combined with Hyodeoxycholic Acid.,Hyodeoxycholic Acid
DB09075,The risk or severity of bleeding can be increased when Edoxaban is combined with Lepirudin.,Edoxaban
DB09053,The risk or severity of bleeding and hemorrhage can be increased when Ibrutinib is combined with Lepirudin.,Ibrutinib
DB08935,The risk or severity of bleeding and hemorrhage can be increased when Lepirudin is combined with Obinutuzumab.,Obinutuzumab
DB06228,Lepirudin may increase the anticoagulant activities of Rivaroxaban.,Rivaroxaban
DB06206,The risk or severity of bleeding and hemorrhage can be increased when Lepirudin is combined with Sugammadex.,Sugammadex
DB09070,Tibolone may increase the anticoagulant activities of Lepirudin.,Tibolone
DB00932,The risk or severity of bleeding and hemorrhage can be increased when Tipranavir is combined with Lepirudin.,Tipranavir
DB00013,Urokinase may increase the anticoagulant activities of Lepirudin.,Urokinase
DB00163,Vitamin E may increase the anticoagulant activities of Lepirudin.,Vitamin E
DB09030,The risk or severity of bleeding and hemorrhage can be increased when Vorapaxar is combined with Lepirudin.,Vorapaxar
DB01381,The therapeutic efficacy of Lepirudin can be increased when used in combination with Ginkgo biloba.,Ginkgo biloba
DB01181,The risk or severity of bleeding can be increased when Ifosfamide is combined with Lepirudin.,Ifosfamide
DB00468,The therapeutic efficacy of Lepirudin can be increased when used in combination with Quinine.,Quinine
DB00908,The therapeutic efficacy of Lepirudin can be increased when used in combination with Quinidine.,Quinidine
DB00675,The risk or severity of bleeding can be increased when Tamoxifen is combined with Lepirudin.,Tamoxifen
DB00539,The risk or severity of bleeding can be increased when Toremifene is combined with Lepirudin.,Toremifene
DB00806,The therapeutic efficacy of Lepirudin can be increased when used in combination with Pentoxifylline.,Pentoxifylline
DB00686,Pentosan polysulfate may increase the anticoagulant activities of Lepirudin.,Pentosan polysulfate
DB00583,The therapeutic efficacy of Lepirudin can be increased when used in combination with Levocarnitine.,Levocarnitine
DB00255,Diethylstilbestrol may decrease the anticoagulant activities of Lepirudin.,Diethylstilbestrol
DB00269,Chlorotrianisene may decrease the anticoagulant activities of Lepirudin.,Chlorotrianisene
DB00286,Conjugated estrogens may decrease the anticoagulant activities of Lepirudin.,Conjugated estrogens
DB00783,Estradiol may decrease the anticoagulant activities of Lepirudin.,Estradiol
DB00977,Ethinylestradiol may decrease the anticoagulant activities of Lepirudin.,Ethinylestradiol
DB01357,Mestranol may decrease the anticoagulant activities of Lepirudin.,Mestranol
DB04573,Estriol may decrease the anticoagulant activities of Lepirudin.,Estriol
DB04574,Estrone sulfate may decrease the anticoagulant activities of Lepirudin.,Estrone sulfate
DB04575,Quinestrol may decrease the anticoagulant activities of Lepirudin.,Quinestrol
DB07931,Hexestrol may decrease the anticoagulant activities of Lepirudin.,Hexestrol
DB09317,"Synthetic Conjugated Estrogens, A may decrease the anticoagulant activities of Lepirudin.","Synthetic Conjugated Estrogens, A"
DB09318,"Synthetic Conjugated Estrogens, B may decrease the anticoagulant activities of Lepirudin.","Synthetic Conjugated Estrogens, B"
DB09369,Polyestradiol phosphate may decrease the anticoagulant activities of Lepirudin.,Polyestradiol phosphate
DB09381,Esterified estrogens may decrease the anticoagulant activities of Lepirudin.,Esterified estrogens
DB11478,Zeranol may decrease the anticoagulant activities of Lepirudin.,Zeranol
DB11674,Equol may decrease the anticoagulant activities of Lepirudin.,Equol
DB12487,Promestriene may decrease the anticoagulant activities of Lepirudin.,Promestriene
DB13143,Methallenestril may decrease the anticoagulant activities of Lepirudin.,Methallenestril
DB13386,Epimestrol may decrease the anticoagulant activities of Lepirudin.,Epimestrol
DB13418,Moxestrol may decrease the anticoagulant activities of Lepirudin.,Moxestrol
DB13952,Estradiol acetate may decrease the anticoagulant activities of Lepirudin.,Estradiol acetate
DB13953,Estradiol benzoate may decrease the anticoagulant activities of Lepirudin.,Estradiol benzoate
DB13954,Estradiol cypionate may decrease the anticoagulant activities of Lepirudin.,Estradiol cypionate
DB13956,Estradiol valerate may decrease the anticoagulant activities of Lepirudin.,Estradiol valerate
DB15334,Biochanin A may decrease the anticoagulant activities of Lepirudin.,Biochanin A
DB15335,Formononetin may decrease the anticoagulant activities of Lepirudin.,Formononetin
DB09211,The risk or severity of adverse effects can be increased when Limaprost is combined with Lepirudin.,Limaprost
DB00159,The risk or severity of bleeding and hemorrhage can be increased when Icosapent is combined with Lepirudin.,Icosapent
DB00244,The risk or severity of bleeding and hemorrhage can be increased when Mesalazine is combined with Lepirudin.,Mesalazine
DB00328,The risk or severity of bleeding and hemorrhage can be increased when Indomethacin is combined with Lepirudin.,Indomethacin
DB00461,The risk or severity of bleeding and hemorrhage can be increased when Nabumetone is combined with Lepirudin.,Nabumetone
DB00465,The risk or severity of bleeding and hemorrhage can be increased when Ketorolac is combined with Lepirudin.,Ketorolac
DB00469,The risk or severity of bleeding and hemorrhage can be increased when Tenoxicam is combined with Lepirudin.,Tenoxicam
DB00482,The risk or severity of bleeding and hemorrhage can be increased when Celecoxib is combined with Lepirudin.,Celecoxib
DB00500,The risk or severity of bleeding and hemorrhage can be increased when Tolmetin is combined with Lepirudin.,Tolmetin
DB00533,The risk or severity of bleeding and hemorrhage can be increased when Rofecoxib is combined with Lepirudin.,Rofecoxib
DB00554,The risk or severity of bleeding and hemorrhage can be increased when Piroxicam is combined with Lepirudin.,Piroxicam
DB00573,The risk or severity of bleeding and hemorrhage can be increased when Fenoprofen is combined with Lepirudin.,Fenoprofen
DB00580,The risk or severity of bleeding and hemorrhage can be increased when Valdecoxib is combined with Lepirudin.,Valdecoxib
DB00586,The risk or severity of bleeding and hemorrhage can be increased when Diclofenac is combined with Lepirudin.,Diclofenac
DB00605,The risk or severity of bleeding and hemorrhage can be increased when Sulindac is combined with Lepirudin.,Sulindac
DB00712,The risk or severity of bleeding and hemorrhage can be increased when Flurbiprofen is combined with Lepirudin.,Flurbiprofen
DB00749,The risk or severity of bleeding and hemorrhage can be increased when Etodolac is combined with Lepirudin.,Etodolac
DB00784,The risk or severity of bleeding and hemorrhage can be increased when Mefenamic acid is combined with Lepirudin.,Mefenamic acid
DB00788,The risk or severity of bleeding and hemorrhage can be increased when Naproxen is combined with Lepirudin.,Naproxen
DB00795,The risk or severity of bleeding and hemorrhage can be increased when Sulfasalazine is combined with Lepirudin.,Sulfasalazine
DB00812,The risk or severity of bleeding and hemorrhage can be increased when Phenylbutazone is combined with Lepirudin.,Phenylbutazone
DB00814,The risk or severity of bleeding and hemorrhage can be increased when Meloxicam is combined with Lepirudin.,Meloxicam
DB00821,The risk or severity of bleeding and hemorrhage can be increased when Carprofen is combined with Lepirudin.,Carprofen
DB00861,The risk or severity of bleeding and hemorrhage can be increased when Diflunisal is combined with Lepirudin.,Diflunisal
DB00936,The risk or severity of bleeding and hemorrhage can be increased when Salicylic acid is combined with Lepirudin.,Salicylic acid
DB00939,The risk or severity of bleeding and hemorrhage can be increased when Meclofenamic acid is combined with Lepirudin.,Meclofenamic acid
DB00991,The risk or severity of bleeding and hemorrhage can be increased when Oxaprozin is combined with Lepirudin.,Oxaprozin
DB01009,The risk or severity of bleeding and hemorrhage can be increased when Ketoprofen is combined with Lepirudin.,Ketoprofen
DB01014,The risk or severity of bleeding and hemorrhage can be increased when Balsalazide is combined with Lepirudin.,Balsalazide
DB01250,The risk or severity of bleeding and hemorrhage can be increased when Olsalazine is combined with Lepirudin.,Olsalazine
DB01283,The risk or severity of bleeding and hemorrhage can be increased when Lumiracoxib is combined with Lepirudin.,Lumiracoxib
DB01397,The risk or severity of bleeding and hemorrhage can be increased when Magnesium salicylate is combined with Lepirudin.,Magnesium salicylate
DB01399,The risk or severity of bleeding and hemorrhage can be increased when Salsalate is combined with Lepirudin.,Salsalate
DB01401,The risk or severity of bleeding and hemorrhage can be increased when Choline magnesium trisalicylate is combined with Lepirudin.,Choline magnesium trisalicylate
DB01419,The risk or severity of bleeding and hemorrhage can be increased when Antrafenine is combined with Lepirudin.,Antrafenine
DB01424,The risk or severity of bleeding and hemorrhage can be increased when Aminophenazone is combined with Lepirudin.,Aminophenazone
DB01435,The risk or severity of bleeding and hemorrhage can be increased when Antipyrine is combined with Lepirudin.,Antipyrine
DB01600,The risk or severity of bleeding and hemorrhage can be increased when Tiaprofenic acid is combined with Lepirudin.,Tiaprofenic acid
DB01628,The risk or severity of bleeding and hemorrhage can be increased when Etoricoxib is combined with Lepirudin.,Etoricoxib
DB02224,The risk or severity of bleeding and hemorrhage can be increased when Taxifolin is combined with Lepirudin.,Taxifolin
DB03585,The risk or severity of bleeding and hemorrhage can be increased when Oxyphenbutazone is combined with Lepirudin.,Oxyphenbutazone
DB04552,The risk or severity of bleeding and hemorrhage can be increased when Niflumic acid is combined with Lepirudin.,Niflumic acid
DB04725,The risk or severity of bleeding and hemorrhage can be increased when Licofelone is combined with Lepirudin.,Licofelone
DB04812,The risk or severity of bleeding and hemorrhage can be increased when Benoxaprofen is combined with Lepirudin.,Benoxaprofen
DB04817,The risk or severity of bleeding and hemorrhage can be increased when Metamizole is combined with Lepirudin.,Metamizole
DB04828,The risk or severity of bleeding and hemorrhage can be increased when Zomepirac is combined with Lepirudin.,Zomepirac
DB05095,The risk or severity of bleeding and hemorrhage can be increased when Cimicoxib is combined with Lepirudin.,Cimicoxib
DB06725,The risk or severity of bleeding and hemorrhage can be increased when Lornoxicam is combined with Lepirudin.,Lornoxicam
DB06736,The risk or severity of bleeding and hemorrhage can be increased when Aceclofenac is combined with Lepirudin.,Aceclofenac
DB06737,The risk or severity of bleeding and hemorrhage can be increased when Zaltoprofen is combined with Lepirudin.,Zaltoprofen
DB07402,The risk or severity of bleeding and hemorrhage can be increased when Azapropazone is combined with Lepirudin.,Azapropazone
DB07477,The risk or severity of bleeding and hemorrhage can be increased when Felbinac is combined with Lepirudin.,Felbinac
DB08439,The risk or severity of bleeding and hemorrhage can be increased when Parecoxib is combined with Lepirudin.,Parecoxib
DB08797,The risk or severity of bleeding and hemorrhage can be increased when Salicylamide is combined with Lepirudin.,Salicylamide
DB08940,The risk or severity of bleeding and hemorrhage can be increased when Kebuzone is combined with Lepirudin.,Kebuzone
DB08942,The risk or severity of bleeding and hemorrhage can be increased when Isoxicam is combined with Lepirudin.,Isoxicam
DB08951,The risk or severity of bleeding and hemorrhage can be increased when Indoprofen is combined with Lepirudin.,Indoprofen
DB08955,The risk or severity of bleeding and hemorrhage can be increased when Ibuproxam is combined with Lepirudin.,Ibuproxam
DB08976,The risk or severity of bleeding and hemorrhage can be increased when Floctafenine is combined with Lepirudin.,Floctafenine
DB08981,The risk or severity of bleeding and hemorrhage can be increased when Fenbufen is combined with Lepirudin.,Fenbufen
DB08984,The risk or severity of bleeding and hemorrhage can be increased when Etofenamate is combined with Lepirudin.,Etofenamate
DB08991,The risk or severity of bleeding and hemorrhage can be increased when Epirizole is combined with Lepirudin.,Epirizole
DB09084,The risk or severity of bleeding and hemorrhage can be increased when Benzydamine is combined with Lepirudin.,Benzydamine
DB09212,The risk or severity of bleeding and hemorrhage can be increased when Loxoprofen is combined with Lepirudin.,Loxoprofen
DB09214,The risk or severity of bleeding and hemorrhage can be increased when Dexketoprofen is combined with Lepirudin.,Dexketoprofen
DB09215,The risk or severity of bleeding and hemorrhage can be increased when Droxicam is combined with Lepirudin.,Droxicam
DB09216,The risk or severity of bleeding and hemorrhage can be increased when Tolfenamic acid is combined with Lepirudin.,Tolfenamic acid
DB09217,The risk or severity of bleeding and hemorrhage can be increased when Firocoxib is combined with Lepirudin.,Firocoxib
DB09218,The risk or severity of bleeding and hemorrhage can be increased when Clonixin is combined with Lepirudin.,Clonixin
DB09285,The risk or severity of bleeding and hemorrhage can be increased when Morniflumate is combined with Lepirudin.,Morniflumate
DB09288,The risk or severity of bleeding and hemorrhage can be increased when Propacetamol is combined with Lepirudin.,Propacetamol
DB09295,The risk or severity of bleeding and hemorrhage can be increased when Talniflumate is combined with Lepirudin.,Talniflumate
DB11455,The risk or severity of bleeding and hemorrhage can be increased when Robenacoxib is combined with Lepirudin.,Robenacoxib
DB11466,The risk or severity of bleeding and hemorrhage can be increased when Tepoxalin is combined with Lepirudin.,Tepoxalin
DB11518,The risk or severity of bleeding and hemorrhage can be increased when Flunixin is combined with Lepirudin.,Flunixin
DB12399,The risk or severity of bleeding and hemorrhage can be increased when Polmacoxib is combined with Lepirudin.,Polmacoxib
DB12480,The risk or severity of bleeding and hemorrhage can be increased when Betulinic Acid is combined with Lepirudin.,Betulinic Acid
DB12610,The risk or severity of bleeding and hemorrhage can be increased when Ebselen is combined with Lepirudin.,Ebselen
DB13001,The risk or severity of bleeding and hemorrhage can be increased when Tinoridine is combined with Lepirudin.,Tinoridine
DB13167,The risk or severity of bleeding and hemorrhage can be increased when Alclofenac is combined with Lepirudin.,Alclofenac
DB13217,The risk or severity of bleeding and hemorrhage can be increased when Fentiazac is combined with Lepirudin.,Fentiazac
DB13232,The risk or severity of bleeding and hemorrhage can be increased when Suxibuzone is combined with Lepirudin.,Suxibuzone
DB13286,The risk or severity of bleeding and hemorrhage can be increased when Bumadizone is combined with Lepirudin.,Bumadizone
DB13314,The risk or severity of bleeding and hemorrhage can be increased when Alminoprofen is combined with Lepirudin.,Alminoprofen
DB13317,The risk or severity of bleeding and hemorrhage can be increased when Flunoxaprofen is combined with Lepirudin.,Flunoxaprofen
DB13364,The risk or severity of bleeding and hemorrhage can be increased when Feprazone is combined with Lepirudin.,Feprazone
DB13371,The risk or severity of bleeding and hemorrhage can be increased when Difenpiramide is combined with Lepirudin.,Difenpiramide
DB13407,The risk or severity of bleeding and hemorrhage can be increased when Nifenazone is combined with Lepirudin.,Nifenazone
DB13432,The risk or severity of bleeding and hemorrhage can be increased when Lonazolac is combined with Lepirudin.,Lonazolac
DB13481,The risk or severity of bleeding and hemorrhage can be increased when Tenidap is combined with Lepirudin.,Tenidap
DB13501,The risk or severity of bleeding and hemorrhage can be increased when Bendazac is combined with Lepirudin.,Bendazac
DB13514,The risk or severity of bleeding and hemorrhage can be increased when Pranoprofen is combined with Lepirudin.,Pranoprofen
DB13524,The risk or severity of bleeding and hemorrhage can be increased when Propyphenazone is combined with Lepirudin.,Propyphenazone
DB13527,The risk or severity of bleeding and hemorrhage can be increased when Proglumetacin is combined with Lepirudin.,Proglumetacin
DB13538,The risk or severity of bleeding and hemorrhage can be increased when Guacetisal is combined with Lepirudin.,Guacetisal
DB13544,The risk or severity of bleeding and hemorrhage can be increased when Ethenzamide is combined with Lepirudin.,Ethenzamide
DB13612,The risk or severity of bleeding and hemorrhage can be increased when Carbaspirin calcium is combined with Lepirudin.,Carbaspirin calcium
DB13629,The risk or severity of bleeding and hemorrhage can be increased when Mofebutazone is combined with Lepirudin.,Mofebutazone
DB13649,The risk or severity of bleeding and hemorrhage can be increased when Proquazone is combined with Lepirudin.,Proquazone
DB13657,The risk or severity of bleeding and hemorrhage can be increased when Benorilate is combined with Lepirudin.,Benorilate
DB13722,The risk or severity of bleeding and hemorrhage can be increased when Pirprofen is combined with Lepirudin.,Pirprofen
DB13860,The risk or severity of bleeding and hemorrhage can be increased when Imidazole salicylate is combined with Lepirudin.,Imidazole salicylate
DB14059,The risk or severity of bleeding and hemorrhage can be increased when SC-236 is combined with Lepirudin.,SC-236
DB14060,The risk or severity of bleeding and hemorrhage can be increased when NS-398 is combined with Lepirudin.,NS-398
DB14938,The risk or severity of bleeding and hemorrhage can be increased when Flurbiprofen axetil is combined with Lepirudin.,Flurbiprofen axetil
DB04865,The risk or severity of bleeding can be increased when Lepirudin is combined with Omacetaxine mepesuccinate.,Omacetaxine mepesuccinate
DB11133,Omega-3 fatty acids may increase the anticoagulant activities of Lepirudin.,Omega-3 fatty acids
DB00081,The risk or severity of bleeding and hemorrhage can be increased when Lepirudin is combined with Tositumomab.,Tositumomab
DB00048,The risk or severity of adverse effects can be increased when Lepirudin is combined with Collagenase clostridium histolyticum.,Collagenase clostridium histolyticum
DB00389,Carbimazole may increase the anticoagulant activities of Lepirudin.,Carbimazole
DB00550,Propylthiouracil may increase the anticoagulant activities of Lepirudin.,Propylthiouracil
DB00763,Methimazole may increase the anticoagulant activities of Lepirudin.,Methimazole
DB03374,"3,5-Diiodotyrosine may increase the anticoagulant activities of Lepirudin.","3,5-Diiodotyrosine"
DB06715,Potassium Iodide may increase the anticoagulant activities of Lepirudin.,Potassium Iodide
DB07637,Dibromotyrosine may increase the anticoagulant activities of Lepirudin.,Dibromotyrosine
DB09418,Potassium perchlorate may increase the anticoagulant activities of Lepirudin.,Potassium perchlorate
DB13644,Methylthiouracil may increase the anticoagulant activities of Lepirudin.,Methylthiouracil
DB13804,Benzylthiouracil may increase the anticoagulant activities of Lepirudin.,Benzylthiouracil
DB00834,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Mifepristone.,Mifepristone
DB04066,The therapeutic efficacy of Lepirudin can be decreased when used in combination with p-Coumaric acid.,p-Coumaric acid
DB04682,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Octylphenoxy polyethoxyethanol.,Octylphenoxy polyethoxyethanol
DB05830,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Trestolone.,Trestolone
DB06266,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Lonidamine.,Lonidamine
DB08867,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Ulipristal.,Ulipristal
DB09401,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Isosorbide.,Isosorbide
DB11507,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cloprostenol.,Cloprostenol
DB12025,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Triptolide.,Triptolide
DB13044,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Gossypol.,Gossypol
DB13310,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Ormeloxifene.,Ormeloxifene
DB00294,Etonogestrel may decrease the anticoagulant activities of Lepirudin.,Etonogestrel
DB00304,Desogestrel may decrease the anticoagulant activities of Lepirudin.,Desogestrel
DB00351,Megestrol acetate may decrease the anticoagulant activities of Lepirudin.,Megestrol acetate
DB00367,Levonorgestrel may decrease the anticoagulant activities of Lepirudin.,Levonorgestrel
DB00378,Dydrogesterone may decrease the anticoagulant activities of Lepirudin.,Dydrogesterone
DB00396,Progesterone may decrease the anticoagulant activities of Lepirudin.,Progesterone
DB00603,Medroxyprogesterone acetate may decrease the anticoagulant activities of Lepirudin.,Medroxyprogesterone acetate
DB00717,Norethisterone may decrease the anticoagulant activities of Lepirudin.,Norethisterone
DB00823,Ethynodiol diacetate may decrease the anticoagulant activities of Lepirudin.,Ethynodiol diacetate
DB00957,Norgestimate may decrease the anticoagulant activities of Lepirudin.,Norgestimate
DB01395,Drospirenone may decrease the anticoagulant activities of Lepirudin.,Drospirenone
DB01431,Allylestrenol may decrease the anticoagulant activities of Lepirudin.,Allylestrenol
DB04839,Cyproterone acetate may decrease the anticoagulant activities of Lepirudin.,Cyproterone acetate
DB06713,Norelgestromin may decrease the anticoagulant activities of Lepirudin.,Norelgestromin
DB06730,Gestodene may decrease the anticoagulant activities of Lepirudin.,Gestodene
DB06789,Hydroxyprogesterone caproate may decrease the anticoagulant activities of Lepirudin.,Hydroxyprogesterone caproate
DB09123,Dienogest may decrease the anticoagulant activities of Lepirudin.,Dienogest
DB09124,Medrogestone may decrease the anticoagulant activities of Lepirudin.,Medrogestone
DB09371,Norethynodrel may decrease the anticoagulant activities of Lepirudin.,Norethynodrel
DB09389,Norgestrel may decrease the anticoagulant activities of Lepirudin.,Norgestrel
DB11372,Altrenogest may decrease the anticoagulant activities of Lepirudin.,Altrenogest
DB11619,Gestrinone may decrease the anticoagulant activities of Lepirudin.,Gestrinone
DB11636,Nomegestrol may decrease the anticoagulant activities of Lepirudin.,Nomegestrol
DB12474,Lynestrenol may decrease the anticoagulant activities of Lepirudin.,Lynestrenol
DB13230,Gestonorone may decrease the anticoagulant activities of Lepirudin.,Gestonorone
DB13528,Chlormadinone may decrease the anticoagulant activities of Lepirudin.,Chlormadinone
DB13533,Methylestrenolone may decrease the anticoagulant activities of Lepirudin.,Methylestrenolone
DB13563,Norgestrienone may decrease the anticoagulant activities of Lepirudin.,Norgestrienone
DB13602,Promegestone may decrease the anticoagulant activities of Lepirudin.,Promegestone
DB13685,Quingestanol may decrease the anticoagulant activities of Lepirudin.,Quingestanol
DB13857,Demegestone may decrease the anticoagulant activities of Lepirudin.,Demegestone
DB13866,Etynodiol may decrease the anticoagulant activities of Lepirudin.,Etynodiol
DB13981,Nomegestrol acetate may decrease the anticoagulant activities of Lepirudin.,Nomegestrol acetate
DB14570,Hydroxyprogesterone may decrease the anticoagulant activities of Lepirudin.,Hydroxyprogesterone
DB14678,Norethindrone enanthate may decrease the anticoagulant activities of Lepirudin.,Norethindrone enanthate
DB14679,Quingestanol acetate may decrease the anticoagulant activities of Lepirudin.,Quingestanol acetate
DB00233,The risk or severity of bleeding can be increased when Aminosalicylic acid is combined with Lepirudin.,Aminosalicylic acid
DB01294,The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Lepirudin.,Bismuth subsalicylate
DB06251,The risk or severity of bleeding can be increased when Dersalazine is combined with Lepirudin.,Dersalazine
DB06807,The risk or severity of bleeding can be increased when Phenyl aminosalicylate is combined with Lepirudin.,Phenyl aminosalicylate
DB09543,The risk or severity of bleeding can be increased when Methyl salicylate is combined with Lepirudin.,Methyl salicylate
DB11079,The risk or severity of bleeding can be increased when Trolamine salicylate is combined with Lepirudin.,Trolamine salicylate
DB13509,The risk or severity of bleeding can be increased when Aloxiprin is combined with Lepirudin.,Aloxiprin
DB14006,The risk or severity of bleeding can be increased when Choline salicylate is combined with Lepirudin.,Choline salicylate
DB14026,The risk or severity of bleeding can be increased when Thiosalicylic acid is combined with Lepirudin.,Thiosalicylic acid
DB00054,The risk or severity of bleeding can be increased when Abciximab is combined with Lepirudin.,Abciximab
DB00063,The risk or severity of bleeding can be increased when Eptifibatide is combined with Lepirudin.,Eptifibatide
DB00208,The risk or severity of bleeding can be increased when Ticlopidine is combined with Lepirudin.,Ticlopidine
DB00261,The risk or severity of bleeding can be increased when Anagrelide is combined with Lepirudin.,Anagrelide
DB00758,The risk or severity of bleeding can be increased when Clopidogrel is combined with Lepirudin.,Clopidogrel
DB00775,The risk or severity of bleeding can be increased when Tirofiban is combined with Lepirudin.,Tirofiban
DB00975,The risk or severity of bleeding can be increased when Dipyridamole is combined with Lepirudin.,Dipyridamole
DB01088,The risk or severity of bleeding can be increased when Iloprost is combined with Lepirudin.,Iloprost
DB01138,The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Lepirudin.,Sulfinpyrazone
DB01166,The risk or severity of bleeding can be increased when Cilostazol is combined with Lepirudin.,Cilostazol
DB01207,The risk or severity of bleeding can be increased when Ridogrel is combined with Lepirudin.,Ridogrel
DB01236,The risk or severity of bleeding can be increased when Sevoflurane is combined with Lepirudin.,Sevoflurane
DB01240,The risk or severity of bleeding can be increased when Epoprostenol is combined with Lepirudin.,Epoprostenol
DB02709,The risk or severity of bleeding can be increased when Resveratrol is combined with Lepirudin.,Resveratrol
DB04743,The risk or severity of bleeding can be increased when Nimesulide is combined with Lepirudin.,Nimesulide
DB04905,The risk or severity of bleeding can be increased when Tesmilifene is combined with Lepirudin.,Tesmilifene
DB04932,The risk or severity of bleeding can be increased when Defibrotide is combined with Lepirudin.,Defibrotide
DB05229,The risk or severity of bleeding can be increased when Beraprost is combined with Lepirudin.,Beraprost
DB05266,The risk or severity of bleeding can be increased when Ibudilast is combined with Lepirudin.,Ibudilast
DB05767,The risk or severity of bleeding can be increased when Andrographolide is combined with Lepirudin.,Andrographolide
DB06081,The risk or severity of bleeding can be increased when Caplacizumab is combined with Lepirudin.,Caplacizumab
DB06209,The risk or severity of bleeding can be increased when Prasugrel is combined with Lepirudin.,Prasugrel
DB06441,The risk or severity of bleeding can be increased when Cangrelor is combined with Lepirudin.,Cangrelor
DB07615,The risk or severity of bleeding can be increased when Tranilast is combined with Lepirudin.,Tranilast
DB08814,The risk or severity of bleeding can be increased when Triflusal is combined with Lepirudin.,Triflusal
DB08816,The risk or severity of bleeding can be increased when Ticagrelor is combined with Lepirudin.,Ticagrelor
DB08887,The risk or severity of bleeding can be increased when Icosapent ethyl is combined with Lepirudin.,Icosapent ethyl
DB09283,The risk or severity of bleeding can be increased when Trapidil is combined with Lepirudin.,Trapidil
DB12092,The risk or severity of bleeding can be increased when Naftopidil is combined with Lepirudin.,Naftopidil
DB12163,The risk or severity of bleeding can be increased when Sarpogrelate is combined with Lepirudin.,Sarpogrelate
DB12321,The risk or severity of bleeding can be increased when Ifetroban is combined with Lepirudin.,Ifetroban
DB12445,The risk or severity of bleeding can be increased when Nitroaspirin is combined with Lepirudin.,Nitroaspirin
DB12465,The risk or severity of bleeding can be increased when Ketanserin is combined with Lepirudin.,Ketanserin
DB12545,The risk or severity of bleeding can be increased when Indobufen is combined with Lepirudin.,Indobufen
DB12749,The risk or severity of bleeding can be increased when Butylphthalide is combined with Lepirudin.,Butylphthalide
DB12771,The risk or severity of bleeding can be increased when Hydroxytyrosol is combined with Lepirudin.,Hydroxytyrosol
DB13036,The risk or severity of bleeding can be increased when Ramatroban is combined with Lepirudin.,Ramatroban
DB13327,The risk or severity of bleeding can be increased when Picotamide is combined with Lepirudin.,Picotamide
DB13367,The risk or severity of bleeding can be increased when Cloricromen is combined with Lepirudin.,Cloricromen
DB13400,The risk or severity of bleeding can be increased when Linsidomine is combined with Lepirudin.,Linsidomine
DB13510,The risk or severity of bleeding can be increased when Buflomedil is combined with Lepirudin.,Buflomedil
DB13929,The risk or severity of bleeding can be increased when Relcovaptan is combined with Lepirudin.,Relcovaptan
DB00374,The risk or severity of bleeding can be increased when Treprostinil is combined with Lepirudin.,Treprostinil
DB03404,Hemin may increase the anticoagulant activities of Lepirudin.,Hemin
DB13783,The risk or severity of bleeding and hemorrhage can be increased when Acemetacin is combined with Lepirudin.,Acemetacin
DB00624,Testosterone may increase the anticoagulant activities of Lepirudin.,Testosterone
DB01420,Testosterone propionate may increase the anticoagulant activities of Lepirudin.,Testosterone propionate
DB01481,1-Testosterone may increase the anticoagulant activities of Lepirudin.,1-Testosterone
DB01485,4-Hydroxytestosterone may increase the anticoagulant activities of Lepirudin.,4-Hydroxytestosterone
DB01510,Dehydrochloromethyltestosterone may increase the anticoagulant activities of Lepirudin.,Dehydrochloromethyltestosterone
DB01541,Boldenone may increase the anticoagulant activities of Lepirudin.,Boldenone
DB01543,18-methyl-19-nortestosterone may increase the anticoagulant activities of Lepirudin.,18-methyl-19-nortestosterone
DB01564,Calusterone may increase the anticoagulant activities of Lepirudin.,Calusterone
DB01569,Formebolone may increase the anticoagulant activities of Lepirudin.,Formebolone
DB01572,Methyl-1-testosterone may increase the anticoagulant activities of Lepirudin.,Methyl-1-testosterone
DB02901,Stanolone may increase the anticoagulant activities of Lepirudin.,Stanolone
DB07447,5beta-dihydrotestosterone may increase the anticoagulant activities of Lepirudin.,5beta-dihydrotestosterone
DB08619,Testosterone succinate may increase the anticoagulant activities of Lepirudin.,Testosterone succinate
DB11429,Mibolerone may increase the anticoagulant activities of Lepirudin.,Mibolerone
DB13943,Testosterone cypionate may increase the anticoagulant activities of Lepirudin.,Testosterone cypionate
DB13944,Testosterone enanthate may increase the anticoagulant activities of Lepirudin.,Testosterone enanthate
DB13946,Testosterone undecanoate may increase the anticoagulant activities of Lepirudin.,Testosterone undecanoate
DB13947,Testosterone enantate benzilic acid hydrazone may increase the anticoagulant activities of Lepirudin.,Testosterone enantate benzilic acid hydrazone
DB13951,Stanolone acetate may increase the anticoagulant activities of Lepirudin.,Stanolone acetate
DB13958,Trestolone acetate may increase the anticoagulant activities of Lepirudin.,Trestolone acetate
DB14093,"(1,2,6,7-3H)Testosterone may increase the anticoagulant activities of Lepirudin.","(1,2,6,7-3H)Testosterone"
DB14655,Drostanolone propionate may increase the anticoagulant activities of Lepirudin.,Drostanolone propionate
DB11051,The risk or severity of adverse effects can be increased when Lepirudin is combined with Azficel-T.,Azficel-T
DB09568,The therapeutic efficacy of Lepirudin can be increased when used in combination with Omega-3-carboxylic acids.,Omega-3-carboxylic acids
DB00025,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Lepirudin.","Antihemophilic factor, human recombinant"
DB00036,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Lepirudin.,Coagulation factor VIIa Recombinant Human
DB00100,The therapeutic efficacy of Coagulation Factor IX (Recombinant) can be decreased when used in combination with Lepirudin.,Coagulation Factor IX (Recombinant)
DB00258,The therapeutic efficacy of Calcium acetate can be decreased when used in combination with Lepirudin.,Calcium acetate
DB01164,The therapeutic efficacy of Calcium chloride can be decreased when used in combination with Lepirudin.,Calcium chloride
DB01373,The therapeutic efficacy of Calcium can be decreased when used in combination with Lepirudin.,Calcium
DB01783,The therapeutic efficacy of Pantothenic acid can be decreased when used in combination with Lepirudin.,Pantothenic acid
DB01942,The therapeutic efficacy of Formic acid can be decreased when used in combination with Lepirudin.,Formic acid
DB02261,The therapeutic efficacy of Platelet Activating Factor can be decreased when used in combination with Lepirudin.,Platelet Activating Factor
DB06724,The therapeutic efficacy of Calcium carbonate can be decreased when used in combination with Lepirudin.,Calcium carbonate
DB09109,The therapeutic efficacy of Turoctocog alfa can be decreased when used in combination with Lepirudin.,Turoctocog alfa
DB09222,The therapeutic efficacy of Fibrinogen human can be decreased when used in combination with Lepirudin.,Fibrinogen human
DB09310,The therapeutic efficacy of Catridecacog can be decreased when used in combination with Lepirudin.,Catridecacog
DB09329,"The therapeutic efficacy of Antihemophilic Factor (Recombinant), PEGylated can be decreased when used in combination with Lepirudin.","Antihemophilic Factor (Recombinant), PEGylated"
DB11093,The therapeutic efficacy of Calcium citrate can be decreased when used in combination with Lepirudin.,Calcium citrate
DB11126,The therapeutic efficacy of Calcium gluconate can be decreased when used in combination with Lepirudin.,Calcium gluconate
DB11168,The therapeutic efficacy of Calcium threonate can be decreased when used in combination with Lepirudin.,Calcium threonate
DB11311,The therapeutic efficacy of Prothrombin can be decreased when used in combination with Lepirudin.,Prothrombin
DB11330,The therapeutic efficacy of Factor IX Complex (Human) can be decreased when used in combination with Lepirudin.,Factor IX Complex (Human)
DB11348,The therapeutic efficacy of Calcium Phosphate can be decreased when used in combination with Lepirudin.,Calcium Phosphate
DB11606,The therapeutic efficacy of Susoctocog alfa can be decreased when used in combination with Lepirudin.,Susoctocog alfa
DB11608,The therapeutic efficacy of Eftrenonacog alfa can be decreased when used in combination with Lepirudin.,Eftrenonacog alfa
DB11668,The therapeutic efficacy of Rusalatide acetate can be decreased when used in combination with Lepirudin.,Rusalatide acetate
DB12409,The therapeutic efficacy of Vatreptacog alfa can be decreased when used in combination with Lepirudin.,Vatreptacog alfa
DB12909,The therapeutic efficacy of Factor XIII (human) can be decreased when used in combination with Lepirudin.,Factor XIII (human)
DB13133,The therapeutic efficacy of Von Willebrand Factor Human can be decreased when used in combination with Lepirudin.,Von Willebrand Factor Human
DB13148,The therapeutic efficacy of Coagulation factor X human can be decreased when used in combination with Lepirudin.,Coagulation factor X human
DB13150,The therapeutic efficacy of Coagulation factor VII human can be decreased when used in combination with Lepirudin.,Coagulation factor VII human
DB13151,The therapeutic efficacy of Anti-inhibitor coagulant complex can be decreased when used in combination with Lepirudin.,Anti-inhibitor coagulant complex
DB13152,The therapeutic efficacy of Coagulation Factor IX Human can be decreased when used in combination with Lepirudin.,Coagulation Factor IX Human
DB13192,The therapeutic efficacy of Antihemophilic factor human can be decreased when used in combination with Lepirudin.,Antihemophilic factor human
DB13197,The therapeutic efficacy of Kallidinogenase can be decreased when used in combination with Lepirudin.,Kallidinogenase
DB13201,The therapeutic efficacy of Trenonacog alfa can be decreased when used in combination with Lepirudin.,Trenonacog alfa
DB13884,The therapeutic efficacy of Albutrepenonacog alfa can be decreased when used in combination with Lepirudin.,Albutrepenonacog alfa
DB13923,The therapeutic efficacy of Emicizumab can be decreased when used in combination with Lepirudin.,Emicizumab
DB13933,The therapeutic efficacy of Nonacog beta pegol can be decreased when used in combination with Lepirudin.,Nonacog beta pegol
DB13999,The therapeutic efficacy of Moroctocog alfa can be decreased when used in combination with Lepirudin.,Moroctocog alfa
DB14473,The therapeutic efficacy of Beroctocog alfa can be decreased when used in combination with Lepirudin.,Beroctocog alfa
DB14562,The therapeutic efficacy of Andexanet alfa can be decreased when used in combination with Lepirudin.,Andexanet alfa
DB14577,The therapeutic efficacy of Calcium cation can be decreased when used in combination with Lepirudin.,Calcium cation
DB14700,The therapeutic efficacy of Damoctocog alfa pegol can be decreased when used in combination with Lepirudin.,Damoctocog alfa pegol
DB14738,The therapeutic efficacy of Turoctocog alfa pegol can be decreased when used in combination with Lepirudin.,Turoctocog alfa pegol
DB00176,The risk or severity of hemorrhage can be increased when Fluvoxamine is combined with Lepirudin.,Fluvoxamine
DB00215,The risk or severity of hemorrhage can be increased when Citalopram is combined with Lepirudin.,Citalopram
DB00472,The risk or severity of hemorrhage can be increased when Fluoxetine is combined with Lepirudin.,Fluoxetine
DB00715,The risk or severity of hemorrhage can be increased when Paroxetine is combined with Lepirudin.,Paroxetine
DB01149,The risk or severity of hemorrhage can be increased when Nefazodone is combined with Lepirudin.,Nefazodone
DB04832,The risk or severity of hemorrhage can be increased when Zimelidine is combined with Lepirudin.,Zimelidine
DB04884,The risk or severity of hemorrhage can be increased when Dapoxetine is combined with Lepirudin.,Dapoxetine
DB06731,The risk or severity of hemorrhage can be increased when Seproxetine is combined with Lepirudin.,Seproxetine
DB08953,The risk or severity of hemorrhage can be increased when Indalpine is combined with Lepirudin.,Indalpine
DB12693,The risk or severity of hemorrhage can be increased when Ritanserin is combined with Lepirudin.,Ritanserin
DB13233,The risk or severity of hemorrhage can be increased when Alaproclate is combined with Lepirudin.,Alaproclate
DB00476,The risk or severity of hemorrhage can be increased when Duloxetine is combined with Lepirudin.,Duloxetine
DB01105,The risk or severity of hemorrhage can be increased when Sibutramine is combined with Lepirudin.,Sibutramine
DB04896,The risk or severity of hemorrhage can be increased when Milnacipran is combined with Lepirudin.,Milnacipran
DB06700,The risk or severity of hemorrhage can be increased when Desvenlafaxine is combined with Lepirudin.,Desvenlafaxine
DB08918,The risk or severity of hemorrhage can be increased when Levomilnacipran is combined with Lepirudin.,Levomilnacipran
DB00285,Venlafaxine may increase the antiplatelet activities of Lepirudin.,Venlafaxine
DB00182,The risk or severity of bleeding and hemorrhage can be increased when Amphetamine is combined with Lepirudin.,Amphetamine
DB00601,The risk or severity of bleeding and hemorrhage can be increased when Linezolid is combined with Lepirudin.,Linezolid
DB00614,The risk or severity of bleeding and hemorrhage can be increased when Furazolidone is combined with Lepirudin.,Furazolidone
DB00721,The risk or severity of bleeding and hemorrhage can be increased when Procaine is combined with Lepirudin.,Procaine
DB00752,The risk or severity of bleeding and hemorrhage can be increased when Tranylcypromine is combined with Lepirudin.,Tranylcypromine
DB00780,The risk or severity of bleeding and hemorrhage can be increased when Phenelzine is combined with Lepirudin.,Phenelzine
DB00805,The risk or severity of bleeding and hemorrhage can be increased when Minaprine is combined with Lepirudin.,Minaprine
DB01037,The risk or severity of bleeding and hemorrhage can be increased when Selegiline is combined with Lepirudin.,Selegiline
DB01168,The risk or severity of bleeding and hemorrhage can be increased when Procarbazine is combined with Lepirudin.,Procarbazine
DB01171,The risk or severity of bleeding and hemorrhage can be increased when Moclobemide is combined with Lepirudin.,Moclobemide
DB01247,The risk or severity of bleeding and hemorrhage can be increased when Isocarboxazid is combined with Lepirudin.,Isocarboxazid
DB01367,The risk or severity of bleeding and hemorrhage can be increased when Rasagiline is combined with Lepirudin.,Rasagiline
DB01626,The risk or severity of bleeding and hemorrhage can be increased when Pargyline is combined with Lepirudin.,Pargyline
DB04017,The risk or severity of bleeding and hemorrhage can be increased when Clorgiline is combined with Lepirudin.,Clorgiline
DB04818,The risk or severity of bleeding and hemorrhage can be increased when Iproniazid is combined with Lepirudin.,Iproniazid
DB04820,The risk or severity of bleeding and hemorrhage can be increased when Nialamide is combined with Lepirudin.,Nialamide
DB06654,The risk or severity of bleeding and hemorrhage can be increased when Safinamide is combined with Lepirudin.,Safinamide
DB08550,"The risk or severity of bleeding and hemorrhage can be increased when 7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline is combined with Lepirudin.","7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline"
DB09241,The risk or severity of bleeding and hemorrhage can be increased when Methylene blue is combined with Lepirudin.,Methylene blue
DB09243,The risk or severity of bleeding and hemorrhage can be increased when Hydracarbazine is combined with Lepirudin.,Hydracarbazine
DB09244,The risk or severity of bleeding and hemorrhage can be increased when Pirlindole is combined with Lepirudin.,Pirlindole
DB09245,The risk or severity of bleeding and hemorrhage can be increased when Toloxatone is combined with Lepirudin.,Toloxatone
DB09246,The risk or severity of bleeding and hemorrhage can be increased when Benmoxin is combined with Lepirudin.,Benmoxin
DB09248,The risk or severity of bleeding and hemorrhage can be increased when Mebanazine is combined with Lepirudin.,Mebanazine
DB09249,The risk or severity of bleeding and hemorrhage can be increased when Octamoxin is combined with Lepirudin.,Octamoxin
DB09250,The risk or severity of bleeding and hemorrhage can be increased when Pheniprazine is combined with Lepirudin.,Pheniprazine
DB09251,The risk or severity of bleeding and hemorrhage can be increased when Phenoxypropazine is combined with Lepirudin.,Phenoxypropazine
DB09252,The risk or severity of bleeding and hemorrhage can be increased when Pivhydrazine is combined with Lepirudin.,Pivhydrazine
DB09253,The risk or severity of bleeding and hemorrhage can be increased when Safrazine is combined with Lepirudin.,Safrazine
DB09254,The risk or severity of bleeding and hemorrhage can be increased when Caroxazone is combined with Lepirudin.,Caroxazone
DB13875,The risk or severity of bleeding and hemorrhage can be increased when Harmaline is combined with Lepirudin.,Harmaline
DB13876,The risk or severity of bleeding and hemorrhage can be increased when Brofaromine is combined with Lepirudin.,Brofaromine
DB00006,The risk or severity of bleeding can be increased when Bivalirudin is combined with Lepirudin.,Bivalirudin
DB00266,The risk or severity of bleeding can be increased when Dicoumarol is combined with Lepirudin.,Dicoumarol
DB00278,The risk or severity of bleeding can be increased when Argatroban is combined with Lepirudin.,Argatroban
DB00407,The risk or severity of bleeding can be increased when Ardeparin is combined with Lepirudin.,Ardeparin
DB00498,The risk or severity of bleeding can be increased when Phenindione is combined with Lepirudin.,Phenindione
DB00569,The risk or severity of bleeding can be increased when Fondaparinux is combined with Lepirudin.,Fondaparinux
DB00682,The risk or severity of bleeding can be increased when Warfarin is combined with Lepirudin.,Warfarin
DB00946,The risk or severity of bleeding can be increased when Phenprocoumon is combined with Lepirudin.,Phenprocoumon
DB00974,The risk or severity of bleeding can be increased when Edetic acid is combined with Lepirudin.,Edetic acid
DB01109,The risk or severity of bleeding can be increased when Heparin is combined with Lepirudin.,Heparin
DB01225,The risk or severity of bleeding can be increased when Enoxaparin is combined with Lepirudin.,Enoxaparin
DB01418,The risk or severity of bleeding can be increased when Acenocoumarol is combined with Lepirudin.,Acenocoumarol
DB04898,The risk or severity of bleeding can be increased when Ximelagatran is combined with Lepirudin.,Ximelagatran
DB05099,The risk or severity of bleeding can be increased when Ancrod is combined with Lepirudin.,Ancrod
DB06271,The risk or severity of bleeding can be increased when Sulodexide is combined with Lepirudin.,Sulodexide
DB06406,The risk or severity of bleeding can be increased when Idraparinux is combined with Lepirudin.,Idraparinux
DB06635,The risk or severity of bleeding can be increased when Otamixaban is combined with Lepirudin.,Otamixaban
DB06754,The risk or severity of bleeding can be increased when Danaparoid is combined with Lepirudin.,Danaparoid
DB06779,The risk or severity of bleeding can be increased when Dalteparin is combined with Lepirudin.,Dalteparin
DB07767,The risk or severity of bleeding can be increased when Ferulic acid is combined with Lepirudin.,Ferulic acid
DB08794,The risk or severity of bleeding can be increased when Ethyl biscoumacetate is combined with Lepirudin.,Ethyl biscoumacetate
DB08813,The risk or severity of bleeding can be increased when Nadroparin is combined with Lepirudin.,Nadroparin
DB09255,The risk or severity of bleeding can be increased when Dextran is combined with Lepirudin.,Dextran
DB09259,The risk or severity of bleeding can be increased when Reviparin is combined with Lepirudin.,Reviparin
DB09261,The risk or severity of bleeding can be increased when Certoparin is combined with Lepirudin.,Certoparin
DB11095,The risk or severity of bleeding can be increased when Desirudin is combined with Lepirudin.,Desirudin
DB11268,The risk or severity of bleeding can be increased when Protocatechualdehyde is combined with Lepirudin.,Protocatechualdehyde
DB11312,The risk or severity of bleeding can be increased when Protein C is combined with Lepirudin.,Protein C
DB11598,The risk or severity of bleeding can be increased when Antithrombin III human is combined with Lepirudin.,Antithrombin III human
DB11984,The risk or severity of bleeding can be increased when Letaxaban is combined with Lepirudin.,Letaxaban
DB12289,The risk or severity of bleeding can be increased when Darexaban is combined with Lepirudin.,Darexaban
DB12598,The risk or severity of bleeding can be increased when Nafamostat is combined with Lepirudin.,Nafamostat
DB12831,The risk or severity of bleeding can be increased when Gabexate is combined with Lepirudin.,Gabexate
DB13124,The risk or severity of bleeding can be increased when Troxerutin is combined with Lepirudin.,Troxerutin
DB13136,The risk or severity of bleeding can be increased when Fluindione is combined with Lepirudin.,Fluindione
DB13149,The risk or severity of bleeding can be increased when Protein S human is combined with Lepirudin.,Protein S human
DB13616,The risk or severity of bleeding can be increased when Melagatran is combined with Lepirudin.,Melagatran
DB09125,The risk or severity of bleeding can be increased when Potassium citrate is combined with Lepirudin.,Potassium citrate
DB09154,The risk or severity of bleeding can be increased when Sodium citrate is combined with Lepirudin.,Sodium citrate
DB00031,The risk or severity of bleeding can be increased when Tenecteplase is combined with Lepirudin.,Tenecteplase
DB00055,The risk or severity of bleeding can be increased when Drotrecogin alfa is combined with Lepirudin.,Drotrecogin alfa
DB06822,The risk or severity of bleeding can be increased when Tinzaparin is combined with Lepirudin.,Tinzaparin
DB13199,The risk or severity of bleeding can be increased when Brinase is combined with Lepirudin.,Brinase
DB13646,The risk or severity of bleeding can be increased when Saruplase is combined with Lepirudin.,Saruplase
DB00086,The risk or severity of bleeding can be increased when Streptokinase is combined with Lepirudin.,Streptokinase
DB04925,The risk or severity of bleeding can be increased when Desmoteplase is combined with Lepirudin.,Desmoteplase
DB05254,The risk or severity of bleeding can be increased when Fibrinolysin is combined with Lepirudin.,Fibrinolysin
DB06543,The risk or severity of bleeding can be increased when Astaxanthin is combined with Lepirudin.,Astaxanthin
DB08994,The risk or severity of bleeding can be increased when Ditazole is combined with Lepirudin.,Ditazole
DB09258,The risk or severity of bleeding can be increased when Bemiparin is combined with Lepirudin.,Bemiparin
DB09260,The risk or severity of bleeding can be increased when Parnaparin is combined with Lepirudin.,Parnaparin
DB13275,The risk or severity of bleeding can be increased when Clorindione is combined with Lepirudin.,Clorindione
DB13347,The risk or severity of bleeding can be increased when Diphenadione is combined with Lepirudin.,Diphenadione
DB13451,The risk or severity of bleeding can be increased when Tioclomarol is combined with Lepirudin.,Tioclomarol
DB00009,The risk or severity of bleeding can be increased when Lepirudin is combined with Alteplase.,Alteplase
DB00015,The risk or severity of bleeding can be increased when Lepirudin is combined with Reteplase.,Reteplase
DB00029,The risk or severity of bleeding can be increased when Lepirudin is combined with Anistreplase.,Anistreplase
DB14094,The risk or severity of bleeding can be increased when Lepirudin is combined with Tocopherylquinone.,Tocopherylquinone
DB06679,The risk or severity of bleeding can be increased when Lepirudin is combined with Amediplase.,Amediplase
DB03410,The risk or severity of bleeding can be increased when Lepirudin is combined with 4-hydroxycoumarin.,4-hydroxycoumarin
DB08496,The risk or severity of bleeding can be increased when Lepirudin is combined with (R)-warfarin.,(R)-warfarin
DB14055,The risk or severity of bleeding can be increased when Lepirudin is combined with (S)-Warfarin.,(S)-Warfarin
DB12364,The risk or severity of bleeding can be increased when Lepirudin is combined with Betrixaban.,Betrixaban
DB14598,The risk or severity of bleeding can be increased when Lepirudin is combined with Edetate calcium disodium anhydrous.,Edetate calcium disodium anhydrous
DB11154,The risk or severity of bleeding can be increased when Lepirudin is combined with Zinc citrate.,Zinc citrate
DB11166,The risk or severity of bleeding can be increased when Lepirudin is combined with Antithrombin Alfa.,Antithrombin Alfa
DB04665,The risk or severity of bleeding can be increased when Lepirudin is combined with Coumarin.,Coumarin
DB14726,The risk or severity of bleeding can be increased when Lepirudin is combined with Dabigatran.,Dabigatran
DB06294,The risk or severity of bleeding can be increased when Lepirudin is combined with Semuloparin.,Semuloparin
DB12726,The risk or severity of bleeding can be increased when Lepirudin is combined with Monteplase.,Monteplase
DB00203,The risk or severity of hemorrhage can be increased when Lepirudin is combined with Sildenafil.,Sildenafil
DB00008,The risk or severity of bleeding can be increased when Lepirudin is combined with Peginterferon alfa-2a.,Peginterferon alfa-2a
DB00011,The risk or severity of bleeding can be increased when Lepirudin is combined with Interferon alfa-n1.,Interferon alfa-n1
DB00018,The risk or severity of bleeding can be increased when Lepirudin is combined with Interferon alfa-n3.,Interferon alfa-n3
DB00022,The risk or severity of bleeding can be increased when Lepirudin is combined with Peginterferon alfa-2b.,Peginterferon alfa-2b
DB00033,The risk or severity of bleeding can be increased when Lepirudin is combined with Interferon gamma-1b.,Interferon gamma-1b
DB00034,"The risk or severity of bleeding can be increased when Lepirudin is combined with Interferon alfa-2a, Recombinant.","Interferon alfa-2a, Recombinant"
DB00041,The risk or severity of bleeding can be increased when Lepirudin is combined with Aldesleukin.,Aldesleukin
DB00056,The risk or severity of bleeding can be increased when Lepirudin is combined with Gemtuzumab ozogamicin.,Gemtuzumab ozogamicin
DB00068,The risk or severity of bleeding can be increased when Lepirudin is combined with Interferon beta-1b.,Interferon beta-1b
DB00069,The risk or severity of bleeding can be increased when Lepirudin is combined with Interferon alfacon-1.,Interferon alfacon-1
DB00073,The risk or severity of bleeding can be increased when Lepirudin is combined with Rituximab.,Rituximab
DB00078,The risk or severity of bleeding can be increased when Lepirudin is combined with Ibritumomab tiuxetan.,Ibritumomab tiuxetan
DB00087,The risk or severity of bleeding can be increased when Lepirudin is combined with Alemtuzumab.,Alemtuzumab
DB00105,The risk or severity of bleeding can be increased when Lepirudin is combined with Interferon alfa-2b.,Interferon alfa-2b
DB00120,The risk or severity of bleeding can be increased when Lepirudin is combined with Phenylalanine.,Phenylalanine
DB00188,The risk or severity of bleeding can be increased when Lepirudin is combined with Bortezomib.,Bortezomib
DB00242,The risk or severity of bleeding can be increased when Lepirudin is combined with Cladribine.,Cladribine
DB00262,The risk or severity of bleeding can be increased when Lepirudin is combined with Carmustine.,Carmustine
DB00276,The risk or severity of bleeding can be increased when Lepirudin is combined with Amsacrine.,Amsacrine
DB00291,The risk or severity of bleeding can be increased when Lepirudin is combined with Chlorambucil.,Chlorambucil
DB00293,The risk or severity of bleeding can be increased when Lepirudin is combined with Raltitrexed.,Raltitrexed
DB00305,The risk or severity of bleeding can be increased when Lepirudin is combined with Mitomycin.,Mitomycin
DB00307,The risk or severity of bleeding can be increased when Lepirudin is combined with Bexarotene.,Bexarotene
DB00309,The risk or severity of bleeding can be increased when Lepirudin is combined with Vindesine.,Vindesine
DB00322,The risk or severity of bleeding can be increased when Lepirudin is combined with Floxuridine.,Floxuridine
DB00352,The risk or severity of bleeding can be increased when Lepirudin is combined with Tioguanine.,Tioguanine
DB00361,The risk or severity of bleeding can be increased when Lepirudin is combined with Vinorelbine.,Vinorelbine
DB00380,The risk or severity of bleeding can be increased when Lepirudin is combined with Dexrazoxane.,Dexrazoxane
DB00398,The risk or severity of bleeding can be increased when Lepirudin is combined with Sorafenib.,Sorafenib
DB00428,The risk or severity of bleeding can be increased when Lepirudin is combined with Streptozocin.,Streptozocin
DB00441,The risk or severity of bleeding can be increased when Lepirudin is combined with Gemcitabine.,Gemcitabine
DB00444,The risk or severity of bleeding can be increased when Lepirudin is combined with Teniposide.,Teniposide
DB00445,The risk or severity of bleeding can be increased when Lepirudin is combined with Epirubicin.,Epirubicin
DB00446,The risk or severity of bleeding can be increased when Lepirudin is combined with Chloramphenicol.,Chloramphenicol
DB00480,The risk or severity of bleeding can be increased when Lepirudin is combined with Lenalidomide.,Lenalidomide
DB00488,The risk or severity of bleeding can be increased when Lepirudin is combined with Altretamine.,Altretamine
DB00495,The risk or severity of bleeding can be increased when Lepirudin is combined with Zidovudine.,Zidovudine
DB00515,The risk or severity of bleeding can be increased when Lepirudin is combined with Cisplatin.,Cisplatin
DB00526,The risk or severity of bleeding can be increased when Lepirudin is combined with Oxaliplatin.,Oxaliplatin
DB00531,The risk or severity of bleeding can be increased when Lepirudin is combined with Cyclophosphamide.,Cyclophosphamide
DB00544,The risk or severity of bleeding can be increased when Lepirudin is combined with Fluorouracil.,Fluorouracil
DB00552,The risk or severity of bleeding can be increased when Lepirudin is combined with Pentostatin.,Pentostatin
DB00563,The risk or severity of bleeding can be increased when Lepirudin is combined with Methotrexate.,Methotrexate
DB00564,The risk or severity of bleeding can be increased when Lepirudin is combined with Carbamazepine.,Carbamazepine
DB00570,The risk or severity of bleeding can be increased when Lepirudin is combined with Vinblastine.,Vinblastine
DB00619,The risk or severity of bleeding can be increased when Lepirudin is combined with Imatinib.,Imatinib
DB00631,The risk or severity of bleeding can be increased when Lepirudin is combined with Clofarabine.,Clofarabine
DB00642,The risk or severity of bleeding can be increased when Lepirudin is combined with Pemetrexed.,Pemetrexed
DB00694,The risk or severity of bleeding can be increased when Lepirudin is combined with Daunorubicin.,Daunorubicin
DB00762,The risk or severity of bleeding can be increased when Lepirudin is combined with Irinotecan.,Irinotecan
DB00773,The risk or severity of bleeding can be increased when Lepirudin is combined with Etoposide.,Etoposide
DB00851,The risk or severity of bleeding can be increased when Lepirudin is combined with Dacarbazine.,Dacarbazine
DB00853,The risk or severity of bleeding can be increased when Lepirudin is combined with Temozolomide.,Temozolomide
DB00859,The risk or severity of bleeding can be increased when Lepirudin is combined with Penicillamine.,Penicillamine
DB00864,The risk or severity of bleeding can be increased when Lepirudin is combined with Tacrolimus.,Tacrolimus
DB00877,The risk or severity of bleeding can be increased when Lepirudin is combined with Sirolimus.,Sirolimus
DB00888,The risk or severity of bleeding can be increased when Lepirudin is combined with Mechlorethamine.,Mechlorethamine
DB00928,The risk or severity of bleeding can be increased when Lepirudin is combined with Azacitidine.,Azacitidine
DB00958,The risk or severity of bleeding can be increased when Lepirudin is combined with Carboplatin.,Carboplatin
DB00970,The risk or severity of bleeding can be increased when Lepirudin is combined with Dactinomycin.,Dactinomycin
DB00987,The risk or severity of bleeding can be increased when Lepirudin is combined with Cytarabine.,Cytarabine
DB00997,The risk or severity of bleeding can be increased when Lepirudin is combined with Doxorubicin.,Doxorubicin
DB01005,The risk or severity of bleeding can be increased when Lepirudin is combined with Hydroxyurea.,Hydroxyurea
DB01008,The risk or severity of bleeding can be increased when Lepirudin is combined with Busulfan.,Busulfan
DB01030,The risk or severity of bleeding can be increased when Lepirudin is combined with Topotecan.,Topotecan
DB01033,The risk or severity of bleeding can be increased when Lepirudin is combined with Mercaptopurine.,Mercaptopurine
DB01041,The risk or severity of bleeding can be increased when Lepirudin is combined with Thalidomide.,Thalidomide
DB01042,The risk or severity of bleeding can be increased when Lepirudin is combined with Melphalan.,Melphalan
DB01073,The risk or severity of bleeding can be increased when Lepirudin is combined with Fludarabine.,Fludarabine
DB01099,The risk or severity of bleeding can be increased when Lepirudin is combined with Flucytosine.,Flucytosine
DB01101,The risk or severity of bleeding can be increased when Lepirudin is combined with Capecitabine.,Capecitabine
DB01169,The risk or severity of bleeding can be increased when Lepirudin is combined with Arsenic trioxide.,Arsenic trioxide
DB01177,The risk or severity of bleeding can be increased when Lepirudin is combined with Idarubicin.,Idarubicin
DB01204,The risk or severity of bleeding can be increased when Lepirudin is combined with Mitoxantrone.,Mitoxantrone
DB01206,The risk or severity of bleeding can be increased when Lepirudin is combined with Lomustine.,Lomustine
DB01229,The risk or severity of bleeding can be increased when Lepirudin is combined with Paclitaxel.,Paclitaxel
DB01248,The risk or severity of bleeding can be increased when Lepirudin is combined with Docetaxel.,Docetaxel
DB01262,The risk or severity of bleeding can be increased when Lepirudin is combined with Decitabine.,Decitabine
DB01280,The risk or severity of bleeding can be increased when Lepirudin is combined with Nelarabine.,Nelarabine
DB01590,The risk or severity of bleeding can be increased when Lepirudin is combined with Everolimus.,Everolimus
DB02546,The risk or severity of bleeding can be increased when Lepirudin is combined with Vorinostat.,Vorinostat
DB04572,The risk or severity of bleeding can be increased when Lepirudin is combined with Thiotepa.,Thiotepa
DB04845,The risk or severity of bleeding can be increased when Lepirudin is combined with Ixabepilone.,Ixabepilone
DB04868,The risk or severity of bleeding can be increased when Lepirudin is combined with Nilotinib.,Nilotinib
DB05015,The risk or severity of bleeding can be increased when Lepirudin is combined with Belinostat.,Belinostat
DB05109,The risk or severity of bleeding can be increased when Lepirudin is combined with Trabectedin.,Trabectedin
DB05258,The risk or severity of bleeding can be increased when Lepirudin is combined with Interferon alfa.,Interferon alfa
DB05472,The risk or severity of bleeding can be increased when Lepirudin is combined with omega interferon.,omega interferon
DB05773,The risk or severity of bleeding can be increased when Lepirudin is combined with Trastuzumab emtansine.,Trastuzumab emtansine
DB06287,The risk or severity of bleeding can be increased when Lepirudin is combined with Temsirolimus.,Temsirolimus
DB06616,The risk or severity of bleeding can be increased when Lepirudin is combined with Bosutinib.,Bosutinib
DB06769,The risk or severity of bleeding can be increased when Lepirudin is combined with Bendamustine.,Bendamustine
DB06772,The risk or severity of bleeding can be increased when Lepirudin is combined with Cabazitaxel.,Cabazitaxel
DB08871,The risk or severity of bleeding can be increased when Lepirudin is combined with Eribulin.,Eribulin
DB08877,The risk or severity of bleeding can be increased when Lepirudin is combined with Ruxolitinib.,Ruxolitinib
DB08889,The risk or severity of bleeding can be increased when Lepirudin is combined with Carfilzomib.,Carfilzomib
DB08895,The risk or severity of bleeding can be increased when Lepirudin is combined with Tofacitinib.,Tofacitinib
DB08901,The risk or severity of bleeding can be increased when Lepirudin is combined with Ponatinib.,Ponatinib
DB08910,The risk or severity of bleeding can be increased when Lepirudin is combined with Pomalidomide.,Pomalidomide
DB09042,The risk or severity of bleeding can be increased when Lepirudin is combined with Tedizolid phosphate.,Tedizolid phosphate
DB09052,The risk or severity of bleeding can be increased when Lepirudin is combined with Blinatumomab.,Blinatumomab
DB09073,The risk or severity of bleeding can be increased when Lepirudin is combined with Palbociclib.,Palbociclib
DB09074,The risk or severity of bleeding can be increased when Lepirudin is combined with Olaparib.,Olaparib
DB09077,The risk or severity of bleeding can be increased when Lepirudin is combined with Dinutuximab.,Dinutuximab
DB09122,The risk or severity of bleeding can be increased when Lepirudin is combined with Peginterferon beta-1a.,Peginterferon beta-1a
DB12814,The risk or severity of bleeding can be increased when Lepirudin is combined with Cepeginterferon alfa-2B.,Cepeginterferon alfa-2B
DB00229,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefotiam.,Cefotiam
DB00267,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefmenoxime.,Cefmenoxime
DB00274,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefmetazole.,Cefmetazole
DB00430,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefpiramide.,Cefpiramide
DB00438,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Ceftazidime.,Ceftazidime
DB00447,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Loracarbef.,Loracarbef
DB00456,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefalotin.,Cefalotin
DB00493,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefotaxime.,Cefotaxime
DB00535,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefdinir.,Cefdinir
DB00567,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cephalexin.,Cephalexin
DB00671,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefixime.,Cefixime
DB00689,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cephaloglycin.,Cephaloglycin
DB00833,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefaclor.,Cefaclor
DB00923,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Ceforanide.,Ceforanide
DB01066,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefditoren.,Cefditoren
DB01112,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefuroxime.,Cefuroxime
DB01139,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefapirin.,Cefapirin
DB01140,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefadroxil.,Cefadroxil
DB01150,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefprozil.,Cefprozil
DB01212,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Ceftriaxone.,Ceftriaxone
DB01326,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefamandole.,Cefamandole
DB01327,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefazolin.,Cefazolin
DB01328,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefonicid.,Cefonicid
DB01329,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefoperazone.,Cefoperazone
DB01330,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefotetan.,Cefotetan
DB01331,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefoxitin.,Cefoxitin
DB01332,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Ceftizoxime.,Ceftizoxime
DB01333,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefradine.,Cefradine
DB01413,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefepime.,Cefepime
DB01414,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefacetrile.,Cefacetrile
DB01415,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Ceftibuten.,Ceftibuten
DB01416,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefpodoxime.,Cefpodoxime
DB04570,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Latamoxef.,Latamoxef
DB04918,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Ceftobiprole.,Ceftobiprole
DB06590,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Ceftaroline fosamil.,Ceftaroline fosamil
DB09008,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefaloridine.,Cefaloridine
DB09050,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Ceftolozane.,Ceftolozane
DB09062,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefminox.,Cefminox
DB11367,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefroxadine.,Cefroxadine
DB11935,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Flomoxef.,Flomoxef
DB13266,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefatrizine.,Cefatrizine
DB13461,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefcapene.,Cefcapene
DB13470,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefodizime.,Cefodizime
DB13499,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefsulodin.,Cefsulodin
DB13504,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefetamet.,Cefetamet
DB13638,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefbuperazone.,Cefbuperazone
DB13667,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefozopran.,Cefozopran
DB13682,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefpirome.,Cefpirome
DB13778,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefazedone.,Cefazedone
DB13821,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Ceftezole.,Ceftezole
DB14725,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefamandole nafate.,Cefamandole nafate
DB00254,The risk or severity of bleeding can be increased when Doxycycline is combined with Lepirudin.,Doxycycline
DB00207,The risk or severity of adverse effects can be increased when Azithromycin is combined with Lepirudin.,Azithromycin
DB09539,The risk or severity of bleeding can be increased when Omega-3-acid ethyl esters is combined with Lepirudin.,Omega-3-acid ethyl esters
DB00945,Acetylsalicylic acid may increase the anticoagulant activities of Lepirudin.,Acetylsalicylic acid
DB01606,The risk or severity of bleeding can be increased when Tazobactam is combined with Lepirudin.,Tazobactam
DB00199,The risk or severity of bleeding can be increased when Erythromycin is combined with Lepirudin.,Erythromycin
DB00656,The risk or severity of bleeding can be increased when Trazodone is combined with Lepirudin.,Trazodone
DB00620,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Triamcinolone.,Triamcinolone
DB09079,The risk or severity of bleeding can be increased when Lepirudin is combined with Nintedanib.,Nintedanib
DB01175,The risk or severity of bleeding can be increased when Escitalopram is combined with Lepirudin.,Escitalopram
DB01104,The risk or severity of bleeding can be increased when Sertraline is combined with Lepirudin.,Sertraline
DB00232,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Methyclothiazide.,Methyclothiazide
DB00436,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Bendroflumethiazide.,Bendroflumethiazide
DB00562,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Benzthiazide.,Benzthiazide
DB00606,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cyclothiazide.,Cyclothiazide
DB00774,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Hydroflumethiazide.,Hydroflumethiazide
DB00880,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Chlorothiazide.,Chlorothiazide
DB00999,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Hydrochlorothiazide.,Hydrochlorothiazide
DB01021,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Trichlormethiazide.,Trichlormethiazide
DB01324,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Polythiazide.,Polythiazide
DB13430,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Mebutizide.,Mebutizide
DB13532,The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cyclopenthiazide.,Cyclopenthiazide
DB00012,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Cetuximab.,Darbepoetin alfa
DB00016,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Cetuximab.,Erythropoietin
DB08894,The risk or severity of Thrombosis can be increased when Peginesatide is combined with Cetuximab.,Peginesatide
DB09107,The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Cetuximab.,Methoxy polyethylene glycol-epoetin beta
DB00255,Diethylstilbestrol may increase the thrombogenic activities of Cetuximab.,Diethylstilbestrol
DB00269,Chlorotrianisene may increase the thrombogenic activities of Cetuximab.,Chlorotrianisene
DB00286,Conjugated estrogens may increase the thrombogenic activities of Cetuximab.,Conjugated estrogens
DB00655,Estrone may increase the thrombogenic activities of Cetuximab.,Estrone
DB00783,Estradiol may increase the thrombogenic activities of Cetuximab.,Estradiol
DB00890,Dienestrol may increase the thrombogenic activities of Cetuximab.,Dienestrol
DB00977,Ethinylestradiol may increase the thrombogenic activities of Cetuximab.,Ethinylestradiol
DB01357,Mestranol may increase the thrombogenic activities of Cetuximab.,Mestranol
DB04573,Estriol may increase the thrombogenic activities of Cetuximab.,Estriol
DB04574,Estrone sulfate may increase the thrombogenic activities of Cetuximab.,Estrone sulfate
DB04575,Quinestrol may increase the thrombogenic activities of Cetuximab.,Quinestrol
DB07931,Hexestrol may increase the thrombogenic activities of Cetuximab.,Hexestrol
DB09070,Tibolone may increase the thrombogenic activities of Cetuximab.,Tibolone
DB09317,"Synthetic Conjugated Estrogens, A may increase the thrombogenic activities of Cetuximab.","Synthetic Conjugated Estrogens, A"
DB09318,"Synthetic Conjugated Estrogens, B may increase the thrombogenic activities of Cetuximab.","Synthetic Conjugated Estrogens, B"
DB09369,Polyestradiol phosphate may increase the thrombogenic activities of Cetuximab.,Polyestradiol phosphate
DB09381,Esterified estrogens may increase the thrombogenic activities of Cetuximab.,Esterified estrogens
DB11478,Zeranol may increase the thrombogenic activities of Cetuximab.,Zeranol
DB11674,Equol may increase the thrombogenic activities of Cetuximab.,Equol
DB12487,Promestriene may increase the thrombogenic activities of Cetuximab.,Promestriene
DB13143,Methallenestril may increase the thrombogenic activities of Cetuximab.,Methallenestril
DB13386,Epimestrol may increase the thrombogenic activities of Cetuximab.,Epimestrol
DB13418,Moxestrol may increase the thrombogenic activities of Cetuximab.,Moxestrol
DB13952,Estradiol acetate may increase the thrombogenic activities of Cetuximab.,Estradiol acetate
DB13953,Estradiol benzoate may increase the thrombogenic activities of Cetuximab.,Estradiol benzoate
DB13954,Estradiol cypionate may increase the thrombogenic activities of Cetuximab.,Estradiol cypionate
DB13956,Estradiol valerate may increase the thrombogenic activities of Cetuximab.,Estradiol valerate
DB15334,Biochanin A may increase the thrombogenic activities of Cetuximab.,Biochanin A
DB15335,Formononetin may increase the thrombogenic activities of Cetuximab.,Formononetin
DB00028,The risk or severity of adverse effects can be increased when Cetuximab is combined with Human immunoglobulin G.,Human immunoglobulin G
DB00043,The risk or severity of adverse effects can be increased when Cetuximab is combined with Omalizumab.,Omalizumab
DB00051,The risk or severity of adverse effects can be increased when Cetuximab is combined with Adalimumab.,Adalimumab
DB00054,The risk or severity of adverse effects can be increased when Cetuximab is combined with Abciximab.,Abciximab
DB00056,The risk or severity of adverse effects can be increased when Cetuximab is combined with Gemtuzumab ozogamicin.,Gemtuzumab ozogamicin
DB00057,The risk or severity of adverse effects can be increased when Cetuximab is combined with Indium In-111 satumomab pendetide.,Indium In-111 satumomab pendetide
DB00065,The risk or severity of adverse effects can be increased when Cetuximab is combined with Infliximab.,Infliximab
DB00072,The risk or severity of adverse effects can be increased when Cetuximab is combined with Trastuzumab.,Trastuzumab
DB00073,The risk or severity of adverse effects can be increased when Cetuximab is combined with Rituximab.,Rituximab
DB00074,The risk or severity of adverse effects can be increased when Cetuximab is combined with Basiliximab.,Basiliximab
DB00075,The risk or severity of adverse effects can be increased when Cetuximab is combined with Muromonab.,Muromonab
DB00076,The risk or severity of adverse effects can be increased when Cetuximab is combined with Digoxin Immune Fab (Ovine).,Digoxin Immune Fab (Ovine)
DB00078,The risk or severity of adverse effects can be increased when Cetuximab is combined with Ibritumomab tiuxetan.,Ibritumomab tiuxetan
DB00081,The risk or severity of adverse effects can be increased when Cetuximab is combined with Tositumomab.,Tositumomab
DB00087,The risk or severity of adverse effects can be increased when Cetuximab is combined with Alemtuzumab.,Alemtuzumab
DB00089,The risk or severity of adverse effects can be increased when Cetuximab is combined with Capromab pendetide.,Capromab pendetide
DB00095,The risk or severity of adverse effects can be increased when Cetuximab is combined with Efalizumab.,Efalizumab
DB00098,The risk or severity of adverse effects can be increased when Cetuximab is combined with Antithymocyte immunoglobulin (rabbit).,Antithymocyte immunoglobulin (rabbit)
DB00108,The risk or severity of adverse effects can be increased when Cetuximab is combined with Natalizumab.,Natalizumab
DB00110,The risk or severity of adverse effects can be increased when Cetuximab is combined with Palivizumab.,Palivizumab
DB00111,The risk or severity of adverse effects can be increased when Cetuximab is combined with Daclizumab.,Daclizumab
DB00112,The risk or severity of adverse effects can be increased when Cetuximab is combined with Bevacizumab.,Bevacizumab
DB00113,The risk or severity of adverse effects can be increased when Cetuximab is combined with Technetium Tc-99m arcitumomab.,Technetium Tc-99m arcitumomab
DB01257,The risk or severity of adverse effects can be increased when Cetuximab is combined with Eculizumab.,Eculizumab
DB01269,The risk or severity of adverse effects can be increased when Cetuximab is combined with Panitumumab.,Panitumumab
DB01270,The risk or severity of adverse effects can be increased when Cetuximab is combined with Ranibizumab.,Ranibizumab
DB04901,The risk or severity of adverse effects can be increased when Cetuximab is combined with Galiximab.,Galiximab
DB04949,The risk or severity of adverse effects can be increased when Cetuximab is combined with Pexelizumab.,Pexelizumab
DB04956,The risk or severity of adverse effects can be increased when Cetuximab is combined with Afelimomab.,Afelimomab
DB04958,The risk or severity of adverse effects can be increased when Cetuximab is combined with Epratuzumab.,Epratuzumab
DB04962,The risk or severity of adverse effects can be increased when Cetuximab is combined with Bectumomab.,Bectumomab
DB04964,The risk or severity of adverse effects can be increased when Cetuximab is combined with Oregovomab.,Oregovomab
DB04988,The risk or severity of adverse effects can be increased when Cetuximab is combined with IGN311.,IGN311
DB05006,The risk or severity of adverse effects can be increased when Cetuximab is combined with Adecatumumab.,Adecatumumab
DB05097,The risk or severity of adverse effects can be increased when Cetuximab is combined with Labetuzumab.,Labetuzumab
DB05101,The risk or severity of adverse effects can be increased when Cetuximab is combined with Matuzumab.,Matuzumab
DB05111,The risk or severity of adverse effects can be increased when Cetuximab is combined with Fontolizumab.,Fontolizumab
DB05136,The risk or severity of adverse effects can be increased when Cetuximab is combined with Bavituximab.,Bavituximab
DB05139,The risk or severity of adverse effects can be increased when Cetuximab is combined with CR002.,CR002
DB05209,The risk or severity of adverse effects can be increased when Cetuximab is combined with Rozrolimupab.,Rozrolimupab
DB05304,The risk or severity of adverse effects can be increased when Cetuximab is combined with Girentuximab.,Girentuximab
DB05336,The risk or severity of adverse effects can be increased when Cetuximab is combined with Obiltoxaximab.,Obiltoxaximab
DB05405,The risk or severity of adverse effects can be increased when Cetuximab is combined with XTL-001.,XTL-001
DB05437,The risk or severity of adverse effects can be increased when Cetuximab is combined with NAV 1800.,NAV 1800
DB05459,The risk or severity of adverse effects can be increased when Cetuximab is combined with Briakinumab.,Briakinumab
DB05496,The risk or severity of adverse effects can be increased when Cetuximab is combined with Otelixizumab.,Otelixizumab
DB05545,The risk or severity of adverse effects can be increased when Cetuximab is combined with AMG 108.,AMG 108
DB05550,The risk or severity of adverse effects can be increased when Cetuximab is combined with Iratumumab.,Iratumumab
DB05555,The risk or severity of adverse effects can be increased when Cetuximab is combined with Enokizumab.,Enokizumab
DB05578,The risk or severity of adverse effects can be increased when Cetuximab is combined with Ramucirumab.,Ramucirumab
DB05595,The risk or severity of adverse effects can be increased when Cetuximab is combined with Farletuzumab.,Farletuzumab
DB05656,The risk or severity of adverse effects can be increased when Cetuximab is combined with Veltuzumab.,Veltuzumab
DB05679,The risk or severity of adverse effects can be increased when Cetuximab is combined with Ustekinumab.,Ustekinumab
DB05773,The risk or severity of adverse effects can be increased when Cetuximab is combined with Trastuzumab emtansine.,Trastuzumab emtansine
DB05793,The risk or severity of adverse effects can be increased when Cetuximab is combined with PRO-542.,PRO-542
DB05797,The risk or severity of adverse effects can be increased when Cetuximab is combined with TNX-901.,TNX-901
DB05889,The risk or severity of adverse effects can be increased when Cetuximab is combined with Inotuzumab ozogamicin.,Inotuzumab ozogamicin
DB05892,The risk or severity of adverse effects can be increased when Cetuximab is combined with RI 624.,RI 624
DB05915,The risk or severity of adverse effects can be increased when Cetuximab is combined with MYO-029.,MYO-029
DB05916,The risk or severity of adverse effects can be increased when Cetuximab is combined with CT-011.,CT-011
DB05941,The risk or severity of adverse effects can be increased when Cetuximab is combined with Leronlimab.,Leronlimab
DB05996,The risk or severity of adverse effects can be increased when Cetuximab is combined with Glembatumumab vedotin.,Glembatumumab vedotin
DB06043,The risk or severity of adverse effects can be increased when Cetuximab is combined with Olaratumab.,Olaratumab
DB06049,The risk or severity of adverse effects can be increased when Cetuximab is combined with IPH 2101.,IPH 2101
DB06050,The risk or severity of adverse effects can be increased when Cetuximab is combined with TB-402.,TB-402
DB06081,The risk or severity of adverse effects can be increased when Cetuximab is combined with Caplacizumab.,Caplacizumab
DB06101,The risk or severity of adverse effects can be increased when Cetuximab is combined with IMC-1C11.,IMC-1C11
DB06116,The risk or severity of adverse effects can be increased when Cetuximab is combined with Eldelumab.,Eldelumab
DB06162,The risk or severity of adverse effects can be increased when Cetuximab is combined with Lumiliximab.,Lumiliximab
DB06168,The risk or severity of adverse effects can be increased when Cetuximab is combined with Canakinumab.,Canakinumab
DB06186,The risk or severity of adverse effects can be increased when Cetuximab is combined with Ipilimumab.,Ipilimumab
DB06192,The risk or severity of adverse effects can be increased when Cetuximab is combined with Nimotuzumab.,Nimotuzumab
DB06241,The risk or severity of adverse effects can be increased when Cetuximab is combined with Clenoliximab.,Clenoliximab
DB06273,The risk or severity of adverse effects can be increased when Cetuximab is combined with Tocilizumab.,Tocilizumab
DB06304,The risk or severity of adverse effects can be increased when Cetuximab is combined with BIIB015.,BIIB015
DB06305,The risk or severity of adverse effects can be increased when Cetuximab is combined with Sonepcizumab.,Sonepcizumab
DB06310,The risk or severity of adverse effects can be increased when Cetuximab is combined with Motavizumab.,Motavizumab
DB06317,The risk or severity of adverse effects can be increased when Cetuximab is combined with Elotuzumab.,Elotuzumab
DB06318,The risk or severity of adverse effects can be increased when Cetuximab is combined with AVE9633.,AVE9633
DB06322,The risk or severity of adverse effects can be increased when Cetuximab is combined with Carotuximab.,Carotuximab
DB06324,The risk or severity of adverse effects can be increased when Cetuximab is combined with XmAb 2513.,XmAb 2513
DB06342,The risk or severity of adverse effects can be increased when Cetuximab is combined with Coltuximab ravtansine.,Coltuximab ravtansine
DB06343,The risk or severity of adverse effects can be increased when Cetuximab is combined with Teprotumumab.,Teprotumumab
DB06360,The risk or severity of adverse effects can be increased when Cetuximab is combined with Lucatumumab.,Lucatumumab
DB06366,The risk or severity of adverse effects can be increased when Cetuximab is combined with Pertuzumab.,Pertuzumab
DB06371,The risk or severity of adverse effects can be increased when Cetuximab is combined with Siplizumab.,Siplizumab
DB06467,The risk or severity of adverse effects can be increased when Cetuximab is combined with Apolizumab.,Apolizumab
DB06474,The risk or severity of adverse effects can be increased when Cetuximab is combined with Sibrotuzumab.,Sibrotuzumab
DB06550,The risk or severity of adverse effects can be increased when Cetuximab is combined with Bivatuzumab.,Bivatuzumab
DB06557,The risk or severity of adverse effects can be increased when Cetuximab is combined with Lerdelimumab.,Lerdelimumab
DB06599,The risk or severity of adverse effects can be increased when Cetuximab is combined with Lexatumumab.,Lexatumumab
DB06602,The risk or severity of adverse effects can be increased when Cetuximab is combined with Reslizumab.,Reslizumab
DB06606,The risk or severity of adverse effects can be increased when Cetuximab is combined with Teplizumab.,Teplizumab
DB06607,The risk or severity of adverse effects can be increased when Cetuximab is combined with Catumaxomab.,Catumaxomab
DB06612,The risk or severity of adverse effects can be increased when Cetuximab is combined with Mepolizumab.,Mepolizumab
DB06643,The risk or severity of adverse effects can be increased when Cetuximab is combined with Denosumab.,Denosumab
DB06647,The risk or severity of adverse effects can be increased when Cetuximab is combined with Volociximab.,Volociximab
DB06650,The risk or severity of adverse effects can be increased when Cetuximab is combined with Ofatumumab.,Ofatumumab
DB06674,The risk or severity of adverse effects can be increased when Cetuximab is combined with Golimumab.,Golimumab
DB08870,The risk or severity of adverse effects can be increased when Cetuximab is combined with Brentuximab vedotin.,Brentuximab vedotin
DB08879,The risk or severity of adverse effects can be increased when Cetuximab is combined with Belimumab.,Belimumab
DB08902,The risk or severity of adverse effects can be increased when Cetuximab is combined with Raxibacumab.,Raxibacumab
DB08904,The risk or severity of adverse effects can be increased when Cetuximab is combined with Certolizumab pegol.,Certolizumab pegol
DB08935,The risk or severity of adverse effects can be increased when Cetuximab is combined with Obinutuzumab.,Obinutuzumab
DB09029,The risk or severity of adverse effects can be increased when Cetuximab is combined with Secukinumab.,Secukinumab
DB09033,The risk or severity of adverse effects can be increased when Cetuximab is combined with Vedolizumab.,Vedolizumab
DB09035,The risk or severity of adverse effects can be increased when Cetuximab is combined with Nivolumab.,Nivolumab
DB09036,The risk or severity of adverse effects can be increased when Cetuximab is combined with Siltuximab.,Siltuximab
DB09037,The risk or severity of adverse effects can be increased when Cetuximab is combined with Pembrolizumab.,Pembrolizumab
DB09045,The risk or severity of adverse effects can be increased when Cetuximab is combined with Dulaglutide.,Dulaglutide
DB09052,The risk or severity of adverse effects can be increased when Cetuximab is combined with Blinatumomab.,Blinatumomab
DB09057,The risk or severity of adverse effects can be increased when Cetuximab is combined with Anthrax immune globulin human.,Anthrax immune globulin human
DB09077,The risk or severity of adverse effects can be increased when Cetuximab is combined with Dinutuximab.,Dinutuximab
DB09105,The risk or severity of adverse effects can be increased when Cetuximab is combined with Asfotase alfa.,Asfotase alfa
DB09264,The risk or severity of adverse effects can be increased when Cetuximab is combined with Idarucizumab.,Idarucizumab
DB09302,The risk or severity of adverse effects can be increased when Cetuximab is combined with Alirocumab.,Alirocumab
DB09303,The risk or severity of adverse effects can be increased when Cetuximab is combined with Evolocumab.,Evolocumab
DB09312,The risk or severity of adverse effects can be increased when Cetuximab is combined with Antilymphocyte immunoglobulin (horse).,Antilymphocyte immunoglobulin (horse)
DB09331,The risk or severity of adverse effects can be increased when Cetuximab is combined with Daratumumab.,Daratumumab
DB09559,The risk or severity of adverse effects can be increased when Cetuximab is combined with Necitumumab.,Necitumumab
DB11569,The risk or severity of adverse effects can be increased when Cetuximab is combined with Ixekizumab.,Ixekizumab
DB11580,The risk or severity of adverse effects can be increased when Cetuximab is combined with Ravulizumab.,Ravulizumab
DB11595,The risk or severity of adverse effects can be increased when Cetuximab is combined with Atezolizumab.,Atezolizumab
DB11604,The risk or severity of adverse effects can be increased when Cetuximab is combined with Tetanus Immune Globulin.,Tetanus Immune Globulin
DB11608,The risk or severity of adverse effects can be increased when Cetuximab is combined with Eftrenonacog alfa.,Eftrenonacog alfa
DB11621,The risk or severity of adverse effects can be increased when Cetuximab is combined with Human Varicella-Zoster Immune Globulin.,Human Varicella-Zoster Immune Globulin
DB11646,The risk or severity of adverse effects can be increased when Cetuximab is combined with Conatumumab.,Conatumumab
DB11657,The risk or severity of adverse effects can be increased when Cetuximab is combined with Tabalumab.,Tabalumab
DB11680,The risk or severity of adverse effects can be increased when Cetuximab is combined with Ficlatuzumab.,Ficlatuzumab
DB11685,The risk or severity of adverse effects can be increased when Cetuximab is combined with Figitumumab.,Figitumumab
DB11714,The risk or severity of adverse effects can be increased when Cetuximab is combined with Durvalumab.,Durvalumab
DB11715,The risk or severity of adverse effects can be increased when Cetuximab is combined with Bapineuzumab.,Bapineuzumab
DB11731,The risk or severity of adverse effects can be increased when Cetuximab is combined with Depatuxizumab mafodotin.,Depatuxizumab mafodotin
DB11746,The risk or severity of adverse effects can be increased when Cetuximab is combined with Onartuzumab.,Onartuzumab
DB11756,The risk or severity of adverse effects can be increased when Cetuximab is combined with Solanezumab.,Solanezumab
DB11767,The risk or severity of adverse effects can be increased when Cetuximab is combined with Sarilumab.,Sarilumab
DB11771,The risk or severity of adverse effects can be increased when Cetuximab is combined with Tremelimumab.,Tremelimumab
DB11776,The risk or severity of adverse effects can be increased when Cetuximab is combined with Brodalumab.,Brodalumab
DB11803,The risk or severity of adverse effects can be increased when Cetuximab is combined with Sirukumab.,Sirukumab
DB11826,The risk or severity of adverse effects can be increased when Cetuximab is combined with Lampalizumab.,Lampalizumab
DB11834,The risk or severity of adverse effects can be increased when Cetuximab is combined with Guselkumab.,Guselkumab
DB11840,The risk or severity of adverse effects can be increased when Cetuximab is combined with Dalotuzumab.,Dalotuzumab
DB11849,The risk or severity of adverse effects can be increased when Cetuximab is combined with Emibetuzumab.,Emibetuzumab
DB11850,The risk or severity of adverse effects can be increased when Cetuximab is combined with Ublituximab.,Ublituximab
DB11856,The risk or severity of adverse effects can be increased when Cetuximab is combined with Ligelizumab.,Ligelizumab
DB11857,The risk or severity of adverse effects can be increased when Cetuximab is combined with Seribantumab.,Seribantumab
DB11862,The risk or severity of adverse effects can be increased when Cetuximab is combined with Landogrozumab.,Landogrozumab
DB11866,The risk or severity of adverse effects can be increased when Cetuximab is combined with Romosozumab.,Romosozumab
DB11884,The risk or severity of adverse effects can be increased when Cetuximab is combined with Vadastuximab Talirine.,Vadastuximab Talirine
DB11914,The risk or severity of adverse effects can be increased when Cetuximab is combined with Lebrikizumab.,Lebrikizumab
DB11930,The risk or severity of adverse effects can be increased when Cetuximab is combined with Varlilumab.,Varlilumab
DB11945,The risk or severity of adverse effects can be increased when Cetuximab is combined with Avelumab.,Avelumab
DB11959,The risk or severity of adverse effects can be increased when Cetuximab is combined with Crenezumab.,Crenezumab
DB11972,The risk or severity of adverse effects can be increased when Cetuximab is combined with Rilotumumab.,Rilotumumab
DB11976,The risk or severity of adverse effects can be increased when Cetuximab is combined with Anifrolumab.,Anifrolumab
DB11988,The risk or severity of adverse effects can be increased when Cetuximab is combined with Ocrelizumab.,Ocrelizumab
DB12023,The risk or severity of adverse effects can be increased when Cetuximab is combined with Benralizumab.,Benralizumab
DB12034,The risk or severity of adverse effects can be increased when Cetuximab is combined with Gantenerumab.,Gantenerumab
DB12053,The risk or severity of adverse effects can be increased when Cetuximab is combined with Visilizumab.,Visilizumab
DB12077,The risk or severity of adverse effects can be increased when Cetuximab is combined with Urelumab.,Urelumab
DB12089,The risk or severity of adverse effects can be increased when Cetuximab is combined with Lorvotuzumab mertansine.,Lorvotuzumab mertansine
DB12090,The risk or severity of adverse effects can be increased when Cetuximab is combined with Patritumab.,Patritumab
DB12102,The risk or severity of adverse effects can be increased when Cetuximab is combined with Fulranumab.,Fulranumab
DB12104,The risk or severity of adverse effects can be increased when Cetuximab is combined with Tarextumab.,Tarextumab
DB12118,The risk or severity of adverse effects can be increased when Cetuximab is combined with Sotatercept.,Sotatercept
DB12119,The risk or severity of adverse effects can be increased when Cetuximab is combined with Gevokizumab.,Gevokizumab
DB12142,The risk or severity of adverse effects can be increased when Cetuximab is combined with Duligotuzumab.,Duligotuzumab
DB12152,The risk or severity of adverse effects can be increased when Cetuximab is combined with Simtuzumab.,Simtuzumab
DB12157,The risk or severity of adverse effects can be increased when Cetuximab is combined with Fasinumab.,Fasinumab
DB12159,The risk or severity of adverse effects can be increased when Cetuximab is combined with Dupilumab.,Dupilumab
DB12169,The risk or severity of adverse effects can be increased when Cetuximab is combined with Tralokinumab.,Tralokinumab
DB12189,The risk or severity of adverse effects can be increased when Cetuximab is combined with Etrolizumab.,Etrolizumab
DB12202,The risk or severity of adverse effects can be increased when Cetuximab is combined with Zalutumumab.,Zalutumumab
DB12205,The risk or severity of adverse effects can be increased when Cetuximab is combined with Ganitumab.,Ganitumab
DB12213,The risk or severity of adverse effects can be increased when Cetuximab is combined with Etaracizumab.,Etaracizumab
DB12240,The risk or severity of adverse effects can be increased when Cetuximab is combined with Polatuzumab vedotin.,Polatuzumab vedotin
DB12246,The risk or severity of adverse effects can be increased when Cetuximab is combined with Inclacumab.,Inclacumab
DB12250,The risk or severity of adverse effects can be increased when Cetuximab is combined with Cixutumumab.,Cixutumumab
DB12261,The risk or severity of adverse effects can be increased when Cetuximab is combined with Ascrinvacumab.,Ascrinvacumab
DB12274,The risk or severity of adverse effects can be increased when Cetuximab is combined with Aducanumab.,Aducanumab
DB12281,The risk or severity of adverse effects can be increased when Cetuximab is combined with Luspatercept.,Luspatercept
DB12296,The risk or severity of adverse effects can be increased when Cetuximab is combined with GS-5745.,GS-5745
DB12317,The risk or severity of adverse effects can be increased when Cetuximab is combined with Vanucizumab.,Vanucizumab
DB12331,The risk or severity of adverse effects can be increased when Cetuximab is combined with Labetuzumab govitecan.,Labetuzumab govitecan
DB12335,The risk or severity of adverse effects can be increased when Cetuximab is combined with Tanezumab.,Tanezumab
DB12342,The risk or severity of adverse effects can be increased when Cetuximab is combined with Ensituximab.,Ensituximab
DB12344,The risk or severity of adverse effects can be increased when Cetuximab is combined with Fezakinumab.,Fezakinumab
DB12363,The risk or severity of adverse effects can be increased when Cetuximab is combined with Dusigitumab.,Dusigitumab
DB12396,The risk or severity of adverse effects can be increased when Cetuximab is combined with Fresolimumab.,Fresolimumab
DB12413,The risk or severity of adverse effects can be increased when Cetuximab is combined with Indusatumab vedotin.,Indusatumab vedotin
DB12456,The risk or severity of adverse effects can be increased when Cetuximab is combined with Bococizumab.,Bococizumab
DB12489,The risk or severity of adverse effects can be increased when Cetuximab is combined with Mirvetuximab Soravtansine.,Mirvetuximab Soravtansine
DB12498,The risk or severity of adverse effects can be increased when Cetuximab is combined with Mogamulizumab.,Mogamulizumab
DB12520,The risk or severity of adverse effects can be increased when Cetuximab is combined with Plozalizumab.,Plozalizumab
DB12530,The risk or severity of adverse effects can be increased when Cetuximab is combined with Inebilizumab.,Inebilizumab
DB12534,The risk or severity of adverse effects can be increased when Cetuximab is combined with Mavrilimumab.,Mavrilimumab
DB12560,The risk or severity of adverse effects can be increased when Cetuximab is combined with Blosozumab.,Blosozumab
DB12584,The risk or severity of adverse effects can be increased when Cetuximab is combined with Bimagrumab.,Bimagrumab
DB12589,The risk or severity of adverse effects can be increased when Cetuximab is combined with Dacetuzumab.,Dacetuzumab
DB12609,The risk or severity of adverse effects can be increased when Cetuximab is combined with Tovetumab.,Tovetumab
DB12683,The risk or severity of adverse effects can be increased when Cetuximab is combined with Lumretuzumab.,Lumretuzumab
DB12698,The risk or severity of adverse effects can be increased when Cetuximab is combined with Ibalizumab.,Ibalizumab
DB12701,The risk or severity of adverse effects can be increased when Cetuximab is combined with Intetumumab.,Intetumumab
DB12718,The risk or severity of adverse effects can be increased when Cetuximab is combined with Carlumab.,Carlumab
DB12734,The risk or severity of adverse effects can be increased when Cetuximab is combined with Demcizumab.,Demcizumab
DB12773,The risk or severity of adverse effects can be increased when Cetuximab is combined with Sifalimumab.,Sifalimumab
DB12775,The risk or severity of adverse effects can be increased when Cetuximab is combined with Abituzumab.,Abituzumab
DB12797,The risk or severity of adverse effects can be increased when Cetuximab is combined with Ecromeximab.,Ecromeximab
DB12807,The risk or severity of adverse effects can be increased when Cetuximab is combined with Naptumomab Estafenatox.,Naptumomab Estafenatox
DB12815,The risk or severity of adverse effects can be increased when Cetuximab is combined with Crotedumab.,Crotedumab
DB12820,The risk or severity of adverse effects can be increased when Cetuximab is combined with Concizumab.,Concizumab
DB12826,The risk or severity of adverse effects can be increased when Cetuximab is combined with Depatuxizumab.,Depatuxizumab
DB12844,The risk or severity of adverse effects can be increased when Cetuximab is combined with Rontalizumab.,Rontalizumab
DB12845,The risk or severity of adverse effects can be increased when Cetuximab is combined with Amatuximab.,Amatuximab
DB12849,The risk or severity of adverse effects can be increased when Cetuximab is combined with Clazakizumab.,Clazakizumab
DB12891,The risk or severity of adverse effects can be increased when Cetuximab is combined with Ozanezumab.,Ozanezumab
DB12893,The risk or severity of adverse effects can be increased when Cetuximab is combined with Sacituzumab govitecan.,Sacituzumab govitecan
DB12917,The risk or severity of adverse effects can be increased when Cetuximab is combined with Bimekizumab.,Bimekizumab
DB12943,The risk or severity of adverse effects can be increased when Cetuximab is combined with Milatuzumab.,Milatuzumab
DB12976,The risk or severity of adverse effects can be increased when Cetuximab is combined with Robatumumab.,Robatumumab
DB13017,The risk or severity of adverse effects can be increased when Cetuximab is combined with Rovalpituzumab Tesirine.,Rovalpituzumab Tesirine
DB13037,The risk or severity of adverse effects can be increased when Cetuximab is combined with Namilumab.,Namilumab
DB13045,The risk or severity of adverse effects can be increased when Cetuximab is combined with Racotumomab.,Racotumomab
DB13073,The risk or severity of adverse effects can be increased when Cetuximab is combined with Tregalizumab.,Tregalizumab
DB13127,The risk or severity of adverse effects can be increased when Cetuximab is combined with Olokizumab.,Olokizumab
DB13140,The risk or severity of adverse effects can be increased when Cetuximab is combined with Bezlotoxumab.,Bezlotoxumab
DB13375,The risk or severity of adverse effects can be increased when Cetuximab is combined with Edrecolomab.,Edrecolomab
DB13535,The risk or severity of adverse effects can be increased when Cetuximab is combined with Nebacumab.,Nebacumab
DB13886,The risk or severity of adverse effects can be increased when Cetuximab is combined with Human cytomegalovirus immune globulin.,Human cytomegalovirus immune globulin
DB13923,The risk or severity of adverse effects can be increased when Cetuximab is combined with Emicizumab.,Emicizumab
DB13976,The risk or severity of adverse effects can be increased when Cetuximab is combined with Sulesomab.,Sulesomab
DB13979,The risk or severity of adverse effects can be increased when Cetuximab is combined with Besilesomab.,Besilesomab
DB14004,The risk or severity of adverse effects can be increased when Cetuximab is combined with Tildrakizumab.,Tildrakizumab
DB14012,The risk or severity of adverse effects can be increased when Cetuximab is combined with Burosumab.,Burosumab
DB14039,The risk or severity of adverse effects can be increased when Cetuximab is combined with Erenumab.,Erenumab
DB14040,The risk or severity of adverse effects can be increased when Cetuximab is combined with Eptinezumab.,Eptinezumab
DB14041,The risk or severity of adverse effects can be increased when Cetuximab is combined with Fremanezumab.,Fremanezumab
DB14042,The risk or severity of adverse effects can be increased when Cetuximab is combined with Galcanezumab.,Galcanezumab
DB14211,The risk or severity of adverse effects can be increased when Cetuximab is combined with Fanolesomab.,Fanolesomab
DB14580,The risk or severity of adverse effects can be increased when Cetuximab is combined with Lecanemab.,Lecanemab
DB14597,The risk or severity of adverse effects can be increased when Cetuximab is combined with Lanadelumab.,Lanadelumab
DB14707,The risk or severity of adverse effects can be increased when Cetuximab is combined with Cemiplimab.,Cemiplimab
DB14724,The risk or severity of adverse effects can be increased when Cetuximab is combined with Emapalumab.,Emapalumab
DB14762,The risk or severity of adverse effects can be increased when Cetuximab is combined with Risankizumab.,Risankizumab
DB14776,The risk or severity of adverse effects can be increased when Cetuximab is combined with Camrelizumab.,Camrelizumab
DB14778,The risk or severity of adverse effects can be increased when Cetuximab is combined with Setrusumab.,Setrusumab
DB14784,The risk or severity of adverse effects can be increased when Cetuximab is combined with Gancotamab.,Gancotamab
DB14809,The risk or severity of adverse effects can be increased when Cetuximab is combined with Anetumab ravtansine.,Anetumab ravtansine
DB14811,The risk or severity of adverse effects can be increased when Cetuximab is combined with Isatuximab.,Isatuximab
DB14824,The risk or severity of adverse effects can be increased when Cetuximab is combined with Icrucumab.,Icrucumab
DB14843,The risk or severity of adverse effects can be increased when Cetuximab is combined with Codrituzumab.,Codrituzumab
DB14864,The risk or severity of adverse effects can be increased when Cetuximab is combined with Brolucizumab.,Brolucizumab
DB14871,The risk or severity of adverse effects can be increased when Cetuximab is combined with Xentuzumab.,Xentuzumab
DB14877,The risk or severity of adverse effects can be increased when Cetuximab is combined with Lintuzumab.,Lintuzumab
DB14891,The risk or severity of adverse effects can be increased when Cetuximab is combined with Vobarilizumab.,Vobarilizumab
DB14897,The risk or severity of adverse effects can be increased when Cetuximab is combined with Parsatuzumab.,Parsatuzumab
DB14905,The risk or severity of adverse effects can be increased when Cetuximab is combined with Emactuzumab.,Emactuzumab
DB14907,The risk or severity of adverse effects can be increased when Cetuximab is combined with Bevacizumab zirconium Zr-89.,Bevacizumab zirconium Zr-89
DB14908,The risk or severity of adverse effects can be increased when Cetuximab is combined with Refanezumab.,Refanezumab
DB14919,The risk or severity of adverse effects can be increased when Cetuximab is combined with Rozanolixizumab.,Rozanolixizumab
DB14947,The risk or severity of adverse effects can be increased when Cetuximab is combined with Bermekimab.,Bermekimab
DB14952,The risk or severity of adverse effects can be increased when Cetuximab is combined with Pamrevlumab.,Pamrevlumab
DB14959,The risk or severity of adverse effects can be increased when Cetuximab is combined with Opicinumab.,Opicinumab
DB14962,The risk or severity of adverse effects can be increased when Cetuximab is combined with Trastuzumab deruxtecan.,Trastuzumab deruxtecan
DB14967,The risk or severity of adverse effects can be increased when Cetuximab is combined with Margetuximab.,Margetuximab
DB14988,The risk or severity of adverse effects can be increased when Cetuximab is combined with Dalantercept.,Dalantercept
DB14997,The risk or severity of adverse effects can be increased when Cetuximab is combined with Pateclizumab.,Pateclizumab
DB15014,The risk or severity of adverse effects can be increased when Cetuximab is combined with Gremubamab.,Gremubamab
DB15022,The risk or severity of adverse effects can be increased when Cetuximab is combined with Apomab.,Apomab
DB15044,The risk or severity of adverse effects can be increased when Cetuximab is combined with Tafasitamab.,Tafasitamab
DB15045,The risk or severity of adverse effects can be increased when Cetuximab is combined with Ipafricept.,Ipafricept
DB15076,The risk or severity of adverse effects can be increased when Cetuximab is combined with Abrilumab.,Abrilumab
DB15089,The risk or severity of adverse effects can be increased when Cetuximab is combined with Frovocimab.,Frovocimab
DB15090,The risk or severity of adverse effects can be increased when Cetuximab is combined with Tezepelumab.,Tezepelumab
DB15101,The risk or severity of adverse effects can be increased when Cetuximab is combined with Tigatuzumab.,Tigatuzumab
DB15104,The risk or severity of adverse effects can be increased when Cetuximab is combined with Telisotuzumab vedotin.,Telisotuzumab vedotin
DB15113,The risk or severity of adverse effects can be increased when Cetuximab is combined with Utomilumab.,Utomilumab
DB15118,The risk or severity of adverse effects can be increased when Cetuximab is combined with Zolbetuximab.,Zolbetuximab
DB15135,The risk or severity of adverse effects can be increased when Cetuximab is combined with Ponezumab.,Ponezumab
DB15160,The risk or severity of adverse effects can be increased when Cetuximab is combined with Asunercept.,Asunercept
DB15172,The risk or severity of adverse effects can be increased when Cetuximab is combined with Suvratoxumab.,Suvratoxumab
DB15225,The risk or severity of adverse effects can be increased when Cetuximab is combined with Mitazalimab.,Mitazalimab
DB15252,The risk or severity of adverse effects can be increased when Cetuximab is combined with Nemolizumab.,Nemolizumab
DB15253,The risk or severity of adverse effects can be increased when Cetuximab is combined with Bleselumab.,Bleselumab
DB15277,The risk or severity of adverse effects can be increased when Cetuximab is combined with Gedivumab.,Gedivumab
DB15336,The risk or severity of adverse effects can be increased when Cetuximab is combined with Valanafusp alfa.,Valanafusp alfa
DB15349,The risk or severity of adverse effects can be increased when Cetuximab is combined with Sofituzumab vedotin.,Sofituzumab vedotin
DB15354,The risk or severity of adverse effects can be increased when Cetuximab is combined with Evinacumab.,Evinacumab
DB15363,The risk or severity of adverse effects can be increased when Cetuximab is combined with Istiratumab.,Istiratumab
DB15383,The risk or severity of adverse effects can be increased when Cetuximab is combined with Pidilizumab.,Pidilizumab
DB15397,The risk or severity of adverse effects can be increased when Cetuximab is combined with GMA-161.,GMA-161
DB15409,The risk or severity of adverse effects can be increased when Cetuximab is combined with Ladiratuzumab vedotin.,Ladiratuzumab vedotin
DB15415,The risk or severity of adverse effects can be increased when Cetuximab is combined with Tomaralimab.,Tomaralimab
DB15428,The risk or severity of adverse effects can be increased when Cetuximab is combined with Vesencumab.,Vesencumab
DB15432,The risk or severity of adverse effects can be increased when Cetuximab is combined with Pinatuzumab vedotin.,Pinatuzumab vedotin
DB15441,The risk or severity of adverse effects can be increased when Cetuximab is combined with Lulizumab pegol.,Lulizumab pegol
DB15443,The risk or severity of adverse effects can be increased when Cetuximab is combined with Lorukafusp alfa.,Lorukafusp alfa
DB15453,The risk or severity of adverse effects can be increased when Cetuximab is combined with Naratuximab emtansine.,Naratuximab emtansine
DB15559,The risk or severity of adverse effects can be increased when Cetuximab is combined with Zenocutuzumab.,Zenocutuzumab
DB15595,"The therapeutic efficacy of Ebola Zaire vaccine (live, attenuated) can be decreased when used in combination with Cetuximab.","Ebola Zaire vaccine (live, attenuated)"
DB00012,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Denileukin diftitox.,Darbepoetin alfa
DB00016,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Denileukin diftitox.,Erythropoietin
DB08894,The risk or severity of Thrombosis can be increased when Peginesatide is combined with Denileukin diftitox.,Peginesatide
DB09107,The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Denileukin diftitox.,Methoxy polyethylene glycol-epoetin beta
DB01281,The risk or severity of infection can be increased when Etanercept is combined with Abatacept.,Abatacept
DB00026,The risk or severity of adverse effects can be increased when Etanercept is combined with Anakinra.,Anakinra
DB08879,The risk or severity of adverse effects can be increased when Etanercept is combined with Belimumab.,Belimumab
DB06168,The risk or severity of infection and neutropenia can be increased when Etanercept is combined with Canakinumab.,Canakinumab
DB08904,The risk or severity of infection can be increased when Etanercept is combined with Certolizumab pegol.,Certolizumab pegol
DB00531,The risk or severity of adverse effects can be increased when Etanercept is combined with Cyclophosphamide.,Cyclophosphamide
DB06643,The risk or severity of adverse effects can be increased when Denosumab is combined with Etanercept.,Denosumab
DB00065,Etanercept may increase the immunosuppressive activities of Infliximab.,Infliximab
DB00008,The risk or severity of adverse effects can be increased when Etanercept is combined with Peginterferon alfa-2a.,Peginterferon alfa-2a
DB00011,The risk or severity of adverse effects can be increased when Etanercept is combined with Interferon alfa-n1.,Interferon alfa-n1
DB00018,The risk or severity of adverse effects can be increased when Etanercept is combined with Interferon alfa-n3.,Interferon alfa-n3
DB00022,The risk or severity of adverse effects can be increased when Etanercept is combined with Peginterferon alfa-2b.,Peginterferon alfa-2b
DB00033,The risk or severity of adverse effects can be increased when Etanercept is combined with Interferon gamma-1b.,Interferon gamma-1b
DB00034,"The risk or severity of adverse effects can be increased when Etanercept is combined with Interferon alfa-2a, Recombinant.","Interferon alfa-2a, Recombinant"
DB00041,The risk or severity of adverse effects can be increased when Etanercept is combined with Aldesleukin.,Aldesleukin
DB00051,The risk or severity of adverse effects can be increased when Etanercept is combined with Adalimumab.,Adalimumab
DB00056,The risk or severity of adverse effects can be increased when Etanercept is combined with Gemtuzumab ozogamicin.,Gemtuzumab ozogamicin
DB00059,The risk or severity of adverse effects can be increased when Etanercept is combined with Pegaspargase.,Pegaspargase
DB00068,The risk or severity of adverse effects can be increased when Etanercept is combined with Interferon beta-1b.,Interferon beta-1b
DB00069,The risk or severity of adverse effects can be increased when Etanercept is combined with Interferon alfacon-1.,Interferon alfacon-1
DB00073,The risk or severity of adverse effects can be increased when Etanercept is combined with Rituximab.,Rituximab
DB00074,The risk or severity of adverse effects can be increased when Etanercept is combined with Basiliximab.,Basiliximab
DB00075,The risk or severity of adverse effects can be increased when Etanercept is combined with Muromonab.,Muromonab
DB00078,The risk or severity of adverse effects can be increased when Etanercept is combined with Ibritumomab tiuxetan.,Ibritumomab tiuxetan
DB00081,The risk or severity of adverse effects can be increased when Etanercept is combined with Tositumomab.,Tositumomab
DB00087,The risk or severity of adverse effects can be increased when Etanercept is combined with Alemtuzumab.,Alemtuzumab
DB00092,The risk or severity of adverse effects can be increased when Etanercept is combined with Alefacept.,Alefacept
DB00095,The risk or severity of adverse effects can be increased when Etanercept is combined with Efalizumab.,Efalizumab
DB00098,The risk or severity of adverse effects can be increased when Etanercept is combined with Antithymocyte immunoglobulin (rabbit).,Antithymocyte immunoglobulin (rabbit)
DB00105,The risk or severity of adverse effects can be increased when Etanercept is combined with Interferon alfa-2b.,Interferon alfa-2b
DB00111,The risk or severity of adverse effects can be increased when Etanercept is combined with Daclizumab.,Daclizumab
DB00112,The risk or severity of adverse effects can be increased when Etanercept is combined with Bevacizumab.,Bevacizumab
DB00120,The risk or severity of adverse effects can be increased when Etanercept is combined with Phenylalanine.,Phenylalanine
DB00242,The risk or severity of adverse effects can be increased when Etanercept is combined with Cladribine.,Cladribine
DB00276,The risk or severity of adverse effects can be increased when Etanercept is combined with Amsacrine.,Amsacrine
DB00290,The risk or severity of adverse effects can be increased when Etanercept is combined with Bleomycin.,Bleomycin
DB00291,The risk or severity of adverse effects can be increased when Etanercept is combined with Chlorambucil.,Chlorambucil
DB00293,The risk or severity of adverse effects can be increased when Etanercept is combined with Raltitrexed.,Raltitrexed
DB00305,The risk or severity of adverse effects can be increased when Etanercept is combined with Mitomycin.,Mitomycin
DB00322,The risk or severity of adverse effects can be increased when Etanercept is combined with Floxuridine.,Floxuridine
DB00352,The risk or severity of adverse effects can be increased when Etanercept is combined with Tioguanine.,Tioguanine
DB00380,The risk or severity of adverse effects can be increased when Etanercept is combined with Dexrazoxane.,Dexrazoxane
DB00428,The risk or severity of adverse effects can be increased when Etanercept is combined with Streptozocin.,Streptozocin
DB00432,The risk or severity of adverse effects can be increased when Etanercept is combined with Trifluridine.,Trifluridine
DB00441,The risk or severity of adverse effects can be increased when Etanercept is combined with Gemcitabine.,Gemcitabine
DB00445,The risk or severity of adverse effects can be increased when Etanercept is combined with Epirubicin.,Epirubicin
DB00446,The risk or severity of adverse effects can be increased when Etanercept is combined with Chloramphenicol.,Chloramphenicol
DB00480,The risk or severity of adverse effects can be increased when Etanercept is combined with Lenalidomide.,Lenalidomide
DB00488,The risk or severity of adverse effects can be increased when Etanercept is combined with Altretamine.,Altretamine
DB00515,The risk or severity of adverse effects can be increased when Etanercept is combined with Cisplatin.,Cisplatin
DB00526,The risk or severity of adverse effects can be increased when Etanercept is combined with Oxaliplatin.,Oxaliplatin
DB00550,The risk or severity of adverse effects can be increased when Etanercept is combined with Propylthiouracil.,Propylthiouracil
DB00552,The risk or severity of adverse effects can be increased when Etanercept is combined with Pentostatin.,Pentostatin
DB00601,The risk or severity of adverse effects can be increased when Etanercept is combined with Linezolid.,Linezolid
DB00631,The risk or severity of adverse effects can be increased when Etanercept is combined with Clofarabine.,Clofarabine
DB00763,The risk or severity of adverse effects can be increased when Etanercept is combined with Methimazole.,Methimazole
DB00853,The risk or severity of adverse effects can be increased when Etanercept is combined with Temozolomide.,Temozolomide
DB00859,The risk or severity of adverse effects can be increased when Etanercept is combined with Penicillamine.,Penicillamine
DB00888,The risk or severity of adverse effects can be increased when Etanercept is combined with Mechlorethamine.,Mechlorethamine
DB00928,The risk or severity of adverse effects can be increased when Etanercept is combined with Azacitidine.,Azacitidine
DB00958,The risk or severity of adverse effects can be increased when Etanercept is combined with Carboplatin.,Carboplatin
DB00970,The risk or severity of adverse effects can be increased when Etanercept is combined with Dactinomycin.,Dactinomycin
DB01005,The risk or severity of adverse effects can be increased when Etanercept is combined with Hydroxyurea.,Hydroxyurea
DB01024,The risk or severity of adverse effects can be increased when Etanercept is combined with Mycophenolic acid.,Mycophenolic acid
DB01030,The risk or severity of adverse effects can be increased when Etanercept is combined with Topotecan.,Topotecan
DB01033,The risk or severity of adverse effects can be increased when Etanercept is combined with Mercaptopurine.,Mercaptopurine
DB01042,The risk or severity of adverse effects can be increased when Etanercept is combined with Melphalan.,Melphalan
DB01073,The risk or severity of adverse effects can be increased when Etanercept is combined with Fludarabine.,Fludarabine
DB01099,The risk or severity of adverse effects can be increased when Etanercept is combined with Flucytosine.,Flucytosine
DB01168,The risk or severity of adverse effects can be increased when Etanercept is combined with Procarbazine.,Procarbazine
DB01169,The risk or severity of adverse effects can be increased when Etanercept is combined with Arsenic trioxide.,Arsenic trioxide
DB01204,The risk or severity of adverse effects can be increased when Etanercept is combined with Mitoxantrone.,Mitoxantrone
DB01206,The risk or severity of adverse effects can be increased when Etanercept is combined with Lomustine.,Lomustine
DB01257,The risk or severity of adverse effects can be increased when Etanercept is combined with Eculizumab.,Eculizumab
DB01262,The risk or severity of adverse effects can be increased when Etanercept is combined with Decitabine.,Decitabine
DB01280,The risk or severity of adverse effects can be increased when Etanercept is combined with Nelarabine.,Nelarabine
DB01423,The risk or severity of adverse effects can be increased when Etanercept is combined with Stepronin.,Stepronin
DB01816,The risk or severity of adverse effects can be increased when Etanercept is combined with Castanospermine.,Castanospermine
DB02546,The risk or severity of adverse effects can be increased when Etanercept is combined with Vorinostat.,Vorinostat
DB02806,The risk or severity of adverse effects can be increased when Etanercept is combined with 2-Methoxyethanol.,2-Methoxyethanol
DB03523,The risk or severity of adverse effects can be increased when Etanercept is combined with Brequinar.,Brequinar
DB04956,The risk or severity of adverse effects can be increased when Etanercept is combined with Afelimomab.,Afelimomab
DB05258,The risk or severity of adverse effects can be increased when Etanercept is combined with Interferon alfa.,Interferon alfa
DB05259,The risk or severity of adverse effects can be increased when Etanercept is combined with Glatiramer.,Glatiramer
DB05260,The risk or severity of adverse effects can be increased when Etanercept is combined with Gallium nitrate.,Gallium nitrate
DB05459,The risk or severity of adverse effects can be increased when Etanercept is combined with Briakinumab.,Briakinumab
DB05472,The risk or severity of adverse effects can be increased when Etanercept is combined with omega interferon.,omega interferon
DB06612,The risk or severity of adverse effects can be increased when Etanercept is combined with Mepolizumab.,Mepolizumab
DB06662,The risk or severity of adverse effects can be increased when Etanercept is combined with Abetimus.,Abetimus
DB06674,The risk or severity of adverse effects can be increased when Etanercept is combined with Golimumab.,Golimumab
DB06681,The risk or severity of adverse effects can be increased when Etanercept is combined with Belatacept.,Belatacept
DB06813,The risk or severity of adverse effects can be increased when Etanercept is combined with Pralatrexate.,Pralatrexate
DB08059,The risk or severity of adverse effects can be increased when Etanercept is combined with Wortmannin.,Wortmannin
DB08871,The risk or severity of adverse effects can be increased when Etanercept is combined with Eribulin.,Eribulin
DB08880,The risk or severity of adverse effects can be increased when Etanercept is combined with Teriflunomide.,Teriflunomide
DB08889,The risk or severity of adverse effects can be increased when Etanercept is combined with Carfilzomib.,Carfilzomib
DB08908,The risk or severity of adverse effects can be increased when Etanercept is combined with Dimethyl fumarate.,Dimethyl fumarate
DB08935,The risk or severity of adverse effects can be increased when Etanercept is combined with Obinutuzumab.,Obinutuzumab
DB09029,The risk or severity of adverse effects can be increased when Etanercept is combined with Secukinumab.,Secukinumab
DB09036,The risk or severity of adverse effects can be increased when Etanercept is combined with Siltuximab.,Siltuximab
DB09052,The risk or severity of adverse effects can be increased when Etanercept is combined with Blinatumomab.,Blinatumomab
DB09077,The risk or severity of adverse effects can be increased when Etanercept is combined with Dinutuximab.,Dinutuximab
DB09091,The risk or severity of adverse effects can be increased when Etanercept is combined with Tixocortol.,Tixocortol
DB09122,The risk or severity of adverse effects can be increased when Etanercept is combined with Peginterferon beta-1a.,Peginterferon beta-1a
DB09312,The risk or severity of adverse effects can be increased when Etanercept is combined with Antilymphocyte immunoglobulin (horse).,Antilymphocyte immunoglobulin (horse)
DB11466,The risk or severity of adverse effects can be increased when Etanercept is combined with Tepoxalin.,Tepoxalin
DB11569,The risk or severity of adverse effects can be increased when Etanercept is combined with Ixekizumab.,Ixekizumab
DB11580,The risk or severity of adverse effects can be increased when Etanercept is combined with Ravulizumab.,Ravulizumab
DB11616,The risk or severity of adverse effects can be increased when Etanercept is combined with Pirarubicin.,Pirarubicin
DB11693,The risk or severity of adverse effects can be increased when Etanercept is combined with Voclosporin.,Voclosporin
DB11708,The risk or severity of adverse effects can be increased when Etanercept is combined with Peficitinib.,Peficitinib
DB11767,The risk or severity of adverse effects can be increased when Etanercept is combined with Sarilumab.,Sarilumab
DB11776,The risk or severity of adverse effects can be increased when Etanercept is combined with Brodalumab.,Brodalumab
DB11803,The risk or severity of adverse effects can be increased when Etanercept is combined with Sirukumab.,Sirukumab
DB11834,The risk or severity of adverse effects can be increased when Etanercept is combined with Guselkumab.,Guselkumab
DB11988,The risk or severity of adverse effects can be increased when Etanercept is combined with Ocrelizumab.,Ocrelizumab
DB12025,The risk or severity of adverse effects can be increased when Etanercept is combined with Triptolide.,Triptolide
DB12612,The risk or severity of adverse effects can be increased when Etanercept is combined with Ozanimod.,Ozanimod
DB12617,The risk or severity of adverse effects can be increased when Etanercept is combined with Mizoribine.,Mizoribine
DB12692,The risk or severity of adverse effects can be increased when Etanercept is combined with Gusperimus.,Gusperimus
DB12814,The risk or severity of adverse effects can be increased when Etanercept is combined with Cepeginterferon alfa-2B.,Cepeginterferon alfa-2B
DB12902,The risk or severity of adverse effects can be increased when Etanercept is combined with Trofosfamide.,Trofosfamide
DB12947,The risk or severity of adverse effects can be increased when Etanercept is combined with Doxifluridine.,Doxifluridine
DB12991,The risk or severity of adverse effects can be increased when Etanercept is combined with Deoxyspergualin.,Deoxyspergualin
DB12996,The risk or severity of adverse effects can be increased when Etanercept is combined with Acteoside.,Acteoside
DB13003,The risk or severity of adverse effects can be increased when Etanercept is combined with Cortivazol.,Cortivazol
DB13014,The risk or severity of adverse effects can be increased when Etanercept is combined with Hypericin.,Hypericin
DB13068,The risk or severity of adverse effects can be increased when Etanercept is combined with 9-(N-methyl-L-isoleucine)-cyclosporin A.,9-(N-methyl-L-isoleucine)-cyclosporin A
DB13223,The risk or severity of adverse effects can be increased when Etanercept is combined with Fluocortin.,Fluocortin
DB13241,The risk or severity of adverse effects can be increased when Etanercept is combined with Begelomab.,Begelomab
DB13491,The risk or severity of adverse effects can be increased when Etanercept is combined with Fluperolone.,Fluperolone
DB13664,The risk or severity of adverse effects can be increased when Etanercept is combined with Formocortal.,Formocortal
DB13728,The risk or severity of adverse effects can be increased when Etanercept is combined with Halometasone.,Halometasone
DB13843,The risk or severity of adverse effects can be increased when Etanercept is combined with Cloprednol.,Cloprednol
DB13856,The risk or severity of adverse effects can be increased when Etanercept is combined with Fluclorolone.,Fluclorolone
DB14219,The risk or severity of adverse effects can be increased when Etanercept is combined with Monomethyl fumarate.,Monomethyl fumarate
DB14724,The risk or severity of adverse effects can be increased when Etanercept is combined with Emapalumab.,Emapalumab
DB14762,The risk or severity of adverse effects can be increased when Etanercept is combined with Risankizumab.,Risankizumab
DB14919,The risk or severity of adverse effects can be increased when Etanercept is combined with Rozanolixizumab.,Rozanolixizumab
DB15253,The risk or severity of adverse effects can be increased when Etanercept is combined with Bleselumab.,Bleselumab
DB00180,The risk or severity of adverse effects can be increased when Etanercept is combined with Flunisolide.,Flunisolide
DB00394,The risk or severity of adverse effects can be increased when Etanercept is combined with Beclomethasone dipropionate.,Beclomethasone dipropionate
DB00443,The risk or severity of adverse effects can be increased when Etanercept is combined with Betamethasone.,Betamethasone
DB00591,The risk or severity of adverse effects can be increased when Etanercept is combined with Fluocinolone acetonide.,Fluocinolone acetonide
DB00635,The risk or severity of adverse effects can be increased when Etanercept is combined with Prednisone.,Prednisone
DB00687,The risk or severity of adverse effects can be increased when Etanercept is combined with Fludrocortisone.,Fludrocortisone
DB00764,The risk or severity of adverse effects can be increased when Etanercept is combined with Mometasone.,Mometasone
DB00860,The risk or severity of adverse effects can be increased when Etanercept is combined with Prednisolone.,Prednisolone
DB00959,The risk or severity of adverse effects can be increased when Etanercept is combined with Methylprednisolone.,Methylprednisolone
DB01196,The risk or severity of adverse effects can be increased when Etanercept is combined with Estramustine.,Estramustine
DB01285,The risk or severity of adverse effects can be increased when Etanercept is combined with Corticotropin.,Corticotropin
DB01380,The risk or severity of adverse effects can be increased when Etanercept is combined with Cortisone acetate.,Cortisone acetate
DB01384,The risk or severity of adverse effects can be increased when Etanercept is combined with Paramethasone.,Paramethasone
DB01611,The risk or severity of adverse effects can be increased when Etanercept is combined with Hydroxychloroquine.,Hydroxychloroquine
DB04630,The risk or severity of adverse effects can be increased when Etanercept is combined with Aldosterone.,Aldosterone
DB08970,The risk or severity of adverse effects can be increased when Etanercept is combined with Fluprednidene.,Fluprednidene
DB08971,The risk or severity of adverse effects can be increased when Etanercept is combined with Fluocortolone.,Fluocortolone
DB09082,The risk or severity of adverse effects can be increased when Etanercept is combined with Vilanterol.,Vilanterol
DB09378,The risk or severity of adverse effects can be increased when Etanercept is combined with Fluprednisolone.,Fluprednisolone
DB09383,The risk or severity of adverse effects can be increased when Etanercept is combined with Meprednisone.,Meprednisone
DB11487,The risk or severity of adverse effects can be increased when Etanercept is combined with Dexamethasone isonicotinate.,Dexamethasone isonicotinate
DB11529,The risk or severity of adverse effects can be increased when Etanercept is combined with Melengestrol.,Melengestrol
DB11750,The risk or severity of adverse effects can be increased when Etanercept is combined with Clobetasol.,Clobetasol
DB11817,The risk or severity of adverse effects can be increased when Etanercept is combined with Baricitinib.,Baricitinib
DB11921,The risk or severity of adverse effects can be increased when Etanercept is combined with Deflazacort.,Deflazacort
DB13208,The risk or severity of adverse effects can be increased when Etanercept is combined with Prednylidene.,Prednylidene
DB14066,The risk or severity of adverse effects can be increased when Etanercept is combined with Tetrandrine.,Tetrandrine
DB14512,The risk or severity of adverse effects can be increased when Etanercept is combined with Mometasone furoate.,Mometasone furoate
DB14545,The risk or severity of adverse effects can be increased when Etanercept is combined with Hydrocortisone succinate.,Hydrocortisone succinate
DB01222,The risk or severity of adverse effects can be increased when Etanercept is combined with Budesonide.,Budesonide
DB01394,The risk or severity of adverse effects can be increased when Etanercept is combined with Colchicine.,Colchicine
DB00108,The risk or severity of adverse effects can be increased when Etanercept is combined with Natalizumab.,Natalizumab
DB00337,The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Etanercept.,Pimecrolimus
DB06372,The risk or severity of adverse effects can be increased when Etanercept is combined with Rilonacept.,Rilonacept
DB01656,Etanercept may increase the immunosuppressive activities of Roflumilast.,Roflumilast
DB06688,The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Etanercept.,Sipuleucel-T
DB06273,Tocilizumab may increase the immunosuppressive activities of Etanercept.,Tocilizumab
DB08895,The risk or severity of adverse effects can be increased when Etanercept is combined with Tofacitinib.,Tofacitinib
DB09033,The risk or severity of infection can be increased when Etanercept is combined with Vedolizumab.,Vedolizumab
DB01015,The risk or severity of myelosuppression can be increased when Sulfamethoxazole is combined with Etanercept.,Sulfamethoxazole
DB01097,The risk or severity of adverse effects can be increased when Etanercept is combined with Leflunomide.,Leflunomide
DB00072,Trastuzumab may increase the neutropenic activities of Etanercept.,Trastuzumab
DB08868,Etanercept may increase the immunosuppressive activities of Fingolimod.,Fingolimod
DB00864,Tacrolimus may increase the immunosuppressive activities of Etanercept.,Tacrolimus
DB04914,The therapeutic efficacy of G17DT can be decreased when used in combination with Etanercept.,G17DT
DB05144,The therapeutic efficacy of PEV3A can be decreased when used in combination with Etanercept.,PEV3A
DB05325,The therapeutic efficacy of INGN 225 can be decreased when used in combination with Etanercept.,INGN 225
DB05374,The therapeutic efficacy of Rindopepimut can be decreased when used in combination with Etanercept.,Rindopepimut
DB05440,The therapeutic efficacy of SRP 299 can be decreased when used in combination with Etanercept.,SRP 299
DB05942,The therapeutic efficacy of GI-5005 can be decreased when used in combination with Etanercept.,GI-5005
DB06400,The therapeutic efficacy of Vitespen can be decreased when used in combination with Etanercept.,Vitespen
DB06584,The therapeutic efficacy of TG4010 can be decreased when used in combination with Etanercept.,TG4010
DB09057,The therapeutic efficacy of Anthrax immune globulin human can be decreased when used in combination with Etanercept.,Anthrax immune globulin human
DB10062,"The therapeutic efficacy of Rabies virus inactivated antigen, B can be decreased when used in combination with Etanercept.","Rabies virus inactivated antigen, B"
DB10076,The therapeutic efficacy of Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Etanercept.,Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen
DB10276,The therapeutic efficacy of Rotavirus vaccine can be decreased when used in combination with Etanercept.,Rotavirus vaccine
DB10283,"The therapeutic efficacy of Rabies virus inactivated antigen, A can be decreased when used in combination with Etanercept.","Rabies virus inactivated antigen, A"
DB10342,The therapeutic efficacy of Haemophilus influenzae type B capsular polysaccharide meningococcal outer membrane protein conjugate antigen can be decreased when used in combination with Etanercept.,Haemophilus influenzae type B capsular polysaccharide meningococcal outer membrane protein conjugate antigen
DB10583,The therapeutic efficacy of Clostridium tetani toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Etanercept.,Clostridium tetani toxoid antigen (formaldehyde inactivated)
DB10584,The therapeutic efficacy of Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Etanercept.,Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated)
DB10600,The therapeutic efficacy of Influenza A virus A/California/7/2009 X-181 (H1N1) antigen (propiolactone inactivated) can be decreased when used in combination with Etanercept.,Influenza A virus A/California/7/2009 X-181 (H1N1) antigen (propiolactone inactivated)
DB10769,The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Etanercept.,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated)
DB10794,The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 antigen (formaldehyde inactivated) can be decreased when used in combination with Etanercept.,Influenza B virus B/Brisbane/60/2008 antigen (formaldehyde inactivated)
DB10803,The therapeutic efficacy of Typhoid Vi polysaccharide vaccine can be decreased when used in combination with Etanercept.,Typhoid Vi polysaccharide vaccine
DB10989,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Etanercept.,Hepatitis A Vaccine
DB10990,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Etanercept.,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen
DB11038,The therapeutic efficacy of Influenza A virus A/Brisbane/59/2007(H1N1) hemagglutinin antigen (propiolactone inactivated) can be decreased when used in combination with Etanercept.,Influenza A virus A/Brisbane/59/2007(H1N1) hemagglutinin antigen (propiolactone inactivated)
DB11040,The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (propiolactone inactivated) can be decreased when used in combination with Etanercept.,Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (propiolactone inactivated)
DB11041,The therapeutic efficacy of Influenza A virus A/California/7/2009 X-181 (H1N1) hemagglutinin antigen (propiolactone inactivated) can be decreased when used in combination with Etanercept.,Influenza A virus A/California/7/2009 X-181 (H1N1) hemagglutinin antigen (propiolactone inactivated)
DB11044,The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 antigen (propiolactone inactivated) can be decreased when used in combination with Etanercept.,Influenza B virus B/Brisbane/60/2008 antigen (propiolactone inactivated)
DB11603,The therapeutic efficacy of Human rabies virus immune globulin can be decreased when used in combination with Etanercept.,Human rabies virus immune globulin
DB11627,The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Etanercept.,Hepatitis B Vaccine (Recombinant)
DB12568,The therapeutic efficacy of Tecemotide can be decreased when used in combination with Etanercept.,Tecemotide
DB14022,The therapeutic efficacy of Typhoid vaccine can be decreased when used in combination with Etanercept.,Typhoid vaccine
DB14384,The therapeutic efficacy of Influenza A virus A/Victoria/210/2009 X-187 (H3N2) hemagglutinin antigen (formaldehyde inactivated) can be decreased when used in combination with Etanercept.,Influenza A virus A/Victoria/210/2009 X-187 (H3N2) hemagglutinin antigen (formaldehyde inactivated)
DB14385,The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (formaldehyde inactivated) can be decreased when used in combination with Etanercept.,Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (formaldehyde inactivated)
DB14394,The therapeutic efficacy of Influenza A virus A/California/7/2009 (H1N1) live (attenuated) antigen can be decreased when used in combination with Etanercept.,Influenza A virus A/California/7/2009 (H1N1) live (attenuated) antigen
DB14445,The therapeutic efficacy of Influenza A virus A/Victoria/210/2009 X-187 (H3N2) antigen (formaldehyde inactivated) can be decreased when used in combination with Etanercept.,Influenza A virus A/Victoria/210/2009 X-187 (H3N2) antigen (formaldehyde inactivated)
DB14449,The therapeutic efficacy of Influenza A virus A/Perth/16/2009 (H3N2) live (attenuated) antigen can be decreased when used in combination with Etanercept.,Influenza A virus A/Perth/16/2009 (H3N2) live (attenuated) antigen
DB14619,The therapeutic efficacy of Influenza A virus A/Uruguay/716/2007(H3N2) antigen (propiolactone inactivated) can be decreased when used in combination with Etanercept.,Influenza A virus A/Uruguay/716/2007(H3N2) antigen (propiolactone inactivated)
DB14620,The therapeutic efficacy of Influenza A virus A/Brisbane/59/2007(H1N1) antigen (propiolactone inactivated) can be decreased when used in combination with Etanercept.,Influenza A virus A/Brisbane/59/2007(H1N1) antigen (propiolactone inactivated)
DB14711,The therapeutic efficacy of Vaccinia virus strain new york city board of health live antigen can be decreased when used in combination with Etanercept.,Vaccinia virus strain new york city board of health live antigen
DB15274,The therapeutic efficacy of Pertussis vaccine can be decreased when used in combination with Etanercept.,Pertussis vaccine
DB15461,The therapeutic efficacy of Yersinia pestis 195/p antigen (formaldehyde inactivated) can be decreased when used in combination with Etanercept.,Yersinia pestis 195/p antigen (formaldehyde inactivated)
DB13924,The therapeutic efficacy of Varicella Zoster Vaccine (Recombinant) can be decreased when used in combination with Etanercept.,Varicella Zoster Vaccine (Recombinant)
DB15483,The therapeutic efficacy of Modified vaccinia ankara can be decreased when used in combination with Etanercept.,Modified vaccinia ankara
DB15595,"The therapeutic efficacy of Ebola Zaire vaccine (live, attenuated) can be decreased when used in combination with Etanercept.","Ebola Zaire vaccine (live, attenuated)"
DB10317,The risk or severity of infection can be increased when Rubella virus vaccine is combined with Etanercept.,Rubella virus vaccine
DB10318,The risk or severity of infection can be increased when Varicella Zoster Vaccine (Live/attenuated) is combined with Etanercept.,Varicella Zoster Vaccine (Live/attenuated)
DB10343,The risk or severity of infection can be increased when Bacillus calmette-guerin substrain tice live antigen is combined with Etanercept.,Bacillus calmette-guerin substrain tice live antigen
DB10804,The risk or severity of infection can be increased when Bacillus calmette-guerin substrain connaught live antigen is combined with Etanercept.,Bacillus calmette-guerin substrain connaught live antigen
DB10805,The risk or severity of infection can be increased when Yellow Fever Vaccine is combined with Etanercept.,Yellow Fever Vaccine
DB11003,The risk or severity of infection can be increased when Anthrax vaccine is combined with Etanercept.,Anthrax vaccine
DB11050,The risk or severity of infection can be increased when Typhoid Vaccine Live is combined with Etanercept.,Typhoid Vaccine Live
DB12386,The risk or severity of infection can be increased when Bacillus calmette-guerin substrain danish 1331 live antigen is combined with Etanercept.,Bacillus calmette-guerin substrain danish 1331 live antigen
DB12768,The risk or severity of infection can be increased when BCG vaccine is combined with Etanercept.,BCG vaccine
DB14409,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Etanercept.,Human adenovirus e serotype 4 strain cl-68578 antigen
DB14443,The risk or severity of infection can be increased when Vibrio cholerae CVD 103-HgR strain live antigen is combined with Etanercept.,Vibrio cholerae CVD 103-HgR strain live antigen
DB14685,The risk or severity of infection can be increased when Adenovirus type 7 vaccine live is combined with Etanercept.,Adenovirus type 7 vaccine live
DB00795,The risk or severity of neutropenia can be increased when Etanercept is combined with Sulfasalazine.,Sulfasalazine
DB00201,The metabolism of Caffeine can be increased when combined with Etanercept.,Caffeine
DB00176,The metabolism of Fluvoxamine can be increased when combined with Etanercept.,Fluvoxamine
DB00195,The metabolism of Betaxolol can be increased when combined with Etanercept.,Betaxolol
DB00261,The metabolism of Anagrelide can be increased when combined with Etanercept.,Anagrelide
DB00262,The metabolism of Carmustine can be increased when combined with Etanercept.,Carmustine
DB00268,The metabolism of Ropinirole can be increased when combined with Etanercept.,Ropinirole
DB00280,The metabolism of Disopyramide can be increased when combined with Etanercept.,Disopyramide
DB00286,The metabolism of Conjugated estrogens can be increased when combined with Etanercept.,Conjugated estrogens
DB00296,The metabolism of Ropivacaine can be increased when combined with Etanercept.,Ropivacaine
DB00315,The metabolism of Zolmitriptan can be increased when combined with Etanercept.,Zolmitriptan
DB00316,The metabolism of Acetaminophen can be increased when combined with Etanercept.,Acetaminophen
DB00334,The metabolism of Olanzapine can be increased when combined with Etanercept.,Olanzapine
DB00356,The metabolism of Chlorzoxazone can be increased when combined with Etanercept.,Chlorzoxazone
DB00365,The metabolism of Grepafloxacin can be increased when combined with Etanercept.,Grepafloxacin
DB00370,The metabolism of Mirtazapine can be increased when combined with Etanercept.,Mirtazapine
DB00379,The metabolism of Mexiletine can be increased when combined with Etanercept.,Mexiletine
DB00382,The metabolism of Tacrine can be increased when combined with Etanercept.,Tacrine
DB00384,The metabolism of Triamterene can be increased when combined with Etanercept.,Triamterene
DB00442,The metabolism of Entecavir can be increased when combined with Etanercept.,Entecavir
DB00477,The metabolism of Chlorpromazine can be increased when combined with Etanercept.,Chlorpromazine
DB00518,The metabolism of Albendazole can be increased when combined with Etanercept.,Albendazole
DB00544,The metabolism of Fluorouracil can be increased when combined with Etanercept.,Fluorouracil
DB00629,The metabolism of Guanabenz can be increased when combined with Etanercept.,Guanabenz
DB00642,The metabolism of Pemetrexed can be increased when combined with Etanercept.,Pemetrexed
DB00730,The metabolism of Thiabendazole can be increased when combined with Etanercept.,Thiabendazole
DB00740,The metabolism of Riluzole can be increased when combined with Etanercept.,Riluzole
DB00787,The metabolism of Acyclovir can be increased when combined with Etanercept.,Acyclovir
DB00806,The metabolism of Pentoxifylline can be increased when combined with Etanercept.,Pentoxifylline
DB00831,The metabolism of Trifluoperazine can be increased when combined with Etanercept.,Trifluoperazine
DB00863,The metabolism of Ranitidine can be increased when combined with Etanercept.,Ranitidine
DB00898,The metabolism of Ethanol can be increased when combined with Etanercept.,Ethanol
DB00934,The metabolism of Maprotiline can be increased when combined with Etanercept.,Maprotiline
DB00978,The metabolism of Lomefloxacin can be increased when combined with Etanercept.,Lomefloxacin
DB00993,The metabolism of Azathioprine can be increased when combined with Etanercept.,Azathioprine
DB00998,The metabolism of Frovatriptan can be increased when combined with Etanercept.,Frovatriptan
DB01002,The metabolism of Levobupivacaine can be increased when combined with Etanercept.,Levobupivacaine
DB01012,The metabolism of Cinacalcet can be increased when combined with Etanercept.,Cinacalcet
DB01056,The metabolism of Tocainide can be increased when combined with Etanercept.,Tocainide
DB01087,The metabolism of Primaquine can be increased when combined with Etanercept.,Primaquine
DB01094,The metabolism of Hesperetin can be increased when combined with Etanercept.,Hesperetin
DB01182,The metabolism of Propafenone can be increased when combined with Etanercept.,Propafenone
DB01191,The metabolism of Dexfenfluramine can be increased when combined with Etanercept.,Dexfenfluramine
DB01303,The metabolism of Oxtriphylline can be increased when combined with Etanercept.,Oxtriphylline
DB01367,The metabolism of Rasagiline can be increased when combined with Etanercept.,Rasagiline
DB01405,The metabolism of Temafloxacin can be increased when combined with Etanercept.,Temafloxacin
DB01412,The metabolism of Theobromine can be increased when combined with Etanercept.,Theobromine
DB01482,The metabolism of Fenethylline can be increased when combined with Etanercept.,Fenethylline
DB01558,The metabolism of Bromazepam can be increased when combined with Etanercept.,Bromazepam
DB01623,The metabolism of Thiothixene can be increased when combined with Etanercept.,Thiothixene
DB01645,The metabolism of Genistein can be increased when combined with Etanercept.,Genistein
DB01667,The metabolism of 8-azaguanine can be increased when combined with Etanercept.,8-azaguanine
DB02134,The metabolism of Xanthine can be increased when combined with Etanercept.,Xanthine
DB02489,The metabolism of 9-Methylguanine can be increased when combined with Etanercept.,9-Methylguanine
DB02568,The metabolism of Peldesine can be increased when combined with Etanercept.,Peldesine
DB02709,The metabolism of Resveratrol can be increased when combined with Etanercept.,Resveratrol
DB04076,The metabolism of Hypoxanthine can be increased when combined with Etanercept.,Hypoxanthine
DB04356,The metabolism of 9-Deazaguanine can be increased when combined with Etanercept.,9-Deazaguanine
DB04871,The metabolism of Lorcaserin can be increased when combined with Etanercept.,Lorcaserin
DB04948,The metabolism of Lofexidine can be increased when combined with Etanercept.,Lofexidine
DB04951,The metabolism of Pirfenidone can be increased when combined with Etanercept.,Pirfenidone
DB06148,The metabolism of Mianserin can be increased when combined with Etanercept.,Mianserin
DB06210,The metabolism of Eltrombopag can be increased when combined with Etanercept.,Eltrombopag
DB06216,The metabolism of Asenapine can be increased when combined with Etanercept.,Asenapine
DB06235,The metabolism of Vadimezan can be increased when combined with Etanercept.,Vadimezan
DB06479,The metabolism of Propentofylline can be increased when combined with Etanercept.,Propentofylline
DB06594,The metabolism of Agomelatine can be increased when combined with Etanercept.,Agomelatine
DB06769,The metabolism of Bendamustine can be increased when combined with Etanercept.,Bendamustine
DB06770,The metabolism of Benzyl alcohol can be increased when combined with Etanercept.,Benzyl alcohol
DB06774,The metabolism of Capsaicin can be increased when combined with Etanercept.,Capsaicin
DB08496,The metabolism of (R)-warfarin can be increased when combined with Etanercept.,(R)-warfarin
DB09071,The metabolism of Tasimelteon can be increased when combined with Etanercept.,Tasimelteon
DB09118,The metabolism of Stiripentol can be increased when combined with Etanercept.,Stiripentol
DB09225,The metabolism of Zotepine can be increased when combined with Etanercept.,Zotepine
DB09273,The metabolism of Doxofylline can be increased when combined with Etanercept.,Doxofylline
DB09290,The metabolism of Ramosetron can be increased when combined with Etanercept.,Ramosetron
DB11919,The metabolism of 6-O-benzylguanine can be increased when combined with Etanercept.,6-O-benzylguanine
DB11967,The metabolism of Binimetinib can be increased when combined with Etanercept.,Binimetinib
DB12026,The metabolism of Voxilaprevir can be increased when combined with Etanercept.,Voxilaprevir
DB12245,The metabolism of Triclabendazole can be increased when combined with Etanercept.,Triclabendazole
DB12332,The metabolism of Rucaparib can be increased when combined with Etanercept.,Rucaparib
DB12406,The metabolism of Lisofylline can be increased when combined with Etanercept.,Lisofylline
DB12531,The metabolism of Lobucavir can be increased when combined with Etanercept.,Lobucavir
DB12926,The metabolism of Cafedrine can be increased when combined with Etanercept.,Cafedrine
DB12927,The metabolism of Theodrenaline can be increased when combined with Etanercept.,Theodrenaline
DB12945,The metabolism of Dihydralazine can be increased when combined with Etanercept.,Dihydralazine
DB13203,The metabolism of Bamifylline can be increased when combined with Etanercept.,Bamifylline
DB13449,The metabolism of Proxyphylline can be increased when combined with Etanercept.,Proxyphylline
DB13573,The metabolism of Acefylline can be increased when combined with Etanercept.,Acefylline
DB13592,The metabolism of Etamiphylline can be increased when combined with Etanercept.,Etamiphylline
DB13634,The metabolism of Pentifylline can be increased when combined with Etanercept.,Pentifylline
DB13812,The metabolism of Bufylline can be increased when combined with Etanercept.,Bufylline
DB14018,The metabolism of Bromotheophylline can be increased when combined with Etanercept.,Bromotheophylline
DB14132,The metabolism of 8-chlorotheophylline can be increased when combined with Etanercept.,8-chlorotheophylline
DB11757,The metabolism of Istradefylline can be increased when combined with Etanercept.,Istradefylline
DB04889,The metabolism of Bicifadine can be increased when combined with Etanercept.,Bicifadine
DB05708,The metabolism of GTS-21 can be increased when combined with Etanercept.,GTS-21
DB00977,The metabolism of Ethinylestradiol can be increased when combined with Etanercept.,Ethinylestradiol
DB00425,The metabolism of Zolpidem can be increased when combined with Etanercept.,Zolpidem
DB00458,The metabolism of Imipramine can be increased when combined with Etanercept.,Imipramine
DB00532,The metabolism of Mephenytoin can be increased when combined with Etanercept.,Mephenytoin
DB00540,The metabolism of Nortriptyline can be increased when combined with Etanercept.,Nortriptyline
DB00575,The metabolism of Clonidine can be increased when combined with Etanercept.,Clonidine
DB00924,The metabolism of Cyclobenzaprine can be increased when combined with Etanercept.,Cyclobenzaprine
DB01242,The metabolism of Clomipramine can be increased when combined with Etanercept.,Clomipramine
DB11689,The metabolism of Selumetinib can be increased when combined with Etanercept.,Selumetinib
DB00277,The metabolism of Theophylline can be increased when combined with Etanercept.,Theophylline
DB00564,The metabolism of Carbamazepine can be increased when combined with Etanercept.,Carbamazepine
DB00682,The metabolism of Warfarin can be increased when combined with Etanercept.,Warfarin
DB00697,The metabolism of Tizanidine can be increased when combined with Etanercept.,Tizanidine
DB01100,The metabolism of Pimozide can be increased when combined with Etanercept.,Pimozide
DB01223,The metabolism of Aminophylline can be increased when combined with Etanercept.,Aminophylline
DB01418,The metabolism of Acenocoumarol can be increased when combined with Etanercept.,Acenocoumarol
DB09256,The metabolism of Tegafur can be increased when combined with Etanercept.,Tegafur
DB00851,The metabolism of Dacarbazine can be increased when combined with Etanercept.,Dacarbazine
DB08910,The metabolism of Pomalidomide can be increased when combined with Etanercept.,Pomalidomide
DB00238,The metabolism of Nevirapine can be increased when combined with Etanercept.,Nevirapine
DB00471,The metabolism of Montelukast can be increased when combined with Etanercept.,Montelukast
DB00690,The metabolism of Flurazepam can be increased when combined with Etanercept.,Flurazepam
DB00916,The metabolism of Metronidazole can be increased when combined with Etanercept.,Metronidazole
DB00983,The metabolism of Formoterol can be increased when combined with Etanercept.,Formoterol
DB01006,The metabolism of Letrozole can be increased when combined with Etanercept.,Letrozole
DB01028,The metabolism of Methoxyflurane can be increased when combined with Etanercept.,Methoxyflurane
DB01159,The metabolism of Halothane can be increased when combined with Etanercept.,Halothane
DB01236,The metabolism of Sevoflurane can be increased when combined with Etanercept.,Sevoflurane
DB01274,The metabolism of Arformoterol can be increased when combined with Etanercept.,Arformoterol
DB01544,The metabolism of Flunitrazepam can be increased when combined with Etanercept.,Flunitrazepam
DB06292,The metabolism of Dapagliflozin can be increased when combined with Etanercept.,Dapagliflozin
DB06470,The metabolism of Clomethiazole can be increased when combined with Etanercept.,Clomethiazole
DB09068,The metabolism of Vortioxetine can be increased when combined with Etanercept.,Vortioxetine
DB09327,The metabolism of Tegafur-uracil can be increased when combined with Etanercept.,Tegafur-uracil
DB11586,The metabolism of Asunaprevir can be increased when combined with Etanercept.,Asunaprevir
DB04977,The metabolism of Plitidepsin can be increased when combined with Etanercept.,Plitidepsin
DB06119,The metabolism of Cenobamate can be increased when combined with Etanercept.,Cenobamate
DB00193,The metabolism of Tramadol can be increased when combined with Etanercept.,Tramadol
DB00333,The metabolism of Methadone can be increased when combined with Etanercept.,Methadone
DB00349,The metabolism of Clobazam can be increased when combined with Etanercept.,Clobazam
DB00625,The metabolism of Efavirenz can be increased when combined with Etanercept.,Efavirenz
DB00753,The metabolism of Isoflurane can be increased when combined with Etanercept.,Isoflurane
DB00818,The metabolism of Propofol can be increased when combined with Etanercept.,Propofol
DB00835,The metabolism of Brompheniramine can be increased when combined with Etanercept.,Brompheniramine
DB00836,The metabolism of Loperamide can be increased when combined with Etanercept.,Loperamide
DB00849,The metabolism of Methylphenobarbital can be increased when combined with Etanercept.,Methylphenobarbital
DB00865,The metabolism of Benzphetamine can be increased when combined with Etanercept.,Benzphetamine
DB01069,The metabolism of Promethazine can be increased when combined with Etanercept.,Promethazine
DB01074,The metabolism of Perhexiline can be increased when combined with Etanercept.,Perhexiline
DB01221,The metabolism of Ketamine can be increased when combined with Etanercept.,Ketamine
DB01466,The metabolism of Ethylmorphine can be increased when combined with Etanercept.,Ethylmorphine
DB01559,The metabolism of Clotiazepam can be increased when combined with Etanercept.,Clotiazepam
DB04938,The metabolism of Ospemifene can be increased when combined with Etanercept.,Ospemifene
DB04975,The metabolism of Banoxantrone can be increased when combined with Etanercept.,Banoxantrone
DB05541,The metabolism of Brivaracetam can be increased when combined with Etanercept.,Brivaracetam
DB06176,The metabolism of Romidepsin can be increased when combined with Etanercept.,Romidepsin
DB06209,The metabolism of Prasugrel can be increased when combined with Etanercept.,Prasugrel
DB06697,The metabolism of Artemether can be increased when combined with Etanercept.,Artemether
DB06710,The metabolism of Methyltestosterone can be increased when combined with Etanercept.,Methyltestosterone
DB06738,The metabolism of Ketobemidone can be increased when combined with Etanercept.,Ketobemidone
DB06739,The metabolism of Seratrodast can be increased when combined with Etanercept.,Seratrodast
DB11613,The metabolism of Velpatasvir can be increased when combined with Etanercept.,Velpatasvir
DB13132,The metabolism of Artemisinin can be increased when combined with Etanercept.,Artemisinin
DB13943,The metabolism of Testosterone cypionate can be increased when combined with Etanercept.,Testosterone cypionate
DB13944,The metabolism of Testosterone enanthate can be increased when combined with Etanercept.,Testosterone enanthate
DB13946,The metabolism of Testosterone undecanoate can be increased when combined with Etanercept.,Testosterone undecanoate
DB01156,The metabolism of Bupropion can be increased when combined with Etanercept.,Bupropion
DB00956,The metabolism of Hydrocodone can be increased when combined with Etanercept.,Hydrocodone
DB14975,The metabolism of Voxelotor can be increased when combined with Etanercept.,Voxelotor
DB11837,The metabolism of Osilodrostat can be increased when combined with Etanercept.,Osilodrostat
DB13384,The metabolism of Melitracen can be increased when combined with Etanercept.,Melitracen
DB13411,The metabolism of Lofepramine can be increased when combined with Etanercept.,Lofepramine
DB00714,The metabolism of Apomorphine can be increased when combined with Etanercept.,Apomorphine
DB09167,The metabolism of Dosulepin can be increased when combined with Etanercept.,Dosulepin
DB00213,The metabolism of Pantoprazole can be increased when combined with Etanercept.,Pantoprazole
DB00215,The metabolism of Citalopram can be increased when combined with Etanercept.,Citalopram
DB00312,The metabolism of Pentobarbital can be increased when combined with Etanercept.,Pentobarbital
DB00338,The metabolism of Omeprazole can be increased when combined with Etanercept.,Omeprazole
DB00347,The metabolism of Trimethadione can be increased when combined with Etanercept.,Trimethadione
DB00395,The metabolism of Carisoprodol can be increased when combined with Etanercept.,Carisoprodol
DB00448,The metabolism of Lansoprazole can be increased when combined with Etanercept.,Lansoprazole
DB00474,The metabolism of Methohexital can be increased when combined with Etanercept.,Methohexital
DB00582,The metabolism of Voriconazole can be increased when combined with Etanercept.,Voriconazole
DB00679,The metabolism of Thioridazine can be increased when combined with Etanercept.,Thioridazine
DB00736,The metabolism of Esomeprazole can be increased when combined with Etanercept.,Esomeprazole
DB00794,The metabolism of Primidone can be increased when combined with Etanercept.,Primidone
DB00909,The metabolism of Zonisamide can be increased when combined with Etanercept.,Zonisamide
DB01129,The metabolism of Rabeprazole can be increased when combined with Etanercept.,Rabeprazole
DB01131,The metabolism of Proguanil can be increased when combined with Etanercept.,Proguanil
DB01175,The metabolism of Escitalopram can be increased when combined with Etanercept.,Escitalopram
DB01259,The metabolism of Lapatinib can be increased when combined with Etanercept.,Lapatinib
DB01323,The metabolism of St. John's Wort can be increased when combined with Etanercept.,St. John's Wort
DB01355,The metabolism of Hexobarbital can be increased when combined with Etanercept.,Hexobarbital
DB01483,The metabolism of Barbital can be increased when combined with Etanercept.,Barbital
DB05246,The metabolism of Methsuximide can be increased when combined with Etanercept.,Methsuximide
DB05351,The metabolism of Dexlansoprazole can be increased when combined with Etanercept.,Dexlansoprazole
DB06218,The metabolism of Lacosamide can be increased when combined with Etanercept.,Lacosamide
DB06414,The metabolism of Etravirine can be increased when combined with Etanercept.,Etravirine
DB06605,The metabolism of Apixaban can be increased when combined with Etanercept.,Apixaban
DB09166,The metabolism of Etizolam can be increased when combined with Etanercept.,Etizolam
DB12130,The metabolism of Lorlatinib can be increased when combined with Etanercept.,Lorlatinib
DB12474,The metabolism of Lynestrenol can be increased when combined with Etanercept.,Lynestrenol
DB13762,The metabolism of Dexrabeprazole can be increased when combined with Etanercept.,Dexrabeprazole
DB14055,The metabolism of (S)-Warfarin can be increased when combined with Etanercept.,(S)-Warfarin
DB00715,The metabolism of Paroxetine can be increased when combined with Etanercept.,Paroxetine
DB12500,The metabolism of Fedratinib can be increased when combined with Etanercept.,Fedratinib
DB04861,The metabolism of Nebivolol can be increased when combined with Etanercept.,Nebivolol
DB06684,The metabolism of Vilazodone can be increased when combined with Etanercept.,Vilazodone
DB01104,The metabolism of Sertraline can be increased when combined with Etanercept.,Sertraline
DB11823,The metabolism of Esketamine can be increased when combined with Etanercept.,Esketamine
DB00252,The metabolism of Phenytoin can be increased when combined with Etanercept.,Phenytoin
DB00599,The metabolism of Thiopental can be increased when combined with Etanercept.,Thiopental
DB01174,The metabolism of Phenobarbital can be increased when combined with Etanercept.,Phenobarbital
DB01320,The metabolism of Fosphenytoin can be increased when combined with Etanercept.,Fosphenytoin
DB00613,The metabolism of Amodiaquine can be increased when combined with Etanercept.,Amodiaquine
DB00799,The metabolism of Tazarotene can be increased when combined with Etanercept.,Tazarotene
DB05229,The metabolism of Beraprost can be increased when combined with Etanercept.,Beraprost
DB06510,The metabolism of Muraglitazar can be increased when combined with Etanercept.,Muraglitazar
DB09296,The metabolism of Ombitasvir can be increased when combined with Etanercept.,Ombitasvir
DB01217,The metabolism of Anastrozole can be increased when combined with Etanercept.,Anastrozole
DB00255,The metabolism of Diethylstilbestrol can be increased when combined with Etanercept.,Diethylstilbestrol
DB00295,The metabolism of Morphine can be increased when combined with Etanercept.,Morphine
DB00359,The metabolism of Sulfadiazine can be increased when combined with Etanercept.,Sulfadiazine
DB00402,The metabolism of Eszopiclone can be increased when combined with Etanercept.,Eszopiclone
DB00622,The metabolism of Nicardipine can be increased when combined with Etanercept.,Nicardipine
DB00912,The metabolism of Repaglinide can be increased when combined with Etanercept.,Repaglinide
DB01261,The metabolism of Sitagliptin can be increased when combined with Etanercept.,Sitagliptin
DB06670,The metabolism of Odanacatib can be increased when combined with Etanercept.,Odanacatib
DB08502,The metabolism of Capravirine can be increased when combined with Etanercept.,Capravirine
DB08931,The metabolism of Riociguat can be increased when combined with Etanercept.,Riociguat
DB09198,The metabolism of Lobeglitazone can be increased when combined with Etanercept.,Lobeglitazone
DB09199,The metabolism of Netoglitazone can be increased when combined with Etanercept.,Netoglitazone
DB09200,The metabolism of Rivoglitazone can be increased when combined with Etanercept.,Rivoglitazone
DB09201,The metabolism of Ciglitazone can be increased when combined with Etanercept.,Ciglitazone
DB11362,The metabolism of Selexipag can be increased when combined with Etanercept.,Selexipag
DB11901,The metabolism of Apalutamide can be increased when combined with Etanercept.,Apalutamide
DB11978,The metabolism of Glasdegib can be increased when combined with Etanercept.,Glasdegib
DB12781,The metabolism of Balaglitazone can be increased when combined with Etanercept.,Balaglitazone
DB01132,The metabolism of Pioglitazone can be increased when combined with Etanercept.,Pioglitazone
DB11652,The metabolism of Tucatinib can be increased when combined with Etanercept.,Tucatinib
DB00946,The metabolism of Phenprocoumon can be increased when combined with Etanercept.,Phenprocoumon
DB01229,The metabolism of Paclitaxel can be increased when combined with Etanercept.,Paclitaxel
DB00177,The metabolism of Valsartan can be increased when combined with Etanercept.,Valsartan
DB00184,The metabolism of Nicotine can be increased when combined with Etanercept.,Nicotine
DB00197,The metabolism of Troglitazone can be increased when combined with Etanercept.,Troglitazone
DB00214,The metabolism of Torasemide can be increased when combined with Etanercept.,Torasemide
DB00222,The metabolism of Glimepiride can be increased when combined with Etanercept.,Glimepiride
DB00285,The metabolism of Venlafaxine can be increased when combined with Etanercept.,Venlafaxine
DB00304,The metabolism of Desogestrel can be increased when combined with Etanercept.,Desogestrel
DB00307,The metabolism of Bexarotene can be increased when combined with Etanercept.,Bexarotene
DB00327,The metabolism of Hydromorphone can be increased when combined with Etanercept.,Hydromorphone
DB00328,The metabolism of Indomethacin can be increased when combined with Etanercept.,Indomethacin
DB00343,The metabolism of Diltiazem can be increased when combined with Etanercept.,Diltiazem
DB00374,The metabolism of Treprostinil can be increased when combined with Etanercept.,Treprostinil
DB00412,The metabolism of Rosiglitazone can be increased when combined with Etanercept.,Rosiglitazone
DB00414,The metabolism of Acetohexamide can be increased when combined with Etanercept.,Acetohexamide
DB00420,The metabolism of Promazine can be increased when combined with Etanercept.,Promazine
DB00440,The metabolism of Trimethoprim can be increased when combined with Etanercept.,Trimethoprim
DB00461,The metabolism of Nabumetone can be increased when combined with Etanercept.,Nabumetone
DB00468,The metabolism of Quinine can be increased when combined with Etanercept.,Quinine
DB00469,The metabolism of Tenoxicam can be increased when combined with Etanercept.,Tenoxicam
DB00472,The metabolism of Fluoxetine can be increased when combined with Etanercept.,Fluoxetine
DB00476,The metabolism of Duloxetine can be increased when combined with Etanercept.,Duloxetine
DB00482,The metabolism of Celecoxib can be increased when combined with Etanercept.,Celecoxib
DB00495,The metabolism of Zidovudine can be increased when combined with Etanercept.,Zidovudine
DB00502,The metabolism of Haloperidol can be increased when combined with Etanercept.,Haloperidol
DB00533,The metabolism of Rofecoxib can be increased when combined with Etanercept.,Rofecoxib
DB00549,The metabolism of Zafirlukast can be increased when combined with Etanercept.,Zafirlukast
DB00554,The metabolism of Piroxicam can be increased when combined with Etanercept.,Piroxicam
DB00559,The metabolism of Bosentan can be increased when combined with Etanercept.,Bosentan
DB00568,The metabolism of Cinnarizine can be increased when combined with Etanercept.,Cinnarizine
DB00580,The metabolism of Valdecoxib can be increased when combined with Etanercept.,Valdecoxib
DB00586,The metabolism of Diclofenac can be increased when combined with Etanercept.,Diclofenac
DB00617,The metabolism of Paramethadione can be increased when combined with Etanercept.,Paramethadione
DB00661,The metabolism of Verapamil can be increased when combined with Etanercept.,Verapamil
DB00672,The metabolism of Chlorpropamide can be increased when combined with Etanercept.,Chlorpropamide
DB00678,The metabolism of Losartan can be increased when combined with Etanercept.,Losartan
DB00701,The metabolism of Amprenavir can be increased when combined with Etanercept.,Amprenavir
DB00712,The metabolism of Flurbiprofen can be increased when combined with Etanercept.,Flurbiprofen
DB00731,The metabolism of Nateglinide can be increased when combined with Etanercept.,Nateglinide
DB00744,The metabolism of Zileuton can be increased when combined with Etanercept.,Zileuton
DB00749,The metabolism of Etodolac can be increased when combined with Etanercept.,Etodolac
DB00755,The metabolism of Tretinoin can be increased when combined with Etanercept.,Tretinoin
DB00758,The metabolism of Clopidogrel can be increased when combined with Etanercept.,Clopidogrel
DB00783,The metabolism of Estradiol can be increased when combined with Etanercept.,Estradiol
DB00784,The metabolism of Mefenamic acid can be increased when combined with Etanercept.,Mefenamic acid
DB00788,The metabolism of Naproxen can be increased when combined with Etanercept.,Naproxen
DB00796,The metabolism of Candesartan cilexetil can be increased when combined with Etanercept.,Candesartan cilexetil
DB00812,The metabolism of Phenylbutazone can be increased when combined with Etanercept.,Phenylbutazone
DB00814,The metabolism of Meloxicam can be increased when combined with Etanercept.,Meloxicam
DB00839,The metabolism of Tolazamide can be increased when combined with Etanercept.,Tolazamide
DB00843,The metabolism of Donepezil can be increased when combined with Etanercept.,Donepezil
DB00857,The metabolism of Terbinafine can be increased when combined with Etanercept.,Terbinafine
DB00904,The metabolism of Ondansetron can be increased when combined with Etanercept.,Ondansetron
DB00921,The metabolism of Buprenorphine can be increased when combined with Etanercept.,Buprenorphine
DB00936,The metabolism of Salicylic acid can be increased when combined with Etanercept.,Salicylic acid
DB00945,The metabolism of Acetylsalicylic acid can be increased when combined with Etanercept.,Acetylsalicylic acid
DB00969,The metabolism of Alosetron can be increased when combined with Etanercept.,Alosetron
DB00972,The metabolism of Azelastine can be increased when combined with Etanercept.,Azelastine
DB00980,The metabolism of Ramelteon can be increased when combined with Etanercept.,Ramelteon
DB01016,The metabolism of Glyburide can be increased when combined with Etanercept.,Glyburide
DB01029,The metabolism of Irbesartan can be increased when combined with Etanercept.,Irbesartan
DB01036,The metabolism of Tolterodine can be increased when combined with Etanercept.,Tolterodine
DB01037,The metabolism of Selegiline can be increased when combined with Etanercept.,Selegiline
DB01041,The metabolism of Thalidomide can be increased when combined with Etanercept.,Thalidomide
DB01050,The metabolism of Ibuprofen can be increased when combined with Etanercept.,Ibuprofen
DB01065,The metabolism of Melatonin can be increased when combined with Etanercept.,Melatonin
DB01067,The metabolism of Glipizide can be increased when combined with Etanercept.,Glipizide
DB01072,The metabolism of Atazanavir can be increased when combined with Etanercept.,Atazanavir
DB01075,The metabolism of Diphenhydramine can be increased when combined with Etanercept.,Diphenhydramine
DB01095,The metabolism of Fluvastatin can be increased when combined with Etanercept.,Fluvastatin
DB01098,The metabolism of Rosuvastatin can be increased when combined with Etanercept.,Rosuvastatin
DB01120,The metabolism of Gliclazide can be increased when combined with Etanercept.,Gliclazide
DB01124,The metabolism of Tolbutamide can be increased when combined with Etanercept.,Tolbutamide
DB01136,The metabolism of Carvedilol can be increased when combined with Etanercept.,Carvedilol
DB01154,The metabolism of Thiamylal can be increased when combined with Etanercept.,Thiamylal
DB01171,The metabolism of Moclobemide can be increased when combined with Etanercept.,Moclobemide
DB01177,The metabolism of Idarubicin can be increased when combined with Etanercept.,Idarubicin
DB01198,The metabolism of Zopiclone can be increased when combined with Etanercept.,Zopiclone
DB01251,The metabolism of Gliquidone can be increased when combined with Etanercept.,Gliquidone
DB01283,The metabolism of Lumiracoxib can be increased when combined with Etanercept.,Lumiracoxib
DB01289,The metabolism of Glisoxepide can be increased when combined with Etanercept.,Glisoxepide
DB01357,The metabolism of Mestranol can be increased when combined with Etanercept.,Mestranol
DB01424,The metabolism of Aminophenazone can be increased when combined with Etanercept.,Aminophenazone
DB01435,The metabolism of Antipyrine can be increased when combined with Etanercept.,Antipyrine
DB01589,The metabolism of Quazepam can be increased when combined with Etanercept.,Quazepam
DB01628,The metabolism of Etoricoxib can be increased when combined with Etanercept.,Etoricoxib
DB03756,The metabolism of Doconexent can be increased when combined with Etanercept.,Doconexent
DB03783,The metabolism of Phenacetin can be increased when combined with Etanercept.,Phenacetin
DB04557,The metabolism of Arachidonic Acid can be increased when combined with Etanercept.,Arachidonic Acid
DB04574,The metabolism of Estrone sulfate can be increased when combined with Etanercept.,Estrone sulfate
DB04665,The metabolism of Coumarin can be increased when combined with Etanercept.,Coumarin
DB04725,The metabolism of Licofelone can be increased when combined with Etanercept.,Licofelone
DB04841,The metabolism of Flunarizine can be increased when combined with Etanercept.,Flunarizine
DB04898,The metabolism of Ximelagatran can be increased when combined with Etanercept.,Ximelagatran
DB06204,The metabolism of Tapentadol can be increased when combined with Etanercept.,Tapentadol
DB06268,The metabolism of Sitaxentan can be increased when combined with Etanercept.,Sitaxentan
DB06370,The metabolism of Indisulam can be increased when combined with Etanercept.,Indisulam
DB06652,The metabolism of Vicriviroc can be increased when combined with Etanercept.,Vicriviroc
DB06725,The metabolism of Lornoxicam can be increased when combined with Etanercept.,Lornoxicam
DB06737,The metabolism of Zaltoprofen can be increased when combined with Etanercept.,Zaltoprofen
DB06803,The metabolism of Niclosamide can be increased when combined with Etanercept.,Niclosamide
DB07615,The metabolism of Tranilast can be increased when combined with Etanercept.,Tranilast
DB08439,The metabolism of Parecoxib can be increased when combined with Etanercept.,Parecoxib
DB08828,The metabolism of Vismodegib can be increased when combined with Etanercept.,Vismodegib
DB08860,The metabolism of Pitavastatin can be increased when combined with Etanercept.,Pitavastatin
DB08875,The metabolism of Cabozantinib can be increased when combined with Etanercept.,Cabozantinib
DB08899,The metabolism of Enzalutamide can be increased when combined with Etanercept.,Enzalutamide
DB08962,The metabolism of Glibornuride can be increased when combined with Etanercept.,Glibornuride
DB09048,The metabolism of Netupitant can be increased when combined with Etanercept.,Netupitant
DB09061,The metabolism of Cannabidiol can be increased when combined with Etanercept.,Cannabidiol
DB09080,The metabolism of Olodaterol can be increased when combined with Etanercept.,Olodaterol
DB09288,The metabolism of Propacetamol can be increased when combined with Etanercept.,Propacetamol
DB11560,The metabolism of Lesinurad can be increased when combined with Etanercept.,Lesinurad
DB11614,The metabolism of Rupatadine can be increased when combined with Etanercept.,Rupatadine
DB13406,The metabolism of Carbutamide can be increased when combined with Etanercept.,Carbutamide
DB13675,The metabolism of Metahexamide can be increased when combined with Etanercept.,Metahexamide
DB13919,The metabolism of Candesartan can be increased when combined with Etanercept.,Candesartan
DB13941,The metabolism of Piperaquine can be increased when combined with Etanercept.,Piperaquine
DB13952,The metabolism of Estradiol acetate can be increased when combined with Etanercept.,Estradiol acetate
DB13953,The metabolism of Estradiol benzoate can be increased when combined with Etanercept.,Estradiol benzoate
DB13954,The metabolism of Estradiol cypionate can be increased when combined with Etanercept.,Estradiol cypionate
DB13955,The metabolism of Estradiol dienanthate can be increased when combined with Etanercept.,Estradiol dienanthate
DB13956,The metabolism of Estradiol valerate can be increased when combined with Etanercept.,Estradiol valerate
DB14009,The metabolism of Medical Cannabis can be increased when combined with Etanercept.,Medical Cannabis
DB14011,The metabolism of Nabiximols can be increased when combined with Etanercept.,Nabiximols
DB00829,The metabolism of Diazepam can be increased when combined with Etanercept.,Diazepam
DB00514,The metabolism of Dextromethorphan can be increased when combined with Etanercept.,Dextromethorphan
DB00470,The metabolism of Dronabinol can be increased when combined with Etanercept.,Dronabinol
DB09213,The metabolism of Dexibuprofen can be increased when combined with Etanercept.,Dexibuprofen
DB00465,The metabolism of Ketorolac can be increased when combined with Etanercept.,Ketorolac
DB15233,The metabolism of Avapritinib can be increased when combined with Etanercept.,Avapritinib
DB00321,The metabolism of Amitriptyline can be increased when combined with Etanercept.,Amitriptyline
DB01142,The metabolism of Doxepin can be increased when combined with Etanercept.,Doxepin
DB00216,The metabolism of Eletriptan can be increased when combined with Etanercept.,Eletriptan
DB00404,The metabolism of Alprazolam can be increased when combined with Etanercept.,Alprazolam
DB00726,The metabolism of Trimipramine can be increased when combined with Etanercept.,Trimipramine
DB01101,The metabolism of Capecitabine can be increased when combined with Etanercept.,Capecitabine
DB00266,The metabolism of Dicoumarol can be increased when combined with Etanercept.,Dicoumarol
DB00313,The metabolism of Valproic acid can be increased when combined with Etanercept.,Valproic acid
DB00908,The metabolism of Quinidine can be increased when combined with Etanercept.,Quinidine
DB13136,The metabolism of Fluindione can be increased when combined with Etanercept.,Fluindione
DB01224,The metabolism of Quetiapine can be increased when combined with Etanercept.,Quetiapine
DB00182,The metabolism of Amphetamine can be increased when combined with Etanercept.,Amphetamine
DB00187,The metabolism of Esmolol can be increased when combined with Etanercept.,Esmolol
DB00245,The metabolism of Benzatropine can be increased when combined with Etanercept.,Benzatropine
DB00289,The metabolism of Atomoxetine can be increased when combined with Etanercept.,Atomoxetine
DB00335,The metabolism of Atenolol can be increased when combined with Etanercept.,Atenolol
DB00373,The metabolism of Timolol can be increased when combined with Etanercept.,Timolol
DB00409,The metabolism of Remoxipride can be increased when combined with Etanercept.,Remoxipride
DB00592,The metabolism of Piperazine can be increased when combined with Etanercept.,Piperazine
DB00699,The metabolism of Nicergoline can be increased when combined with Etanercept.,Nicergoline
DB00737,The metabolism of Meclizine can be increased when combined with Etanercept.,Meclizine
DB00805,The metabolism of Minaprine can be increased when combined with Etanercept.,Minaprine
DB00866,The metabolism of Alprenolol can be increased when combined with Etanercept.,Alprenolol
DB00914,The metabolism of Phenformin can be increased when combined with Etanercept.,Phenformin
DB00933,The metabolism of Mesoridazine can be increased when combined with Etanercept.,Mesoridazine
DB00960,The metabolism of Pindolol can be increased when combined with Etanercept.,Pindolol
DB01071,The metabolism of Mequitazine can be increased when combined with Etanercept.,Mequitazine
DB01079,The metabolism of Tegaserod can be increased when combined with Etanercept.,Tegaserod
DB01193,The metabolism of Acebutolol can be increased when combined with Etanercept.,Acebutolol
DB01203,The metabolism of Nadolol can be increased when combined with Etanercept.,Nadolol
DB01228,The metabolism of Encainide can be increased when combined with Etanercept.,Encainide
DB01233,The metabolism of Metoclopramide can be increased when combined with Etanercept.,Metoclopramide
DB01255,The metabolism of Lisdexamfetamine can be increased when combined with Etanercept.,Lisdexamfetamine
DB01295,The metabolism of Bevantolol can be increased when combined with Etanercept.,Bevantolol
DB01297,The metabolism of Practolol can be increased when combined with Etanercept.,Practolol
DB01359,The metabolism of Penbutolol can be increased when combined with Etanercept.,Penbutolol
DB01403,The metabolism of Methotrimeprazine can be increased when combined with Etanercept.,Methotrimeprazine
DB01429,The metabolism of Aprindine can be increased when combined with Etanercept.,Aprindine
DB01454,The metabolism of Midomafetamine can be increased when combined with Etanercept.,Midomafetamine
DB01472,The metabolism of 4-Methoxyamphetamine can be increased when combined with Etanercept.,4-Methoxyamphetamine
DB01576,The metabolism of Dextroamphetamine can be increased when combined with Etanercept.,Dextroamphetamine
DB01577,The metabolism of Metamfetamine can be increased when combined with Etanercept.,Metamfetamine
DB01580,The metabolism of Oxprenolol can be increased when combined with Etanercept.,Oxprenolol
DB04840,The metabolism of Debrisoquine can be increased when combined with Etanercept.,Debrisoquine
DB04844,The metabolism of Tetrabenazine can be increased when combined with Etanercept.,Tetrabenazine
DB04846,The metabolism of Celiprolol can be increased when combined with Etanercept.,Celiprolol
DB06217,The metabolism of Vernakalant can be increased when combined with Etanercept.,Vernakalant
DB06506,The metabolism of Repinotan can be increased when combined with Etanercept.,Repinotan
DB06608,The metabolism of Tafenoquine can be increased when combined with Etanercept.,Tafenoquine
DB06678,The metabolism of Esmirtazapine can be increased when combined with Etanercept.,Esmirtazapine
DB06726,The metabolism of Bufuralol can be increased when combined with Etanercept.,Bufuralol
DB06727,The metabolism of Sparteine can be increased when combined with Etanercept.,Sparteine
DB06735,The metabolism of Enclomiphene can be increased when combined with Etanercept.,Enclomiphene
DB08807,The metabolism of Bopindolol can be increased when combined with Etanercept.,Bopindolol
DB08808,The metabolism of Bupranolol can be increased when combined with Etanercept.,Bupranolol
DB08952,The metabolism of Indenolol can be increased when combined with Etanercept.,Indenolol
DB09013,The metabolism of Befunolol can be increased when combined with Etanercept.,Befunolol
DB09076,The metabolism of Umeclidinium can be increased when combined with Etanercept.,Umeclidinium
DB09204,The metabolism of Arotinolol can be increased when combined with Etanercept.,Arotinolol
DB09351,The metabolism of Levobetaxolol can be increased when combined with Etanercept.,Levobetaxolol
DB11770,The metabolism of Talinolol can be increased when combined with Etanercept.,Talinolol
DB11785,The metabolism of Anisodamine can be increased when combined with Etanercept.,Anisodamine
DB11855,The metabolism of Revefenacin can be increased when combined with Etanercept.,Revefenacin
DB11979,The metabolism of Elagolix can be increased when combined with Etanercept.,Elagolix
DB12070,The metabolism of Letermovir can be increased when combined with Etanercept.,Letermovir
DB12212,The metabolism of Landiolol can be increased when combined with Etanercept.,Landiolol
DB12752,The metabolism of Bucindolol can be increased when combined with Etanercept.,Bucindolol
DB13443,The metabolism of Esatenolol can be increased when combined with Etanercept.,Esatenolol
DB13508,The metabolism of Cloranolol can be increased when combined with Etanercept.,Cloranolol
DB13530,The metabolism of Mepindolol can be increased when combined with Etanercept.,Mepindolol
DB13679,The metabolism of Dexchlorpheniramine can be increased when combined with Etanercept.,Dexchlorpheniramine
DB13757,The metabolism of Epanolol can be increased when combined with Etanercept.,Epanolol
DB13775,The metabolism of Tertatolol can be increased when combined with Etanercept.,Tertatolol
DB00850,The metabolism of Perphenazine can be increased when combined with Etanercept.,Perphenazine
DB09173,The metabolism of Butyrfentanyl can be increased when combined with Etanercept.,Butyrfentanyl
DB00281,The metabolism of Lidocaine can be increased when combined with Etanercept.,Lidocaine
DB00598,The metabolism of Labetalol can be increased when combined with Etanercept.,Labetalol
DB14010,"The metabolism of 5-methoxy-N,N-dimethyltryptamine can be increased when combined with Etanercept.","5-methoxy-N,N-dimethyltryptamine"
DB01410,The metabolism of Ciclesonide can be increased when combined with Etanercept.,Ciclesonide
DB00918,The metabolism of Almotriptan can be increased when combined with Etanercept.,Almotriptan
DB08918,The metabolism of Levomilnacipran can be increased when combined with Etanercept.,Levomilnacipran
DB08922,The metabolism of Perospirone can be increased when combined with Etanercept.,Perospirone
DB09183,The metabolism of Dasabuvir can be increased when combined with Etanercept.,Dasabuvir
DB00185,The metabolism of Cevimeline can be increased when combined with Etanercept.,Cevimeline
DB00243,The metabolism of Ranolazine can be increased when combined with Etanercept.,Ranolazine
DB00297,The metabolism of Bupivacaine can be increased when combined with Etanercept.,Bupivacaine
DB00318,The metabolism of Codeine can be increased when combined with Etanercept.,Codeine
DB00377,The metabolism of Palonosetron can be increased when combined with Etanercept.,Palonosetron
DB00589,The metabolism of Lisuride can be increased when combined with Etanercept.,Lisuride
DB00647,The metabolism of Dextropropoxyphene can be increased when combined with Etanercept.,Dextropropoxyphene
DB00674,The metabolism of Galantamine can be increased when combined with Etanercept.,Galantamine
DB00705,The metabolism of Delavirdine can be increased when combined with Etanercept.,Delavirdine
DB00706,The metabolism of Tamsulosin can be increased when combined with Etanercept.,Tamsulosin
DB00757,The metabolism of Dolasetron can be increased when combined with Etanercept.,Dolasetron
DB01149,The metabolism of Nefazodone can be increased when combined with Etanercept.,Nefazodone
DB01192,The metabolism of Oxymorphone can be increased when combined with Etanercept.,Oxymorphone
DB01244,The metabolism of Bepridil can be increased when combined with Etanercept.,Bepridil
DB01392,The metabolism of Yohimbine can be increased when combined with Etanercept.,Yohimbine
DB01409,The metabolism of Tiotropium can be increased when combined with Etanercept.,Tiotropium
DB01551,The metabolism of Dihydrocodeine can be increased when combined with Etanercept.,Dihydrocodeine
DB01591,The metabolism of Solifenacin can be increased when combined with Etanercept.,Solifenacin
DB01621,The metabolism of Pipotiazine can be increased when combined with Etanercept.,Pipotiazine
DB02703,The metabolism of Fusidic acid can be increased when combined with Etanercept.,Fusidic acid
DB04829,The metabolism of Lysergic acid diethylamide can be increased when combined with Etanercept.,Lysergic acid diethylamide
DB04884,The metabolism of Dapoxetine can be increased when combined with Etanercept.,Dapoxetine
DB04905,The metabolism of Tesmilifene can be increased when combined with Etanercept.,Tesmilifene
DB04920,The metabolism of Clevidipine can be increased when combined with Etanercept.,Clevidipine
DB05271,The metabolism of Rotigotine can be increased when combined with Etanercept.,Rotigotine
DB06016,The metabolism of Cariprazine can be increased when combined with Etanercept.,Cariprazine
DB06144,The metabolism of Sertindole can be increased when combined with Etanercept.,Sertindole
DB06203,The metabolism of Alogliptin can be increased when combined with Etanercept.,Alogliptin
DB06702,The metabolism of Fesoterodine can be increased when combined with Etanercept.,Fesoterodine
DB08893,The metabolism of Mirabegron can be increased when combined with Etanercept.,Mirabegron
DB09128,The metabolism of Brexpiprazole can be increased when combined with Etanercept.,Brexpiprazole
DB09195,The metabolism of Lorpiprazole can be increased when combined with Etanercept.,Lorpiprazole
DB09555,The metabolism of Dexchlorpheniramine maleate can be increased when combined with Etanercept.,Dexchlorpheniramine maleate
DB11130,The metabolism of Opium can be increased when combined with Etanercept.,Opium
DB11642,The metabolism of Pitolisant can be increased when combined with Etanercept.,Pitolisant
DB13293,The metabolism of Ipecac can be increased when combined with Etanercept.,Ipecac
DB00344,The metabolism of Protriptyline can be increased when combined with Etanercept.,Protriptyline
DB00496,The metabolism of Darifenacin can be increased when combined with Etanercept.,Darifenacin
DB00543,The metabolism of Amoxapine can be increased when combined with Etanercept.,Amoxapine
DB00932,The metabolism of Tipranavir can be increased when combined with Etanercept.,Tipranavir
DB09039,The metabolism of Eliglustat can be increased when combined with Etanercept.,Eliglustat
DB12930,The metabolism of Opipramol can be increased when combined with Etanercept.,Opipramol
DB00489,The metabolism of Sotalol can be increased when combined with Etanercept.,Sotalol
DB01035,The metabolism of Procainamide can be increased when combined with Etanercept.,Procainamide
DB01195,The metabolism of Flecainide can be increased when combined with Etanercept.,Flecainide
DB00228,The metabolism of Enflurane can be increased when combined with Etanercept.,Enflurane
DB06712,The metabolism of Nilvadipine can be increased when combined with Etanercept.,Nilvadipine
DB06728,The metabolism of Aniline can be increased when combined with Etanercept.,Aniline
DB00949,The metabolism of Felbamate can be increased when combined with Etanercept.,Felbamate
DB00593,The metabolism of Ethosuximide can be increased when combined with Etanercept.,Ethosuximide
DB00186,The metabolism of Lorazepam can be increased when combined with Etanercept.,Lorazepam
DB00191,The metabolism of Phentermine can be increased when combined with Etanercept.,Phentermine
DB00207,The metabolism of Azithromycin can be increased when combined with Etanercept.,Azithromycin
DB00208,The metabolism of Ticlopidine can be increased when combined with Etanercept.,Ticlopidine
DB00264,The metabolism of Metoprolol can be increased when combined with Etanercept.,Metoprolol
DB00426,The metabolism of Famciclovir can be increased when combined with Etanercept.,Famciclovir
DB00433,The metabolism of Prochlorperazine can be increased when combined with Etanercept.,Prochlorperazine
DB00567,The metabolism of Cephalexin can be increased when combined with Etanercept.,Cephalexin
DB00590,The metabolism of Doxazosin can be increased when combined with Etanercept.,Doxazosin
DB01039,The metabolism of Fenofibrate can be increased when combined with Etanercept.,Fenofibrate
DB01395,The metabolism of Drospirenone can be increased when combined with Etanercept.,Drospirenone
DB01411,The metabolism of Pranlukast can be increased when combined with Etanercept.,Pranlukast
DB01431,The metabolism of Allylestrenol can be increased when combined with Etanercept.,Allylestrenol
DB01624,The metabolism of Zuclopenthixol can be increased when combined with Etanercept.,Zuclopenthixol
DB06201,The metabolism of Rufinamide can be increased when combined with Etanercept.,Rufinamide
DB06480,The metabolism of Prucalopride can be increased when combined with Etanercept.,Prucalopride
DB08882,The metabolism of Linagliptin can be increased when combined with Etanercept.,Linagliptin
DB09030,The metabolism of Vorapaxar can be increased when combined with Etanercept.,Vorapaxar
DB09034,The metabolism of Suvorexant can be increased when combined with Etanercept.,Suvorexant
DB09079,The metabolism of Nintedanib can be increased when combined with Etanercept.,Nintedanib
DB09299,The metabolism of Tenofovir alafenamide can be increased when combined with Etanercept.,Tenofovir alafenamide
DB09330,The metabolism of Osimertinib can be increased when combined with Etanercept.,Osimertinib
DB11094,The metabolism of Vitamin D can be increased when combined with Etanercept.,Vitamin D
DB11273,The metabolism of Dihydroergocornine can be increased when combined with Etanercept.,Dihydroergocornine
DB11730,The metabolism of Ribociclib can be increased when combined with Etanercept.,Ribociclib
DB11952,The metabolism of Duvelisib can be increased when combined with Etanercept.,Duvelisib
DB12141,The metabolism of Gilteritinib can be increased when combined with Etanercept.,Gilteritinib
DB12515,The metabolism of 9-aminocamptothecin can be increased when combined with Etanercept.,9-aminocamptothecin
DB12952,The metabolism of Methylprednisone can be increased when combined with Etanercept.,Methylprednisone
DB13345,The metabolism of Dihydroergocristine can be increased when combined with Etanercept.,Dihydroergocristine
DB13385,The metabolism of Dihydroergocryptine can be increased when combined with Etanercept.,Dihydroergocryptine
DB14126,The metabolism of Tenofovir can be increased when combined with Etanercept.,Tenofovir
DB15444,The metabolism of Elexacaftor can be increased when combined with Etanercept.,Elexacaftor
DB06717,The metabolism of Fosaprepitant can be increased when combined with Etanercept.,Fosaprepitant
DB12825,The metabolism of Lefamulin can be increased when combined with Etanercept.,Lefamulin
DB12887,The metabolism of Tazemetostat can be increased when combined with Etanercept.,Tazemetostat
DB00454,The metabolism of Meperidine can be increased when combined with Etanercept.,Meperidine
DB01151,The metabolism of Desipramine can be increased when combined with Etanercept.,Desipramine
DB12371,The metabolism of Siponimod can be increased when combined with Etanercept.,Siponimod
DB00247,The metabolism of Methysergide can be increased when combined with Etanercept.,Methysergide
DB08827,The metabolism of Lomitapide can be increased when combined with Etanercept.,Lomitapide
DB11742,The metabolism of Ebastine can be increased when combined with Etanercept.,Ebastine
DB05015,The metabolism of Belinostat can be increased when combined with Etanercept.,Belinostat
DB01118,The metabolism of Amiodarone can be increased when combined with Etanercept.,Amiodarone
DB00675,The metabolism of Tamoxifen can be increased when combined with Etanercept.,Tamoxifen
DB00204,The metabolism of Dofetilide can be increased when combined with Etanercept.,Dofetilide
DB00342,The metabolism of Terfenadine can be increased when combined with Etanercept.,Terfenadine
DB00451,The metabolism of Levothyroxine can be increased when combined with Etanercept.,Levothyroxine
DB00604,The metabolism of Cisapride can be increased when combined with Etanercept.,Cisapride
DB00877,The metabolism of Sirolimus can be increased when combined with Etanercept.,Sirolimus
DB01008,The metabolism of Busulfan can be increased when combined with Etanercept.,Busulfan
DB01254,The metabolism of Dasatinib can be increased when combined with Etanercept.,Dasatinib
DB01396,The metabolism of Digitoxin can be increased when combined with Etanercept.,Digitoxin
DB01590,The metabolism of Everolimus can be increased when combined with Etanercept.,Everolimus
DB03410,The metabolism of 4-hydroxycoumarin can be increased when combined with Etanercept.,4-hydroxycoumarin
DB04855,The metabolism of Dronedarone can be increased when combined with Etanercept.,Dronedarone
DB06287,The metabolism of Temsirolimus can be increased when combined with Etanercept.,Temsirolimus
DB09053,The metabolism of Ibrutinib can be increased when combined with Etanercept.,Ibrutinib
DB09289,The metabolism of Tianeptine can be increased when combined with Etanercept.,Tianeptine
DB11633,The metabolism of Isavuconazole can be increased when combined with Etanercept.,Isavuconazole
DB13275,The metabolism of Clorindione can be increased when combined with Etanercept.,Clorindione
DB00398,The metabolism of Sorafenib can be increased when combined with Etanercept.,Sorafenib
DB00444,The metabolism of Teniposide can be increased when combined with Etanercept.,Teniposide
DB00530,The metabolism of Erlotinib can be increased when combined with Etanercept.,Erlotinib
DB00541,The metabolism of Vincristine can be increased when combined with Etanercept.,Vincristine
DB00619,The metabolism of Imatinib can be increased when combined with Etanercept.,Imatinib
DB00773,The metabolism of Etoposide can be increased when combined with Etanercept.,Etoposide
DB01248,The metabolism of Docetaxel can be increased when combined with Etanercept.,Docetaxel
DB01268,The metabolism of Sunitinib can be increased when combined with Etanercept.,Sunitinib
DB06626,The metabolism of Axitinib can be increased when combined with Etanercept.,Axitinib
DB08865,The metabolism of Crizotinib can be increased when combined with Etanercept.,Crizotinib
DB08901,The metabolism of Ponatinib can be increased when combined with Etanercept.,Ponatinib
DB12483,The metabolism of Copanlisib can be increased when combined with Etanercept.,Copanlisib
DB00188,The metabolism of Bortezomib can be increased when combined with Etanercept.,Bortezomib
DB00363,The metabolism of Clozapine can be increased when combined with Etanercept.,Clozapine
DB01181,The metabolism of Ifosfamide can be increased when combined with Etanercept.,Ifosfamide
DB05109,The metabolism of Trabectedin can be increased when combined with Etanercept.,Trabectedin
DB12147,The metabolism of Erdafitinib can be increased when combined with Etanercept.,Erdafitinib
DB13874,The metabolism of Enasidenib can be increased when combined with Etanercept.,Enasidenib
DB06589,The metabolism of Pazopanib can be increased when combined with Etanercept.,Pazopanib
DB05239,The metabolism of Cobimetinib can be increased when combined with Etanercept.,Cobimetinib
DB09063,The metabolism of Ceritinib can be increased when combined with Etanercept.,Ceritinib
DB11963,The metabolism of Dacomitinib can be increased when combined with Etanercept.,Dacomitinib
DB12015,The metabolism of Alpelisib can be increased when combined with Etanercept.,Alpelisib
DB00309,The metabolism of Vindesine can be increased when combined with Etanercept.,Vindesine
DB00361,The metabolism of Vinorelbine can be increased when combined with Etanercept.,Vinorelbine
DB00570,The metabolism of Vinblastine can be increased when combined with Etanercept.,Vinblastine
DB00694,The metabolism of Daunorubicin can be increased when combined with Etanercept.,Daunorubicin
DB00987,The metabolism of Cytarabine can be increased when combined with Etanercept.,Cytarabine
DB00997,The metabolism of Doxorubicin can be increased when combined with Etanercept.,Doxorubicin
DB01108,The metabolism of Trilostane can be increased when combined with Etanercept.,Trilostane
DB04572,The metabolism of Thiotepa can be increased when combined with Etanercept.,Thiotepa
DB04845,The metabolism of Ixabepilone can be increased when combined with Etanercept.,Ixabepilone
DB04868,The metabolism of Nilotinib can be increased when combined with Etanercept.,Nilotinib
DB06603,The metabolism of Panobinostat can be increased when combined with Etanercept.,Panobinostat
DB06616,The metabolism of Bosutinib can be increased when combined with Etanercept.,Bosutinib
DB08870,The metabolism of Brentuximab vedotin can be increased when combined with Etanercept.,Brentuximab vedotin
DB08877,The metabolism of Ruxolitinib can be increased when combined with Etanercept.,Ruxolitinib
DB09073,The metabolism of Palbociclib can be increased when combined with Etanercept.,Palbociclib
DB08912,The metabolism of Dabrafenib can be increased when combined with Etanercept.,Dabrafenib
DB12267,The metabolism of Brigatinib can be increased when combined with Etanercept.,Brigatinib
DB11718,The metabolism of Encorafenib can be increased when combined with Etanercept.,Encorafenib
DB00563,The metabolism of Methotrexate can be increased when combined with Etanercept.,Methotrexate
DB05294,The metabolism of Vandetanib can be increased when combined with Etanercept.,Vandetanib
DB05812,The metabolism of Abiraterone can be increased when combined with Etanercept.,Abiraterone
DB08881,The metabolism of Vemurafenib can be increased when combined with Etanercept.,Vemurafenib
DB11363,The metabolism of Alectinib can be increased when combined with Etanercept.,Alectinib
DB11581,The metabolism of Venetoclax can be increased when combined with Etanercept.,Venetoclax
DB11641,The metabolism of Vinflunine can be increased when combined with Etanercept.,Vinflunine
DB11703,The metabolism of Acalabrutinib can be increased when combined with Etanercept.,Acalabrutinib
DB15035,The metabolism of Zanubrutinib can be increased when combined with Etanercept.,Zanubrutinib
DB00248,The metabolism of Cabergoline can be increased when combined with Etanercept.,Cabergoline
DB06595,The metabolism of Midostaurin can be increased when combined with Etanercept.,Midostaurin
DB09143,The metabolism of Sonidegib can be increased when combined with Etanercept.,Sonidegib
DB11828,The metabolism of Neratinib can be increased when combined with Etanercept.,Neratinib
DB11986,The metabolism of Entrectinib can be increased when combined with Etanercept.,Entrectinib
DB12978,The metabolism of Pexidartinib can be increased when combined with Etanercept.,Pexidartinib
DB14568,The metabolism of Ivosidenib can be increased when combined with Etanercept.,Ivosidenib
DB09054,The metabolism of Idelalisib can be increased when combined with Etanercept.,Idelalisib
DB09570,The metabolism of Ixazomib can be increased when combined with Etanercept.,Ixazomib
DB00199,The metabolism of Erythromycin can be increased when combined with Etanercept.,Erythromycin
DB00246,The metabolism of Ziprasidone can be increased when combined with Etanercept.,Ziprasidone
DB00439,The metabolism of Cerivastatin can be increased when combined with Etanercept.,Cerivastatin
DB00499,The metabolism of Flutamide can be increased when combined with Etanercept.,Flutamide
DB00528,The metabolism of Lercanidipine can be increased when combined with Etanercept.,Lercanidipine
DB00571,The metabolism of Propranolol can be increased when combined with Etanercept.,Propranolol
DB00588,The metabolism of Fluticasone propionate can be increased when combined with Etanercept.,Fluticasone propionate
DB00608,The metabolism of Chloroquine can be increased when combined with Etanercept.,Chloroquine
DB00688,The metabolism of Mycophenolate mofetil can be increased when combined with Etanercept.,Mycophenolate mofetil
DB00717,The metabolism of Norethisterone can be increased when combined with Etanercept.,Norethisterone
DB00738,The metabolism of Pentamidine can be increased when combined with Etanercept.,Pentamidine
DB00741,The metabolism of Hydrocortisone can be increased when combined with Etanercept.,Hydrocortisone
DB00762,The metabolism of Irinotecan can be increased when combined with Etanercept.,Irinotecan
DB00822,The metabolism of Disulfiram can be increased when combined with Etanercept.,Disulfiram
DB00834,The metabolism of Mifepristone can be increased when combined with Etanercept.,Mifepristone
DB00938,The metabolism of Salmeterol can be increased when combined with Etanercept.,Salmeterol
DB00962,The metabolism of Zaleplon can be increased when combined with Etanercept.,Zaleplon
DB00976,The metabolism of Telithromycin can be increased when combined with Etanercept.,Telithromycin
DB01054,The metabolism of Nitrendipine can be increased when combined with Etanercept.,Nitrendipine
DB01058,The metabolism of Praziquantel can be increased when combined with Etanercept.,Praziquantel
DB01062,The metabolism of Oxybutynin can be increased when combined with Etanercept.,Oxybutynin
DB01076,The metabolism of Atorvastatin can be increased when combined with Etanercept.,Atorvastatin
DB01103,The metabolism of Quinacrine can be increased when combined with Etanercept.,Quinacrine
DB01115,The metabolism of Nifedipine can be increased when combined with Etanercept.,Nifedipine
DB01126,The metabolism of Dutasteride can be increased when combined with Etanercept.,Dutasteride
DB01166,The metabolism of Cilostazol can be increased when combined with Etanercept.,Cilostazol
DB01184,The metabolism of Domperidone can be increased when combined with Etanercept.,Domperidone
DB01211,The metabolism of Clarithromycin can be increased when combined with Etanercept.,Clarithromycin
DB01216,The metabolism of Finasteride can be increased when combined with Etanercept.,Finasteride
DB01218,The metabolism of Halofantrine can be increased when combined with Etanercept.,Halofantrine
DB05521,The metabolism of Telaprevir can be increased when combined with Etanercept.,Telaprevir
DB05773,The metabolism of Trastuzumab emtansine can be increased when combined with Etanercept.,Trastuzumab emtansine
DB06267,The metabolism of Udenafil can be increased when combined with Etanercept.,Udenafil
DB06335,The metabolism of Saxagliptin can be increased when combined with Etanercept.,Saxagliptin
DB06403,The metabolism of Ambrisentan can be increased when combined with Etanercept.,Ambrisentan
DB06419,The metabolism of Cethromycin can be increased when combined with Etanercept.,Cethromycin
DB06772,The metabolism of Cabazitaxel can be increased when combined with Etanercept.,Cabazitaxel
DB06789,The metabolism of Hydroxyprogesterone caproate can be increased when combined with Etanercept.,Hydroxyprogesterone caproate
DB08820,The metabolism of Ivacaftor can be increased when combined with Etanercept.,Ivacaftor
DB08873,The metabolism of Boceprevir can be increased when combined with Etanercept.,Boceprevir
DB08883,The metabolism of Perampanel can be increased when combined with Etanercept.,Perampanel
DB08906,The metabolism of Fluticasone furoate can be increased when combined with Etanercept.,Fluticasone furoate
DB09065,The metabolism of Cobicistat can be increased when combined with Etanercept.,Cobicistat
DB09074,The metabolism of Olaparib can be increased when combined with Etanercept.,Olaparib
DB09102,The metabolism of Daclatasvir can be increased when combined with Etanercept.,Daclatasvir
DB09231,The metabolism of Benidipine can be increased when combined with Etanercept.,Benidipine
DB09297,The metabolism of Paritaprevir can be increased when combined with Etanercept.,Paritaprevir
DB11574,The metabolism of Elbasvir can be increased when combined with Etanercept.,Elbasvir
DB11712,The metabolism of Tezacaftor can be increased when combined with Etanercept.,Tezacaftor
DB11737,The metabolism of Icotinib can be increased when combined with Etanercept.,Icotinib
DB12301,The metabolism of Doravirine can be increased when combined with Etanercept.,Doravirine
DB13867,The metabolism of Fluticasone can be increased when combined with Etanercept.,Fluticasone
DB14538,The metabolism of Hydrocortisone aceponate can be increased when combined with Etanercept.,Hydrocortisone aceponate
DB14539,The metabolism of Hydrocortisone acetate can be increased when combined with Etanercept.,Hydrocortisone acetate
DB14541,The metabolism of Hydrocortisone cypionate can be increased when combined with Etanercept.,Hydrocortisone cypionate
DB14542,The metabolism of Hydrocortisone phosphate can be increased when combined with Etanercept.,Hydrocortisone phosphate
DB00396,The metabolism of Progesterone can be increased when combined with Etanercept.,Progesterone
DB04856,The metabolism of Dexloxiglumide can be increased when combined with Etanercept.,Dexloxiglumide
DB04957,The metabolism of Azimilide can be increased when combined with Etanercept.,Azimilide
DB00250,The metabolism of Dapsone can be increased when combined with Etanercept.,Dapsone
DB00317,The metabolism of Gefitinib can be increased when combined with Etanercept.,Gefitinib
DB00367,The metabolism of Levonorgestrel can be increased when combined with Etanercept.,Levonorgestrel
DB00497,The metabolism of Oxycodone can be increased when combined with Etanercept.,Oxycodone
DB00620,The metabolism of Triamcinolone can be increased when combined with Etanercept.,Triamcinolone
DB00624,The metabolism of Testosterone can be increased when combined with Etanercept.,Testosterone
DB00656,The metabolism of Trazodone can be increased when combined with Etanercept.,Trazodone
DB00734,The metabolism of Risperidone can be increased when combined with Etanercept.,Risperidone
DB01114,The metabolism of Chlorpheniramine can be increased when combined with Etanercept.,Chlorpheniramine
DB01238,The metabolism of Aripiprazole can be increased when combined with Etanercept.,Aripiprazole
DB01267,The metabolism of Paliperidone can be increased when combined with Etanercept.,Paliperidone
DB04946,The metabolism of Iloperidone can be increased when combined with Etanercept.,Iloperidone
DB11915,The metabolism of Valbenazine can be increased when combined with Etanercept.,Valbenazine
DB12161,The metabolism of Deutetrabenazine can be increased when combined with Etanercept.,Deutetrabenazine
DB14185,The metabolism of Aripiprazole lauroxil can be increased when combined with Etanercept.,Aripiprazole lauroxil
DB01234,The metabolism of Dexamethasone can be increased when combined with Etanercept.,Dexamethasone
DB09237,The metabolism of Levamlodipine can be increased when combined with Etanercept.,Levamlodipine
DB11951,The metabolism of Lemborexant can be increased when combined with Etanercept.,Lemborexant
DB00557,The metabolism of Hydroxyzine can be increased when combined with Etanercept.,Hydroxyzine
DB00203,The metabolism of Sildenafil can be increased when combined with Etanercept.,Sildenafil
DB00227,The metabolism of Lovastatin can be increased when combined with Etanercept.,Lovastatin
DB00490,The metabolism of Buspirone can be increased when combined with Etanercept.,Buspirone
DB00641,The metabolism of Simvastatin can be increased when combined with Etanercept.,Simvastatin
DB00673,The metabolism of Aprepitant can be increased when combined with Etanercept.,Aprepitant
DB00820,The metabolism of Tadalafil can be increased when combined with Etanercept.,Tadalafil
DB00862,The metabolism of Vardenafil can be increased when combined with Etanercept.,Vardenafil
DB01190,The metabolism of Clindamycin can be increased when combined with Etanercept.,Clindamycin
DB00503,The metabolism of Ritonavir can be increased when combined with Etanercept.,Ritonavir
DB00224,The metabolism of Indinavir can be increased when combined with Etanercept.,Indinavir
DB00401,The metabolism of Nisoldipine can be increased when combined with Etanercept.,Nisoldipine
DB00637,The metabolism of Astemizole can be increased when combined with Etanercept.,Astemizole
DB00683,The metabolism of Midazolam can be increased when combined with Etanercept.,Midazolam
DB00700,The metabolism of Eplerenone can be increased when combined with Etanercept.,Eplerenone
DB00802,The metabolism of Alfentanil can be increased when combined with Etanercept.,Alfentanil
DB00813,The metabolism of Fentanyl can be increased when combined with Etanercept.,Fentanyl
DB00897,The metabolism of Triazolam can be increased when combined with Etanercept.,Triazolam
DB01023,The metabolism of Felodipine can be increased when combined with Etanercept.,Felodipine
DB01227,The metabolism of Levacetylmethadol can be increased when combined with Etanercept.,Levacetylmethadol
DB01232,The metabolism of Saquinavir can be increased when combined with Etanercept.,Saquinavir
DB06228,The metabolism of Rivaroxaban can be increased when combined with Etanercept.,Rivaroxaban
DB05804,The metabolism of Prasterone sulfate can be increased when combined with Etanercept.,Prasterone sulfate
DB00091,Etanercept may increase the immunosuppressive activities of Cyclosporine.,Cyclosporine
DB05676,The therapeutic efficacy of Apremilast can be decreased when used in combination with Etanercept.,Apremilast
DB14513,The serum concentration of Magnesium can be decreased when it is combined with Etanercept.,Magnesium
DB01601,The serum concentration of Etanercept can be increased when it is combined with Lopinavir.,Lopinavir
DB12530,The risk or severity of infection can be increased when Etanercept is combined with Inebilizumab.,Inebilizumab
DB06605,Apixaban may increase the anticoagulant activities of Bivalirudin.,Apixaban
DB06695,Dabigatran etexilate may increase the anticoagulant activities of Bivalirudin.,Dabigatran etexilate
DB01254,The risk or severity of bleeding and hemorrhage can be increased when Dasatinib is combined with Bivalirudin.,Dasatinib
DB01609,The risk or severity of gastrointestinal bleeding can be increased when Bivalirudin is combined with Deferasirox.,Deferasirox
DB01586,The risk or severity of bleeding and bruising can be increased when Bivalirudin is combined with Ursodeoxycholic acid.,Ursodeoxycholic acid
DB02123,The risk or severity of bleeding and bruising can be increased when Bivalirudin is combined with Glycochenodeoxycholic Acid.,Glycochenodeoxycholic Acid
DB02659,The risk or severity of bleeding and bruising can be increased when Bivalirudin is combined with Cholic Acid.,Cholic Acid
DB02691,The risk or severity of bleeding and bruising can be increased when Bivalirudin is combined with Glycocholic acid.,Glycocholic acid
DB03619,The risk or severity of bleeding and bruising can be increased when Bivalirudin is combined with Deoxycholic acid.,Deoxycholic acid
DB04348,The risk or severity of bleeding and bruising can be increased when Bivalirudin is combined with Taurocholic acid.,Taurocholic acid
DB05990,The risk or severity of bleeding and bruising can be increased when Bivalirudin is combined with Obeticholic acid.,Obeticholic acid
DB06777,The risk or severity of bleeding and bruising can be increased when Bivalirudin is combined with Chenodeoxycholic acid.,Chenodeoxycholic acid
DB08833,The risk or severity of bleeding and bruising can be increased when Bivalirudin is combined with Taurochenodeoxycholic acid.,Taurochenodeoxycholic acid
DB08834,The risk or severity of bleeding and bruising can be increased when Bivalirudin is combined with Tauroursodeoxycholic acid.,Tauroursodeoxycholic acid
DB08857,The risk or severity of bleeding and bruising can be increased when Bivalirudin is combined with Bamet-UD2.,Bamet-UD2
DB11622,The risk or severity of bleeding and bruising can be increased when Bivalirudin is combined with Dehydrocholic acid.,Dehydrocholic acid
DB11789,The risk or severity of bleeding and bruising can be increased when Bivalirudin is combined with Hyodeoxycholic Acid.,Hyodeoxycholic Acid
DB09075,The risk or severity of bleeding can be increased when Edoxaban is combined with Bivalirudin.,Edoxaban
DB09053,The risk or severity of bleeding and hemorrhage can be increased when Ibrutinib is combined with Bivalirudin.,Ibrutinib
DB08935,The risk or severity of bleeding and hemorrhage can be increased when Bivalirudin is combined with Obinutuzumab.,Obinutuzumab
DB06228,Bivalirudin may increase the anticoagulant activities of Rivaroxaban.,Rivaroxaban
DB06206,The risk or severity of bleeding and hemorrhage can be increased when Bivalirudin is combined with Sugammadex.,Sugammadex
DB09070,Tibolone may increase the anticoagulant activities of Bivalirudin.,Tibolone
DB00932,The risk or severity of bleeding and hemorrhage can be increased when Tipranavir is combined with Bivalirudin.,Tipranavir
DB00013,Urokinase may increase the anticoagulant activities of Bivalirudin.,Urokinase
DB00163,Vitamin E may increase the anticoagulant activities of Bivalirudin.,Vitamin E
DB09030,The risk or severity of bleeding and hemorrhage can be increased when Vorapaxar is combined with Bivalirudin.,Vorapaxar
DB01381,The therapeutic efficacy of Bivalirudin can be increased when used in combination with Ginkgo biloba.,Ginkgo biloba
DB01181,The risk or severity of bleeding can be increased when Ifosfamide is combined with Bivalirudin.,Ifosfamide
DB00468,The therapeutic efficacy of Bivalirudin can be increased when used in combination with Quinine.,Quinine
DB00908,The therapeutic efficacy of Bivalirudin can be increased when used in combination with Quinidine.,Quinidine
DB00675,The risk or severity of bleeding can be increased when Tamoxifen is combined with Bivalirudin.,Tamoxifen
DB00539,The risk or severity of bleeding can be increased when Toremifene is combined with Bivalirudin.,Toremifene
DB00806,The therapeutic efficacy of Bivalirudin can be increased when used in combination with Pentoxifylline.,Pentoxifylline
DB00686,Pentosan polysulfate may increase the anticoagulant activities of Bivalirudin.,Pentosan polysulfate
DB00583,The therapeutic efficacy of Bivalirudin can be increased when used in combination with Levocarnitine.,Levocarnitine
DB00255,Diethylstilbestrol may decrease the anticoagulant activities of Bivalirudin.,Diethylstilbestrol
DB00269,Chlorotrianisene may decrease the anticoagulant activities of Bivalirudin.,Chlorotrianisene
DB00286,Conjugated estrogens may decrease the anticoagulant activities of Bivalirudin.,Conjugated estrogens
DB00783,Estradiol may decrease the anticoagulant activities of Bivalirudin.,Estradiol
DB00977,Ethinylestradiol may decrease the anticoagulant activities of Bivalirudin.,Ethinylestradiol
DB01357,Mestranol may decrease the anticoagulant activities of Bivalirudin.,Mestranol
DB04573,Estriol may decrease the anticoagulant activities of Bivalirudin.,Estriol
DB04574,Estrone sulfate may decrease the anticoagulant activities of Bivalirudin.,Estrone sulfate
DB04575,Quinestrol may decrease the anticoagulant activities of Bivalirudin.,Quinestrol
DB07931,Hexestrol may decrease the anticoagulant activities of Bivalirudin.,Hexestrol
DB09317,"Synthetic Conjugated Estrogens, A may decrease the anticoagulant activities of Bivalirudin.","Synthetic Conjugated Estrogens, A"
DB09318,"Synthetic Conjugated Estrogens, B may decrease the anticoagulant activities of Bivalirudin.","Synthetic Conjugated Estrogens, B"
DB09369,Polyestradiol phosphate may decrease the anticoagulant activities of Bivalirudin.,Polyestradiol phosphate
DB09381,Esterified estrogens may decrease the anticoagulant activities of Bivalirudin.,Esterified estrogens
DB11478,Zeranol may decrease the anticoagulant activities of Bivalirudin.,Zeranol
DB11674,Equol may decrease the anticoagulant activities of Bivalirudin.,Equol
DB12487,Promestriene may decrease the anticoagulant activities of Bivalirudin.,Promestriene
DB13143,Methallenestril may decrease the anticoagulant activities of Bivalirudin.,Methallenestril
DB13386,Epimestrol may decrease the anticoagulant activities of Bivalirudin.,Epimestrol
DB13418,Moxestrol may decrease the anticoagulant activities of Bivalirudin.,Moxestrol
DB13952,Estradiol acetate may decrease the anticoagulant activities of Bivalirudin.,Estradiol acetate
DB13953,Estradiol benzoate may decrease the anticoagulant activities of Bivalirudin.,Estradiol benzoate
DB13954,Estradiol cypionate may decrease the anticoagulant activities of Bivalirudin.,Estradiol cypionate
DB13956,Estradiol valerate may decrease the anticoagulant activities of Bivalirudin.,Estradiol valerate
DB15334,Biochanin A may decrease the anticoagulant activities of Bivalirudin.,Biochanin A
DB15335,Formononetin may decrease the anticoagulant activities of Bivalirudin.,Formononetin
DB09211,The risk or severity of adverse effects can be increased when Limaprost is combined with Bivalirudin.,Limaprost
DB00159,The risk or severity of bleeding and hemorrhage can be increased when Icosapent is combined with Bivalirudin.,Icosapent
DB00244,The risk or severity of bleeding and hemorrhage can be increased when Mesalazine is combined with Bivalirudin.,Mesalazine
DB00328,The risk or severity of bleeding and hemorrhage can be increased when Indomethacin is combined with Bivalirudin.,Indomethacin
DB00461,The risk or severity of bleeding and hemorrhage can be increased when Nabumetone is combined with Bivalirudin.,Nabumetone
DB00465,The risk or severity of bleeding and hemorrhage can be increased when Ketorolac is combined with Bivalirudin.,Ketorolac
DB00469,The risk or severity of bleeding and hemorrhage can be increased when Tenoxicam is combined with Bivalirudin.,Tenoxicam
DB00482,The risk or severity of bleeding and hemorrhage can be increased when Celecoxib is combined with Bivalirudin.,Celecoxib
DB00500,The risk or severity of bleeding and hemorrhage can be increased when Tolmetin is combined with Bivalirudin.,Tolmetin
DB00533,The risk or severity of bleeding and hemorrhage can be increased when Rofecoxib is combined with Bivalirudin.,Rofecoxib
DB00554,The risk or severity of bleeding and hemorrhage can be increased when Piroxicam is combined with Bivalirudin.,Piroxicam
DB00573,The risk or severity of bleeding and hemorrhage can be increased when Fenoprofen is combined with Bivalirudin.,Fenoprofen
DB00580,The risk or severity of bleeding and hemorrhage can be increased when Valdecoxib is combined with Bivalirudin.,Valdecoxib
DB00586,The risk or severity of bleeding and hemorrhage can be increased when Diclofenac is combined with Bivalirudin.,Diclofenac
DB00605,The risk or severity of bleeding and hemorrhage can be increased when Sulindac is combined with Bivalirudin.,Sulindac
DB00712,The risk or severity of bleeding and hemorrhage can be increased when Flurbiprofen is combined with Bivalirudin.,Flurbiprofen
DB00749,The risk or severity of bleeding and hemorrhage can be increased when Etodolac is combined with Bivalirudin.,Etodolac
DB00784,The risk or severity of bleeding and hemorrhage can be increased when Mefenamic acid is combined with Bivalirudin.,Mefenamic acid
DB00788,The risk or severity of bleeding and hemorrhage can be increased when Naproxen is combined with Bivalirudin.,Naproxen
DB00795,The risk or severity of bleeding and hemorrhage can be increased when Sulfasalazine is combined with Bivalirudin.,Sulfasalazine
DB00812,The risk or severity of bleeding and hemorrhage can be increased when Phenylbutazone is combined with Bivalirudin.,Phenylbutazone
DB00814,The risk or severity of bleeding and hemorrhage can be increased when Meloxicam is combined with Bivalirudin.,Meloxicam
DB00821,The risk or severity of bleeding and hemorrhage can be increased when Carprofen is combined with Bivalirudin.,Carprofen
DB00861,The risk or severity of bleeding and hemorrhage can be increased when Diflunisal is combined with Bivalirudin.,Diflunisal
DB00936,The risk or severity of bleeding and hemorrhage can be increased when Salicylic acid is combined with Bivalirudin.,Salicylic acid
DB00939,The risk or severity of bleeding and hemorrhage can be increased when Meclofenamic acid is combined with Bivalirudin.,Meclofenamic acid
DB00991,The risk or severity of bleeding and hemorrhage can be increased when Oxaprozin is combined with Bivalirudin.,Oxaprozin
DB01009,The risk or severity of bleeding and hemorrhage can be increased when Ketoprofen is combined with Bivalirudin.,Ketoprofen
DB01014,The risk or severity of bleeding and hemorrhage can be increased when Balsalazide is combined with Bivalirudin.,Balsalazide
DB01250,The risk or severity of bleeding and hemorrhage can be increased when Olsalazine is combined with Bivalirudin.,Olsalazine
DB01283,The risk or severity of bleeding and hemorrhage can be increased when Lumiracoxib is combined with Bivalirudin.,Lumiracoxib
DB01397,The risk or severity of bleeding and hemorrhage can be increased when Magnesium salicylate is combined with Bivalirudin.,Magnesium salicylate
DB01399,The risk or severity of bleeding and hemorrhage can be increased when Salsalate is combined with Bivalirudin.,Salsalate
DB01401,The risk or severity of bleeding and hemorrhage can be increased when Choline magnesium trisalicylate is combined with Bivalirudin.,Choline magnesium trisalicylate
DB01419,The risk or severity of bleeding and hemorrhage can be increased when Antrafenine is combined with Bivalirudin.,Antrafenine
DB01424,The risk or severity of bleeding and hemorrhage can be increased when Aminophenazone is combined with Bivalirudin.,Aminophenazone
DB01435,The risk or severity of bleeding and hemorrhage can be increased when Antipyrine is combined with Bivalirudin.,Antipyrine
DB01600,The risk or severity of bleeding and hemorrhage can be increased when Tiaprofenic acid is combined with Bivalirudin.,Tiaprofenic acid
DB01628,The risk or severity of bleeding and hemorrhage can be increased when Etoricoxib is combined with Bivalirudin.,Etoricoxib
DB02224,The risk or severity of bleeding and hemorrhage can be increased when Taxifolin is combined with Bivalirudin.,Taxifolin
DB03585,The risk or severity of bleeding and hemorrhage can be increased when Oxyphenbutazone is combined with Bivalirudin.,Oxyphenbutazone
DB04552,The risk or severity of bleeding and hemorrhage can be increased when Niflumic acid is combined with Bivalirudin.,Niflumic acid
DB04725,The risk or severity of bleeding and hemorrhage can be increased when Licofelone is combined with Bivalirudin.,Licofelone
DB04812,The risk or severity of bleeding and hemorrhage can be increased when Benoxaprofen is combined with Bivalirudin.,Benoxaprofen
DB04817,The risk or severity of bleeding and hemorrhage can be increased when Metamizole is combined with Bivalirudin.,Metamizole
DB04828,The risk or severity of bleeding and hemorrhage can be increased when Zomepirac is combined with Bivalirudin.,Zomepirac
DB05095,The risk or severity of bleeding and hemorrhage can be increased when Cimicoxib is combined with Bivalirudin.,Cimicoxib
DB06725,The risk or severity of bleeding and hemorrhage can be increased when Lornoxicam is combined with Bivalirudin.,Lornoxicam
DB06736,The risk or severity of bleeding and hemorrhage can be increased when Aceclofenac is combined with Bivalirudin.,Aceclofenac
DB06737,The risk or severity of bleeding and hemorrhage can be increased when Zaltoprofen is combined with Bivalirudin.,Zaltoprofen
DB07402,The risk or severity of bleeding and hemorrhage can be increased when Azapropazone is combined with Bivalirudin.,Azapropazone
DB07477,The risk or severity of bleeding and hemorrhage can be increased when Felbinac is combined with Bivalirudin.,Felbinac
DB08439,The risk or severity of bleeding and hemorrhage can be increased when Parecoxib is combined with Bivalirudin.,Parecoxib
DB08797,The risk or severity of bleeding and hemorrhage can be increased when Salicylamide is combined with Bivalirudin.,Salicylamide
DB08940,The risk or severity of bleeding and hemorrhage can be increased when Kebuzone is combined with Bivalirudin.,Kebuzone
DB08942,The risk or severity of bleeding and hemorrhage can be increased when Isoxicam is combined with Bivalirudin.,Isoxicam
DB08951,The risk or severity of bleeding and hemorrhage can be increased when Indoprofen is combined with Bivalirudin.,Indoprofen
DB08955,The risk or severity of bleeding and hemorrhage can be increased when Ibuproxam is combined with Bivalirudin.,Ibuproxam
DB08976,The risk or severity of bleeding and hemorrhage can be increased when Floctafenine is combined with Bivalirudin.,Floctafenine
DB08981,The risk or severity of bleeding and hemorrhage can be increased when Fenbufen is combined with Bivalirudin.,Fenbufen
DB08984,The risk or severity of bleeding and hemorrhage can be increased when Etofenamate is combined with Bivalirudin.,Etofenamate
DB08991,The risk or severity of bleeding and hemorrhage can be increased when Epirizole is combined with Bivalirudin.,Epirizole
DB09084,The risk or severity of bleeding and hemorrhage can be increased when Benzydamine is combined with Bivalirudin.,Benzydamine
DB09212,The risk or severity of bleeding and hemorrhage can be increased when Loxoprofen is combined with Bivalirudin.,Loxoprofen
DB09214,The risk or severity of bleeding and hemorrhage can be increased when Dexketoprofen is combined with Bivalirudin.,Dexketoprofen
DB09215,The risk or severity of bleeding and hemorrhage can be increased when Droxicam is combined with Bivalirudin.,Droxicam
DB09216,The risk or severity of bleeding and hemorrhage can be increased when Tolfenamic acid is combined with Bivalirudin.,Tolfenamic acid
DB09217,The risk or severity of bleeding and hemorrhage can be increased when Firocoxib is combined with Bivalirudin.,Firocoxib
DB09218,The risk or severity of bleeding and hemorrhage can be increased when Clonixin is combined with Bivalirudin.,Clonixin
DB09285,The risk or severity of bleeding and hemorrhage can be increased when Morniflumate is combined with Bivalirudin.,Morniflumate
DB09288,The risk or severity of bleeding and hemorrhage can be increased when Propacetamol is combined with Bivalirudin.,Propacetamol
DB09295,The risk or severity of bleeding and hemorrhage can be increased when Talniflumate is combined with Bivalirudin.,Talniflumate
DB11455,The risk or severity of bleeding and hemorrhage can be increased when Robenacoxib is combined with Bivalirudin.,Robenacoxib
DB11466,The risk or severity of bleeding and hemorrhage can be increased when Tepoxalin is combined with Bivalirudin.,Tepoxalin
DB11518,The risk or severity of bleeding and hemorrhage can be increased when Flunixin is combined with Bivalirudin.,Flunixin
DB12399,The risk or severity of bleeding and hemorrhage can be increased when Polmacoxib is combined with Bivalirudin.,Polmacoxib
DB12480,The risk or severity of bleeding and hemorrhage can be increased when Betulinic Acid is combined with Bivalirudin.,Betulinic Acid
DB12610,The risk or severity of bleeding and hemorrhage can be increased when Ebselen is combined with Bivalirudin.,Ebselen
DB13001,The risk or severity of bleeding and hemorrhage can be increased when Tinoridine is combined with Bivalirudin.,Tinoridine
DB13167,The risk or severity of bleeding and hemorrhage can be increased when Alclofenac is combined with Bivalirudin.,Alclofenac
DB13217,The risk or severity of bleeding and hemorrhage can be increased when Fentiazac is combined with Bivalirudin.,Fentiazac
DB13232,The risk or severity of bleeding and hemorrhage can be increased when Suxibuzone is combined with Bivalirudin.,Suxibuzone
DB13286,The risk or severity of bleeding and hemorrhage can be increased when Bumadizone is combined with Bivalirudin.,Bumadizone
DB13314,The risk or severity of bleeding and hemorrhage can be increased when Alminoprofen is combined with Bivalirudin.,Alminoprofen
DB13317,The risk or severity of bleeding and hemorrhage can be increased when Flunoxaprofen is combined with Bivalirudin.,Flunoxaprofen
DB13364,The risk or severity of bleeding and hemorrhage can be increased when Feprazone is combined with Bivalirudin.,Feprazone
DB13371,The risk or severity of bleeding and hemorrhage can be increased when Difenpiramide is combined with Bivalirudin.,Difenpiramide
DB13407,The risk or severity of bleeding and hemorrhage can be increased when Nifenazone is combined with Bivalirudin.,Nifenazone
DB13432,The risk or severity of bleeding and hemorrhage can be increased when Lonazolac is combined with Bivalirudin.,Lonazolac
DB13481,The risk or severity of bleeding and hemorrhage can be increased when Tenidap is combined with Bivalirudin.,Tenidap
DB13501,The risk or severity of bleeding and hemorrhage can be increased when Bendazac is combined with Bivalirudin.,Bendazac
DB13514,The risk or severity of bleeding and hemorrhage can be increased when Pranoprofen is combined with Bivalirudin.,Pranoprofen
DB13524,The risk or severity of bleeding and hemorrhage can be increased when Propyphenazone is combined with Bivalirudin.,Propyphenazone
DB13527,The risk or severity of bleeding and hemorrhage can be increased when Proglumetacin is combined with Bivalirudin.,Proglumetacin
DB13538,The risk or severity of bleeding and hemorrhage can be increased when Guacetisal is combined with Bivalirudin.,Guacetisal
DB13544,The risk or severity of bleeding and hemorrhage can be increased when Ethenzamide is combined with Bivalirudin.,Ethenzamide
DB13612,The risk or severity of bleeding and hemorrhage can be increased when Carbaspirin calcium is combined with Bivalirudin.,Carbaspirin calcium
DB13629,The risk or severity of bleeding and hemorrhage can be increased when Mofebutazone is combined with Bivalirudin.,Mofebutazone
DB13649,The risk or severity of bleeding and hemorrhage can be increased when Proquazone is combined with Bivalirudin.,Proquazone
DB13657,The risk or severity of bleeding and hemorrhage can be increased when Benorilate is combined with Bivalirudin.,Benorilate
DB13722,The risk or severity of bleeding and hemorrhage can be increased when Pirprofen is combined with Bivalirudin.,Pirprofen
DB13860,The risk or severity of bleeding and hemorrhage can be increased when Imidazole salicylate is combined with Bivalirudin.,Imidazole salicylate
DB14059,The risk or severity of bleeding and hemorrhage can be increased when SC-236 is combined with Bivalirudin.,SC-236
DB14060,The risk or severity of bleeding and hemorrhage can be increased when NS-398 is combined with Bivalirudin.,NS-398
DB14938,The risk or severity of bleeding and hemorrhage can be increased when Flurbiprofen axetil is combined with Bivalirudin.,Flurbiprofen axetil
DB04865,The risk or severity of bleeding can be increased when Bivalirudin is combined with Omacetaxine mepesuccinate.,Omacetaxine mepesuccinate
DB11133,Omega-3 fatty acids may increase the anticoagulant activities of Bivalirudin.,Omega-3 fatty acids
DB00081,The risk or severity of bleeding and hemorrhage can be increased when Bivalirudin is combined with Tositumomab.,Tositumomab
DB00048,The risk or severity of adverse effects can be increased when Bivalirudin is combined with Collagenase clostridium histolyticum.,Collagenase clostridium histolyticum
DB00389,Carbimazole may increase the anticoagulant activities of Bivalirudin.,Carbimazole
DB00550,Propylthiouracil may increase the anticoagulant activities of Bivalirudin.,Propylthiouracil
DB00763,Methimazole may increase the anticoagulant activities of Bivalirudin.,Methimazole
DB03374,"3,5-Diiodotyrosine may increase the anticoagulant activities of Bivalirudin.","3,5-Diiodotyrosine"
DB06715,Potassium Iodide may increase the anticoagulant activities of Bivalirudin.,Potassium Iodide
DB07637,Dibromotyrosine may increase the anticoagulant activities of Bivalirudin.,Dibromotyrosine
DB09418,Potassium perchlorate may increase the anticoagulant activities of Bivalirudin.,Potassium perchlorate
DB13644,Methylthiouracil may increase the anticoagulant activities of Bivalirudin.,Methylthiouracil
DB13804,Benzylthiouracil may increase the anticoagulant activities of Bivalirudin.,Benzylthiouracil
DB00834,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Mifepristone.,Mifepristone
DB04066,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with p-Coumaric acid.,p-Coumaric acid
DB04682,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Octylphenoxy polyethoxyethanol.,Octylphenoxy polyethoxyethanol
DB05830,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Trestolone.,Trestolone
DB06266,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Lonidamine.,Lonidamine
DB08867,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Ulipristal.,Ulipristal
DB09401,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Isosorbide.,Isosorbide
DB11507,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cloprostenol.,Cloprostenol
DB12025,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Triptolide.,Triptolide
DB13044,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Gossypol.,Gossypol
DB13310,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Ormeloxifene.,Ormeloxifene
DB00294,Etonogestrel may decrease the anticoagulant activities of Bivalirudin.,Etonogestrel
DB00304,Desogestrel may decrease the anticoagulant activities of Bivalirudin.,Desogestrel
DB00351,Megestrol acetate may decrease the anticoagulant activities of Bivalirudin.,Megestrol acetate
DB00367,Levonorgestrel may decrease the anticoagulant activities of Bivalirudin.,Levonorgestrel
DB00378,Dydrogesterone may decrease the anticoagulant activities of Bivalirudin.,Dydrogesterone
DB00396,Progesterone may decrease the anticoagulant activities of Bivalirudin.,Progesterone
DB00603,Medroxyprogesterone acetate may decrease the anticoagulant activities of Bivalirudin.,Medroxyprogesterone acetate
DB00717,Norethisterone may decrease the anticoagulant activities of Bivalirudin.,Norethisterone
DB00823,Ethynodiol diacetate may decrease the anticoagulant activities of Bivalirudin.,Ethynodiol diacetate
DB00957,Norgestimate may decrease the anticoagulant activities of Bivalirudin.,Norgestimate
DB01395,Drospirenone may decrease the anticoagulant activities of Bivalirudin.,Drospirenone
DB01431,Allylestrenol may decrease the anticoagulant activities of Bivalirudin.,Allylestrenol
DB04839,Cyproterone acetate may decrease the anticoagulant activities of Bivalirudin.,Cyproterone acetate
DB06713,Norelgestromin may decrease the anticoagulant activities of Bivalirudin.,Norelgestromin
DB06730,Gestodene may decrease the anticoagulant activities of Bivalirudin.,Gestodene
DB06789,Hydroxyprogesterone caproate may decrease the anticoagulant activities of Bivalirudin.,Hydroxyprogesterone caproate
DB09123,Dienogest may decrease the anticoagulant activities of Bivalirudin.,Dienogest
DB09124,Medrogestone may decrease the anticoagulant activities of Bivalirudin.,Medrogestone
DB09371,Norethynodrel may decrease the anticoagulant activities of Bivalirudin.,Norethynodrel
DB09389,Norgestrel may decrease the anticoagulant activities of Bivalirudin.,Norgestrel
DB11372,Altrenogest may decrease the anticoagulant activities of Bivalirudin.,Altrenogest
DB11619,Gestrinone may decrease the anticoagulant activities of Bivalirudin.,Gestrinone
DB11636,Nomegestrol may decrease the anticoagulant activities of Bivalirudin.,Nomegestrol
DB12474,Lynestrenol may decrease the anticoagulant activities of Bivalirudin.,Lynestrenol
DB13230,Gestonorone may decrease the anticoagulant activities of Bivalirudin.,Gestonorone
DB13528,Chlormadinone may decrease the anticoagulant activities of Bivalirudin.,Chlormadinone
DB13533,Methylestrenolone may decrease the anticoagulant activities of Bivalirudin.,Methylestrenolone
DB13563,Norgestrienone may decrease the anticoagulant activities of Bivalirudin.,Norgestrienone
DB13602,Promegestone may decrease the anticoagulant activities of Bivalirudin.,Promegestone
DB13685,Quingestanol may decrease the anticoagulant activities of Bivalirudin.,Quingestanol
DB13857,Demegestone may decrease the anticoagulant activities of Bivalirudin.,Demegestone
DB13866,Etynodiol may decrease the anticoagulant activities of Bivalirudin.,Etynodiol
DB13981,Nomegestrol acetate may decrease the anticoagulant activities of Bivalirudin.,Nomegestrol acetate
DB14570,Hydroxyprogesterone may decrease the anticoagulant activities of Bivalirudin.,Hydroxyprogesterone
DB14678,Norethindrone enanthate may decrease the anticoagulant activities of Bivalirudin.,Norethindrone enanthate
DB14679,Quingestanol acetate may decrease the anticoagulant activities of Bivalirudin.,Quingestanol acetate
DB00233,The risk or severity of bleeding can be increased when Aminosalicylic acid is combined with Bivalirudin.,Aminosalicylic acid
DB01294,The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Bivalirudin.,Bismuth subsalicylate
DB06251,The risk or severity of bleeding can be increased when Dersalazine is combined with Bivalirudin.,Dersalazine
DB06807,The risk or severity of bleeding can be increased when Phenyl aminosalicylate is combined with Bivalirudin.,Phenyl aminosalicylate
DB09543,The risk or severity of bleeding can be increased when Methyl salicylate is combined with Bivalirudin.,Methyl salicylate
DB11079,The risk or severity of bleeding can be increased when Trolamine salicylate is combined with Bivalirudin.,Trolamine salicylate
DB13509,The risk or severity of bleeding can be increased when Aloxiprin is combined with Bivalirudin.,Aloxiprin
DB14006,The risk or severity of bleeding can be increased when Choline salicylate is combined with Bivalirudin.,Choline salicylate
DB14026,The risk or severity of bleeding can be increased when Thiosalicylic acid is combined with Bivalirudin.,Thiosalicylic acid
DB00054,The risk or severity of bleeding can be increased when Abciximab is combined with Bivalirudin.,Abciximab
DB00063,The risk or severity of bleeding can be increased when Eptifibatide is combined with Bivalirudin.,Eptifibatide
DB00208,The risk or severity of bleeding can be increased when Ticlopidine is combined with Bivalirudin.,Ticlopidine
DB00261,The risk or severity of bleeding can be increased when Anagrelide is combined with Bivalirudin.,Anagrelide
DB00758,The risk or severity of bleeding can be increased when Clopidogrel is combined with Bivalirudin.,Clopidogrel
DB00775,The risk or severity of bleeding can be increased when Tirofiban is combined with Bivalirudin.,Tirofiban
DB00975,The risk or severity of bleeding can be increased when Dipyridamole is combined with Bivalirudin.,Dipyridamole
DB01088,The risk or severity of bleeding can be increased when Iloprost is combined with Bivalirudin.,Iloprost
DB01138,The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Bivalirudin.,Sulfinpyrazone
DB01166,The risk or severity of bleeding can be increased when Cilostazol is combined with Bivalirudin.,Cilostazol
DB01207,The risk or severity of bleeding can be increased when Ridogrel is combined with Bivalirudin.,Ridogrel
DB01236,The risk or severity of bleeding can be increased when Sevoflurane is combined with Bivalirudin.,Sevoflurane
DB01240,The risk or severity of bleeding can be increased when Epoprostenol is combined with Bivalirudin.,Epoprostenol
DB02709,The risk or severity of bleeding can be increased when Resveratrol is combined with Bivalirudin.,Resveratrol
DB04743,The risk or severity of bleeding can be increased when Nimesulide is combined with Bivalirudin.,Nimesulide
DB04905,The risk or severity of bleeding can be increased when Tesmilifene is combined with Bivalirudin.,Tesmilifene
DB04932,The risk or severity of bleeding can be increased when Defibrotide is combined with Bivalirudin.,Defibrotide
DB05229,The risk or severity of bleeding can be increased when Beraprost is combined with Bivalirudin.,Beraprost
DB05266,The risk or severity of bleeding can be increased when Ibudilast is combined with Bivalirudin.,Ibudilast
DB05767,The risk or severity of bleeding can be increased when Andrographolide is combined with Bivalirudin.,Andrographolide
DB06081,The risk or severity of bleeding can be increased when Caplacizumab is combined with Bivalirudin.,Caplacizumab
DB06209,The risk or severity of bleeding can be increased when Prasugrel is combined with Bivalirudin.,Prasugrel
DB06441,The risk or severity of bleeding can be increased when Cangrelor is combined with Bivalirudin.,Cangrelor
DB07615,The risk or severity of bleeding can be increased when Tranilast is combined with Bivalirudin.,Tranilast
DB08814,The risk or severity of bleeding can be increased when Triflusal is combined with Bivalirudin.,Triflusal
DB08816,The risk or severity of bleeding can be increased when Ticagrelor is combined with Bivalirudin.,Ticagrelor
DB08887,The risk or severity of bleeding can be increased when Icosapent ethyl is combined with Bivalirudin.,Icosapent ethyl
DB09283,The risk or severity of bleeding can be increased when Trapidil is combined with Bivalirudin.,Trapidil
DB12092,The risk or severity of bleeding can be increased when Naftopidil is combined with Bivalirudin.,Naftopidil
DB12163,The risk or severity of bleeding can be increased when Sarpogrelate is combined with Bivalirudin.,Sarpogrelate
DB12321,The risk or severity of bleeding can be increased when Ifetroban is combined with Bivalirudin.,Ifetroban
DB12445,The risk or severity of bleeding can be increased when Nitroaspirin is combined with Bivalirudin.,Nitroaspirin
DB12465,The risk or severity of bleeding can be increased when Ketanserin is combined with Bivalirudin.,Ketanserin
DB12545,The risk or severity of bleeding can be increased when Indobufen is combined with Bivalirudin.,Indobufen
DB12749,The risk or severity of bleeding can be increased when Butylphthalide is combined with Bivalirudin.,Butylphthalide
DB12771,The risk or severity of bleeding can be increased when Hydroxytyrosol is combined with Bivalirudin.,Hydroxytyrosol
DB13036,The risk or severity of bleeding can be increased when Ramatroban is combined with Bivalirudin.,Ramatroban
DB13327,The risk or severity of bleeding can be increased when Picotamide is combined with Bivalirudin.,Picotamide
DB13367,The risk or severity of bleeding can be increased when Cloricromen is combined with Bivalirudin.,Cloricromen
DB13400,The risk or severity of bleeding can be increased when Linsidomine is combined with Bivalirudin.,Linsidomine
DB13510,The risk or severity of bleeding can be increased when Buflomedil is combined with Bivalirudin.,Buflomedil
DB13929,The risk or severity of bleeding can be increased when Relcovaptan is combined with Bivalirudin.,Relcovaptan
DB00374,The risk or severity of bleeding can be increased when Treprostinil is combined with Bivalirudin.,Treprostinil
DB03404,Hemin may increase the anticoagulant activities of Bivalirudin.,Hemin
DB13783,The risk or severity of bleeding and hemorrhage can be increased when Acemetacin is combined with Bivalirudin.,Acemetacin
DB00624,Testosterone may increase the anticoagulant activities of Bivalirudin.,Testosterone
DB01420,Testosterone propionate may increase the anticoagulant activities of Bivalirudin.,Testosterone propionate
DB01481,1-Testosterone may increase the anticoagulant activities of Bivalirudin.,1-Testosterone
DB01485,4-Hydroxytestosterone may increase the anticoagulant activities of Bivalirudin.,4-Hydroxytestosterone
DB01510,Dehydrochloromethyltestosterone may increase the anticoagulant activities of Bivalirudin.,Dehydrochloromethyltestosterone
DB01541,Boldenone may increase the anticoagulant activities of Bivalirudin.,Boldenone
DB01543,18-methyl-19-nortestosterone may increase the anticoagulant activities of Bivalirudin.,18-methyl-19-nortestosterone
DB01564,Calusterone may increase the anticoagulant activities of Bivalirudin.,Calusterone
DB01569,Formebolone may increase the anticoagulant activities of Bivalirudin.,Formebolone
DB01572,Methyl-1-testosterone may increase the anticoagulant activities of Bivalirudin.,Methyl-1-testosterone
DB02901,Stanolone may increase the anticoagulant activities of Bivalirudin.,Stanolone
DB07447,5beta-dihydrotestosterone may increase the anticoagulant activities of Bivalirudin.,5beta-dihydrotestosterone
DB08619,Testosterone succinate may increase the anticoagulant activities of Bivalirudin.,Testosterone succinate
DB11429,Mibolerone may increase the anticoagulant activities of Bivalirudin.,Mibolerone
DB13943,Testosterone cypionate may increase the anticoagulant activities of Bivalirudin.,Testosterone cypionate
DB13944,Testosterone enanthate may increase the anticoagulant activities of Bivalirudin.,Testosterone enanthate
DB13946,Testosterone undecanoate may increase the anticoagulant activities of Bivalirudin.,Testosterone undecanoate
DB13947,Testosterone enantate benzilic acid hydrazone may increase the anticoagulant activities of Bivalirudin.,Testosterone enantate benzilic acid hydrazone
DB13951,Stanolone acetate may increase the anticoagulant activities of Bivalirudin.,Stanolone acetate
DB13958,Trestolone acetate may increase the anticoagulant activities of Bivalirudin.,Trestolone acetate
DB14093,"(1,2,6,7-3H)Testosterone may increase the anticoagulant activities of Bivalirudin.","(1,2,6,7-3H)Testosterone"
DB14655,Drostanolone propionate may increase the anticoagulant activities of Bivalirudin.,Drostanolone propionate
DB11051,The risk or severity of adverse effects can be increased when Bivalirudin is combined with Azficel-T.,Azficel-T
DB09568,The therapeutic efficacy of Bivalirudin can be increased when used in combination with Omega-3-carboxylic acids.,Omega-3-carboxylic acids
DB00025,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Bivalirudin.","Antihemophilic factor, human recombinant"
DB00036,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Bivalirudin.,Coagulation factor VIIa Recombinant Human
DB00100,The therapeutic efficacy of Coagulation Factor IX (Recombinant) can be decreased when used in combination with Bivalirudin.,Coagulation Factor IX (Recombinant)
DB00258,The therapeutic efficacy of Calcium acetate can be decreased when used in combination with Bivalirudin.,Calcium acetate
DB01164,The therapeutic efficacy of Calcium chloride can be decreased when used in combination with Bivalirudin.,Calcium chloride
DB01373,The therapeutic efficacy of Calcium can be decreased when used in combination with Bivalirudin.,Calcium
DB01783,The therapeutic efficacy of Pantothenic acid can be decreased when used in combination with Bivalirudin.,Pantothenic acid
DB01942,The therapeutic efficacy of Formic acid can be decreased when used in combination with Bivalirudin.,Formic acid
DB02261,The therapeutic efficacy of Platelet Activating Factor can be decreased when used in combination with Bivalirudin.,Platelet Activating Factor
DB06724,The therapeutic efficacy of Calcium carbonate can be decreased when used in combination with Bivalirudin.,Calcium carbonate
DB09109,The therapeutic efficacy of Turoctocog alfa can be decreased when used in combination with Bivalirudin.,Turoctocog alfa
DB09222,The therapeutic efficacy of Fibrinogen human can be decreased when used in combination with Bivalirudin.,Fibrinogen human
DB09310,The therapeutic efficacy of Catridecacog can be decreased when used in combination with Bivalirudin.,Catridecacog
DB09329,"The therapeutic efficacy of Antihemophilic Factor (Recombinant), PEGylated can be decreased when used in combination with Bivalirudin.","Antihemophilic Factor (Recombinant), PEGylated"
DB11093,The therapeutic efficacy of Calcium citrate can be decreased when used in combination with Bivalirudin.,Calcium citrate
DB11126,The therapeutic efficacy of Calcium gluconate can be decreased when used in combination with Bivalirudin.,Calcium gluconate
DB11168,The therapeutic efficacy of Calcium threonate can be decreased when used in combination with Bivalirudin.,Calcium threonate
DB11311,The therapeutic efficacy of Prothrombin can be decreased when used in combination with Bivalirudin.,Prothrombin
DB11330,The therapeutic efficacy of Factor IX Complex (Human) can be decreased when used in combination with Bivalirudin.,Factor IX Complex (Human)
DB11348,The therapeutic efficacy of Calcium Phosphate can be decreased when used in combination with Bivalirudin.,Calcium Phosphate
DB11606,The therapeutic efficacy of Susoctocog alfa can be decreased when used in combination with Bivalirudin.,Susoctocog alfa
DB11608,The therapeutic efficacy of Eftrenonacog alfa can be decreased when used in combination with Bivalirudin.,Eftrenonacog alfa
DB11668,The therapeutic efficacy of Rusalatide acetate can be decreased when used in combination with Bivalirudin.,Rusalatide acetate
DB12409,The therapeutic efficacy of Vatreptacog alfa can be decreased when used in combination with Bivalirudin.,Vatreptacog alfa
DB12909,The therapeutic efficacy of Factor XIII (human) can be decreased when used in combination with Bivalirudin.,Factor XIII (human)
DB13133,The therapeutic efficacy of Von Willebrand Factor Human can be decreased when used in combination with Bivalirudin.,Von Willebrand Factor Human
DB13148,The therapeutic efficacy of Coagulation factor X human can be decreased when used in combination with Bivalirudin.,Coagulation factor X human
DB13150,The therapeutic efficacy of Coagulation factor VII human can be decreased when used in combination with Bivalirudin.,Coagulation factor VII human
DB13151,The therapeutic efficacy of Anti-inhibitor coagulant complex can be decreased when used in combination with Bivalirudin.,Anti-inhibitor coagulant complex
DB13152,The therapeutic efficacy of Coagulation Factor IX Human can be decreased when used in combination with Bivalirudin.,Coagulation Factor IX Human
DB13192,The therapeutic efficacy of Antihemophilic factor human can be decreased when used in combination with Bivalirudin.,Antihemophilic factor human
DB13197,The therapeutic efficacy of Kallidinogenase can be decreased when used in combination with Bivalirudin.,Kallidinogenase
DB13201,The therapeutic efficacy of Trenonacog alfa can be decreased when used in combination with Bivalirudin.,Trenonacog alfa
DB13884,The therapeutic efficacy of Albutrepenonacog alfa can be decreased when used in combination with Bivalirudin.,Albutrepenonacog alfa
DB13923,The therapeutic efficacy of Emicizumab can be decreased when used in combination with Bivalirudin.,Emicizumab
DB13933,The therapeutic efficacy of Nonacog beta pegol can be decreased when used in combination with Bivalirudin.,Nonacog beta pegol
DB13999,The therapeutic efficacy of Moroctocog alfa can be decreased when used in combination with Bivalirudin.,Moroctocog alfa
DB14473,The therapeutic efficacy of Beroctocog alfa can be decreased when used in combination with Bivalirudin.,Beroctocog alfa
DB14562,The therapeutic efficacy of Andexanet alfa can be decreased when used in combination with Bivalirudin.,Andexanet alfa
DB14577,The therapeutic efficacy of Calcium cation can be decreased when used in combination with Bivalirudin.,Calcium cation
DB14700,The therapeutic efficacy of Damoctocog alfa pegol can be decreased when used in combination with Bivalirudin.,Damoctocog alfa pegol
DB14738,The therapeutic efficacy of Turoctocog alfa pegol can be decreased when used in combination with Bivalirudin.,Turoctocog alfa pegol
DB00176,The risk or severity of hemorrhage can be increased when Fluvoxamine is combined with Bivalirudin.,Fluvoxamine
DB00215,The risk or severity of hemorrhage can be increased when Citalopram is combined with Bivalirudin.,Citalopram
DB00472,The risk or severity of hemorrhage can be increased when Fluoxetine is combined with Bivalirudin.,Fluoxetine
DB00715,The risk or severity of hemorrhage can be increased when Paroxetine is combined with Bivalirudin.,Paroxetine
DB01149,The risk or severity of hemorrhage can be increased when Nefazodone is combined with Bivalirudin.,Nefazodone
DB04832,The risk or severity of hemorrhage can be increased when Zimelidine is combined with Bivalirudin.,Zimelidine
DB04884,The risk or severity of hemorrhage can be increased when Dapoxetine is combined with Bivalirudin.,Dapoxetine
DB06731,The risk or severity of hemorrhage can be increased when Seproxetine is combined with Bivalirudin.,Seproxetine
DB08953,The risk or severity of hemorrhage can be increased when Indalpine is combined with Bivalirudin.,Indalpine
DB12693,The risk or severity of hemorrhage can be increased when Ritanserin is combined with Bivalirudin.,Ritanserin
DB13233,The risk or severity of hemorrhage can be increased when Alaproclate is combined with Bivalirudin.,Alaproclate
DB00476,The risk or severity of hemorrhage can be increased when Duloxetine is combined with Bivalirudin.,Duloxetine
DB01105,The risk or severity of hemorrhage can be increased when Sibutramine is combined with Bivalirudin.,Sibutramine
DB04896,The risk or severity of hemorrhage can be increased when Milnacipran is combined with Bivalirudin.,Milnacipran
DB06700,The risk or severity of hemorrhage can be increased when Desvenlafaxine is combined with Bivalirudin.,Desvenlafaxine
DB08918,The risk or severity of hemorrhage can be increased when Levomilnacipran is combined with Bivalirudin.,Levomilnacipran
DB00285,Venlafaxine may increase the antiplatelet activities of Bivalirudin.,Venlafaxine
DB00182,The risk or severity of bleeding and hemorrhage can be increased when Amphetamine is combined with Bivalirudin.,Amphetamine
DB00601,The risk or severity of bleeding and hemorrhage can be increased when Linezolid is combined with Bivalirudin.,Linezolid
DB00614,The risk or severity of bleeding and hemorrhage can be increased when Furazolidone is combined with Bivalirudin.,Furazolidone
DB00721,The risk or severity of bleeding and hemorrhage can be increased when Procaine is combined with Bivalirudin.,Procaine
DB00752,The risk or severity of bleeding and hemorrhage can be increased when Tranylcypromine is combined with Bivalirudin.,Tranylcypromine
DB00780,The risk or severity of bleeding and hemorrhage can be increased when Phenelzine is combined with Bivalirudin.,Phenelzine
DB00805,The risk or severity of bleeding and hemorrhage can be increased when Minaprine is combined with Bivalirudin.,Minaprine
DB01037,The risk or severity of bleeding and hemorrhage can be increased when Selegiline is combined with Bivalirudin.,Selegiline
DB01168,The risk or severity of bleeding and hemorrhage can be increased when Procarbazine is combined with Bivalirudin.,Procarbazine
DB01171,The risk or severity of bleeding and hemorrhage can be increased when Moclobemide is combined with Bivalirudin.,Moclobemide
DB01247,The risk or severity of bleeding and hemorrhage can be increased when Isocarboxazid is combined with Bivalirudin.,Isocarboxazid
DB01367,The risk or severity of bleeding and hemorrhage can be increased when Rasagiline is combined with Bivalirudin.,Rasagiline
DB01626,The risk or severity of bleeding and hemorrhage can be increased when Pargyline is combined with Bivalirudin.,Pargyline
DB04017,The risk or severity of bleeding and hemorrhage can be increased when Clorgiline is combined with Bivalirudin.,Clorgiline
DB04818,The risk or severity of bleeding and hemorrhage can be increased when Iproniazid is combined with Bivalirudin.,Iproniazid
DB04820,The risk or severity of bleeding and hemorrhage can be increased when Nialamide is combined with Bivalirudin.,Nialamide
DB06654,The risk or severity of bleeding and hemorrhage can be increased when Safinamide is combined with Bivalirudin.,Safinamide
DB08550,"The risk or severity of bleeding and hemorrhage can be increased when 7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline is combined with Bivalirudin.","7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline"
DB09241,The risk or severity of bleeding and hemorrhage can be increased when Methylene blue is combined with Bivalirudin.,Methylene blue
DB09243,The risk or severity of bleeding and hemorrhage can be increased when Hydracarbazine is combined with Bivalirudin.,Hydracarbazine
DB09244,The risk or severity of bleeding and hemorrhage can be increased when Pirlindole is combined with Bivalirudin.,Pirlindole
DB09245,The risk or severity of bleeding and hemorrhage can be increased when Toloxatone is combined with Bivalirudin.,Toloxatone
DB09246,The risk or severity of bleeding and hemorrhage can be increased when Benmoxin is combined with Bivalirudin.,Benmoxin
DB09248,The risk or severity of bleeding and hemorrhage can be increased when Mebanazine is combined with Bivalirudin.,Mebanazine
DB09249,The risk or severity of bleeding and hemorrhage can be increased when Octamoxin is combined with Bivalirudin.,Octamoxin
DB09250,The risk or severity of bleeding and hemorrhage can be increased when Pheniprazine is combined with Bivalirudin.,Pheniprazine
DB09251,The risk or severity of bleeding and hemorrhage can be increased when Phenoxypropazine is combined with Bivalirudin.,Phenoxypropazine
DB09252,The risk or severity of bleeding and hemorrhage can be increased when Pivhydrazine is combined with Bivalirudin.,Pivhydrazine
DB09253,The risk or severity of bleeding and hemorrhage can be increased when Safrazine is combined with Bivalirudin.,Safrazine
DB09254,The risk or severity of bleeding and hemorrhage can be increased when Caroxazone is combined with Bivalirudin.,Caroxazone
DB13875,The risk or severity of bleeding and hemorrhage can be increased when Harmaline is combined with Bivalirudin.,Harmaline
DB13876,The risk or severity of bleeding and hemorrhage can be increased when Brofaromine is combined with Bivalirudin.,Brofaromine
DB00266,The risk or severity of bleeding can be increased when Bivalirudin is combined with Dicoumarol.,Dicoumarol
DB00278,The risk or severity of bleeding can be increased when Bivalirudin is combined with Argatroban.,Argatroban
DB00407,The risk or severity of bleeding can be increased when Bivalirudin is combined with Ardeparin.,Ardeparin
DB00498,The risk or severity of bleeding can be increased when Bivalirudin is combined with Phenindione.,Phenindione
DB00569,The risk or severity of bleeding can be increased when Bivalirudin is combined with Fondaparinux.,Fondaparinux
DB00682,The risk or severity of bleeding can be increased when Bivalirudin is combined with Warfarin.,Warfarin
DB00946,The risk or severity of bleeding can be increased when Bivalirudin is combined with Phenprocoumon.,Phenprocoumon
DB00974,The risk or severity of bleeding can be increased when Bivalirudin is combined with Edetic acid.,Edetic acid
DB01109,The risk or severity of bleeding can be increased when Bivalirudin is combined with Heparin.,Heparin
DB01225,The risk or severity of bleeding can be increased when Bivalirudin is combined with Enoxaparin.,Enoxaparin
DB01418,The risk or severity of bleeding can be increased when Bivalirudin is combined with Acenocoumarol.,Acenocoumarol
DB04898,The risk or severity of bleeding can be increased when Bivalirudin is combined with Ximelagatran.,Ximelagatran
DB05099,The risk or severity of bleeding can be increased when Bivalirudin is combined with Ancrod.,Ancrod
DB06271,The risk or severity of bleeding can be increased when Bivalirudin is combined with Sulodexide.,Sulodexide
DB06406,The risk or severity of bleeding can be increased when Bivalirudin is combined with Idraparinux.,Idraparinux
DB06635,The risk or severity of bleeding can be increased when Bivalirudin is combined with Otamixaban.,Otamixaban
DB06754,The risk or severity of bleeding can be increased when Bivalirudin is combined with Danaparoid.,Danaparoid
DB06779,The risk or severity of bleeding can be increased when Bivalirudin is combined with Dalteparin.,Dalteparin
DB07767,The risk or severity of bleeding can be increased when Bivalirudin is combined with Ferulic acid.,Ferulic acid
DB08794,The risk or severity of bleeding can be increased when Bivalirudin is combined with Ethyl biscoumacetate.,Ethyl biscoumacetate
DB08813,The risk or severity of bleeding can be increased when Bivalirudin is combined with Nadroparin.,Nadroparin
DB09255,The risk or severity of bleeding can be increased when Bivalirudin is combined with Dextran.,Dextran
DB09259,The risk or severity of bleeding can be increased when Bivalirudin is combined with Reviparin.,Reviparin
DB09261,The risk or severity of bleeding can be increased when Bivalirudin is combined with Certoparin.,Certoparin
DB11095,The risk or severity of bleeding can be increased when Bivalirudin is combined with Desirudin.,Desirudin
DB11268,The risk or severity of bleeding can be increased when Bivalirudin is combined with Protocatechualdehyde.,Protocatechualdehyde
DB11312,The risk or severity of bleeding can be increased when Bivalirudin is combined with Protein C.,Protein C
DB11598,The risk or severity of bleeding can be increased when Bivalirudin is combined with Antithrombin III human.,Antithrombin III human
DB11984,The risk or severity of bleeding can be increased when Bivalirudin is combined with Letaxaban.,Letaxaban
DB12289,The risk or severity of bleeding can be increased when Bivalirudin is combined with Darexaban.,Darexaban
DB12598,The risk or severity of bleeding can be increased when Bivalirudin is combined with Nafamostat.,Nafamostat
DB12831,The risk or severity of bleeding can be increased when Bivalirudin is combined with Gabexate.,Gabexate
DB13124,The risk or severity of bleeding can be increased when Bivalirudin is combined with Troxerutin.,Troxerutin
DB13136,The risk or severity of bleeding can be increased when Bivalirudin is combined with Fluindione.,Fluindione
DB13149,The risk or severity of bleeding can be increased when Bivalirudin is combined with Protein S human.,Protein S human
DB13616,The risk or severity of bleeding can be increased when Bivalirudin is combined with Melagatran.,Melagatran
DB09125,The risk or severity of bleeding can be increased when Bivalirudin is combined with Potassium citrate.,Potassium citrate
DB09154,The risk or severity of bleeding can be increased when Bivalirudin is combined with Sodium citrate.,Sodium citrate
DB00031,The risk or severity of bleeding can be increased when Bivalirudin is combined with Tenecteplase.,Tenecteplase
DB00055,The risk or severity of bleeding can be increased when Bivalirudin is combined with Drotrecogin alfa.,Drotrecogin alfa
DB06822,The risk or severity of bleeding can be increased when Bivalirudin is combined with Tinzaparin.,Tinzaparin
DB13199,The risk or severity of bleeding can be increased when Bivalirudin is combined with Brinase.,Brinase
DB13646,The risk or severity of bleeding can be increased when Bivalirudin is combined with Saruplase.,Saruplase
DB00086,The risk or severity of bleeding can be increased when Bivalirudin is combined with Streptokinase.,Streptokinase
DB04925,The risk or severity of bleeding can be increased when Bivalirudin is combined with Desmoteplase.,Desmoteplase
DB05254,The risk or severity of bleeding can be increased when Bivalirudin is combined with Fibrinolysin.,Fibrinolysin
DB06543,The risk or severity of bleeding can be increased when Bivalirudin is combined with Astaxanthin.,Astaxanthin
DB08994,The risk or severity of bleeding can be increased when Bivalirudin is combined with Ditazole.,Ditazole
DB09258,The risk or severity of bleeding can be increased when Bivalirudin is combined with Bemiparin.,Bemiparin
DB09260,The risk or severity of bleeding can be increased when Bivalirudin is combined with Parnaparin.,Parnaparin
DB13275,The risk or severity of bleeding can be increased when Bivalirudin is combined with Clorindione.,Clorindione
DB13347,The risk or severity of bleeding can be increased when Bivalirudin is combined with Diphenadione.,Diphenadione
DB13451,The risk or severity of bleeding can be increased when Bivalirudin is combined with Tioclomarol.,Tioclomarol
DB00001,The risk or severity of bleeding can be increased when Bivalirudin is combined with Lepirudin.,Lepirudin
DB00009,The risk or severity of bleeding can be increased when Bivalirudin is combined with Alteplase.,Alteplase
DB00015,The risk or severity of bleeding can be increased when Bivalirudin is combined with Reteplase.,Reteplase
DB00029,The risk or severity of bleeding can be increased when Bivalirudin is combined with Anistreplase.,Anistreplase
DB14094,The risk or severity of bleeding can be increased when Bivalirudin is combined with Tocopherylquinone.,Tocopherylquinone
DB06679,The risk or severity of bleeding can be increased when Bivalirudin is combined with Amediplase.,Amediplase
DB03410,The risk or severity of bleeding can be increased when Bivalirudin is combined with 4-hydroxycoumarin.,4-hydroxycoumarin
DB08496,The risk or severity of bleeding can be increased when Bivalirudin is combined with (R)-warfarin.,(R)-warfarin
DB14055,The risk or severity of bleeding can be increased when Bivalirudin is combined with (S)-Warfarin.,(S)-Warfarin
DB12364,The risk or severity of bleeding can be increased when Bivalirudin is combined with Betrixaban.,Betrixaban
DB14598,The risk or severity of bleeding can be increased when Bivalirudin is combined with Edetate calcium disodium anhydrous.,Edetate calcium disodium anhydrous
DB11154,The risk or severity of bleeding can be increased when Bivalirudin is combined with Zinc citrate.,Zinc citrate
DB11166,The risk or severity of bleeding can be increased when Bivalirudin is combined with Antithrombin Alfa.,Antithrombin Alfa
DB04665,The risk or severity of bleeding can be increased when Bivalirudin is combined with Coumarin.,Coumarin
DB14726,The risk or severity of bleeding can be increased when Bivalirudin is combined with Dabigatran.,Dabigatran
DB06294,The risk or severity of bleeding can be increased when Bivalirudin is combined with Semuloparin.,Semuloparin
DB12726,The risk or severity of bleeding can be increased when Bivalirudin is combined with Monteplase.,Monteplase
DB00203,The risk or severity of hemorrhage can be increased when Bivalirudin is combined with Sildenafil.,Sildenafil
DB00008,The risk or severity of bleeding can be increased when Bivalirudin is combined with Peginterferon alfa-2a.,Peginterferon alfa-2a
DB00011,The risk or severity of bleeding can be increased when Bivalirudin is combined with Interferon alfa-n1.,Interferon alfa-n1
DB00018,The risk or severity of bleeding can be increased when Bivalirudin is combined with Interferon alfa-n3.,Interferon alfa-n3
DB00022,The risk or severity of bleeding can be increased when Bivalirudin is combined with Peginterferon alfa-2b.,Peginterferon alfa-2b
DB00033,The risk or severity of bleeding can be increased when Bivalirudin is combined with Interferon gamma-1b.,Interferon gamma-1b
DB00034,"The risk or severity of bleeding can be increased when Bivalirudin is combined with Interferon alfa-2a, Recombinant.","Interferon alfa-2a, Recombinant"
DB00041,The risk or severity of bleeding can be increased when Bivalirudin is combined with Aldesleukin.,Aldesleukin
DB00056,The risk or severity of bleeding can be increased when Bivalirudin is combined with Gemtuzumab ozogamicin.,Gemtuzumab ozogamicin
DB00068,The risk or severity of bleeding can be increased when Bivalirudin is combined with Interferon beta-1b.,Interferon beta-1b
DB00069,The risk or severity of bleeding can be increased when Bivalirudin is combined with Interferon alfacon-1.,Interferon alfacon-1
DB00073,The risk or severity of bleeding can be increased when Bivalirudin is combined with Rituximab.,Rituximab
DB00078,The risk or severity of bleeding can be increased when Bivalirudin is combined with Ibritumomab tiuxetan.,Ibritumomab tiuxetan
DB00087,The risk or severity of bleeding can be increased when Bivalirudin is combined with Alemtuzumab.,Alemtuzumab
DB00105,The risk or severity of bleeding can be increased when Bivalirudin is combined with Interferon alfa-2b.,Interferon alfa-2b
DB00120,The risk or severity of bleeding can be increased when Bivalirudin is combined with Phenylalanine.,Phenylalanine
DB00188,The risk or severity of bleeding can be increased when Bivalirudin is combined with Bortezomib.,Bortezomib
DB00242,The risk or severity of bleeding can be increased when Bivalirudin is combined with Cladribine.,Cladribine
DB00262,The risk or severity of bleeding can be increased when Bivalirudin is combined with Carmustine.,Carmustine
DB00276,The risk or severity of bleeding can be increased when Bivalirudin is combined with Amsacrine.,Amsacrine
DB00291,The risk or severity of bleeding can be increased when Bivalirudin is combined with Chlorambucil.,Chlorambucil
DB00293,The risk or severity of bleeding can be increased when Bivalirudin is combined with Raltitrexed.,Raltitrexed
DB00305,The risk or severity of bleeding can be increased when Bivalirudin is combined with Mitomycin.,Mitomycin
DB00307,The risk or severity of bleeding can be increased when Bivalirudin is combined with Bexarotene.,Bexarotene
DB00309,The risk or severity of bleeding can be increased when Bivalirudin is combined with Vindesine.,Vindesine
DB00322,The risk or severity of bleeding can be increased when Bivalirudin is combined with Floxuridine.,Floxuridine
DB00352,The risk or severity of bleeding can be increased when Bivalirudin is combined with Tioguanine.,Tioguanine
DB00361,The risk or severity of bleeding can be increased when Bivalirudin is combined with Vinorelbine.,Vinorelbine
DB00380,The risk or severity of bleeding can be increased when Bivalirudin is combined with Dexrazoxane.,Dexrazoxane
DB00398,The risk or severity of bleeding can be increased when Bivalirudin is combined with Sorafenib.,Sorafenib
DB00428,The risk or severity of bleeding can be increased when Bivalirudin is combined with Streptozocin.,Streptozocin
DB00441,The risk or severity of bleeding can be increased when Bivalirudin is combined with Gemcitabine.,Gemcitabine
DB00444,The risk or severity of bleeding can be increased when Bivalirudin is combined with Teniposide.,Teniposide
DB00445,The risk or severity of bleeding can be increased when Bivalirudin is combined with Epirubicin.,Epirubicin
DB00446,The risk or severity of bleeding can be increased when Bivalirudin is combined with Chloramphenicol.,Chloramphenicol
DB00480,The risk or severity of bleeding can be increased when Bivalirudin is combined with Lenalidomide.,Lenalidomide
DB00488,The risk or severity of bleeding can be increased when Bivalirudin is combined with Altretamine.,Altretamine
DB00495,The risk or severity of bleeding can be increased when Bivalirudin is combined with Zidovudine.,Zidovudine
DB00515,The risk or severity of bleeding can be increased when Bivalirudin is combined with Cisplatin.,Cisplatin
DB00526,The risk or severity of bleeding can be increased when Bivalirudin is combined with Oxaliplatin.,Oxaliplatin
DB00531,The risk or severity of bleeding can be increased when Bivalirudin is combined with Cyclophosphamide.,Cyclophosphamide
DB00544,The risk or severity of bleeding can be increased when Bivalirudin is combined with Fluorouracil.,Fluorouracil
DB00552,The risk or severity of bleeding can be increased when Bivalirudin is combined with Pentostatin.,Pentostatin
DB00563,The risk or severity of bleeding can be increased when Bivalirudin is combined with Methotrexate.,Methotrexate
DB00564,The risk or severity of bleeding can be increased when Bivalirudin is combined with Carbamazepine.,Carbamazepine
DB00570,The risk or severity of bleeding can be increased when Bivalirudin is combined with Vinblastine.,Vinblastine
DB00619,The risk or severity of bleeding can be increased when Bivalirudin is combined with Imatinib.,Imatinib
DB00631,The risk or severity of bleeding can be increased when Bivalirudin is combined with Clofarabine.,Clofarabine
DB00642,The risk or severity of bleeding can be increased when Bivalirudin is combined with Pemetrexed.,Pemetrexed
DB00694,The risk or severity of bleeding can be increased when Bivalirudin is combined with Daunorubicin.,Daunorubicin
DB00762,The risk or severity of bleeding can be increased when Bivalirudin is combined with Irinotecan.,Irinotecan
DB00773,The risk or severity of bleeding can be increased when Bivalirudin is combined with Etoposide.,Etoposide
DB00851,The risk or severity of bleeding can be increased when Bivalirudin is combined with Dacarbazine.,Dacarbazine
DB00853,The risk or severity of bleeding can be increased when Bivalirudin is combined with Temozolomide.,Temozolomide
DB00859,The risk or severity of bleeding can be increased when Bivalirudin is combined with Penicillamine.,Penicillamine
DB00864,The risk or severity of bleeding can be increased when Bivalirudin is combined with Tacrolimus.,Tacrolimus
DB00877,The risk or severity of bleeding can be increased when Bivalirudin is combined with Sirolimus.,Sirolimus
DB00888,The risk or severity of bleeding can be increased when Bivalirudin is combined with Mechlorethamine.,Mechlorethamine
DB00928,The risk or severity of bleeding can be increased when Bivalirudin is combined with Azacitidine.,Azacitidine
DB00958,The risk or severity of bleeding can be increased when Bivalirudin is combined with Carboplatin.,Carboplatin
DB00970,The risk or severity of bleeding can be increased when Bivalirudin is combined with Dactinomycin.,Dactinomycin
DB00987,The risk or severity of bleeding can be increased when Bivalirudin is combined with Cytarabine.,Cytarabine
DB00997,The risk or severity of bleeding can be increased when Bivalirudin is combined with Doxorubicin.,Doxorubicin
DB01005,The risk or severity of bleeding can be increased when Bivalirudin is combined with Hydroxyurea.,Hydroxyurea
DB01008,The risk or severity of bleeding can be increased when Bivalirudin is combined with Busulfan.,Busulfan
DB01030,The risk or severity of bleeding can be increased when Bivalirudin is combined with Topotecan.,Topotecan
DB01033,The risk or severity of bleeding can be increased when Bivalirudin is combined with Mercaptopurine.,Mercaptopurine
DB01041,The risk or severity of bleeding can be increased when Bivalirudin is combined with Thalidomide.,Thalidomide
DB01042,The risk or severity of bleeding can be increased when Bivalirudin is combined with Melphalan.,Melphalan
DB01073,The risk or severity of bleeding can be increased when Bivalirudin is combined with Fludarabine.,Fludarabine
DB01099,The risk or severity of bleeding can be increased when Bivalirudin is combined with Flucytosine.,Flucytosine
DB01101,The risk or severity of bleeding can be increased when Bivalirudin is combined with Capecitabine.,Capecitabine
DB01169,The risk or severity of bleeding can be increased when Bivalirudin is combined with Arsenic trioxide.,Arsenic trioxide
DB01177,The risk or severity of bleeding can be increased when Bivalirudin is combined with Idarubicin.,Idarubicin
DB01204,The risk or severity of bleeding can be increased when Bivalirudin is combined with Mitoxantrone.,Mitoxantrone
DB01206,The risk or severity of bleeding can be increased when Bivalirudin is combined with Lomustine.,Lomustine
DB01229,The risk or severity of bleeding can be increased when Bivalirudin is combined with Paclitaxel.,Paclitaxel
DB01248,The risk or severity of bleeding can be increased when Bivalirudin is combined with Docetaxel.,Docetaxel
DB01262,The risk or severity of bleeding can be increased when Bivalirudin is combined with Decitabine.,Decitabine
DB01280,The risk or severity of bleeding can be increased when Bivalirudin is combined with Nelarabine.,Nelarabine
DB01590,The risk or severity of bleeding can be increased when Bivalirudin is combined with Everolimus.,Everolimus
DB02546,The risk or severity of bleeding can be increased when Bivalirudin is combined with Vorinostat.,Vorinostat
DB04572,The risk or severity of bleeding can be increased when Bivalirudin is combined with Thiotepa.,Thiotepa
DB04845,The risk or severity of bleeding can be increased when Bivalirudin is combined with Ixabepilone.,Ixabepilone
DB04868,The risk or severity of bleeding can be increased when Bivalirudin is combined with Nilotinib.,Nilotinib
DB05015,The risk or severity of bleeding can be increased when Bivalirudin is combined with Belinostat.,Belinostat
DB05109,The risk or severity of bleeding can be increased when Bivalirudin is combined with Trabectedin.,Trabectedin
DB05258,The risk or severity of bleeding can be increased when Bivalirudin is combined with Interferon alfa.,Interferon alfa
DB05472,The risk or severity of bleeding can be increased when Bivalirudin is combined with omega interferon.,omega interferon
DB05773,The risk or severity of bleeding can be increased when Bivalirudin is combined with Trastuzumab emtansine.,Trastuzumab emtansine
DB06287,The risk or severity of bleeding can be increased when Bivalirudin is combined with Temsirolimus.,Temsirolimus
DB06616,The risk or severity of bleeding can be increased when Bivalirudin is combined with Bosutinib.,Bosutinib
DB06769,The risk or severity of bleeding can be increased when Bivalirudin is combined with Bendamustine.,Bendamustine
DB06772,The risk or severity of bleeding can be increased when Bivalirudin is combined with Cabazitaxel.,Cabazitaxel
DB08871,The risk or severity of bleeding can be increased when Bivalirudin is combined with Eribulin.,Eribulin
DB08877,The risk or severity of bleeding can be increased when Bivalirudin is combined with Ruxolitinib.,Ruxolitinib
DB08889,The risk or severity of bleeding can be increased when Bivalirudin is combined with Carfilzomib.,Carfilzomib
DB08895,The risk or severity of bleeding can be increased when Bivalirudin is combined with Tofacitinib.,Tofacitinib
DB08901,The risk or severity of bleeding can be increased when Bivalirudin is combined with Ponatinib.,Ponatinib
DB08910,The risk or severity of bleeding can be increased when Bivalirudin is combined with Pomalidomide.,Pomalidomide
DB09042,The risk or severity of bleeding can be increased when Bivalirudin is combined with Tedizolid phosphate.,Tedizolid phosphate
DB09052,The risk or severity of bleeding can be increased when Bivalirudin is combined with Blinatumomab.,Blinatumomab
DB09073,The risk or severity of bleeding can be increased when Bivalirudin is combined with Palbociclib.,Palbociclib
DB09074,The risk or severity of bleeding can be increased when Bivalirudin is combined with Olaparib.,Olaparib
DB09077,The risk or severity of bleeding can be increased when Bivalirudin is combined with Dinutuximab.,Dinutuximab
DB09122,The risk or severity of bleeding can be increased when Bivalirudin is combined with Peginterferon beta-1a.,Peginterferon beta-1a
DB12814,The risk or severity of bleeding can be increased when Bivalirudin is combined with Cepeginterferon alfa-2B.,Cepeginterferon alfa-2B
DB00229,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cefotiam.,Cefotiam
DB00267,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cefmenoxime.,Cefmenoxime
DB00274,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cefmetazole.,Cefmetazole
DB00430,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cefpiramide.,Cefpiramide
DB00438,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Ceftazidime.,Ceftazidime
DB00447,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Loracarbef.,Loracarbef
DB00456,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cefalotin.,Cefalotin
DB00493,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cefotaxime.,Cefotaxime
DB00535,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cefdinir.,Cefdinir
DB00567,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cephalexin.,Cephalexin
DB00671,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cefixime.,Cefixime
DB00689,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cephaloglycin.,Cephaloglycin
DB00833,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cefaclor.,Cefaclor
DB00923,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Ceforanide.,Ceforanide
DB01066,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cefditoren.,Cefditoren
DB01112,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cefuroxime.,Cefuroxime
DB01139,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cefapirin.,Cefapirin
DB01140,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cefadroxil.,Cefadroxil
DB01150,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cefprozil.,Cefprozil
DB01212,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Ceftriaxone.,Ceftriaxone
DB01326,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cefamandole.,Cefamandole
DB01327,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cefazolin.,Cefazolin
DB01328,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cefonicid.,Cefonicid
DB01329,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cefoperazone.,Cefoperazone
DB01330,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cefotetan.,Cefotetan
DB01331,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cefoxitin.,Cefoxitin
DB01332,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Ceftizoxime.,Ceftizoxime
DB01333,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cefradine.,Cefradine
DB01413,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cefepime.,Cefepime
DB01414,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cefacetrile.,Cefacetrile
DB01415,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Ceftibuten.,Ceftibuten
DB01416,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cefpodoxime.,Cefpodoxime
DB04570,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Latamoxef.,Latamoxef
DB04918,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Ceftobiprole.,Ceftobiprole
DB06590,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Ceftaroline fosamil.,Ceftaroline fosamil
DB09008,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cefaloridine.,Cefaloridine
DB09050,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Ceftolozane.,Ceftolozane
DB09062,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cefminox.,Cefminox
DB11367,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cefroxadine.,Cefroxadine
DB11935,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Flomoxef.,Flomoxef
DB13266,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cefatrizine.,Cefatrizine
DB13461,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cefcapene.,Cefcapene
DB13470,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cefodizime.,Cefodizime
DB13499,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cefsulodin.,Cefsulodin
DB13504,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cefetamet.,Cefetamet
DB13638,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cefbuperazone.,Cefbuperazone
DB13667,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cefozopran.,Cefozopran
DB13682,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cefpirome.,Cefpirome
DB13778,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cefazedone.,Cefazedone
DB13821,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Ceftezole.,Ceftezole
DB14725,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cefamandole nafate.,Cefamandole nafate
DB00254,The risk or severity of bleeding can be increased when Doxycycline is combined with Bivalirudin.,Doxycycline
DB00207,The risk or severity of adverse effects can be increased when Azithromycin is combined with Bivalirudin.,Azithromycin
DB09539,The risk or severity of bleeding can be increased when Omega-3-acid ethyl esters is combined with Bivalirudin.,Omega-3-acid ethyl esters
DB00945,Acetylsalicylic acid may increase the anticoagulant activities of Bivalirudin.,Acetylsalicylic acid
DB01606,The risk or severity of bleeding can be increased when Tazobactam is combined with Bivalirudin.,Tazobactam
DB00199,The risk or severity of bleeding can be increased when Erythromycin is combined with Bivalirudin.,Erythromycin
DB00656,The risk or severity of bleeding can be increased when Trazodone is combined with Bivalirudin.,Trazodone
DB00620,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Triamcinolone.,Triamcinolone
DB09079,The risk or severity of bleeding can be increased when Bivalirudin is combined with Nintedanib.,Nintedanib
DB01175,The risk or severity of bleeding can be increased when Escitalopram is combined with Bivalirudin.,Escitalopram
DB01104,The risk or severity of bleeding can be increased when Sertraline is combined with Bivalirudin.,Sertraline
DB00232,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Methyclothiazide.,Methyclothiazide
DB00436,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Bendroflumethiazide.,Bendroflumethiazide
DB00562,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Benzthiazide.,Benzthiazide
DB00606,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cyclothiazide.,Cyclothiazide
DB00774,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Hydroflumethiazide.,Hydroflumethiazide
DB00880,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Chlorothiazide.,Chlorothiazide
DB00999,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Hydrochlorothiazide.,Hydrochlorothiazide
DB01021,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Trichlormethiazide.,Trichlormethiazide
DB01324,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Polythiazide.,Polythiazide
DB13430,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Mebutizide.,Mebutizide
DB13532,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cyclopenthiazide.,Cyclopenthiazide
DB09066,The therapeutic efficacy of Corifollitropin alfa can be increased when used in combination with Leuprolide.,Corifollitropin alfa
DB09083,Ivabradine may increase the QTc-prolonging activities of Leuprolide.,Ivabradine
DB08894,The risk or severity of Thrombosis can be increased when Leuprolide is combined with Peginesatide.,Peginesatide
DB00012,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Leuprolide.,Darbepoetin alfa
DB00016,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Leuprolide.,Erythropoietin
DB09107,The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Leuprolide.,Methoxy polyethylene glycol-epoetin beta
DB09277,Leuprolide may decrease effectiveness of Choline C 11 as a diagnostic agent.,Choline C 11
DB00089,Leuprolide may decrease effectiveness of Capromab pendetide as a diagnostic agent.,Capromab pendetide
DB00030,The therapeutic efficacy of Insulin human can be decreased when used in combination with Leuprolide.,Insulin human
DB00046,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Leuprolide.,Insulin lispro
DB00047,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Leuprolide.,Insulin glargine
DB00071,The therapeutic efficacy of Insulin pork can be decreased when used in combination with Leuprolide.,Insulin pork
DB00197,The therapeutic efficacy of Troglitazone can be decreased when used in combination with Leuprolide.,Troglitazone
DB00222,The therapeutic efficacy of Glimepiride can be decreased when used in combination with Leuprolide.,Glimepiride
DB00284,The therapeutic efficacy of Acarbose can be decreased when used in combination with Leuprolide.,Acarbose
DB00359,The therapeutic efficacy of Sulfadiazine can be decreased when used in combination with Leuprolide.,Sulfadiazine
DB00412,The therapeutic efficacy of Rosiglitazone can be decreased when used in combination with Leuprolide.,Rosiglitazone
DB00414,The therapeutic efficacy of Acetohexamide can be decreased when used in combination with Leuprolide.,Acetohexamide
DB00491,The therapeutic efficacy of Miglitol can be decreased when used in combination with Leuprolide.,Miglitol
DB00672,The therapeutic efficacy of Chlorpropamide can be decreased when used in combination with Leuprolide.,Chlorpropamide
DB00731,The therapeutic efficacy of Nateglinide can be decreased when used in combination with Leuprolide.,Nateglinide
DB00839,The therapeutic efficacy of Tolazamide can be decreased when used in combination with Leuprolide.,Tolazamide
DB00912,The therapeutic efficacy of Repaglinide can be decreased when used in combination with Leuprolide.,Repaglinide
DB00914,The therapeutic efficacy of Phenformin can be decreased when used in combination with Leuprolide.,Phenformin
DB01016,The therapeutic efficacy of Glyburide can be decreased when used in combination with Leuprolide.,Glyburide
DB01067,The therapeutic efficacy of Glipizide can be decreased when used in combination with Leuprolide.,Glipizide
DB01120,The therapeutic efficacy of Gliclazide can be decreased when used in combination with Leuprolide.,Gliclazide
DB01124,The therapeutic efficacy of Tolbutamide can be decreased when used in combination with Leuprolide.,Tolbutamide
DB01132,The therapeutic efficacy of Pioglitazone can be decreased when used in combination with Leuprolide.,Pioglitazone
DB01251,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Leuprolide.,Gliquidone
DB01252,The therapeutic efficacy of Mitiglinide can be decreased when used in combination with Leuprolide.,Mitiglinide
DB01261,The therapeutic efficacy of Sitagliptin can be decreased when used in combination with Leuprolide.,Sitagliptin
DB01276,The therapeutic efficacy of Exenatide can be decreased when used in combination with Leuprolide.,Exenatide
DB01277,The therapeutic efficacy of Mecasermin can be decreased when used in combination with Leuprolide.,Mecasermin
DB01278,The therapeutic efficacy of Pramlintide can be decreased when used in combination with Leuprolide.,Pramlintide
DB01289,The therapeutic efficacy of Glisoxepide can be decreased when used in combination with Leuprolide.,Glisoxepide
DB01306,The therapeutic efficacy of Insulin aspart can be decreased when used in combination with Leuprolide.,Insulin aspart
DB01307,The therapeutic efficacy of Insulin detemir can be decreased when used in combination with Leuprolide.,Insulin detemir
DB01309,The therapeutic efficacy of Insulin glulisine can be decreased when used in combination with Leuprolide.,Insulin glulisine
DB01382,The therapeutic efficacy of Glymidine can be decreased when used in combination with Leuprolide.,Glymidine
DB01700,The therapeutic efficacy of AICA ribonucleotide can be decreased when used in combination with Leuprolide.,AICA ribonucleotide
DB04830,The therapeutic efficacy of Buformin can be decreased when used in combination with Leuprolide.,Buformin
DB04876,The therapeutic efficacy of Vildagliptin can be decreased when used in combination with Leuprolide.,Vildagliptin
DB04878,The therapeutic efficacy of Voglibose can be decreased when used in combination with Leuprolide.,Voglibose
DB05115,The therapeutic efficacy of NN344 can be decreased when used in combination with Leuprolide.,NN344
DB05819,The therapeutic efficacy of NBI-6024 can be decreased when used in combination with Leuprolide.,NBI-6024
DB06011,The therapeutic efficacy of AMG-222 can be decreased when used in combination with Leuprolide.,AMG-222
DB06127,The therapeutic efficacy of Bisegliptin can be decreased when used in combination with Leuprolide.,Bisegliptin
DB06203,The therapeutic efficacy of Alogliptin can be decreased when used in combination with Leuprolide.,Alogliptin
DB06292,The therapeutic efficacy of Dapagliflozin can be decreased when used in combination with Leuprolide.,Dapagliflozin
DB06335,The therapeutic efficacy of Saxagliptin can be decreased when used in combination with Leuprolide.,Saxagliptin
DB06655,The therapeutic efficacy of Liraglutide can be decreased when used in combination with Leuprolide.,Liraglutide
DB08382,The therapeutic efficacy of Gosogliptin can be decreased when used in combination with Leuprolide.,Gosogliptin
DB08882,The therapeutic efficacy of Linagliptin can be decreased when used in combination with Leuprolide.,Linagliptin
DB08907,The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Leuprolide.,Canagliflozin
DB08962,The therapeutic efficacy of Glibornuride can be decreased when used in combination with Leuprolide.,Glibornuride
DB09022,The therapeutic efficacy of Benfluorex can be decreased when used in combination with Leuprolide.,Benfluorex
DB09038,The therapeutic efficacy of Empagliflozin can be decreased when used in combination with Leuprolide.,Empagliflozin
DB09043,The therapeutic efficacy of Albiglutide can be decreased when used in combination with Leuprolide.,Albiglutide
DB09045,The therapeutic efficacy of Dulaglutide can be decreased when used in combination with Leuprolide.,Dulaglutide
DB09198,The therapeutic efficacy of Lobeglitazone can be decreased when used in combination with Leuprolide.,Lobeglitazone
DB09199,The therapeutic efficacy of Netoglitazone can be decreased when used in combination with Leuprolide.,Netoglitazone
DB09200,The therapeutic efficacy of Rivoglitazone can be decreased when used in combination with Leuprolide.,Rivoglitazone
DB09201,The therapeutic efficacy of Ciglitazone can be decreased when used in combination with Leuprolide.,Ciglitazone
DB09265,The therapeutic efficacy of Lixisenatide can be decreased when used in combination with Leuprolide.,Lixisenatide
DB09456,The therapeutic efficacy of Insulin beef can be decreased when used in combination with Leuprolide.,Insulin beef
DB09564,The therapeutic efficacy of Insulin degludec can be decreased when used in combination with Leuprolide.,Insulin degludec
DB11567,The therapeutic efficacy of Insulin peglispro can be decreased when used in combination with Leuprolide.,Insulin peglispro
DB11568,The therapeutic efficacy of Insulin tregopil can be decreased when used in combination with Leuprolide.,Insulin tregopil
DB11698,The therapeutic efficacy of Ipragliflozin can be decreased when used in combination with Leuprolide.,Ipragliflozin
DB11723,The therapeutic efficacy of Dutogliptin can be decreased when used in combination with Leuprolide.,Dutogliptin
DB11780,The therapeutic efficacy of Allicin can be decreased when used in combination with Leuprolide.,Allicin
DB11824,The therapeutic efficacy of Tofogliflozin can be decreased when used in combination with Leuprolide.,Tofogliflozin
DB11827,The therapeutic efficacy of Ertugliflozin can be decreased when used in combination with Leuprolide.,Ertugliflozin
DB11898,"The therapeutic efficacy of 2,4-thiazolidinedione can be decreased when used in combination with Leuprolide.","2,4-thiazolidinedione"
DB11950,The therapeutic efficacy of Teneligliptin can be decreased when used in combination with Leuprolide.,Teneligliptin
DB11992,The therapeutic efficacy of Omarigliptin can be decreased when used in combination with Leuprolide.,Omarigliptin
DB12268,The therapeutic efficacy of Carmegliptin can be decreased when used in combination with Leuprolide.,Carmegliptin
DB12412,The therapeutic efficacy of Gemigliptin can be decreased when used in combination with Leuprolide.,Gemigliptin
DB12417,The therapeutic efficacy of Anagliptin can be decreased when used in combination with Leuprolide.,Anagliptin
DB12625,The therapeutic efficacy of Evogliptin can be decreased when used in combination with Leuprolide.,Evogliptin
DB12713,The therapeutic efficacy of Sotagliflozin can be decreased when used in combination with Leuprolide.,Sotagliflozin
DB12781,The therapeutic efficacy of Balaglitazone can be decreased when used in combination with Leuprolide.,Balaglitazone
DB12935,The therapeutic efficacy of Remogliflozin etabonate can be decreased when used in combination with Leuprolide.,Remogliflozin etabonate
DB13406,The therapeutic efficacy of Carbutamide can be decreased when used in combination with Leuprolide.,Carbutamide
DB13446,The therapeutic efficacy of Guar gum can be decreased when used in combination with Leuprolide.,Guar gum
DB13675,The therapeutic efficacy of Metahexamide can be decreased when used in combination with Leuprolide.,Metahexamide
DB13928,The therapeutic efficacy of Semaglutide can be decreased when used in combination with Leuprolide.,Semaglutide
DB14027,The therapeutic efficacy of Taspoglutide can be decreased when used in combination with Leuprolide.,Taspoglutide
DB14035,The therapeutic efficacy of Englitazone can be decreased when used in combination with Leuprolide.,Englitazone
DB15171,The therapeutic efficacy of Tirzepatide can be decreased when used in combination with Leuprolide.,Tirzepatide
DB15217,The therapeutic efficacy of Gastric inhibitory polypeptide can be decreased when used in combination with Leuprolide.,Gastric inhibitory polypeptide
DB01200,The therapeutic efficacy of Bromocriptine can be decreased when used in combination with Leuprolide.,Bromocriptine
DB00215,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Citalopram.,Citalopram
DB00261,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Anagrelide.,Anagrelide
DB00280,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Disopyramide.,Disopyramide
DB00283,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Clemastine.,Clemastine
DB00308,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Ibutilide.,Ibutilide
DB00313,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Valproic acid.,Valproic acid
DB00365,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Grepafloxacin.,Grepafloxacin
DB00468,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Quinine.,Quinine
DB00489,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Sotalol.,Sotalol
DB00530,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Erlotinib.,Erlotinib
DB00539,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Toremifene.,Toremifene
DB00619,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Imatinib.,Imatinib
DB00679,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Thioridazine.,Thioridazine
DB00685,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Trovafloxacin.,Trovafloxacin
DB00834,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Mifepristone.,Mifepristone
DB00875,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Flupentixol.,Flupentixol
DB00907,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Cocaine.,Cocaine
DB01035,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Procainamide.,Procainamide
DB01169,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Arsenic trioxide.,Arsenic trioxide
DB01175,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Escitalopram.,Escitalopram
DB01184,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Domperidone.,Domperidone
DB01208,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Sparfloxacin.,Sparfloxacin
DB01218,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Halofantrine.,Halofantrine
DB01244,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Bepridil.,Bepridil
DB01267,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Paliperidone.,Paliperidone
DB01356,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Lithium cation.,Lithium cation
DB01405,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Temafloxacin.,Temafloxacin
DB01624,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Zuclopenthixol.,Zuclopenthixol
DB04844,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Tetrabenazine.,Tetrabenazine
DB04868,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Nilotinib.,Nilotinib
DB04946,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Iloperidone.,Iloperidone
DB05294,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Vandetanib.,Vandetanib
DB06176,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Romidepsin.,Romidepsin
DB06216,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Asenapine.,Asenapine
DB06697,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Artemether.,Artemether
DB06708,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Lumefantrine.,Lumefantrine
DB08881,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Vemurafenib.,Vemurafenib
DB11730,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Ribociclib.,Ribociclib
DB11978,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Glasdegib.,Glasdegib
DB12161,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Deutetrabenazine.,Deutetrabenazine
DB13074,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Macimorelin.,Macimorelin
DB13725,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Terodiline.,Terodiline
DB00204,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Dofetilide.,Dofetilide
DB00342,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Terfenadine.,Terfenadine
DB00604,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Cisapride.,Cisapride
DB00637,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Astemizole.,Astemizole
DB00908,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Quinidine.,Quinidine
DB01100,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Pimozide.,Pimozide
DB01118,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Amiodarone.,Amiodarone
DB04855,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Dronedarone.,Dronedarone
DB09039,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Eliglustat.,Eliglustat
DB00014,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Goserelin.,Goserelin
DB00195,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Betaxolol.,Betaxolol
DB00199,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Erythromycin.,Erythromycin
DB00207,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Azithromycin.,Azithromycin
DB00218,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Moxifloxacin.,Moxifloxacin
DB00243,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Ranolazine.,Ranolazine
DB00263,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Sulfisoxazole.,Sulfisoxazole
DB00333,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Methadone.,Methadone
DB00343,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Diltiazem.,Diltiazem
DB00363,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Clozapine.,Clozapine
DB00391,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Sulpiride.,Sulpiride
DB00393,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Nimodipine.,Nimodipine
DB00420,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Promazine.,Promazine
DB00433,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Prochlorperazine.,Prochlorperazine
DB00450,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Droperidol.,Droperidol
DB00477,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Chlorpromazine.,Chlorpromazine
DB00526,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Oxaliplatin.,Oxaliplatin
DB00537,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Ciprofloxacin.,Ciprofloxacin
DB00544,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Fluorouracil.,Fluorouracil
DB00556,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Perflutren.,Perflutren
DB00568,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Cinnarizine.,Cinnarizine
DB00571,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Propranolol.,Propranolol
DB00572,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Atropine.,Atropine
DB00608,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Chloroquine.,Chloroquine
DB00640,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Adenosine.,Adenosine
DB00738,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Pentamidine.,Pentamidine
DB00743,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Gadobenic acid.,Gadobenic acid
DB00748,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Carbinoxamine.,Carbinoxamine
DB00757,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Dolasetron.,Dolasetron
DB00778,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Roxithromycin.,Roxithromycin
DB00779,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Nalidixic acid.,Nalidixic acid
DB00827,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Cinoxacin.,Cinoxacin
DB00889,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Granisetron.,Granisetron
DB00904,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Ondansetron.,Ondansetron
DB00922,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Levosimendan.,Levosimendan
DB00933,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Mesoridazine.,Mesoridazine
DB00967,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Desloratadine.,Desloratadine
DB00978,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Lomefloxacin.,Lomefloxacin
DB00985,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Dimenhydrinate.,Dimenhydrinate
DB01087,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Primaquine.,Primaquine
DB01113,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Papaverine.,Papaverine
DB01114,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Chlorpheniramine.,Chlorpheniramine
DB01115,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Nifedipine.,Nifedipine
DB01137,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Levofloxacin.,Levofloxacin
DB01155,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Gemifloxacin.,Gemifloxacin
DB01165,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Ofloxacin.,Ofloxacin
DB01182,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Propafenone.,Propafenone
DB01193,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Acebutolol.,Acebutolol
DB01195,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Flecainide.,Flecainide
DB01580,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Oxprenolol.,Oxprenolol
DB01599,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Probucol.,Probucol
DB01615,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Aceprometazine.,Aceprometazine
DB02638,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Terlipressin.,Terlipressin
DB04825,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Prenylamine.,Prenylamine
DB04842,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Fluspirilene.,Fluspirilene
DB04948,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Lofexidine.,Lofexidine
DB04957,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Azimilide.,Azimilide
DB05223,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Pracinostat.,Pracinostat
DB05488,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Technetium Tc-99m ciprofloxacin.,Technetium Tc-99m ciprofloxacin
DB06160,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Garenoxacin.,Garenoxacin
DB06200,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Tedisamil.,Tedisamil
DB06334,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Tucidinostat.,Tucidinostat
DB06402,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Telavancin.,Telavancin
DB06589,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Pazopanib.,Pazopanib
DB06600,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Nemonoxacin.,Nemonoxacin
DB06603,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Panobinostat.,Panobinostat
DB06712,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Nilvadipine.,Nilvadipine
DB08799,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Antazoline.,Antazoline
DB08865,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Crizotinib.,Crizotinib
DB08903,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Bedaquiline.,Bedaquiline
DB08980,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Fendiline.,Fendiline
DB08992,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Eperisone.,Eperisone
DB09016,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Butriptyline.,Butriptyline
DB09063,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Ceritinib.,Ceritinib
DB09078,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Lenvatinib.,Lenvatinib
DB09224,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Melperone.,Melperone
DB09231,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Benidipine.,Benidipine
DB09555,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Dexchlorpheniramine maleate.,Dexchlorpheniramine maleate
DB11640,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Amifampridine.,Amifampridine
DB11830,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Mocetinostat.,Mocetinostat
DB11841,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Entinostat.,Entinostat
DB12141,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Gilteritinib.,Gilteritinib
DB12174,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with CUDC-101.,CUDC-101
DB12286,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Simendan.,Simendan
DB12376,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Ricolinostat.,Ricolinostat
DB12523,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Mizolastine.,Mizolastine
DB12565,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Abexinostat.,Abexinostat
DB12877,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Oxatomide.,Oxatomide
DB13261,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Sitafloxacin.,Sitafloxacin
DB13273,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Sultopride.,Sultopride
DB13500,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Otilonium.,Otilonium
DB13546,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Nizofenone.,Nizofenone
DB13652,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Bunaftine.,Bunaftine
DB13653,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Lorcainide.,Lorcainide
DB13679,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Dexchlorpheniramine.,Dexchlorpheniramine
DB13791,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Penfluridol.,Penfluridol
DB14063,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Dexverapamil.,Dexverapamil
DB14568,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Ivosidenib.,Ivosidenib
DB00625,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Efavirenz.,Efavirenz
DB00836,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Loperamide.,Loperamide
DB00976,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Telithromycin.,Telithromycin
DB01211,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Clarithromycin.,Clarithromycin
DB01224,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Quetiapine.,Quetiapine
DB01227,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Levacetylmethadol.,Levacetylmethadol
DB01232,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Saquinavir.,Saquinavir
DB01388,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Mibefradil.,Mibefradil
DB00321,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Amitriptyline.,Amitriptyline
DB00458,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Imipramine.,Imipramine
DB01242,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Clomipramine.,Clomipramine
DB11718,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Encorafenib.,Encorafenib
DB00104,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Leuprolide.,Octreotide
DB00107,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Leuprolide.,Oxytocin
DB00187,The risk or severity of QTc prolongation can be increased when Esmolol is combined with Leuprolide.,Esmolol
DB00188,The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Leuprolide.,Bortezomib
DB00196,The risk or severity of QTc prolongation can be increased when Fluconazole is combined with Leuprolide.,Fluconazole
DB00230,The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Leuprolide.,Pregabalin
DB00245,The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Leuprolide.,Benzatropine
DB00270,The risk or severity of QTc prolongation can be increased when Isradipine is combined with Leuprolide.,Isradipine
DB00285,The risk or severity of QTc prolongation can be increased when Venlafaxine is combined with Leuprolide.,Venlafaxine
DB00289,The risk or severity of QTc prolongation can be increased when Atomoxetine is combined with Leuprolide.,Atomoxetine
DB00334,The risk or severity of QTc prolongation can be increased when Olanzapine is combined with Leuprolide.,Olanzapine
DB00341,The risk or severity of QTc prolongation can be increased when Cetirizine is combined with Leuprolide.,Cetirizine
DB00344,The risk or severity of QTc prolongation can be increased when Protriptyline is combined with Leuprolide.,Protriptyline
DB00346,The risk or severity of QTc prolongation can be increased when Alfuzosin is combined with Leuprolide.,Alfuzosin
DB00347,The risk or severity of QTc prolongation can be increased when Trimethadione is combined with Leuprolide.,Trimethadione
DB00354,The risk or severity of QTc prolongation can be increased when Buclizine is combined with Leuprolide.,Buclizine
DB00358,The risk or severity of QTc prolongation can be increased when Mefloquine is combined with Leuprolide.,Mefloquine
DB00366,The risk or severity of QTc prolongation can be increased when Doxylamine is combined with Leuprolide.,Doxylamine
DB00370,The risk or severity of QTc prolongation can be increased when Mirtazapine is combined with Leuprolide.,Mirtazapine
DB00373,The risk or severity of QTc prolongation can be increased when Timolol is combined with Leuprolide.,Timolol
DB00374,The risk or severity of QTc prolongation can be increased when Treprostinil is combined with Leuprolide.,Treprostinil
DB00398,The risk or severity of QTc prolongation can be increased when Sorafenib is combined with Leuprolide.,Sorafenib
DB00405,The risk or severity of QTc prolongation can be increased when Dexbrompheniramine is combined with Leuprolide.,Dexbrompheniramine
DB00424,The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Leuprolide.,Hyoscyamine
DB00427,The risk or severity of QTc prolongation can be increased when Triprolidine is combined with Leuprolide.,Triprolidine
DB00434,The risk or severity of QTc prolongation can be increased when Cyproheptadine is combined with Leuprolide.,Cyproheptadine
DB00467,The risk or severity of QTc prolongation can be increased when Enoxacin is combined with Leuprolide.,Enoxacin
DB00487,The risk or severity of QTc prolongation can be increased when Pefloxacin is combined with Leuprolide.,Pefloxacin
DB00529,The risk or severity of QTc prolongation can be increased when Foscarnet is combined with Leuprolide.,Foscarnet
DB00543,The risk or severity of QTc prolongation can be increased when Amoxapine is combined with Leuprolide.,Amoxapine
DB00555,The risk or severity of QTc prolongation can be increased when Lamotrigine is combined with Leuprolide.,Lamotrigine
DB00613,The risk or severity of QTc prolongation can be increased when Amodiaquine is combined with Leuprolide.,Amodiaquine
DB00622,The risk or severity of QTc prolongation can be increased when Nicardipine is combined with Leuprolide.,Nicardipine
DB00674,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Leuprolide.,Galantamine
DB00675,The risk or severity of QTc prolongation can be increased when Tamoxifen is combined with Leuprolide.,Tamoxifen
DB00678,The risk or severity of QTc prolongation can be increased when Losartan is combined with Leuprolide.,Losartan
DB00680,The risk or severity of QTc prolongation can be increased when Moricizine is combined with Leuprolide.,Moricizine
DB00691,The risk or severity of QTc prolongation can be increased when Moexipril is combined with Leuprolide.,Moexipril
DB00697,The risk or severity of QTc prolongation can be increased when Tizanidine is combined with Leuprolide.,Tizanidine
DB00710,The risk or severity of QTc prolongation can be increased when Ibandronate is combined with Leuprolide.,Ibandronate
DB00714,The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Leuprolide.,Apomorphine
DB00719,The risk or severity of QTc prolongation can be increased when Azatadine is combined with Leuprolide.,Azatadine
DB00734,The risk or severity of QTc prolongation can be increased when Risperidone is combined with Leuprolide.,Risperidone
DB00753,The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Leuprolide.,Isoflurane
DB00808,The risk or severity of QTc prolongation can be increased when Indapamide is combined with Leuprolide.,Indapamide
DB00817,The risk or severity of QTc prolongation can be increased when Rosoxacin is combined with Leuprolide.,Rosoxacin
DB00818,The risk or severity of QTc prolongation can be increased when Propofol is combined with Leuprolide.,Propofol
DB00822,The risk or severity of QTc prolongation can be increased when Disulfiram is combined with Leuprolide.,Disulfiram
DB00825,The risk or severity of QTc prolongation can be increased when Levomenthol is combined with Leuprolide.,Levomenthol
DB00835,The risk or severity of QTc prolongation can be increased when Brompheniramine is combined with Leuprolide.,Brompheniramine
DB00871,The risk or severity of QTc prolongation can be increased when Terbutaline is combined with Leuprolide.,Terbutaline
DB00909,The risk or severity of QTc prolongation can be increased when Zonisamide is combined with Leuprolide.,Zonisamide
DB00915,The risk or severity of QTc prolongation can be increased when Amantadine is combined with Leuprolide.,Amantadine
DB00916,The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Leuprolide.,Metronidazole
DB00920,The risk or severity of QTc prolongation can be increased when Ketotifen is combined with Leuprolide.,Ketotifen
DB00927,The risk or severity of QTc prolongation can be increased when Famotidine is combined with Leuprolide.,Famotidine
DB00934,The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Leuprolide.,Maprotiline
DB00938,The risk or severity of QTc prolongation can be increased when Salmeterol is combined with Leuprolide.,Salmeterol
DB00949,The risk or severity of QTc prolongation can be increased when Felbamate is combined with Leuprolide.,Felbamate
DB00983,The risk or severity of QTc prolongation can be increased when Formoterol is combined with Leuprolide.,Formoterol
DB00999,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Leuprolide.,Hydrochlorothiazide
DB01001,The risk or severity of QTc prolongation can be increased when Salbutamol is combined with Leuprolide.,Salbutamol
DB01015,The risk or severity of QTc prolongation can be increased when Sulfamethoxazole is combined with Leuprolide.,Sulfamethoxazole
DB01036,The risk or severity of QTc prolongation can be increased when Tolterodine is combined with Leuprolide.,Tolterodine
DB01044,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Leuprolide.,Gatifloxacin
DB01054,The risk or severity of QTc prolongation can be increased when Nitrendipine is combined with Leuprolide.,Nitrendipine
DB01059,The risk or severity of QTc prolongation can be increased when Norfloxacin is combined with Leuprolide.,Norfloxacin
DB01069,The risk or severity of QTc prolongation can be increased when Promethazine is combined with Leuprolide.,Promethazine
DB01071,The risk or severity of QTc prolongation can be increased when Mequitazine is combined with Leuprolide.,Mequitazine
DB01074,The risk or severity of QTc prolongation can be increased when Perhexiline is combined with Leuprolide.,Perhexiline
DB01075,The risk or severity of QTc prolongation can be increased when Diphenhydramine is combined with Leuprolide.,Diphenhydramine
DB01106,The risk or severity of QTc prolongation can be increased when Levocabastine is combined with Leuprolide.,Levocabastine
DB01158,The risk or severity of QTc prolongation can be increased when Bretylium is combined with Leuprolide.,Bretylium
DB01166,The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Leuprolide.,Cilostazol
DB01173,The risk or severity of QTc prolongation can be increased when Orphenadrine is combined with Leuprolide.,Orphenadrine
DB01176,The risk or severity of QTc prolongation can be increased when Cyclizine is combined with Leuprolide.,Cyclizine
DB01189,The risk or severity of QTc prolongation can be increased when Desflurane is combined with Leuprolide.,Desflurane
DB01228,The risk or severity of QTc prolongation can be increased when Encainide is combined with Leuprolide.,Encainide
DB01233,The risk or severity of QTc prolongation can be increased when Metoclopramide is combined with Leuprolide.,Metoclopramide
DB01236,The risk or severity of QTc prolongation can be increased when Sevoflurane is combined with Leuprolide.,Sevoflurane
DB01238,The risk or severity of QTc prolongation can be increased when Aripiprazole is combined with Leuprolide.,Aripiprazole
DB01239,The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Leuprolide.,Chlorprothixene
DB01246,The risk or severity of QTc prolongation can be increased when Alimemazine is combined with Leuprolide.,Alimemazine
DB01259,The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Leuprolide.,Lapatinib
DB01268,The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Leuprolide.,Sunitinib
DB01274,The risk or severity of QTc prolongation can be increased when Arformoterol is combined with Leuprolide.,Arformoterol
DB01403,The risk or severity of QTc prolongation can be increased when Methotrimeprazine is combined with Leuprolide.,Methotrimeprazine
DB01426,The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Leuprolide.,Ajmaline
DB01591,The risk or severity of QTc prolongation can be increased when Solifenacin is combined with Leuprolide.,Solifenacin
DB01611,The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Leuprolide.,Hydroxychloroquine
DB01620,The risk or severity of QTc prolongation can be increased when Pheniramine is combined with Leuprolide.,Pheniramine
DB01623,The risk or severity of QTc prolongation can be increased when Thiothixene is combined with Leuprolide.,Thiothixene
DB02546,The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Leuprolide.,Vorinostat
DB04576,The risk or severity of QTc prolongation can be increased when Fleroxacin is combined with Leuprolide.,Fleroxacin
DB04695,The risk or severity of QTc prolongation can be increased when Farnesyl thiopyrophosphate is combined with Leuprolide.,Farnesyl thiopyrophosphate
DB04846,The risk or severity of QTc prolongation can be increased when Celiprolol is combined with Leuprolide.,Celiprolol
DB04953,The risk or severity of QTc prolongation can be increased when Ezogabine is combined with Leuprolide.,Ezogabine
DB05039,The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Leuprolide.,Indacaterol
DB05246,The risk or severity of QTc prolongation can be increased when Methsuximide is combined with Leuprolide.,Methsuximide
DB05465,The risk or severity of QTc prolongation can be increased when Tandutinib is combined with Leuprolide.,Tandutinib
DB06217,The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Leuprolide.,Vernakalant
DB06282,The risk or severity of QTc prolongation can be increased when Levocetirizine is combined with Leuprolide.,Levocetirizine
DB06288,The risk or severity of QTc prolongation can be increased when Amisulpride is combined with Leuprolide.,Amisulpride
DB06468,The risk or severity of QTc prolongation can be increased when Cariporide is combined with Leuprolide.,Cariporide
DB06663,The risk or severity of QTc prolongation can be increased when Pasireotide is combined with Leuprolide.,Pasireotide
DB06691,The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Leuprolide.,Mepyramine
DB06699,The risk or severity of QTc prolongation can be increased when Degarelix is combined with Leuprolide.,Degarelix
DB06719,The risk or severity of QTc prolongation can be increased when Buserelin is combined with Leuprolide.,Buserelin
DB06788,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Leuprolide.,Histrelin
DB06825,The risk or severity of QTc prolongation can be increased when Triptorelin is combined with Leuprolide.,Triptorelin
DB07780,The risk or severity of QTc prolongation can be increased when Farnesyl diphosphate is combined with Leuprolide.,Farnesyl diphosphate
DB07841,The risk or severity of QTc prolongation can be increased when Geranylgeranyl diphosphate is combined with Leuprolide.,Geranylgeranyl diphosphate
DB08808,The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Leuprolide.,Bupranolol
DB08871,The risk or severity of QTc prolongation can be increased when Eribulin is combined with Leuprolide.,Eribulin
DB08893,The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Leuprolide.,Mirabegron
DB08912,The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Leuprolide.,Dabrafenib
DB08936,The risk or severity of QTc prolongation can be increased when Chlorcyclizine is combined with Leuprolide.,Chlorcyclizine
DB08952,The risk or severity of QTc prolongation can be increased when Indenolol is combined with Leuprolide.,Indenolol
DB08972,The risk or severity of QTc prolongation can be increased when Flumequine is combined with Leuprolide.,Flumequine
DB09080,The risk or severity of QTc prolongation can be increased when Olodaterol is combined with Leuprolide.,Olodaterol
DB09082,The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Leuprolide.,Vilanterol
DB09089,The risk or severity of QTc prolongation can be increased when Trimebutine is combined with Leuprolide.,Trimebutine
DB09090,The risk or severity of QTc prolongation can be increased when Pinaverium is combined with Leuprolide.,Pinaverium
DB09167,The risk or severity of QTc prolongation can be increased when Dosulepin is combined with Leuprolide.,Dosulepin
DB09229,The risk or severity of QTc prolongation can be increased when Aranidipine is combined with Leuprolide.,Aranidipine
DB09235,The risk or severity of QTc prolongation can be increased when Efonidipine is combined with Leuprolide.,Efonidipine
DB09236,The risk or severity of QTc prolongation can be increased when Lacidipine is combined with Leuprolide.,Lacidipine
DB09239,The risk or severity of QTc prolongation can be increased when Niguldipine is combined with Leuprolide.,Niguldipine
DB09488,The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Leuprolide.,Acrivastine
DB11390,The risk or severity of QTc prolongation can be increased when Coumaphos is combined with Leuprolide.,Coumaphos
DB11397,The risk or severity of QTc prolongation can be increased when Dichlorvos is combined with Leuprolide.,Dichlorvos
DB11408,The risk or severity of QTc prolongation can be increased when Famphur is combined with Leuprolide.,Famphur
DB11412,The risk or severity of QTc prolongation can be increased when Fenthion is combined with Leuprolide.,Fenthion
DB11443,The risk or severity of QTc prolongation can be increased when Orbifloxacin is combined with Leuprolide.,Orbifloxacin
DB11448,The risk or severity of QTc prolongation can be increased when Phosmet is combined with Leuprolide.,Phosmet
DB11491,The risk or severity of QTc prolongation can be increased when Sarafloxacin is combined with Leuprolide.,Sarafloxacin
DB11511,The risk or severity of QTc prolongation can be increased when Difloxacin is combined with Leuprolide.,Difloxacin
DB11591,The risk or severity of QTc prolongation can be increased when Bilastine is combined with Leuprolide.,Bilastine
DB11614,The risk or severity of QTc prolongation can be increased when Rupatadine is combined with Leuprolide.,Rupatadine
DB11770,The risk or severity of QTc prolongation can be increased when Talinolol is combined with Leuprolide.,Talinolol
DB11774,The risk or severity of QTc prolongation can be increased when Pazufloxacin is combined with Leuprolide.,Pazufloxacin
DB11785,The risk or severity of QTc prolongation can be increased when Anisodamine is combined with Leuprolide.,Anisodamine
DB11891,The risk or severity of QTc prolongation can be increased when CUDC-907 is combined with Leuprolide.,CUDC-907
DB11892,The risk or severity of QTc prolongation can be increased when Prulifloxacin is combined with Leuprolide.,Prulifloxacin
DB11943,The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Leuprolide.,Delafloxacin
DB12093,The risk or severity of QTc prolongation can be increased when Tetrahydropalmatine is combined with Leuprolide.,Tetrahydropalmatine
DB12231,The risk or severity of QTc prolongation can be increased when Temefos is combined with Leuprolide.,Temefos
DB12245,The risk or severity of QTc prolongation can be increased when Triclabendazole is combined with Leuprolide.,Triclabendazole
DB12645,The risk or severity of QTc prolongation can be increased when Givinostat is combined with Leuprolide.,Givinostat
DB12712,The risk or severity of QTc prolongation can be increased when Pilsicainide is combined with Leuprolide.,Pilsicainide
DB12766,The risk or severity of QTc prolongation can be increased when Cicletanine is combined with Leuprolide.,Cicletanine
DB12923,The risk or severity of QTc prolongation can be increased when Gallopamil is combined with Leuprolide.,Gallopamil
DB13358,The risk or severity of QTc prolongation can be increased when Cibenzoline is combined with Leuprolide.,Cibenzoline
DB13488,The risk or severity of QTc prolongation can be increased when Bencyclane is combined with Leuprolide.,Bencyclane
DB13555,The risk or severity of QTc prolongation can be increased when Prajmaline is combined with Leuprolide.,Prajmaline
DB13627,The risk or severity of QTc prolongation can be increased when Oxolinic acid is combined with Leuprolide.,Oxolinic acid
DB13651,The risk or severity of QTc prolongation can be increased when Lorajmine is combined with Leuprolide.,Lorajmine
DB13691,The risk or severity of QTc prolongation can be increased when Acetyldigoxin is combined with Leuprolide.,Acetyldigoxin
DB13744,The risk or severity of QTc prolongation can be increased when Piromidic acid is combined with Leuprolide.,Piromidic acid
DB13766,The risk or severity of QTc prolongation can be increased when Lidoflazine is combined with Leuprolide.,Lidoflazine
DB13772,The risk or severity of QTc prolongation can be increased when Rufloxacin is combined with Leuprolide.,Rufloxacin
DB13823,The risk or severity of QTc prolongation can be increased when Pipemidic acid is combined with Leuprolide.,Pipemidic acid
DB14185,The risk or severity of QTc prolongation can be increased when Aripiprazole lauroxil is combined with Leuprolide.,Aripiprazole lauroxil
DB14713,The risk or severity of QTc prolongation can be increased when Inotersen is combined with Leuprolide.,Inotersen
DB00220,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Nelfinavir.,Nelfinavir
DB00726,The risk or severity of QTc prolongation can be increased when Trimipramine is combined with Leuprolide.,Trimipramine
DB00540,The risk or severity of QTc prolongation can be increased when Nortriptyline is combined with Leuprolide.,Nortriptyline
DB00582,The risk or severity of QTc prolongation can be increased when Voriconazole is combined with Leuprolide.,Voriconazole
DB00593,The risk or severity of QTc prolongation can be increased when Ethosuximide is combined with Leuprolide.,Ethosuximide
DB00862,The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Leuprolide.,Vardenafil
DB00864,The risk or severity of QTc prolongation can be increased when Tacrolimus is combined with Leuprolide.,Tacrolimus
DB01023,The risk or severity of QTc prolongation can be increased when Felodipine is combined with Leuprolide.,Felodipine
DB01026,The risk or severity of QTc prolongation can be increased when Ketoconazole is combined with Leuprolide.,Ketoconazole
DB01072,The risk or severity of QTc prolongation can be increased when Atazanavir is combined with Leuprolide.,Atazanavir
DB01167,The risk or severity of QTc prolongation can be increased when Itraconazole is combined with Leuprolide.,Itraconazole
DB01254,The risk or severity of QTc prolongation can be increased when Dasatinib is combined with Leuprolide.,Dasatinib
DB01263,The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Leuprolide.,Posaconazole
DB01396,The risk or severity of QTc prolongation can be increased when Digitoxin is combined with Leuprolide.,Digitoxin
DB08815,The risk or severity of QTc prolongation can be increased when Lurasidone is combined with Leuprolide.,Lurasidone
DB08864,The risk or severity of QTc prolongation can be increased when Rilpivirine is combined with Leuprolide.,Rilpivirine
DB11742,The risk or severity of QTc prolongation can be increased when Ebastine is combined with Leuprolide.,Ebastine
DB01142,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Doxepin.,Doxepin
DB01151,The risk or severity of QTc prolongation can be increased when Desipramine is combined with Leuprolide.,Desipramine
DB00503,The risk or severity of QTc prolongation can be increased when Ritonavir is combined with Leuprolide.,Ritonavir
DB00845,The risk or severity of QTc prolongation can be increased when Clofazimine is combined with Leuprolide.,Clofazimine
DB11637,Leuprolide may increase the QTc-prolonging activities of Delamanid.,Delamanid
DB00159,Icosapent may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Icosapent
DB00229,Cefotiam may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Cefotiam
DB00244,Mesalazine may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Mesalazine
DB00267,Cefmenoxime may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Cefmenoxime
DB00274,Cefmetazole may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Cefmetazole
DB00282,Pamidronic acid may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Pamidronic acid
DB00300,Tenofovir disoproxil may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Tenofovir disoproxil
DB00328,Indomethacin may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Indomethacin
DB00369,Cidofovir may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Cidofovir
DB00384,Triamterene may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Triamterene
DB00430,Cefpiramide may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Cefpiramide
DB00438,Ceftazidime may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Ceftazidime
DB00447,Loracarbef may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Loracarbef
DB00456,Cefalotin may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Cefalotin
DB00461,Nabumetone may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Nabumetone
DB00465,Ketorolac may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Ketorolac
DB00469,Tenoxicam may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Tenoxicam
DB00482,Celecoxib may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Celecoxib
DB00493,Cefotaxime may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Cefotaxime
DB00500,Tolmetin may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Tolmetin
DB00533,Rofecoxib may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Rofecoxib
DB00554,Piroxicam may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Piroxicam
DB00563,Methotrexate may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Methotrexate
DB00567,Cephalexin may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Cephalexin
DB00573,Fenoprofen may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Fenoprofen
DB00577,Valaciclovir may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Valaciclovir
DB00580,Valdecoxib may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Valdecoxib
DB00586,Diclofenac may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Diclofenac
DB00605,Sulindac may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Sulindac
DB00626,Bacitracin may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Bacitracin
DB00681,Amphotericin B may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Amphotericin B
DB00689,Cephaloglycin may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Cephaloglycin
DB00712,Flurbiprofen may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Flurbiprofen
DB00718,Adefovir dipivoxil may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Adefovir dipivoxil
DB00742,Mannitol may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Mannitol
DB00749,Etodolac may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Etodolac
DB00784,Mefenamic acid may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Mefenamic acid
DB00787,Acyclovir may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Acyclovir
DB00788,Naproxen may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Naproxen
DB00795,Sulfasalazine may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Sulfasalazine
DB00812,Phenylbutazone may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Phenylbutazone
DB00814,Meloxicam may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Meloxicam
DB00821,Carprofen may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Carprofen
DB00833,Cefaclor may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Cefaclor
DB00861,Diflunisal may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Diflunisal
DB00903,Etacrynic acid may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Etacrynic acid
DB00923,Ceforanide may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Ceforanide
DB00936,Salicylic acid may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Salicylic acid
DB00939,Meclofenamic acid may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Meclofenamic acid
DB00945,Acetylsalicylic acid may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Acetylsalicylic acid
DB00958,Carboplatin may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Carboplatin
DB00991,Oxaprozin may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Oxaprozin
DB01009,Ketoprofen may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Ketoprofen
DB01014,Balsalazide may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Balsalazide
DB01050,Ibuprofen may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Ibuprofen
DB01066,Cefditoren may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Cefditoren
DB01111,Colistimethate may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Colistimethate
DB01112,Cefuroxime may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Cefuroxime
DB01139,Cefapirin may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Cefapirin
DB01140,Cefadroxil may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Cefadroxil
DB01150,Cefprozil may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Cefprozil
DB01212,Ceftriaxone may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Ceftriaxone
DB01250,Olsalazine may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Olsalazine
DB01283,Lumiracoxib may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Lumiracoxib
DB01326,Cefamandole may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Cefamandole
DB01327,Cefazolin may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Cefazolin
DB01328,Cefonicid may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Cefonicid
DB01329,Cefoperazone may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Cefoperazone
DB01330,Cefotetan may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Cefotetan
DB01331,Cefoxitin may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Cefoxitin
DB01332,Ceftizoxime may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Ceftizoxime
DB01333,Cefradine may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Cefradine
DB01397,Magnesium salicylate may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Magnesium salicylate
DB01399,Salsalate may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Salsalate
DB01401,Choline magnesium trisalicylate may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Choline magnesium trisalicylate
DB01413,Cefepime may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Cefepime
DB01414,Cefacetrile may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Cefacetrile
DB01415,Ceftibuten may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Ceftibuten
DB01416,Cefpodoxime may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Cefpodoxime
DB01419,Antrafenine may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Antrafenine
DB01424,Aminophenazone may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Aminophenazone
DB01435,Antipyrine may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Antipyrine
DB01600,Tiaprofenic acid may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Tiaprofenic acid
DB01628,Etoricoxib may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Etoricoxib
DB02247,Hydrolyzed Cephalothin may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Hydrolyzed Cephalothin
DB03450,Cephalothin Group may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Cephalothin Group
DB03585,Oxyphenbutazone may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Oxyphenbutazone
DB04552,Niflumic acid may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Niflumic acid
DB04570,Latamoxef may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Latamoxef
DB04743,Nimesulide may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Nimesulide
DB04812,Benoxaprofen may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Benoxaprofen
DB04817,Metamizole may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Metamizole
DB04828,Zomepirac may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Zomepirac
DB04918,Ceftobiprole may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Ceftobiprole
DB05095,Cimicoxib may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Cimicoxib
DB06590,Ceftaroline fosamil may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Ceftaroline fosamil
DB06725,Lornoxicam may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Lornoxicam
DB06736,Aceclofenac may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Aceclofenac
DB06737,Zaltoprofen may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Zaltoprofen
DB07402,Azapropazone may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Azapropazone
DB07477,Felbinac may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Felbinac
DB08439,Parecoxib may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Parecoxib
DB08797,Salicylamide may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Salicylamide
DB08940,Kebuzone may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Kebuzone
DB08942,Isoxicam may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Isoxicam
DB08951,Indoprofen may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Indoprofen
DB08955,Ibuproxam may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Ibuproxam
DB08976,Floctafenine may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Floctafenine
DB08981,Fenbufen may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Fenbufen
DB08984,Etofenamate may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Etofenamate
DB08991,Epirizole may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Epirizole
DB09008,Cefaloridine may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Cefaloridine
DB09062,Cefminox may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Cefminox
DB09084,Benzydamine may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Benzydamine
DB09212,Loxoprofen may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Loxoprofen
DB09213,Dexibuprofen may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Dexibuprofen
DB09214,Dexketoprofen may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Dexketoprofen
DB09215,Droxicam may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Droxicam
DB09216,Tolfenamic acid may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Tolfenamic acid
DB09217,Firocoxib may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Firocoxib
DB09218,Clonixin may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Clonixin
DB09285,Morniflumate may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Morniflumate
DB09288,Propacetamol may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Propacetamol
DB09295,Talniflumate may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Talniflumate
DB09299,Tenofovir alafenamide may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Tenofovir alafenamide
DB11367,Cefroxadine may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Cefroxadine
DB11455,Robenacoxib may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Robenacoxib
DB11466,Tepoxalin may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Tepoxalin
DB11518,Flunixin may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Flunixin
DB11935,Flomoxef may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Flomoxef
DB12151,Brincidofovir may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Brincidofovir
DB12445,Nitroaspirin may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Nitroaspirin
DB12545,Indobufen may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Indobufen
DB13001,Tinoridine may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Tinoridine
DB13167,Alclofenac may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Alclofenac
DB13217,Fentiazac may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Fentiazac
DB13232,Suxibuzone may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Suxibuzone
DB13266,Cefatrizine may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Cefatrizine
DB13286,Bumadizone may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Bumadizone
DB13314,Alminoprofen may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Alminoprofen
DB13317,Flunoxaprofen may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Flunoxaprofen
DB13364,Feprazone may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Feprazone
DB13371,Difenpiramide may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Difenpiramide
DB13407,Nifenazone may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Nifenazone
DB13432,Lonazolac may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Lonazolac
DB13461,Cefcapene may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Cefcapene
DB13470,Cefodizime may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Cefodizime
DB13481,Tenidap may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Tenidap
DB13499,Cefsulodin may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Cefsulodin
DB13501,Bendazac may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Bendazac
DB13504,Cefetamet may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Cefetamet
DB13514,Pranoprofen may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Pranoprofen
DB13524,Propyphenazone may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Propyphenazone
DB13527,Proglumetacin may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Proglumetacin
DB13538,Guacetisal may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Guacetisal
DB13544,Ethenzamide may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Ethenzamide
DB13612,Carbaspirin calcium may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Carbaspirin calcium
DB13629,Mofebutazone may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Mofebutazone
DB13638,Cefbuperazone may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Cefbuperazone
DB13649,Proquazone may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Proquazone
DB13657,Benorilate may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Benorilate
DB13667,Cefozopran may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Cefozopran
DB13682,Cefpirome may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Cefpirome
DB13722,Pirprofen may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Pirprofen
DB13778,Cefazedone may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Cefazedone
DB13783,Acemetacin may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Acemetacin
DB13821,Ceftezole may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Ceftezole
DB13860,Imidazole salicylate may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Imidazole salicylate
DB13868,Adefovir may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Adefovir
DB14059,SC-236 may decrease the excretion rate of Leuprolide which could result in a higher serum level.,SC-236
DB14060,NS-398 may decrease the excretion rate of Leuprolide which could result in a higher serum level.,NS-398
DB14126,Tenofovir may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Tenofovir
DB01438,Phenazopyridine may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Phenazopyridine
DB00091,Cyclosporine may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Cyclosporine
DB15066,Givosiran may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Givosiran
DB01601,Lopinavir may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Lopinavir
DB14507,Lithium citrate may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Lithium citrate
DB00017,Leuprolide may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Salmon calcitonin
DB00035,Leuprolide may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Desmopressin
DB00041,Leuprolide may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Aldesleukin
DB00081,Leuprolide may decrease the excretion rate of Tositumomab which could result in a higher serum level.,Tositumomab
DB00115,Leuprolide may decrease the excretion rate of Cyanocobalamin which could result in a higher serum level.,Cyanocobalamin
DB00158,Leuprolide may decrease the excretion rate of Folic acid which could result in a higher serum level.,Folic acid
DB00165,Leuprolide may decrease the excretion rate of Pyridoxine which could result in a higher serum level.,Pyridoxine
DB00176,Leuprolide may decrease the excretion rate of Fluvoxamine which could result in a higher serum level.,Fluvoxamine
DB00182,Leuprolide may decrease the excretion rate of Amphetamine which could result in a higher serum level.,Amphetamine
DB00185,Leuprolide may decrease the excretion rate of Cevimeline which could result in a higher serum level.,Cevimeline
DB00186,Leuprolide may decrease the excretion rate of Lorazepam which could result in a higher serum level.,Lorazepam
DB00190,Leuprolide may decrease the excretion rate of Carbidopa which could result in a higher serum level.,Carbidopa
DB00193,Leuprolide may decrease the excretion rate of Tramadol which could result in a higher serum level.,Tramadol
DB00198,Leuprolide may decrease the excretion rate of Oseltamivir which could result in a higher serum level.,Oseltamivir
DB00200,Leuprolide may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level.,Hydroxocobalamin
DB00206,Leuprolide may decrease the excretion rate of Reserpine which could result in a higher serum level.,Reserpine
DB00208,Leuprolide may decrease the excretion rate of Ticlopidine which could result in a higher serum level.,Ticlopidine
DB00213,Leuprolide may decrease the excretion rate of Pantoprazole which could result in a higher serum level.,Pantoprazole
DB00225,Leuprolide may decrease the excretion rate of Gadodiamide which could result in a higher serum level.,Gadodiamide
DB00231,Leuprolide may decrease the excretion rate of Temazepam which could result in a higher serum level.,Temazepam
DB00235,Leuprolide may decrease the excretion rate of Milrinone which could result in a higher serum level.,Milrinone
DB00237,Leuprolide may decrease the excretion rate of Butabarbital which could result in a higher serum level.,Butabarbital
DB00254,Leuprolide may decrease the excretion rate of Doxycycline which could result in a higher serum level.,Doxycycline
DB00262,Leuprolide may decrease the excretion rate of Carmustine which could result in a higher serum level.,Carmustine
DB00264,Leuprolide may decrease the excretion rate of Metoprolol which could result in a higher serum level.,Metoprolol
DB00271,Leuprolide may decrease the excretion rate of Diatrizoate which could result in a higher serum level.,Diatrizoate
DB00273,Leuprolide may decrease the excretion rate of Topiramate which could result in a higher serum level.,Topiramate
DB00279,Leuprolide may decrease the excretion rate of Liothyronine which could result in a higher serum level.,Liothyronine
DB00286,Leuprolide may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.,Conjugated estrogens
DB00290,Leuprolide may decrease the excretion rate of Bleomycin which could result in a higher serum level.,Bleomycin
DB00292,Leuprolide may decrease the excretion rate of Etomidate which could result in a higher serum level.,Etomidate
DB00294,Leuprolide may decrease the excretion rate of Etonogestrel which could result in a higher serum level.,Etonogestrel
DB00296,Leuprolide may decrease the excretion rate of Ropivacaine which could result in a higher serum level.,Ropivacaine
DB00303,Leuprolide may decrease the excretion rate of Ertapenem which could result in a higher serum level.,Ertapenem
DB00316,Leuprolide may decrease the excretion rate of Acetaminophen which could result in a higher serum level.,Acetaminophen
DB00319,Leuprolide may decrease the excretion rate of Piperacillin which could result in a higher serum level.,Piperacillin
DB00322,Leuprolide may decrease the excretion rate of Floxuridine which could result in a higher serum level.,Floxuridine
DB00323,Leuprolide may decrease the excretion rate of Tolcapone which could result in a higher serum level.,Tolcapone
DB00325,Leuprolide may decrease the excretion rate of Nitroprusside which could result in a higher serum level.,Nitroprusside
DB00327,Leuprolide may decrease the excretion rate of Hydromorphone which could result in a higher serum level.,Hydromorphone
DB00330,Leuprolide may decrease the excretion rate of Ethambutol which could result in a higher serum level.,Ethambutol
DB00339,Leuprolide may decrease the excretion rate of Pyrazinamide which could result in a higher serum level.,Pyrazinamide
DB00349,Leuprolide may decrease the excretion rate of Clobazam which could result in a higher serum level.,Clobazam
DB00351,Leuprolide may decrease the excretion rate of Megestrol acetate which could result in a higher serum level.,Megestrol acetate
DB00355,Leuprolide may decrease the excretion rate of Aztreonam which could result in a higher serum level.,Aztreonam
DB00356,Leuprolide may decrease the excretion rate of Chlorzoxazone which could result in a higher serum level.,Chlorzoxazone
DB00364,Leuprolide may decrease the excretion rate of Sucralfate which could result in a higher serum level.,Sucralfate
DB00372,Leuprolide may decrease the excretion rate of Thiethylperazine which could result in a higher serum level.,Thiethylperazine
DB00377,Leuprolide may decrease the excretion rate of Palonosetron which could result in a higher serum level.,Palonosetron
DB00380,Leuprolide may decrease the excretion rate of Dexrazoxane which could result in a higher serum level.,Dexrazoxane
DB00402,Leuprolide may decrease the excretion rate of Eszopiclone which could result in a higher serum level.,Eszopiclone
DB00413,Leuprolide may decrease the excretion rate of Pramipexole which could result in a higher serum level.,Pramipexole
DB00415,Leuprolide may decrease the excretion rate of Ampicillin which could result in a higher serum level.,Ampicillin
DB00418,Leuprolide may decrease the excretion rate of Secobarbital which could result in a higher serum level.,Secobarbital
DB00422,Leuprolide may decrease the excretion rate of Methylphenidate which could result in a higher serum level.,Methylphenidate
DB00432,Leuprolide may decrease the excretion rate of Trifluridine which could result in a higher serum level.,Trifluridine
DB00435,Leuprolide may decrease the excretion rate of Nitric Oxide which could result in a higher serum level.,Nitric Oxide
DB00437,Leuprolide may decrease the excretion rate of Allopurinol which could result in a higher serum level.,Allopurinol
DB00441,Leuprolide may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,Gemcitabine
DB00476,Leuprolide may decrease the excretion rate of Duloxetine which could result in a higher serum level.,Duloxetine
DB00480,Leuprolide may decrease the excretion rate of Lenalidomide which could result in a higher serum level.,Lenalidomide
DB00492,Leuprolide may decrease the excretion rate of Fosinopril which could result in a higher serum level.,Fosinopril
DB00499,Leuprolide may decrease the excretion rate of Flutamide which could result in a higher serum level.,Flutamide
DB00535,Leuprolide may decrease the excretion rate of Cefdinir which could result in a higher serum level.,Cefdinir
DB00548,Leuprolide may decrease the excretion rate of Azelaic acid which could result in a higher serum level.,Azelaic acid
DB00553,Leuprolide may decrease the excretion rate of Methoxsalen which could result in a higher serum level.,Methoxsalen
DB00558,Leuprolide may decrease the excretion rate of Zanamivir which could result in a higher serum level.,Zanamivir
DB00569,Leuprolide may decrease the excretion rate of Fondaparinux which could result in a higher serum level.,Fondaparinux
DB00583,Leuprolide may decrease the excretion rate of Levocarnitine which could result in a higher serum level.,Levocarnitine
DB00591,Leuprolide may decrease the excretion rate of Fluocinolone acetonide which could result in a higher serum level.,Fluocinolone acetonide
DB00597,Leuprolide may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,Gadoteridol
DB00598,Leuprolide may decrease the excretion rate of Labetalol which could result in a higher serum level.,Labetalol
DB00603,Leuprolide may decrease the excretion rate of Medroxyprogesterone acetate which could result in a higher serum level.,Medroxyprogesterone acetate
DB00612,Leuprolide may decrease the excretion rate of Bisoprolol which could result in a higher serum level.,Bisoprolol
DB00624,Leuprolide may decrease the excretion rate of Testosterone which could result in a higher serum level.,Testosterone
DB00628,Leuprolide may decrease the excretion rate of Clorazepic acid which could result in a higher serum level.,Clorazepic acid
DB00631,Leuprolide may decrease the excretion rate of Clofarabine which could result in a higher serum level.,Clofarabine
DB00633,Leuprolide may decrease the excretion rate of Dexmedetomidine which could result in a higher serum level.,Dexmedetomidine
DB00635,Leuprolide may decrease the excretion rate of Prednisone which could result in a higher serum level.,Prednisone
DB00651,Leuprolide may decrease the excretion rate of Dyphylline which could result in a higher serum level.,Dyphylline
DB00657,Leuprolide may decrease the excretion rate of Mecamylamine which could result in a higher serum level.,Mecamylamine
DB00660,Leuprolide may decrease the excretion rate of Metaxalone which could result in a higher serum level.,Metaxalone
DB00665,Leuprolide may decrease the excretion rate of Nilutamide which could result in a higher serum level.,Nilutamide
DB00669,Leuprolide may decrease the excretion rate of Sumatriptan which could result in a higher serum level.,Sumatriptan
DB00690,Leuprolide may decrease the excretion rate of Flurazepam which could result in a higher serum level.,Flurazepam
DB00692,Leuprolide may decrease the excretion rate of Phentolamine which could result in a higher serum level.,Phentolamine
DB00698,Leuprolide may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.,Nitrofurantoin
DB00706,Leuprolide may decrease the excretion rate of Tamsulosin which could result in a higher serum level.,Tamsulosin
DB00713,Leuprolide may decrease the excretion rate of Oxacillin which could result in a higher serum level.,Oxacillin
DB00716,Leuprolide may decrease the excretion rate of Nedocromil which could result in a higher serum level.,Nedocromil
DB00722,Leuprolide may decrease the excretion rate of Lisinopril which could result in a higher serum level.,Lisinopril
DB00730,Leuprolide may decrease the excretion rate of Thiabendazole which could result in a higher serum level.,Thiabendazole
DB00733,Leuprolide may decrease the excretion rate of Pralidoxime which could result in a higher serum level.,Pralidoxime
DB00759,Leuprolide may decrease the excretion rate of Tetracycline which could result in a higher serum level.,Tetracycline
DB00760,Leuprolide may decrease the excretion rate of Meropenem which could result in a higher serum level.,Meropenem
DB00761,Leuprolide may decrease the excretion rate of Potassium chloride which could result in a higher serum level.,Potassium chloride
DB00775,Leuprolide may decrease the excretion rate of Tirofiban which could result in a higher serum level.,Tirofiban
DB00780,Leuprolide may decrease the excretion rate of Phenelzine which could result in a higher serum level.,Phenelzine
DB00782,Leuprolide may decrease the excretion rate of Propantheline which could result in a higher serum level.,Propantheline
DB00783,Leuprolide may decrease the excretion rate of Estradiol which could result in a higher serum level.,Estradiol
DB00789,Leuprolide may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,Gadopentetic acid
DB00790,Leuprolide may decrease the excretion rate of Perindopril which could result in a higher serum level.,Perindopril
DB00800,Leuprolide may decrease the excretion rate of Fenoldopam which could result in a higher serum level.,Fenoldopam
DB00804,Leuprolide may decrease the excretion rate of Dicyclomine which could result in a higher serum level.,Dicyclomine
DB00806,Leuprolide may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.,Pentoxifylline
DB00811,Leuprolide may decrease the excretion rate of Ribavirin which could result in a higher serum level.,Ribavirin
DB00828,Leuprolide may decrease the excretion rate of Fosfomycin which could result in a higher serum level.,Fosfomycin
DB00829,Leuprolide may decrease the excretion rate of Diazepam which could result in a higher serum level.,Diazepam
DB00841,Leuprolide may decrease the excretion rate of Dobutamine which could result in a higher serum level.,Dobutamine
DB00842,Leuprolide may decrease the excretion rate of Oxazepam which could result in a higher serum level.,Oxazepam
DB00851,Leuprolide may decrease the excretion rate of Dacarbazine which could result in a higher serum level.,Dacarbazine
DB00853,Leuprolide may decrease the excretion rate of Temozolomide which could result in a higher serum level.,Temozolomide
DB00894,Leuprolide may decrease the excretion rate of Testolactone which could result in a higher serum level.,Testolactone
DB00900,Leuprolide may decrease the excretion rate of Didanosine which could result in a higher serum level.,Didanosine
DB00911,Leuprolide may decrease the excretion rate of Tinidazole which could result in a higher serum level.,Tinidazole
DB00918,Leuprolide may decrease the excretion rate of Almotriptan which could result in a higher serum level.,Almotriptan
DB00928,Leuprolide may decrease the excretion rate of Azacitidine which could result in a higher serum level.,Azacitidine
DB00953,Leuprolide may decrease the excretion rate of Rizatriptan which could result in a higher serum level.,Rizatriptan
DB00960,Leuprolide may decrease the excretion rate of Pindolol which could result in a higher serum level.,Pindolol
DB00961,Leuprolide may decrease the excretion rate of Mepivacaine which could result in a higher serum level.,Mepivacaine
DB00962,Leuprolide may decrease the excretion rate of Zaleplon which could result in a higher serum level.,Zaleplon
DB00980,Leuprolide may decrease the excretion rate of Ramelteon which could result in a higher serum level.,Ramelteon
DB00988,Leuprolide may decrease the excretion rate of Dopamine which could result in a higher serum level.,Dopamine
DB00993,Leuprolide may decrease the excretion rate of Azathioprine which could result in a higher serum level.,Azathioprine
DB00995,Leuprolide may decrease the excretion rate of Auranofin which could result in a higher serum level.,Auranofin
DB01002,Leuprolide may decrease the excretion rate of Levobupivacaine which could result in a higher serum level.,Levobupivacaine
DB01010,Leuprolide may decrease the excretion rate of Edrophonium which could result in a higher serum level.,Edrophonium
DB01011,Leuprolide may decrease the excretion rate of Metyrapone which could result in a higher serum level.,Metyrapone
DB01018,Leuprolide may decrease the excretion rate of Guanfacine which could result in a higher serum level.,Guanfacine
DB01020,Leuprolide may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.,Isosorbide mononitrate
DB01022,Leuprolide may decrease the excretion rate of Phylloquinone which could result in a higher serum level.,Phylloquinone
DB01024,Leuprolide may decrease the excretion rate of Mycophenolic acid which could result in a higher serum level.,Mycophenolic acid
DB01030,Leuprolide may decrease the excretion rate of Topotecan which could result in a higher serum level.,Topotecan
DB01032,Leuprolide may decrease the excretion rate of Probenecid which could result in a higher serum level.,Probenecid
DB01043,Leuprolide may decrease the excretion rate of Memantine which could result in a higher serum level.,Memantine
DB01046,Leuprolide may decrease the excretion rate of Lubiprostone which could result in a higher serum level.,Lubiprostone
DB01048,Leuprolide may decrease the excretion rate of Abacavir which could result in a higher serum level.,Abacavir
DB01060,Leuprolide may decrease the excretion rate of Amoxicillin which could result in a higher serum level.,Amoxicillin
DB01068,Leuprolide may decrease the excretion rate of Clonazepam which could result in a higher serum level.,Clonazepam
DB01093,Leuprolide may decrease the excretion rate of Dimethyl sulfoxide which could result in a higher serum level.,Dimethyl sulfoxide
DB01099,Leuprolide may decrease the excretion rate of Flucytosine which could result in a higher serum level.,Flucytosine
DB01101,Leuprolide may decrease the excretion rate of Capecitabine which could result in a higher serum level.,Capecitabine
DB01105,Leuprolide may decrease the excretion rate of Sibutramine which could result in a higher serum level.,Sibutramine
DB01129,Leuprolide may decrease the excretion rate of Rabeprazole which could result in a higher serum level.,Rabeprazole
DB01133,Leuprolide may decrease the excretion rate of Tiludronic acid which could result in a higher serum level.,Tiludronic acid
DB01135,Leuprolide may decrease the excretion rate of Doxacurium which could result in a higher serum level.,Doxacurium
DB01148,Leuprolide may decrease the excretion rate of Flavoxate which could result in a higher serum level.,Flavoxate
DB01156,Leuprolide may decrease the excretion rate of Bupropion which could result in a higher serum level.,Bupropion
DB01157,Leuprolide may decrease the excretion rate of Trimetrexate which could result in a higher serum level.,Trimetrexate
DB01170,Leuprolide may decrease the excretion rate of Guanethidine which could result in a higher serum level.,Guanethidine
DB01181,Leuprolide may decrease the excretion rate of Ifosfamide which could result in a higher serum level.,Ifosfamide
DB01203,Leuprolide may decrease the excretion rate of Nadolol which could result in a higher serum level.,Nadolol
DB01205,Leuprolide may decrease the excretion rate of Flumazenil which could result in a higher serum level.,Flumazenil
DB01213,Leuprolide may decrease the excretion rate of Fomepizole which could result in a higher serum level.,Fomepizole
DB01215,Leuprolide may decrease the excretion rate of Estazolam which could result in a higher serum level.,Estazolam
DB01221,Leuprolide may decrease the excretion rate of Ketamine which could result in a higher serum level.,Ketamine
DB01240,Leuprolide may decrease the excretion rate of Epoprostenol which could result in a higher serum level.,Epoprostenol
DB01249,Leuprolide may decrease the excretion rate of Iodixanol which could result in a higher serum level.,Iodixanol
DB01273,Leuprolide may decrease the excretion rate of Varenicline which could result in a higher serum level.,Varenicline
DB01275,Leuprolide may decrease the excretion rate of Hydralazine which could result in a higher serum level.,Hydralazine
DB01359,Leuprolide may decrease the excretion rate of Penbutolol which could result in a higher serum level.,Penbutolol
DB01367,Leuprolide may decrease the excretion rate of Rasagiline which could result in a higher serum level.,Rasagiline
DB01409,Leuprolide may decrease the excretion rate of Tiotropium which could result in a higher serum level.,Tiotropium
DB01420,Leuprolide may decrease the excretion rate of Testosterone propionate which could result in a higher serum level.,Testosterone propionate
DB01427,Leuprolide may decrease the excretion rate of Amrinone which could result in a higher serum level.,Amrinone
DB01428,Leuprolide may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,Oxybenzone
DB01431,Leuprolide may decrease the excretion rate of Allylestrenol which could result in a higher serum level.,Allylestrenol
DB01550,Leuprolide may decrease the excretion rate of Fenproporex which could result in a higher serum level.,Fenproporex
DB01558,Leuprolide may decrease the excretion rate of Bromazepam which could result in a higher serum level.,Bromazepam
DB01563,Leuprolide may decrease the excretion rate of Chloral hydrate which could result in a higher serum level.,Chloral hydrate
DB01577,Leuprolide may decrease the excretion rate of Metamfetamine which could result in a higher serum level.,Metamfetamine
DB01587,Leuprolide may decrease the excretion rate of Ketazolam which could result in a higher serum level.,Ketazolam
DB01610,Leuprolide may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,Valganciclovir
DB01638,Leuprolide may decrease the excretion rate of Sorbitol which could result in a higher serum level.,Sorbitol
DB01656,Leuprolide may decrease the excretion rate of Roflumilast which could result in a higher serum level.,Roflumilast
DB01685,Leuprolide may decrease the excretion rate of Topiroxostat which could result in a higher serum level.,Topiroxostat
DB04574,Leuprolide may decrease the excretion rate of Estrone sulfate which could result in a higher serum level.,Estrone sulfate
DB04871,Leuprolide may decrease the excretion rate of Lorcaserin which could result in a higher serum level.,Lorcaserin
DB04895,Leuprolide may decrease the excretion rate of Pegaptanib which could result in a higher serum level.,Pegaptanib
DB04896,Leuprolide may decrease the excretion rate of Milnacipran which could result in a higher serum level.,Milnacipran
DB04920,Leuprolide may decrease the excretion rate of Clevidipine which could result in a higher serum level.,Clevidipine
DB05018,Leuprolide may decrease the excretion rate of Migalastat which could result in a higher serum level.,Migalastat
DB05541,Leuprolide may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,Brivaracetam
DB06154,Leuprolide may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.,Pentaerythritol tetranitrate
DB06186,Leuprolide may decrease the excretion rate of Ipilimumab which could result in a higher serum level.,Ipilimumab
DB06196,Leuprolide may decrease the excretion rate of Icatibant which could result in a higher serum level.,Icatibant
DB06209,Leuprolide may decrease the excretion rate of Prasugrel which could result in a higher serum level.,Prasugrel
DB06211,Leuprolide may decrease the excretion rate of Doripenem which could result in a higher serum level.,Doripenem
DB06230,Leuprolide may decrease the excretion rate of Nalmefene which could result in a higher serum level.,Nalmefene
DB06262,Leuprolide may decrease the excretion rate of Droxidopa which could result in a higher serum level.,Droxidopa
DB06480,Leuprolide may decrease the excretion rate of Prucalopride which could result in a higher serum level.,Prucalopride
DB06623,Leuprolide may decrease the excretion rate of Flupirtine which could result in a higher serum level.,Flupirtine
DB06637,Leuprolide may decrease the excretion rate of Dalfampridine which could result in a higher serum level.,Dalfampridine
DB06695,Leuprolide may decrease the excretion rate of Dabigatran etexilate which could result in a higher serum level.,Dabigatran etexilate
DB06700,Leuprolide may decrease the excretion rate of Desvenlafaxine which could result in a higher serum level.,Desvenlafaxine
DB06702,Leuprolide may decrease the excretion rate of Fesoterodine which could result in a higher serum level.,Fesoterodine
DB06705,Leuprolide may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,Gadofosveset trisodium
DB06710,Leuprolide may decrease the excretion rate of Methyltestosterone which could result in a higher serum level.,Methyltestosterone
DB06767,Leuprolide may decrease the excretion rate of Ammonium chloride which could result in a higher serum level.,Ammonium chloride
DB06782,Leuprolide may decrease the excretion rate of Dimercaprol which could result in a higher serum level.,Dimercaprol
DB06796,Leuprolide may decrease the excretion rate of Mangafodipir which could result in a higher serum level.,Mangafodipir
DB06800,Leuprolide may decrease the excretion rate of Methylnaltrexone which could result in a higher serum level.,Methylnaltrexone
DB06809,Leuprolide may decrease the excretion rate of Plerixafor which could result in a higher serum level.,Plerixafor
DB06813,Leuprolide may decrease the excretion rate of Pralatrexate which could result in a higher serum level.,Pralatrexate
DB06823,Leuprolide may decrease the excretion rate of Tiopronin which could result in a higher serum level.,Tiopronin
DB06824,Leuprolide may decrease the excretion rate of Triethylenetetramine which could result in a higher serum level.,Triethylenetetramine
DB08824,Leuprolide may decrease the excretion rate of Ioflupane I-123 which could result in a higher serum level.,Ioflupane I-123
DB08826,Leuprolide may decrease the excretion rate of Deferiprone which could result in a higher serum level.,Deferiprone
DB08840,Leuprolide may decrease the excretion rate of N-methylnicotinamide which could result in a higher serum level.,N-methylnicotinamide
DB08872,Leuprolide may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,Gabapentin enacarbil
DB08877,Leuprolide may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.,Ruxolitinib
DB08897,Leuprolide may decrease the excretion rate of Aclidinium which could result in a higher serum level.,Aclidinium
DB08900,Leuprolide may decrease the excretion rate of Teduglutide which could result in a higher serum level.,Teduglutide
DB08905,Leuprolide may decrease the excretion rate of Formestane which could result in a higher serum level.,Formestane
DB08909,Leuprolide may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,Glycerol phenylbutyrate
DB08910,Leuprolide may decrease the excretion rate of Pomalidomide which could result in a higher serum level.,Pomalidomide
DB08911,Leuprolide may decrease the excretion rate of Trametinib which could result in a higher serum level.,Trametinib
DB08918,Leuprolide may decrease the excretion rate of Levomilnacipran which could result in a higher serum level.,Levomilnacipran
DB08932,Leuprolide may decrease the excretion rate of Macitentan which could result in a higher serum level.,Macitentan
DB08934,Leuprolide may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.,Sofosbuvir
DB08964,Leuprolide may decrease the excretion rate of Gemeprost which could result in a higher serum level.,Gemeprost
DB09027,Leuprolide may decrease the excretion rate of Ledipasvir which could result in a higher serum level.,Ledipasvir
DB09050,Leuprolide may decrease the excretion rate of Ceftolozane which could result in a higher serum level.,Ceftolozane
DB09068,Leuprolide may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,Vortioxetine
DB09071,Leuprolide may decrease the excretion rate of Tasimelteon which could result in a higher serum level.,Tasimelteon
DB09075,Leuprolide may decrease the excretion rate of Edoxaban which could result in a higher serum level.,Edoxaban
DB09081,Leuprolide may decrease the excretion rate of Idebenone which could result in a higher serum level.,Idebenone
DB09091,Leuprolide may decrease the excretion rate of Tixocortol which could result in a higher serum level.,Tixocortol
DB09103,Leuprolide may decrease the excretion rate of Ancestim which could result in a higher serum level.,Ancestim
DB09104,Leuprolide may decrease the excretion rate of Magnesium hydroxide which could result in a higher serum level.,Magnesium hydroxide
DB09106,Leuprolide may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,Hydroxyethyl Starch
DB09111,Leuprolide may decrease the excretion rate of Pentastarch which could result in a higher serum level.,Pentastarch
DB09121,Leuprolide may decrease the excretion rate of Aurothioglucose which could result in a higher serum level.,Aurothioglucose
DB09123,Leuprolide may decrease the excretion rate of Dienogest which could result in a higher serum level.,Dienogest
DB09129,Leuprolide may decrease the excretion rate of Chromic chloride which could result in a higher serum level.,Chromic chloride
DB09132,Leuprolide may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,Gadoteric acid
DB09133,Leuprolide may decrease the excretion rate of Iothalamic acid which could result in a higher serum level.,Iothalamic acid
DB09134,Leuprolide may decrease the excretion rate of Ioversol which could result in a higher serum level.,Ioversol
DB09135,Leuprolide may decrease the excretion rate of Ioxilan which could result in a higher serum level.,Ioxilan
DB09136,Leuprolide may decrease the excretion rate of Isosulfan blue which could result in a higher serum level.,Isosulfan blue
DB09137,Leuprolide may decrease the excretion rate of Technetium Tc-99m mebrofenin which could result in a higher serum level.,Technetium Tc-99m mebrofenin
DB09139,Leuprolide may decrease the excretion rate of Technetium Tc-99m oxidronate which could result in a higher serum level.,Technetium Tc-99m oxidronate
DB09148,Leuprolide may decrease the excretion rate of Florbetaben (18F) which could result in a higher serum level.,Florbetaben (18F)
DB09149,Leuprolide may decrease the excretion rate of Florbetapir (18F) which could result in a higher serum level.,Florbetapir (18F)
DB09156,Leuprolide may decrease the excretion rate of Iopromide which could result in a higher serum level.,Iopromide
DB09163,Leuprolide may decrease the excretion rate of Technetium Tc-99m exametazime which could result in a higher serum level.,Technetium Tc-99m exametazime
DB09165,Leuprolide may decrease the excretion rate of Technetium Tc-99m pyrophosphate which could result in a higher serum level.,Technetium Tc-99m pyrophosphate
DB09185,Leuprolide may decrease the excretion rate of Viloxazine which could result in a higher serum level.,Viloxazine
DB09194,Leuprolide may decrease the excretion rate of Etoperidone which could result in a higher serum level.,Etoperidone
DB09195,Leuprolide may decrease the excretion rate of Lorpiprazole which could result in a higher serum level.,Lorpiprazole
DB09204,Leuprolide may decrease the excretion rate of Arotinolol which could result in a higher serum level.,Arotinolol
DB09205,Leuprolide may decrease the excretion rate of Moxisylyte which could result in a higher serum level.,Moxisylyte
DB09209,Leuprolide may decrease the excretion rate of Pholcodine which could result in a higher serum level.,Pholcodine
DB09210,Leuprolide may decrease the excretion rate of Piracetam which could result in a higher serum level.,Piracetam
DB09219,Leuprolide may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,Bisoxatin
DB09220,Leuprolide may decrease the excretion rate of Nicorandil which could result in a higher serum level.,Nicorandil
DB09223,Leuprolide may decrease the excretion rate of Blonanserin which could result in a higher serum level.,Blonanserin
DB09241,Leuprolide may decrease the excretion rate of Methylene blue which could result in a higher serum level.,Methylene blue
DB09244,Leuprolide may decrease the excretion rate of Pirlindole which could result in a higher serum level.,Pirlindole
DB09245,Leuprolide may decrease the excretion rate of Toloxatone which could result in a higher serum level.,Toloxatone
DB09255,Leuprolide may decrease the excretion rate of Dextran which could result in a higher serum level.,Dextran
DB09256,Leuprolide may decrease the excretion rate of Tegafur which could result in a higher serum level.,Tegafur
DB09257,Leuprolide may decrease the excretion rate of Gimeracil which could result in a higher serum level.,Gimeracil
DB09262,Leuprolide may decrease the excretion rate of Imidafenacin which could result in a higher serum level.,Imidafenacin
DB09264,Leuprolide may decrease the excretion rate of Idarucizumab which could result in a higher serum level.,Idarucizumab
DB09268,Leuprolide may decrease the excretion rate of Picosulfuric acid which could result in a higher serum level.,Picosulfuric acid
DB09276,Leuprolide may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level.,Sodium aurothiomalate
DB09281,Leuprolide may decrease the excretion rate of Magnesium trisilicate which could result in a higher serum level.,Magnesium trisilicate
DB09292,Leuprolide may decrease the excretion rate of Sacubitril which could result in a higher serum level.,Sacubitril
DB09301,Leuprolide may decrease the excretion rate of Chondroitin sulfate which could result in a higher serum level.,Chondroitin sulfate
DB09317,"Leuprolide may decrease the excretion rate of Synthetic Conjugated Estrogens, A which could result in a higher serum level.","Synthetic Conjugated Estrogens, A"
DB09318,"Leuprolide may decrease the excretion rate of Synthetic Conjugated Estrogens, B which could result in a higher serum level.","Synthetic Conjugated Estrogens, B"
DB09320,Leuprolide may decrease the excretion rate of Procaine benzylpenicillin which could result in a higher serum level.,Procaine benzylpenicillin
DB09324,Leuprolide may decrease the excretion rate of Sulbactam which could result in a higher serum level.,Sulbactam
DB09325,Leuprolide may decrease the excretion rate of Sodium fluoride which could result in a higher serum level.,Sodium fluoride
DB09329,"Leuprolide may decrease the excretion rate of Antihemophilic Factor (Recombinant), PEGylated which could result in a higher serum level.","Antihemophilic Factor (Recombinant), PEGylated"
DB09344,Leuprolide may decrease the excretion rate of Invert sugar which could result in a higher serum level.,Invert sugar
DB09357,Leuprolide may decrease the excretion rate of Dexpanthenol which could result in a higher serum level.,Dexpanthenol
DB09394,Leuprolide may decrease the excretion rate of Phosphoric acid which could result in a higher serum level.,Phosphoric acid
DB09395,Leuprolide may decrease the excretion rate of Sodium acetate which could result in a higher serum level.,Sodium acetate
DB09407,Leuprolide may decrease the excretion rate of Magnesium chloride which could result in a higher serum level.,Magnesium chloride
DB09418,Leuprolide may decrease the excretion rate of Potassium perchlorate which could result in a higher serum level.,Potassium perchlorate
DB09472,Leuprolide may decrease the excretion rate of Sodium sulfate which could result in a higher serum level.,Sodium sulfate
DB09477,Leuprolide may decrease the excretion rate of Enalaprilat which could result in a higher serum level.,Enalaprilat
DB09481,Leuprolide may decrease the excretion rate of Magnesium carbonate which could result in a higher serum level.,Magnesium carbonate
DB09496,Leuprolide may decrease the excretion rate of Octinoxate which could result in a higher serum level.,Octinoxate
DB09502,Leuprolide may decrease the excretion rate of Fludeoxyglucose (18F) which could result in a higher serum level.,Fludeoxyglucose (18F)
DB09546,Leuprolide may decrease the excretion rate of Iobenguane sulfate I-123 which could result in a higher serum level.,Iobenguane sulfate I-123
DB09570,Leuprolide may decrease the excretion rate of Ixazomib which could result in a higher serum level.,Ixazomib
DB11077,Leuprolide may decrease the excretion rate of Polyethylene glycol 400 which could result in a higher serum level.,Polyethylene glycol 400
DB11090,Leuprolide may decrease the excretion rate of Potassium nitrate which could result in a higher serum level.,Potassium nitrate
DB11098,Leuprolide may decrease the excretion rate of Potassium bicarbonate which could result in a higher serum level.,Potassium bicarbonate
DB11102,Leuprolide may decrease the excretion rate of N-acetyltyrosine which could result in a higher serum level.,N-acetyltyrosine
DB11114,Leuprolide may decrease the excretion rate of Eucalyptus oil which could result in a higher serum level.,Eucalyptus oil
DB11127,Leuprolide may decrease the excretion rate of Selenious acid which could result in a higher serum level.,Selenious acid
DB11130,Leuprolide may decrease the excretion rate of Opium which could result in a higher serum level.,Opium
DB11135,Leuprolide may decrease the excretion rate of Selenium which could result in a higher serum level.,Selenium
DB11136,Leuprolide may decrease the excretion rate of Chromium which could result in a higher serum level.,Chromium
DB11145,Leuprolide may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,Oxyquinoline
DB11156,Leuprolide may decrease the excretion rate of Pyrantel which could result in a higher serum level.,Pyrantel
DB11164,Leuprolide may decrease the excretion rate of Bicisate which could result in a higher serum level.,Bicisate
DB11251,Leuprolide may decrease the excretion rate of Tocopherol which could result in a higher serum level.,Tocopherol
DB11278,Leuprolide may decrease the excretion rate of DL-Methylephedrine which could result in a higher serum level.,DL-Methylephedrine
DB11328,Leuprolide may decrease the excretion rate of Tetradecyl hydrogen sulfate (ester) which could result in a higher serum level.,Tetradecyl hydrogen sulfate (ester)
DB11338,Leuprolide may decrease the excretion rate of Clove oil which could result in a higher serum level.,Clove oil
DB11358,Leuprolide may decrease the excretion rate of Evening primrose oil which could result in a higher serum level.,Evening primrose oil
DB11364,Leuprolide may decrease the excretion rate of Pidotimod which could result in a higher serum level.,Pidotimod
DB11560,Leuprolide may decrease the excretion rate of Lesinurad which could result in a higher serum level.,Lesinurad
DB11577,Leuprolide may decrease the excretion rate of Indigotindisulfonic acid which could result in a higher serum level.,Indigotindisulfonic acid
DB11587,Leuprolide may decrease the excretion rate of Etafedrine which could result in a higher serum level.,Etafedrine
DB11598,Leuprolide may decrease the excretion rate of Antithrombin III human which could result in a higher serum level.,Antithrombin III human
DB11691,Leuprolide may decrease the excretion rate of Naldemedine which could result in a higher serum level.,Naldemedine
DB11699,Leuprolide may decrease the excretion rate of Tropisetron which could result in a higher serum level.,Tropisetron
DB11817,Leuprolide may decrease the excretion rate of Baricitinib which could result in a higher serum level.,Baricitinib
DB11915,Leuprolide may decrease the excretion rate of Valbenazine which could result in a higher serum level.,Valbenazine
DB11989,Leuprolide may decrease the excretion rate of Benznidazole which could result in a higher serum level.,Benznidazole
DB12007,Leuprolide may decrease the excretion rate of Isoflavone which could result in a higher serum level.,Isoflavone
DB12107,Leuprolide may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,Vaborbactam
DB12278,Leuprolide may decrease the excretion rate of Propiverine which could result in a higher serum level.,Propiverine
DB12783,Leuprolide may decrease the excretion rate of Benserazide which could result in a higher serum level.,Benserazide
DB13025,Leuprolide may decrease the excretion rate of Tiapride which could result in a higher serum level.,Tiapride
DB13139,Leuprolide may decrease the excretion rate of Levosalbutamol which could result in a higher serum level.,Levosalbutamol
DB13156,Leuprolide may decrease the excretion rate of Inosine pranobex which could result in a higher serum level.,Inosine pranobex
DB13178,Leuprolide may decrease the excretion rate of Inositol which could result in a higher serum level.,Inositol
DB13185,Leuprolide may decrease the excretion rate of Oxabolone cipionate which could result in a higher serum level.,Oxabolone cipionate
DB13191,Leuprolide may decrease the excretion rate of Phosphocreatine which could result in a higher serum level.,Phosphocreatine
DB13269,Leuprolide may decrease the excretion rate of Dichlorobenzyl alcohol which could result in a higher serum level.,Dichlorobenzyl alcohol
DB13595,Leuprolide may decrease the excretion rate of Almasilate which could result in a higher serum level.,Almasilate
DB13884,Leuprolide may decrease the excretion rate of Albutrepenonacog alfa which could result in a higher serum level.,Albutrepenonacog alfa
DB13909,Leuprolide may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,Bismuth subgallate
DB13943,Leuprolide may decrease the excretion rate of Testosterone cypionate which could result in a higher serum level.,Testosterone cypionate
DB13944,Leuprolide may decrease the excretion rate of Testosterone enanthate which could result in a higher serum level.,Testosterone enanthate
DB13946,Leuprolide may decrease the excretion rate of Testosterone undecanoate which could result in a higher serum level.,Testosterone undecanoate
DB13952,Leuprolide may decrease the excretion rate of Estradiol acetate which could result in a higher serum level.,Estradiol acetate
DB13954,Leuprolide may decrease the excretion rate of Estradiol cypionate which could result in a higher serum level.,Estradiol cypionate
DB13955,Leuprolide may decrease the excretion rate of Estradiol dienanthate which could result in a higher serum level.,Estradiol dienanthate
DB13956,Leuprolide may decrease the excretion rate of Estradiol valerate which could result in a higher serum level.,Estradiol valerate
DB13967,Leuprolide may decrease the excretion rate of Patent Blue which could result in a higher serum level.,Patent Blue
DB14006,Leuprolide may decrease the excretion rate of Choline salicylate which could result in a higher serum level.,Choline salicylate
DB14007,Leuprolide may decrease the excretion rate of Pentetic acid which could result in a higher serum level.,Pentetic acid
DB14498,Leuprolide may decrease the excretion rate of Potassium acetate which could result in a higher serum level.,Potassium acetate
DB14499,Leuprolide may decrease the excretion rate of Potassium sulfate which could result in a higher serum level.,Potassium sulfate
DB14526,Leuprolide may decrease the excretion rate of Chromic citrate which could result in a higher serum level.,Chromic citrate
DB14527,Leuprolide may decrease the excretion rate of Chromic nitrate which could result in a higher serum level.,Chromic nitrate
DB14528,Leuprolide may decrease the excretion rate of Chromium gluconate which could result in a higher serum level.,Chromium gluconate
DB14529,Leuprolide may decrease the excretion rate of Chromium nicotinate which could result in a higher serum level.,Chromium nicotinate
DB14530,Leuprolide may decrease the excretion rate of Chromous sulfate which could result in a higher serum level.,Chromous sulfate
DB14754,Leuprolide may decrease the excretion rate of Solriamfetol which could result in a higher serum level.,Solriamfetol
DB06815,Leuprolide may decrease the excretion rate of Pyrithione which could result in a higher serum level.,Pyrithione
DB11121,Leuprolide may decrease the excretion rate of Chloroxylenol which could result in a higher serum level.,Chloroxylenol
DB11085,Leuprolide may decrease the excretion rate of Resorcinol which could result in a higher serum level.,Resorcinol
DB00312,Leuprolide may decrease the excretion rate of Pentobarbital which could result in a higher serum level.,Pentobarbital
DB00401,Leuprolide may decrease the excretion rate of Nisoldipine which could result in a higher serum level.,Nisoldipine
DB00404,Leuprolide may decrease the excretion rate of Alprazolam which could result in a higher serum level.,Alprazolam
DB00490,Leuprolide may decrease the excretion rate of Buspirone which could result in a higher serum level.,Buspirone
DB00661,Leuprolide may decrease the excretion rate of Verapamil which could result in a higher serum level.,Verapamil
DB00683,Leuprolide may decrease the excretion rate of Midazolam which could result in a higher serum level.,Midazolam
DB00763,Leuprolide may decrease the excretion rate of Methimazole which could result in a higher serum level.,Methimazole
DB00820,Leuprolide may decrease the excretion rate of Tadalafil which could result in a higher serum level.,Tadalafil
DB01149,Leuprolide may decrease the excretion rate of Nefazodone which could result in a higher serum level.,Nefazodone
DB01183,Leuprolide may decrease the excretion rate of Naloxone which could result in a higher serum level.,Naloxone
DB01222,Leuprolide may decrease the excretion rate of Budesonide which could result in a higher serum level.,Budesonide
DB05676,Leuprolide may decrease the excretion rate of Apremilast which could result in a higher serum level.,Apremilast
DB06228,Leuprolide may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.,Rivaroxaban
DB08899,Leuprolide may decrease the excretion rate of Enzalutamide which could result in a higher serum level.,Enzalutamide
DB08904,Leuprolide may decrease the excretion rate of Certolizumab pegol which could result in a higher serum level.,Certolizumab pegol
DB09118,Leuprolide may decrease the excretion rate of Stiripentol which could result in a higher serum level.,Stiripentol
DB11901,Leuprolide may decrease the excretion rate of Apalutamide which could result in a higher serum level.,Apalutamide
DB15593,Leuprolide may decrease the excretion rate of Golodirsen which could result in a higher serum level.,Golodirsen
DB00318,Leuprolide may decrease the excretion rate of Codeine which could result in a higher serum level.,Codeine
DB00454,Leuprolide may decrease the excretion rate of Meperidine which could result in a higher serum level.,Meperidine
DB00813,Leuprolide may decrease the excretion rate of Fentanyl which could result in a higher serum level.,Fentanyl
DB00879,Leuprolide may decrease the excretion rate of Emtricitabine which could result in a higher serum level.,Emtricitabine
DB08996,Leuprolide may decrease the excretion rate of Dimetacrine which could result in a higher serum level.,Dimetacrine
DB14506,Leuprolide may decrease the excretion rate of Lithium hydroxide which could result in a higher serum level.,Lithium hydroxide
DB00452,Framycetin may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Framycetin
DB00479,Amikacin may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Amikacin
DB00684,Tobramycin may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Tobramycin
DB00798,Gentamicin may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Gentamicin
DB00955,Netilmicin may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Netilmicin
DB00994,Neomycin may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Neomycin
DB01082,Streptomycin may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Streptomycin
DB01172,Kanamycin may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Kanamycin
DB01421,Paromomycin may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Paromomycin
DB03615,Ribostamycin may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Ribostamycin
DB04263,Geneticin may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Geneticin
DB04626,Apramycin may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Apramycin
DB04729,Gentamicin C1a may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Gentamicin C1a
DB04808,Neamine may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Neamine
DB06696,Arbekacin may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Arbekacin
DB08437,Puromycin may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Puromycin
DB11512,Dihydrostreptomycin may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Dihydrostreptomycin
DB11520,Hygromycin B may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Hygromycin B
DB12604,Sisomicin may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Sisomicin
DB13270,Dibekacin may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Dibekacin
DB13274,Micronomicin may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Micronomicin
DB13540,Isepamicin may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Isepamicin
DB13673,Bekanamycin may decrease the excretion rate of Leuprolide which could result in a higher serum level.,Bekanamycin
DB00552,Leuprolide may decrease the excretion rate of Pentostatin which could result in a higher serum level.,Pentostatin
DB13145,Leuprolide may decrease the excretion rate of Nedaplatin which could result in a higher serum level.,Nedaplatin
DB00314,Leuprolide may decrease the excretion rate of Capreomycin which could result in a higher serum level.,Capreomycin
DB00390,Leuprolide may decrease the excretion rate of Digoxin which could result in a higher serum level.,Digoxin
DB00512,Leuprolide may decrease the excretion rate of Vancomycin which could result in a higher serum level.,Vancomycin
DB00515,Leuprolide may decrease the excretion rate of Cisplatin which could result in a higher serum level.,Cisplatin
DB00642,Leuprolide may decrease the excretion rate of Pemetrexed which could result in a higher serum level.,Pemetrexed
DB00982,Leuprolide may decrease the excretion rate of Isotretinoin which could result in a higher serum level.,Isotretinoin
DB12615,Leuprolide may decrease the excretion rate of Plazomicin which could result in a higher serum level.,Plazomicin
DB14509,Leuprolide may decrease the excretion rate of Lithium carbonate which could result in a higher serum level.,Lithium carbonate
DB00564,Leuprolide may decrease the excretion rate of Carbamazepine which could result in a higher serum level.,Carbamazepine
DB00682,Leuprolide may decrease the excretion rate of Warfarin which could result in a higher serum level.,Warfarin
DB00524,Leuprolide may increase the excretion rate of Metolazone which could result in a lower serum level and potentially a reduction in efficacy.,Metolazone
DB00695,Leuprolide may increase the excretion rate of Furosemide which could result in a lower serum level and potentially a reduction in efficacy.,Furosemide
DB09338,Leuprolide may increase the excretion rate of Mersalyl which could result in a lower serum level and potentially a reduction in efficacy.,Mersalyl
DB00214,Torasemide may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.,Torasemide
DB00232,Methyclothiazide may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.,Methyclothiazide
DB00310,Chlorthalidone may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.,Chlorthalidone
DB00311,Ethoxzolamide may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.,Ethoxzolamide
DB00421,Spironolactone may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.,Spironolactone
DB00436,Bendroflumethiazide may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.,Bendroflumethiazide
DB00562,Benzthiazide may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.,Benzthiazide
DB00594,Amiloride may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.,Amiloride
DB00606,Cyclothiazide may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.,Cyclothiazide
DB00774,Hydroflumethiazide may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.,Hydroflumethiazide
DB00880,Chlorothiazide may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.,Chlorothiazide
DB01021,Trichlormethiazide may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.,Trichlormethiazide
DB01119,Diazoxide may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.,Diazoxide
DB01144,Diclofenamide may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.,Diclofenamide
DB01324,Polythiazide may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.,Polythiazide
DB01325,Quinethazone may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.,Quinethazone
DB01412,Theobromine may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.,Theobromine
DB02925,Piretanide may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.,Piretanide
DB04831,Tienilic acid may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.,Tienilic acid
DB05034,Ularitide may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.,Ularitide
DB08961,Azosemide may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.,Azosemide
DB09015,Canrenoic acid may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.,Canrenoic acid
DB09125,Potassium citrate may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.,Potassium citrate
DB09401,Isosorbide may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.,Isosorbide
DB12221,Canrenone may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.,Canrenone
DB12670,Rolofylline may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.,Rolofylline
DB12704,Spiradoline may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.,Spiradoline
DB13284,Meticrane may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.,Meticrane
DB13316,Ibopamine may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.,Ibopamine
DB13405,Mefruside may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.,Mefruside
DB13430,Mebutizide may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.,Mebutizide
DB13532,Cyclopenthiazide may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.,Cyclopenthiazide
DB13617,Clorexolone may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.,Clorexolone
DB13663,Clofenamide may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.,Clofenamide
DB13708,Fenquizone may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.,Fenquizone
DB13792,Clopamide may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.,Clopamide
DB13801,Muzolimine may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.,Muzolimine
DB13803,Xipamide may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.,Xipamide
DB13989,Epitizide may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.,Epitizide
DB14018,Bromotheophylline may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.,Bromotheophylline
DB14500,Potassium may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.,Potassium
DB00703,Methazolamide may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.,Methazolamide
DB00700,Eplerenone may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.,Eplerenone
DB00819,Acetazolamide may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.,Acetazolamide
DB00872,Conivaptan may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.,Conivaptan
DB01395,Drospirenone may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.,Drospirenone
DB06212,Tolvaptan may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.,Tolvaptan
DB06370,Indisulam may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.,Indisulam
DB00052,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Somatotropin.",Somatotropin
DB00080,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Daptomycin.",Daptomycin
DB00175,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Pravastatin.",Pravastatin
DB00181,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Baclofen.",Baclofen
DB00242,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Cladribine.",Cladribine
DB00382,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Tacrine.",Tacrine
DB00389,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Carbimazole.",Carbimazole
DB00439,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Cerivastatin.",Cerivastatin
DB00443,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Betamethasone.",Betamethasone
DB00471,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Montelukast.",Montelukast
DB00495,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Zidovudine.",Zidovudine
DB00501,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Cimetidine.",Cimetidine
DB00528,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Lercanidipine.",Lercanidipine
DB00541,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Vincristine.",Vincristine
DB00550,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Propylthiouracil.",Propylthiouracil
DB00584,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Enalapril.",Enalapril
DB00585,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Nizatidine.",Nizatidine
DB00602,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Ivermectin.",Ivermectin
DB00620,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Triamcinolone.",Triamcinolone
DB00627,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Niacin.",Niacin
DB00630,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Alendronic acid.",Alendronic acid
DB00636,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Clofibrate.",Clofibrate
DB00649,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Stavudine.",Stavudine
DB00666,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Nafarelin.",Nafarelin
DB00688,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Mycophenolate mofetil.",Mycophenolate mofetil
DB00704,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Naltrexone.",Naltrexone
DB00709,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Lamivudine.",Lamivudine
DB00857,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Terbinafine.",Terbinafine
DB00859,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Penicillamine.",Penicillamine
DB00863,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Ranitidine.",Ranitidine
DB00876,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Eprosartan.",Eprosartan
DB00884,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Risedronic acid.",Risedronic acid
DB00887,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Bumetanide.",Bumetanide
DB00898,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Ethanol.",Ethanol
DB00968,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Methyldopa.",Methyldopa
DB00987,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Cytarabine.",Cytarabine
DB01004,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Ganciclovir.",Ganciclovir
DB01006,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Letrozole.",Letrozole
DB01017,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Minocycline.",Minocycline
DB01039,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Fenofibrate.",Fenofibrate
DB01076,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Atorvastatin.",Atorvastatin
DB01088,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Iloprost.",Iloprost
DB01095,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Fluvastatin.",Fluvastatin
DB01097,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Leflunomide.",Leflunomide
DB01098,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Rosuvastatin.",Rosuvastatin
DB01168,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Procarbazine.",Procarbazine
DB01197,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Captopril.",Captopril
DB01241,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Gemfibrozil.",Gemfibrozil
DB01248,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Docetaxel.",Docetaxel
DB01393,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Bezafibrate.",Bezafibrate
DB02703,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Fusidic acid.",Fusidic acid
DB05109,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Trabectedin.",Trabectedin
DB06693,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Mevastatin.",Mevastatin
DB06817,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Raltegravir.",Raltegravir
DB08860,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Pitavastatin.",Pitavastatin
DB08983,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Etofibrate.",Etofibrate
DB09055,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Acipimox.",Acipimox
DB09064,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Ciprofibrate.",Ciprofibrate
DB09270,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Ubidecarenone.",Ubidecarenone
DB12554,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Mebeverine.",Mebeverine
DB13293,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Ipecac.",Ipecac
DB13393,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Emetine.",Emetine
DB13433,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Simfibrate.",Simfibrate
DB13460,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Ronifibrate.",Ronifibrate
DB13780,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Aluminium clofibrate.",Aluminium clofibrate
DB13849,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Clofibride.",Clofibride
DB13873,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Fenofibric acid.",Fenofibric acid
DB00951,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Isoniazid.",Isoniazid
DB00897,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Triazolam.",Triazolam
DB01394,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Colchicine.",Colchicine
DB00065,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Infliximab.",Infliximab
DB00203,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Sildenafil.",Sildenafil
DB00224,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Indinavir.",Indinavir
DB00227,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Lovastatin.",Lovastatin
DB00252,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Phenytoin.",Phenytoin
DB00641,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Simvastatin.",Simvastatin
DB01229,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Paclitaxel.",Paclitaxel
DB01234,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Dexamethasone.",Dexamethasone
DB09289,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Tianeptine.",Tianeptine
DB00440,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Trimethoprim.",Trimethoprim
DB00331,The therapeutic efficacy of Metformin can be decreased when used in combination with Leuprolide.,Metformin
DB00656,The risk or severity of QTc prolongation can be increased when Trazodone is combined with Leuprolide.,Trazodone
DB11986,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Entrectinib.,Entrectinib
DB11642,Leuprolide may increase the QTc-prolonging activities of Pitolisant.,Pitolisant
DB12825,Lefamulin may increase the QTc-prolonging activities of Leuprolide.,Lefamulin
DB00557,The risk or severity of QTc prolongation can be increased when Hydroxyzine is combined with Leuprolide.,Hydroxyzine
DB00246,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Ziprasidone.,Ziprasidone
DB00502,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Haloperidol.,Haloperidol
DB00472,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Fluoxetine.,Fluoxetine
DB06643,The risk or severity of adverse effects can be increased when Denosumab is combined with Peginterferon alfa-2a.,Denosumab
DB00005,The risk or severity of adverse effects can be increased when Etanercept is combined with Peginterferon alfa-2a.,Etanercept
DB00011,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Interferon alfa-n1.,Interferon alfa-n1
DB00018,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Interferon alfa-n3.,Interferon alfa-n3
DB00022,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Peginterferon alfa-2b.,Peginterferon alfa-2b
DB00026,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Anakinra.,Anakinra
DB00033,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Interferon gamma-1b.,Interferon gamma-1b
DB00034,"The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Interferon alfa-2a, Recombinant.","Interferon alfa-2a, Recombinant"
DB00051,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Adalimumab.,Adalimumab
DB00056,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Gemtuzumab ozogamicin.,Gemtuzumab ozogamicin
DB00059,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Pegaspargase.,Pegaspargase
DB00065,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Infliximab.,Infliximab
DB00068,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Interferon beta-1b.,Interferon beta-1b
DB00069,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Interferon alfacon-1.,Interferon alfacon-1
DB00073,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Rituximab.,Rituximab
DB00074,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Basiliximab.,Basiliximab
DB00075,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Muromonab.,Muromonab
DB00078,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Ibritumomab tiuxetan.,Ibritumomab tiuxetan
DB00081,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Tositumomab.,Tositumomab
DB00087,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Alemtuzumab.,Alemtuzumab
DB00092,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Alefacept.,Alefacept
DB00095,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Efalizumab.,Efalizumab
DB00098,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Antithymocyte immunoglobulin (rabbit).,Antithymocyte immunoglobulin (rabbit)
DB00105,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Interferon alfa-2b.,Interferon alfa-2b
DB00111,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Daclizumab.,Daclizumab
DB00112,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Bevacizumab.,Bevacizumab
DB00120,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Phenylalanine.,Phenylalanine
DB00180,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Flunisolide.,Flunisolide
DB00188,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Bortezomib.,Bortezomib
DB00242,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Cladribine.,Cladribine
DB00262,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Carmustine.,Carmustine
DB00276,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Amsacrine.,Amsacrine
DB00290,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Bleomycin.,Bleomycin
DB00291,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Chlorambucil.,Chlorambucil
DB00293,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Raltitrexed.,Raltitrexed
DB00305,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Mitomycin.,Mitomycin
DB00307,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Bexarotene.,Bexarotene
DB00309,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Vindesine.,Vindesine
DB00322,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Floxuridine.,Floxuridine
DB00328,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Indomethacin.,Indomethacin
DB00352,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Tioguanine.,Tioguanine
DB00361,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Vinorelbine.,Vinorelbine
DB00380,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Dexrazoxane.,Dexrazoxane
DB00394,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Beclomethasone dipropionate.,Beclomethasone dipropionate
DB00398,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Sorafenib.,Sorafenib
DB00428,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Streptozocin.,Streptozocin
DB00432,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Trifluridine.,Trifluridine
DB00441,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Gemcitabine.,Gemcitabine
DB00443,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Betamethasone.,Betamethasone
DB00444,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Teniposide.,Teniposide
DB00445,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Epirubicin.,Epirubicin
DB00446,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Chloramphenicol.,Chloramphenicol
DB00480,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Lenalidomide.,Lenalidomide
DB00488,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Altretamine.,Altretamine
DB00515,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Cisplatin.,Cisplatin
DB00526,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Oxaliplatin.,Oxaliplatin
DB00531,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Cyclophosphamide.,Cyclophosphamide
DB00541,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Vincristine.,Vincristine
DB00544,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Fluorouracil.,Fluorouracil
DB00550,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Propylthiouracil.,Propylthiouracil
DB00552,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Pentostatin.,Pentostatin
DB00563,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Methotrexate.,Methotrexate
DB00564,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Carbamazepine.,Carbamazepine
DB00570,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Vinblastine.,Vinblastine
DB00588,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Fluticasone propionate.,Fluticasone propionate
DB00591,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Fluocinolone acetonide.,Fluocinolone acetonide
DB00601,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Linezolid.,Linezolid
DB00619,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Imatinib.,Imatinib
DB00620,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Triamcinolone.,Triamcinolone
DB00631,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Clofarabine.,Clofarabine
DB00635,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Prednisone.,Prednisone
DB00642,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Pemetrexed.,Pemetrexed
DB00687,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Fludrocortisone.,Fludrocortisone
DB00688,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Mycophenolate mofetil.,Mycophenolate mofetil
DB00694,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Daunorubicin.,Daunorubicin
DB00755,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Tretinoin.,Tretinoin
DB00762,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Irinotecan.,Irinotecan
DB00763,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Methimazole.,Methimazole
DB00764,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Mometasone.,Mometasone
DB00773,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Etoposide.,Etoposide
DB00795,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Sulfasalazine.,Sulfasalazine
DB00851,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Dacarbazine.,Dacarbazine
DB00853,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Temozolomide.,Temozolomide
DB00859,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Penicillamine.,Penicillamine
DB00860,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Prednisolone.,Prednisolone
DB00877,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Sirolimus.,Sirolimus
DB00888,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Mechlorethamine.,Mechlorethamine
DB00928,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Azacitidine.,Azacitidine
DB00958,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Carboplatin.,Carboplatin
DB00959,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Methylprednisolone.,Methylprednisolone
DB00970,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Dactinomycin.,Dactinomycin
DB00987,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Cytarabine.,Cytarabine
DB00993,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Azathioprine.,Azathioprine
DB00997,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Doxorubicin.,Doxorubicin
DB01005,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Hydroxyurea.,Hydroxyurea
DB01008,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Busulfan.,Busulfan
DB01024,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Mycophenolic acid.,Mycophenolic acid
DB01030,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Topotecan.,Topotecan
DB01033,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Mercaptopurine.,Mercaptopurine
DB01041,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Thalidomide.,Thalidomide
DB01042,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Melphalan.,Melphalan
DB01073,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Fludarabine.,Fludarabine
DB01099,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Flucytosine.,Flucytosine
DB01101,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Capecitabine.,Capecitabine
DB01108,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Trilostane.,Trilostane
DB01168,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Procarbazine.,Procarbazine
DB01169,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Arsenic trioxide.,Arsenic trioxide
DB01177,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Idarubicin.,Idarubicin
DB01181,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Ifosfamide.,Ifosfamide
DB01196,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Estramustine.,Estramustine
DB01204,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Mitoxantrone.,Mitoxantrone
DB01206,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Lomustine.,Lomustine
DB01222,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Budesonide.,Budesonide
DB01229,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Paclitaxel.,Paclitaxel
DB01234,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Dexamethasone.,Dexamethasone
DB01248,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Docetaxel.,Docetaxel
DB01254,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Dasatinib.,Dasatinib
DB01257,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Eculizumab.,Eculizumab
DB01262,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Decitabine.,Decitabine
DB01268,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Sunitinib.,Sunitinib
DB01280,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Nelarabine.,Nelarabine
DB01281,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Abatacept.,Abatacept
DB01285,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Corticotropin.,Corticotropin
DB01380,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Cortisone acetate.,Cortisone acetate
DB01384,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Paramethasone.,Paramethasone
DB01394,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Colchicine.,Colchicine
DB01410,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Ciclesonide.,Ciclesonide
DB01423,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Stepronin.,Stepronin
DB01590,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Everolimus.,Everolimus
DB01611,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Hydroxychloroquine.,Hydroxychloroquine
DB01816,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Castanospermine.,Castanospermine
DB02546,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Vorinostat.,Vorinostat
DB02806,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with 2-Methoxyethanol.,2-Methoxyethanol
DB03523,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Brequinar.,Brequinar
DB04572,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Thiotepa.,Thiotepa
DB04630,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Aldosterone.,Aldosterone
DB04845,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Ixabepilone.,Ixabepilone
DB04868,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Nilotinib.,Nilotinib
DB04951,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Pirfenidone.,Pirfenidone
DB04956,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Afelimomab.,Afelimomab
DB05015,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Belinostat.,Belinostat
DB05109,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Trabectedin.,Trabectedin
DB05258,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Interferon alfa.,Interferon alfa
DB05259,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Glatiramer.,Glatiramer
DB05260,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Gallium nitrate.,Gallium nitrate
DB05459,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Briakinumab.,Briakinumab
DB05472,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with omega interferon.,omega interferon
DB05676,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Apremilast.,Apremilast
DB05773,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Trastuzumab emtansine.,Trastuzumab emtansine
DB06168,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Canakinumab.,Canakinumab
DB06273,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Tocilizumab.,Tocilizumab
DB06287,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Temsirolimus.,Temsirolimus
DB06372,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Rilonacept.,Rilonacept
DB06589,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Pazopanib.,Pazopanib
DB06603,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Panobinostat.,Panobinostat
DB06612,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Mepolizumab.,Mepolizumab
DB06616,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Bosutinib.,Bosutinib
DB06662,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Abetimus.,Abetimus
DB06674,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Golimumab.,Golimumab
DB06681,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Belatacept.,Belatacept
DB06769,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Bendamustine.,Bendamustine
DB06772,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Cabazitaxel.,Cabazitaxel
DB06813,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Pralatrexate.,Pralatrexate
DB08059,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Wortmannin.,Wortmannin
DB08870,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Brentuximab vedotin.,Brentuximab vedotin
DB08871,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Eribulin.,Eribulin
DB08877,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Ruxolitinib.,Ruxolitinib
DB08879,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Belimumab.,Belimumab
DB08880,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Teriflunomide.,Teriflunomide
DB08889,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Carfilzomib.,Carfilzomib
DB08901,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Ponatinib.,Ponatinib
DB08904,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Certolizumab pegol.,Certolizumab pegol
DB08906,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Fluticasone furoate.,Fluticasone furoate
DB08908,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Dimethyl fumarate.,Dimethyl fumarate
DB08910,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Pomalidomide.,Pomalidomide
DB08935,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Obinutuzumab.,Obinutuzumab
DB08970,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Fluprednidene.,Fluprednidene
DB08971,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Fluocortolone.,Fluocortolone
DB09029,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Secukinumab.,Secukinumab
DB09033,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Vedolizumab.,Vedolizumab
DB09036,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Siltuximab.,Siltuximab
DB09052,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Blinatumomab.,Blinatumomab
DB09053,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Ibrutinib.,Ibrutinib
DB09054,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Idelalisib.,Idelalisib
DB09073,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Palbociclib.,Palbociclib
DB09074,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Olaparib.,Olaparib
DB09077,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Dinutuximab.,Dinutuximab
DB09082,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Vilanterol.,Vilanterol
DB09091,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Tixocortol.,Tixocortol
DB09122,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Peginterferon beta-1a.,Peginterferon beta-1a
DB09312,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Antilymphocyte immunoglobulin (horse).,Antilymphocyte immunoglobulin (horse)
DB09378,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Fluprednisolone.,Fluprednisolone
DB09383,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Meprednisone.,Meprednisone
DB11466,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Tepoxalin.,Tepoxalin
DB11487,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Dexamethasone isonicotinate.,Dexamethasone isonicotinate
DB11529,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Melengestrol.,Melengestrol
DB11569,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Ixekizumab.,Ixekizumab
DB11580,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Ravulizumab.,Ravulizumab
DB11616,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Pirarubicin.,Pirarubicin
DB11693,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Voclosporin.,Voclosporin
DB11708,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Peficitinib.,Peficitinib
DB11750,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Clobetasol.,Clobetasol
DB11767,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Sarilumab.,Sarilumab
DB11776,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Brodalumab.,Brodalumab
DB11803,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Sirukumab.,Sirukumab
DB11817,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Baricitinib.,Baricitinib
DB11834,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Guselkumab.,Guselkumab
DB11921,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Deflazacort.,Deflazacort
DB11988,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Ocrelizumab.,Ocrelizumab
DB12025,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Triptolide.,Triptolide
DB12371,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Siponimod.,Siponimod
DB12612,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Ozanimod.,Ozanimod
DB12617,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Mizoribine.,Mizoribine
DB12692,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Gusperimus.,Gusperimus
DB12814,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Cepeginterferon alfa-2B.,Cepeginterferon alfa-2B
DB12902,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Trofosfamide.,Trofosfamide
DB12947,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Doxifluridine.,Doxifluridine
DB12991,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Deoxyspergualin.,Deoxyspergualin
DB12996,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Acteoside.,Acteoside
DB13003,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Cortivazol.,Cortivazol
DB13014,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Hypericin.,Hypericin
DB13068,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with 9-(N-methyl-L-isoleucine)-cyclosporin A.,9-(N-methyl-L-isoleucine)-cyclosporin A
DB13208,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Prednylidene.,Prednylidene
DB13223,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Fluocortin.,Fluocortin
DB13241,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Begelomab.,Begelomab
DB13491,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Fluperolone.,Fluperolone
DB13664,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Formocortal.,Formocortal
DB13728,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Halometasone.,Halometasone
DB13843,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Cloprednol.,Cloprednol
DB13856,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Fluclorolone.,Fluclorolone
DB13867,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Fluticasone.,Fluticasone
DB14066,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Tetrandrine.,Tetrandrine
DB14219,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Monomethyl fumarate.,Monomethyl fumarate
DB14512,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Mometasone furoate.,Mometasone furoate
DB14538,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Hydrocortisone aceponate.,Hydrocortisone aceponate
DB14539,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Hydrocortisone acetate.,Hydrocortisone acetate
DB14545,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Hydrocortisone succinate.,Hydrocortisone succinate
DB14724,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Emapalumab.,Emapalumab
DB14762,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Risankizumab.,Risankizumab
DB14919,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Rozanolixizumab.,Rozanolixizumab
DB15253,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Bleselumab.,Bleselumab
DB00108,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Natalizumab.,Natalizumab
DB00337,The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Peginterferon alfa-2a.,Pimecrolimus
DB01656,Roflumilast may increase the immunosuppressive activities of Peginterferon alfa-2a.,Roflumilast
DB06688,The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Peginterferon alfa-2a.,Sipuleucel-T
DB00041,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Aldesleukin.,Aldesleukin
DB00363,The risk or severity of neutropenia can be increased when Peginterferon alfa-2a is combined with Clozapine.,Clozapine
DB00333,The serum concentration of Methadone can be increased when it is combined with Peginterferon alfa-2a.,Methadone
DB01265,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Telbivudine.,Telbivudine
DB00495,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Zidovudine.,Zidovudine
DB08894,The risk or severity of Thrombosis can be increased when Peginterferon alfa-2a is combined with Peginesatide.,Peginesatide
DB09107,The risk or severity of Thrombosis can be increased when Peginterferon alfa-2a is combined with Methoxy polyethylene glycol-epoetin beta.,Methoxy polyethylene glycol-epoetin beta
DB00012,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Peginterferon alfa-2a.,Darbepoetin alfa
DB00016,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Peginterferon alfa-2a.,Erythropoietin
DB00315,The metabolism of Zolmitriptan can be decreased when combined with Peginterferon alfa-2a.,Zolmitriptan
DB01015,The risk or severity of myelosuppression can be increased when Sulfamethoxazole is combined with Peginterferon alfa-2a.,Sulfamethoxazole
DB04817,The risk or severity of myelosuppression can be increased when Metamizole is combined with Peginterferon alfa-2a.,Metamizole
DB01097,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Leflunomide.,Leflunomide
DB08895,Peginterferon alfa-2a may increase the immunosuppressive activities of Tofacitinib.,Tofacitinib
DB00072,Trastuzumab may increase the neutropenic activities of Peginterferon alfa-2a.,Trastuzumab
DB00019,The therapeutic efficacy of Pegfilgrastim can be decreased when used in combination with Peginterferon alfa-2a.,Pegfilgrastim
DB00061,The therapeutic efficacy of Pegademase can be decreased when used in combination with Peginterferon alfa-2a.,Pegademase
DB00082,The therapeutic efficacy of Pegvisomant can be decreased when used in combination with Peginterferon alfa-2a.,Pegvisomant
DB01839,The therapeutic efficacy of Propylene glycol can be decreased when used in combination with Peginterferon alfa-2a.,Propylene glycol
DB03394,The therapeutic efficacy of Heptaethylene glycol can be decreased when used in combination with Peginterferon alfa-2a.,Heptaethylene glycol
DB04895,The therapeutic efficacy of Pegaptanib can be decreased when used in combination with Peginterferon alfa-2a.,Pegaptanib
DB05202,The therapeutic efficacy of Egaptivon pegol can be decreased when used in combination with Peginterferon alfa-2a.,Egaptivon pegol
DB05321,The therapeutic efficacy of PEG-uricase can be decreased when used in combination with Peginterferon alfa-2a.,PEG-uricase
DB05860,The therapeutic efficacy of Peginterferon alfacon-1 can be decreased when used in combination with Peginterferon alfa-2a.,Peginterferon alfacon-1
DB06022,The therapeutic efficacy of GlycoPEG-GCSF can be decreased when used in combination with Peginterferon alfa-2a.,GlycoPEG-GCSF
DB06293,The therapeutic efficacy of Pegnivacogin can be decreased when used in combination with Peginterferon alfa-2a.,Pegnivacogin
DB06325,The therapeutic efficacy of Pegpleranib can be decreased when used in combination with Peginterferon alfa-2a.,Pegpleranib
DB06611,The therapeutic efficacy of Pegsunercept can be decreased when used in combination with Peginterferon alfa-2a.,Pegsunercept
DB06811,The therapeutic efficacy of Polidocanol can be decreased when used in combination with Peginterferon alfa-2a.,Polidocanol
DB09208,The therapeutic efficacy of Pegloticase can be decreased when used in combination with Peginterferon alfa-2a.,Pegloticase
DB09287,The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Peginterferon alfa-2a.,Polyethylene glycol
DB09329,"The therapeutic efficacy of Antihemophilic Factor (Recombinant), PEGylated can be decreased when used in combination with Peginterferon alfa-2a.","Antihemophilic Factor (Recombinant), PEGylated"
DB11077,The therapeutic efficacy of Polyethylene glycol 400 can be decreased when used in combination with Peginterferon alfa-2a.,Polyethylene glycol 400
DB11567,The therapeutic efficacy of Insulin peglispro can be decreased when used in combination with Peginterferon alfa-2a.,Insulin peglispro
DB11661,The therapeutic efficacy of Eptacog alfa pegol (activated) can be decreased when used in combination with Peginterferon alfa-2a.,Eptacog alfa pegol (activated)
DB11707,The therapeutic efficacy of Olaptesed Pegol can be decreased when used in combination with Peginterferon alfa-2a.,Olaptesed Pegol
DB12258,The therapeutic efficacy of Abicipar Pegol can be decreased when used in combination with Peginterferon alfa-2a.,Abicipar Pegol
DB12578,The therapeutic efficacy of Lexaptepid Pegol can be decreased when used in combination with Peginterferon alfa-2a.,Lexaptepid Pegol
DB12839,The therapeutic efficacy of Pegvaliase can be decreased when used in combination with Peginterferon alfa-2a.,Pegvaliase
DB12842,The therapeutic efficacy of Pegamotecan can be decreased when used in combination with Peginterferon alfa-2a.,Pegamotecan
DB13933,The therapeutic efficacy of Nonacog beta pegol can be decreased when used in combination with Peginterferon alfa-2a.,Nonacog beta pegol
DB14700,The therapeutic efficacy of Damoctocog alfa pegol can be decreased when used in combination with Peginterferon alfa-2a.,Damoctocog alfa pegol
DB14712,The therapeutic efficacy of Elapegademase can be decreased when used in combination with Peginterferon alfa-2a.,Elapegademase
DB08868,Peginterferon alfa-2a may increase the immunosuppressive activities of Fingolimod.,Fingolimod
DB00864,Tacrolimus may increase the immunosuppressive activities of Peginterferon alfa-2a.,Tacrolimus
DB00201,The metabolism of Caffeine can be decreased when combined with Peginterferon alfa-2a.,Caffeine
DB00651,The metabolism of Dyphylline can be decreased when combined with Peginterferon alfa-2a.,Dyphylline
DB00806,The metabolism of Pentoxifylline can be decreased when combined with Peginterferon alfa-2a.,Pentoxifylline
DB01303,The metabolism of Oxtriphylline can be decreased when combined with Peginterferon alfa-2a.,Oxtriphylline
DB01412,The metabolism of Theobromine can be decreased when combined with Peginterferon alfa-2a.,Theobromine
DB01482,The metabolism of Fenethylline can be decreased when combined with Peginterferon alfa-2a.,Fenethylline
DB01667,The metabolism of 8-azaguanine can be decreased when combined with Peginterferon alfa-2a.,8-azaguanine
DB01978,"The metabolism of 7,9-Dimethylguanine can be decreased when combined with Peginterferon alfa-2a.","7,9-Dimethylguanine"
DB02134,The metabolism of Xanthine can be decreased when combined with Peginterferon alfa-2a.,Xanthine
DB02245,The metabolism of 7-Deazaguanine can be decreased when combined with Peginterferon alfa-2a.,7-Deazaguanine
DB02377,The metabolism of Guanine can be decreased when combined with Peginterferon alfa-2a.,Guanine
DB02489,The metabolism of 9-Methylguanine can be decreased when combined with Peginterferon alfa-2a.,9-Methylguanine
DB02568,The metabolism of Peldesine can be decreased when combined with Peginterferon alfa-2a.,Peldesine
DB04076,The metabolism of Hypoxanthine can be decreased when combined with Peginterferon alfa-2a.,Hypoxanthine
DB04356,The metabolism of 9-Deazaguanine can be decreased when combined with Peginterferon alfa-2a.,9-Deazaguanine
DB06479,The metabolism of Propentofylline can be decreased when combined with Peginterferon alfa-2a.,Propentofylline
DB06575,The metabolism of Valomaciclovir can be decreased when combined with Peginterferon alfa-2a.,Valomaciclovir
DB07954,The metabolism of 3-isobutyl-1-methyl-7H-xanthine can be decreased when combined with Peginterferon alfa-2a.,3-isobutyl-1-methyl-7H-xanthine
DB08844,The metabolism of Uric acid can be decreased when combined with Peginterferon alfa-2a.,Uric acid
DB09273,The metabolism of Doxofylline can be decreased when combined with Peginterferon alfa-2a.,Doxofylline
DB11919,The metabolism of 6-O-benzylguanine can be decreased when combined with Peginterferon alfa-2a.,6-O-benzylguanine
DB12406,The metabolism of Lisofylline can be decreased when combined with Peginterferon alfa-2a.,Lisofylline
DB12531,The metabolism of Lobucavir can be decreased when combined with Peginterferon alfa-2a.,Lobucavir
DB12926,The metabolism of Cafedrine can be decreased when combined with Peginterferon alfa-2a.,Cafedrine
DB12927,The metabolism of Theodrenaline can be decreased when combined with Peginterferon alfa-2a.,Theodrenaline
DB13203,The metabolism of Bamifylline can be decreased when combined with Peginterferon alfa-2a.,Bamifylline
DB13449,The metabolism of Proxyphylline can be decreased when combined with Peginterferon alfa-2a.,Proxyphylline
DB13573,The metabolism of Acefylline can be decreased when combined with Peginterferon alfa-2a.,Acefylline
DB13592,The metabolism of Etamiphylline can be decreased when combined with Peginterferon alfa-2a.,Etamiphylline
DB13634,The metabolism of Pentifylline can be decreased when combined with Peginterferon alfa-2a.,Pentifylline
DB13812,The metabolism of Bufylline can be decreased when combined with Peginterferon alfa-2a.,Bufylline
DB14018,The metabolism of Bromotheophylline can be decreased when combined with Peginterferon alfa-2a.,Bromotheophylline
DB14029,The metabolism of Furafylline can be decreased when combined with Peginterferon alfa-2a.,Furafylline
DB14132,The metabolism of 8-chlorotheophylline can be decreased when combined with Peginterferon alfa-2a.,8-chlorotheophylline
DB15122,The metabolism of PCS-499 can be decreased when combined with Peginterferon alfa-2a.,PCS-499
DB00390,Digoxin may decrease the cardiotoxic activities of Peginterferon alfa-2a.,Digoxin
DB00511,Acetyldigitoxin may decrease the cardiotoxic activities of Peginterferon alfa-2a.,Acetyldigitoxin
DB01078,Deslanoside may decrease the cardiotoxic activities of Peginterferon alfa-2a.,Deslanoside
DB01092,Ouabain may decrease the cardiotoxic activities of Peginterferon alfa-2a.,Ouabain
DB01396,Digitoxin may decrease the cardiotoxic activities of Peginterferon alfa-2a.,Digitoxin
DB12843,Oleandrin may decrease the cardiotoxic activities of Peginterferon alfa-2a.,Oleandrin
DB13240,Cymarin may decrease the cardiotoxic activities of Peginterferon alfa-2a.,Cymarin
DB13307,Proscillaridin may decrease the cardiotoxic activities of Peginterferon alfa-2a.,Proscillaridin
DB13401,Metildigoxin may decrease the cardiotoxic activities of Peginterferon alfa-2a.,Metildigoxin
DB13467,Lanatoside C may decrease the cardiotoxic activities of Peginterferon alfa-2a.,Lanatoside C
DB13537,Gitoformate may decrease the cardiotoxic activities of Peginterferon alfa-2a.,Gitoformate
DB13691,Acetyldigoxin may decrease the cardiotoxic activities of Peginterferon alfa-2a.,Acetyldigoxin
DB13756,Peruvoside may decrease the cardiotoxic activities of Peginterferon alfa-2a.,Peruvoside
DB01217,The risk or severity of cardiotoxicity can be increased when Peginterferon alfa-2a is combined with Anastrozole.,Anastrozole
DB06013,The risk or severity of cardiotoxicity can be increased when Peginterferon alfa-2a is combined with Aldoxorubicin.,Aldoxorubicin
DB06171,The risk or severity of cardiotoxicity can be increased when Peginterferon alfa-2a is combined with Paclitaxel trevatide.,Paclitaxel trevatide
DB13809,The risk or severity of cardiotoxicity can be increased when Peginterferon alfa-2a is combined with Paclitaxel poliglumex.,Paclitaxel poliglumex
DB04914,The therapeutic efficacy of G17DT can be decreased when used in combination with Peginterferon alfa-2a.,G17DT
DB05144,The therapeutic efficacy of PEV3A can be decreased when used in combination with Peginterferon alfa-2a.,PEV3A
DB05325,The therapeutic efficacy of INGN 225 can be decreased when used in combination with Peginterferon alfa-2a.,INGN 225
DB05374,The therapeutic efficacy of Rindopepimut can be decreased when used in combination with Peginterferon alfa-2a.,Rindopepimut
DB05440,The therapeutic efficacy of SRP 299 can be decreased when used in combination with Peginterferon alfa-2a.,SRP 299
DB05942,The therapeutic efficacy of GI-5005 can be decreased when used in combination with Peginterferon alfa-2a.,GI-5005
DB06400,The therapeutic efficacy of Vitespen can be decreased when used in combination with Peginterferon alfa-2a.,Vitespen
DB06584,The therapeutic efficacy of TG4010 can be decreased when used in combination with Peginterferon alfa-2a.,TG4010
DB09057,The therapeutic efficacy of Anthrax immune globulin human can be decreased when used in combination with Peginterferon alfa-2a.,Anthrax immune globulin human
DB10062,"The therapeutic efficacy of Rabies virus inactivated antigen, B can be decreased when used in combination with Peginterferon alfa-2a.","Rabies virus inactivated antigen, B"
DB10076,The therapeutic efficacy of Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Peginterferon alfa-2a.,Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen
DB10276,The therapeutic efficacy of Rotavirus vaccine can be decreased when used in combination with Peginterferon alfa-2a.,Rotavirus vaccine
DB10283,"The therapeutic efficacy of Rabies virus inactivated antigen, A can be decreased when used in combination with Peginterferon alfa-2a.","Rabies virus inactivated antigen, A"
DB10342,The therapeutic efficacy of Haemophilus influenzae type B capsular polysaccharide meningococcal outer membrane protein conjugate antigen can be decreased when used in combination with Peginterferon alfa-2a.,Haemophilus influenzae type B capsular polysaccharide meningococcal outer membrane protein conjugate antigen
DB10583,The therapeutic efficacy of Clostridium tetani toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Peginterferon alfa-2a.,Clostridium tetani toxoid antigen (formaldehyde inactivated)
DB10584,The therapeutic efficacy of Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Peginterferon alfa-2a.,Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated)
DB10600,The therapeutic efficacy of Influenza A virus A/California/7/2009 X-181 (H1N1) antigen (propiolactone inactivated) can be decreased when used in combination with Peginterferon alfa-2a.,Influenza A virus A/California/7/2009 X-181 (H1N1) antigen (propiolactone inactivated)
DB10769,The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Peginterferon alfa-2a.,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated)
DB10794,The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 antigen (formaldehyde inactivated) can be decreased when used in combination with Peginterferon alfa-2a.,Influenza B virus B/Brisbane/60/2008 antigen (formaldehyde inactivated)
DB10803,The therapeutic efficacy of Typhoid Vi polysaccharide vaccine can be decreased when used in combination with Peginterferon alfa-2a.,Typhoid Vi polysaccharide vaccine
DB10989,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Peginterferon alfa-2a.,Hepatitis A Vaccine
DB10990,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Peginterferon alfa-2a.,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen
DB11038,The therapeutic efficacy of Influenza A virus A/Brisbane/59/2007(H1N1) hemagglutinin antigen (propiolactone inactivated) can be decreased when used in combination with Peginterferon alfa-2a.,Influenza A virus A/Brisbane/59/2007(H1N1) hemagglutinin antigen (propiolactone inactivated)
DB11040,The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (propiolactone inactivated) can be decreased when used in combination with Peginterferon alfa-2a.,Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (propiolactone inactivated)
DB11041,The therapeutic efficacy of Influenza A virus A/California/7/2009 X-181 (H1N1) hemagglutinin antigen (propiolactone inactivated) can be decreased when used in combination with Peginterferon alfa-2a.,Influenza A virus A/California/7/2009 X-181 (H1N1) hemagglutinin antigen (propiolactone inactivated)
DB11044,The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 antigen (propiolactone inactivated) can be decreased when used in combination with Peginterferon alfa-2a.,Influenza B virus B/Brisbane/60/2008 antigen (propiolactone inactivated)
DB11603,The therapeutic efficacy of Human rabies virus immune globulin can be decreased when used in combination with Peginterferon alfa-2a.,Human rabies virus immune globulin
DB11627,The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Peginterferon alfa-2a.,Hepatitis B Vaccine (Recombinant)
DB12568,The therapeutic efficacy of Tecemotide can be decreased when used in combination with Peginterferon alfa-2a.,Tecemotide
DB14022,The therapeutic efficacy of Typhoid vaccine can be decreased when used in combination with Peginterferon alfa-2a.,Typhoid vaccine
DB14384,The therapeutic efficacy of Influenza A virus A/Victoria/210/2009 X-187 (H3N2) hemagglutinin antigen (formaldehyde inactivated) can be decreased when used in combination with Peginterferon alfa-2a.,Influenza A virus A/Victoria/210/2009 X-187 (H3N2) hemagglutinin antigen (formaldehyde inactivated)
DB14385,The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (formaldehyde inactivated) can be decreased when used in combination with Peginterferon alfa-2a.,Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (formaldehyde inactivated)
DB14394,The therapeutic efficacy of Influenza A virus A/California/7/2009 (H1N1) live (attenuated) antigen can be decreased when used in combination with Peginterferon alfa-2a.,Influenza A virus A/California/7/2009 (H1N1) live (attenuated) antigen
DB14445,The therapeutic efficacy of Influenza A virus A/Victoria/210/2009 X-187 (H3N2) antigen (formaldehyde inactivated) can be decreased when used in combination with Peginterferon alfa-2a.,Influenza A virus A/Victoria/210/2009 X-187 (H3N2) antigen (formaldehyde inactivated)
DB14449,The therapeutic efficacy of Influenza A virus A/Perth/16/2009 (H3N2) live (attenuated) antigen can be decreased when used in combination with Peginterferon alfa-2a.,Influenza A virus A/Perth/16/2009 (H3N2) live (attenuated) antigen
DB14619,The therapeutic efficacy of Influenza A virus A/Uruguay/716/2007(H3N2) antigen (propiolactone inactivated) can be decreased when used in combination with Peginterferon alfa-2a.,Influenza A virus A/Uruguay/716/2007(H3N2) antigen (propiolactone inactivated)
DB14620,The therapeutic efficacy of Influenza A virus A/Brisbane/59/2007(H1N1) antigen (propiolactone inactivated) can be decreased when used in combination with Peginterferon alfa-2a.,Influenza A virus A/Brisbane/59/2007(H1N1) antigen (propiolactone inactivated)
DB14711,The therapeutic efficacy of Vaccinia virus strain new york city board of health live antigen can be decreased when used in combination with Peginterferon alfa-2a.,Vaccinia virus strain new york city board of health live antigen
DB15274,The therapeutic efficacy of Pertussis vaccine can be decreased when used in combination with Peginterferon alfa-2a.,Pertussis vaccine
DB15461,The therapeutic efficacy of Yersinia pestis 195/p antigen (formaldehyde inactivated) can be decreased when used in combination with Peginterferon alfa-2a.,Yersinia pestis 195/p antigen (formaldehyde inactivated)
DB13924,The therapeutic efficacy of Varicella Zoster Vaccine (Recombinant) can be decreased when used in combination with Peginterferon alfa-2a.,Varicella Zoster Vaccine (Recombinant)
DB15483,The therapeutic efficacy of Modified vaccinia ankara can be decreased when used in combination with Peginterferon alfa-2a.,Modified vaccinia ankara
DB15595,"The therapeutic efficacy of Ebola Zaire vaccine (live, attenuated) can be decreased when used in combination with Peginterferon alfa-2a.","Ebola Zaire vaccine (live, attenuated)"
DB00054,The risk or severity of bleeding can be increased when Abciximab is combined with Peginterferon alfa-2a.,Abciximab
DB00063,The risk or severity of bleeding can be increased when Eptifibatide is combined with Peginterferon alfa-2a.,Eptifibatide
DB00208,The risk or severity of bleeding can be increased when Ticlopidine is combined with Peginterferon alfa-2a.,Ticlopidine
DB00775,The risk or severity of bleeding can be increased when Tirofiban is combined with Peginterferon alfa-2a.,Tirofiban
DB00945,The risk or severity of bleeding can be increased when Acetylsalicylic acid is combined with Peginterferon alfa-2a.,Acetylsalicylic acid
DB00975,The risk or severity of bleeding can be increased when Dipyridamole is combined with Peginterferon alfa-2a.,Dipyridamole
DB01088,The risk or severity of bleeding can be increased when Iloprost is combined with Peginterferon alfa-2a.,Iloprost
DB01138,The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Peginterferon alfa-2a.,Sulfinpyrazone
DB01207,The risk or severity of bleeding can be increased when Ridogrel is combined with Peginterferon alfa-2a.,Ridogrel
DB01236,The risk or severity of bleeding can be increased when Sevoflurane is combined with Peginterferon alfa-2a.,Sevoflurane
DB01240,The risk or severity of bleeding can be increased when Epoprostenol is combined with Peginterferon alfa-2a.,Epoprostenol
DB04743,The risk or severity of bleeding can be increased when Nimesulide is combined with Peginterferon alfa-2a.,Nimesulide
DB04905,The risk or severity of bleeding can be increased when Tesmilifene is combined with Peginterferon alfa-2a.,Tesmilifene
DB04932,The risk or severity of bleeding can be increased when Defibrotide is combined with Peginterferon alfa-2a.,Defibrotide
DB05229,The risk or severity of bleeding can be increased when Beraprost is combined with Peginterferon alfa-2a.,Beraprost
DB05266,The risk or severity of bleeding can be increased when Ibudilast is combined with Peginterferon alfa-2a.,Ibudilast
DB05767,The risk or severity of bleeding can be increased when Andrographolide is combined with Peginterferon alfa-2a.,Andrographolide
DB06081,The risk or severity of bleeding can be increased when Caplacizumab is combined with Peginterferon alfa-2a.,Caplacizumab
DB06209,The risk or severity of bleeding can be increased when Prasugrel is combined with Peginterferon alfa-2a.,Prasugrel
DB06441,The risk or severity of bleeding can be increased when Cangrelor is combined with Peginterferon alfa-2a.,Cangrelor
DB07615,The risk or severity of bleeding can be increased when Tranilast is combined with Peginterferon alfa-2a.,Tranilast
DB08814,The risk or severity of bleeding can be increased when Triflusal is combined with Peginterferon alfa-2a.,Triflusal
DB08816,The risk or severity of bleeding can be increased when Ticagrelor is combined with Peginterferon alfa-2a.,Ticagrelor
DB08887,The risk or severity of bleeding can be increased when Icosapent ethyl is combined with Peginterferon alfa-2a.,Icosapent ethyl
DB09030,The risk or severity of bleeding can be increased when Vorapaxar is combined with Peginterferon alfa-2a.,Vorapaxar
DB09283,The risk or severity of bleeding can be increased when Trapidil is combined with Peginterferon alfa-2a.,Trapidil
DB12092,The risk or severity of bleeding can be increased when Naftopidil is combined with Peginterferon alfa-2a.,Naftopidil
DB12163,The risk or severity of bleeding can be increased when Sarpogrelate is combined with Peginterferon alfa-2a.,Sarpogrelate
DB12321,The risk or severity of bleeding can be increased when Ifetroban is combined with Peginterferon alfa-2a.,Ifetroban
DB12445,The risk or severity of bleeding can be increased when Nitroaspirin is combined with Peginterferon alfa-2a.,Nitroaspirin
DB12465,The risk or severity of bleeding can be increased when Ketanserin is combined with Peginterferon alfa-2a.,Ketanserin
DB12545,The risk or severity of bleeding can be increased when Indobufen is combined with Peginterferon alfa-2a.,Indobufen
DB12749,The risk or severity of bleeding can be increased when Butylphthalide is combined with Peginterferon alfa-2a.,Butylphthalide
DB12771,The risk or severity of bleeding can be increased when Hydroxytyrosol is combined with Peginterferon alfa-2a.,Hydroxytyrosol
DB13036,The risk or severity of bleeding can be increased when Ramatroban is combined with Peginterferon alfa-2a.,Ramatroban
DB13327,The risk or severity of bleeding can be increased when Picotamide is combined with Peginterferon alfa-2a.,Picotamide
DB13367,The risk or severity of bleeding can be increased when Cloricromen is combined with Peginterferon alfa-2a.,Cloricromen
DB13400,The risk or severity of bleeding can be increased when Linsidomine is combined with Peginterferon alfa-2a.,Linsidomine
DB13510,The risk or severity of bleeding can be increased when Buflomedil is combined with Peginterferon alfa-2a.,Buflomedil
DB13929,The risk or severity of bleeding can be increased when Relcovaptan is combined with Peginterferon alfa-2a.,Relcovaptan
DB13200,Peginterferon alfa-2a may increase the myelosuppressive activities of Lipegfilgrastim.,Lipegfilgrastim
DB10318,The risk or severity of infection can be increased when Peginterferon alfa-2a is combined with Varicella Zoster Vaccine (Live/attenuated).,Varicella Zoster Vaccine (Live/attenuated)
DB10317,The risk or severity of infection can be increased when Rubella virus vaccine is combined with Peginterferon alfa-2a.,Rubella virus vaccine
DB10343,The risk or severity of infection can be increased when Bacillus calmette-guerin substrain tice live antigen is combined with Peginterferon alfa-2a.,Bacillus calmette-guerin substrain tice live antigen
DB10804,The risk or severity of infection can be increased when Bacillus calmette-guerin substrain connaught live antigen is combined with Peginterferon alfa-2a.,Bacillus calmette-guerin substrain connaught live antigen
DB10805,The risk or severity of infection can be increased when Yellow Fever Vaccine is combined with Peginterferon alfa-2a.,Yellow Fever Vaccine
DB11003,The risk or severity of infection can be increased when Anthrax vaccine is combined with Peginterferon alfa-2a.,Anthrax vaccine
DB11050,The risk or severity of infection can be increased when Typhoid Vaccine Live is combined with Peginterferon alfa-2a.,Typhoid Vaccine Live
DB12386,The risk or severity of infection can be increased when Bacillus calmette-guerin substrain danish 1331 live antigen is combined with Peginterferon alfa-2a.,Bacillus calmette-guerin substrain danish 1331 live antigen
DB12768,The risk or severity of infection can be increased when BCG vaccine is combined with Peginterferon alfa-2a.,BCG vaccine
DB14409,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Peginterferon alfa-2a.,Human adenovirus e serotype 4 strain cl-68578 antigen
DB14443,The risk or severity of infection can be increased when Vibrio cholerae CVD 103-HgR strain live antigen is combined with Peginterferon alfa-2a.,Vibrio cholerae CVD 103-HgR strain live antigen
DB14685,The risk or severity of infection can be increased when Adenovirus type 7 vaccine live is combined with Peginterferon alfa-2a.,Adenovirus type 7 vaccine live
DB00039,The therapeutic efficacy of Palifermin can be decreased when used in combination with Peginterferon alfa-2a.,Palifermin
DB00176,The metabolism of Fluvoxamine can be decreased when combined with Peginterferon alfa-2a.,Fluvoxamine
DB00184,The metabolism of Nicotine can be decreased when combined with Peginterferon alfa-2a.,Nicotine
DB00195,The metabolism of Betaxolol can be decreased when combined with Peginterferon alfa-2a.,Betaxolol
DB00261,The metabolism of Anagrelide can be decreased when combined with Peginterferon alfa-2a.,Anagrelide
DB00280,The metabolism of Disopyramide can be decreased when combined with Peginterferon alfa-2a.,Disopyramide
DB00281,The metabolism of Lidocaine can be decreased when combined with Peginterferon alfa-2a.,Lidocaine
DB00286,The metabolism of Conjugated estrogens can be decreased when combined with Peginterferon alfa-2a.,Conjugated estrogens
DB00296,The metabolism of Ropivacaine can be decreased when combined with Peginterferon alfa-2a.,Ropivacaine
DB00316,The metabolism of Acetaminophen can be decreased when combined with Peginterferon alfa-2a.,Acetaminophen
DB00334,The metabolism of Olanzapine can be decreased when combined with Peginterferon alfa-2a.,Olanzapine
DB00356,The metabolism of Chlorzoxazone can be decreased when combined with Peginterferon alfa-2a.,Chlorzoxazone
DB00365,The metabolism of Grepafloxacin can be decreased when combined with Peginterferon alfa-2a.,Grepafloxacin
DB00370,The metabolism of Mirtazapine can be decreased when combined with Peginterferon alfa-2a.,Mirtazapine
DB00379,The metabolism of Mexiletine can be decreased when combined with Peginterferon alfa-2a.,Mexiletine
DB00382,The metabolism of Tacrine can be decreased when combined with Peginterferon alfa-2a.,Tacrine
DB00384,The metabolism of Triamterene can be decreased when combined with Peginterferon alfa-2a.,Triamterene
DB00420,The metabolism of Promazine can be decreased when combined with Peginterferon alfa-2a.,Promazine
DB00425,The metabolism of Zolpidem can be decreased when combined with Peginterferon alfa-2a.,Zolpidem
DB00442,The metabolism of Entecavir can be decreased when combined with Peginterferon alfa-2a.,Entecavir
DB00461,The metabolism of Nabumetone can be decreased when combined with Peginterferon alfa-2a.,Nabumetone
DB00468,The metabolism of Quinine can be decreased when combined with Peginterferon alfa-2a.,Quinine
DB00472,The metabolism of Fluoxetine can be decreased when combined with Peginterferon alfa-2a.,Fluoxetine
DB00476,The metabolism of Duloxetine can be decreased when combined with Peginterferon alfa-2a.,Duloxetine
DB00477,The metabolism of Chlorpromazine can be decreased when combined with Peginterferon alfa-2a.,Chlorpromazine
DB00499,The metabolism of Flutamide can be decreased when combined with Peginterferon alfa-2a.,Flutamide
DB00502,The metabolism of Haloperidol can be decreased when combined with Peginterferon alfa-2a.,Haloperidol
DB00518,The metabolism of Albendazole can be decreased when combined with Peginterferon alfa-2a.,Albendazole
DB00533,The metabolism of Rofecoxib can be decreased when combined with Peginterferon alfa-2a.,Rofecoxib
DB00568,The metabolism of Cinnarizine can be decreased when combined with Peginterferon alfa-2a.,Cinnarizine
DB00571,The metabolism of Propranolol can be decreased when combined with Peginterferon alfa-2a.,Propranolol
DB00586,The metabolism of Diclofenac can be decreased when combined with Peginterferon alfa-2a.,Diclofenac
DB00629,The metabolism of Guanabenz can be decreased when combined with Peginterferon alfa-2a.,Guanabenz
DB00661,The metabolism of Verapamil can be decreased when combined with Peginterferon alfa-2a.,Verapamil
DB00715,The metabolism of Paroxetine can be decreased when combined with Peginterferon alfa-2a.,Paroxetine
DB00730,The metabolism of Thiabendazole can be decreased when combined with Peginterferon alfa-2a.,Thiabendazole
DB00740,The metabolism of Riluzole can be decreased when combined with Peginterferon alfa-2a.,Riluzole
DB00744,The metabolism of Zileuton can be decreased when combined with Peginterferon alfa-2a.,Zileuton
DB00758,The metabolism of Clopidogrel can be decreased when combined with Peginterferon alfa-2a.,Clopidogrel
DB00783,The metabolism of Estradiol can be decreased when combined with Peginterferon alfa-2a.,Estradiol
DB00787,The metabolism of Acyclovir can be decreased when combined with Peginterferon alfa-2a.,Acyclovir
DB00788,The metabolism of Naproxen can be decreased when combined with Peginterferon alfa-2a.,Naproxen
DB00831,The metabolism of Trifluoperazine can be decreased when combined with Peginterferon alfa-2a.,Trifluoperazine
DB00850,The metabolism of Perphenazine can be decreased when combined with Peginterferon alfa-2a.,Perphenazine
DB00857,The metabolism of Terbinafine can be decreased when combined with Peginterferon alfa-2a.,Terbinafine
DB00863,The metabolism of Ranitidine can be decreased when combined with Peginterferon alfa-2a.,Ranitidine
DB00898,The metabolism of Ethanol can be decreased when combined with Peginterferon alfa-2a.,Ethanol
DB00934,The metabolism of Maprotiline can be decreased when combined with Peginterferon alfa-2a.,Maprotiline
DB00969,The metabolism of Alosetron can be decreased when combined with Peginterferon alfa-2a.,Alosetron
DB00978,The metabolism of Lomefloxacin can be decreased when combined with Peginterferon alfa-2a.,Lomefloxacin
DB00980,The metabolism of Ramelteon can be decreased when combined with Peginterferon alfa-2a.,Ramelteon
DB00998,The metabolism of Frovatriptan can be decreased when combined with Peginterferon alfa-2a.,Frovatriptan
DB01002,The metabolism of Levobupivacaine can be decreased when combined with Peginterferon alfa-2a.,Levobupivacaine
DB01012,The metabolism of Cinacalcet can be decreased when combined with Peginterferon alfa-2a.,Cinacalcet
DB01037,The metabolism of Selegiline can be decreased when combined with Peginterferon alfa-2a.,Selegiline
DB01056,The metabolism of Tocainide can be decreased when combined with Peginterferon alfa-2a.,Tocainide
DB01058,The metabolism of Praziquantel can be decreased when combined with Peginterferon alfa-2a.,Praziquantel
DB01065,The metabolism of Melatonin can be decreased when combined with Peginterferon alfa-2a.,Melatonin
DB01087,The metabolism of Primaquine can be decreased when combined with Peginterferon alfa-2a.,Primaquine
DB01094,The metabolism of Hesperetin can be decreased when combined with Peginterferon alfa-2a.,Hesperetin
DB01115,The metabolism of Nifedipine can be decreased when combined with Peginterferon alfa-2a.,Nifedipine
DB01136,The metabolism of Carvedilol can be decreased when combined with Peginterferon alfa-2a.,Carvedilol
DB01166,The metabolism of Cilostazol can be decreased when combined with Peginterferon alfa-2a.,Cilostazol
DB01182,The metabolism of Propafenone can be decreased when combined with Peginterferon alfa-2a.,Propafenone
DB01184,The metabolism of Domperidone can be decreased when combined with Peginterferon alfa-2a.,Domperidone
DB01191,The metabolism of Dexfenfluramine can be decreased when combined with Peginterferon alfa-2a.,Dexfenfluramine
DB01367,The metabolism of Rasagiline can be decreased when combined with Peginterferon alfa-2a.,Rasagiline
DB01405,The metabolism of Temafloxacin can be decreased when combined with Peginterferon alfa-2a.,Temafloxacin
DB01424,The metabolism of Aminophenazone can be decreased when combined with Peginterferon alfa-2a.,Aminophenazone
DB01435,The metabolism of Antipyrine can be decreased when combined with Peginterferon alfa-2a.,Antipyrine
DB01558,The metabolism of Bromazepam can be decreased when combined with Peginterferon alfa-2a.,Bromazepam
DB01623,The metabolism of Thiothixene can be decreased when combined with Peginterferon alfa-2a.,Thiothixene
DB01628,The metabolism of Etoricoxib can be decreased when combined with Peginterferon alfa-2a.,Etoricoxib
DB01645,The metabolism of Genistein can be decreased when combined with Peginterferon alfa-2a.,Genistein
DB02709,The metabolism of Resveratrol can be decreased when combined with Peginterferon alfa-2a.,Resveratrol
DB03783,The metabolism of Phenacetin can be decreased when combined with Peginterferon alfa-2a.,Phenacetin
DB04574,The metabolism of Estrone sulfate can be decreased when combined with Peginterferon alfa-2a.,Estrone sulfate
DB04841,The metabolism of Flunarizine can be decreased when combined with Peginterferon alfa-2a.,Flunarizine
DB04871,The metabolism of Lorcaserin can be decreased when combined with Peginterferon alfa-2a.,Lorcaserin
DB04948,The metabolism of Lofexidine can be decreased when combined with Peginterferon alfa-2a.,Lofexidine
DB06148,The metabolism of Mianserin can be decreased when combined with Peginterferon alfa-2a.,Mianserin
DB06210,The metabolism of Eltrombopag can be decreased when combined with Peginterferon alfa-2a.,Eltrombopag
DB06216,The metabolism of Asenapine can be decreased when combined with Peginterferon alfa-2a.,Asenapine
DB06235,The metabolism of Vadimezan can be decreased when combined with Peginterferon alfa-2a.,Vadimezan
DB06292,The metabolism of Dapagliflozin can be decreased when combined with Peginterferon alfa-2a.,Dapagliflozin
DB06594,The metabolism of Agomelatine can be decreased when combined with Peginterferon alfa-2a.,Agomelatine
DB06626,The metabolism of Axitinib can be decreased when combined with Peginterferon alfa-2a.,Axitinib
DB06770,The metabolism of Benzyl alcohol can be decreased when combined with Peginterferon alfa-2a.,Benzyl alcohol
DB06774,The metabolism of Capsaicin can be decreased when combined with Peginterferon alfa-2a.,Capsaicin
DB08496,The metabolism of (R)-warfarin can be decreased when combined with Peginterferon alfa-2a.,(R)-warfarin
DB08883,The metabolism of Perampanel can be decreased when combined with Peginterferon alfa-2a.,Perampanel
DB09071,The metabolism of Tasimelteon can be decreased when combined with Peginterferon alfa-2a.,Tasimelteon
DB09118,The metabolism of Stiripentol can be decreased when combined with Peginterferon alfa-2a.,Stiripentol
DB09225,The metabolism of Zotepine can be decreased when combined with Peginterferon alfa-2a.,Zotepine
DB09288,The metabolism of Propacetamol can be decreased when combined with Peginterferon alfa-2a.,Propacetamol
DB09290,The metabolism of Ramosetron can be decreased when combined with Peginterferon alfa-2a.,Ramosetron
DB11967,The metabolism of Binimetinib can be decreased when combined with Peginterferon alfa-2a.,Binimetinib
DB12026,The metabolism of Voxilaprevir can be decreased when combined with Peginterferon alfa-2a.,Voxilaprevir
DB12245,The metabolism of Triclabendazole can be decreased when combined with Peginterferon alfa-2a.,Triclabendazole
DB12332,The metabolism of Rucaparib can be decreased when combined with Peginterferon alfa-2a.,Rucaparib
DB12945,The metabolism of Dihydralazine can be decreased when combined with Peginterferon alfa-2a.,Dihydralazine
DB13952,The metabolism of Estradiol acetate can be decreased when combined with Peginterferon alfa-2a.,Estradiol acetate
DB13953,The metabolism of Estradiol benzoate can be decreased when combined with Peginterferon alfa-2a.,Estradiol benzoate
DB13954,The metabolism of Estradiol cypionate can be decreased when combined with Peginterferon alfa-2a.,Estradiol cypionate
DB13955,The metabolism of Estradiol dienanthate can be decreased when combined with Peginterferon alfa-2a.,Estradiol dienanthate
DB13956,The metabolism of Estradiol valerate can be decreased when combined with Peginterferon alfa-2a.,Estradiol valerate
DB11757,The metabolism of Istradefylline can be decreased when combined with Peginterferon alfa-2a.,Istradefylline
DB00972,The metabolism of Azelastine can be decreased when combined with Peginterferon alfa-2a.,Azelastine
DB00625,The metabolism of Efavirenz can be decreased when combined with Peginterferon alfa-2a.,Efavirenz
DB01233,The metabolism of Metoclopramide can be decreased when combined with Peginterferon alfa-2a.,Metoclopramide
DB04889,The metabolism of Bicifadine can be decreased when combined with Peginterferon alfa-2a.,Bicifadine
DB05708,The metabolism of GTS-21 can be decreased when combined with Peginterferon alfa-2a.,GTS-21
DB01195,The metabolism of Flecainide can be decreased when combined with Peginterferon alfa-2a.,Flecainide
DB00977,The metabolism of Ethinylestradiol can be decreased when combined with Peginterferon alfa-2a.,Ethinylestradiol
DB00321,The metabolism of Amitriptyline can be decreased when combined with Peginterferon alfa-2a.,Amitriptyline
DB00458,The metabolism of Imipramine can be decreased when combined with Peginterferon alfa-2a.,Imipramine
DB01142,The metabolism of Doxepin can be decreased when combined with Peginterferon alfa-2a.,Doxepin
DB00532,The metabolism of Mephenytoin can be decreased when combined with Peginterferon alfa-2a.,Mephenytoin
DB00540,The metabolism of Nortriptyline can be decreased when combined with Peginterferon alfa-2a.,Nortriptyline
DB00575,The metabolism of Clonidine can be decreased when combined with Peginterferon alfa-2a.,Clonidine
DB00924,The metabolism of Cyclobenzaprine can be decreased when combined with Peginterferon alfa-2a.,Cyclobenzaprine
DB01151,The metabolism of Desipramine can be decreased when combined with Peginterferon alfa-2a.,Desipramine
DB01242,The metabolism of Clomipramine can be decreased when combined with Peginterferon alfa-2a.,Clomipramine
DB11689,The metabolism of Selumetinib can be decreased when combined with Peginterferon alfa-2a.,Selumetinib
DB00675,The metabolism of Tamoxifen can be decreased when combined with Peginterferon alfa-2a.,Tamoxifen
DB00277,The metabolism of Theophylline can be decreased when combined with Peginterferon alfa-2a.,Theophylline
DB00682,The metabolism of Warfarin can be decreased when combined with Peginterferon alfa-2a.,Warfarin
DB00697,The metabolism of Tizanidine can be decreased when combined with Peginterferon alfa-2a.,Tizanidine
DB01100,The metabolism of Pimozide can be decreased when combined with Peginterferon alfa-2a.,Pimozide
DB01223,The metabolism of Aminophylline can be decreased when combined with Peginterferon alfa-2a.,Aminophylline
DB01418,The metabolism of Acenocoumarol can be decreased when combined with Peginterferon alfa-2a.,Acenocoumarol
DB00530,The metabolism of Erlotinib can be decreased when combined with Peginterferon alfa-2a.,Erlotinib
DB09256,The metabolism of Tegafur can be decreased when combined with Peginterferon alfa-2a.,Tegafur
DB13874,The metabolism of Enasidenib can be decreased when combined with Peginterferon alfa-2a.,Enasidenib
DB00001,The risk or severity of bleeding can be increased when Lepirudin is combined with Peginterferon alfa-2a.,Lepirudin
DB00006,The risk or severity of bleeding can be increased when Bivalirudin is combined with Peginterferon alfa-2a.,Bivalirudin
DB00009,The risk or severity of bleeding can be increased when Alteplase is combined with Peginterferon alfa-2a.,Alteplase
DB00013,The risk or severity of bleeding can be increased when Urokinase is combined with Peginterferon alfa-2a.,Urokinase
DB00015,The risk or severity of bleeding can be increased when Reteplase is combined with Peginterferon alfa-2a.,Reteplase
DB00029,The risk or severity of bleeding can be increased when Anistreplase is combined with Peginterferon alfa-2a.,Anistreplase
DB00031,The risk or severity of bleeding can be increased when Tenecteplase is combined with Peginterferon alfa-2a.,Tenecteplase
DB00055,The risk or severity of bleeding can be increased when Drotrecogin alfa is combined with Peginterferon alfa-2a.,Drotrecogin alfa
DB00086,The risk or severity of bleeding can be increased when Streptokinase is combined with Peginterferon alfa-2a.,Streptokinase
DB00266,The risk or severity of bleeding can be increased when Dicoumarol is combined with Peginterferon alfa-2a.,Dicoumarol
DB00278,The risk or severity of bleeding can be increased when Argatroban is combined with Peginterferon alfa-2a.,Argatroban
DB00407,The risk or severity of bleeding can be increased when Ardeparin is combined with Peginterferon alfa-2a.,Ardeparin
DB00498,The risk or severity of bleeding can be increased when Phenindione is combined with Peginterferon alfa-2a.,Phenindione
DB00569,The risk or severity of bleeding can be increased when Fondaparinux is combined with Peginterferon alfa-2a.,Fondaparinux
DB00686,The risk or severity of bleeding can be increased when Pentosan polysulfate is combined with Peginterferon alfa-2a.,Pentosan polysulfate
DB00946,The risk or severity of bleeding can be increased when Phenprocoumon is combined with Peginterferon alfa-2a.,Phenprocoumon
DB01109,The risk or severity of bleeding can be increased when Heparin is combined with Peginterferon alfa-2a.,Heparin
DB01225,The risk or severity of bleeding can be increased when Enoxaparin is combined with Peginterferon alfa-2a.,Enoxaparin
DB03410,The risk or severity of bleeding can be increased when 4-hydroxycoumarin is combined with Peginterferon alfa-2a.,4-hydroxycoumarin
DB04665,The risk or severity of bleeding can be increased when Coumarin is combined with Peginterferon alfa-2a.,Coumarin
DB04898,The risk or severity of bleeding can be increased when Ximelagatran is combined with Peginterferon alfa-2a.,Ximelagatran
DB04925,The risk or severity of bleeding can be increased when Desmoteplase is combined with Peginterferon alfa-2a.,Desmoteplase
DB05099,The risk or severity of bleeding can be increased when Ancrod is combined with Peginterferon alfa-2a.,Ancrod
DB05254,The risk or severity of bleeding can be increased when Fibrinolysin is combined with Peginterferon alfa-2a.,Fibrinolysin
DB06228,The risk or severity of bleeding can be increased when Rivaroxaban is combined with Peginterferon alfa-2a.,Rivaroxaban
DB06271,The risk or severity of bleeding can be increased when Sulodexide is combined with Peginterferon alfa-2a.,Sulodexide
DB06294,The risk or severity of bleeding can be increased when Semuloparin is combined with Peginterferon alfa-2a.,Semuloparin
DB06406,The risk or severity of bleeding can be increased when Idraparinux is combined with Peginterferon alfa-2a.,Idraparinux
DB06543,The risk or severity of bleeding can be increased when Astaxanthin is combined with Peginterferon alfa-2a.,Astaxanthin
DB06605,The risk or severity of bleeding can be increased when Apixaban is combined with Peginterferon alfa-2a.,Apixaban
DB06635,The risk or severity of bleeding can be increased when Otamixaban is combined with Peginterferon alfa-2a.,Otamixaban
DB06679,The risk or severity of bleeding can be increased when Amediplase is combined with Peginterferon alfa-2a.,Amediplase
DB06695,The risk or severity of bleeding can be increased when Dabigatran etexilate is combined with Peginterferon alfa-2a.,Dabigatran etexilate
DB06754,The risk or severity of bleeding can be increased when Danaparoid is combined with Peginterferon alfa-2a.,Danaparoid
DB06779,The risk or severity of bleeding can be increased when Dalteparin is combined with Peginterferon alfa-2a.,Dalteparin
DB06822,The risk or severity of bleeding can be increased when Tinzaparin is combined with Peginterferon alfa-2a.,Tinzaparin
DB07767,The risk or severity of bleeding can be increased when Ferulic acid is combined with Peginterferon alfa-2a.,Ferulic acid
DB08794,The risk or severity of bleeding can be increased when Ethyl biscoumacetate is combined with Peginterferon alfa-2a.,Ethyl biscoumacetate
DB08813,The risk or severity of bleeding can be increased when Nadroparin is combined with Peginterferon alfa-2a.,Nadroparin
DB08994,The risk or severity of bleeding can be increased when Ditazole is combined with Peginterferon alfa-2a.,Ditazole
DB09075,The risk or severity of bleeding can be increased when Edoxaban is combined with Peginterferon alfa-2a.,Edoxaban
DB09125,The risk or severity of bleeding can be increased when Potassium citrate is combined with Peginterferon alfa-2a.,Potassium citrate
DB09154,The risk or severity of bleeding can be increased when Sodium citrate is combined with Peginterferon alfa-2a.,Sodium citrate
DB09255,The risk or severity of bleeding can be increased when Dextran is combined with Peginterferon alfa-2a.,Dextran
DB09258,The risk or severity of bleeding can be increased when Bemiparin is combined with Peginterferon alfa-2a.,Bemiparin
DB09259,The risk or severity of bleeding can be increased when Reviparin is combined with Peginterferon alfa-2a.,Reviparin
DB09260,The risk or severity of bleeding can be increased when Parnaparin is combined with Peginterferon alfa-2a.,Parnaparin
DB09261,The risk or severity of bleeding can be increased when Certoparin is combined with Peginterferon alfa-2a.,Certoparin
DB11095,The risk or severity of bleeding can be increased when Desirudin is combined with Peginterferon alfa-2a.,Desirudin
DB11154,The risk or severity of bleeding can be increased when Zinc citrate is combined with Peginterferon alfa-2a.,Zinc citrate
DB11166,The risk or severity of bleeding can be increased when Antithrombin Alfa is combined with Peginterferon alfa-2a.,Antithrombin Alfa
DB11312,The risk or severity of bleeding can be increased when Protein C is combined with Peginterferon alfa-2a.,Protein C
DB11598,The risk or severity of bleeding can be increased when Antithrombin III human is combined with Peginterferon alfa-2a.,Antithrombin III human
DB11984,The risk or severity of bleeding can be increased when Letaxaban is combined with Peginterferon alfa-2a.,Letaxaban
DB12289,The risk or severity of bleeding can be increased when Darexaban is combined with Peginterferon alfa-2a.,Darexaban
DB12364,The risk or severity of bleeding can be increased when Betrixaban is combined with Peginterferon alfa-2a.,Betrixaban
DB12598,The risk or severity of bleeding can be increased when Nafamostat is combined with Peginterferon alfa-2a.,Nafamostat
DB12726,The risk or severity of bleeding can be increased when Monteplase is combined with Peginterferon alfa-2a.,Monteplase
DB12831,The risk or severity of bleeding can be increased when Gabexate is combined with Peginterferon alfa-2a.,Gabexate
DB13136,The risk or severity of bleeding can be increased when Fluindione is combined with Peginterferon alfa-2a.,Fluindione
DB13149,The risk or severity of bleeding can be increased when Protein S human is combined with Peginterferon alfa-2a.,Protein S human
DB13199,The risk or severity of bleeding can be increased when Brinase is combined with Peginterferon alfa-2a.,Brinase
DB13275,The risk or severity of bleeding can be increased when Clorindione is combined with Peginterferon alfa-2a.,Clorindione
DB13347,The risk or severity of bleeding can be increased when Diphenadione is combined with Peginterferon alfa-2a.,Diphenadione
DB13451,The risk or severity of bleeding can be increased when Tioclomarol is combined with Peginterferon alfa-2a.,Tioclomarol
DB13616,The risk or severity of bleeding can be increased when Melagatran is combined with Peginterferon alfa-2a.,Melagatran
DB13646,The risk or severity of bleeding can be increased when Saruplase is combined with Peginterferon alfa-2a.,Saruplase
DB14055,The risk or severity of bleeding can be increased when (S)-Warfarin is combined with Peginterferon alfa-2a.,(S)-Warfarin
DB14094,The risk or severity of bleeding can be increased when Tocopherylquinone is combined with Peginterferon alfa-2a.,Tocopherylquinone
DB14598,The risk or severity of bleeding can be increased when Edetate calcium disodium anhydrous is combined with Peginterferon alfa-2a.,Edetate calcium disodium anhydrous
DB14726,The risk or severity of bleeding can be increased when Dabigatran is combined with Peginterferon alfa-2a.,Dabigatran
DB00232,The risk or severity of neutropenia and thrombocytopenia can be increased when Methyclothiazide is combined with Peginterferon alfa-2a.,Methyclothiazide
DB00436,The risk or severity of neutropenia and thrombocytopenia can be increased when Bendroflumethiazide is combined with Peginterferon alfa-2a.,Bendroflumethiazide
DB00562,The risk or severity of neutropenia and thrombocytopenia can be increased when Benzthiazide is combined with Peginterferon alfa-2a.,Benzthiazide
DB00606,The risk or severity of neutropenia and thrombocytopenia can be increased when Cyclothiazide is combined with Peginterferon alfa-2a.,Cyclothiazide
DB00774,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydroflumethiazide is combined with Peginterferon alfa-2a.,Hydroflumethiazide
DB00880,The risk or severity of neutropenia and thrombocytopenia can be increased when Chlorothiazide is combined with Peginterferon alfa-2a.,Chlorothiazide
DB00999,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydrochlorothiazide is combined with Peginterferon alfa-2a.,Hydrochlorothiazide
DB01021,The risk or severity of neutropenia and thrombocytopenia can be increased when Trichlormethiazide is combined with Peginterferon alfa-2a.,Trichlormethiazide
DB01324,The risk or severity of neutropenia and thrombocytopenia can be increased when Polythiazide is combined with Peginterferon alfa-2a.,Polythiazide
DB13430,The risk or severity of neutropenia and thrombocytopenia can be increased when Mebutizide is combined with Peginterferon alfa-2a.,Mebutizide
DB13532,The risk or severity of neutropenia and thrombocytopenia can be increased when Cyclopenthiazide is combined with Peginterferon alfa-2a.,Cyclopenthiazide
DB09042,The risk or severity of myelosuppression can be increased when Peginterferon alfa-2a is combined with Tedizolid phosphate.,Tedizolid phosphate
DB00091,Peginterferon alfa-2a may increase the immunosuppressive activities of Cyclosporine.,Cyclosporine
DB00268,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Ropinirole.,Ropinirole
DB00115,The therapeutic efficacy of Cyanocobalamin can be decreased when used in combination with Peginterferon alfa-2a.,Cyanocobalamin
DB00437,The risk or severity of adverse effects can be increased when Allopurinol is combined with Peginterferon alfa-2a.,Allopurinol
DB12978,Peginterferon alfa-2a may increase the hepatotoxic activities of Pexidartinib.,Pexidartinib
DB14513,The serum concentration of Magnesium can be decreased when it is combined with Peginterferon alfa-2a.,Magnesium
DB01601,The serum concentration of Peginterferon alfa-2a can be increased when it is combined with Lopinavir.,Lopinavir
DB12530,The risk or severity of infection can be increased when Peginterferon alfa-2a is combined with Inebilizumab.,Inebilizumab
DB06605,Apixaban may increase the anticoagulant activities of Alteplase.,Apixaban
DB06695,Dabigatran etexilate may increase the anticoagulant activities of Alteplase.,Dabigatran etexilate
DB01254,The risk or severity of bleeding and hemorrhage can be increased when Dasatinib is combined with Alteplase.,Dasatinib
DB01609,The risk or severity of gastrointestinal bleeding can be increased when Alteplase is combined with Deferasirox.,Deferasirox
DB01586,The risk or severity of bleeding and bruising can be increased when Alteplase is combined with Ursodeoxycholic acid.,Ursodeoxycholic acid
DB02123,The risk or severity of bleeding and bruising can be increased when Alteplase is combined with Glycochenodeoxycholic Acid.,Glycochenodeoxycholic Acid
DB02659,The risk or severity of bleeding and bruising can be increased when Alteplase is combined with Cholic Acid.,Cholic Acid
DB02691,The risk or severity of bleeding and bruising can be increased when Alteplase is combined with Glycocholic acid.,Glycocholic acid
DB03619,The risk or severity of bleeding and bruising can be increased when Alteplase is combined with Deoxycholic acid.,Deoxycholic acid
DB04348,The risk or severity of bleeding and bruising can be increased when Alteplase is combined with Taurocholic acid.,Taurocholic acid
DB05990,The risk or severity of bleeding and bruising can be increased when Alteplase is combined with Obeticholic acid.,Obeticholic acid
DB06777,The risk or severity of bleeding and bruising can be increased when Alteplase is combined with Chenodeoxycholic acid.,Chenodeoxycholic acid
DB08833,The risk or severity of bleeding and bruising can be increased when Alteplase is combined with Taurochenodeoxycholic acid.,Taurochenodeoxycholic acid
DB08834,The risk or severity of bleeding and bruising can be increased when Alteplase is combined with Tauroursodeoxycholic acid.,Tauroursodeoxycholic acid
DB08857,The risk or severity of bleeding and bruising can be increased when Alteplase is combined with Bamet-UD2.,Bamet-UD2
DB11622,The risk or severity of bleeding and bruising can be increased when Alteplase is combined with Dehydrocholic acid.,Dehydrocholic acid
DB11789,The risk or severity of bleeding and bruising can be increased when Alteplase is combined with Hyodeoxycholic Acid.,Hyodeoxycholic Acid
DB09075,The risk or severity of bleeding can be increased when Edoxaban is combined with Alteplase.,Edoxaban
DB09053,The risk or severity of bleeding and hemorrhage can be increased when Ibrutinib is combined with Alteplase.,Ibrutinib
DB08935,The risk or severity of bleeding and hemorrhage can be increased when Alteplase is combined with Obinutuzumab.,Obinutuzumab
DB06228,Alteplase may increase the anticoagulant activities of Rivaroxaban.,Rivaroxaban
DB06206,The risk or severity of bleeding and hemorrhage can be increased when Alteplase is combined with Sugammadex.,Sugammadex
DB09070,Tibolone may increase the anticoagulant activities of Alteplase.,Tibolone
DB00932,The risk or severity of bleeding and hemorrhage can be increased when Tipranavir is combined with Alteplase.,Tipranavir
DB00013,Urokinase may increase the anticoagulant activities of Alteplase.,Urokinase
DB00163,Vitamin E may increase the anticoagulant activities of Alteplase.,Vitamin E
DB09030,The risk or severity of bleeding and hemorrhage can be increased when Vorapaxar is combined with Alteplase.,Vorapaxar
DB06692,The therapeutic efficacy of Alteplase can be decreased when used in combination with Aprotinin.,Aprotinin
DB00727,The serum concentration of Alteplase can be decreased when it is combined with Nitroglycerin.,Nitroglycerin
DB01381,The therapeutic efficacy of Alteplase can be increased when used in combination with Ginkgo biloba.,Ginkgo biloba
DB01181,The risk or severity of bleeding can be increased when Ifosfamide is combined with Alteplase.,Ifosfamide
DB00468,The therapeutic efficacy of Alteplase can be increased when used in combination with Quinine.,Quinine
DB00908,The therapeutic efficacy of Alteplase can be increased when used in combination with Quinidine.,Quinidine
DB00675,The risk or severity of bleeding can be increased when Tamoxifen is combined with Alteplase.,Tamoxifen
DB00539,The risk or severity of bleeding can be increased when Toremifene is combined with Alteplase.,Toremifene
DB00806,The therapeutic efficacy of Alteplase can be increased when used in combination with Pentoxifylline.,Pentoxifylline
DB00686,Pentosan polysulfate may increase the anticoagulant activities of Alteplase.,Pentosan polysulfate
DB00583,The therapeutic efficacy of Alteplase can be increased when used in combination with Levocarnitine.,Levocarnitine
DB00255,Diethylstilbestrol may decrease the anticoagulant activities of Alteplase.,Diethylstilbestrol
DB00269,Chlorotrianisene may decrease the anticoagulant activities of Alteplase.,Chlorotrianisene
DB00286,Conjugated estrogens may decrease the anticoagulant activities of Alteplase.,Conjugated estrogens
DB00783,Estradiol may decrease the anticoagulant activities of Alteplase.,Estradiol
DB00977,Ethinylestradiol may decrease the anticoagulant activities of Alteplase.,Ethinylestradiol
DB01357,Mestranol may decrease the anticoagulant activities of Alteplase.,Mestranol
DB04573,Estriol may decrease the anticoagulant activities of Alteplase.,Estriol
DB04574,Estrone sulfate may decrease the anticoagulant activities of Alteplase.,Estrone sulfate
DB04575,Quinestrol may decrease the anticoagulant activities of Alteplase.,Quinestrol
DB07931,Hexestrol may decrease the anticoagulant activities of Alteplase.,Hexestrol
DB09317,"Synthetic Conjugated Estrogens, A may decrease the anticoagulant activities of Alteplase.","Synthetic Conjugated Estrogens, A"
DB09318,"Synthetic Conjugated Estrogens, B may decrease the anticoagulant activities of Alteplase.","Synthetic Conjugated Estrogens, B"
DB09369,Polyestradiol phosphate may decrease the anticoagulant activities of Alteplase.,Polyestradiol phosphate
DB09381,Esterified estrogens may decrease the anticoagulant activities of Alteplase.,Esterified estrogens
DB11478,Zeranol may decrease the anticoagulant activities of Alteplase.,Zeranol
DB11674,Equol may decrease the anticoagulant activities of Alteplase.,Equol
DB12487,Promestriene may decrease the anticoagulant activities of Alteplase.,Promestriene
DB13143,Methallenestril may decrease the anticoagulant activities of Alteplase.,Methallenestril
DB13386,Epimestrol may decrease the anticoagulant activities of Alteplase.,Epimestrol
DB13418,Moxestrol may decrease the anticoagulant activities of Alteplase.,Moxestrol
DB13952,Estradiol acetate may decrease the anticoagulant activities of Alteplase.,Estradiol acetate
DB13953,Estradiol benzoate may decrease the anticoagulant activities of Alteplase.,Estradiol benzoate
DB13954,Estradiol cypionate may decrease the anticoagulant activities of Alteplase.,Estradiol cypionate
DB13956,Estradiol valerate may decrease the anticoagulant activities of Alteplase.,Estradiol valerate
DB15334,Biochanin A may decrease the anticoagulant activities of Alteplase.,Biochanin A
DB15335,Formononetin may decrease the anticoagulant activities of Alteplase.,Formononetin
DB00159,The risk or severity of bleeding and hemorrhage can be increased when Icosapent is combined with Alteplase.,Icosapent
DB00244,The risk or severity of bleeding and hemorrhage can be increased when Mesalazine is combined with Alteplase.,Mesalazine
DB00328,The risk or severity of bleeding and hemorrhage can be increased when Indomethacin is combined with Alteplase.,Indomethacin
DB00461,The risk or severity of bleeding and hemorrhage can be increased when Nabumetone is combined with Alteplase.,Nabumetone
DB00465,The risk or severity of bleeding and hemorrhage can be increased when Ketorolac is combined with Alteplase.,Ketorolac
DB00469,The risk or severity of bleeding and hemorrhage can be increased when Tenoxicam is combined with Alteplase.,Tenoxicam
DB00482,The risk or severity of bleeding and hemorrhage can be increased when Celecoxib is combined with Alteplase.,Celecoxib
DB00500,The risk or severity of bleeding and hemorrhage can be increased when Tolmetin is combined with Alteplase.,Tolmetin
DB00533,The risk or severity of bleeding and hemorrhage can be increased when Rofecoxib is combined with Alteplase.,Rofecoxib
DB00554,The risk or severity of bleeding and hemorrhage can be increased when Piroxicam is combined with Alteplase.,Piroxicam
DB00573,The risk or severity of bleeding and hemorrhage can be increased when Fenoprofen is combined with Alteplase.,Fenoprofen
DB00580,The risk or severity of bleeding and hemorrhage can be increased when Valdecoxib is combined with Alteplase.,Valdecoxib
DB00586,The risk or severity of bleeding and hemorrhage can be increased when Diclofenac is combined with Alteplase.,Diclofenac
DB00605,The risk or severity of bleeding and hemorrhage can be increased when Sulindac is combined with Alteplase.,Sulindac
DB00712,The risk or severity of bleeding and hemorrhage can be increased when Flurbiprofen is combined with Alteplase.,Flurbiprofen
DB00749,The risk or severity of bleeding and hemorrhage can be increased when Etodolac is combined with Alteplase.,Etodolac
DB00784,The risk or severity of bleeding and hemorrhage can be increased when Mefenamic acid is combined with Alteplase.,Mefenamic acid
DB00788,The risk or severity of bleeding and hemorrhage can be increased when Naproxen is combined with Alteplase.,Naproxen
DB00795,The risk or severity of bleeding and hemorrhage can be increased when Sulfasalazine is combined with Alteplase.,Sulfasalazine
DB00812,The risk or severity of bleeding and hemorrhage can be increased when Phenylbutazone is combined with Alteplase.,Phenylbutazone
DB00814,The risk or severity of bleeding and hemorrhage can be increased when Meloxicam is combined with Alteplase.,Meloxicam
DB00821,The risk or severity of bleeding and hemorrhage can be increased when Carprofen is combined with Alteplase.,Carprofen
DB00861,The risk or severity of bleeding and hemorrhage can be increased when Diflunisal is combined with Alteplase.,Diflunisal
DB00936,The risk or severity of bleeding and hemorrhage can be increased when Salicylic acid is combined with Alteplase.,Salicylic acid
DB00939,The risk or severity of bleeding and hemorrhage can be increased when Meclofenamic acid is combined with Alteplase.,Meclofenamic acid
DB00991,The risk or severity of bleeding and hemorrhage can be increased when Oxaprozin is combined with Alteplase.,Oxaprozin
DB01009,The risk or severity of bleeding and hemorrhage can be increased when Ketoprofen is combined with Alteplase.,Ketoprofen
DB01014,The risk or severity of bleeding and hemorrhage can be increased when Balsalazide is combined with Alteplase.,Balsalazide
DB01250,The risk or severity of bleeding and hemorrhage can be increased when Olsalazine is combined with Alteplase.,Olsalazine
DB01283,The risk or severity of bleeding and hemorrhage can be increased when Lumiracoxib is combined with Alteplase.,Lumiracoxib
DB01397,The risk or severity of bleeding and hemorrhage can be increased when Magnesium salicylate is combined with Alteplase.,Magnesium salicylate
DB01399,The risk or severity of bleeding and hemorrhage can be increased when Salsalate is combined with Alteplase.,Salsalate
DB01401,The risk or severity of bleeding and hemorrhage can be increased when Choline magnesium trisalicylate is combined with Alteplase.,Choline magnesium trisalicylate
DB01419,The risk or severity of bleeding and hemorrhage can be increased when Antrafenine is combined with Alteplase.,Antrafenine
DB01424,The risk or severity of bleeding and hemorrhage can be increased when Aminophenazone is combined with Alteplase.,Aminophenazone
DB01435,The risk or severity of bleeding and hemorrhage can be increased when Antipyrine is combined with Alteplase.,Antipyrine
DB01600,The risk or severity of bleeding and hemorrhage can be increased when Tiaprofenic acid is combined with Alteplase.,Tiaprofenic acid
DB01628,The risk or severity of bleeding and hemorrhage can be increased when Etoricoxib is combined with Alteplase.,Etoricoxib
DB02224,The risk or severity of bleeding and hemorrhage can be increased when Taxifolin is combined with Alteplase.,Taxifolin
DB03585,The risk or severity of bleeding and hemorrhage can be increased when Oxyphenbutazone is combined with Alteplase.,Oxyphenbutazone
DB04552,The risk or severity of bleeding and hemorrhage can be increased when Niflumic acid is combined with Alteplase.,Niflumic acid
DB04725,The risk or severity of bleeding and hemorrhage can be increased when Licofelone is combined with Alteplase.,Licofelone
DB04812,The risk or severity of bleeding and hemorrhage can be increased when Benoxaprofen is combined with Alteplase.,Benoxaprofen
DB04817,The risk or severity of bleeding and hemorrhage can be increased when Metamizole is combined with Alteplase.,Metamizole
DB04828,The risk or severity of bleeding and hemorrhage can be increased when Zomepirac is combined with Alteplase.,Zomepirac
DB05095,The risk or severity of bleeding and hemorrhage can be increased when Cimicoxib is combined with Alteplase.,Cimicoxib
DB06725,The risk or severity of bleeding and hemorrhage can be increased when Lornoxicam is combined with Alteplase.,Lornoxicam
DB06736,The risk or severity of bleeding and hemorrhage can be increased when Aceclofenac is combined with Alteplase.,Aceclofenac
DB06737,The risk or severity of bleeding and hemorrhage can be increased when Zaltoprofen is combined with Alteplase.,Zaltoprofen
DB07402,The risk or severity of bleeding and hemorrhage can be increased when Azapropazone is combined with Alteplase.,Azapropazone
DB07477,The risk or severity of bleeding and hemorrhage can be increased when Felbinac is combined with Alteplase.,Felbinac
DB08439,The risk or severity of bleeding and hemorrhage can be increased when Parecoxib is combined with Alteplase.,Parecoxib
DB08797,The risk or severity of bleeding and hemorrhage can be increased when Salicylamide is combined with Alteplase.,Salicylamide
DB08940,The risk or severity of bleeding and hemorrhage can be increased when Kebuzone is combined with Alteplase.,Kebuzone
DB08942,The risk or severity of bleeding and hemorrhage can be increased when Isoxicam is combined with Alteplase.,Isoxicam
DB08951,The risk or severity of bleeding and hemorrhage can be increased when Indoprofen is combined with Alteplase.,Indoprofen
DB08955,The risk or severity of bleeding and hemorrhage can be increased when Ibuproxam is combined with Alteplase.,Ibuproxam
DB08976,The risk or severity of bleeding and hemorrhage can be increased when Floctafenine is combined with Alteplase.,Floctafenine
DB08981,The risk or severity of bleeding and hemorrhage can be increased when Fenbufen is combined with Alteplase.,Fenbufen
DB08984,The risk or severity of bleeding and hemorrhage can be increased when Etofenamate is combined with Alteplase.,Etofenamate
DB08991,The risk or severity of bleeding and hemorrhage can be increased when Epirizole is combined with Alteplase.,Epirizole
DB09084,The risk or severity of bleeding and hemorrhage can be increased when Benzydamine is combined with Alteplase.,Benzydamine
DB09212,The risk or severity of bleeding and hemorrhage can be increased when Loxoprofen is combined with Alteplase.,Loxoprofen
DB09214,The risk or severity of bleeding and hemorrhage can be increased when Dexketoprofen is combined with Alteplase.,Dexketoprofen
DB09215,The risk or severity of bleeding and hemorrhage can be increased when Droxicam is combined with Alteplase.,Droxicam
DB09216,The risk or severity of bleeding and hemorrhage can be increased when Tolfenamic acid is combined with Alteplase.,Tolfenamic acid
DB09217,The risk or severity of bleeding and hemorrhage can be increased when Firocoxib is combined with Alteplase.,Firocoxib
DB09218,The risk or severity of bleeding and hemorrhage can be increased when Clonixin is combined with Alteplase.,Clonixin
DB09285,The risk or severity of bleeding and hemorrhage can be increased when Morniflumate is combined with Alteplase.,Morniflumate
DB09288,The risk or severity of bleeding and hemorrhage can be increased when Propacetamol is combined with Alteplase.,Propacetamol
DB09295,The risk or severity of bleeding and hemorrhage can be increased when Talniflumate is combined with Alteplase.,Talniflumate
DB11455,The risk or severity of bleeding and hemorrhage can be increased when Robenacoxib is combined with Alteplase.,Robenacoxib
DB11466,The risk or severity of bleeding and hemorrhage can be increased when Tepoxalin is combined with Alteplase.,Tepoxalin
DB11518,The risk or severity of bleeding and hemorrhage can be increased when Flunixin is combined with Alteplase.,Flunixin
DB12399,The risk or severity of bleeding and hemorrhage can be increased when Polmacoxib is combined with Alteplase.,Polmacoxib
DB12480,The risk or severity of bleeding and hemorrhage can be increased when Betulinic Acid is combined with Alteplase.,Betulinic Acid
DB12610,The risk or severity of bleeding and hemorrhage can be increased when Ebselen is combined with Alteplase.,Ebselen
DB13001,The risk or severity of bleeding and hemorrhage can be increased when Tinoridine is combined with Alteplase.,Tinoridine
DB13167,The risk or severity of bleeding and hemorrhage can be increased when Alclofenac is combined with Alteplase.,Alclofenac
DB13217,The risk or severity of bleeding and hemorrhage can be increased when Fentiazac is combined with Alteplase.,Fentiazac
DB13232,The risk or severity of bleeding and hemorrhage can be increased when Suxibuzone is combined with Alteplase.,Suxibuzone
DB13286,The risk or severity of bleeding and hemorrhage can be increased when Bumadizone is combined with Alteplase.,Bumadizone
DB13314,The risk or severity of bleeding and hemorrhage can be increased when Alminoprofen is combined with Alteplase.,Alminoprofen
DB13317,The risk or severity of bleeding and hemorrhage can be increased when Flunoxaprofen is combined with Alteplase.,Flunoxaprofen
DB13364,The risk or severity of bleeding and hemorrhage can be increased when Feprazone is combined with Alteplase.,Feprazone
DB13371,The risk or severity of bleeding and hemorrhage can be increased when Difenpiramide is combined with Alteplase.,Difenpiramide
DB13407,The risk or severity of bleeding and hemorrhage can be increased when Nifenazone is combined with Alteplase.,Nifenazone
DB13432,The risk or severity of bleeding and hemorrhage can be increased when Lonazolac is combined with Alteplase.,Lonazolac
DB13481,The risk or severity of bleeding and hemorrhage can be increased when Tenidap is combined with Alteplase.,Tenidap
DB13501,The risk or severity of bleeding and hemorrhage can be increased when Bendazac is combined with Alteplase.,Bendazac
DB13514,The risk or severity of bleeding and hemorrhage can be increased when Pranoprofen is combined with Alteplase.,Pranoprofen
DB13524,The risk or severity of bleeding and hemorrhage can be increased when Propyphenazone is combined with Alteplase.,Propyphenazone
DB13527,The risk or severity of bleeding and hemorrhage can be increased when Proglumetacin is combined with Alteplase.,Proglumetacin
DB13538,The risk or severity of bleeding and hemorrhage can be increased when Guacetisal is combined with Alteplase.,Guacetisal
DB13544,The risk or severity of bleeding and hemorrhage can be increased when Ethenzamide is combined with Alteplase.,Ethenzamide
DB13612,The risk or severity of bleeding and hemorrhage can be increased when Carbaspirin calcium is combined with Alteplase.,Carbaspirin calcium
DB13629,The risk or severity of bleeding and hemorrhage can be increased when Mofebutazone is combined with Alteplase.,Mofebutazone
DB13649,The risk or severity of bleeding and hemorrhage can be increased when Proquazone is combined with Alteplase.,Proquazone
DB13657,The risk or severity of bleeding and hemorrhage can be increased when Benorilate is combined with Alteplase.,Benorilate
DB13722,The risk or severity of bleeding and hemorrhage can be increased when Pirprofen is combined with Alteplase.,Pirprofen
DB13860,The risk or severity of bleeding and hemorrhage can be increased when Imidazole salicylate is combined with Alteplase.,Imidazole salicylate
DB14059,The risk or severity of bleeding and hemorrhage can be increased when SC-236 is combined with Alteplase.,SC-236
DB14060,The risk or severity of bleeding and hemorrhage can be increased when NS-398 is combined with Alteplase.,NS-398
DB14938,The risk or severity of bleeding and hemorrhage can be increased when Flurbiprofen axetil is combined with Alteplase.,Flurbiprofen axetil
DB04865,The risk or severity of bleeding can be increased when Alteplase is combined with Omacetaxine mepesuccinate.,Omacetaxine mepesuccinate
DB11133,Omega-3 fatty acids may increase the anticoagulant activities of Alteplase.,Omega-3 fatty acids
DB00081,The risk or severity of bleeding and hemorrhage can be increased when Alteplase is combined with Tositumomab.,Tositumomab
DB09211,The risk or severity of adverse effects can be increased when Limaprost is combined with Alteplase.,Limaprost
DB00048,The risk or severity of adverse effects can be increased when Alteplase is combined with Collagenase clostridium histolyticum.,Collagenase clostridium histolyticum
DB00389,Carbimazole may increase the anticoagulant activities of Alteplase.,Carbimazole
DB00550,Propylthiouracil may increase the anticoagulant activities of Alteplase.,Propylthiouracil
DB00763,Methimazole may increase the anticoagulant activities of Alteplase.,Methimazole
DB03374,"3,5-Diiodotyrosine may increase the anticoagulant activities of Alteplase.","3,5-Diiodotyrosine"
DB06715,Potassium Iodide may increase the anticoagulant activities of Alteplase.,Potassium Iodide
DB07637,Dibromotyrosine may increase the anticoagulant activities of Alteplase.,Dibromotyrosine
DB09418,Potassium perchlorate may increase the anticoagulant activities of Alteplase.,Potassium perchlorate
DB13644,Methylthiouracil may increase the anticoagulant activities of Alteplase.,Methylthiouracil
DB13804,Benzylthiouracil may increase the anticoagulant activities of Alteplase.,Benzylthiouracil
DB00834,The therapeutic efficacy of Alteplase can be decreased when used in combination with Mifepristone.,Mifepristone
DB04066,The therapeutic efficacy of Alteplase can be decreased when used in combination with p-Coumaric acid.,p-Coumaric acid
DB04682,The therapeutic efficacy of Alteplase can be decreased when used in combination with Octylphenoxy polyethoxyethanol.,Octylphenoxy polyethoxyethanol
DB05830,The therapeutic efficacy of Alteplase can be decreased when used in combination with Trestolone.,Trestolone
DB06266,The therapeutic efficacy of Alteplase can be decreased when used in combination with Lonidamine.,Lonidamine
DB08867,The therapeutic efficacy of Alteplase can be decreased when used in combination with Ulipristal.,Ulipristal
DB09401,The therapeutic efficacy of Alteplase can be decreased when used in combination with Isosorbide.,Isosorbide
DB11507,The therapeutic efficacy of Alteplase can be decreased when used in combination with Cloprostenol.,Cloprostenol
DB12025,The therapeutic efficacy of Alteplase can be decreased when used in combination with Triptolide.,Triptolide
DB13044,The therapeutic efficacy of Alteplase can be decreased when used in combination with Gossypol.,Gossypol
DB13310,The therapeutic efficacy of Alteplase can be decreased when used in combination with Ormeloxifene.,Ormeloxifene
DB00294,Etonogestrel may decrease the anticoagulant activities of Alteplase.,Etonogestrel
DB00304,Desogestrel may decrease the anticoagulant activities of Alteplase.,Desogestrel
DB00351,Megestrol acetate may decrease the anticoagulant activities of Alteplase.,Megestrol acetate
DB00367,Levonorgestrel may decrease the anticoagulant activities of Alteplase.,Levonorgestrel
DB00378,Dydrogesterone may decrease the anticoagulant activities of Alteplase.,Dydrogesterone
DB00396,Progesterone may decrease the anticoagulant activities of Alteplase.,Progesterone
DB00603,Medroxyprogesterone acetate may decrease the anticoagulant activities of Alteplase.,Medroxyprogesterone acetate
DB00717,Norethisterone may decrease the anticoagulant activities of Alteplase.,Norethisterone
DB00823,Ethynodiol diacetate may decrease the anticoagulant activities of Alteplase.,Ethynodiol diacetate
DB00957,Norgestimate may decrease the anticoagulant activities of Alteplase.,Norgestimate
DB01395,Drospirenone may decrease the anticoagulant activities of Alteplase.,Drospirenone
DB01431,Allylestrenol may decrease the anticoagulant activities of Alteplase.,Allylestrenol
DB04839,Cyproterone acetate may decrease the anticoagulant activities of Alteplase.,Cyproterone acetate
DB06713,Norelgestromin may decrease the anticoagulant activities of Alteplase.,Norelgestromin
DB06730,Gestodene may decrease the anticoagulant activities of Alteplase.,Gestodene
DB06789,Hydroxyprogesterone caproate may decrease the anticoagulant activities of Alteplase.,Hydroxyprogesterone caproate
DB09123,Dienogest may decrease the anticoagulant activities of Alteplase.,Dienogest
DB09124,Medrogestone may decrease the anticoagulant activities of Alteplase.,Medrogestone
DB09371,Norethynodrel may decrease the anticoagulant activities of Alteplase.,Norethynodrel
DB09389,Norgestrel may decrease the anticoagulant activities of Alteplase.,Norgestrel
DB11372,Altrenogest may decrease the anticoagulant activities of Alteplase.,Altrenogest
DB11619,Gestrinone may decrease the anticoagulant activities of Alteplase.,Gestrinone
DB11636,Nomegestrol may decrease the anticoagulant activities of Alteplase.,Nomegestrol
DB12474,Lynestrenol may decrease the anticoagulant activities of Alteplase.,Lynestrenol
DB13230,Gestonorone may decrease the anticoagulant activities of Alteplase.,Gestonorone
DB13528,Chlormadinone may decrease the anticoagulant activities of Alteplase.,Chlormadinone
DB13533,Methylestrenolone may decrease the anticoagulant activities of Alteplase.,Methylestrenolone
DB13563,Norgestrienone may decrease the anticoagulant activities of Alteplase.,Norgestrienone
DB13602,Promegestone may decrease the anticoagulant activities of Alteplase.,Promegestone
DB13685,Quingestanol may decrease the anticoagulant activities of Alteplase.,Quingestanol
DB13857,Demegestone may decrease the anticoagulant activities of Alteplase.,Demegestone
DB13866,Etynodiol may decrease the anticoagulant activities of Alteplase.,Etynodiol
DB13981,Nomegestrol acetate may decrease the anticoagulant activities of Alteplase.,Nomegestrol acetate
DB14570,Hydroxyprogesterone may decrease the anticoagulant activities of Alteplase.,Hydroxyprogesterone
DB14678,Norethindrone enanthate may decrease the anticoagulant activities of Alteplase.,Norethindrone enanthate
DB14679,Quingestanol acetate may decrease the anticoagulant activities of Alteplase.,Quingestanol acetate
DB00233,The risk or severity of bleeding can be increased when Aminosalicylic acid is combined with Alteplase.,Aminosalicylic acid
DB01294,The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Alteplase.,Bismuth subsalicylate
DB06251,The risk or severity of bleeding can be increased when Dersalazine is combined with Alteplase.,Dersalazine
DB06807,The risk or severity of bleeding can be increased when Phenyl aminosalicylate is combined with Alteplase.,Phenyl aminosalicylate
DB09543,The risk or severity of bleeding can be increased when Methyl salicylate is combined with Alteplase.,Methyl salicylate
DB11079,The risk or severity of bleeding can be increased when Trolamine salicylate is combined with Alteplase.,Trolamine salicylate
DB13509,The risk or severity of bleeding can be increased when Aloxiprin is combined with Alteplase.,Aloxiprin
DB14006,The risk or severity of bleeding can be increased when Choline salicylate is combined with Alteplase.,Choline salicylate
DB14026,The risk or severity of bleeding can be increased when Thiosalicylic acid is combined with Alteplase.,Thiosalicylic acid
DB00054,The risk or severity of bleeding can be increased when Abciximab is combined with Alteplase.,Abciximab
DB00063,The risk or severity of bleeding can be increased when Eptifibatide is combined with Alteplase.,Eptifibatide
DB00208,The risk or severity of bleeding can be increased when Ticlopidine is combined with Alteplase.,Ticlopidine
DB00261,The risk or severity of bleeding can be increased when Anagrelide is combined with Alteplase.,Anagrelide
DB00758,The risk or severity of bleeding can be increased when Clopidogrel is combined with Alteplase.,Clopidogrel
DB00775,The risk or severity of bleeding can be increased when Tirofiban is combined with Alteplase.,Tirofiban
DB00975,The risk or severity of bleeding can be increased when Dipyridamole is combined with Alteplase.,Dipyridamole
DB01088,The risk or severity of bleeding can be increased when Iloprost is combined with Alteplase.,Iloprost
DB01138,The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Alteplase.,Sulfinpyrazone
DB01166,The risk or severity of bleeding can be increased when Cilostazol is combined with Alteplase.,Cilostazol
DB01207,The risk or severity of bleeding can be increased when Ridogrel is combined with Alteplase.,Ridogrel
DB01236,The risk or severity of bleeding can be increased when Sevoflurane is combined with Alteplase.,Sevoflurane
DB01240,The risk or severity of bleeding can be increased when Epoprostenol is combined with Alteplase.,Epoprostenol
DB02709,The risk or severity of bleeding can be increased when Resveratrol is combined with Alteplase.,Resveratrol
DB04743,The risk or severity of bleeding can be increased when Nimesulide is combined with Alteplase.,Nimesulide
DB04905,The risk or severity of bleeding can be increased when Tesmilifene is combined with Alteplase.,Tesmilifene
DB04932,The risk or severity of bleeding can be increased when Defibrotide is combined with Alteplase.,Defibrotide
DB05229,The risk or severity of bleeding can be increased when Beraprost is combined with Alteplase.,Beraprost
DB05266,The risk or severity of bleeding can be increased when Ibudilast is combined with Alteplase.,Ibudilast
DB05767,The risk or severity of bleeding can be increased when Andrographolide is combined with Alteplase.,Andrographolide
DB06081,The risk or severity of bleeding can be increased when Caplacizumab is combined with Alteplase.,Caplacizumab
DB06209,The risk or severity of bleeding can be increased when Prasugrel is combined with Alteplase.,Prasugrel
DB06441,The risk or severity of bleeding can be increased when Cangrelor is combined with Alteplase.,Cangrelor
DB07615,The risk or severity of bleeding can be increased when Tranilast is combined with Alteplase.,Tranilast
DB08814,The risk or severity of bleeding can be increased when Triflusal is combined with Alteplase.,Triflusal
DB08816,The risk or severity of bleeding can be increased when Ticagrelor is combined with Alteplase.,Ticagrelor
DB08887,The risk or severity of bleeding can be increased when Icosapent ethyl is combined with Alteplase.,Icosapent ethyl
DB09283,The risk or severity of bleeding can be increased when Trapidil is combined with Alteplase.,Trapidil
DB12092,The risk or severity of bleeding can be increased when Naftopidil is combined with Alteplase.,Naftopidil
DB12163,The risk or severity of bleeding can be increased when Sarpogrelate is combined with Alteplase.,Sarpogrelate
DB12321,The risk or severity of bleeding can be increased when Ifetroban is combined with Alteplase.,Ifetroban
DB12445,The risk or severity of bleeding can be increased when Nitroaspirin is combined with Alteplase.,Nitroaspirin
DB12465,The risk or severity of bleeding can be increased when Ketanserin is combined with Alteplase.,Ketanserin
DB12545,The risk or severity of bleeding can be increased when Indobufen is combined with Alteplase.,Indobufen
DB12749,The risk or severity of bleeding can be increased when Butylphthalide is combined with Alteplase.,Butylphthalide
DB12771,The risk or severity of bleeding can be increased when Hydroxytyrosol is combined with Alteplase.,Hydroxytyrosol
DB13036,The risk or severity of bleeding can be increased when Ramatroban is combined with Alteplase.,Ramatroban
DB13327,The risk or severity of bleeding can be increased when Picotamide is combined with Alteplase.,Picotamide
DB13367,The risk or severity of bleeding can be increased when Cloricromen is combined with Alteplase.,Cloricromen
DB13400,The risk or severity of bleeding can be increased when Linsidomine is combined with Alteplase.,Linsidomine
DB13510,The risk or severity of bleeding can be increased when Buflomedil is combined with Alteplase.,Buflomedil
DB13929,The risk or severity of bleeding can be increased when Relcovaptan is combined with Alteplase.,Relcovaptan
DB00374,The risk or severity of adverse effects can be increased when Alteplase is combined with Treprostinil.,Treprostinil
DB03404,Hemin may increase the anticoagulant activities of Alteplase.,Hemin
DB13783,The risk or severity of bleeding and hemorrhage can be increased when Acemetacin is combined with Alteplase.,Acemetacin
DB00624,Testosterone may increase the anticoagulant activities of Alteplase.,Testosterone
DB01420,Testosterone propionate may increase the anticoagulant activities of Alteplase.,Testosterone propionate
DB01481,1-Testosterone may increase the anticoagulant activities of Alteplase.,1-Testosterone
DB01485,4-Hydroxytestosterone may increase the anticoagulant activities of Alteplase.,4-Hydroxytestosterone
DB01510,Dehydrochloromethyltestosterone may increase the anticoagulant activities of Alteplase.,Dehydrochloromethyltestosterone
DB01541,Boldenone may increase the anticoagulant activities of Alteplase.,Boldenone
DB01543,18-methyl-19-nortestosterone may increase the anticoagulant activities of Alteplase.,18-methyl-19-nortestosterone
DB01564,Calusterone may increase the anticoagulant activities of Alteplase.,Calusterone
DB01569,Formebolone may increase the anticoagulant activities of Alteplase.,Formebolone
DB01572,Methyl-1-testosterone may increase the anticoagulant activities of Alteplase.,Methyl-1-testosterone
DB02901,Stanolone may increase the anticoagulant activities of Alteplase.,Stanolone
DB07447,5beta-dihydrotestosterone may increase the anticoagulant activities of Alteplase.,5beta-dihydrotestosterone
DB08619,Testosterone succinate may increase the anticoagulant activities of Alteplase.,Testosterone succinate
DB11429,Mibolerone may increase the anticoagulant activities of Alteplase.,Mibolerone
DB13943,Testosterone cypionate may increase the anticoagulant activities of Alteplase.,Testosterone cypionate
DB13944,Testosterone enanthate may increase the anticoagulant activities of Alteplase.,Testosterone enanthate
DB13946,Testosterone undecanoate may increase the anticoagulant activities of Alteplase.,Testosterone undecanoate
DB13947,Testosterone enantate benzilic acid hydrazone may increase the anticoagulant activities of Alteplase.,Testosterone enantate benzilic acid hydrazone
DB13951,Stanolone acetate may increase the anticoagulant activities of Alteplase.,Stanolone acetate
DB13958,Trestolone acetate may increase the anticoagulant activities of Alteplase.,Trestolone acetate
DB14093,"(1,2,6,7-3H)Testosterone may increase the anticoagulant activities of Alteplase.","(1,2,6,7-3H)Testosterone"
DB14655,Drostanolone propionate may increase the anticoagulant activities of Alteplase.,Drostanolone propionate
DB11051,The risk or severity of adverse effects can be increased when Alteplase is combined with Azficel-T.,Azficel-T
DB09568,The therapeutic efficacy of Alteplase can be increased when used in combination with Omega-3-carboxylic acids.,Omega-3-carboxylic acids
DB00258,The therapeutic efficacy of Calcium acetate can be decreased when used in combination with Alteplase.,Calcium acetate
DB01164,The therapeutic efficacy of Calcium chloride can be decreased when used in combination with Alteplase.,Calcium chloride
DB01373,The therapeutic efficacy of Calcium can be decreased when used in combination with Alteplase.,Calcium
DB11126,The therapeutic efficacy of Calcium gluconate can be decreased when used in combination with Alteplase.,Calcium gluconate
DB11608,The therapeutic efficacy of Eftrenonacog alfa can be decreased when used in combination with Alteplase.,Eftrenonacog alfa
DB13884,The therapeutic efficacy of Albutrepenonacog alfa can be decreased when used in combination with Alteplase.,Albutrepenonacog alfa
DB13923,The therapeutic efficacy of Emicizumab can be decreased when used in combination with Alteplase.,Emicizumab
DB14738,The therapeutic efficacy of Turoctocog alfa pegol can be decreased when used in combination with Alteplase.,Turoctocog alfa pegol
DB00025,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Alteplase.","Antihemophilic factor, human recombinant"
DB00036,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Alteplase.,Coagulation factor VIIa Recombinant Human
DB00100,The therapeutic efficacy of Coagulation Factor IX (Recombinant) can be decreased when used in combination with Alteplase.,Coagulation Factor IX (Recombinant)
DB01783,The therapeutic efficacy of Pantothenic acid can be decreased when used in combination with Alteplase.,Pantothenic acid
DB01942,The therapeutic efficacy of Formic acid can be decreased when used in combination with Alteplase.,Formic acid
DB02261,The therapeutic efficacy of Platelet Activating Factor can be decreased when used in combination with Alteplase.,Platelet Activating Factor
DB06724,The therapeutic efficacy of Calcium carbonate can be decreased when used in combination with Alteplase.,Calcium carbonate
DB09109,The therapeutic efficacy of Turoctocog alfa can be decreased when used in combination with Alteplase.,Turoctocog alfa
DB09222,The therapeutic efficacy of Fibrinogen human can be decreased when used in combination with Alteplase.,Fibrinogen human
DB09310,The therapeutic efficacy of Catridecacog can be decreased when used in combination with Alteplase.,Catridecacog
DB09329,"The therapeutic efficacy of Antihemophilic Factor (Recombinant), PEGylated can be decreased when used in combination with Alteplase.","Antihemophilic Factor (Recombinant), PEGylated"
DB11093,The therapeutic efficacy of Calcium citrate can be decreased when used in combination with Alteplase.,Calcium citrate
DB11168,The therapeutic efficacy of Calcium threonate can be decreased when used in combination with Alteplase.,Calcium threonate
DB11311,The therapeutic efficacy of Prothrombin can be decreased when used in combination with Alteplase.,Prothrombin
DB11330,The therapeutic efficacy of Factor IX Complex (Human) can be decreased when used in combination with Alteplase.,Factor IX Complex (Human)
DB11348,The therapeutic efficacy of Calcium Phosphate can be decreased when used in combination with Alteplase.,Calcium Phosphate
DB11606,The therapeutic efficacy of Susoctocog alfa can be decreased when used in combination with Alteplase.,Susoctocog alfa
DB11668,The therapeutic efficacy of Rusalatide acetate can be decreased when used in combination with Alteplase.,Rusalatide acetate
DB12409,The therapeutic efficacy of Vatreptacog alfa can be decreased when used in combination with Alteplase.,Vatreptacog alfa
DB12909,The therapeutic efficacy of Factor XIII (human) can be decreased when used in combination with Alteplase.,Factor XIII (human)
DB13133,The therapeutic efficacy of Von Willebrand Factor Human can be decreased when used in combination with Alteplase.,Von Willebrand Factor Human
DB13148,The therapeutic efficacy of Coagulation factor X human can be decreased when used in combination with Alteplase.,Coagulation factor X human
DB13150,The therapeutic efficacy of Coagulation factor VII human can be decreased when used in combination with Alteplase.,Coagulation factor VII human
DB13151,The therapeutic efficacy of Anti-inhibitor coagulant complex can be decreased when used in combination with Alteplase.,Anti-inhibitor coagulant complex
DB13152,The therapeutic efficacy of Coagulation Factor IX Human can be decreased when used in combination with Alteplase.,Coagulation Factor IX Human
DB13192,The therapeutic efficacy of Antihemophilic factor human can be decreased when used in combination with Alteplase.,Antihemophilic factor human
DB13197,The therapeutic efficacy of Kallidinogenase can be decreased when used in combination with Alteplase.,Kallidinogenase
DB13201,The therapeutic efficacy of Trenonacog alfa can be decreased when used in combination with Alteplase.,Trenonacog alfa
DB13933,The therapeutic efficacy of Nonacog beta pegol can be decreased when used in combination with Alteplase.,Nonacog beta pegol
DB13999,The therapeutic efficacy of Moroctocog alfa can be decreased when used in combination with Alteplase.,Moroctocog alfa
DB14473,The therapeutic efficacy of Beroctocog alfa can be decreased when used in combination with Alteplase.,Beroctocog alfa
DB14562,The therapeutic efficacy of Andexanet alfa can be decreased when used in combination with Alteplase.,Andexanet alfa
DB14577,The therapeutic efficacy of Calcium cation can be decreased when used in combination with Alteplase.,Calcium cation
DB14700,The therapeutic efficacy of Damoctocog alfa pegol can be decreased when used in combination with Alteplase.,Damoctocog alfa pegol
DB00176,The risk or severity of hemorrhage can be increased when Fluvoxamine is combined with Alteplase.,Fluvoxamine
DB00215,The risk or severity of hemorrhage can be increased when Citalopram is combined with Alteplase.,Citalopram
DB00472,The risk or severity of hemorrhage can be increased when Fluoxetine is combined with Alteplase.,Fluoxetine
DB00715,The risk or severity of hemorrhage can be increased when Paroxetine is combined with Alteplase.,Paroxetine
DB01149,The risk or severity of hemorrhage can be increased when Nefazodone is combined with Alteplase.,Nefazodone
DB04832,The risk or severity of hemorrhage can be increased when Zimelidine is combined with Alteplase.,Zimelidine
DB04884,The risk or severity of hemorrhage can be increased when Dapoxetine is combined with Alteplase.,Dapoxetine
DB06731,The risk or severity of hemorrhage can be increased when Seproxetine is combined with Alteplase.,Seproxetine
DB08953,The risk or severity of hemorrhage can be increased when Indalpine is combined with Alteplase.,Indalpine
DB12693,The risk or severity of hemorrhage can be increased when Ritanserin is combined with Alteplase.,Ritanserin
DB13233,The risk or severity of hemorrhage can be increased when Alaproclate is combined with Alteplase.,Alaproclate
DB00476,The risk or severity of hemorrhage can be increased when Duloxetine is combined with Alteplase.,Duloxetine
DB01105,The risk or severity of hemorrhage can be increased when Sibutramine is combined with Alteplase.,Sibutramine
DB04896,The risk or severity of hemorrhage can be increased when Milnacipran is combined with Alteplase.,Milnacipran
DB06700,The risk or severity of hemorrhage can be increased when Desvenlafaxine is combined with Alteplase.,Desvenlafaxine
DB08918,The risk or severity of hemorrhage can be increased when Levomilnacipran is combined with Alteplase.,Levomilnacipran
DB00285,Venlafaxine may increase the antiplatelet activities of Alteplase.,Venlafaxine
DB00182,The risk or severity of bleeding and hemorrhage can be increased when Amphetamine is combined with Alteplase.,Amphetamine
DB00601,The risk or severity of bleeding and hemorrhage can be increased when Linezolid is combined with Alteplase.,Linezolid
DB00614,The risk or severity of bleeding and hemorrhage can be increased when Furazolidone is combined with Alteplase.,Furazolidone
DB00721,The risk or severity of bleeding and hemorrhage can be increased when Procaine is combined with Alteplase.,Procaine
DB00752,The risk or severity of bleeding and hemorrhage can be increased when Tranylcypromine is combined with Alteplase.,Tranylcypromine
DB00780,The risk or severity of bleeding and hemorrhage can be increased when Phenelzine is combined with Alteplase.,Phenelzine
DB00805,The risk or severity of bleeding and hemorrhage can be increased when Minaprine is combined with Alteplase.,Minaprine
DB01037,The risk or severity of bleeding and hemorrhage can be increased when Selegiline is combined with Alteplase.,Selegiline
DB01168,The risk or severity of bleeding and hemorrhage can be increased when Procarbazine is combined with Alteplase.,Procarbazine
DB01171,The risk or severity of bleeding and hemorrhage can be increased when Moclobemide is combined with Alteplase.,Moclobemide
DB01247,The risk or severity of bleeding and hemorrhage can be increased when Isocarboxazid is combined with Alteplase.,Isocarboxazid
DB01367,The risk or severity of bleeding and hemorrhage can be increased when Rasagiline is combined with Alteplase.,Rasagiline
DB01626,The risk or severity of bleeding and hemorrhage can be increased when Pargyline is combined with Alteplase.,Pargyline
DB04017,The risk or severity of bleeding and hemorrhage can be increased when Clorgiline is combined with Alteplase.,Clorgiline
DB04818,The risk or severity of bleeding and hemorrhage can be increased when Iproniazid is combined with Alteplase.,Iproniazid
DB04820,The risk or severity of bleeding and hemorrhage can be increased when Nialamide is combined with Alteplase.,Nialamide
DB06654,The risk or severity of bleeding and hemorrhage can be increased when Safinamide is combined with Alteplase.,Safinamide
DB08550,"The risk or severity of bleeding and hemorrhage can be increased when 7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline is combined with Alteplase.","7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline"
DB09241,The risk or severity of bleeding and hemorrhage can be increased when Methylene blue is combined with Alteplase.,Methylene blue
DB09243,The risk or severity of bleeding and hemorrhage can be increased when Hydracarbazine is combined with Alteplase.,Hydracarbazine
DB09244,The risk or severity of bleeding and hemorrhage can be increased when Pirlindole is combined with Alteplase.,Pirlindole
DB09245,The risk or severity of bleeding and hemorrhage can be increased when Toloxatone is combined with Alteplase.,Toloxatone
DB09246,The risk or severity of bleeding and hemorrhage can be increased when Benmoxin is combined with Alteplase.,Benmoxin
DB09248,The risk or severity of bleeding and hemorrhage can be increased when Mebanazine is combined with Alteplase.,Mebanazine
DB09249,The risk or severity of bleeding and hemorrhage can be increased when Octamoxin is combined with Alteplase.,Octamoxin
DB09250,The risk or severity of bleeding and hemorrhage can be increased when Pheniprazine is combined with Alteplase.,Pheniprazine
DB09251,The risk or severity of bleeding and hemorrhage can be increased when Phenoxypropazine is combined with Alteplase.,Phenoxypropazine
DB09252,The risk or severity of bleeding and hemorrhage can be increased when Pivhydrazine is combined with Alteplase.,Pivhydrazine
DB09253,The risk or severity of bleeding and hemorrhage can be increased when Safrazine is combined with Alteplase.,Safrazine
DB09254,The risk or severity of bleeding and hemorrhage can be increased when Caroxazone is combined with Alteplase.,Caroxazone
DB13875,The risk or severity of bleeding and hemorrhage can be increased when Harmaline is combined with Alteplase.,Harmaline
DB13876,The risk or severity of bleeding and hemorrhage can be increased when Brofaromine is combined with Alteplase.,Brofaromine
DB00006,The risk or severity of bleeding can be increased when Bivalirudin is combined with Alteplase.,Bivalirudin
DB00266,The risk or severity of bleeding can be increased when Dicoumarol is combined with Alteplase.,Dicoumarol
DB00278,The risk or severity of bleeding can be increased when Argatroban is combined with Alteplase.,Argatroban
DB00407,The risk or severity of bleeding can be increased when Ardeparin is combined with Alteplase.,Ardeparin
DB00498,The risk or severity of bleeding can be increased when Phenindione is combined with Alteplase.,Phenindione
DB00569,The risk or severity of bleeding can be increased when Fondaparinux is combined with Alteplase.,Fondaparinux
DB00682,The risk or severity of bleeding can be increased when Warfarin is combined with Alteplase.,Warfarin
DB00946,The risk or severity of bleeding can be increased when Phenprocoumon is combined with Alteplase.,Phenprocoumon
DB00974,The risk or severity of bleeding can be increased when Edetic acid is combined with Alteplase.,Edetic acid
DB01109,The risk or severity of bleeding can be increased when Heparin is combined with Alteplase.,Heparin
DB01225,The risk or severity of bleeding can be increased when Enoxaparin is combined with Alteplase.,Enoxaparin
DB01418,The risk or severity of bleeding can be increased when Acenocoumarol is combined with Alteplase.,Acenocoumarol
DB04898,The risk or severity of bleeding can be increased when Ximelagatran is combined with Alteplase.,Ximelagatran
DB05099,The risk or severity of bleeding can be increased when Ancrod is combined with Alteplase.,Ancrod
DB06271,The risk or severity of bleeding can be increased when Sulodexide is combined with Alteplase.,Sulodexide
DB06406,The risk or severity of bleeding can be increased when Idraparinux is combined with Alteplase.,Idraparinux
DB06635,The risk or severity of bleeding can be increased when Otamixaban is combined with Alteplase.,Otamixaban
DB06754,The risk or severity of bleeding can be increased when Danaparoid is combined with Alteplase.,Danaparoid
DB06779,The risk or severity of bleeding can be increased when Dalteparin is combined with Alteplase.,Dalteparin
DB07767,The risk or severity of bleeding can be increased when Ferulic acid is combined with Alteplase.,Ferulic acid
DB08794,The risk or severity of bleeding can be increased when Ethyl biscoumacetate is combined with Alteplase.,Ethyl biscoumacetate
DB08813,The risk or severity of bleeding can be increased when Nadroparin is combined with Alteplase.,Nadroparin
DB09255,The risk or severity of bleeding can be increased when Dextran is combined with Alteplase.,Dextran
DB09259,The risk or severity of bleeding can be increased when Reviparin is combined with Alteplase.,Reviparin
DB09261,The risk or severity of bleeding can be increased when Certoparin is combined with Alteplase.,Certoparin
DB11095,The risk or severity of bleeding can be increased when Desirudin is combined with Alteplase.,Desirudin
DB11268,The risk or severity of bleeding can be increased when Protocatechualdehyde is combined with Alteplase.,Protocatechualdehyde
DB11312,The risk or severity of bleeding can be increased when Protein C is combined with Alteplase.,Protein C
DB11598,The risk or severity of bleeding can be increased when Antithrombin III human is combined with Alteplase.,Antithrombin III human
DB11984,The risk or severity of bleeding can be increased when Letaxaban is combined with Alteplase.,Letaxaban
DB12289,The risk or severity of bleeding can be increased when Darexaban is combined with Alteplase.,Darexaban
DB12598,The risk or severity of bleeding can be increased when Nafamostat is combined with Alteplase.,Nafamostat
DB12831,The risk or severity of bleeding can be increased when Gabexate is combined with Alteplase.,Gabexate
DB13124,The risk or severity of bleeding can be increased when Troxerutin is combined with Alteplase.,Troxerutin
DB13136,The risk or severity of bleeding can be increased when Fluindione is combined with Alteplase.,Fluindione
DB13149,The risk or severity of bleeding can be increased when Protein S human is combined with Alteplase.,Protein S human
DB13616,The risk or severity of bleeding can be increased when Melagatran is combined with Alteplase.,Melagatran
DB09125,The risk or severity of bleeding can be increased when Potassium citrate is combined with Alteplase.,Potassium citrate
DB09154,The risk or severity of bleeding can be increased when Sodium citrate is combined with Alteplase.,Sodium citrate
DB00031,The risk or severity of bleeding can be increased when Tenecteplase is combined with Alteplase.,Tenecteplase
DB00055,The risk or severity of bleeding can be increased when Drotrecogin alfa is combined with Alteplase.,Drotrecogin alfa
DB06822,The risk or severity of bleeding can be increased when Tinzaparin is combined with Alteplase.,Tinzaparin
DB13199,The risk or severity of bleeding can be increased when Brinase is combined with Alteplase.,Brinase
DB13646,The risk or severity of bleeding can be increased when Saruplase is combined with Alteplase.,Saruplase
DB00086,The risk or severity of bleeding can be increased when Streptokinase is combined with Alteplase.,Streptokinase
DB04925,The risk or severity of bleeding can be increased when Desmoteplase is combined with Alteplase.,Desmoteplase
DB05254,The risk or severity of bleeding can be increased when Fibrinolysin is combined with Alteplase.,Fibrinolysin
DB06543,The risk or severity of bleeding can be increased when Astaxanthin is combined with Alteplase.,Astaxanthin
DB08994,The risk or severity of bleeding can be increased when Ditazole is combined with Alteplase.,Ditazole
DB09258,The risk or severity of bleeding can be increased when Bemiparin is combined with Alteplase.,Bemiparin
DB09260,The risk or severity of bleeding can be increased when Parnaparin is combined with Alteplase.,Parnaparin
DB13275,The risk or severity of bleeding can be increased when Clorindione is combined with Alteplase.,Clorindione
DB13347,The risk or severity of bleeding can be increased when Diphenadione is combined with Alteplase.,Diphenadione
DB13451,The risk or severity of bleeding can be increased when Tioclomarol is combined with Alteplase.,Tioclomarol
DB00001,The risk or severity of bleeding can be increased when Lepirudin is combined with Alteplase.,Lepirudin
DB00015,The risk or severity of bleeding can be increased when Alteplase is combined with Reteplase.,Reteplase
DB00029,The risk or severity of bleeding can be increased when Alteplase is combined with Anistreplase.,Anistreplase
DB14094,The risk or severity of bleeding can be increased when Alteplase is combined with Tocopherylquinone.,Tocopherylquinone
DB06679,The risk or severity of bleeding can be increased when Alteplase is combined with Amediplase.,Amediplase
DB03410,The risk or severity of bleeding can be increased when Alteplase is combined with 4-hydroxycoumarin.,4-hydroxycoumarin
DB08496,The risk or severity of bleeding can be increased when Alteplase is combined with (R)-warfarin.,(R)-warfarin
DB14055,The risk or severity of bleeding can be increased when Alteplase is combined with (S)-Warfarin.,(S)-Warfarin
DB12364,The risk or severity of bleeding can be increased when Alteplase is combined with Betrixaban.,Betrixaban
DB14598,The risk or severity of bleeding can be increased when Alteplase is combined with Edetate calcium disodium anhydrous.,Edetate calcium disodium anhydrous
DB11154,The risk or severity of bleeding can be increased when Alteplase is combined with Zinc citrate.,Zinc citrate
DB11166,The risk or severity of bleeding can be increased when Alteplase is combined with Antithrombin Alfa.,Antithrombin Alfa
DB04665,The risk or severity of bleeding can be increased when Alteplase is combined with Coumarin.,Coumarin
DB14726,The risk or severity of bleeding can be increased when Alteplase is combined with Dabigatran.,Dabigatran
DB06294,The risk or severity of bleeding can be increased when Alteplase is combined with Semuloparin.,Semuloparin
DB12726,The risk or severity of bleeding can be increased when Alteplase is combined with Monteplase.,Monteplase
DB00177,The risk or severity of angioedema can be increased when Alteplase is combined with Valsartan.,Valsartan
DB00178,The risk or severity of angioedema can be increased when Alteplase is combined with Ramipril.,Ramipril
DB00230,The risk or severity of angioedema can be increased when Alteplase is combined with Pregabalin.,Pregabalin
DB00492,The risk or severity of angioedema can be increased when Alteplase is combined with Fosinopril.,Fosinopril
DB00519,The risk or severity of angioedema can be increased when Alteplase is combined with Trandolapril.,Trandolapril
DB00542,The risk or severity of angioedema can be increased when Alteplase is combined with Benazepril.,Benazepril
DB00584,The risk or severity of angioedema can be increased when Alteplase is combined with Enalapril.,Enalapril
DB00678,The risk or severity of angioedema can be increased when Alteplase is combined with Losartan.,Losartan
DB00691,The risk or severity of angioedema can be increased when Alteplase is combined with Moexipril.,Moexipril
DB00722,The risk or severity of angioedema can be increased when Alteplase is combined with Lisinopril.,Lisinopril
DB00790,The risk or severity of angioedema can be increased when Alteplase is combined with Perindopril.,Perindopril
DB00876,The risk or severity of angioedema can be increased when Alteplase is combined with Eprosartan.,Eprosartan
DB00877,The risk or severity of angioedema can be increased when Alteplase is combined with Sirolimus.,Sirolimus
DB00881,The risk or severity of angioedema can be increased when Alteplase is combined with Quinapril.,Quinapril
DB00886,The risk or severity of angioedema can be increased when Alteplase is combined with Omapatrilat.,Omapatrilat
DB00966,The risk or severity of angioedema can be increased when Alteplase is combined with Telmisartan.,Telmisartan
DB01050,The risk or severity of angioedema can be increased when Alteplase is combined with Ibuprofen.,Ibuprofen
DB01180,The risk or severity of angioedema can be increased when Alteplase is combined with Rescinnamine.,Rescinnamine
DB01197,The risk or severity of angioedema can be increased when Alteplase is combined with Captopril.,Captopril
DB01261,The risk or severity of angioedema can be increased when Alteplase is combined with Sitagliptin.,Sitagliptin
DB01340,The risk or severity of angioedema can be increased when Alteplase is combined with Cilazapril.,Cilazapril
DB01342,The risk or severity of angioedema can be increased when Alteplase is combined with Forasartan.,Forasartan
DB01347,The risk or severity of angioedema can be increased when Alteplase is combined with Saprisartan.,Saprisartan
DB01348,The risk or severity of angioedema can be increased when Alteplase is combined with Spirapril.,Spirapril
DB04876,The risk or severity of angioedema can be increased when Alteplase is combined with Vildagliptin.,Vildagliptin
DB06011,The risk or severity of angioedema can be increased when Alteplase is combined with AMG-222.,AMG-222
DB06127,The risk or severity of angioedema can be increased when Alteplase is combined with Bisegliptin.,Bisegliptin
DB06196,The risk or severity of angioedema can be increased when Alteplase is combined with Icatibant.,Icatibant
DB06203,The risk or severity of angioedema can be increased when Alteplase is combined with Alogliptin.,Alogliptin
DB06245,The risk or severity of angioedema can be increased when Alteplase is combined with Lanoteplase.,Lanoteplase
DB06287,The risk or severity of angioedema can be increased when Alteplase is combined with Temsirolimus.,Temsirolimus
DB06335,The risk or severity of angioedema can be increased when Alteplase is combined with Saxagliptin.,Saxagliptin
DB08382,The risk or severity of angioedema can be increased when Alteplase is combined with Gosogliptin.,Gosogliptin
DB08822,The risk or severity of angioedema can be increased when Alteplase is combined with Azilsartan medoxomil.,Azilsartan medoxomil
DB08836,The risk or severity of angioedema can be increased when Alteplase is combined with Temocapril.,Temocapril
DB08882,The risk or severity of angioedema can be increased when Alteplase is combined with Linagliptin.,Linagliptin
DB09292,The risk or severity of angioedema can be increased when Alteplase is combined with Sacubitril.,Sacubitril
DB09477,The risk or severity of angioedema can be increased when Alteplase is combined with Enalaprilat.,Enalaprilat
DB11723,The risk or severity of angioedema can be increased when Alteplase is combined with Dutogliptin.,Dutogliptin
DB11783,The risk or severity of angioedema can be increased when Alteplase is combined with Imidapril.,Imidapril
DB11950,The risk or severity of angioedema can be increased when Alteplase is combined with Teneligliptin.,Teneligliptin
DB11992,The risk or severity of angioedema can be increased when Alteplase is combined with Omarigliptin.,Omarigliptin
DB12268,The risk or severity of angioedema can be increased when Alteplase is combined with Carmegliptin.,Carmegliptin
DB12412,The risk or severity of angioedema can be increased when Alteplase is combined with Gemigliptin.,Gemigliptin
DB12417,The risk or severity of angioedema can be increased when Alteplase is combined with Anagliptin.,Anagliptin
DB12625,The risk or severity of angioedema can be increased when Alteplase is combined with Evogliptin.,Evogliptin
DB13166,The risk or severity of angioedema can be increased when Alteplase is combined with Zofenopril.,Zofenopril
DB13312,The risk or severity of angioedema can be increased when Alteplase is combined with Delapril.,Delapril
DB14125,The risk or severity of angioedema can be increased when Alteplase is combined with Benazeprilat.,Benazeprilat
DB14207,The risk or severity of angioedema can be increased when Alteplase is combined with Fosinoprilat.,Fosinoprilat
DB14208,The risk or severity of angioedema can be increased when Alteplase is combined with Ramiprilat.,Ramiprilat
DB14209,The risk or severity of angioedema can be increased when Alteplase is combined with Trandolaprilat.,Trandolaprilat
DB14210,The risk or severity of angioedema can be increased when Alteplase is combined with Moexiprilat.,Moexiprilat
DB14213,The risk or severity of angioedema can be increased when Alteplase is combined with Perindoprilat.,Perindoprilat
DB14217,The risk or severity of angioedema can be increased when Alteplase is combined with Quinaprilat.,Quinaprilat
DB14231,The risk or severity of angioedema can be increased when Alteplase is combined with Quinoline Yellow WS.,Quinoline Yellow WS
DB00203,The risk or severity of hemorrhage can be increased when Alteplase is combined with Sildenafil.,Sildenafil
DB00008,The risk or severity of bleeding can be increased when Alteplase is combined with Peginterferon alfa-2a.,Peginterferon alfa-2a
DB00011,The risk or severity of bleeding can be increased when Alteplase is combined with Interferon alfa-n1.,Interferon alfa-n1
DB00018,The risk or severity of bleeding can be increased when Alteplase is combined with Interferon alfa-n3.,Interferon alfa-n3
DB00022,The risk or severity of bleeding can be increased when Alteplase is combined with Peginterferon alfa-2b.,Peginterferon alfa-2b
DB00033,The risk or severity of bleeding can be increased when Alteplase is combined with Interferon gamma-1b.,Interferon gamma-1b
DB00034,"The risk or severity of bleeding can be increased when Alteplase is combined with Interferon alfa-2a, Recombinant.","Interferon alfa-2a, Recombinant"
DB00041,The risk or severity of bleeding can be increased when Alteplase is combined with Aldesleukin.,Aldesleukin
DB00056,The risk or severity of bleeding can be increased when Alteplase is combined with Gemtuzumab ozogamicin.,Gemtuzumab ozogamicin
DB00068,The risk or severity of bleeding can be increased when Alteplase is combined with Interferon beta-1b.,Interferon beta-1b
DB00069,The risk or severity of bleeding can be increased when Alteplase is combined with Interferon alfacon-1.,Interferon alfacon-1
DB00073,The risk or severity of bleeding can be increased when Alteplase is combined with Rituximab.,Rituximab
DB00078,The risk or severity of bleeding can be increased when Alteplase is combined with Ibritumomab tiuxetan.,Ibritumomab tiuxetan
DB00087,The risk or severity of bleeding can be increased when Alteplase is combined with Alemtuzumab.,Alemtuzumab
DB00105,The risk or severity of bleeding can be increased when Alteplase is combined with Interferon alfa-2b.,Interferon alfa-2b
DB00120,The risk or severity of bleeding can be increased when Alteplase is combined with Phenylalanine.,Phenylalanine
DB00188,The risk or severity of bleeding can be increased when Alteplase is combined with Bortezomib.,Bortezomib
DB00242,The risk or severity of bleeding can be increased when Alteplase is combined with Cladribine.,Cladribine
DB00262,The risk or severity of bleeding can be increased when Alteplase is combined with Carmustine.,Carmustine
DB00276,The risk or severity of bleeding can be increased when Alteplase is combined with Amsacrine.,Amsacrine
DB00291,The risk or severity of bleeding can be increased when Alteplase is combined with Chlorambucil.,Chlorambucil
DB00293,The risk or severity of bleeding can be increased when Alteplase is combined with Raltitrexed.,Raltitrexed
DB00305,The risk or severity of bleeding can be increased when Alteplase is combined with Mitomycin.,Mitomycin
DB00307,The risk or severity of bleeding can be increased when Alteplase is combined with Bexarotene.,Bexarotene
DB00309,The risk or severity of bleeding can be increased when Alteplase is combined with Vindesine.,Vindesine
DB00322,The risk or severity of bleeding can be increased when Alteplase is combined with Floxuridine.,Floxuridine
DB00352,The risk or severity of bleeding can be increased when Alteplase is combined with Tioguanine.,Tioguanine
DB00361,The risk or severity of bleeding can be increased when Alteplase is combined with Vinorelbine.,Vinorelbine
DB00380,The risk or severity of bleeding can be increased when Alteplase is combined with Dexrazoxane.,Dexrazoxane
DB00398,The risk or severity of bleeding can be increased when Alteplase is combined with Sorafenib.,Sorafenib
DB00428,The risk or severity of bleeding can be increased when Alteplase is combined with Streptozocin.,Streptozocin
DB00441,The risk or severity of bleeding can be increased when Alteplase is combined with Gemcitabine.,Gemcitabine
DB00444,The risk or severity of bleeding can be increased when Alteplase is combined with Teniposide.,Teniposide
DB00445,The risk or severity of bleeding can be increased when Alteplase is combined with Epirubicin.,Epirubicin
DB00446,The risk or severity of bleeding can be increased when Alteplase is combined with Chloramphenicol.,Chloramphenicol
DB00480,The risk or severity of bleeding can be increased when Alteplase is combined with Lenalidomide.,Lenalidomide
DB00488,The risk or severity of bleeding can be increased when Alteplase is combined with Altretamine.,Altretamine
DB00495,The risk or severity of bleeding can be increased when Alteplase is combined with Zidovudine.,Zidovudine
DB00515,The risk or severity of bleeding can be increased when Alteplase is combined with Cisplatin.,Cisplatin
DB00526,The risk or severity of bleeding can be increased when Alteplase is combined with Oxaliplatin.,Oxaliplatin
DB00531,The risk or severity of bleeding can be increased when Alteplase is combined with Cyclophosphamide.,Cyclophosphamide
DB00544,The risk or severity of bleeding can be increased when Alteplase is combined with Fluorouracil.,Fluorouracil
DB00552,The risk or severity of bleeding can be increased when Alteplase is combined with Pentostatin.,Pentostatin
DB00563,The risk or severity of bleeding can be increased when Alteplase is combined with Methotrexate.,Methotrexate
DB00564,The risk or severity of bleeding can be increased when Alteplase is combined with Carbamazepine.,Carbamazepine
DB00570,The risk or severity of bleeding can be increased when Alteplase is combined with Vinblastine.,Vinblastine
DB00619,The risk or severity of bleeding can be increased when Alteplase is combined with Imatinib.,Imatinib
DB00631,The risk or severity of bleeding can be increased when Alteplase is combined with Clofarabine.,Clofarabine
DB00642,The risk or severity of bleeding can be increased when Alteplase is combined with Pemetrexed.,Pemetrexed
DB00694,The risk or severity of bleeding can be increased when Alteplase is combined with Daunorubicin.,Daunorubicin
DB00762,The risk or severity of bleeding can be increased when Alteplase is combined with Irinotecan.,Irinotecan
DB00773,The risk or severity of bleeding can be increased when Alteplase is combined with Etoposide.,Etoposide
DB00851,The risk or severity of bleeding can be increased when Alteplase is combined with Dacarbazine.,Dacarbazine
DB00853,The risk or severity of bleeding can be increased when Alteplase is combined with Temozolomide.,Temozolomide
DB00859,The risk or severity of bleeding can be increased when Alteplase is combined with Penicillamine.,Penicillamine
DB00864,The risk or severity of bleeding can be increased when Alteplase is combined with Tacrolimus.,Tacrolimus
DB00888,The risk or severity of bleeding can be increased when Alteplase is combined with Mechlorethamine.,Mechlorethamine
DB00928,The risk or severity of bleeding can be increased when Alteplase is combined with Azacitidine.,Azacitidine
DB00958,The risk or severity of bleeding can be increased when Alteplase is combined with Carboplatin.,Carboplatin
DB00970,The risk or severity of bleeding can be increased when Alteplase is combined with Dactinomycin.,Dactinomycin
DB00987,The risk or severity of bleeding can be increased when Alteplase is combined with Cytarabine.,Cytarabine
DB00997,The risk or severity of bleeding can be increased when Alteplase is combined with Doxorubicin.,Doxorubicin
DB01005,The risk or severity of bleeding can be increased when Alteplase is combined with Hydroxyurea.,Hydroxyurea
DB01008,The risk or severity of bleeding can be increased when Alteplase is combined with Busulfan.,Busulfan
DB01030,The risk or severity of bleeding can be increased when Alteplase is combined with Topotecan.,Topotecan
DB01033,The risk or severity of bleeding can be increased when Alteplase is combined with Mercaptopurine.,Mercaptopurine
DB01041,The risk or severity of bleeding can be increased when Alteplase is combined with Thalidomide.,Thalidomide
DB01042,The risk or severity of bleeding can be increased when Alteplase is combined with Melphalan.,Melphalan
DB01073,The risk or severity of bleeding can be increased when Alteplase is combined with Fludarabine.,Fludarabine
DB01099,The risk or severity of bleeding can be increased when Alteplase is combined with Flucytosine.,Flucytosine
DB01101,The risk or severity of bleeding can be increased when Alteplase is combined with Capecitabine.,Capecitabine
DB01169,The risk or severity of bleeding can be increased when Alteplase is combined with Arsenic trioxide.,Arsenic trioxide
DB01177,The risk or severity of bleeding can be increased when Alteplase is combined with Idarubicin.,Idarubicin
DB01204,The risk or severity of bleeding can be increased when Alteplase is combined with Mitoxantrone.,Mitoxantrone
DB01206,The risk or severity of bleeding can be increased when Alteplase is combined with Lomustine.,Lomustine
DB01229,The risk or severity of bleeding can be increased when Alteplase is combined with Paclitaxel.,Paclitaxel
DB01248,The risk or severity of bleeding can be increased when Alteplase is combined with Docetaxel.,Docetaxel
DB01262,The risk or severity of bleeding can be increased when Alteplase is combined with Decitabine.,Decitabine
DB01280,The risk or severity of bleeding can be increased when Alteplase is combined with Nelarabine.,Nelarabine
DB01590,The risk or severity of bleeding can be increased when Alteplase is combined with Everolimus.,Everolimus
DB02546,The risk or severity of bleeding can be increased when Alteplase is combined with Vorinostat.,Vorinostat
DB04572,The risk or severity of bleeding can be increased when Alteplase is combined with Thiotepa.,Thiotepa
DB04845,The risk or severity of bleeding can be increased when Alteplase is combined with Ixabepilone.,Ixabepilone
DB04868,The risk or severity of bleeding can be increased when Alteplase is combined with Nilotinib.,Nilotinib
DB05015,The risk or severity of bleeding can be increased when Alteplase is combined with Belinostat.,Belinostat
DB05109,The risk or severity of bleeding can be increased when Alteplase is combined with Trabectedin.,Trabectedin
DB05258,The risk or severity of bleeding can be increased when Alteplase is combined with Interferon alfa.,Interferon alfa
DB05472,The risk or severity of bleeding can be increased when Alteplase is combined with omega interferon.,omega interferon
DB05773,The risk or severity of bleeding can be increased when Alteplase is combined with Trastuzumab emtansine.,Trastuzumab emtansine
DB06616,The risk or severity of bleeding can be increased when Alteplase is combined with Bosutinib.,Bosutinib
DB06769,The risk or severity of bleeding can be increased when Alteplase is combined with Bendamustine.,Bendamustine
DB06772,The risk or severity of bleeding can be increased when Alteplase is combined with Cabazitaxel.,Cabazitaxel
DB08871,The risk or severity of bleeding can be increased when Alteplase is combined with Eribulin.,Eribulin
DB08877,The risk or severity of bleeding can be increased when Alteplase is combined with Ruxolitinib.,Ruxolitinib
DB08889,The risk or severity of bleeding can be increased when Alteplase is combined with Carfilzomib.,Carfilzomib
DB08895,The risk or severity of bleeding can be increased when Alteplase is combined with Tofacitinib.,Tofacitinib
DB08901,The risk or severity of bleeding can be increased when Alteplase is combined with Ponatinib.,Ponatinib
DB08910,The risk or severity of bleeding can be increased when Alteplase is combined with Pomalidomide.,Pomalidomide
DB09042,The risk or severity of bleeding can be increased when Alteplase is combined with Tedizolid phosphate.,Tedizolid phosphate
DB09052,The risk or severity of bleeding can be increased when Alteplase is combined with Blinatumomab.,Blinatumomab
DB09073,The risk or severity of bleeding can be increased when Alteplase is combined with Palbociclib.,Palbociclib
DB09074,The risk or severity of bleeding can be increased when Alteplase is combined with Olaparib.,Olaparib
DB09077,The risk or severity of bleeding can be increased when Alteplase is combined with Dinutuximab.,Dinutuximab
DB09122,The risk or severity of bleeding can be increased when Alteplase is combined with Peginterferon beta-1a.,Peginterferon beta-1a
DB12814,The risk or severity of bleeding can be increased when Alteplase is combined with Cepeginterferon alfa-2B.,Cepeginterferon alfa-2B
DB00229,The therapeutic efficacy of Alteplase can be decreased when used in combination with Cefotiam.,Cefotiam
DB00267,The therapeutic efficacy of Alteplase can be decreased when used in combination with Cefmenoxime.,Cefmenoxime
DB00274,The therapeutic efficacy of Alteplase can be decreased when used in combination with Cefmetazole.,Cefmetazole
DB00430,The therapeutic efficacy of Alteplase can be decreased when used in combination with Cefpiramide.,Cefpiramide
DB00438,The therapeutic efficacy of Alteplase can be decreased when used in combination with Ceftazidime.,Ceftazidime
DB00447,The therapeutic efficacy of Alteplase can be decreased when used in combination with Loracarbef.,Loracarbef
DB00456,The therapeutic efficacy of Alteplase can be decreased when used in combination with Cefalotin.,Cefalotin
DB00493,The therapeutic efficacy of Alteplase can be decreased when used in combination with Cefotaxime.,Cefotaxime
DB00535,The therapeutic efficacy of Alteplase can be decreased when used in combination with Cefdinir.,Cefdinir
DB00567,The therapeutic efficacy of Alteplase can be decreased when used in combination with Cephalexin.,Cephalexin
DB00671,The therapeutic efficacy of Alteplase can be decreased when used in combination with Cefixime.,Cefixime
DB00689,The therapeutic efficacy of Alteplase can be decreased when used in combination with Cephaloglycin.,Cephaloglycin
DB00833,The therapeutic efficacy of Alteplase can be decreased when used in combination with Cefaclor.,Cefaclor
DB00923,The therapeutic efficacy of Alteplase can be decreased when used in combination with Ceforanide.,Ceforanide
DB01066,The therapeutic efficacy of Alteplase can be decreased when used in combination with Cefditoren.,Cefditoren
DB01112,The therapeutic efficacy of Alteplase can be decreased when used in combination with Cefuroxime.,Cefuroxime
DB01139,The therapeutic efficacy of Alteplase can be decreased when used in combination with Cefapirin.,Cefapirin
DB01140,The therapeutic efficacy of Alteplase can be decreased when used in combination with Cefadroxil.,Cefadroxil
DB01150,The therapeutic efficacy of Alteplase can be decreased when used in combination with Cefprozil.,Cefprozil
DB01212,The therapeutic efficacy of Alteplase can be decreased when used in combination with Ceftriaxone.,Ceftriaxone
DB01326,The therapeutic efficacy of Alteplase can be decreased when used in combination with Cefamandole.,Cefamandole
DB01327,The therapeutic efficacy of Alteplase can be decreased when used in combination with Cefazolin.,Cefazolin
DB01328,The therapeutic efficacy of Alteplase can be decreased when used in combination with Cefonicid.,Cefonicid
DB01329,The therapeutic efficacy of Alteplase can be decreased when used in combination with Cefoperazone.,Cefoperazone
DB01330,The therapeutic efficacy of Alteplase can be decreased when used in combination with Cefotetan.,Cefotetan
DB01331,The therapeutic efficacy of Alteplase can be decreased when used in combination with Cefoxitin.,Cefoxitin
DB01332,The therapeutic efficacy of Alteplase can be decreased when used in combination with Ceftizoxime.,Ceftizoxime
DB01333,The therapeutic efficacy of Alteplase can be decreased when used in combination with Cefradine.,Cefradine
DB01413,The therapeutic efficacy of Alteplase can be decreased when used in combination with Cefepime.,Cefepime
DB01414,The therapeutic efficacy of Alteplase can be decreased when used in combination with Cefacetrile.,Cefacetrile
DB01415,The therapeutic efficacy of Alteplase can be decreased when used in combination with Ceftibuten.,Ceftibuten
DB01416,The therapeutic efficacy of Alteplase can be decreased when used in combination with Cefpodoxime.,Cefpodoxime
DB04570,The therapeutic efficacy of Alteplase can be decreased when used in combination with Latamoxef.,Latamoxef
DB04918,The therapeutic efficacy of Alteplase can be decreased when used in combination with Ceftobiprole.,Ceftobiprole
DB06590,The therapeutic efficacy of Alteplase can be decreased when used in combination with Ceftaroline fosamil.,Ceftaroline fosamil
DB09008,The therapeutic efficacy of Alteplase can be decreased when used in combination with Cefaloridine.,Cefaloridine
DB09050,The therapeutic efficacy of Alteplase can be decreased when used in combination with Ceftolozane.,Ceftolozane
DB09062,The therapeutic efficacy of Alteplase can be decreased when used in combination with Cefminox.,Cefminox
DB11367,The therapeutic efficacy of Alteplase can be decreased when used in combination with Cefroxadine.,Cefroxadine
DB11935,The therapeutic efficacy of Alteplase can be decreased when used in combination with Flomoxef.,Flomoxef
DB13266,The therapeutic efficacy of Alteplase can be decreased when used in combination with Cefatrizine.,Cefatrizine
DB13461,The therapeutic efficacy of Alteplase can be decreased when used in combination with Cefcapene.,Cefcapene
DB13470,The therapeutic efficacy of Alteplase can be decreased when used in combination with Cefodizime.,Cefodizime
DB13499,The therapeutic efficacy of Alteplase can be decreased when used in combination with Cefsulodin.,Cefsulodin
DB13504,The therapeutic efficacy of Alteplase can be decreased when used in combination with Cefetamet.,Cefetamet
DB13638,The therapeutic efficacy of Alteplase can be decreased when used in combination with Cefbuperazone.,Cefbuperazone
DB13667,The therapeutic efficacy of Alteplase can be decreased when used in combination with Cefozopran.,Cefozopran
DB13682,The therapeutic efficacy of Alteplase can be decreased when used in combination with Cefpirome.,Cefpirome
DB13778,The therapeutic efficacy of Alteplase can be decreased when used in combination with Cefazedone.,Cefazedone
DB13821,The therapeutic efficacy of Alteplase can be decreased when used in combination with Ceftezole.,Ceftezole
DB14725,The therapeutic efficacy of Alteplase can be decreased when used in combination with Cefamandole nafate.,Cefamandole nafate
DB00254,The risk or severity of bleeding can be increased when Doxycycline is combined with Alteplase.,Doxycycline
DB00207,The risk or severity of adverse effects can be increased when Azithromycin is combined with Alteplase.,Azithromycin
DB09539,The risk or severity of bleeding can be increased when Omega-3-acid ethyl esters is combined with Alteplase.,Omega-3-acid ethyl esters
DB00945,Acetylsalicylic acid may increase the anticoagulant activities of Alteplase.,Acetylsalicylic acid
DB01606,The risk or severity of bleeding can be increased when Tazobactam is combined with Alteplase.,Tazobactam
DB00199,The risk or severity of bleeding can be increased when Erythromycin is combined with Alteplase.,Erythromycin
DB00656,The risk or severity of bleeding can be increased when Trazodone is combined with Alteplase.,Trazodone
DB00620,The therapeutic efficacy of Alteplase can be decreased when used in combination with Triamcinolone.,Triamcinolone
DB09079,The risk or severity of bleeding can be increased when Alteplase is combined with Nintedanib.,Nintedanib
DB01175,The risk or severity of bleeding can be increased when Escitalopram is combined with Alteplase.,Escitalopram
DB01104,The risk or severity of bleeding can be increased when Sertraline is combined with Alteplase.,Sertraline
DB00232,The therapeutic efficacy of Alteplase can be decreased when used in combination with Methyclothiazide.,Methyclothiazide
DB00436,The therapeutic efficacy of Alteplase can be decreased when used in combination with Bendroflumethiazide.,Bendroflumethiazide
DB00562,The therapeutic efficacy of Alteplase can be decreased when used in combination with Benzthiazide.,Benzthiazide
DB00606,The therapeutic efficacy of Alteplase can be decreased when used in combination with Cyclothiazide.,Cyclothiazide
DB00774,The therapeutic efficacy of Alteplase can be decreased when used in combination with Hydroflumethiazide.,Hydroflumethiazide
DB00880,The therapeutic efficacy of Alteplase can be decreased when used in combination with Chlorothiazide.,Chlorothiazide
DB00999,The therapeutic efficacy of Alteplase can be decreased when used in combination with Hydrochlorothiazide.,Hydrochlorothiazide
DB01021,The therapeutic efficacy of Alteplase can be decreased when used in combination with Trichlormethiazide.,Trichlormethiazide
DB01324,The therapeutic efficacy of Alteplase can be decreased when used in combination with Polythiazide.,Polythiazide
DB13430,The therapeutic efficacy of Alteplase can be decreased when used in combination with Mebutizide.,Mebutizide
DB13532,The therapeutic efficacy of Alteplase can be decreased when used in combination with Cyclopenthiazide.,Cyclopenthiazide
DB06643,The risk or severity of adverse effects can be increased when Denosumab is combined with Interferon alfa-n1.,Denosumab
DB00005,The risk or severity of adverse effects can be increased when Etanercept is combined with Interferon alfa-n1.,Etanercept
DB00008,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Interferon alfa-n1.,Peginterferon alfa-2a
DB00018,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Interferon alfa-n3.,Interferon alfa-n3
DB00022,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Peginterferon alfa-2b.,Peginterferon alfa-2b
DB00026,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Anakinra.,Anakinra
DB00033,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Interferon gamma-1b.,Interferon gamma-1b
DB00034,"The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Interferon alfa-2a, Recombinant.","Interferon alfa-2a, Recombinant"
DB00041,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Aldesleukin.,Aldesleukin
DB00051,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Adalimumab.,Adalimumab
DB00056,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Gemtuzumab ozogamicin.,Gemtuzumab ozogamicin
DB00059,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Pegaspargase.,Pegaspargase
DB00065,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Infliximab.,Infliximab
DB00068,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Interferon beta-1b.,Interferon beta-1b
DB00069,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Interferon alfacon-1.,Interferon alfacon-1
DB00073,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Rituximab.,Rituximab
DB00074,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Basiliximab.,Basiliximab
DB00075,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Muromonab.,Muromonab
DB00078,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Ibritumomab tiuxetan.,Ibritumomab tiuxetan
DB00081,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Tositumomab.,Tositumomab
DB00087,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Alemtuzumab.,Alemtuzumab
DB00092,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Alefacept.,Alefacept
DB00095,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Efalizumab.,Efalizumab
DB00098,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Antithymocyte immunoglobulin (rabbit).,Antithymocyte immunoglobulin (rabbit)
DB00105,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Interferon alfa-2b.,Interferon alfa-2b
DB00111,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Daclizumab.,Daclizumab
DB00112,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Bevacizumab.,Bevacizumab
DB00120,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Phenylalanine.,Phenylalanine
DB00180,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Flunisolide.,Flunisolide
DB00188,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Bortezomib.,Bortezomib
DB00242,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Cladribine.,Cladribine
DB00262,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Carmustine.,Carmustine
DB00276,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Amsacrine.,Amsacrine
DB00290,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Bleomycin.,Bleomycin
DB00291,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Chlorambucil.,Chlorambucil
DB00293,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Raltitrexed.,Raltitrexed
DB00305,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Mitomycin.,Mitomycin
DB00307,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Bexarotene.,Bexarotene
DB00309,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Vindesine.,Vindesine
DB00322,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Floxuridine.,Floxuridine
DB00328,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Indomethacin.,Indomethacin
DB00352,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Tioguanine.,Tioguanine
DB00361,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Vinorelbine.,Vinorelbine
DB00380,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Dexrazoxane.,Dexrazoxane
DB00394,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Beclomethasone dipropionate.,Beclomethasone dipropionate
DB00398,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Sorafenib.,Sorafenib
DB00428,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Streptozocin.,Streptozocin
DB00432,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Trifluridine.,Trifluridine
DB00441,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Gemcitabine.,Gemcitabine
DB00443,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Betamethasone.,Betamethasone
DB00444,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Teniposide.,Teniposide
DB00445,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Epirubicin.,Epirubicin
DB00446,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Chloramphenicol.,Chloramphenicol
DB00480,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Lenalidomide.,Lenalidomide
DB00488,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Altretamine.,Altretamine
DB00495,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Zidovudine.,Zidovudine
DB00515,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Cisplatin.,Cisplatin
DB00526,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Oxaliplatin.,Oxaliplatin
DB00531,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Cyclophosphamide.,Cyclophosphamide
DB00541,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Vincristine.,Vincristine
DB00544,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Fluorouracil.,Fluorouracil
DB00550,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Propylthiouracil.,Propylthiouracil
DB00552,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Pentostatin.,Pentostatin
DB00563,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Methotrexate.,Methotrexate
DB00564,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Carbamazepine.,Carbamazepine
DB00570,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Vinblastine.,Vinblastine
DB00588,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Fluticasone propionate.,Fluticasone propionate
DB00591,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Fluocinolone acetonide.,Fluocinolone acetonide
DB00601,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Linezolid.,Linezolid
DB00619,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Imatinib.,Imatinib
DB00620,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Triamcinolone.,Triamcinolone
DB00631,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Clofarabine.,Clofarabine
DB00635,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Prednisone.,Prednisone
DB00642,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Pemetrexed.,Pemetrexed
DB00687,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Fludrocortisone.,Fludrocortisone
DB00688,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Mycophenolate mofetil.,Mycophenolate mofetil
DB00694,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Daunorubicin.,Daunorubicin
DB00755,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Tretinoin.,Tretinoin
DB00762,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Irinotecan.,Irinotecan
DB00763,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Methimazole.,Methimazole
DB00764,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Mometasone.,Mometasone
DB00773,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Etoposide.,Etoposide
DB00795,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Sulfasalazine.,Sulfasalazine
DB00851,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Dacarbazine.,Dacarbazine
DB00853,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Temozolomide.,Temozolomide
DB00859,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Penicillamine.,Penicillamine
DB00860,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Prednisolone.,Prednisolone
DB00877,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Sirolimus.,Sirolimus
DB00888,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Mechlorethamine.,Mechlorethamine
DB00928,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Azacitidine.,Azacitidine
DB00958,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Carboplatin.,Carboplatin
DB00959,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Methylprednisolone.,Methylprednisolone
DB00970,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Dactinomycin.,Dactinomycin
DB00987,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Cytarabine.,Cytarabine
DB00993,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Azathioprine.,Azathioprine
DB00997,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Doxorubicin.,Doxorubicin
DB01005,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Hydroxyurea.,Hydroxyurea
DB01008,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Busulfan.,Busulfan
DB01024,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Mycophenolic acid.,Mycophenolic acid
DB01030,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Topotecan.,Topotecan
DB01033,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Mercaptopurine.,Mercaptopurine
DB01041,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Thalidomide.,Thalidomide
DB01042,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Melphalan.,Melphalan
DB01073,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Fludarabine.,Fludarabine
DB01099,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Flucytosine.,Flucytosine
DB01101,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Capecitabine.,Capecitabine
DB01108,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Trilostane.,Trilostane
DB01168,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Procarbazine.,Procarbazine
DB01169,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Arsenic trioxide.,Arsenic trioxide
DB01177,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Idarubicin.,Idarubicin
DB01181,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Ifosfamide.,Ifosfamide
DB01196,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Estramustine.,Estramustine
DB01204,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Mitoxantrone.,Mitoxantrone
DB01206,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Lomustine.,Lomustine
DB01222,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Budesonide.,Budesonide
DB01229,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Paclitaxel.,Paclitaxel
DB01234,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Dexamethasone.,Dexamethasone
DB01248,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Docetaxel.,Docetaxel
DB01254,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Dasatinib.,Dasatinib
DB01257,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Eculizumab.,Eculizumab
DB01262,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Decitabine.,Decitabine
DB01268,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Sunitinib.,Sunitinib
DB01280,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Nelarabine.,Nelarabine
DB01281,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Abatacept.,Abatacept
DB01285,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Corticotropin.,Corticotropin
DB01380,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Cortisone acetate.,Cortisone acetate
DB01384,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Paramethasone.,Paramethasone
DB01394,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Colchicine.,Colchicine
DB01410,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Ciclesonide.,Ciclesonide
DB01423,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Stepronin.,Stepronin
DB01590,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Everolimus.,Everolimus
DB01611,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Hydroxychloroquine.,Hydroxychloroquine
DB01816,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Castanospermine.,Castanospermine
DB02546,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Vorinostat.,Vorinostat
DB02806,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with 2-Methoxyethanol.,2-Methoxyethanol
DB03523,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Brequinar.,Brequinar
DB04572,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Thiotepa.,Thiotepa
DB04630,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Aldosterone.,Aldosterone
DB04845,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Ixabepilone.,Ixabepilone
DB04868,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Nilotinib.,Nilotinib
DB04951,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Pirfenidone.,Pirfenidone
DB04956,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Afelimomab.,Afelimomab
DB05015,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Belinostat.,Belinostat
DB05109,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Trabectedin.,Trabectedin
DB05258,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Interferon alfa.,Interferon alfa
DB05259,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Glatiramer.,Glatiramer
DB05260,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Gallium nitrate.,Gallium nitrate
DB05459,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Briakinumab.,Briakinumab
DB05472,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with omega interferon.,omega interferon
DB05676,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Apremilast.,Apremilast
DB05773,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Trastuzumab emtansine.,Trastuzumab emtansine
DB06168,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Canakinumab.,Canakinumab
DB06273,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Tocilizumab.,Tocilizumab
DB06287,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Temsirolimus.,Temsirolimus
DB06372,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Rilonacept.,Rilonacept
DB06589,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Pazopanib.,Pazopanib
DB06603,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Panobinostat.,Panobinostat
DB06612,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Mepolizumab.,Mepolizumab
DB06616,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Bosutinib.,Bosutinib
DB06662,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Abetimus.,Abetimus
DB06674,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Golimumab.,Golimumab
DB06681,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Belatacept.,Belatacept
DB06769,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Bendamustine.,Bendamustine
DB06772,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Cabazitaxel.,Cabazitaxel
DB06813,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Pralatrexate.,Pralatrexate
DB08059,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Wortmannin.,Wortmannin
DB08870,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Brentuximab vedotin.,Brentuximab vedotin
DB08871,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Eribulin.,Eribulin
DB08877,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Ruxolitinib.,Ruxolitinib
DB08879,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Belimumab.,Belimumab
DB08880,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Teriflunomide.,Teriflunomide
DB08889,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Carfilzomib.,Carfilzomib
DB08901,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Ponatinib.,Ponatinib
DB08904,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Certolizumab pegol.,Certolizumab pegol
DB08906,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Fluticasone furoate.,Fluticasone furoate
DB08908,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Dimethyl fumarate.,Dimethyl fumarate
DB08910,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Pomalidomide.,Pomalidomide
DB08935,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Obinutuzumab.,Obinutuzumab
DB08970,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Fluprednidene.,Fluprednidene
DB08971,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Fluocortolone.,Fluocortolone
DB09029,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Secukinumab.,Secukinumab
DB09033,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Vedolizumab.,Vedolizumab
DB09036,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Siltuximab.,Siltuximab
DB09052,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Blinatumomab.,Blinatumomab
DB09053,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Ibrutinib.,Ibrutinib
DB09054,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Idelalisib.,Idelalisib
DB09073,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Palbociclib.,Palbociclib
DB09074,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Olaparib.,Olaparib
DB09077,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Dinutuximab.,Dinutuximab
DB09082,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Vilanterol.,Vilanterol
DB09091,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Tixocortol.,Tixocortol
DB09122,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Peginterferon beta-1a.,Peginterferon beta-1a
DB09312,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Antilymphocyte immunoglobulin (horse).,Antilymphocyte immunoglobulin (horse)
DB09378,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Fluprednisolone.,Fluprednisolone
DB09383,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Meprednisone.,Meprednisone
DB11466,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Tepoxalin.,Tepoxalin
DB11487,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Dexamethasone isonicotinate.,Dexamethasone isonicotinate
DB11529,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Melengestrol.,Melengestrol
DB11569,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Ixekizumab.,Ixekizumab
DB11580,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Ravulizumab.,Ravulizumab
DB11616,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Pirarubicin.,Pirarubicin
DB11693,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Voclosporin.,Voclosporin
DB11708,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Peficitinib.,Peficitinib
DB11750,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Clobetasol.,Clobetasol
DB11767,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Sarilumab.,Sarilumab
DB11776,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Brodalumab.,Brodalumab
DB11803,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Sirukumab.,Sirukumab
DB11817,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Baricitinib.,Baricitinib
DB11834,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Guselkumab.,Guselkumab
DB11921,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Deflazacort.,Deflazacort
DB11988,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Ocrelizumab.,Ocrelizumab
DB12025,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Triptolide.,Triptolide
DB12371,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Siponimod.,Siponimod
DB12612,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Ozanimod.,Ozanimod
DB12617,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Mizoribine.,Mizoribine
DB12692,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Gusperimus.,Gusperimus
DB12814,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Cepeginterferon alfa-2B.,Cepeginterferon alfa-2B
DB12902,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Trofosfamide.,Trofosfamide
DB12947,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Doxifluridine.,Doxifluridine
DB12991,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Deoxyspergualin.,Deoxyspergualin
DB12996,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Acteoside.,Acteoside
DB13003,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Cortivazol.,Cortivazol
DB13014,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Hypericin.,Hypericin
DB13068,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with 9-(N-methyl-L-isoleucine)-cyclosporin A.,9-(N-methyl-L-isoleucine)-cyclosporin A
DB13208,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Prednylidene.,Prednylidene
DB13223,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Fluocortin.,Fluocortin
DB13241,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Begelomab.,Begelomab
DB13491,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Fluperolone.,Fluperolone
DB13664,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Formocortal.,Formocortal
DB13728,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Halometasone.,Halometasone
DB13843,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Cloprednol.,Cloprednol
DB13856,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Fluclorolone.,Fluclorolone
DB13867,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Fluticasone.,Fluticasone
DB14066,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Tetrandrine.,Tetrandrine
DB14219,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Monomethyl fumarate.,Monomethyl fumarate
DB14512,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Mometasone furoate.,Mometasone furoate
DB14538,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Hydrocortisone aceponate.,Hydrocortisone aceponate
DB14539,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Hydrocortisone acetate.,Hydrocortisone acetate
DB14545,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Hydrocortisone succinate.,Hydrocortisone succinate
DB14724,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Emapalumab.,Emapalumab
DB14762,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Risankizumab.,Risankizumab
DB14919,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Rozanolixizumab.,Rozanolixizumab
DB15253,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Bleselumab.,Bleselumab
DB00108,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Natalizumab.,Natalizumab
DB00337,The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Interferon alfa-n1.,Pimecrolimus
DB01656,Roflumilast may increase the immunosuppressive activities of Interferon alfa-n1.,Roflumilast
DB06688,The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Interferon alfa-n1.,Sipuleucel-T
DB00363,The risk or severity of neutropenia can be increased when Interferon alfa-n1 is combined with Clozapine.,Clozapine
DB00315,The metabolism of Zolmitriptan can be decreased when combined with Interferon alfa-n1.,Zolmitriptan
DB01015,The risk or severity of myelosuppression can be increased when Sulfamethoxazole is combined with Interferon alfa-n1.,Sulfamethoxazole
DB01097,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Leflunomide.,Leflunomide
DB08895,Interferon alfa-n1 may increase the immunosuppressive activities of Tofacitinib.,Tofacitinib
DB00072,Trastuzumab may increase the neutropenic activities of Interferon alfa-n1.,Trastuzumab
DB08868,Interferon alfa-n1 may increase the immunosuppressive activities of Fingolimod.,Fingolimod
DB00864,Tacrolimus may increase the immunosuppressive activities of Interferon alfa-n1.,Tacrolimus
DB00201,The metabolism of Caffeine can be decreased when combined with Interferon alfa-n1.,Caffeine
DB00651,The metabolism of Dyphylline can be decreased when combined with Interferon alfa-n1.,Dyphylline
DB00806,The metabolism of Pentoxifylline can be decreased when combined with Interferon alfa-n1.,Pentoxifylline
DB01303,The metabolism of Oxtriphylline can be decreased when combined with Interferon alfa-n1.,Oxtriphylline
DB01412,The metabolism of Theobromine can be decreased when combined with Interferon alfa-n1.,Theobromine
DB01482,The metabolism of Fenethylline can be decreased when combined with Interferon alfa-n1.,Fenethylline
DB01667,The metabolism of 8-azaguanine can be decreased when combined with Interferon alfa-n1.,8-azaguanine
DB01978,"The metabolism of 7,9-Dimethylguanine can be decreased when combined with Interferon alfa-n1.","7,9-Dimethylguanine"
DB02134,The metabolism of Xanthine can be decreased when combined with Interferon alfa-n1.,Xanthine
DB02245,The metabolism of 7-Deazaguanine can be decreased when combined with Interferon alfa-n1.,7-Deazaguanine
DB02377,The metabolism of Guanine can be decreased when combined with Interferon alfa-n1.,Guanine
DB02489,The metabolism of 9-Methylguanine can be decreased when combined with Interferon alfa-n1.,9-Methylguanine
DB02568,The metabolism of Peldesine can be decreased when combined with Interferon alfa-n1.,Peldesine
DB04076,The metabolism of Hypoxanthine can be decreased when combined with Interferon alfa-n1.,Hypoxanthine
DB04356,The metabolism of 9-Deazaguanine can be decreased when combined with Interferon alfa-n1.,9-Deazaguanine
DB06479,The metabolism of Propentofylline can be decreased when combined with Interferon alfa-n1.,Propentofylline
DB06575,The metabolism of Valomaciclovir can be decreased when combined with Interferon alfa-n1.,Valomaciclovir
DB07954,The metabolism of 3-isobutyl-1-methyl-7H-xanthine can be decreased when combined with Interferon alfa-n1.,3-isobutyl-1-methyl-7H-xanthine
DB08844,The metabolism of Uric acid can be decreased when combined with Interferon alfa-n1.,Uric acid
DB09273,The metabolism of Doxofylline can be decreased when combined with Interferon alfa-n1.,Doxofylline
DB11919,The metabolism of 6-O-benzylguanine can be decreased when combined with Interferon alfa-n1.,6-O-benzylguanine
DB12406,The metabolism of Lisofylline can be decreased when combined with Interferon alfa-n1.,Lisofylline
DB12531,The metabolism of Lobucavir can be decreased when combined with Interferon alfa-n1.,Lobucavir
DB12926,The metabolism of Cafedrine can be decreased when combined with Interferon alfa-n1.,Cafedrine
DB12927,The metabolism of Theodrenaline can be decreased when combined with Interferon alfa-n1.,Theodrenaline
DB13203,The metabolism of Bamifylline can be decreased when combined with Interferon alfa-n1.,Bamifylline
DB13449,The metabolism of Proxyphylline can be decreased when combined with Interferon alfa-n1.,Proxyphylline
DB13573,The metabolism of Acefylline can be decreased when combined with Interferon alfa-n1.,Acefylline
DB13592,The metabolism of Etamiphylline can be decreased when combined with Interferon alfa-n1.,Etamiphylline
DB13634,The metabolism of Pentifylline can be decreased when combined with Interferon alfa-n1.,Pentifylline
DB13812,The metabolism of Bufylline can be decreased when combined with Interferon alfa-n1.,Bufylline
DB14018,The metabolism of Bromotheophylline can be decreased when combined with Interferon alfa-n1.,Bromotheophylline
DB14029,The metabolism of Furafylline can be decreased when combined with Interferon alfa-n1.,Furafylline
DB14132,The metabolism of 8-chlorotheophylline can be decreased when combined with Interferon alfa-n1.,8-chlorotheophylline
DB15122,The metabolism of PCS-499 can be decreased when combined with Interferon alfa-n1.,PCS-499
DB04914,The therapeutic efficacy of G17DT can be decreased when used in combination with Interferon alfa-n1.,G17DT
DB05144,The therapeutic efficacy of PEV3A can be decreased when used in combination with Interferon alfa-n1.,PEV3A
DB05325,The therapeutic efficacy of INGN 225 can be decreased when used in combination with Interferon alfa-n1.,INGN 225
DB05374,The therapeutic efficacy of Rindopepimut can be decreased when used in combination with Interferon alfa-n1.,Rindopepimut
DB05440,The therapeutic efficacy of SRP 299 can be decreased when used in combination with Interferon alfa-n1.,SRP 299
DB05942,The therapeutic efficacy of GI-5005 can be decreased when used in combination with Interferon alfa-n1.,GI-5005
DB06400,The therapeutic efficacy of Vitespen can be decreased when used in combination with Interferon alfa-n1.,Vitespen
DB06584,The therapeutic efficacy of TG4010 can be decreased when used in combination with Interferon alfa-n1.,TG4010
DB09057,The therapeutic efficacy of Anthrax immune globulin human can be decreased when used in combination with Interferon alfa-n1.,Anthrax immune globulin human
DB10062,"The therapeutic efficacy of Rabies virus inactivated antigen, B can be decreased when used in combination with Interferon alfa-n1.","Rabies virus inactivated antigen, B"
DB10076,The therapeutic efficacy of Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Interferon alfa-n1.,Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen
DB10276,The therapeutic efficacy of Rotavirus vaccine can be decreased when used in combination with Interferon alfa-n1.,Rotavirus vaccine
DB10283,"The therapeutic efficacy of Rabies virus inactivated antigen, A can be decreased when used in combination with Interferon alfa-n1.","Rabies virus inactivated antigen, A"
DB10342,The therapeutic efficacy of Haemophilus influenzae type B capsular polysaccharide meningococcal outer membrane protein conjugate antigen can be decreased when used in combination with Interferon alfa-n1.,Haemophilus influenzae type B capsular polysaccharide meningococcal outer membrane protein conjugate antigen
DB10583,The therapeutic efficacy of Clostridium tetani toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Interferon alfa-n1.,Clostridium tetani toxoid antigen (formaldehyde inactivated)
DB10584,The therapeutic efficacy of Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Interferon alfa-n1.,Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated)
DB10600,The therapeutic efficacy of Influenza A virus A/California/7/2009 X-181 (H1N1) antigen (propiolactone inactivated) can be decreased when used in combination with Interferon alfa-n1.,Influenza A virus A/California/7/2009 X-181 (H1N1) antigen (propiolactone inactivated)
DB10769,The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Interferon alfa-n1.,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated)
DB10794,The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 antigen (formaldehyde inactivated) can be decreased when used in combination with Interferon alfa-n1.,Influenza B virus B/Brisbane/60/2008 antigen (formaldehyde inactivated)
DB10803,The therapeutic efficacy of Typhoid Vi polysaccharide vaccine can be decreased when used in combination with Interferon alfa-n1.,Typhoid Vi polysaccharide vaccine
DB10989,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Interferon alfa-n1.,Hepatitis A Vaccine
DB10990,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Interferon alfa-n1.,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen
DB11038,The therapeutic efficacy of Influenza A virus A/Brisbane/59/2007(H1N1) hemagglutinin antigen (propiolactone inactivated) can be decreased when used in combination with Interferon alfa-n1.,Influenza A virus A/Brisbane/59/2007(H1N1) hemagglutinin antigen (propiolactone inactivated)
DB11040,The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (propiolactone inactivated) can be decreased when used in combination with Interferon alfa-n1.,Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (propiolactone inactivated)
DB11041,The therapeutic efficacy of Influenza A virus A/California/7/2009 X-181 (H1N1) hemagglutinin antigen (propiolactone inactivated) can be decreased when used in combination with Interferon alfa-n1.,Influenza A virus A/California/7/2009 X-181 (H1N1) hemagglutinin antigen (propiolactone inactivated)
DB11044,The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 antigen (propiolactone inactivated) can be decreased when used in combination with Interferon alfa-n1.,Influenza B virus B/Brisbane/60/2008 antigen (propiolactone inactivated)
DB11603,The therapeutic efficacy of Human rabies virus immune globulin can be decreased when used in combination with Interferon alfa-n1.,Human rabies virus immune globulin
DB11627,The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Interferon alfa-n1.,Hepatitis B Vaccine (Recombinant)
DB12568,The therapeutic efficacy of Tecemotide can be decreased when used in combination with Interferon alfa-n1.,Tecemotide
DB14022,The therapeutic efficacy of Typhoid vaccine can be decreased when used in combination with Interferon alfa-n1.,Typhoid vaccine
DB14384,The therapeutic efficacy of Influenza A virus A/Victoria/210/2009 X-187 (H3N2) hemagglutinin antigen (formaldehyde inactivated) can be decreased when used in combination with Interferon alfa-n1.,Influenza A virus A/Victoria/210/2009 X-187 (H3N2) hemagglutinin antigen (formaldehyde inactivated)
DB14385,The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (formaldehyde inactivated) can be decreased when used in combination with Interferon alfa-n1.,Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (formaldehyde inactivated)
DB14394,The therapeutic efficacy of Influenza A virus A/California/7/2009 (H1N1) live (attenuated) antigen can be decreased when used in combination with Interferon alfa-n1.,Influenza A virus A/California/7/2009 (H1N1) live (attenuated) antigen
DB14445,The therapeutic efficacy of Influenza A virus A/Victoria/210/2009 X-187 (H3N2) antigen (formaldehyde inactivated) can be decreased when used in combination with Interferon alfa-n1.,Influenza A virus A/Victoria/210/2009 X-187 (H3N2) antigen (formaldehyde inactivated)
DB14449,The therapeutic efficacy of Influenza A virus A/Perth/16/2009 (H3N2) live (attenuated) antigen can be decreased when used in combination with Interferon alfa-n1.,Influenza A virus A/Perth/16/2009 (H3N2) live (attenuated) antigen
DB14619,The therapeutic efficacy of Influenza A virus A/Uruguay/716/2007(H3N2) antigen (propiolactone inactivated) can be decreased when used in combination with Interferon alfa-n1.,Influenza A virus A/Uruguay/716/2007(H3N2) antigen (propiolactone inactivated)
DB14620,The therapeutic efficacy of Influenza A virus A/Brisbane/59/2007(H1N1) antigen (propiolactone inactivated) can be decreased when used in combination with Interferon alfa-n1.,Influenza A virus A/Brisbane/59/2007(H1N1) antigen (propiolactone inactivated)
DB14711,The therapeutic efficacy of Vaccinia virus strain new york city board of health live antigen can be decreased when used in combination with Interferon alfa-n1.,Vaccinia virus strain new york city board of health live antigen
DB15274,The therapeutic efficacy of Pertussis vaccine can be decreased when used in combination with Interferon alfa-n1.,Pertussis vaccine
DB15461,The therapeutic efficacy of Yersinia pestis 195/p antigen (formaldehyde inactivated) can be decreased when used in combination with Interferon alfa-n1.,Yersinia pestis 195/p antigen (formaldehyde inactivated)
DB13924,The therapeutic efficacy of Varicella Zoster Vaccine (Recombinant) can be decreased when used in combination with Interferon alfa-n1.,Varicella Zoster Vaccine (Recombinant)
DB15483,The therapeutic efficacy of Modified vaccinia ankara can be decreased when used in combination with Interferon alfa-n1.,Modified vaccinia ankara
DB15595,"The therapeutic efficacy of Ebola Zaire vaccine (live, attenuated) can be decreased when used in combination with Interferon alfa-n1.","Ebola Zaire vaccine (live, attenuated)"
DB00054,The risk or severity of bleeding can be increased when Abciximab is combined with Interferon alfa-n1.,Abciximab
DB00063,The risk or severity of bleeding can be increased when Eptifibatide is combined with Interferon alfa-n1.,Eptifibatide
DB00208,The risk or severity of bleeding can be increased when Ticlopidine is combined with Interferon alfa-n1.,Ticlopidine
DB00775,The risk or severity of bleeding can be increased when Tirofiban is combined with Interferon alfa-n1.,Tirofiban
DB00945,The risk or severity of bleeding can be increased when Acetylsalicylic acid is combined with Interferon alfa-n1.,Acetylsalicylic acid
DB00975,The risk or severity of bleeding can be increased when Dipyridamole is combined with Interferon alfa-n1.,Dipyridamole
DB01088,The risk or severity of bleeding can be increased when Iloprost is combined with Interferon alfa-n1.,Iloprost
DB01138,The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Interferon alfa-n1.,Sulfinpyrazone
DB01207,The risk or severity of bleeding can be increased when Ridogrel is combined with Interferon alfa-n1.,Ridogrel
DB01236,The risk or severity of bleeding can be increased when Sevoflurane is combined with Interferon alfa-n1.,Sevoflurane
DB01240,The risk or severity of bleeding can be increased when Epoprostenol is combined with Interferon alfa-n1.,Epoprostenol
DB04743,The risk or severity of bleeding can be increased when Nimesulide is combined with Interferon alfa-n1.,Nimesulide
DB04905,The risk or severity of bleeding can be increased when Tesmilifene is combined with Interferon alfa-n1.,Tesmilifene
DB04932,The risk or severity of bleeding can be increased when Defibrotide is combined with Interferon alfa-n1.,Defibrotide
DB05229,The risk or severity of bleeding can be increased when Beraprost is combined with Interferon alfa-n1.,Beraprost
DB05266,The risk or severity of bleeding can be increased when Ibudilast is combined with Interferon alfa-n1.,Ibudilast
DB05767,The risk or severity of bleeding can be increased when Andrographolide is combined with Interferon alfa-n1.,Andrographolide
DB06081,The risk or severity of bleeding can be increased when Caplacizumab is combined with Interferon alfa-n1.,Caplacizumab
DB06209,The risk or severity of bleeding can be increased when Prasugrel is combined with Interferon alfa-n1.,Prasugrel
DB06441,The risk or severity of bleeding can be increased when Cangrelor is combined with Interferon alfa-n1.,Cangrelor
DB07615,The risk or severity of bleeding can be increased when Tranilast is combined with Interferon alfa-n1.,Tranilast
DB08814,The risk or severity of bleeding can be increased when Triflusal is combined with Interferon alfa-n1.,Triflusal
DB08816,The risk or severity of bleeding can be increased when Ticagrelor is combined with Interferon alfa-n1.,Ticagrelor
DB08887,The risk or severity of bleeding can be increased when Icosapent ethyl is combined with Interferon alfa-n1.,Icosapent ethyl
DB09030,The risk or severity of bleeding can be increased when Vorapaxar is combined with Interferon alfa-n1.,Vorapaxar
DB09283,The risk or severity of bleeding can be increased when Trapidil is combined with Interferon alfa-n1.,Trapidil
DB12092,The risk or severity of bleeding can be increased when Naftopidil is combined with Interferon alfa-n1.,Naftopidil
DB12163,The risk or severity of bleeding can be increased when Sarpogrelate is combined with Interferon alfa-n1.,Sarpogrelate
DB12321,The risk or severity of bleeding can be increased when Ifetroban is combined with Interferon alfa-n1.,Ifetroban
DB12445,The risk or severity of bleeding can be increased when Nitroaspirin is combined with Interferon alfa-n1.,Nitroaspirin
DB12465,The risk or severity of bleeding can be increased when Ketanserin is combined with Interferon alfa-n1.,Ketanserin
DB12545,The risk or severity of bleeding can be increased when Indobufen is combined with Interferon alfa-n1.,Indobufen
DB12749,The risk or severity of bleeding can be increased when Butylphthalide is combined with Interferon alfa-n1.,Butylphthalide
DB12771,The risk or severity of bleeding can be increased when Hydroxytyrosol is combined with Interferon alfa-n1.,Hydroxytyrosol
DB13036,The risk or severity of bleeding can be increased when Ramatroban is combined with Interferon alfa-n1.,Ramatroban
DB13327,The risk or severity of bleeding can be increased when Picotamide is combined with Interferon alfa-n1.,Picotamide
DB13367,The risk or severity of bleeding can be increased when Cloricromen is combined with Interferon alfa-n1.,Cloricromen
DB13400,The risk or severity of bleeding can be increased when Linsidomine is combined with Interferon alfa-n1.,Linsidomine
DB13510,The risk or severity of bleeding can be increased when Buflomedil is combined with Interferon alfa-n1.,Buflomedil
DB13929,The risk or severity of bleeding can be increased when Relcovaptan is combined with Interferon alfa-n1.,Relcovaptan
DB13200,Interferon alfa-n1 may increase the myelosuppressive activities of Lipegfilgrastim.,Lipegfilgrastim
DB10318,The risk or severity of infection can be increased when Interferon alfa-n1 is combined with Varicella Zoster Vaccine (Live/attenuated).,Varicella Zoster Vaccine (Live/attenuated)
DB10317,The risk or severity of infection can be increased when Rubella virus vaccine is combined with Interferon alfa-n1.,Rubella virus vaccine
DB10343,The risk or severity of infection can be increased when Bacillus calmette-guerin substrain tice live antigen is combined with Interferon alfa-n1.,Bacillus calmette-guerin substrain tice live antigen
DB10804,The risk or severity of infection can be increased when Bacillus calmette-guerin substrain connaught live antigen is combined with Interferon alfa-n1.,Bacillus calmette-guerin substrain connaught live antigen
DB10805,The risk or severity of infection can be increased when Yellow Fever Vaccine is combined with Interferon alfa-n1.,Yellow Fever Vaccine
DB11003,The risk or severity of infection can be increased when Anthrax vaccine is combined with Interferon alfa-n1.,Anthrax vaccine
DB11050,The risk or severity of infection can be increased when Typhoid Vaccine Live is combined with Interferon alfa-n1.,Typhoid Vaccine Live
DB12386,The risk or severity of infection can be increased when Bacillus calmette-guerin substrain danish 1331 live antigen is combined with Interferon alfa-n1.,Bacillus calmette-guerin substrain danish 1331 live antigen
DB12768,The risk or severity of infection can be increased when BCG vaccine is combined with Interferon alfa-n1.,BCG vaccine
DB14409,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Interferon alfa-n1.,Human adenovirus e serotype 4 strain cl-68578 antigen
DB14443,The risk or severity of infection can be increased when Vibrio cholerae CVD 103-HgR strain live antigen is combined with Interferon alfa-n1.,Vibrio cholerae CVD 103-HgR strain live antigen
DB14685,The risk or severity of infection can be increased when Adenovirus type 7 vaccine live is combined with Interferon alfa-n1.,Adenovirus type 7 vaccine live
DB00039,The therapeutic efficacy of Palifermin can be decreased when used in combination with Interferon alfa-n1.,Palifermin
DB00176,The metabolism of Fluvoxamine can be decreased when combined with Interferon alfa-n1.,Fluvoxamine
DB00184,The metabolism of Nicotine can be decreased when combined with Interferon alfa-n1.,Nicotine
DB00195,The metabolism of Betaxolol can be decreased when combined with Interferon alfa-n1.,Betaxolol
DB00261,The metabolism of Anagrelide can be decreased when combined with Interferon alfa-n1.,Anagrelide
DB00280,The metabolism of Disopyramide can be decreased when combined with Interferon alfa-n1.,Disopyramide
DB00281,The metabolism of Lidocaine can be decreased when combined with Interferon alfa-n1.,Lidocaine
DB00286,The metabolism of Conjugated estrogens can be decreased when combined with Interferon alfa-n1.,Conjugated estrogens
DB00296,The metabolism of Ropivacaine can be decreased when combined with Interferon alfa-n1.,Ropivacaine
DB00316,The metabolism of Acetaminophen can be decreased when combined with Interferon alfa-n1.,Acetaminophen
DB00334,The metabolism of Olanzapine can be decreased when combined with Interferon alfa-n1.,Olanzapine
DB00356,The metabolism of Chlorzoxazone can be decreased when combined with Interferon alfa-n1.,Chlorzoxazone
DB00365,The metabolism of Grepafloxacin can be decreased when combined with Interferon alfa-n1.,Grepafloxacin
DB00370,The metabolism of Mirtazapine can be decreased when combined with Interferon alfa-n1.,Mirtazapine
DB00379,The metabolism of Mexiletine can be decreased when combined with Interferon alfa-n1.,Mexiletine
DB00382,The metabolism of Tacrine can be decreased when combined with Interferon alfa-n1.,Tacrine
DB00384,The metabolism of Triamterene can be decreased when combined with Interferon alfa-n1.,Triamterene
DB00420,The metabolism of Promazine can be decreased when combined with Interferon alfa-n1.,Promazine
DB00425,The metabolism of Zolpidem can be decreased when combined with Interferon alfa-n1.,Zolpidem
DB00442,The metabolism of Entecavir can be decreased when combined with Interferon alfa-n1.,Entecavir
DB00461,The metabolism of Nabumetone can be decreased when combined with Interferon alfa-n1.,Nabumetone
DB00468,The metabolism of Quinine can be decreased when combined with Interferon alfa-n1.,Quinine
DB00472,The metabolism of Fluoxetine can be decreased when combined with Interferon alfa-n1.,Fluoxetine
DB00476,The metabolism of Duloxetine can be decreased when combined with Interferon alfa-n1.,Duloxetine
DB00477,The metabolism of Chlorpromazine can be decreased when combined with Interferon alfa-n1.,Chlorpromazine
DB00499,The metabolism of Flutamide can be decreased when combined with Interferon alfa-n1.,Flutamide
DB00502,The metabolism of Haloperidol can be decreased when combined with Interferon alfa-n1.,Haloperidol
DB00518,The metabolism of Albendazole can be decreased when combined with Interferon alfa-n1.,Albendazole
DB00533,The metabolism of Rofecoxib can be decreased when combined with Interferon alfa-n1.,Rofecoxib
DB00568,The metabolism of Cinnarizine can be decreased when combined with Interferon alfa-n1.,Cinnarizine
DB00571,The metabolism of Propranolol can be decreased when combined with Interferon alfa-n1.,Propranolol
DB00586,The metabolism of Diclofenac can be decreased when combined with Interferon alfa-n1.,Diclofenac
DB00629,The metabolism of Guanabenz can be decreased when combined with Interferon alfa-n1.,Guanabenz
DB00661,The metabolism of Verapamil can be decreased when combined with Interferon alfa-n1.,Verapamil
DB00715,The metabolism of Paroxetine can be decreased when combined with Interferon alfa-n1.,Paroxetine
DB00730,The metabolism of Thiabendazole can be decreased when combined with Interferon alfa-n1.,Thiabendazole
DB00740,The metabolism of Riluzole can be decreased when combined with Interferon alfa-n1.,Riluzole
DB00744,The metabolism of Zileuton can be decreased when combined with Interferon alfa-n1.,Zileuton
DB00758,The metabolism of Clopidogrel can be decreased when combined with Interferon alfa-n1.,Clopidogrel
DB00783,The metabolism of Estradiol can be decreased when combined with Interferon alfa-n1.,Estradiol
DB00787,The metabolism of Acyclovir can be decreased when combined with Interferon alfa-n1.,Acyclovir
DB00788,The metabolism of Naproxen can be decreased when combined with Interferon alfa-n1.,Naproxen
DB00831,The metabolism of Trifluoperazine can be decreased when combined with Interferon alfa-n1.,Trifluoperazine
DB00850,The metabolism of Perphenazine can be decreased when combined with Interferon alfa-n1.,Perphenazine
DB00857,The metabolism of Terbinafine can be decreased when combined with Interferon alfa-n1.,Terbinafine
DB00863,The metabolism of Ranitidine can be decreased when combined with Interferon alfa-n1.,Ranitidine
DB00898,The metabolism of Ethanol can be decreased when combined with Interferon alfa-n1.,Ethanol
DB00934,The metabolism of Maprotiline can be decreased when combined with Interferon alfa-n1.,Maprotiline
DB00969,The metabolism of Alosetron can be decreased when combined with Interferon alfa-n1.,Alosetron
DB00978,The metabolism of Lomefloxacin can be decreased when combined with Interferon alfa-n1.,Lomefloxacin
DB00980,The metabolism of Ramelteon can be decreased when combined with Interferon alfa-n1.,Ramelteon
DB00998,The metabolism of Frovatriptan can be decreased when combined with Interferon alfa-n1.,Frovatriptan
DB01002,The metabolism of Levobupivacaine can be decreased when combined with Interferon alfa-n1.,Levobupivacaine
DB01012,The metabolism of Cinacalcet can be decreased when combined with Interferon alfa-n1.,Cinacalcet
DB01037,The metabolism of Selegiline can be decreased when combined with Interferon alfa-n1.,Selegiline
DB01056,The metabolism of Tocainide can be decreased when combined with Interferon alfa-n1.,Tocainide
DB01058,The metabolism of Praziquantel can be decreased when combined with Interferon alfa-n1.,Praziquantel
DB01065,The metabolism of Melatonin can be decreased when combined with Interferon alfa-n1.,Melatonin
DB01087,The metabolism of Primaquine can be decreased when combined with Interferon alfa-n1.,Primaquine
DB01094,The metabolism of Hesperetin can be decreased when combined with Interferon alfa-n1.,Hesperetin
DB01115,The metabolism of Nifedipine can be decreased when combined with Interferon alfa-n1.,Nifedipine
DB01136,The metabolism of Carvedilol can be decreased when combined with Interferon alfa-n1.,Carvedilol
DB01166,The metabolism of Cilostazol can be decreased when combined with Interferon alfa-n1.,Cilostazol
DB01182,The metabolism of Propafenone can be decreased when combined with Interferon alfa-n1.,Propafenone
DB01184,The metabolism of Domperidone can be decreased when combined with Interferon alfa-n1.,Domperidone
DB01191,The metabolism of Dexfenfluramine can be decreased when combined with Interferon alfa-n1.,Dexfenfluramine
DB01367,The metabolism of Rasagiline can be decreased when combined with Interferon alfa-n1.,Rasagiline
DB01405,The metabolism of Temafloxacin can be decreased when combined with Interferon alfa-n1.,Temafloxacin
DB01424,The metabolism of Aminophenazone can be decreased when combined with Interferon alfa-n1.,Aminophenazone
DB01435,The metabolism of Antipyrine can be decreased when combined with Interferon alfa-n1.,Antipyrine
DB01558,The metabolism of Bromazepam can be decreased when combined with Interferon alfa-n1.,Bromazepam
DB01623,The metabolism of Thiothixene can be decreased when combined with Interferon alfa-n1.,Thiothixene
DB01628,The metabolism of Etoricoxib can be decreased when combined with Interferon alfa-n1.,Etoricoxib
DB01645,The metabolism of Genistein can be decreased when combined with Interferon alfa-n1.,Genistein
DB02709,The metabolism of Resveratrol can be decreased when combined with Interferon alfa-n1.,Resveratrol
DB03783,The metabolism of Phenacetin can be decreased when combined with Interferon alfa-n1.,Phenacetin
DB04574,The metabolism of Estrone sulfate can be decreased when combined with Interferon alfa-n1.,Estrone sulfate
DB04841,The metabolism of Flunarizine can be decreased when combined with Interferon alfa-n1.,Flunarizine
DB04871,The metabolism of Lorcaserin can be decreased when combined with Interferon alfa-n1.,Lorcaserin
DB04948,The metabolism of Lofexidine can be decreased when combined with Interferon alfa-n1.,Lofexidine
DB06148,The metabolism of Mianserin can be decreased when combined with Interferon alfa-n1.,Mianserin
DB06210,The metabolism of Eltrombopag can be decreased when combined with Interferon alfa-n1.,Eltrombopag
DB06216,The metabolism of Asenapine can be decreased when combined with Interferon alfa-n1.,Asenapine
DB06235,The metabolism of Vadimezan can be decreased when combined with Interferon alfa-n1.,Vadimezan
DB06292,The metabolism of Dapagliflozin can be decreased when combined with Interferon alfa-n1.,Dapagliflozin
DB06594,The metabolism of Agomelatine can be decreased when combined with Interferon alfa-n1.,Agomelatine
DB06626,The metabolism of Axitinib can be decreased when combined with Interferon alfa-n1.,Axitinib
DB06770,The metabolism of Benzyl alcohol can be decreased when combined with Interferon alfa-n1.,Benzyl alcohol
DB06774,The metabolism of Capsaicin can be decreased when combined with Interferon alfa-n1.,Capsaicin
DB08496,The metabolism of (R)-warfarin can be decreased when combined with Interferon alfa-n1.,(R)-warfarin
DB08883,The metabolism of Perampanel can be decreased when combined with Interferon alfa-n1.,Perampanel
DB09071,The metabolism of Tasimelteon can be decreased when combined with Interferon alfa-n1.,Tasimelteon
DB09118,The metabolism of Stiripentol can be decreased when combined with Interferon alfa-n1.,Stiripentol
DB09225,The metabolism of Zotepine can be decreased when combined with Interferon alfa-n1.,Zotepine
DB09288,The metabolism of Propacetamol can be decreased when combined with Interferon alfa-n1.,Propacetamol
DB09290,The metabolism of Ramosetron can be decreased when combined with Interferon alfa-n1.,Ramosetron
DB11967,The metabolism of Binimetinib can be decreased when combined with Interferon alfa-n1.,Binimetinib
DB12026,The metabolism of Voxilaprevir can be decreased when combined with Interferon alfa-n1.,Voxilaprevir
DB12245,The metabolism of Triclabendazole can be decreased when combined with Interferon alfa-n1.,Triclabendazole
DB12332,The metabolism of Rucaparib can be decreased when combined with Interferon alfa-n1.,Rucaparib
DB12945,The metabolism of Dihydralazine can be decreased when combined with Interferon alfa-n1.,Dihydralazine
DB13952,The metabolism of Estradiol acetate can be decreased when combined with Interferon alfa-n1.,Estradiol acetate
DB13953,The metabolism of Estradiol benzoate can be decreased when combined with Interferon alfa-n1.,Estradiol benzoate
DB13954,The metabolism of Estradiol cypionate can be decreased when combined with Interferon alfa-n1.,Estradiol cypionate
DB13955,The metabolism of Estradiol dienanthate can be decreased when combined with Interferon alfa-n1.,Estradiol dienanthate
DB13956,The metabolism of Estradiol valerate can be decreased when combined with Interferon alfa-n1.,Estradiol valerate
DB11757,The metabolism of Istradefylline can be decreased when combined with Interferon alfa-n1.,Istradefylline
DB00972,The metabolism of Azelastine can be decreased when combined with Interferon alfa-n1.,Azelastine
DB00625,The metabolism of Efavirenz can be decreased when combined with Interferon alfa-n1.,Efavirenz
DB01233,The metabolism of Metoclopramide can be decreased when combined with Interferon alfa-n1.,Metoclopramide
DB04889,The metabolism of Bicifadine can be decreased when combined with Interferon alfa-n1.,Bicifadine
DB05708,The metabolism of GTS-21 can be decreased when combined with Interferon alfa-n1.,GTS-21
DB01195,The metabolism of Flecainide can be decreased when combined with Interferon alfa-n1.,Flecainide
DB00977,The metabolism of Ethinylestradiol can be decreased when combined with Interferon alfa-n1.,Ethinylestradiol
DB00321,The metabolism of Amitriptyline can be decreased when combined with Interferon alfa-n1.,Amitriptyline
DB00458,The metabolism of Imipramine can be decreased when combined with Interferon alfa-n1.,Imipramine
DB01142,The metabolism of Doxepin can be decreased when combined with Interferon alfa-n1.,Doxepin
DB00532,The metabolism of Mephenytoin can be decreased when combined with Interferon alfa-n1.,Mephenytoin
DB00540,The metabolism of Nortriptyline can be decreased when combined with Interferon alfa-n1.,Nortriptyline
DB00575,The metabolism of Clonidine can be decreased when combined with Interferon alfa-n1.,Clonidine
DB00924,The metabolism of Cyclobenzaprine can be decreased when combined with Interferon alfa-n1.,Cyclobenzaprine
DB01151,The metabolism of Desipramine can be decreased when combined with Interferon alfa-n1.,Desipramine
DB01242,The metabolism of Clomipramine can be decreased when combined with Interferon alfa-n1.,Clomipramine
DB11689,The metabolism of Selumetinib can be decreased when combined with Interferon alfa-n1.,Selumetinib
DB00277,The metabolism of Theophylline can be decreased when combined with Interferon alfa-n1.,Theophylline
DB00682,The metabolism of Warfarin can be decreased when combined with Interferon alfa-n1.,Warfarin
DB00697,The metabolism of Tizanidine can be decreased when combined with Interferon alfa-n1.,Tizanidine
DB01100,The metabolism of Pimozide can be decreased when combined with Interferon alfa-n1.,Pimozide
DB01223,The metabolism of Aminophylline can be decreased when combined with Interferon alfa-n1.,Aminophylline
DB01418,The metabolism of Acenocoumarol can be decreased when combined with Interferon alfa-n1.,Acenocoumarol
DB00530,The metabolism of Erlotinib can be decreased when combined with Interferon alfa-n1.,Erlotinib
DB09256,The metabolism of Tegafur can be decreased when combined with Interferon alfa-n1.,Tegafur
DB13874,The metabolism of Enasidenib can be decreased when combined with Interferon alfa-n1.,Enasidenib
DB00675,The metabolism of Tamoxifen can be decreased when combined with Interferon alfa-n1.,Tamoxifen
DB00001,The risk or severity of bleeding can be increased when Lepirudin is combined with Interferon alfa-n1.,Lepirudin
DB00006,The risk or severity of bleeding can be increased when Bivalirudin is combined with Interferon alfa-n1.,Bivalirudin
DB00009,The risk or severity of bleeding can be increased when Alteplase is combined with Interferon alfa-n1.,Alteplase
DB00013,The risk or severity of bleeding can be increased when Urokinase is combined with Interferon alfa-n1.,Urokinase
DB00015,The risk or severity of bleeding can be increased when Reteplase is combined with Interferon alfa-n1.,Reteplase
DB00029,The risk or severity of bleeding can be increased when Anistreplase is combined with Interferon alfa-n1.,Anistreplase
DB00031,The risk or severity of bleeding can be increased when Tenecteplase is combined with Interferon alfa-n1.,Tenecteplase
DB00055,The risk or severity of bleeding can be increased when Drotrecogin alfa is combined with Interferon alfa-n1.,Drotrecogin alfa
DB00086,The risk or severity of bleeding can be increased when Streptokinase is combined with Interferon alfa-n1.,Streptokinase
DB00266,The risk or severity of bleeding can be increased when Dicoumarol is combined with Interferon alfa-n1.,Dicoumarol
DB00278,The risk or severity of bleeding can be increased when Argatroban is combined with Interferon alfa-n1.,Argatroban
DB00407,The risk or severity of bleeding can be increased when Ardeparin is combined with Interferon alfa-n1.,Ardeparin
DB00498,The risk or severity of bleeding can be increased when Phenindione is combined with Interferon alfa-n1.,Phenindione
DB00569,The risk or severity of bleeding can be increased when Fondaparinux is combined with Interferon alfa-n1.,Fondaparinux
DB00686,The risk or severity of bleeding can be increased when Pentosan polysulfate is combined with Interferon alfa-n1.,Pentosan polysulfate
DB00946,The risk or severity of bleeding can be increased when Phenprocoumon is combined with Interferon alfa-n1.,Phenprocoumon
DB01109,The risk or severity of bleeding can be increased when Heparin is combined with Interferon alfa-n1.,Heparin
DB01225,The risk or severity of bleeding can be increased when Enoxaparin is combined with Interferon alfa-n1.,Enoxaparin
DB03410,The risk or severity of bleeding can be increased when 4-hydroxycoumarin is combined with Interferon alfa-n1.,4-hydroxycoumarin
DB04665,The risk or severity of bleeding can be increased when Coumarin is combined with Interferon alfa-n1.,Coumarin
DB04898,The risk or severity of bleeding can be increased when Ximelagatran is combined with Interferon alfa-n1.,Ximelagatran
DB04925,The risk or severity of bleeding can be increased when Desmoteplase is combined with Interferon alfa-n1.,Desmoteplase
DB05099,The risk or severity of bleeding can be increased when Ancrod is combined with Interferon alfa-n1.,Ancrod
DB05254,The risk or severity of bleeding can be increased when Fibrinolysin is combined with Interferon alfa-n1.,Fibrinolysin
DB06228,The risk or severity of bleeding can be increased when Rivaroxaban is combined with Interferon alfa-n1.,Rivaroxaban
DB06271,The risk or severity of bleeding can be increased when Sulodexide is combined with Interferon alfa-n1.,Sulodexide
DB06294,The risk or severity of bleeding can be increased when Semuloparin is combined with Interferon alfa-n1.,Semuloparin
DB06406,The risk or severity of bleeding can be increased when Idraparinux is combined with Interferon alfa-n1.,Idraparinux
DB06543,The risk or severity of bleeding can be increased when Astaxanthin is combined with Interferon alfa-n1.,Astaxanthin
DB06605,The risk or severity of bleeding can be increased when Apixaban is combined with Interferon alfa-n1.,Apixaban
DB06635,The risk or severity of bleeding can be increased when Otamixaban is combined with Interferon alfa-n1.,Otamixaban
DB06679,The risk or severity of bleeding can be increased when Amediplase is combined with Interferon alfa-n1.,Amediplase
DB06695,The risk or severity of bleeding can be increased when Dabigatran etexilate is combined with Interferon alfa-n1.,Dabigatran etexilate
DB06754,The risk or severity of bleeding can be increased when Danaparoid is combined with Interferon alfa-n1.,Danaparoid
DB06779,The risk or severity of bleeding can be increased when Dalteparin is combined with Interferon alfa-n1.,Dalteparin
DB06822,The risk or severity of bleeding can be increased when Tinzaparin is combined with Interferon alfa-n1.,Tinzaparin
DB07767,The risk or severity of bleeding can be increased when Ferulic acid is combined with Interferon alfa-n1.,Ferulic acid
DB08794,The risk or severity of bleeding can be increased when Ethyl biscoumacetate is combined with Interferon alfa-n1.,Ethyl biscoumacetate
DB08813,The risk or severity of bleeding can be increased when Nadroparin is combined with Interferon alfa-n1.,Nadroparin
DB08994,The risk or severity of bleeding can be increased when Ditazole is combined with Interferon alfa-n1.,Ditazole
DB09075,The risk or severity of bleeding can be increased when Edoxaban is combined with Interferon alfa-n1.,Edoxaban
DB09125,The risk or severity of bleeding can be increased when Potassium citrate is combined with Interferon alfa-n1.,Potassium citrate
DB09154,The risk or severity of bleeding can be increased when Sodium citrate is combined with Interferon alfa-n1.,Sodium citrate
DB09255,The risk or severity of bleeding can be increased when Dextran is combined with Interferon alfa-n1.,Dextran
DB09258,The risk or severity of bleeding can be increased when Bemiparin is combined with Interferon alfa-n1.,Bemiparin
DB09259,The risk or severity of bleeding can be increased when Reviparin is combined with Interferon alfa-n1.,Reviparin
DB09260,The risk or severity of bleeding can be increased when Parnaparin is combined with Interferon alfa-n1.,Parnaparin
DB09261,The risk or severity of bleeding can be increased when Certoparin is combined with Interferon alfa-n1.,Certoparin
DB11095,The risk or severity of bleeding can be increased when Desirudin is combined with Interferon alfa-n1.,Desirudin
DB11154,The risk or severity of bleeding can be increased when Zinc citrate is combined with Interferon alfa-n1.,Zinc citrate
DB11166,The risk or severity of bleeding can be increased when Antithrombin Alfa is combined with Interferon alfa-n1.,Antithrombin Alfa
DB11312,The risk or severity of bleeding can be increased when Protein C is combined with Interferon alfa-n1.,Protein C
DB11598,The risk or severity of bleeding can be increased when Antithrombin III human is combined with Interferon alfa-n1.,Antithrombin III human
DB11984,The risk or severity of bleeding can be increased when Letaxaban is combined with Interferon alfa-n1.,Letaxaban
DB12289,The risk or severity of bleeding can be increased when Darexaban is combined with Interferon alfa-n1.,Darexaban
DB12364,The risk or severity of bleeding can be increased when Betrixaban is combined with Interferon alfa-n1.,Betrixaban
DB12598,The risk or severity of bleeding can be increased when Nafamostat is combined with Interferon alfa-n1.,Nafamostat
DB12726,The risk or severity of bleeding can be increased when Monteplase is combined with Interferon alfa-n1.,Monteplase
DB12831,The risk or severity of bleeding can be increased when Gabexate is combined with Interferon alfa-n1.,Gabexate
DB13136,The risk or severity of bleeding can be increased when Fluindione is combined with Interferon alfa-n1.,Fluindione
DB13149,The risk or severity of bleeding can be increased when Protein S human is combined with Interferon alfa-n1.,Protein S human
DB13199,The risk or severity of bleeding can be increased when Brinase is combined with Interferon alfa-n1.,Brinase
DB13275,The risk or severity of bleeding can be increased when Clorindione is combined with Interferon alfa-n1.,Clorindione
DB13347,The risk or severity of bleeding can be increased when Diphenadione is combined with Interferon alfa-n1.,Diphenadione
DB13451,The risk or severity of bleeding can be increased when Tioclomarol is combined with Interferon alfa-n1.,Tioclomarol
DB13616,The risk or severity of bleeding can be increased when Melagatran is combined with Interferon alfa-n1.,Melagatran
DB13646,The risk or severity of bleeding can be increased when Saruplase is combined with Interferon alfa-n1.,Saruplase
DB14055,The risk or severity of bleeding can be increased when (S)-Warfarin is combined with Interferon alfa-n1.,(S)-Warfarin
DB14094,The risk or severity of bleeding can be increased when Tocopherylquinone is combined with Interferon alfa-n1.,Tocopherylquinone
DB14598,The risk or severity of bleeding can be increased when Edetate calcium disodium anhydrous is combined with Interferon alfa-n1.,Edetate calcium disodium anhydrous
DB14726,The risk or severity of bleeding can be increased when Dabigatran is combined with Interferon alfa-n1.,Dabigatran
DB00232,The risk or severity of neutropenia and thrombocytopenia can be increased when Methyclothiazide is combined with Interferon alfa-n1.,Methyclothiazide
DB00436,The risk or severity of neutropenia and thrombocytopenia can be increased when Bendroflumethiazide is combined with Interferon alfa-n1.,Bendroflumethiazide
DB00562,The risk or severity of neutropenia and thrombocytopenia can be increased when Benzthiazide is combined with Interferon alfa-n1.,Benzthiazide
DB00606,The risk or severity of neutropenia and thrombocytopenia can be increased when Cyclothiazide is combined with Interferon alfa-n1.,Cyclothiazide
DB00774,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydroflumethiazide is combined with Interferon alfa-n1.,Hydroflumethiazide
DB00880,The risk or severity of neutropenia and thrombocytopenia can be increased when Chlorothiazide is combined with Interferon alfa-n1.,Chlorothiazide
DB00999,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydrochlorothiazide is combined with Interferon alfa-n1.,Hydrochlorothiazide
DB01021,The risk or severity of neutropenia and thrombocytopenia can be increased when Trichlormethiazide is combined with Interferon alfa-n1.,Trichlormethiazide
DB01324,The risk or severity of neutropenia and thrombocytopenia can be increased when Polythiazide is combined with Interferon alfa-n1.,Polythiazide
DB13430,The risk or severity of neutropenia and thrombocytopenia can be increased when Mebutizide is combined with Interferon alfa-n1.,Mebutizide
DB13532,The risk or severity of neutropenia and thrombocytopenia can be increased when Cyclopenthiazide is combined with Interferon alfa-n1.,Cyclopenthiazide
DB09042,The risk or severity of myelosuppression can be increased when Interferon alfa-n1 is combined with Tedizolid phosphate.,Tedizolid phosphate
DB00091,Interferon alfa-n1 may increase the immunosuppressive activities of Cyclosporine.,Cyclosporine
DB00268,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Ropinirole.,Ropinirole
DB00115,The therapeutic efficacy of Cyanocobalamin can be decreased when used in combination with Interferon alfa-n1.,Cyanocobalamin
DB00437,The risk or severity of adverse effects can be increased when Allopurinol is combined with Interferon alfa-n1.,Allopurinol
DB14513,The serum concentration of Magnesium can be decreased when it is combined with Interferon alfa-n1.,Magnesium
DB01601,The serum concentration of Interferon alfa-n1 can be increased when it is combined with Lopinavir.,Lopinavir
DB12530,The risk or severity of infection can be increased when Interferon alfa-n1 is combined with Inebilizumab.,Inebilizumab
DB00480,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Lenalidomide.,Lenalidomide
DB01041,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Thalidomide.,Thalidomide
DB08910,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Pomalidomide.,Pomalidomide
DB00002,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Cetuximab.,Cetuximab
DB00004,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Denileukin diftitox.,Denileukin diftitox
DB00007,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Leuprolide.,Leuprolide
DB00008,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Peginterferon alfa-2a.,Peginterferon alfa-2a
DB00014,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Goserelin.,Goserelin
DB00023,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Asparaginase Escherichia coli.,Asparaginase Escherichia coli
DB00041,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Aldesleukin.,Aldesleukin
DB00056,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Gemtuzumab ozogamicin.,Gemtuzumab ozogamicin
DB00059,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Pegaspargase.,Pegaspargase
DB00072,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Trastuzumab.,Trastuzumab
DB00073,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Rituximab.,Rituximab
DB00081,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Tositumomab.,Tositumomab
DB00087,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Alemtuzumab.,Alemtuzumab
DB00104,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Octreotide.,Octreotide
DB00105,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Interferon alfa-2b.,Interferon alfa-2b
DB00112,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Bevacizumab.,Bevacizumab
DB00179,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Masoprocol.,Masoprocol
DB00188,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Bortezomib.,Bortezomib
DB00236,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Pipobroman.,Pipobroman
DB00242,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Cladribine.,Cladribine
DB00248,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Cabergoline.,Cabergoline
DB00261,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Anagrelide.,Anagrelide
DB00262,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Carmustine.,Carmustine
DB00269,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Chlorotrianisene.,Chlorotrianisene
DB00276,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Amsacrine.,Amsacrine
DB00282,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Pamidronic acid.,Pamidronic acid
DB00290,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Bleomycin.,Bleomycin
DB00291,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Chlorambucil.,Chlorambucil
DB00293,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Raltitrexed.,Raltitrexed
DB00305,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Mitomycin.,Mitomycin
DB00307,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Bexarotene.,Bexarotene
DB00313,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Valproic acid.,Valproic acid
DB00317,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Gefitinib.,Gefitinib
DB00322,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Floxuridine.,Floxuridine
DB00351,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Megestrol acetate.,Megestrol acetate
DB00352,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Tioguanine.,Tioguanine
DB00357,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Aminoglutethimide.,Aminoglutethimide
DB00385,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Valrubicin.,Valrubicin
DB00398,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Sorafenib.,Sorafenib
DB00428,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Streptozocin.,Streptozocin
DB00432,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Trifluridine.,Trifluridine
DB00441,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Gemcitabine.,Gemcitabine
DB00444,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Teniposide.,Teniposide
DB00445,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Epirubicin.,Epirubicin
DB00488,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Altretamine.,Altretamine
DB00499,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Flutamide.,Flutamide
DB00515,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Cisplatin.,Cisplatin
DB00523,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Alitretinoin.,Alitretinoin
DB00526,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Oxaliplatin.,Oxaliplatin
DB00530,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Erlotinib.,Erlotinib
DB00539,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Toremifene.,Toremifene
DB00544,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Fluorouracil.,Fluorouracil
DB00552,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Pentostatin.,Pentostatin
DB00563,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Methotrexate.,Methotrexate
DB00603,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Medroxyprogesterone acetate.,Medroxyprogesterone acetate
DB00619,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Imatinib.,Imatinib
DB00631,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Clofarabine.,Clofarabine
DB00635,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Prednisone.,Prednisone
DB00642,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Pemetrexed.,Pemetrexed
DB00648,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Mitotane.,Mitotane
DB00665,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Nilutamide.,Nilutamide
DB00675,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Tamoxifen.,Tamoxifen
DB00694,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Daunorubicin.,Daunorubicin
DB00707,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Porfimer sodium.,Porfimer sodium
DB00755,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Tretinoin.,Tretinoin
DB00762,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Irinotecan.,Irinotecan
DB00773,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Etoposide.,Etoposide
DB00791,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Uracil mustard.,Uracil mustard
DB00851,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Dacarbazine.,Dacarbazine
DB00853,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Temozolomide.,Temozolomide
DB00855,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Aminolevulinic acid.,Aminolevulinic acid
DB00860,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Prednisolone.,Prednisolone
DB00888,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Mechlorethamine.,Mechlorethamine
DB00894,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Testolactone.,Testolactone
DB00928,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Azacitidine.,Azacitidine
DB00947,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Fulvestrant.,Fulvestrant
DB00958,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Carboplatin.,Carboplatin
DB00959,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Methylprednisolone.,Methylprednisolone
DB00970,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Dactinomycin.,Dactinomycin
DB00987,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Cytarabine.,Cytarabine
DB00990,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Exemestane.,Exemestane
DB00997,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Doxorubicin.,Doxorubicin
DB01005,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Hydroxyurea.,Hydroxyurea
DB01006,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Letrozole.,Letrozole
DB01008,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Busulfan.,Busulfan
DB01030,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Topotecan.,Topotecan
DB01033,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Mercaptopurine.,Mercaptopurine
DB01042,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Melphalan.,Melphalan
DB01073,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Fludarabine.,Fludarabine
DB01101,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Capecitabine.,Capecitabine
DB01108,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Trilostane.,Trilostane
DB01128,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Bicalutamide.,Bicalutamide
DB01157,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Trimetrexate.,Trimetrexate
DB01168,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Procarbazine.,Procarbazine
DB01169,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Arsenic trioxide.,Arsenic trioxide
DB01177,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Idarubicin.,Idarubicin
DB01181,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Ifosfamide.,Ifosfamide
DB01196,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Estramustine.,Estramustine
DB01204,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Mitoxantrone.,Mitoxantrone
DB01206,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Lomustine.,Lomustine
DB01217,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Anastrozole.,Anastrozole
DB01229,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Paclitaxel.,Paclitaxel
DB01234,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Dexamethasone.,Dexamethasone
DB01248,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Docetaxel.,Docetaxel
DB01254,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Dasatinib.,Dasatinib
DB01259,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Lapatinib.,Lapatinib
DB01262,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Decitabine.,Decitabine
DB01268,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Sunitinib.,Sunitinib
DB01269,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Panitumumab.,Panitumumab
DB01280,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Nelarabine.,Nelarabine
DB01590,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Everolimus.,Everolimus
DB01645,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Genistein.,Genistein
DB01667,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with 8-azaguanine.,8-azaguanine
DB01873,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Epothilone D.,Epothilone D
DB01933,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with 7-Hydroxystaurosporine.,7-Hydroxystaurosporine
DB02109,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Hadacidin.,Hadacidin
DB02342,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with 2-Methoxyestradiol.,2-Methoxyestradiol
DB02424,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Geldanamycin.,Geldanamycin
DB02546,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Vorinostat.,Vorinostat
DB02640,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Fumagillin.,Fumagillin
DB03010,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Patupilone.,Patupilone
DB03172,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Tubercidin.,Tubercidin
DB03459,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Sparfosic acid.,Sparfosic acid
DB03496,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Alvocidib.,Alvocidib
DB03509,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with 2-(4-Chlorophenyl)-5-Quinoxalinecarboxamide.,2-(4-Chlorophenyl)-5-Quinoxalinecarboxamide
DB03523,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Brequinar.,Brequinar
DB03695,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Piritrexim.,Piritrexim
DB03825,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Rhodamine 6G.,Rhodamine 6G
DB03880,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Batimastat.,Batimastat
DB03946,"The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with 3,4-Dihydroxybenzoic Acid.","3,4-Dihydroxybenzoic Acid"
DB04106,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Fotemustine.,Fotemustine
DB04222,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Sparsomycin.,Sparsomycin
DB04253,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Tretazicar.,Tretazicar
DB04258,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Seocalcitol.,Seocalcitol
DB04331,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Monastrol.,Monastrol
DB04440,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Nebularine.,Nebularine
DB04468,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Afimoxifene.,Afimoxifene
DB04572,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Thiotepa.,Thiotepa
DB04576,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Fleroxacin.,Fleroxacin
DB04655,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Metoprine.,Metoprine
DB04690,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Camptothecin.,Camptothecin
DB04786,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Suramin.,Suramin
DB04827,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Urethane.,Urethane
DB04839,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Cyproterone acetate.,Cyproterone acetate
DB04845,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Ixabepilone.,Ixabepilone
DB04849,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Cediranib.,Cediranib
DB04858,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Tirapazamine.,Tirapazamine
DB04865,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Omacetaxine mepesuccinate.,Omacetaxine mepesuccinate
DB04866,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Halofuginone.,Halofuginone
DB04868,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Nilotinib.,Nilotinib
DB04894,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Vapreotide.,Vapreotide
DB04900,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Thymalfasin.,Thymalfasin
DB04901,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Galiximab.,Galiximab
DB04907,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Sitimagene ceradenovec.,Sitimagene ceradenovec
DB04950,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Ranpirnase.,Ranpirnase
DB04951,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Pirfenidone.,Pirfenidone
DB04958,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Epratuzumab.,Epratuzumab
DB04960,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Tipifarnib.,Tipifarnib
DB04961,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Troxacitabine.,Troxacitabine
DB04964,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Oregovomab.,Oregovomab
DB04975,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Banoxantrone.,Banoxantrone
DB04977,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Plitidepsin.,Plitidepsin
DB04996,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Satraplatin.,Satraplatin
DB05015,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Belinostat.,Belinostat
DB05022,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Amonafide.,Amonafide
DB05076,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Fenretinide.,Fenretinide
DB05088,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Tetrathiomolybdate.,Tetrathiomolybdate
DB05097,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Labetuzumab.,Labetuzumab
DB05109,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Trabectedin.,Trabectedin
DB05129,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Elsamitrucin.,Elsamitrucin
DB05136,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Bavituximab.,Bavituximab
DB05223,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Pracinostat.,Pracinostat
DB05239,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Cobimetinib.,Cobimetinib
DB05260,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Gallium nitrate.,Gallium nitrate
DB05265,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Ecabet.,Ecabet
DB05294,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Vandetanib.,Vandetanib
DB05374,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Rindopepimut.,Rindopepimut
DB05424,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Canertinib.,Canertinib
DB05428,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Motexafin gadolinium.,Motexafin gadolinium
DB05482,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with 7-ethyl-10-hydroxycamptothecin.,7-ethyl-10-hydroxycamptothecin
DB05524,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Pelitinib.,Pelitinib
DB05540,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Alanosine.,Alanosine
DB05578,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Ramucirumab.,Ramucirumab
DB05595,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Farletuzumab.,Farletuzumab
DB05656,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Veltuzumab.,Veltuzumab
DB05668,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Palifosfamide.,Palifosfamide
DB05697,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with AP 12009.,AP 12009
DB05773,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Trastuzumab emtansine.,Trastuzumab emtansine
DB05779,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Oglufanide.,Oglufanide
DB05786,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Irofulven.,Irofulven
DB05812,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Abiraterone.,Abiraterone
DB05889,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Inotuzumab ozogamicin.,Inotuzumab ozogamicin
DB05903,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with KOS-1584.,KOS-1584
DB05916,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with CT-011.,CT-011
DB05974,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Transcrocetinate.,Transcrocetinate
DB05996,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Glembatumumab vedotin.,Glembatumumab vedotin
DB06013,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Aldoxorubicin.,Aldoxorubicin
DB06021,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with AV-412.,AV-412
DB06040,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Filanesib.,Filanesib
DB06043,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Olaratumab.,Olaratumab
DB06159,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Rubitecan.,Rubitecan
DB06160,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Garenoxacin.,Garenoxacin
DB06163,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Plevitrexed.,Plevitrexed
DB06171,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Paclitaxel trevatide.,Paclitaxel trevatide
DB06176,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Romidepsin.,Romidepsin
DB06181,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with IMO-2055.,IMO-2055
DB06186,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Ipilimumab.,Ipilimumab
DB06192,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Nimotuzumab.,Nimotuzumab
DB06193,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Pixantrone.,Pixantrone
DB06195,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Seliciclib.,Seliciclib
DB06199,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Atrasentan.,Atrasentan
DB06233,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Ridaforolimus.,Ridaforolimus
DB06235,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Vadimezan.,Vadimezan
DB06246,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Exisulind.,Exisulind
DB06263,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Amrubicin.,Amrubicin
DB06266,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Lonidamine.,Lonidamine
DB06272,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Maxacalcitol.,Maxacalcitol
DB06287,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Temsirolimus.,Temsirolimus
DB06317,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Elotuzumab.,Elotuzumab
DB06334,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Tucidinostat.,Tucidinostat
DB06365,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Sapacitabine.,Sapacitabine
DB06366,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Pertuzumab.,Pertuzumab
DB06370,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Indisulam.,Indisulam
DB06420,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Annamycin.,Annamycin
DB06423,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Endostatin.,Endostatin
DB06433,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Tezacitabine.,Tezacitabine
DB06436,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Semaxanib.,Semaxanib
DB06445,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Diethylnorspermine.,Diethylnorspermine
DB06461,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Squalamine.,Squalamine
DB06478,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Porfiromycin.,Porfiromycin
DB06517,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with MLN576.,MLN576
DB06589,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Pazopanib.,Pazopanib
DB06595,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Midostaurin.,Midostaurin
DB06603,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Panobinostat.,Panobinostat
DB06607,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Catumaxomab.,Catumaxomab
DB06616,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Bosutinib.,Bosutinib
DB06626,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Axitinib.,Axitinib
DB06647,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Volociximab.,Volociximab
DB06650,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Ofatumumab.,Ofatumumab
DB06699,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Degarelix.,Degarelix
DB06710,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Methyltestosterone.,Methyltestosterone
DB06719,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Buserelin.,Buserelin
DB06748,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Ginsenoside C.,Ginsenoside C
DB06769,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Bendamustine.,Bendamustine
DB06772,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Cabazitaxel.,Cabazitaxel
DB06789,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Hydroxyprogesterone caproate.,Hydroxyprogesterone caproate
DB06791,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Lanreotide.,Lanreotide
DB06810,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Plicamycin.,Plicamycin
DB06813,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Pralatrexate.,Pralatrexate
DB06825,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Triptorelin.,Triptorelin
DB07232,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Veliparib.,Veliparib
DB07931,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Hexestrol.,Hexestrol
DB08313,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Nocodazole.,Nocodazole
DB08437,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Puromycin.,Puromycin
DB08486,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Efaproxiral.,Efaproxiral
DB08633,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with TNP-470.,TNP-470
DB08828,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Vismodegib.,Vismodegib
DB08865,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Crizotinib.,Crizotinib
DB08870,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Brentuximab vedotin.,Brentuximab vedotin
DB08871,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Eribulin.,Eribulin
DB08875,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Cabozantinib.,Cabozantinib
DB08877,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Ruxolitinib.,Ruxolitinib
DB08881,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Vemurafenib.,Vemurafenib
DB08886,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Asparaginase Erwinia chrysanthemi.,Asparaginase Erwinia chrysanthemi
DB08889,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Carfilzomib.,Carfilzomib
DB08896,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Regorafenib.,Regorafenib
DB08899,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Enzalutamide.,Enzalutamide
DB08901,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Ponatinib.,Ponatinib
DB08905,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Formestane.,Formestane
DB08911,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Trametinib.,Trametinib
DB08912,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Dabrafenib.,Dabrafenib
DB08913,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Radium Ra 223 dichloride.,Radium Ra 223 dichloride
DB08916,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Afatinib.,Afatinib
DB08935,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Obinutuzumab.,Obinutuzumab
DB08972,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Flumequine.,Flumequine
DB09010,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Carmofur.,Carmofur
DB09031,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Miltefosine.,Miltefosine
DB09035,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Nivolumab.,Nivolumab
DB09036,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Siltuximab.,Siltuximab
DB09037,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Pembrolizumab.,Pembrolizumab
DB09052,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Blinatumomab.,Blinatumomab
DB09053,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Ibrutinib.,Ibrutinib
DB09054,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Idelalisib.,Idelalisib
DB09063,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Ceritinib.,Ceritinib
DB09073,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Palbociclib.,Palbociclib
DB09074,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Olaparib.,Olaparib
DB09077,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Dinutuximab.,Dinutuximab
DB09078,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Lenvatinib.,Lenvatinib
DB09079,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Nintedanib.,Nintedanib
DB09123,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Dienogest.,Dienogest
DB09143,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Sonidegib.,Sonidegib
DB09239,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Niguldipine.,Niguldipine
DB09256,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Tegafur.,Tegafur
DB09274,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Artesunate.,Artesunate
DB09298,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Silibinin.,Silibinin
DB09330,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Osimertinib.,Osimertinib
DB09331,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Daratumumab.,Daratumumab
DB09559,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Necitumumab.,Necitumumab
DB09570,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Ixazomib.,Ixazomib
DB11363,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Alectinib.,Alectinib
DB11366,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Roquinimex.,Roquinimex
DB11526,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Masitinib.,Masitinib
DB11581,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Venetoclax.,Venetoclax
DB11595,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Atezolizumab.,Atezolizumab
DB11616,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Pirarubicin.,Pirarubicin
DB11617,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Aclarubicin.,Aclarubicin
DB11618,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Zorubicin.,Zorubicin
DB11630,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Temoporfin.,Temoporfin
DB11646,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Conatumumab.,Conatumumab
DB11651,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Dactolisib.,Dactolisib
DB11662,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Rabusertib.,Rabusertib
DB11669,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Ortataxel.,Ortataxel
DB11678,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Treosulfan.,Treosulfan
DB11688,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with 2-chloroethyl-3-sarcosinamide-1-nitrosourea.,2-chloroethyl-3-sarcosinamide-1-nitrosourea
DB11694,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Ilorasertib.,Ilorasertib
DB11714,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Durvalumab.,Durvalumab
DB11716,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Misonidazole.,Misonidazole
DB11717,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Epacadostat.,Epacadostat
DB11718,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Encorafenib.,Encorafenib
DB11727,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Endostar.,Endostar
DB11730,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Ribociclib.,Ribociclib
DB11737,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Icotinib.,Icotinib
DB11752,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Bryostatin 1.,Bryostatin 1
DB11760,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Talazoparib.,Talazoparib
DB11771,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Tremelimumab.,Tremelimumab
DB11793,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Niraparib.,Niraparib
DB11795,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with GSK-2636771.,GSK-2636771
DB11800,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Tivozanib.,Tivozanib
DB11805,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Saracatinib.,Saracatinib
DB11812,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Talaporfin.,Talaporfin
DB11828,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Neratinib.,Neratinib
DB11830,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Mocetinostat.,Mocetinostat
DB11832,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Crenolanib.,Crenolanib
DB11841,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Entinostat.,Entinostat
DB11880,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Acridine Carboxamide.,Acridine Carboxamide
DB11886,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Infigratinib.,Infigratinib
DB11891,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with CUDC-907.,CUDC-907
DB11894,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Efatutazone.,Efatutazone
DB11901,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Apalutamide.,Apalutamide
DB11907,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Rociletinib.,Rociletinib
DB11918,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Guadecitabine.,Guadecitabine
DB11919,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with 6-O-benzylguanine.,6-O-benzylguanine
DB11945,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Avelumab.,Avelumab
DB11960,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Carboxyamidotriazole.,Carboxyamidotriazole
DB11963,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Dacomitinib.,Dacomitinib
DB11967,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Binimetinib.,Binimetinib
DB11972,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Rilotumumab.,Rilotumumab
DB11973,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Tesevatinib.,Tesevatinib
DB11978,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Glasdegib.,Glasdegib
DB11986,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Entrectinib.,Entrectinib
DB11999,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Vosaroxin.,Vosaroxin
DB12001,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Abemaciclib.,Abemaciclib
DB12015,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Alpelisib.,Alpelisib
DB12025,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Triptolide.,Triptolide
DB12028,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Broxuridine.,Broxuridine
DB12036,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Naquotinib.,Naquotinib
DB12056,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Trebananib.,Trebananib
DB12081,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Anecortave.,Anecortave
DB12082,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Vesnarinone.,Vesnarinone
DB12083,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Mafosfamide.,Mafosfamide
DB12085,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with LCL-161.,LCL-161
DB12089,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Lorvotuzumab mertansine.,Lorvotuzumab mertansine
DB12108,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Taselisib.,Taselisib
DB12124,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Namitecan.,Namitecan
DB12130,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Lorlatinib.,Lorlatinib
DB12141,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Gilteritinib.,Gilteritinib
DB12142,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Duligotuzumab.,Duligotuzumab
DB12146,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Rigosertib.,Rigosertib
DB12147,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Erdafitinib.,Erdafitinib
DB12156,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Cordycepin.,Cordycepin
DB12174,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with CUDC-101.,CUDC-101
DB12182,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Binetrakin.,Binetrakin
DB12185,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Exatecan.,Exatecan
DB12202,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Zalutumumab.,Zalutumumab
DB12222,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Lurtotecan.,Lurtotecan
DB12232,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with KRN-7000.,KRN-7000
DB12257,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Platinum.,Platinum
DB12259,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with CG-200745.,CG-200745
DB12266,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Epofolate.,Epofolate
DB12267,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Brigatinib.,Brigatinib
DB12279,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with OBP-801.,OBP-801
DB12332,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Rucaparib.,Rucaparib
DB12340,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Navitoclax.,Navitoclax
DB12352,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Bizelesin.,Bizelesin
DB12376,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Ricolinostat.,Ricolinostat
DB12379,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Indirubin.,Indirubin
DB12381,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Merestinib.,Merestinib
DB12382,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with R-306465.,R-306465
DB12385,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with 10-hydroxycamptothecin.,10-hydroxycamptothecin
DB12391,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Sagopilone.,Sagopilone
DB12422,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Sulforaphane.,Sulforaphane
DB12459,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Belotecan.,Belotecan
DB12473,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Taurolidine.,Taurolidine
DB12480,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Betulinic Acid.,Betulinic Acid
DB12483,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Copanlisib.,Copanlisib
DB12498,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Mogamulizumab.,Mogamulizumab
DB12515,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with 9-aminocamptothecin.,9-aminocamptothecin
DB12525,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Molgramostim.,Molgramostim
DB12539,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Oltipraz.,Oltipraz
DB12549,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Pyrazoloacridine.,Pyrazoloacridine
DB12565,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Abexinostat.,Abexinostat
DB12577,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Fosbretabulin.,Fosbretabulin
DB12589,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Dacetuzumab.,Dacetuzumab
DB12593,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Apaziquone.,Apaziquone
DB12596,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Combretastatin.,Combretastatin
DB12617,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Mizoribine.,Mizoribine
DB12637,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Onapristone.,Onapristone
DB12638,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with PU-H71.,PU-H71
DB12645,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Givinostat.,Givinostat
DB12671,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Beloranib.,Beloranib
DB12677,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Soblidotin.,Soblidotin
DB12681,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Salirasib.,Salirasib
DB12688,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Moxetumomab Pasudotox.,Moxetumomab Pasudotox
DB12692,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Gusperimus.,Gusperimus
DB12695,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Phenethyl Isothiocyanate.,Phenethyl Isothiocyanate
DB12697,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Methylselenocysteine.,Methylselenocysteine
DB12701,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Intetumumab.,Intetumumab
DB12730,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Dolastatin 10.,Dolastatin 10
DB12736,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Etanidazole.,Etanidazole
DB12769,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Lometrexol.,Lometrexol
DB12797,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Ecromeximab.,Ecromeximab
DB12832,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Prednimustine.,Prednimustine
DB12870,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Buthionine Sulfoximine.,Buthionine Sulfoximine
DB12873,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Dianhydrogalactitol.,Dianhydrogalactitol
DB12881,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Indole-3-carbinol.,Indole-3-carbinol
DB12901,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Fiacitabine.,Fiacitabine
DB12902,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Trofosfamide.,Trofosfamide
DB12912,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Nolatrexed.,Nolatrexed
DB12916,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Mitolactol.,Mitolactol
DB12920,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Pinometostat.,Pinometostat
DB12947,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Doxifluridine.,Doxifluridine
DB12948,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Didox.,Didox
DB12967,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Mitoguazone.,Mitoguazone
DB12978,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Pexidartinib.,Pexidartinib
DB12987,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Penclomedine.,Penclomedine
DB12991,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Deoxyspergualin.,Deoxyspergualin
DB12996,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Acteoside.,Acteoside
DB13005,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Rebastinib.,Rebastinib
DB13014,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Hypericin.,Hypericin
DB13046,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Tocladesine.,Tocladesine
DB13066,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Liarozole.,Liarozole
DB13069,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Nimustine.,Nimustine
DB13104,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with X-396.,X-396
DB13128,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Sizofiran.,Sizofiran
DB13145,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Nedaplatin.,Nedaplatin
DB13164,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Olmutinib.,Olmutinib
DB13182,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Daidzein.,Daidzein
DB13243,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Tiazofurine.,Tiazofurine
DB13304,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Triaziquone.,Triaziquone
DB13318,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Demecolcine.,Demecolcine
DB13334,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Mannosulfan.,Mannosulfan
DB13339,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Etoglucid.,Etoglucid
DB13375,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Edrecolomab.,Edrecolomab
DB13480,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Lentinan.,Lentinan
DB13543,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Mitobronitol.,Mitobronitol
DB13627,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Oxolinic acid.,Oxolinic acid
DB13647,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Semustine.,Semustine
DB13677,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Carboquone.,Carboquone
DB13767,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Vorozole.,Vorozole
DB13809,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Paclitaxel poliglumex.,Paclitaxel poliglumex
DB13811,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Oblimersen.,Oblimersen
DB13832,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Ranimustine.,Ranimustine
DB13874,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Enasidenib.,Enasidenib
DB13877,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Iniparib.,Iniparib
DB13896,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Talimogene laherparepvec.,Talimogene laherparepvec
DB13912,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Coumermycin A1.,Coumermycin A1
DB13916,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Toyocamycin.,Toyocamycin
DB14031,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Tretamine.,Tretamine
DB14066,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Tetrandrine.,Tetrandrine
DB14067,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Dofequidar.,Dofequidar
DB14068,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Dexniguldipine.,Dexniguldipine
DB14568,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Ivosidenib.,Ivosidenib
DB14644,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Methylprednisolone hemisuccinate.,Methylprednisolone hemisuccinate
DB14646,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Prednisone acetate.,Prednisone acetate
DB14680,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Combretastatin A4.,Combretastatin A4
DB14707,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Cemiplimab.,Cemiplimab
DB14723,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Larotrectinib.,Larotrectinib
DB14731,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Tagraxofusp.,Tagraxofusp
DB14765,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Rivoceranib.,Rivoceranib
DB14792,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with AZD-5991.,AZD-5991
DB14844,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with ONC-201.,ONC-201
DB14860,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Ensartinib.,Ensartinib
DB14865,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Human interleukin-2.,Human interleukin-2
DB14877,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Lintuzumab.,Lintuzumab
DB14947,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Bermekimab.,Bermekimab
DB14951,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Etirinotecan pegol.,Etirinotecan pegol
DB15035,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Zanubrutinib.,Zanubrutinib
DB15057,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with NUC-1031.,NUC-1031
DB15157,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Voruciclib.,Voruciclib
DB15215,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with KRN-5500.,KRN-5500
DB15289,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Perillyl alcohol.,Perillyl alcohol
DB15321,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Tefinostat.,Tefinostat
DB15334,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Biochanin A.,Biochanin A
DB15351,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Dihematoporphyrin ether.,Dihematoporphyrin ether
DB15366,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with SOR-C13.,SOR-C13
DB15383,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Pidilizumab.,Pidilizumab
DB15419,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Nanatinostat.,Nanatinostat
DB15466,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Tallimustine.,Tallimustine
DB12062,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Volasertib.,Volasertib
DB14811,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Isatuximab.,Isatuximab
DB15102,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Pemigatinib.,Pemigatinib
DB11791,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Capmatinib.,Capmatinib
DB15685,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Selpercatinib.,Selpercatinib
DB00531,The risk or severity of pulmonary toxicity can be increased when Darbepoetin alfa is combined with Cyclophosphamide.,Cyclophosphamide
DB00984,The therapeutic efficacy of Darbepoetin alfa can be increased when used in combination with Nandrolone phenpropionate.,Nandrolone phenpropionate
DB08804,The therapeutic efficacy of Darbepoetin alfa can be increased when used in combination with Nandrolone decanoate.,Nandrolone decanoate
DB13169,The therapeutic efficacy of Darbepoetin alfa can be increased when used in combination with Nandrolone.,Nandrolone
DB00309,The risk or severity of peripheral neuropathy can be increased when Darbepoetin alfa is combined with Vindesine.,Vindesine
DB00361,The risk or severity of peripheral neuropathy can be increased when Darbepoetin alfa is combined with Vinorelbine.,Vinorelbine
DB00541,The risk or severity of peripheral neuropathy can be increased when Darbepoetin alfa is combined with Vincristine.,Vincristine
DB00570,The risk or severity of peripheral neuropathy can be increased when Darbepoetin alfa is combined with Vinblastine.,Vinblastine
DB05168,The risk or severity of peripheral neuropathy can be increased when Darbepoetin alfa is combined with Vintafolide.,Vintafolide
DB11641,The risk or severity of peripheral neuropathy can be increased when Darbepoetin alfa is combined with Vinflunine.,Vinflunine
DB13374,The risk or severity of peripheral neuropathy can be increased when Darbepoetin alfa is combined with Vincamine.,Vincamine
DB06605,Apixaban may increase the anticoagulant activities of Urokinase.,Apixaban
DB06695,Dabigatran etexilate may increase the anticoagulant activities of Urokinase.,Dabigatran etexilate
DB01254,The risk or severity of bleeding and hemorrhage can be increased when Dasatinib is combined with Urokinase.,Dasatinib
DB01609,The risk or severity of gastrointestinal bleeding can be increased when Urokinase is combined with Deferasirox.,Deferasirox
DB01586,The risk or severity of bleeding and bruising can be increased when Urokinase is combined with Ursodeoxycholic acid.,Ursodeoxycholic acid
DB02123,The risk or severity of bleeding and bruising can be increased when Urokinase is combined with Glycochenodeoxycholic Acid.,Glycochenodeoxycholic Acid
DB02659,The risk or severity of bleeding and bruising can be increased when Urokinase is combined with Cholic Acid.,Cholic Acid
DB02691,The risk or severity of bleeding and bruising can be increased when Urokinase is combined with Glycocholic acid.,Glycocholic acid
DB03619,The risk or severity of bleeding and bruising can be increased when Urokinase is combined with Deoxycholic acid.,Deoxycholic acid
DB04348,The risk or severity of bleeding and bruising can be increased when Urokinase is combined with Taurocholic acid.,Taurocholic acid
DB05990,The risk or severity of bleeding and bruising can be increased when Urokinase is combined with Obeticholic acid.,Obeticholic acid
DB06777,The risk or severity of bleeding and bruising can be increased when Urokinase is combined with Chenodeoxycholic acid.,Chenodeoxycholic acid
DB08833,The risk or severity of bleeding and bruising can be increased when Urokinase is combined with Taurochenodeoxycholic acid.,Taurochenodeoxycholic acid
DB08834,The risk or severity of bleeding and bruising can be increased when Urokinase is combined with Tauroursodeoxycholic acid.,Tauroursodeoxycholic acid
DB08857,The risk or severity of bleeding and bruising can be increased when Urokinase is combined with Bamet-UD2.,Bamet-UD2
DB11622,The risk or severity of bleeding and bruising can be increased when Urokinase is combined with Dehydrocholic acid.,Dehydrocholic acid
DB11789,The risk or severity of bleeding and bruising can be increased when Urokinase is combined with Hyodeoxycholic Acid.,Hyodeoxycholic Acid
DB09075,The risk or severity of bleeding can be increased when Edoxaban is combined with Urokinase.,Edoxaban
DB09053,The risk or severity of bleeding and hemorrhage can be increased when Ibrutinib is combined with Urokinase.,Ibrutinib
DB08935,The risk or severity of bleeding and hemorrhage can be increased when Urokinase is combined with Obinutuzumab.,Obinutuzumab
DB06228,Urokinase may increase the anticoagulant activities of Rivaroxaban.,Rivaroxaban
DB06206,The risk or severity of bleeding and hemorrhage can be increased when Urokinase is combined with Sugammadex.,Sugammadex
DB09070,Tibolone may increase the anticoagulant activities of Urokinase.,Tibolone
DB00932,The risk or severity of bleeding and hemorrhage can be increased when Tipranavir is combined with Urokinase.,Tipranavir
DB00001,Urokinase may increase the anticoagulant activities of Lepirudin.,Lepirudin
DB00006,Urokinase may increase the anticoagulant activities of Bivalirudin.,Bivalirudin
DB00009,Urokinase may increase the anticoagulant activities of Alteplase.,Alteplase
DB00015,Urokinase may increase the anticoagulant activities of Reteplase.,Reteplase
DB00029,Urokinase may increase the anticoagulant activities of Anistreplase.,Anistreplase
DB00031,Urokinase may increase the anticoagulant activities of Tenecteplase.,Tenecteplase
DB00054,Urokinase may increase the anticoagulant activities of Abciximab.,Abciximab
DB00055,Urokinase may increase the anticoagulant activities of Drotrecogin alfa.,Drotrecogin alfa
DB00086,Urokinase may increase the anticoagulant activities of Streptokinase.,Streptokinase
DB00266,Urokinase may increase the anticoagulant activities of Dicoumarol.,Dicoumarol
DB00278,Urokinase may increase the anticoagulant activities of Argatroban.,Argatroban
DB00407,Urokinase may increase the anticoagulant activities of Ardeparin.,Ardeparin
DB00498,Urokinase may increase the anticoagulant activities of Phenindione.,Phenindione
DB00569,Urokinase may increase the anticoagulant activities of Fondaparinux.,Fondaparinux
DB00682,Urokinase may increase the anticoagulant activities of Warfarin.,Warfarin
DB00686,Urokinase may increase the anticoagulant activities of Pentosan polysulfate.,Pentosan polysulfate
DB00945,Urokinase may increase the anticoagulant activities of Acetylsalicylic acid.,Acetylsalicylic acid
DB00946,Urokinase may increase the anticoagulant activities of Phenprocoumon.,Phenprocoumon
DB00975,Urokinase may increase the anticoagulant activities of Dipyridamole.,Dipyridamole
DB01088,Urokinase may increase the anticoagulant activities of Iloprost.,Iloprost
DB01109,Urokinase may increase the anticoagulant activities of Heparin.,Heparin
DB01225,Urokinase may increase the anticoagulant activities of Enoxaparin.,Enoxaparin
DB01240,Urokinase may increase the anticoagulant activities of Epoprostenol.,Epoprostenol
DB01418,Urokinase may increase the anticoagulant activities of Acenocoumarol.,Acenocoumarol
DB03410,Urokinase may increase the anticoagulant activities of 4-hydroxycoumarin.,4-hydroxycoumarin
DB04665,Urokinase may increase the anticoagulant activities of Coumarin.,Coumarin
DB04898,Urokinase may increase the anticoagulant activities of Ximelagatran.,Ximelagatran
DB04925,Urokinase may increase the anticoagulant activities of Desmoteplase.,Desmoteplase
DB04932,Urokinase may increase the anticoagulant activities of Defibrotide.,Defibrotide
DB05099,Urokinase may increase the anticoagulant activities of Ancrod.,Ancrod
DB05229,Urokinase may increase the anticoagulant activities of Beraprost.,Beraprost
DB05254,Urokinase may increase the anticoagulant activities of Fibrinolysin.,Fibrinolysin
DB06209,Urokinase may increase the anticoagulant activities of Prasugrel.,Prasugrel
DB06271,Urokinase may increase the anticoagulant activities of Sulodexide.,Sulodexide
DB06294,Urokinase may increase the anticoagulant activities of Semuloparin.,Semuloparin
DB06406,Urokinase may increase the anticoagulant activities of Idraparinux.,Idraparinux
DB06441,Urokinase may increase the anticoagulant activities of Cangrelor.,Cangrelor
DB06543,Urokinase may increase the anticoagulant activities of Astaxanthin.,Astaxanthin
DB06635,Urokinase may increase the anticoagulant activities of Otamixaban.,Otamixaban
DB06679,Urokinase may increase the anticoagulant activities of Amediplase.,Amediplase
DB06754,Urokinase may increase the anticoagulant activities of Danaparoid.,Danaparoid
DB06779,Urokinase may increase the anticoagulant activities of Dalteparin.,Dalteparin
DB06822,Urokinase may increase the anticoagulant activities of Tinzaparin.,Tinzaparin
DB07767,Urokinase may increase the anticoagulant activities of Ferulic acid.,Ferulic acid
DB08496,Urokinase may increase the anticoagulant activities of (R)-warfarin.,(R)-warfarin
DB08794,Urokinase may increase the anticoagulant activities of Ethyl biscoumacetate.,Ethyl biscoumacetate
DB08813,Urokinase may increase the anticoagulant activities of Nadroparin.,Nadroparin
DB08814,Urokinase may increase the anticoagulant activities of Triflusal.,Triflusal
DB08816,Urokinase may increase the anticoagulant activities of Ticagrelor.,Ticagrelor
DB08994,Urokinase may increase the anticoagulant activities of Ditazole.,Ditazole
DB09030,Urokinase may increase the anticoagulant activities of Vorapaxar.,Vorapaxar
DB09125,Urokinase may increase the anticoagulant activities of Potassium citrate.,Potassium citrate
DB09154,Urokinase may increase the anticoagulant activities of Sodium citrate.,Sodium citrate
DB09255,Urokinase may increase the anticoagulant activities of Dextran.,Dextran
DB09258,Urokinase may increase the anticoagulant activities of Bemiparin.,Bemiparin
DB09259,Urokinase may increase the anticoagulant activities of Reviparin.,Reviparin
DB09260,Urokinase may increase the anticoagulant activities of Parnaparin.,Parnaparin
DB09261,Urokinase may increase the anticoagulant activities of Certoparin.,Certoparin
DB11095,Urokinase may increase the anticoagulant activities of Desirudin.,Desirudin
DB11154,Urokinase may increase the anticoagulant activities of Zinc citrate.,Zinc citrate
DB11166,Urokinase may increase the anticoagulant activities of Antithrombin Alfa.,Antithrombin Alfa
DB11312,Urokinase may increase the anticoagulant activities of Protein C.,Protein C
DB11598,Urokinase may increase the anticoagulant activities of Antithrombin III human.,Antithrombin III human
DB11984,Urokinase may increase the anticoagulant activities of Letaxaban.,Letaxaban
DB12289,Urokinase may increase the anticoagulant activities of Darexaban.,Darexaban
DB12364,Urokinase may increase the anticoagulant activities of Betrixaban.,Betrixaban
DB12598,Urokinase may increase the anticoagulant activities of Nafamostat.,Nafamostat
DB12726,Urokinase may increase the anticoagulant activities of Monteplase.,Monteplase
DB12831,Urokinase may increase the anticoagulant activities of Gabexate.,Gabexate
DB13136,Urokinase may increase the anticoagulant activities of Fluindione.,Fluindione
DB13149,Urokinase may increase the anticoagulant activities of Protein S human.,Protein S human
DB13199,Urokinase may increase the anticoagulant activities of Brinase.,Brinase
DB13275,Urokinase may increase the anticoagulant activities of Clorindione.,Clorindione
DB13347,Urokinase may increase the anticoagulant activities of Diphenadione.,Diphenadione
DB13451,Urokinase may increase the anticoagulant activities of Tioclomarol.,Tioclomarol
DB13616,Urokinase may increase the anticoagulant activities of Melagatran.,Melagatran
DB13646,Urokinase may increase the anticoagulant activities of Saruplase.,Saruplase
DB14055,Urokinase may increase the anticoagulant activities of (S)-Warfarin.,(S)-Warfarin
DB14094,Urokinase may increase the anticoagulant activities of Tocopherylquinone.,Tocopherylquinone
DB14598,Urokinase may increase the anticoagulant activities of Edetate calcium disodium anhydrous.,Edetate calcium disodium anhydrous
DB14726,Urokinase may increase the anticoagulant activities of Dabigatran.,Dabigatran
DB00163,Vitamin E may increase the anticoagulant activities of Urokinase.,Vitamin E
DB06692,The therapeutic efficacy of Urokinase can be decreased when used in combination with Aprotinin.,Aprotinin
DB00063,Eptifibatide may increase the anticoagulant activities of Urokinase.,Eptifibatide
DB00208,Ticlopidine may increase the anticoagulant activities of Urokinase.,Ticlopidine
DB00758,Clopidogrel may increase the anticoagulant activities of Urokinase.,Clopidogrel
DB00775,Tirofiban may increase the anticoagulant activities of Urokinase.,Tirofiban
DB00806,Pentoxifylline may increase the anticoagulant activities of Urokinase.,Pentoxifylline
DB01138,Sulfinpyrazone may increase the anticoagulant activities of Urokinase.,Sulfinpyrazone
DB01166,Cilostazol may increase the anticoagulant activities of Urokinase.,Cilostazol
DB01207,Ridogrel may increase the anticoagulant activities of Urokinase.,Ridogrel
DB01236,Sevoflurane may increase the anticoagulant activities of Urokinase.,Sevoflurane
DB02709,Resveratrol may increase the anticoagulant activities of Urokinase.,Resveratrol
DB04743,Nimesulide may increase the anticoagulant activities of Urokinase.,Nimesulide
DB04905,Tesmilifene may increase the anticoagulant activities of Urokinase.,Tesmilifene
DB05266,Ibudilast may increase the anticoagulant activities of Urokinase.,Ibudilast
DB05767,Andrographolide may increase the anticoagulant activities of Urokinase.,Andrographolide
DB06081,Caplacizumab may increase the anticoagulant activities of Urokinase.,Caplacizumab
DB07615,Tranilast may increase the anticoagulant activities of Urokinase.,Tranilast
DB08887,Icosapent ethyl may increase the anticoagulant activities of Urokinase.,Icosapent ethyl
DB09283,Trapidil may increase the anticoagulant activities of Urokinase.,Trapidil
DB12092,Naftopidil may increase the anticoagulant activities of Urokinase.,Naftopidil
DB12163,Sarpogrelate may increase the anticoagulant activities of Urokinase.,Sarpogrelate
DB12321,Ifetroban may increase the anticoagulant activities of Urokinase.,Ifetroban
DB12445,Nitroaspirin may increase the anticoagulant activities of Urokinase.,Nitroaspirin
DB12465,Ketanserin may increase the anticoagulant activities of Urokinase.,Ketanserin
DB12545,Indobufen may increase the anticoagulant activities of Urokinase.,Indobufen
DB12749,Butylphthalide may increase the anticoagulant activities of Urokinase.,Butylphthalide
DB12771,Hydroxytyrosol may increase the anticoagulant activities of Urokinase.,Hydroxytyrosol
DB13036,Ramatroban may increase the anticoagulant activities of Urokinase.,Ramatroban
DB13327,Picotamide may increase the anticoagulant activities of Urokinase.,Picotamide
DB13367,Cloricromen may increase the anticoagulant activities of Urokinase.,Cloricromen
DB13400,Linsidomine may increase the anticoagulant activities of Urokinase.,Linsidomine
DB13510,Buflomedil may increase the anticoagulant activities of Urokinase.,Buflomedil
DB13929,Relcovaptan may increase the anticoagulant activities of Urokinase.,Relcovaptan
DB00261,Anagrelide may increase the anticoagulant activities of Urokinase.,Anagrelide
DB01381,The therapeutic efficacy of Urokinase can be increased when used in combination with Ginkgo biloba.,Ginkgo biloba
DB01181,The risk or severity of bleeding can be increased when Ifosfamide is combined with Urokinase.,Ifosfamide
DB00468,The therapeutic efficacy of Urokinase can be increased when used in combination with Quinine.,Quinine
DB00908,The therapeutic efficacy of Urokinase can be increased when used in combination with Quinidine.,Quinidine
DB00675,The risk or severity of bleeding can be increased when Tamoxifen is combined with Urokinase.,Tamoxifen
DB00539,The risk or severity of bleeding can be increased when Toremifene is combined with Urokinase.,Toremifene
DB00583,The therapeutic efficacy of Urokinase can be increased when used in combination with Levocarnitine.,Levocarnitine
DB00255,Diethylstilbestrol may decrease the anticoagulant activities of Urokinase.,Diethylstilbestrol
DB00269,Chlorotrianisene may decrease the anticoagulant activities of Urokinase.,Chlorotrianisene
DB00286,Conjugated estrogens may decrease the anticoagulant activities of Urokinase.,Conjugated estrogens
DB00783,Estradiol may decrease the anticoagulant activities of Urokinase.,Estradiol
DB00977,Ethinylestradiol may decrease the anticoagulant activities of Urokinase.,Ethinylestradiol
DB01357,Mestranol may decrease the anticoagulant activities of Urokinase.,Mestranol
DB04573,Estriol may decrease the anticoagulant activities of Urokinase.,Estriol
DB04574,Estrone sulfate may decrease the anticoagulant activities of Urokinase.,Estrone sulfate
DB04575,Quinestrol may decrease the anticoagulant activities of Urokinase.,Quinestrol
DB07931,Hexestrol may decrease the anticoagulant activities of Urokinase.,Hexestrol
DB09317,"Synthetic Conjugated Estrogens, A may decrease the anticoagulant activities of Urokinase.","Synthetic Conjugated Estrogens, A"
DB09318,"Synthetic Conjugated Estrogens, B may decrease the anticoagulant activities of Urokinase.","Synthetic Conjugated Estrogens, B"
DB09369,Polyestradiol phosphate may decrease the anticoagulant activities of Urokinase.,Polyestradiol phosphate
DB09381,Esterified estrogens may decrease the anticoagulant activities of Urokinase.,Esterified estrogens
DB11478,Zeranol may decrease the anticoagulant activities of Urokinase.,Zeranol
DB11674,Equol may decrease the anticoagulant activities of Urokinase.,Equol
DB12487,Promestriene may decrease the anticoagulant activities of Urokinase.,Promestriene
DB13143,Methallenestril may decrease the anticoagulant activities of Urokinase.,Methallenestril
DB13386,Epimestrol may decrease the anticoagulant activities of Urokinase.,Epimestrol
DB13418,Moxestrol may decrease the anticoagulant activities of Urokinase.,Moxestrol
DB13952,Estradiol acetate may decrease the anticoagulant activities of Urokinase.,Estradiol acetate
DB13953,Estradiol benzoate may decrease the anticoagulant activities of Urokinase.,Estradiol benzoate
DB13954,Estradiol cypionate may decrease the anticoagulant activities of Urokinase.,Estradiol cypionate
DB13956,Estradiol valerate may decrease the anticoagulant activities of Urokinase.,Estradiol valerate
DB15334,Biochanin A may decrease the anticoagulant activities of Urokinase.,Biochanin A
DB15335,Formononetin may decrease the anticoagulant activities of Urokinase.,Formononetin
DB00159,The risk or severity of bleeding and hemorrhage can be increased when Icosapent is combined with Urokinase.,Icosapent
DB00244,The risk or severity of bleeding and hemorrhage can be increased when Mesalazine is combined with Urokinase.,Mesalazine
DB00328,The risk or severity of bleeding and hemorrhage can be increased when Indomethacin is combined with Urokinase.,Indomethacin
DB00461,The risk or severity of bleeding and hemorrhage can be increased when Nabumetone is combined with Urokinase.,Nabumetone
DB00465,The risk or severity of bleeding and hemorrhage can be increased when Ketorolac is combined with Urokinase.,Ketorolac
DB00469,The risk or severity of bleeding and hemorrhage can be increased when Tenoxicam is combined with Urokinase.,Tenoxicam
DB00482,The risk or severity of bleeding and hemorrhage can be increased when Celecoxib is combined with Urokinase.,Celecoxib
DB00500,The risk or severity of bleeding and hemorrhage can be increased when Tolmetin is combined with Urokinase.,Tolmetin
DB00533,The risk or severity of bleeding and hemorrhage can be increased when Rofecoxib is combined with Urokinase.,Rofecoxib
DB00554,The risk or severity of bleeding and hemorrhage can be increased when Piroxicam is combined with Urokinase.,Piroxicam
DB00573,The risk or severity of bleeding and hemorrhage can be increased when Fenoprofen is combined with Urokinase.,Fenoprofen
DB00580,The risk or severity of bleeding and hemorrhage can be increased when Valdecoxib is combined with Urokinase.,Valdecoxib
DB00586,The risk or severity of bleeding and hemorrhage can be increased when Diclofenac is combined with Urokinase.,Diclofenac
DB00605,The risk or severity of bleeding and hemorrhage can be increased when Sulindac is combined with Urokinase.,Sulindac
DB00712,The risk or severity of bleeding and hemorrhage can be increased when Flurbiprofen is combined with Urokinase.,Flurbiprofen
DB00749,The risk or severity of bleeding and hemorrhage can be increased when Etodolac is combined with Urokinase.,Etodolac
DB00784,The risk or severity of bleeding and hemorrhage can be increased when Mefenamic acid is combined with Urokinase.,Mefenamic acid
DB00788,The risk or severity of bleeding and hemorrhage can be increased when Naproxen is combined with Urokinase.,Naproxen
DB00795,The risk or severity of bleeding and hemorrhage can be increased when Sulfasalazine is combined with Urokinase.,Sulfasalazine
DB00812,The risk or severity of bleeding and hemorrhage can be increased when Phenylbutazone is combined with Urokinase.,Phenylbutazone
DB00814,The risk or severity of bleeding and hemorrhage can be increased when Meloxicam is combined with Urokinase.,Meloxicam
DB00821,The risk or severity of bleeding and hemorrhage can be increased when Carprofen is combined with Urokinase.,Carprofen
DB00861,The risk or severity of bleeding and hemorrhage can be increased when Diflunisal is combined with Urokinase.,Diflunisal
DB00936,The risk or severity of bleeding and hemorrhage can be increased when Salicylic acid is combined with Urokinase.,Salicylic acid
DB00939,The risk or severity of bleeding and hemorrhage can be increased when Meclofenamic acid is combined with Urokinase.,Meclofenamic acid
DB00991,The risk or severity of bleeding and hemorrhage can be increased when Oxaprozin is combined with Urokinase.,Oxaprozin
DB01009,The risk or severity of bleeding and hemorrhage can be increased when Ketoprofen is combined with Urokinase.,Ketoprofen
DB01014,The risk or severity of bleeding and hemorrhage can be increased when Balsalazide is combined with Urokinase.,Balsalazide
DB01250,The risk or severity of bleeding and hemorrhage can be increased when Olsalazine is combined with Urokinase.,Olsalazine
DB01283,The risk or severity of bleeding and hemorrhage can be increased when Lumiracoxib is combined with Urokinase.,Lumiracoxib
DB01397,The risk or severity of bleeding and hemorrhage can be increased when Magnesium salicylate is combined with Urokinase.,Magnesium salicylate
DB01399,The risk or severity of bleeding and hemorrhage can be increased when Salsalate is combined with Urokinase.,Salsalate
DB01401,The risk or severity of bleeding and hemorrhage can be increased when Choline magnesium trisalicylate is combined with Urokinase.,Choline magnesium trisalicylate
DB01419,The risk or severity of bleeding and hemorrhage can be increased when Antrafenine is combined with Urokinase.,Antrafenine
DB01424,The risk or severity of bleeding and hemorrhage can be increased when Aminophenazone is combined with Urokinase.,Aminophenazone
DB01435,The risk or severity of bleeding and hemorrhage can be increased when Antipyrine is combined with Urokinase.,Antipyrine
DB01600,The risk or severity of bleeding and hemorrhage can be increased when Tiaprofenic acid is combined with Urokinase.,Tiaprofenic acid
DB01628,The risk or severity of bleeding and hemorrhage can be increased when Etoricoxib is combined with Urokinase.,Etoricoxib
DB02224,The risk or severity of bleeding and hemorrhage can be increased when Taxifolin is combined with Urokinase.,Taxifolin
DB03585,The risk or severity of bleeding and hemorrhage can be increased when Oxyphenbutazone is combined with Urokinase.,Oxyphenbutazone
DB04552,The risk or severity of bleeding and hemorrhage can be increased when Niflumic acid is combined with Urokinase.,Niflumic acid
DB04725,The risk or severity of bleeding and hemorrhage can be increased when Licofelone is combined with Urokinase.,Licofelone
DB04812,The risk or severity of bleeding and hemorrhage can be increased when Benoxaprofen is combined with Urokinase.,Benoxaprofen
DB04817,The risk or severity of bleeding and hemorrhage can be increased when Metamizole is combined with Urokinase.,Metamizole
DB04828,The risk or severity of bleeding and hemorrhage can be increased when Zomepirac is combined with Urokinase.,Zomepirac
DB05095,The risk or severity of bleeding and hemorrhage can be increased when Cimicoxib is combined with Urokinase.,Cimicoxib
DB06725,The risk or severity of bleeding and hemorrhage can be increased when Lornoxicam is combined with Urokinase.,Lornoxicam
DB06736,The risk or severity of bleeding and hemorrhage can be increased when Aceclofenac is combined with Urokinase.,Aceclofenac
DB06737,The risk or severity of bleeding and hemorrhage can be increased when Zaltoprofen is combined with Urokinase.,Zaltoprofen
DB07402,The risk or severity of bleeding and hemorrhage can be increased when Azapropazone is combined with Urokinase.,Azapropazone
DB07477,The risk or severity of bleeding and hemorrhage can be increased when Felbinac is combined with Urokinase.,Felbinac
DB08439,The risk or severity of bleeding and hemorrhage can be increased when Parecoxib is combined with Urokinase.,Parecoxib
DB08797,The risk or severity of bleeding and hemorrhage can be increased when Salicylamide is combined with Urokinase.,Salicylamide
DB08940,The risk or severity of bleeding and hemorrhage can be increased when Kebuzone is combined with Urokinase.,Kebuzone
DB08942,The risk or severity of bleeding and hemorrhage can be increased when Isoxicam is combined with Urokinase.,Isoxicam
DB08951,The risk or severity of bleeding and hemorrhage can be increased when Indoprofen is combined with Urokinase.,Indoprofen
DB08955,The risk or severity of bleeding and hemorrhage can be increased when Ibuproxam is combined with Urokinase.,Ibuproxam
DB08976,The risk or severity of bleeding and hemorrhage can be increased when Floctafenine is combined with Urokinase.,Floctafenine
DB08981,The risk or severity of bleeding and hemorrhage can be increased when Fenbufen is combined with Urokinase.,Fenbufen
DB08984,The risk or severity of bleeding and hemorrhage can be increased when Etofenamate is combined with Urokinase.,Etofenamate
DB08991,The risk or severity of bleeding and hemorrhage can be increased when Epirizole is combined with Urokinase.,Epirizole
DB09084,The risk or severity of bleeding and hemorrhage can be increased when Benzydamine is combined with Urokinase.,Benzydamine
DB09212,The risk or severity of bleeding and hemorrhage can be increased when Loxoprofen is combined with Urokinase.,Loxoprofen
DB09214,The risk or severity of bleeding and hemorrhage can be increased when Dexketoprofen is combined with Urokinase.,Dexketoprofen
DB09215,The risk or severity of bleeding and hemorrhage can be increased when Droxicam is combined with Urokinase.,Droxicam
DB09216,The risk or severity of bleeding and hemorrhage can be increased when Tolfenamic acid is combined with Urokinase.,Tolfenamic acid
DB09217,The risk or severity of bleeding and hemorrhage can be increased when Firocoxib is combined with Urokinase.,Firocoxib
DB09218,The risk or severity of bleeding and hemorrhage can be increased when Clonixin is combined with Urokinase.,Clonixin
DB09285,The risk or severity of bleeding and hemorrhage can be increased when Morniflumate is combined with Urokinase.,Morniflumate
DB09288,The risk or severity of bleeding and hemorrhage can be increased when Propacetamol is combined with Urokinase.,Propacetamol
DB09295,The risk or severity of bleeding and hemorrhage can be increased when Talniflumate is combined with Urokinase.,Talniflumate
DB11455,The risk or severity of bleeding and hemorrhage can be increased when Robenacoxib is combined with Urokinase.,Robenacoxib
DB11466,The risk or severity of bleeding and hemorrhage can be increased when Tepoxalin is combined with Urokinase.,Tepoxalin
DB11518,The risk or severity of bleeding and hemorrhage can be increased when Flunixin is combined with Urokinase.,Flunixin
DB12399,The risk or severity of bleeding and hemorrhage can be increased when Polmacoxib is combined with Urokinase.,Polmacoxib
DB12480,The risk or severity of bleeding and hemorrhage can be increased when Betulinic Acid is combined with Urokinase.,Betulinic Acid
DB12610,The risk or severity of bleeding and hemorrhage can be increased when Ebselen is combined with Urokinase.,Ebselen
DB13001,The risk or severity of bleeding and hemorrhage can be increased when Tinoridine is combined with Urokinase.,Tinoridine
DB13167,The risk or severity of bleeding and hemorrhage can be increased when Alclofenac is combined with Urokinase.,Alclofenac
DB13217,The risk or severity of bleeding and hemorrhage can be increased when Fentiazac is combined with Urokinase.,Fentiazac
DB13232,The risk or severity of bleeding and hemorrhage can be increased when Suxibuzone is combined with Urokinase.,Suxibuzone
DB13286,The risk or severity of bleeding and hemorrhage can be increased when Bumadizone is combined with Urokinase.,Bumadizone
DB13314,The risk or severity of bleeding and hemorrhage can be increased when Alminoprofen is combined with Urokinase.,Alminoprofen
DB13317,The risk or severity of bleeding and hemorrhage can be increased when Flunoxaprofen is combined with Urokinase.,Flunoxaprofen
DB13364,The risk or severity of bleeding and hemorrhage can be increased when Feprazone is combined with Urokinase.,Feprazone
DB13371,The risk or severity of bleeding and hemorrhage can be increased when Difenpiramide is combined with Urokinase.,Difenpiramide
DB13407,The risk or severity of bleeding and hemorrhage can be increased when Nifenazone is combined with Urokinase.,Nifenazone
DB13432,The risk or severity of bleeding and hemorrhage can be increased when Lonazolac is combined with Urokinase.,Lonazolac
DB13481,The risk or severity of bleeding and hemorrhage can be increased when Tenidap is combined with Urokinase.,Tenidap
DB13501,The risk or severity of bleeding and hemorrhage can be increased when Bendazac is combined with Urokinase.,Bendazac
DB13514,The risk or severity of bleeding and hemorrhage can be increased when Pranoprofen is combined with Urokinase.,Pranoprofen
DB13524,The risk or severity of bleeding and hemorrhage can be increased when Propyphenazone is combined with Urokinase.,Propyphenazone
DB13527,The risk or severity of bleeding and hemorrhage can be increased when Proglumetacin is combined with Urokinase.,Proglumetacin
DB13538,The risk or severity of bleeding and hemorrhage can be increased when Guacetisal is combined with Urokinase.,Guacetisal
DB13544,The risk or severity of bleeding and hemorrhage can be increased when Ethenzamide is combined with Urokinase.,Ethenzamide
DB13612,The risk or severity of bleeding and hemorrhage can be increased when Carbaspirin calcium is combined with Urokinase.,Carbaspirin calcium
DB13629,The risk or severity of bleeding and hemorrhage can be increased when Mofebutazone is combined with Urokinase.,Mofebutazone
DB13649,The risk or severity of bleeding and hemorrhage can be increased when Proquazone is combined with Urokinase.,Proquazone
DB13657,The risk or severity of bleeding and hemorrhage can be increased when Benorilate is combined with Urokinase.,Benorilate
DB13722,The risk or severity of bleeding and hemorrhage can be increased when Pirprofen is combined with Urokinase.,Pirprofen
DB13860,The risk or severity of bleeding and hemorrhage can be increased when Imidazole salicylate is combined with Urokinase.,Imidazole salicylate
DB14059,The risk or severity of bleeding and hemorrhage can be increased when SC-236 is combined with Urokinase.,SC-236
DB14060,The risk or severity of bleeding and hemorrhage can be increased when NS-398 is combined with Urokinase.,NS-398
DB14938,The risk or severity of bleeding and hemorrhage can be increased when Flurbiprofen axetil is combined with Urokinase.,Flurbiprofen axetil
DB04865,The risk or severity of bleeding can be increased when Urokinase is combined with Omacetaxine mepesuccinate.,Omacetaxine mepesuccinate
DB11133,Omega-3 fatty acids may increase the anticoagulant activities of Urokinase.,Omega-3 fatty acids
DB00081,The risk or severity of bleeding and hemorrhage can be increased when Urokinase is combined with Tositumomab.,Tositumomab
DB09211,The risk or severity of adverse effects can be increased when Limaprost is combined with Urokinase.,Limaprost
DB00048,The risk or severity of adverse effects can be increased when Urokinase is combined with Collagenase clostridium histolyticum.,Collagenase clostridium histolyticum
DB00389,Carbimazole may increase the anticoagulant activities of Urokinase.,Carbimazole
DB00550,Propylthiouracil may increase the anticoagulant activities of Urokinase.,Propylthiouracil
DB00763,Methimazole may increase the anticoagulant activities of Urokinase.,Methimazole
DB03374,"3,5-Diiodotyrosine may increase the anticoagulant activities of Urokinase.","3,5-Diiodotyrosine"
DB06715,Potassium Iodide may increase the anticoagulant activities of Urokinase.,Potassium Iodide
DB07637,Dibromotyrosine may increase the anticoagulant activities of Urokinase.,Dibromotyrosine
DB09418,Potassium perchlorate may increase the anticoagulant activities of Urokinase.,Potassium perchlorate
DB13644,Methylthiouracil may increase the anticoagulant activities of Urokinase.,Methylthiouracil
DB13804,Benzylthiouracil may increase the anticoagulant activities of Urokinase.,Benzylthiouracil
DB00834,The therapeutic efficacy of Urokinase can be decreased when used in combination with Mifepristone.,Mifepristone
DB04066,The therapeutic efficacy of Urokinase can be decreased when used in combination with p-Coumaric acid.,p-Coumaric acid
DB04682,The therapeutic efficacy of Urokinase can be decreased when used in combination with Octylphenoxy polyethoxyethanol.,Octylphenoxy polyethoxyethanol
DB05830,The therapeutic efficacy of Urokinase can be decreased when used in combination with Trestolone.,Trestolone
DB06266,The therapeutic efficacy of Urokinase can be decreased when used in combination with Lonidamine.,Lonidamine
DB08867,The therapeutic efficacy of Urokinase can be decreased when used in combination with Ulipristal.,Ulipristal
DB09401,The therapeutic efficacy of Urokinase can be decreased when used in combination with Isosorbide.,Isosorbide
DB11507,The therapeutic efficacy of Urokinase can be decreased when used in combination with Cloprostenol.,Cloprostenol
DB12025,The therapeutic efficacy of Urokinase can be decreased when used in combination with Triptolide.,Triptolide
DB13044,The therapeutic efficacy of Urokinase can be decreased when used in combination with Gossypol.,Gossypol
DB13310,The therapeutic efficacy of Urokinase can be decreased when used in combination with Ormeloxifene.,Ormeloxifene
DB00294,Etonogestrel may decrease the anticoagulant activities of Urokinase.,Etonogestrel
DB00304,Desogestrel may decrease the anticoagulant activities of Urokinase.,Desogestrel
DB00351,Megestrol acetate may decrease the anticoagulant activities of Urokinase.,Megestrol acetate
DB00367,Levonorgestrel may decrease the anticoagulant activities of Urokinase.,Levonorgestrel
DB00378,Dydrogesterone may decrease the anticoagulant activities of Urokinase.,Dydrogesterone
DB00396,Progesterone may decrease the anticoagulant activities of Urokinase.,Progesterone
DB00603,Medroxyprogesterone acetate may decrease the anticoagulant activities of Urokinase.,Medroxyprogesterone acetate
DB00717,Norethisterone may decrease the anticoagulant activities of Urokinase.,Norethisterone
DB00823,Ethynodiol diacetate may decrease the anticoagulant activities of Urokinase.,Ethynodiol diacetate
DB00957,Norgestimate may decrease the anticoagulant activities of Urokinase.,Norgestimate
DB01395,Drospirenone may decrease the anticoagulant activities of Urokinase.,Drospirenone
DB01431,Allylestrenol may decrease the anticoagulant activities of Urokinase.,Allylestrenol
DB04839,Cyproterone acetate may decrease the anticoagulant activities of Urokinase.,Cyproterone acetate
DB06713,Norelgestromin may decrease the anticoagulant activities of Urokinase.,Norelgestromin
DB06730,Gestodene may decrease the anticoagulant activities of Urokinase.,Gestodene
DB06789,Hydroxyprogesterone caproate may decrease the anticoagulant activities of Urokinase.,Hydroxyprogesterone caproate
DB09123,Dienogest may decrease the anticoagulant activities of Urokinase.,Dienogest
DB09124,Medrogestone may decrease the anticoagulant activities of Urokinase.,Medrogestone
DB09371,Norethynodrel may decrease the anticoagulant activities of Urokinase.,Norethynodrel
DB09389,Norgestrel may decrease the anticoagulant activities of Urokinase.,Norgestrel
DB11372,Altrenogest may decrease the anticoagulant activities of Urokinase.,Altrenogest
DB11619,Gestrinone may decrease the anticoagulant activities of Urokinase.,Gestrinone
DB11636,Nomegestrol may decrease the anticoagulant activities of Urokinase.,Nomegestrol
DB12474,Lynestrenol may decrease the anticoagulant activities of Urokinase.,Lynestrenol
DB13230,Gestonorone may decrease the anticoagulant activities of Urokinase.,Gestonorone
DB13528,Chlormadinone may decrease the anticoagulant activities of Urokinase.,Chlormadinone
DB13533,Methylestrenolone may decrease the anticoagulant activities of Urokinase.,Methylestrenolone
DB13563,Norgestrienone may decrease the anticoagulant activities of Urokinase.,Norgestrienone
DB13602,Promegestone may decrease the anticoagulant activities of Urokinase.,Promegestone
DB13685,Quingestanol may decrease the anticoagulant activities of Urokinase.,Quingestanol
DB13857,Demegestone may decrease the anticoagulant activities of Urokinase.,Demegestone
DB13866,Etynodiol may decrease the anticoagulant activities of Urokinase.,Etynodiol
DB13981,Nomegestrol acetate may decrease the anticoagulant activities of Urokinase.,Nomegestrol acetate
DB14570,Hydroxyprogesterone may decrease the anticoagulant activities of Urokinase.,Hydroxyprogesterone
DB14678,Norethindrone enanthate may decrease the anticoagulant activities of Urokinase.,Norethindrone enanthate
DB14679,Quingestanol acetate may decrease the anticoagulant activities of Urokinase.,Quingestanol acetate
DB00233,The risk or severity of bleeding can be increased when Aminosalicylic acid is combined with Urokinase.,Aminosalicylic acid
DB01294,The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Urokinase.,Bismuth subsalicylate
DB06251,The risk or severity of bleeding can be increased when Dersalazine is combined with Urokinase.,Dersalazine
DB06807,The risk or severity of bleeding can be increased when Phenyl aminosalicylate is combined with Urokinase.,Phenyl aminosalicylate
DB09543,The risk or severity of bleeding can be increased when Methyl salicylate is combined with Urokinase.,Methyl salicylate
DB11079,The risk or severity of bleeding can be increased when Trolamine salicylate is combined with Urokinase.,Trolamine salicylate
DB13509,The risk or severity of bleeding can be increased when Aloxiprin is combined with Urokinase.,Aloxiprin
DB14006,The risk or severity of bleeding can be increased when Choline salicylate is combined with Urokinase.,Choline salicylate
DB14026,The risk or severity of bleeding can be increased when Thiosalicylic acid is combined with Urokinase.,Thiosalicylic acid
DB00374,The risk or severity of adverse effects can be increased when Urokinase is combined with Treprostinil.,Treprostinil
DB03404,Hemin may increase the anticoagulant activities of Urokinase.,Hemin
DB13783,The risk or severity of bleeding and hemorrhage can be increased when Acemetacin is combined with Urokinase.,Acemetacin
DB00624,Testosterone may increase the anticoagulant activities of Urokinase.,Testosterone
DB01420,Testosterone propionate may increase the anticoagulant activities of Urokinase.,Testosterone propionate
DB01481,1-Testosterone may increase the anticoagulant activities of Urokinase.,1-Testosterone
DB01485,4-Hydroxytestosterone may increase the anticoagulant activities of Urokinase.,4-Hydroxytestosterone
DB01510,Dehydrochloromethyltestosterone may increase the anticoagulant activities of Urokinase.,Dehydrochloromethyltestosterone
DB01541,Boldenone may increase the anticoagulant activities of Urokinase.,Boldenone
DB01543,18-methyl-19-nortestosterone may increase the anticoagulant activities of Urokinase.,18-methyl-19-nortestosterone
DB01564,Calusterone may increase the anticoagulant activities of Urokinase.,Calusterone
DB01569,Formebolone may increase the anticoagulant activities of Urokinase.,Formebolone
DB01572,Methyl-1-testosterone may increase the anticoagulant activities of Urokinase.,Methyl-1-testosterone
DB02901,Stanolone may increase the anticoagulant activities of Urokinase.,Stanolone
DB07447,5beta-dihydrotestosterone may increase the anticoagulant activities of Urokinase.,5beta-dihydrotestosterone
DB08619,Testosterone succinate may increase the anticoagulant activities of Urokinase.,Testosterone succinate
DB11429,Mibolerone may increase the anticoagulant activities of Urokinase.,Mibolerone
DB13943,Testosterone cypionate may increase the anticoagulant activities of Urokinase.,Testosterone cypionate
DB13944,Testosterone enanthate may increase the anticoagulant activities of Urokinase.,Testosterone enanthate
DB13946,Testosterone undecanoate may increase the anticoagulant activities of Urokinase.,Testosterone undecanoate
DB13947,Testosterone enantate benzilic acid hydrazone may increase the anticoagulant activities of Urokinase.,Testosterone enantate benzilic acid hydrazone
DB13951,Stanolone acetate may increase the anticoagulant activities of Urokinase.,Stanolone acetate
DB13958,Trestolone acetate may increase the anticoagulant activities of Urokinase.,Trestolone acetate
DB14093,"(1,2,6,7-3H)Testosterone may increase the anticoagulant activities of Urokinase.","(1,2,6,7-3H)Testosterone"
DB14655,Drostanolone propionate may increase the anticoagulant activities of Urokinase.,Drostanolone propionate
DB11051,The risk or severity of adverse effects can be increased when Urokinase is combined with Azficel-T.,Azficel-T
DB09568,The therapeutic efficacy of Urokinase can be increased when used in combination with Omega-3-carboxylic acids.,Omega-3-carboxylic acids
DB00258,The therapeutic efficacy of Calcium acetate can be decreased when used in combination with Urokinase.,Calcium acetate
DB01164,The therapeutic efficacy of Calcium chloride can be decreased when used in combination with Urokinase.,Calcium chloride
DB01373,The therapeutic efficacy of Calcium can be decreased when used in combination with Urokinase.,Calcium
DB11126,The therapeutic efficacy of Calcium gluconate can be decreased when used in combination with Urokinase.,Calcium gluconate
DB11608,The therapeutic efficacy of Eftrenonacog alfa can be decreased when used in combination with Urokinase.,Eftrenonacog alfa
DB13884,The therapeutic efficacy of Albutrepenonacog alfa can be decreased when used in combination with Urokinase.,Albutrepenonacog alfa
DB13923,The therapeutic efficacy of Emicizumab can be decreased when used in combination with Urokinase.,Emicizumab
DB14738,The therapeutic efficacy of Turoctocog alfa pegol can be decreased when used in combination with Urokinase.,Turoctocog alfa pegol
DB00025,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Urokinase.","Antihemophilic factor, human recombinant"
DB00036,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Urokinase.,Coagulation factor VIIa Recombinant Human
DB00100,The therapeutic efficacy of Coagulation Factor IX (Recombinant) can be decreased when used in combination with Urokinase.,Coagulation Factor IX (Recombinant)
DB01783,The therapeutic efficacy of Pantothenic acid can be decreased when used in combination with Urokinase.,Pantothenic acid
DB01942,The therapeutic efficacy of Formic acid can be decreased when used in combination with Urokinase.,Formic acid
DB02261,The therapeutic efficacy of Platelet Activating Factor can be decreased when used in combination with Urokinase.,Platelet Activating Factor
DB06724,The therapeutic efficacy of Calcium carbonate can be decreased when used in combination with Urokinase.,Calcium carbonate
DB09109,The therapeutic efficacy of Turoctocog alfa can be decreased when used in combination with Urokinase.,Turoctocog alfa
DB09222,The therapeutic efficacy of Fibrinogen human can be decreased when used in combination with Urokinase.,Fibrinogen human
DB09310,The therapeutic efficacy of Catridecacog can be decreased when used in combination with Urokinase.,Catridecacog
DB09329,"The therapeutic efficacy of Antihemophilic Factor (Recombinant), PEGylated can be decreased when used in combination with Urokinase.","Antihemophilic Factor (Recombinant), PEGylated"
DB11093,The therapeutic efficacy of Calcium citrate can be decreased when used in combination with Urokinase.,Calcium citrate
DB11168,The therapeutic efficacy of Calcium threonate can be decreased when used in combination with Urokinase.,Calcium threonate
DB11311,The therapeutic efficacy of Prothrombin can be decreased when used in combination with Urokinase.,Prothrombin
DB11330,The therapeutic efficacy of Factor IX Complex (Human) can be decreased when used in combination with Urokinase.,Factor IX Complex (Human)
DB11348,The therapeutic efficacy of Calcium Phosphate can be decreased when used in combination with Urokinase.,Calcium Phosphate
DB11606,The therapeutic efficacy of Susoctocog alfa can be decreased when used in combination with Urokinase.,Susoctocog alfa
DB11668,The therapeutic efficacy of Rusalatide acetate can be decreased when used in combination with Urokinase.,Rusalatide acetate
DB12409,The therapeutic efficacy of Vatreptacog alfa can be decreased when used in combination with Urokinase.,Vatreptacog alfa
DB12909,The therapeutic efficacy of Factor XIII (human) can be decreased when used in combination with Urokinase.,Factor XIII (human)
DB13133,The therapeutic efficacy of Von Willebrand Factor Human can be decreased when used in combination with Urokinase.,Von Willebrand Factor Human
DB13148,The therapeutic efficacy of Coagulation factor X human can be decreased when used in combination with Urokinase.,Coagulation factor X human
DB13150,The therapeutic efficacy of Coagulation factor VII human can be decreased when used in combination with Urokinase.,Coagulation factor VII human
DB13151,The therapeutic efficacy of Anti-inhibitor coagulant complex can be decreased when used in combination with Urokinase.,Anti-inhibitor coagulant complex
DB13152,The therapeutic efficacy of Coagulation Factor IX Human can be decreased when used in combination with Urokinase.,Coagulation Factor IX Human
DB13192,The therapeutic efficacy of Antihemophilic factor human can be decreased when used in combination with Urokinase.,Antihemophilic factor human
DB13197,The therapeutic efficacy of Kallidinogenase can be decreased when used in combination with Urokinase.,Kallidinogenase
DB13201,The therapeutic efficacy of Trenonacog alfa can be decreased when used in combination with Urokinase.,Trenonacog alfa
DB13933,The therapeutic efficacy of Nonacog beta pegol can be decreased when used in combination with Urokinase.,Nonacog beta pegol
DB13999,The therapeutic efficacy of Moroctocog alfa can be decreased when used in combination with Urokinase.,Moroctocog alfa
DB14473,The therapeutic efficacy of Beroctocog alfa can be decreased when used in combination with Urokinase.,Beroctocog alfa
DB14562,The therapeutic efficacy of Andexanet alfa can be decreased when used in combination with Urokinase.,Andexanet alfa
DB14577,The therapeutic efficacy of Calcium cation can be decreased when used in combination with Urokinase.,Calcium cation
DB14700,The therapeutic efficacy of Damoctocog alfa pegol can be decreased when used in combination with Urokinase.,Damoctocog alfa pegol
DB00176,The risk or severity of hemorrhage can be increased when Fluvoxamine is combined with Urokinase.,Fluvoxamine
DB00215,The risk or severity of hemorrhage can be increased when Citalopram is combined with Urokinase.,Citalopram
DB00472,The risk or severity of hemorrhage can be increased when Fluoxetine is combined with Urokinase.,Fluoxetine
DB00715,The risk or severity of hemorrhage can be increased when Paroxetine is combined with Urokinase.,Paroxetine
DB01149,The risk or severity of hemorrhage can be increased when Nefazodone is combined with Urokinase.,Nefazodone
DB04832,The risk or severity of hemorrhage can be increased when Zimelidine is combined with Urokinase.,Zimelidine
DB04884,The risk or severity of hemorrhage can be increased when Dapoxetine is combined with Urokinase.,Dapoxetine
DB06731,The risk or severity of hemorrhage can be increased when Seproxetine is combined with Urokinase.,Seproxetine
DB08953,The risk or severity of hemorrhage can be increased when Indalpine is combined with Urokinase.,Indalpine
DB12693,The risk or severity of hemorrhage can be increased when Ritanserin is combined with Urokinase.,Ritanserin
DB13233,The risk or severity of hemorrhage can be increased when Alaproclate is combined with Urokinase.,Alaproclate
DB00476,The risk or severity of hemorrhage can be increased when Duloxetine is combined with Urokinase.,Duloxetine
DB01105,The risk or severity of hemorrhage can be increased when Sibutramine is combined with Urokinase.,Sibutramine
DB04896,The risk or severity of hemorrhage can be increased when Milnacipran is combined with Urokinase.,Milnacipran
DB06700,The risk or severity of hemorrhage can be increased when Desvenlafaxine is combined with Urokinase.,Desvenlafaxine
DB08918,The risk or severity of hemorrhage can be increased when Levomilnacipran is combined with Urokinase.,Levomilnacipran
DB00285,Venlafaxine may increase the antiplatelet activities of Urokinase.,Venlafaxine
DB00182,The risk or severity of bleeding and hemorrhage can be increased when Amphetamine is combined with Urokinase.,Amphetamine
DB00601,The risk or severity of bleeding and hemorrhage can be increased when Linezolid is combined with Urokinase.,Linezolid
DB00614,The risk or severity of bleeding and hemorrhage can be increased when Furazolidone is combined with Urokinase.,Furazolidone
DB00721,The risk or severity of bleeding and hemorrhage can be increased when Procaine is combined with Urokinase.,Procaine
DB00752,The risk or severity of bleeding and hemorrhage can be increased when Tranylcypromine is combined with Urokinase.,Tranylcypromine
DB00780,The risk or severity of bleeding and hemorrhage can be increased when Phenelzine is combined with Urokinase.,Phenelzine
DB00805,The risk or severity of bleeding and hemorrhage can be increased when Minaprine is combined with Urokinase.,Minaprine
DB01037,The risk or severity of bleeding and hemorrhage can be increased when Selegiline is combined with Urokinase.,Selegiline
DB01168,The risk or severity of bleeding and hemorrhage can be increased when Procarbazine is combined with Urokinase.,Procarbazine
DB01171,The risk or severity of bleeding and hemorrhage can be increased when Moclobemide is combined with Urokinase.,Moclobemide
DB01247,The risk or severity of bleeding and hemorrhage can be increased when Isocarboxazid is combined with Urokinase.,Isocarboxazid
DB01367,The risk or severity of bleeding and hemorrhage can be increased when Rasagiline is combined with Urokinase.,Rasagiline
DB01626,The risk or severity of bleeding and hemorrhage can be increased when Pargyline is combined with Urokinase.,Pargyline
DB04017,The risk or severity of bleeding and hemorrhage can be increased when Clorgiline is combined with Urokinase.,Clorgiline
DB04818,The risk or severity of bleeding and hemorrhage can be increased when Iproniazid is combined with Urokinase.,Iproniazid
DB04820,The risk or severity of bleeding and hemorrhage can be increased when Nialamide is combined with Urokinase.,Nialamide
DB06654,The risk or severity of bleeding and hemorrhage can be increased when Safinamide is combined with Urokinase.,Safinamide
DB08550,"The risk or severity of bleeding and hemorrhage can be increased when 7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline is combined with Urokinase.","7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline"
DB09241,The risk or severity of bleeding and hemorrhage can be increased when Methylene blue is combined with Urokinase.,Methylene blue
DB09243,The risk or severity of bleeding and hemorrhage can be increased when Hydracarbazine is combined with Urokinase.,Hydracarbazine
DB09244,The risk or severity of bleeding and hemorrhage can be increased when Pirlindole is combined with Urokinase.,Pirlindole
DB09245,The risk or severity of bleeding and hemorrhage can be increased when Toloxatone is combined with Urokinase.,Toloxatone
DB09246,The risk or severity of bleeding and hemorrhage can be increased when Benmoxin is combined with Urokinase.,Benmoxin
DB09248,The risk or severity of bleeding and hemorrhage can be increased when Mebanazine is combined with Urokinase.,Mebanazine
DB09249,The risk or severity of bleeding and hemorrhage can be increased when Octamoxin is combined with Urokinase.,Octamoxin
DB09250,The risk or severity of bleeding and hemorrhage can be increased when Pheniprazine is combined with Urokinase.,Pheniprazine
DB09251,The risk or severity of bleeding and hemorrhage can be increased when Phenoxypropazine is combined with Urokinase.,Phenoxypropazine
DB09252,The risk or severity of bleeding and hemorrhage can be increased when Pivhydrazine is combined with Urokinase.,Pivhydrazine
DB09253,The risk or severity of bleeding and hemorrhage can be increased when Safrazine is combined with Urokinase.,Safrazine
DB09254,The risk or severity of bleeding and hemorrhage can be increased when Caroxazone is combined with Urokinase.,Caroxazone
DB13875,The risk or severity of bleeding and hemorrhage can be increased when Harmaline is combined with Urokinase.,Harmaline
DB13876,The risk or severity of bleeding and hemorrhage can be increased when Brofaromine is combined with Urokinase.,Brofaromine
DB00974,The risk or severity of bleeding can be increased when Edetic acid is combined with Urokinase.,Edetic acid
DB11268,The risk or severity of bleeding can be increased when Protocatechualdehyde is combined with Urokinase.,Protocatechualdehyde
DB13124,The risk or severity of bleeding can be increased when Troxerutin is combined with Urokinase.,Troxerutin
DB00177,The risk or severity of angioedema can be increased when Urokinase is combined with Valsartan.,Valsartan
DB00178,The risk or severity of angioedema can be increased when Urokinase is combined with Ramipril.,Ramipril
DB00230,The risk or severity of angioedema can be increased when Urokinase is combined with Pregabalin.,Pregabalin
DB00492,The risk or severity of angioedema can be increased when Urokinase is combined with Fosinopril.,Fosinopril
DB00519,The risk or severity of angioedema can be increased when Urokinase is combined with Trandolapril.,Trandolapril
DB00542,The risk or severity of angioedema can be increased when Urokinase is combined with Benazepril.,Benazepril
DB00584,The risk or severity of angioedema can be increased when Urokinase is combined with Enalapril.,Enalapril
DB00678,The risk or severity of angioedema can be increased when Urokinase is combined with Losartan.,Losartan
DB00691,The risk or severity of angioedema can be increased when Urokinase is combined with Moexipril.,Moexipril
DB00722,The risk or severity of angioedema can be increased when Urokinase is combined with Lisinopril.,Lisinopril
DB00790,The risk or severity of angioedema can be increased when Urokinase is combined with Perindopril.,Perindopril
DB00876,The risk or severity of angioedema can be increased when Urokinase is combined with Eprosartan.,Eprosartan
DB00877,The risk or severity of angioedema can be increased when Urokinase is combined with Sirolimus.,Sirolimus
DB00881,The risk or severity of angioedema can be increased when Urokinase is combined with Quinapril.,Quinapril
DB00886,The risk or severity of angioedema can be increased when Urokinase is combined with Omapatrilat.,Omapatrilat
DB00966,The risk or severity of angioedema can be increased when Urokinase is combined with Telmisartan.,Telmisartan
DB01050,The risk or severity of angioedema can be increased when Urokinase is combined with Ibuprofen.,Ibuprofen
DB01180,The risk or severity of angioedema can be increased when Urokinase is combined with Rescinnamine.,Rescinnamine
DB01197,The risk or severity of angioedema can be increased when Urokinase is combined with Captopril.,Captopril
DB01261,The risk or severity of angioedema can be increased when Urokinase is combined with Sitagliptin.,Sitagliptin
DB01340,The risk or severity of angioedema can be increased when Urokinase is combined with Cilazapril.,Cilazapril
DB01342,The risk or severity of angioedema can be increased when Urokinase is combined with Forasartan.,Forasartan
DB01347,The risk or severity of angioedema can be increased when Urokinase is combined with Saprisartan.,Saprisartan
DB01348,The risk or severity of angioedema can be increased when Urokinase is combined with Spirapril.,Spirapril
DB04876,The risk or severity of angioedema can be increased when Urokinase is combined with Vildagliptin.,Vildagliptin
DB06011,The risk or severity of angioedema can be increased when Urokinase is combined with AMG-222.,AMG-222
DB06127,The risk or severity of angioedema can be increased when Urokinase is combined with Bisegliptin.,Bisegliptin
DB06196,The risk or severity of angioedema can be increased when Urokinase is combined with Icatibant.,Icatibant
DB06203,The risk or severity of angioedema can be increased when Urokinase is combined with Alogliptin.,Alogliptin
DB06245,The risk or severity of angioedema can be increased when Urokinase is combined with Lanoteplase.,Lanoteplase
DB06287,The risk or severity of angioedema can be increased when Urokinase is combined with Temsirolimus.,Temsirolimus
DB06335,The risk or severity of angioedema can be increased when Urokinase is combined with Saxagliptin.,Saxagliptin
DB08382,The risk or severity of angioedema can be increased when Urokinase is combined with Gosogliptin.,Gosogliptin
DB08822,The risk or severity of angioedema can be increased when Urokinase is combined with Azilsartan medoxomil.,Azilsartan medoxomil
DB08836,The risk or severity of angioedema can be increased when Urokinase is combined with Temocapril.,Temocapril
DB08882,The risk or severity of angioedema can be increased when Urokinase is combined with Linagliptin.,Linagliptin
DB09292,The risk or severity of angioedema can be increased when Urokinase is combined with Sacubitril.,Sacubitril
DB09477,The risk or severity of angioedema can be increased when Urokinase is combined with Enalaprilat.,Enalaprilat
DB11723,The risk or severity of angioedema can be increased when Urokinase is combined with Dutogliptin.,Dutogliptin
DB11783,The risk or severity of angioedema can be increased when Urokinase is combined with Imidapril.,Imidapril
DB11950,The risk or severity of angioedema can be increased when Urokinase is combined with Teneligliptin.,Teneligliptin
DB11992,The risk or severity of angioedema can be increased when Urokinase is combined with Omarigliptin.,Omarigliptin
DB12268,The risk or severity of angioedema can be increased when Urokinase is combined with Carmegliptin.,Carmegliptin
DB12412,The risk or severity of angioedema can be increased when Urokinase is combined with Gemigliptin.,Gemigliptin
DB12417,The risk or severity of angioedema can be increased when Urokinase is combined with Anagliptin.,Anagliptin
DB12625,The risk or severity of angioedema can be increased when Urokinase is combined with Evogliptin.,Evogliptin
DB13166,The risk or severity of angioedema can be increased when Urokinase is combined with Zofenopril.,Zofenopril
DB13312,The risk or severity of angioedema can be increased when Urokinase is combined with Delapril.,Delapril
DB14125,The risk or severity of angioedema can be increased when Urokinase is combined with Benazeprilat.,Benazeprilat
DB14207,The risk or severity of angioedema can be increased when Urokinase is combined with Fosinoprilat.,Fosinoprilat
DB14208,The risk or severity of angioedema can be increased when Urokinase is combined with Ramiprilat.,Ramiprilat
DB14209,The risk or severity of angioedema can be increased when Urokinase is combined with Trandolaprilat.,Trandolaprilat
DB14210,The risk or severity of angioedema can be increased when Urokinase is combined with Moexiprilat.,Moexiprilat
DB14213,The risk or severity of angioedema can be increased when Urokinase is combined with Perindoprilat.,Perindoprilat
DB14217,The risk or severity of angioedema can be increased when Urokinase is combined with Quinaprilat.,Quinaprilat
DB14231,The risk or severity of angioedema can be increased when Urokinase is combined with Quinoline Yellow WS.,Quinoline Yellow WS
DB00203,The risk or severity of hemorrhage can be increased when Urokinase is combined with Sildenafil.,Sildenafil
DB00008,The risk or severity of bleeding can be increased when Urokinase is combined with Peginterferon alfa-2a.,Peginterferon alfa-2a
DB00011,The risk or severity of bleeding can be increased when Urokinase is combined with Interferon alfa-n1.,Interferon alfa-n1
DB00018,The risk or severity of bleeding can be increased when Urokinase is combined with Interferon alfa-n3.,Interferon alfa-n3
DB00022,The risk or severity of bleeding can be increased when Urokinase is combined with Peginterferon alfa-2b.,Peginterferon alfa-2b
DB00033,The risk or severity of bleeding can be increased when Urokinase is combined with Interferon gamma-1b.,Interferon gamma-1b
DB00034,"The risk or severity of bleeding can be increased when Urokinase is combined with Interferon alfa-2a, Recombinant.","Interferon alfa-2a, Recombinant"
DB00041,The risk or severity of bleeding can be increased when Urokinase is combined with Aldesleukin.,Aldesleukin
DB00056,The risk or severity of bleeding can be increased when Urokinase is combined with Gemtuzumab ozogamicin.,Gemtuzumab ozogamicin
DB00068,The risk or severity of bleeding can be increased when Urokinase is combined with Interferon beta-1b.,Interferon beta-1b
DB00069,The risk or severity of bleeding can be increased when Urokinase is combined with Interferon alfacon-1.,Interferon alfacon-1
DB00073,The risk or severity of bleeding can be increased when Urokinase is combined with Rituximab.,Rituximab
DB00078,The risk or severity of bleeding can be increased when Urokinase is combined with Ibritumomab tiuxetan.,Ibritumomab tiuxetan
DB00087,The risk or severity of bleeding can be increased when Urokinase is combined with Alemtuzumab.,Alemtuzumab
DB00105,The risk or severity of bleeding can be increased when Urokinase is combined with Interferon alfa-2b.,Interferon alfa-2b
DB00120,The risk or severity of bleeding can be increased when Urokinase is combined with Phenylalanine.,Phenylalanine
DB00188,The risk or severity of bleeding can be increased when Urokinase is combined with Bortezomib.,Bortezomib
DB00242,The risk or severity of bleeding can be increased when Urokinase is combined with Cladribine.,Cladribine
DB00262,The risk or severity of bleeding can be increased when Urokinase is combined with Carmustine.,Carmustine
DB00276,The risk or severity of bleeding can be increased when Urokinase is combined with Amsacrine.,Amsacrine
DB00291,The risk or severity of bleeding can be increased when Urokinase is combined with Chlorambucil.,Chlorambucil
DB00293,The risk or severity of bleeding can be increased when Urokinase is combined with Raltitrexed.,Raltitrexed
DB00305,The risk or severity of bleeding can be increased when Urokinase is combined with Mitomycin.,Mitomycin
DB00307,The risk or severity of bleeding can be increased when Urokinase is combined with Bexarotene.,Bexarotene
DB00309,The risk or severity of bleeding can be increased when Urokinase is combined with Vindesine.,Vindesine
DB00322,The risk or severity of bleeding can be increased when Urokinase is combined with Floxuridine.,Floxuridine
DB00352,The risk or severity of bleeding can be increased when Urokinase is combined with Tioguanine.,Tioguanine
DB00361,The risk or severity of bleeding can be increased when Urokinase is combined with Vinorelbine.,Vinorelbine
DB00380,The risk or severity of bleeding can be increased when Urokinase is combined with Dexrazoxane.,Dexrazoxane
DB00398,The risk or severity of bleeding can be increased when Urokinase is combined with Sorafenib.,Sorafenib
DB00428,The risk or severity of bleeding can be increased when Urokinase is combined with Streptozocin.,Streptozocin
DB00441,The risk or severity of bleeding can be increased when Urokinase is combined with Gemcitabine.,Gemcitabine
DB00444,The risk or severity of bleeding can be increased when Urokinase is combined with Teniposide.,Teniposide
DB00445,The risk or severity of bleeding can be increased when Urokinase is combined with Epirubicin.,Epirubicin
DB00446,The risk or severity of bleeding can be increased when Urokinase is combined with Chloramphenicol.,Chloramphenicol
DB00480,The risk or severity of bleeding can be increased when Urokinase is combined with Lenalidomide.,Lenalidomide
DB00488,The risk or severity of bleeding can be increased when Urokinase is combined with Altretamine.,Altretamine
DB00495,The risk or severity of bleeding can be increased when Urokinase is combined with Zidovudine.,Zidovudine
DB00515,The risk or severity of bleeding can be increased when Urokinase is combined with Cisplatin.,Cisplatin
DB00526,The risk or severity of bleeding can be increased when Urokinase is combined with Oxaliplatin.,Oxaliplatin
DB00531,The risk or severity of bleeding can be increased when Urokinase is combined with Cyclophosphamide.,Cyclophosphamide
DB00544,The risk or severity of bleeding can be increased when Urokinase is combined with Fluorouracil.,Fluorouracil
DB00552,The risk or severity of bleeding can be increased when Urokinase is combined with Pentostatin.,Pentostatin
DB00563,The risk or severity of bleeding can be increased when Urokinase is combined with Methotrexate.,Methotrexate
DB00564,The risk or severity of bleeding can be increased when Urokinase is combined with Carbamazepine.,Carbamazepine
DB00570,The risk or severity of bleeding can be increased when Urokinase is combined with Vinblastine.,Vinblastine
DB00619,The risk or severity of bleeding can be increased when Urokinase is combined with Imatinib.,Imatinib
DB00631,The risk or severity of bleeding can be increased when Urokinase is combined with Clofarabine.,Clofarabine
DB00642,The risk or severity of bleeding can be increased when Urokinase is combined with Pemetrexed.,Pemetrexed
DB00694,The risk or severity of bleeding can be increased when Urokinase is combined with Daunorubicin.,Daunorubicin
DB00762,The risk or severity of bleeding can be increased when Urokinase is combined with Irinotecan.,Irinotecan
DB00773,The risk or severity of bleeding can be increased when Urokinase is combined with Etoposide.,Etoposide
DB00851,The risk or severity of bleeding can be increased when Urokinase is combined with Dacarbazine.,Dacarbazine
DB00853,The risk or severity of bleeding can be increased when Urokinase is combined with Temozolomide.,Temozolomide
DB00859,The risk or severity of bleeding can be increased when Urokinase is combined with Penicillamine.,Penicillamine
DB00864,The risk or severity of bleeding can be increased when Urokinase is combined with Tacrolimus.,Tacrolimus
DB00888,The risk or severity of bleeding can be increased when Urokinase is combined with Mechlorethamine.,Mechlorethamine
DB00928,The risk or severity of bleeding can be increased when Urokinase is combined with Azacitidine.,Azacitidine
DB00958,The risk or severity of bleeding can be increased when Urokinase is combined with Carboplatin.,Carboplatin
DB00970,The risk or severity of bleeding can be increased when Urokinase is combined with Dactinomycin.,Dactinomycin
DB00987,The risk or severity of bleeding can be increased when Urokinase is combined with Cytarabine.,Cytarabine
DB00997,The risk or severity of bleeding can be increased when Urokinase is combined with Doxorubicin.,Doxorubicin
DB01005,The risk or severity of bleeding can be increased when Urokinase is combined with Hydroxyurea.,Hydroxyurea
DB01008,The risk or severity of bleeding can be increased when Urokinase is combined with Busulfan.,Busulfan
DB01030,The risk or severity of bleeding can be increased when Urokinase is combined with Topotecan.,Topotecan
DB01033,The risk or severity of bleeding can be increased when Urokinase is combined with Mercaptopurine.,Mercaptopurine
DB01041,The risk or severity of bleeding can be increased when Urokinase is combined with Thalidomide.,Thalidomide
DB01042,The risk or severity of bleeding can be increased when Urokinase is combined with Melphalan.,Melphalan
DB01073,The risk or severity of bleeding can be increased when Urokinase is combined with Fludarabine.,Fludarabine
DB01099,The risk or severity of bleeding can be increased when Urokinase is combined with Flucytosine.,Flucytosine
DB01101,The risk or severity of bleeding can be increased when Urokinase is combined with Capecitabine.,Capecitabine
DB01169,The risk or severity of bleeding can be increased when Urokinase is combined with Arsenic trioxide.,Arsenic trioxide
DB01177,The risk or severity of bleeding can be increased when Urokinase is combined with Idarubicin.,Idarubicin
DB01204,The risk or severity of bleeding can be increased when Urokinase is combined with Mitoxantrone.,Mitoxantrone
DB01206,The risk or severity of bleeding can be increased when Urokinase is combined with Lomustine.,Lomustine
DB01229,The risk or severity of bleeding can be increased when Urokinase is combined with Paclitaxel.,Paclitaxel
DB01248,The risk or severity of bleeding can be increased when Urokinase is combined with Docetaxel.,Docetaxel
DB01262,The risk or severity of bleeding can be increased when Urokinase is combined with Decitabine.,Decitabine
DB01280,The risk or severity of bleeding can be increased when Urokinase is combined with Nelarabine.,Nelarabine
DB01590,The risk or severity of bleeding can be increased when Urokinase is combined with Everolimus.,Everolimus
DB02546,The risk or severity of bleeding can be increased when Urokinase is combined with Vorinostat.,Vorinostat
DB04572,The risk or severity of bleeding can be increased when Urokinase is combined with Thiotepa.,Thiotepa
DB04845,The risk or severity of bleeding can be increased when Urokinase is combined with Ixabepilone.,Ixabepilone
DB04868,The risk or severity of bleeding can be increased when Urokinase is combined with Nilotinib.,Nilotinib
DB05015,The risk or severity of bleeding can be increased when Urokinase is combined with Belinostat.,Belinostat
DB05109,The risk or severity of bleeding can be increased when Urokinase is combined with Trabectedin.,Trabectedin
DB05258,The risk or severity of bleeding can be increased when Urokinase is combined with Interferon alfa.,Interferon alfa
DB05472,The risk or severity of bleeding can be increased when Urokinase is combined with omega interferon.,omega interferon
DB05773,The risk or severity of bleeding can be increased when Urokinase is combined with Trastuzumab emtansine.,Trastuzumab emtansine
DB06616,The risk or severity of bleeding can be increased when Urokinase is combined with Bosutinib.,Bosutinib
DB06769,The risk or severity of bleeding can be increased when Urokinase is combined with Bendamustine.,Bendamustine
DB06772,The risk or severity of bleeding can be increased when Urokinase is combined with Cabazitaxel.,Cabazitaxel
DB08871,The risk or severity of bleeding can be increased when Urokinase is combined with Eribulin.,Eribulin
DB08877,The risk or severity of bleeding can be increased when Urokinase is combined with Ruxolitinib.,Ruxolitinib
DB08889,The risk or severity of bleeding can be increased when Urokinase is combined with Carfilzomib.,Carfilzomib
DB08895,The risk or severity of bleeding can be increased when Urokinase is combined with Tofacitinib.,Tofacitinib
DB08901,The risk or severity of bleeding can be increased when Urokinase is combined with Ponatinib.,Ponatinib
DB08910,The risk or severity of bleeding can be increased when Urokinase is combined with Pomalidomide.,Pomalidomide
DB09042,The risk or severity of bleeding can be increased when Urokinase is combined with Tedizolid phosphate.,Tedizolid phosphate
DB09052,The risk or severity of bleeding can be increased when Urokinase is combined with Blinatumomab.,Blinatumomab
DB09073,The risk or severity of bleeding can be increased when Urokinase is combined with Palbociclib.,Palbociclib
DB09074,The risk or severity of bleeding can be increased when Urokinase is combined with Olaparib.,Olaparib
DB09077,The risk or severity of bleeding can be increased when Urokinase is combined with Dinutuximab.,Dinutuximab
DB09122,The risk or severity of bleeding can be increased when Urokinase is combined with Peginterferon beta-1a.,Peginterferon beta-1a
DB12814,The risk or severity of bleeding can be increased when Urokinase is combined with Cepeginterferon alfa-2B.,Cepeginterferon alfa-2B
DB00229,The therapeutic efficacy of Urokinase can be decreased when used in combination with Cefotiam.,Cefotiam
DB00267,The therapeutic efficacy of Urokinase can be decreased when used in combination with Cefmenoxime.,Cefmenoxime
DB00274,The therapeutic efficacy of Urokinase can be decreased when used in combination with Cefmetazole.,Cefmetazole
DB00430,The therapeutic efficacy of Urokinase can be decreased when used in combination with Cefpiramide.,Cefpiramide
DB00438,The therapeutic efficacy of Urokinase can be decreased when used in combination with Ceftazidime.,Ceftazidime
DB00447,The therapeutic efficacy of Urokinase can be decreased when used in combination with Loracarbef.,Loracarbef
DB00456,The therapeutic efficacy of Urokinase can be decreased when used in combination with Cefalotin.,Cefalotin
DB00493,The therapeutic efficacy of Urokinase can be decreased when used in combination with Cefotaxime.,Cefotaxime
DB00535,The therapeutic efficacy of Urokinase can be decreased when used in combination with Cefdinir.,Cefdinir
DB00567,The therapeutic efficacy of Urokinase can be decreased when used in combination with Cephalexin.,Cephalexin
DB00671,The therapeutic efficacy of Urokinase can be decreased when used in combination with Cefixime.,Cefixime
DB00689,The therapeutic efficacy of Urokinase can be decreased when used in combination with Cephaloglycin.,Cephaloglycin
DB00833,The therapeutic efficacy of Urokinase can be decreased when used in combination with Cefaclor.,Cefaclor
DB00923,The therapeutic efficacy of Urokinase can be decreased when used in combination with Ceforanide.,Ceforanide
DB01066,The therapeutic efficacy of Urokinase can be decreased when used in combination with Cefditoren.,Cefditoren
DB01112,The therapeutic efficacy of Urokinase can be decreased when used in combination with Cefuroxime.,Cefuroxime
DB01139,The therapeutic efficacy of Urokinase can be decreased when used in combination with Cefapirin.,Cefapirin
DB01140,The therapeutic efficacy of Urokinase can be decreased when used in combination with Cefadroxil.,Cefadroxil
DB01150,The therapeutic efficacy of Urokinase can be decreased when used in combination with Cefprozil.,Cefprozil
DB01212,The therapeutic efficacy of Urokinase can be decreased when used in combination with Ceftriaxone.,Ceftriaxone
DB01326,The therapeutic efficacy of Urokinase can be decreased when used in combination with Cefamandole.,Cefamandole
DB01327,The therapeutic efficacy of Urokinase can be decreased when used in combination with Cefazolin.,Cefazolin
DB01328,The therapeutic efficacy of Urokinase can be decreased when used in combination with Cefonicid.,Cefonicid
DB01329,The therapeutic efficacy of Urokinase can be decreased when used in combination with Cefoperazone.,Cefoperazone
DB01330,The therapeutic efficacy of Urokinase can be decreased when used in combination with Cefotetan.,Cefotetan
DB01331,The therapeutic efficacy of Urokinase can be decreased when used in combination with Cefoxitin.,Cefoxitin
DB01332,The therapeutic efficacy of Urokinase can be decreased when used in combination with Ceftizoxime.,Ceftizoxime
DB01333,The therapeutic efficacy of Urokinase can be decreased when used in combination with Cefradine.,Cefradine
DB01413,The therapeutic efficacy of Urokinase can be decreased when used in combination with Cefepime.,Cefepime
DB01414,The therapeutic efficacy of Urokinase can be decreased when used in combination with Cefacetrile.,Cefacetrile
DB01415,The therapeutic efficacy of Urokinase can be decreased when used in combination with Ceftibuten.,Ceftibuten
DB01416,The therapeutic efficacy of Urokinase can be decreased when used in combination with Cefpodoxime.,Cefpodoxime
DB04570,The therapeutic efficacy of Urokinase can be decreased when used in combination with Latamoxef.,Latamoxef
DB04918,The therapeutic efficacy of Urokinase can be decreased when used in combination with Ceftobiprole.,Ceftobiprole
DB06590,The therapeutic efficacy of Urokinase can be decreased when used in combination with Ceftaroline fosamil.,Ceftaroline fosamil
DB09008,The therapeutic efficacy of Urokinase can be decreased when used in combination with Cefaloridine.,Cefaloridine
DB09050,The therapeutic efficacy of Urokinase can be decreased when used in combination with Ceftolozane.,Ceftolozane
DB09062,The therapeutic efficacy of Urokinase can be decreased when used in combination with Cefminox.,Cefminox
DB11367,The therapeutic efficacy of Urokinase can be decreased when used in combination with Cefroxadine.,Cefroxadine
DB11935,The therapeutic efficacy of Urokinase can be decreased when used in combination with Flomoxef.,Flomoxef
DB13266,The therapeutic efficacy of Urokinase can be decreased when used in combination with Cefatrizine.,Cefatrizine
DB13461,The therapeutic efficacy of Urokinase can be decreased when used in combination with Cefcapene.,Cefcapene
DB13470,The therapeutic efficacy of Urokinase can be decreased when used in combination with Cefodizime.,Cefodizime
DB13499,The therapeutic efficacy of Urokinase can be decreased when used in combination with Cefsulodin.,Cefsulodin
DB13504,The therapeutic efficacy of Urokinase can be decreased when used in combination with Cefetamet.,Cefetamet
DB13638,The therapeutic efficacy of Urokinase can be decreased when used in combination with Cefbuperazone.,Cefbuperazone
DB13667,The therapeutic efficacy of Urokinase can be decreased when used in combination with Cefozopran.,Cefozopran
DB13682,The therapeutic efficacy of Urokinase can be decreased when used in combination with Cefpirome.,Cefpirome
DB13778,The therapeutic efficacy of Urokinase can be decreased when used in combination with Cefazedone.,Cefazedone
DB13821,The therapeutic efficacy of Urokinase can be decreased when used in combination with Ceftezole.,Ceftezole
DB14725,The therapeutic efficacy of Urokinase can be decreased when used in combination with Cefamandole nafate.,Cefamandole nafate
DB00254,The risk or severity of bleeding can be increased when Doxycycline is combined with Urokinase.,Doxycycline
DB00207,The risk or severity of adverse effects can be increased when Azithromycin is combined with Urokinase.,Azithromycin
DB09539,The risk or severity of bleeding can be increased when Omega-3-acid ethyl esters is combined with Urokinase.,Omega-3-acid ethyl esters
DB01606,The risk or severity of bleeding can be increased when Tazobactam is combined with Urokinase.,Tazobactam
DB00199,The risk or severity of bleeding can be increased when Erythromycin is combined with Urokinase.,Erythromycin
DB00656,The risk or severity of bleeding can be increased when Trazodone is combined with Urokinase.,Trazodone
DB00620,The therapeutic efficacy of Urokinase can be decreased when used in combination with Triamcinolone.,Triamcinolone
DB09079,The risk or severity of bleeding can be increased when Urokinase is combined with Nintedanib.,Nintedanib
DB01175,The risk or severity of bleeding can be increased when Escitalopram is combined with Urokinase.,Escitalopram
DB01104,The risk or severity of bleeding can be increased when Sertraline is combined with Urokinase.,Sertraline
DB00232,The therapeutic efficacy of Urokinase can be decreased when used in combination with Methyclothiazide.,Methyclothiazide
DB00436,The therapeutic efficacy of Urokinase can be decreased when used in combination with Bendroflumethiazide.,Bendroflumethiazide
DB00562,The therapeutic efficacy of Urokinase can be decreased when used in combination with Benzthiazide.,Benzthiazide
DB00606,The therapeutic efficacy of Urokinase can be decreased when used in combination with Cyclothiazide.,Cyclothiazide
DB00774,The therapeutic efficacy of Urokinase can be decreased when used in combination with Hydroflumethiazide.,Hydroflumethiazide
DB00880,The therapeutic efficacy of Urokinase can be decreased when used in combination with Chlorothiazide.,Chlorothiazide
DB00999,The therapeutic efficacy of Urokinase can be decreased when used in combination with Hydrochlorothiazide.,Hydrochlorothiazide
DB01021,The therapeutic efficacy of Urokinase can be decreased when used in combination with Trichlormethiazide.,Trichlormethiazide
DB01324,The therapeutic efficacy of Urokinase can be decreased when used in combination with Polythiazide.,Polythiazide
DB13430,The therapeutic efficacy of Urokinase can be decreased when used in combination with Mebutizide.,Mebutizide
DB13532,The therapeutic efficacy of Urokinase can be decreased when used in combination with Cyclopenthiazide.,Cyclopenthiazide
DB09066,The therapeutic efficacy of Corifollitropin alfa can be increased when used in combination with Goserelin.,Corifollitropin alfa
DB09083,Ivabradine may increase the QTc-prolonging activities of Goserelin.,Ivabradine
DB08894,The risk or severity of Thrombosis can be increased when Goserelin is combined with Peginesatide.,Peginesatide
DB00012,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Goserelin.,Darbepoetin alfa
DB00016,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Goserelin.,Erythropoietin
DB09107,The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Goserelin.,Methoxy polyethylene glycol-epoetin beta
DB09277,Goserelin may decrease effectiveness of Choline C 11 as a diagnostic agent.,Choline C 11
DB00089,Goserelin may decrease effectiveness of Capromab pendetide as a diagnostic agent.,Capromab pendetide
DB00030,The therapeutic efficacy of Insulin human can be decreased when used in combination with Goserelin.,Insulin human
DB00046,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Goserelin.,Insulin lispro
DB00047,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Goserelin.,Insulin glargine
DB00071,The therapeutic efficacy of Insulin pork can be decreased when used in combination with Goserelin.,Insulin pork
DB00197,The therapeutic efficacy of Troglitazone can be decreased when used in combination with Goserelin.,Troglitazone
DB00222,The therapeutic efficacy of Glimepiride can be decreased when used in combination with Goserelin.,Glimepiride
DB00284,The therapeutic efficacy of Acarbose can be decreased when used in combination with Goserelin.,Acarbose
DB00359,The therapeutic efficacy of Sulfadiazine can be decreased when used in combination with Goserelin.,Sulfadiazine
DB00412,The therapeutic efficacy of Rosiglitazone can be decreased when used in combination with Goserelin.,Rosiglitazone
DB00414,The therapeutic efficacy of Acetohexamide can be decreased when used in combination with Goserelin.,Acetohexamide
DB00491,The therapeutic efficacy of Miglitol can be decreased when used in combination with Goserelin.,Miglitol
DB00672,The therapeutic efficacy of Chlorpropamide can be decreased when used in combination with Goserelin.,Chlorpropamide
DB00731,The therapeutic efficacy of Nateglinide can be decreased when used in combination with Goserelin.,Nateglinide
DB00839,The therapeutic efficacy of Tolazamide can be decreased when used in combination with Goserelin.,Tolazamide
DB00912,The therapeutic efficacy of Repaglinide can be decreased when used in combination with Goserelin.,Repaglinide
DB00914,The therapeutic efficacy of Phenformin can be decreased when used in combination with Goserelin.,Phenformin
DB01016,The therapeutic efficacy of Glyburide can be decreased when used in combination with Goserelin.,Glyburide
DB01067,The therapeutic efficacy of Glipizide can be decreased when used in combination with Goserelin.,Glipizide
DB01120,The therapeutic efficacy of Gliclazide can be decreased when used in combination with Goserelin.,Gliclazide
DB01124,The therapeutic efficacy of Tolbutamide can be decreased when used in combination with Goserelin.,Tolbutamide
DB01132,The therapeutic efficacy of Pioglitazone can be decreased when used in combination with Goserelin.,Pioglitazone
DB01200,The therapeutic efficacy of Bromocriptine can be decreased when used in combination with Goserelin.,Bromocriptine
DB01251,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Goserelin.,Gliquidone
DB01252,The therapeutic efficacy of Mitiglinide can be decreased when used in combination with Goserelin.,Mitiglinide
DB01261,The therapeutic efficacy of Sitagliptin can be decreased when used in combination with Goserelin.,Sitagliptin
DB01276,The therapeutic efficacy of Exenatide can be decreased when used in combination with Goserelin.,Exenatide
DB01277,The therapeutic efficacy of Mecasermin can be decreased when used in combination with Goserelin.,Mecasermin
DB01278,The therapeutic efficacy of Pramlintide can be decreased when used in combination with Goserelin.,Pramlintide
DB01289,The therapeutic efficacy of Glisoxepide can be decreased when used in combination with Goserelin.,Glisoxepide
DB01306,The therapeutic efficacy of Insulin aspart can be decreased when used in combination with Goserelin.,Insulin aspart
DB01307,The therapeutic efficacy of Insulin detemir can be decreased when used in combination with Goserelin.,Insulin detemir
DB01309,The therapeutic efficacy of Insulin glulisine can be decreased when used in combination with Goserelin.,Insulin glulisine
DB01382,The therapeutic efficacy of Glymidine can be decreased when used in combination with Goserelin.,Glymidine
DB01700,The therapeutic efficacy of AICA ribonucleotide can be decreased when used in combination with Goserelin.,AICA ribonucleotide
DB04830,The therapeutic efficacy of Buformin can be decreased when used in combination with Goserelin.,Buformin
DB04876,The therapeutic efficacy of Vildagliptin can be decreased when used in combination with Goserelin.,Vildagliptin
DB04878,The therapeutic efficacy of Voglibose can be decreased when used in combination with Goserelin.,Voglibose
DB05115,The therapeutic efficacy of NN344 can be decreased when used in combination with Goserelin.,NN344
DB05819,The therapeutic efficacy of NBI-6024 can be decreased when used in combination with Goserelin.,NBI-6024
DB06011,The therapeutic efficacy of AMG-222 can be decreased when used in combination with Goserelin.,AMG-222
DB06127,The therapeutic efficacy of Bisegliptin can be decreased when used in combination with Goserelin.,Bisegliptin
DB06203,The therapeutic efficacy of Alogliptin can be decreased when used in combination with Goserelin.,Alogliptin
DB06292,The therapeutic efficacy of Dapagliflozin can be decreased when used in combination with Goserelin.,Dapagliflozin
DB06335,The therapeutic efficacy of Saxagliptin can be decreased when used in combination with Goserelin.,Saxagliptin
DB06655,The therapeutic efficacy of Liraglutide can be decreased when used in combination with Goserelin.,Liraglutide
DB08382,The therapeutic efficacy of Gosogliptin can be decreased when used in combination with Goserelin.,Gosogliptin
DB08882,The therapeutic efficacy of Linagliptin can be decreased when used in combination with Goserelin.,Linagliptin
DB08907,The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Goserelin.,Canagliflozin
DB08962,The therapeutic efficacy of Glibornuride can be decreased when used in combination with Goserelin.,Glibornuride
DB09022,The therapeutic efficacy of Benfluorex can be decreased when used in combination with Goserelin.,Benfluorex
DB09038,The therapeutic efficacy of Empagliflozin can be decreased when used in combination with Goserelin.,Empagliflozin
DB09043,The therapeutic efficacy of Albiglutide can be decreased when used in combination with Goserelin.,Albiglutide
DB09045,The therapeutic efficacy of Dulaglutide can be decreased when used in combination with Goserelin.,Dulaglutide
DB09198,The therapeutic efficacy of Lobeglitazone can be decreased when used in combination with Goserelin.,Lobeglitazone
DB09199,The therapeutic efficacy of Netoglitazone can be decreased when used in combination with Goserelin.,Netoglitazone
DB09200,The therapeutic efficacy of Rivoglitazone can be decreased when used in combination with Goserelin.,Rivoglitazone
DB09201,The therapeutic efficacy of Ciglitazone can be decreased when used in combination with Goserelin.,Ciglitazone
DB09265,The therapeutic efficacy of Lixisenatide can be decreased when used in combination with Goserelin.,Lixisenatide
DB09456,The therapeutic efficacy of Insulin beef can be decreased when used in combination with Goserelin.,Insulin beef
DB09564,The therapeutic efficacy of Insulin degludec can be decreased when used in combination with Goserelin.,Insulin degludec
DB11567,The therapeutic efficacy of Insulin peglispro can be decreased when used in combination with Goserelin.,Insulin peglispro
DB11568,The therapeutic efficacy of Insulin tregopil can be decreased when used in combination with Goserelin.,Insulin tregopil
DB11698,The therapeutic efficacy of Ipragliflozin can be decreased when used in combination with Goserelin.,Ipragliflozin
DB11723,The therapeutic efficacy of Dutogliptin can be decreased when used in combination with Goserelin.,Dutogliptin
DB11780,The therapeutic efficacy of Allicin can be decreased when used in combination with Goserelin.,Allicin
DB11824,The therapeutic efficacy of Tofogliflozin can be decreased when used in combination with Goserelin.,Tofogliflozin
DB11827,The therapeutic efficacy of Ertugliflozin can be decreased when used in combination with Goserelin.,Ertugliflozin
DB11898,"The therapeutic efficacy of 2,4-thiazolidinedione can be decreased when used in combination with Goserelin.","2,4-thiazolidinedione"
DB11950,The therapeutic efficacy of Teneligliptin can be decreased when used in combination with Goserelin.,Teneligliptin
DB11992,The therapeutic efficacy of Omarigliptin can be decreased when used in combination with Goserelin.,Omarigliptin
DB12268,The therapeutic efficacy of Carmegliptin can be decreased when used in combination with Goserelin.,Carmegliptin
DB12412,The therapeutic efficacy of Gemigliptin can be decreased when used in combination with Goserelin.,Gemigliptin
DB12417,The therapeutic efficacy of Anagliptin can be decreased when used in combination with Goserelin.,Anagliptin
DB12625,The therapeutic efficacy of Evogliptin can be decreased when used in combination with Goserelin.,Evogliptin
DB12713,The therapeutic efficacy of Sotagliflozin can be decreased when used in combination with Goserelin.,Sotagliflozin
DB12781,The therapeutic efficacy of Balaglitazone can be decreased when used in combination with Goserelin.,Balaglitazone
DB12935,The therapeutic efficacy of Remogliflozin etabonate can be decreased when used in combination with Goserelin.,Remogliflozin etabonate
DB13406,The therapeutic efficacy of Carbutamide can be decreased when used in combination with Goserelin.,Carbutamide
DB13446,The therapeutic efficacy of Guar gum can be decreased when used in combination with Goserelin.,Guar gum
DB13675,The therapeutic efficacy of Metahexamide can be decreased when used in combination with Goserelin.,Metahexamide
DB13928,The therapeutic efficacy of Semaglutide can be decreased when used in combination with Goserelin.,Semaglutide
DB14027,The therapeutic efficacy of Taspoglutide can be decreased when used in combination with Goserelin.,Taspoglutide
DB14035,The therapeutic efficacy of Englitazone can be decreased when used in combination with Goserelin.,Englitazone
DB15171,The therapeutic efficacy of Tirzepatide can be decreased when used in combination with Goserelin.,Tirzepatide
DB15217,The therapeutic efficacy of Gastric inhibitory polypeptide can be decreased when used in combination with Goserelin.,Gastric inhibitory polypeptide
DB00204,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Dofetilide.,Dofetilide
DB00215,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Citalopram.,Citalopram
DB00261,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Anagrelide.,Anagrelide
DB00280,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Disopyramide.,Disopyramide
DB00283,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Clemastine.,Clemastine
DB00308,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Ibutilide.,Ibutilide
DB00313,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Valproic acid.,Valproic acid
DB00342,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Terfenadine.,Terfenadine
DB00365,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Grepafloxacin.,Grepafloxacin
DB00468,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Quinine.,Quinine
DB00489,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Sotalol.,Sotalol
DB00530,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Erlotinib.,Erlotinib
DB00539,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Toremifene.,Toremifene
DB00604,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Cisapride.,Cisapride
DB00619,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Imatinib.,Imatinib
DB00637,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Astemizole.,Astemizole
DB00679,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Thioridazine.,Thioridazine
DB00685,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Trovafloxacin.,Trovafloxacin
DB00834,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Mifepristone.,Mifepristone
DB00875,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Flupentixol.,Flupentixol
DB00907,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Cocaine.,Cocaine
DB00908,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Quinidine.,Quinidine
DB01035,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Procainamide.,Procainamide
DB01100,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Pimozide.,Pimozide
DB01118,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Amiodarone.,Amiodarone
DB01169,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Arsenic trioxide.,Arsenic trioxide
DB01175,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Escitalopram.,Escitalopram
DB01184,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Domperidone.,Domperidone
DB01208,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Sparfloxacin.,Sparfloxacin
DB01218,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Halofantrine.,Halofantrine
DB01244,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Bepridil.,Bepridil
DB01267,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Paliperidone.,Paliperidone
DB01356,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Lithium cation.,Lithium cation
DB01405,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Temafloxacin.,Temafloxacin
DB01624,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Zuclopenthixol.,Zuclopenthixol
DB04844,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Tetrabenazine.,Tetrabenazine
DB04855,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Dronedarone.,Dronedarone
DB04868,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Nilotinib.,Nilotinib
DB04946,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Iloperidone.,Iloperidone
DB05294,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Vandetanib.,Vandetanib
DB06176,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Romidepsin.,Romidepsin
DB06216,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Asenapine.,Asenapine
DB06697,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Artemether.,Artemether
DB06708,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Lumefantrine.,Lumefantrine
DB08881,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Vemurafenib.,Vemurafenib
DB09039,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Eliglustat.,Eliglustat
DB11730,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Ribociclib.,Ribociclib
DB11978,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Glasdegib.,Glasdegib
DB12161,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Deutetrabenazine.,Deutetrabenazine
DB13074,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Macimorelin.,Macimorelin
DB13725,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Terodiline.,Terodiline
DB00007,The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Goserelin.,Leuprolide
DB00195,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Betaxolol.,Betaxolol
DB00199,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Erythromycin.,Erythromycin
DB00207,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Azithromycin.,Azithromycin
DB00218,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Moxifloxacin.,Moxifloxacin
DB00243,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Ranolazine.,Ranolazine
DB00263,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Sulfisoxazole.,Sulfisoxazole
DB00333,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Methadone.,Methadone
DB00343,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Diltiazem.,Diltiazem
DB00363,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Clozapine.,Clozapine
DB00391,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Sulpiride.,Sulpiride
DB00393,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Nimodipine.,Nimodipine
DB00420,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Promazine.,Promazine
DB00433,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Prochlorperazine.,Prochlorperazine
DB00450,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Droperidol.,Droperidol
DB00477,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Chlorpromazine.,Chlorpromazine
DB00526,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Oxaliplatin.,Oxaliplatin
DB00537,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Ciprofloxacin.,Ciprofloxacin
DB00544,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Fluorouracil.,Fluorouracil
DB00556,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Perflutren.,Perflutren
DB00568,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Cinnarizine.,Cinnarizine
DB00571,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Propranolol.,Propranolol
DB00572,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Atropine.,Atropine
DB00608,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Chloroquine.,Chloroquine
DB00625,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Efavirenz.,Efavirenz
DB00640,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Adenosine.,Adenosine
DB00738,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Pentamidine.,Pentamidine
DB00743,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Gadobenic acid.,Gadobenic acid
DB00748,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Carbinoxamine.,Carbinoxamine
DB00757,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Dolasetron.,Dolasetron
DB00778,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Roxithromycin.,Roxithromycin
DB00779,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Nalidixic acid.,Nalidixic acid
DB00827,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Cinoxacin.,Cinoxacin
DB00836,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Loperamide.,Loperamide
DB00889,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Granisetron.,Granisetron
DB00904,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Ondansetron.,Ondansetron
DB00922,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Levosimendan.,Levosimendan
DB00933,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Mesoridazine.,Mesoridazine
DB00967,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Desloratadine.,Desloratadine
DB00976,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Telithromycin.,Telithromycin
DB00978,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Lomefloxacin.,Lomefloxacin
DB00985,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Dimenhydrinate.,Dimenhydrinate
DB01087,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Primaquine.,Primaquine
DB01113,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Papaverine.,Papaverine
DB01114,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Chlorpheniramine.,Chlorpheniramine
DB01115,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Nifedipine.,Nifedipine
DB01137,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Levofloxacin.,Levofloxacin
DB01155,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Gemifloxacin.,Gemifloxacin
DB01165,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Ofloxacin.,Ofloxacin
DB01182,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Propafenone.,Propafenone
DB01193,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Acebutolol.,Acebutolol
DB01195,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Flecainide.,Flecainide
DB01211,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Clarithromycin.,Clarithromycin
DB01227,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Levacetylmethadol.,Levacetylmethadol
DB01232,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Saquinavir.,Saquinavir
DB01388,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Mibefradil.,Mibefradil
DB01580,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Oxprenolol.,Oxprenolol
DB01599,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Probucol.,Probucol
DB01615,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Aceprometazine.,Aceprometazine
DB02638,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Terlipressin.,Terlipressin
DB04825,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Prenylamine.,Prenylamine
DB04842,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Fluspirilene.,Fluspirilene
DB04948,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Lofexidine.,Lofexidine
DB04957,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Azimilide.,Azimilide
DB05223,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Pracinostat.,Pracinostat
DB05488,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Technetium Tc-99m ciprofloxacin.,Technetium Tc-99m ciprofloxacin
DB06160,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Garenoxacin.,Garenoxacin
DB06200,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Tedisamil.,Tedisamil
DB06334,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Tucidinostat.,Tucidinostat
DB06402,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Telavancin.,Telavancin
DB06589,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Pazopanib.,Pazopanib
DB06600,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Nemonoxacin.,Nemonoxacin
DB06603,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Panobinostat.,Panobinostat
DB06712,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Nilvadipine.,Nilvadipine
DB08799,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Antazoline.,Antazoline
DB08865,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Crizotinib.,Crizotinib
DB08903,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Bedaquiline.,Bedaquiline
DB08980,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Fendiline.,Fendiline
DB08992,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Eperisone.,Eperisone
DB09016,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Butriptyline.,Butriptyline
DB09063,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Ceritinib.,Ceritinib
DB09078,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Lenvatinib.,Lenvatinib
DB09224,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Melperone.,Melperone
DB09231,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Benidipine.,Benidipine
DB09555,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Dexchlorpheniramine maleate.,Dexchlorpheniramine maleate
DB11640,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Amifampridine.,Amifampridine
DB11830,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Mocetinostat.,Mocetinostat
DB11841,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Entinostat.,Entinostat
DB12141,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Gilteritinib.,Gilteritinib
DB12174,The risk or severity of QTc prolongation can be increased when Goserelin is combined with CUDC-101.,CUDC-101
DB12286,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Simendan.,Simendan
DB12376,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Ricolinostat.,Ricolinostat
DB12523,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Mizolastine.,Mizolastine
DB12565,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Abexinostat.,Abexinostat
DB12877,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Oxatomide.,Oxatomide
DB13261,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Sitafloxacin.,Sitafloxacin
DB13273,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Sultopride.,Sultopride
DB13500,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Otilonium.,Otilonium
DB13546,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Nizofenone.,Nizofenone
DB13652,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Bunaftine.,Bunaftine
DB13653,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Lorcainide.,Lorcainide
DB13679,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Dexchlorpheniramine.,Dexchlorpheniramine
DB13791,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Penfluridol.,Penfluridol
DB14063,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Dexverapamil.,Dexverapamil
DB14568,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Ivosidenib.,Ivosidenib
DB01224,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Quetiapine.,Quetiapine
DB00321,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Amitriptyline.,Amitriptyline
DB00458,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Imipramine.,Imipramine
DB01242,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Clomipramine.,Clomipramine
DB11718,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Encorafenib.,Encorafenib
DB00104,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Goserelin.,Octreotide
DB00107,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Goserelin.,Oxytocin
DB00187,The risk or severity of QTc prolongation can be increased when Esmolol is combined with Goserelin.,Esmolol
DB00188,The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Goserelin.,Bortezomib
DB00196,The risk or severity of QTc prolongation can be increased when Fluconazole is combined with Goserelin.,Fluconazole
DB00220,The risk or severity of QTc prolongation can be increased when Nelfinavir is combined with Goserelin.,Nelfinavir
DB00230,The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Goserelin.,Pregabalin
DB00245,The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Goserelin.,Benzatropine
DB00270,The risk or severity of QTc prolongation can be increased when Isradipine is combined with Goserelin.,Isradipine
DB00285,The risk or severity of QTc prolongation can be increased when Venlafaxine is combined with Goserelin.,Venlafaxine
DB00289,The risk or severity of QTc prolongation can be increased when Atomoxetine is combined with Goserelin.,Atomoxetine
DB00334,The risk or severity of QTc prolongation can be increased when Olanzapine is combined with Goserelin.,Olanzapine
DB00341,The risk or severity of QTc prolongation can be increased when Cetirizine is combined with Goserelin.,Cetirizine
DB00344,The risk or severity of QTc prolongation can be increased when Protriptyline is combined with Goserelin.,Protriptyline
DB00346,The risk or severity of QTc prolongation can be increased when Alfuzosin is combined with Goserelin.,Alfuzosin
DB00347,The risk or severity of QTc prolongation can be increased when Trimethadione is combined with Goserelin.,Trimethadione
DB00354,The risk or severity of QTc prolongation can be increased when Buclizine is combined with Goserelin.,Buclizine
DB00358,The risk or severity of QTc prolongation can be increased when Mefloquine is combined with Goserelin.,Mefloquine
DB00366,The risk or severity of QTc prolongation can be increased when Doxylamine is combined with Goserelin.,Doxylamine
DB00370,The risk or severity of QTc prolongation can be increased when Mirtazapine is combined with Goserelin.,Mirtazapine
DB00373,The risk or severity of QTc prolongation can be increased when Timolol is combined with Goserelin.,Timolol
DB00374,The risk or severity of QTc prolongation can be increased when Treprostinil is combined with Goserelin.,Treprostinil
DB00398,The risk or severity of QTc prolongation can be increased when Sorafenib is combined with Goserelin.,Sorafenib
DB00405,The risk or severity of QTc prolongation can be increased when Dexbrompheniramine is combined with Goserelin.,Dexbrompheniramine
DB00424,The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Goserelin.,Hyoscyamine
DB00427,The risk or severity of QTc prolongation can be increased when Triprolidine is combined with Goserelin.,Triprolidine
DB00434,The risk or severity of QTc prolongation can be increased when Cyproheptadine is combined with Goserelin.,Cyproheptadine
DB00467,The risk or severity of QTc prolongation can be increased when Enoxacin is combined with Goserelin.,Enoxacin
DB00487,The risk or severity of QTc prolongation can be increased when Pefloxacin is combined with Goserelin.,Pefloxacin
DB00503,The risk or severity of QTc prolongation can be increased when Ritonavir is combined with Goserelin.,Ritonavir
DB00529,The risk or severity of QTc prolongation can be increased when Foscarnet is combined with Goserelin.,Foscarnet
DB00540,The risk or severity of QTc prolongation can be increased when Nortriptyline is combined with Goserelin.,Nortriptyline
DB00543,The risk or severity of QTc prolongation can be increased when Amoxapine is combined with Goserelin.,Amoxapine
DB00555,The risk or severity of QTc prolongation can be increased when Lamotrigine is combined with Goserelin.,Lamotrigine
DB00582,The risk or severity of QTc prolongation can be increased when Voriconazole is combined with Goserelin.,Voriconazole
DB00593,The risk or severity of QTc prolongation can be increased when Ethosuximide is combined with Goserelin.,Ethosuximide
DB00613,The risk or severity of QTc prolongation can be increased when Amodiaquine is combined with Goserelin.,Amodiaquine
DB00622,The risk or severity of QTc prolongation can be increased when Nicardipine is combined with Goserelin.,Nicardipine
DB00674,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Goserelin.,Galantamine
DB00675,The risk or severity of QTc prolongation can be increased when Tamoxifen is combined with Goserelin.,Tamoxifen
DB00678,The risk or severity of QTc prolongation can be increased when Losartan is combined with Goserelin.,Losartan
DB00680,The risk or severity of QTc prolongation can be increased when Moricizine is combined with Goserelin.,Moricizine
DB00691,The risk or severity of QTc prolongation can be increased when Moexipril is combined with Goserelin.,Moexipril
DB00697,The risk or severity of QTc prolongation can be increased when Tizanidine is combined with Goserelin.,Tizanidine
DB00710,The risk or severity of QTc prolongation can be increased when Ibandronate is combined with Goserelin.,Ibandronate
DB00714,The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Goserelin.,Apomorphine
DB00719,The risk or severity of QTc prolongation can be increased when Azatadine is combined with Goserelin.,Azatadine
DB00726,The risk or severity of QTc prolongation can be increased when Trimipramine is combined with Goserelin.,Trimipramine
DB00734,The risk or severity of QTc prolongation can be increased when Risperidone is combined with Goserelin.,Risperidone
DB00753,The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Goserelin.,Isoflurane
DB00808,The risk or severity of QTc prolongation can be increased when Indapamide is combined with Goserelin.,Indapamide
DB00817,The risk or severity of QTc prolongation can be increased when Rosoxacin is combined with Goserelin.,Rosoxacin
DB00818,The risk or severity of QTc prolongation can be increased when Propofol is combined with Goserelin.,Propofol
DB00822,The risk or severity of QTc prolongation can be increased when Disulfiram is combined with Goserelin.,Disulfiram
DB00825,The risk or severity of QTc prolongation can be increased when Levomenthol is combined with Goserelin.,Levomenthol
DB00835,The risk or severity of QTc prolongation can be increased when Brompheniramine is combined with Goserelin.,Brompheniramine
DB00862,The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Goserelin.,Vardenafil
DB00871,The risk or severity of QTc prolongation can be increased when Terbutaline is combined with Goserelin.,Terbutaline
DB00909,The risk or severity of QTc prolongation can be increased when Zonisamide is combined with Goserelin.,Zonisamide
DB00915,The risk or severity of QTc prolongation can be increased when Amantadine is combined with Goserelin.,Amantadine
DB00916,The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Goserelin.,Metronidazole
DB00920,The risk or severity of QTc prolongation can be increased when Ketotifen is combined with Goserelin.,Ketotifen
DB00927,The risk or severity of QTc prolongation can be increased when Famotidine is combined with Goserelin.,Famotidine
DB00934,The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Goserelin.,Maprotiline
DB00938,The risk or severity of QTc prolongation can be increased when Salmeterol is combined with Goserelin.,Salmeterol
DB00949,The risk or severity of QTc prolongation can be increased when Felbamate is combined with Goserelin.,Felbamate
DB00983,The risk or severity of QTc prolongation can be increased when Formoterol is combined with Goserelin.,Formoterol
DB00999,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Goserelin.,Hydrochlorothiazide
DB01001,The risk or severity of QTc prolongation can be increased when Salbutamol is combined with Goserelin.,Salbutamol
DB01015,The risk or severity of QTc prolongation can be increased when Sulfamethoxazole is combined with Goserelin.,Sulfamethoxazole
DB01023,The risk or severity of QTc prolongation can be increased when Felodipine is combined with Goserelin.,Felodipine
DB01026,The risk or severity of QTc prolongation can be increased when Ketoconazole is combined with Goserelin.,Ketoconazole
DB01036,The risk or severity of QTc prolongation can be increased when Tolterodine is combined with Goserelin.,Tolterodine
DB01044,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Goserelin.,Gatifloxacin
DB01054,The risk or severity of QTc prolongation can be increased when Nitrendipine is combined with Goserelin.,Nitrendipine
DB01059,The risk or severity of QTc prolongation can be increased when Norfloxacin is combined with Goserelin.,Norfloxacin
DB01069,The risk or severity of QTc prolongation can be increased when Promethazine is combined with Goserelin.,Promethazine
DB01071,The risk or severity of QTc prolongation can be increased when Mequitazine is combined with Goserelin.,Mequitazine
DB01072,The risk or severity of QTc prolongation can be increased when Atazanavir is combined with Goserelin.,Atazanavir
DB01074,The risk or severity of QTc prolongation can be increased when Perhexiline is combined with Goserelin.,Perhexiline
DB01075,The risk or severity of QTc prolongation can be increased when Diphenhydramine is combined with Goserelin.,Diphenhydramine
DB01106,The risk or severity of QTc prolongation can be increased when Levocabastine is combined with Goserelin.,Levocabastine
DB01158,The risk or severity of QTc prolongation can be increased when Bretylium is combined with Goserelin.,Bretylium
DB01166,The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Goserelin.,Cilostazol
DB01167,The risk or severity of QTc prolongation can be increased when Itraconazole is combined with Goserelin.,Itraconazole
DB01173,The risk or severity of QTc prolongation can be increased when Orphenadrine is combined with Goserelin.,Orphenadrine
DB01176,The risk or severity of QTc prolongation can be increased when Cyclizine is combined with Goserelin.,Cyclizine
DB01189,The risk or severity of QTc prolongation can be increased when Desflurane is combined with Goserelin.,Desflurane
DB01228,The risk or severity of QTc prolongation can be increased when Encainide is combined with Goserelin.,Encainide
DB01233,The risk or severity of QTc prolongation can be increased when Metoclopramide is combined with Goserelin.,Metoclopramide
DB01236,The risk or severity of QTc prolongation can be increased when Sevoflurane is combined with Goserelin.,Sevoflurane
DB01238,The risk or severity of QTc prolongation can be increased when Aripiprazole is combined with Goserelin.,Aripiprazole
DB01239,The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Goserelin.,Chlorprothixene
DB01246,The risk or severity of QTc prolongation can be increased when Alimemazine is combined with Goserelin.,Alimemazine
DB01254,The risk or severity of QTc prolongation can be increased when Dasatinib is combined with Goserelin.,Dasatinib
DB01259,The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Goserelin.,Lapatinib
DB01263,The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Goserelin.,Posaconazole
DB01268,The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Goserelin.,Sunitinib
DB01274,The risk or severity of QTc prolongation can be increased when Arformoterol is combined with Goserelin.,Arformoterol
DB01396,The risk or severity of QTc prolongation can be increased when Digitoxin is combined with Goserelin.,Digitoxin
DB01403,The risk or severity of QTc prolongation can be increased when Methotrimeprazine is combined with Goserelin.,Methotrimeprazine
DB01426,The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Goserelin.,Ajmaline
DB01591,The risk or severity of QTc prolongation can be increased when Solifenacin is combined with Goserelin.,Solifenacin
DB01611,The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Goserelin.,Hydroxychloroquine
DB01620,The risk or severity of QTc prolongation can be increased when Pheniramine is combined with Goserelin.,Pheniramine
DB01623,The risk or severity of QTc prolongation can be increased when Thiothixene is combined with Goserelin.,Thiothixene
DB02546,The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Goserelin.,Vorinostat
DB04576,The risk or severity of QTc prolongation can be increased when Fleroxacin is combined with Goserelin.,Fleroxacin
DB04695,The risk or severity of QTc prolongation can be increased when Farnesyl thiopyrophosphate is combined with Goserelin.,Farnesyl thiopyrophosphate
DB04846,The risk or severity of QTc prolongation can be increased when Celiprolol is combined with Goserelin.,Celiprolol
DB04953,The risk or severity of QTc prolongation can be increased when Ezogabine is combined with Goserelin.,Ezogabine
DB05039,The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Goserelin.,Indacaterol
DB05246,The risk or severity of QTc prolongation can be increased when Methsuximide is combined with Goserelin.,Methsuximide
DB05465,The risk or severity of QTc prolongation can be increased when Tandutinib is combined with Goserelin.,Tandutinib
DB06217,The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Goserelin.,Vernakalant
DB06282,The risk or severity of QTc prolongation can be increased when Levocetirizine is combined with Goserelin.,Levocetirizine
DB06288,The risk or severity of QTc prolongation can be increased when Amisulpride is combined with Goserelin.,Amisulpride
DB06468,The risk or severity of QTc prolongation can be increased when Cariporide is combined with Goserelin.,Cariporide
DB06663,The risk or severity of QTc prolongation can be increased when Pasireotide is combined with Goserelin.,Pasireotide
DB06691,The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Goserelin.,Mepyramine
DB06699,The risk or severity of QTc prolongation can be increased when Degarelix is combined with Goserelin.,Degarelix
DB06719,The risk or severity of QTc prolongation can be increased when Buserelin is combined with Goserelin.,Buserelin
DB06788,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Goserelin.,Histrelin
DB06825,The risk or severity of QTc prolongation can be increased when Triptorelin is combined with Goserelin.,Triptorelin
DB07780,The risk or severity of QTc prolongation can be increased when Farnesyl diphosphate is combined with Goserelin.,Farnesyl diphosphate
DB07841,The risk or severity of QTc prolongation can be increased when Geranylgeranyl diphosphate is combined with Goserelin.,Geranylgeranyl diphosphate
DB08808,The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Goserelin.,Bupranolol
DB08815,The risk or severity of QTc prolongation can be increased when Lurasidone is combined with Goserelin.,Lurasidone
DB08864,The risk or severity of QTc prolongation can be increased when Rilpivirine is combined with Goserelin.,Rilpivirine
DB08871,The risk or severity of QTc prolongation can be increased when Eribulin is combined with Goserelin.,Eribulin
DB08893,The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Goserelin.,Mirabegron
DB08912,The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Goserelin.,Dabrafenib
DB08936,The risk or severity of QTc prolongation can be increased when Chlorcyclizine is combined with Goserelin.,Chlorcyclizine
DB08952,The risk or severity of QTc prolongation can be increased when Indenolol is combined with Goserelin.,Indenolol
DB08972,The risk or severity of QTc prolongation can be increased when Flumequine is combined with Goserelin.,Flumequine
DB09080,The risk or severity of QTc prolongation can be increased when Olodaterol is combined with Goserelin.,Olodaterol
DB09082,The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Goserelin.,Vilanterol
DB09089,The risk or severity of QTc prolongation can be increased when Trimebutine is combined with Goserelin.,Trimebutine
DB09090,The risk or severity of QTc prolongation can be increased when Pinaverium is combined with Goserelin.,Pinaverium
DB09167,The risk or severity of QTc prolongation can be increased when Dosulepin is combined with Goserelin.,Dosulepin
DB09229,The risk or severity of QTc prolongation can be increased when Aranidipine is combined with Goserelin.,Aranidipine
DB09235,The risk or severity of QTc prolongation can be increased when Efonidipine is combined with Goserelin.,Efonidipine
DB09236,The risk or severity of QTc prolongation can be increased when Lacidipine is combined with Goserelin.,Lacidipine
DB09239,The risk or severity of QTc prolongation can be increased when Niguldipine is combined with Goserelin.,Niguldipine
DB09488,The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Goserelin.,Acrivastine
DB11390,The risk or severity of QTc prolongation can be increased when Coumaphos is combined with Goserelin.,Coumaphos
DB11397,The risk or severity of QTc prolongation can be increased when Dichlorvos is combined with Goserelin.,Dichlorvos
DB11408,The risk or severity of QTc prolongation can be increased when Famphur is combined with Goserelin.,Famphur
DB11412,The risk or severity of QTc prolongation can be increased when Fenthion is combined with Goserelin.,Fenthion
DB11443,The risk or severity of QTc prolongation can be increased when Orbifloxacin is combined with Goserelin.,Orbifloxacin
DB11448,The risk or severity of QTc prolongation can be increased when Phosmet is combined with Goserelin.,Phosmet
DB11491,The risk or severity of QTc prolongation can be increased when Sarafloxacin is combined with Goserelin.,Sarafloxacin
DB11511,The risk or severity of QTc prolongation can be increased when Difloxacin is combined with Goserelin.,Difloxacin
DB11591,The risk or severity of QTc prolongation can be increased when Bilastine is combined with Goserelin.,Bilastine
DB11614,The risk or severity of QTc prolongation can be increased when Rupatadine is combined with Goserelin.,Rupatadine
DB11742,The risk or severity of QTc prolongation can be increased when Ebastine is combined with Goserelin.,Ebastine
DB11770,The risk or severity of QTc prolongation can be increased when Talinolol is combined with Goserelin.,Talinolol
DB11774,The risk or severity of QTc prolongation can be increased when Pazufloxacin is combined with Goserelin.,Pazufloxacin
DB11785,The risk or severity of QTc prolongation can be increased when Anisodamine is combined with Goserelin.,Anisodamine
DB11891,The risk or severity of QTc prolongation can be increased when CUDC-907 is combined with Goserelin.,CUDC-907
DB11892,The risk or severity of QTc prolongation can be increased when Prulifloxacin is combined with Goserelin.,Prulifloxacin
DB11943,The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Goserelin.,Delafloxacin
DB12093,The risk or severity of QTc prolongation can be increased when Tetrahydropalmatine is combined with Goserelin.,Tetrahydropalmatine
DB12231,The risk or severity of QTc prolongation can be increased when Temefos is combined with Goserelin.,Temefos
DB12245,The risk or severity of QTc prolongation can be increased when Triclabendazole is combined with Goserelin.,Triclabendazole
DB12645,The risk or severity of QTc prolongation can be increased when Givinostat is combined with Goserelin.,Givinostat
DB12712,The risk or severity of QTc prolongation can be increased when Pilsicainide is combined with Goserelin.,Pilsicainide
DB12766,The risk or severity of QTc prolongation can be increased when Cicletanine is combined with Goserelin.,Cicletanine
DB12923,The risk or severity of QTc prolongation can be increased when Gallopamil is combined with Goserelin.,Gallopamil
DB13358,The risk or severity of QTc prolongation can be increased when Cibenzoline is combined with Goserelin.,Cibenzoline
DB13488,The risk or severity of QTc prolongation can be increased when Bencyclane is combined with Goserelin.,Bencyclane
DB13555,The risk or severity of QTc prolongation can be increased when Prajmaline is combined with Goserelin.,Prajmaline
DB13627,The risk or severity of QTc prolongation can be increased when Oxolinic acid is combined with Goserelin.,Oxolinic acid
DB13651,The risk or severity of QTc prolongation can be increased when Lorajmine is combined with Goserelin.,Lorajmine
DB13691,The risk or severity of QTc prolongation can be increased when Acetyldigoxin is combined with Goserelin.,Acetyldigoxin
DB13744,The risk or severity of QTc prolongation can be increased when Piromidic acid is combined with Goserelin.,Piromidic acid
DB13766,The risk or severity of QTc prolongation can be increased when Lidoflazine is combined with Goserelin.,Lidoflazine
DB13772,The risk or severity of QTc prolongation can be increased when Rufloxacin is combined with Goserelin.,Rufloxacin
DB13823,The risk or severity of QTc prolongation can be increased when Pipemidic acid is combined with Goserelin.,Pipemidic acid
DB14185,The risk or severity of QTc prolongation can be increased when Aripiprazole lauroxil is combined with Goserelin.,Aripiprazole lauroxil
DB14713,The risk or severity of QTc prolongation can be increased when Inotersen is combined with Goserelin.,Inotersen
DB01142,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Doxepin.,Doxepin
DB01151,The risk or severity of QTc prolongation can be increased when Desipramine is combined with Goserelin.,Desipramine
DB00845,The risk or severity of QTc prolongation can be increased when Clofazimine is combined with Goserelin.,Clofazimine
DB11637,Goserelin may increase the QTc-prolonging activities of Delamanid.,Delamanid
DB00091,Cyclosporine may decrease the excretion rate of Goserelin which could result in a higher serum level.,Cyclosporine
DB00159,Icosapent may decrease the excretion rate of Goserelin which could result in a higher serum level.,Icosapent
DB00229,Cefotiam may decrease the excretion rate of Goserelin which could result in a higher serum level.,Cefotiam
DB00244,Mesalazine may decrease the excretion rate of Goserelin which could result in a higher serum level.,Mesalazine
DB00267,Cefmenoxime may decrease the excretion rate of Goserelin which could result in a higher serum level.,Cefmenoxime
DB00274,Cefmetazole may decrease the excretion rate of Goserelin which could result in a higher serum level.,Cefmetazole
DB00282,Pamidronic acid may decrease the excretion rate of Goserelin which could result in a higher serum level.,Pamidronic acid
DB00300,Tenofovir disoproxil may decrease the excretion rate of Goserelin which could result in a higher serum level.,Tenofovir disoproxil
DB00328,Indomethacin may decrease the excretion rate of Goserelin which could result in a higher serum level.,Indomethacin
DB00369,Cidofovir may decrease the excretion rate of Goserelin which could result in a higher serum level.,Cidofovir
DB00384,Triamterene may decrease the excretion rate of Goserelin which could result in a higher serum level.,Triamterene
DB00430,Cefpiramide may decrease the excretion rate of Goserelin which could result in a higher serum level.,Cefpiramide
DB00438,Ceftazidime may decrease the excretion rate of Goserelin which could result in a higher serum level.,Ceftazidime
DB00447,Loracarbef may decrease the excretion rate of Goserelin which could result in a higher serum level.,Loracarbef
DB00456,Cefalotin may decrease the excretion rate of Goserelin which could result in a higher serum level.,Cefalotin
DB00461,Nabumetone may decrease the excretion rate of Goserelin which could result in a higher serum level.,Nabumetone
DB00465,Ketorolac may decrease the excretion rate of Goserelin which could result in a higher serum level.,Ketorolac
DB00469,Tenoxicam may decrease the excretion rate of Goserelin which could result in a higher serum level.,Tenoxicam
DB00482,Celecoxib may decrease the excretion rate of Goserelin which could result in a higher serum level.,Celecoxib
DB00493,Cefotaxime may decrease the excretion rate of Goserelin which could result in a higher serum level.,Cefotaxime
DB00500,Tolmetin may decrease the excretion rate of Goserelin which could result in a higher serum level.,Tolmetin
DB00533,Rofecoxib may decrease the excretion rate of Goserelin which could result in a higher serum level.,Rofecoxib
DB00554,Piroxicam may decrease the excretion rate of Goserelin which could result in a higher serum level.,Piroxicam
DB00563,Methotrexate may decrease the excretion rate of Goserelin which could result in a higher serum level.,Methotrexate
DB00567,Cephalexin may decrease the excretion rate of Goserelin which could result in a higher serum level.,Cephalexin
DB00573,Fenoprofen may decrease the excretion rate of Goserelin which could result in a higher serum level.,Fenoprofen
DB00577,Valaciclovir may decrease the excretion rate of Goserelin which could result in a higher serum level.,Valaciclovir
DB00580,Valdecoxib may decrease the excretion rate of Goserelin which could result in a higher serum level.,Valdecoxib
DB00586,Diclofenac may decrease the excretion rate of Goserelin which could result in a higher serum level.,Diclofenac
DB00605,Sulindac may decrease the excretion rate of Goserelin which could result in a higher serum level.,Sulindac
DB00626,Bacitracin may decrease the excretion rate of Goserelin which could result in a higher serum level.,Bacitracin
DB00681,Amphotericin B may decrease the excretion rate of Goserelin which could result in a higher serum level.,Amphotericin B
DB00689,Cephaloglycin may decrease the excretion rate of Goserelin which could result in a higher serum level.,Cephaloglycin
DB00712,Flurbiprofen may decrease the excretion rate of Goserelin which could result in a higher serum level.,Flurbiprofen
DB00718,Adefovir dipivoxil may decrease the excretion rate of Goserelin which could result in a higher serum level.,Adefovir dipivoxil
DB00742,Mannitol may decrease the excretion rate of Goserelin which could result in a higher serum level.,Mannitol
DB00749,Etodolac may decrease the excretion rate of Goserelin which could result in a higher serum level.,Etodolac
DB00784,Mefenamic acid may decrease the excretion rate of Goserelin which could result in a higher serum level.,Mefenamic acid
DB00787,Acyclovir may decrease the excretion rate of Goserelin which could result in a higher serum level.,Acyclovir
DB00788,Naproxen may decrease the excretion rate of Goserelin which could result in a higher serum level.,Naproxen
DB00795,Sulfasalazine may decrease the excretion rate of Goserelin which could result in a higher serum level.,Sulfasalazine
DB00812,Phenylbutazone may decrease the excretion rate of Goserelin which could result in a higher serum level.,Phenylbutazone
DB00814,Meloxicam may decrease the excretion rate of Goserelin which could result in a higher serum level.,Meloxicam
DB00821,Carprofen may decrease the excretion rate of Goserelin which could result in a higher serum level.,Carprofen
DB00833,Cefaclor may decrease the excretion rate of Goserelin which could result in a higher serum level.,Cefaclor
DB00861,Diflunisal may decrease the excretion rate of Goserelin which could result in a higher serum level.,Diflunisal
DB00864,Tacrolimus may decrease the excretion rate of Goserelin which could result in a higher serum level.,Tacrolimus
DB00903,Etacrynic acid may decrease the excretion rate of Goserelin which could result in a higher serum level.,Etacrynic acid
DB00923,Ceforanide may decrease the excretion rate of Goserelin which could result in a higher serum level.,Ceforanide
DB00936,Salicylic acid may decrease the excretion rate of Goserelin which could result in a higher serum level.,Salicylic acid
DB00939,Meclofenamic acid may decrease the excretion rate of Goserelin which could result in a higher serum level.,Meclofenamic acid
DB00945,Acetylsalicylic acid may decrease the excretion rate of Goserelin which could result in a higher serum level.,Acetylsalicylic acid
DB00958,Carboplatin may decrease the excretion rate of Goserelin which could result in a higher serum level.,Carboplatin
DB00991,Oxaprozin may decrease the excretion rate of Goserelin which could result in a higher serum level.,Oxaprozin
DB01009,Ketoprofen may decrease the excretion rate of Goserelin which could result in a higher serum level.,Ketoprofen
DB01014,Balsalazide may decrease the excretion rate of Goserelin which could result in a higher serum level.,Balsalazide
DB01050,Ibuprofen may decrease the excretion rate of Goserelin which could result in a higher serum level.,Ibuprofen
DB01066,Cefditoren may decrease the excretion rate of Goserelin which could result in a higher serum level.,Cefditoren
DB01111,Colistimethate may decrease the excretion rate of Goserelin which could result in a higher serum level.,Colistimethate
DB01112,Cefuroxime may decrease the excretion rate of Goserelin which could result in a higher serum level.,Cefuroxime
DB01139,Cefapirin may decrease the excretion rate of Goserelin which could result in a higher serum level.,Cefapirin
DB01140,Cefadroxil may decrease the excretion rate of Goserelin which could result in a higher serum level.,Cefadroxil
DB01150,Cefprozil may decrease the excretion rate of Goserelin which could result in a higher serum level.,Cefprozil
DB01212,Ceftriaxone may decrease the excretion rate of Goserelin which could result in a higher serum level.,Ceftriaxone
DB01250,Olsalazine may decrease the excretion rate of Goserelin which could result in a higher serum level.,Olsalazine
DB01283,Lumiracoxib may decrease the excretion rate of Goserelin which could result in a higher serum level.,Lumiracoxib
DB01326,Cefamandole may decrease the excretion rate of Goserelin which could result in a higher serum level.,Cefamandole
DB01327,Cefazolin may decrease the excretion rate of Goserelin which could result in a higher serum level.,Cefazolin
DB01328,Cefonicid may decrease the excretion rate of Goserelin which could result in a higher serum level.,Cefonicid
DB01329,Cefoperazone may decrease the excretion rate of Goserelin which could result in a higher serum level.,Cefoperazone
DB01330,Cefotetan may decrease the excretion rate of Goserelin which could result in a higher serum level.,Cefotetan
DB01331,Cefoxitin may decrease the excretion rate of Goserelin which could result in a higher serum level.,Cefoxitin
DB01332,Ceftizoxime may decrease the excretion rate of Goserelin which could result in a higher serum level.,Ceftizoxime
DB01333,Cefradine may decrease the excretion rate of Goserelin which could result in a higher serum level.,Cefradine
DB01397,Magnesium salicylate may decrease the excretion rate of Goserelin which could result in a higher serum level.,Magnesium salicylate
DB01399,Salsalate may decrease the excretion rate of Goserelin which could result in a higher serum level.,Salsalate
DB01401,Choline magnesium trisalicylate may decrease the excretion rate of Goserelin which could result in a higher serum level.,Choline magnesium trisalicylate
DB01413,Cefepime may decrease the excretion rate of Goserelin which could result in a higher serum level.,Cefepime
DB01414,Cefacetrile may decrease the excretion rate of Goserelin which could result in a higher serum level.,Cefacetrile
DB01415,Ceftibuten may decrease the excretion rate of Goserelin which could result in a higher serum level.,Ceftibuten
DB01416,Cefpodoxime may decrease the excretion rate of Goserelin which could result in a higher serum level.,Cefpodoxime
DB01419,Antrafenine may decrease the excretion rate of Goserelin which could result in a higher serum level.,Antrafenine
DB01424,Aminophenazone may decrease the excretion rate of Goserelin which could result in a higher serum level.,Aminophenazone
DB01435,Antipyrine may decrease the excretion rate of Goserelin which could result in a higher serum level.,Antipyrine
DB01600,Tiaprofenic acid may decrease the excretion rate of Goserelin which could result in a higher serum level.,Tiaprofenic acid
DB01628,Etoricoxib may decrease the excretion rate of Goserelin which could result in a higher serum level.,Etoricoxib
DB02247,Hydrolyzed Cephalothin may decrease the excretion rate of Goserelin which could result in a higher serum level.,Hydrolyzed Cephalothin
DB03450,Cephalothin Group may decrease the excretion rate of Goserelin which could result in a higher serum level.,Cephalothin Group
DB03585,Oxyphenbutazone may decrease the excretion rate of Goserelin which could result in a higher serum level.,Oxyphenbutazone
DB04552,Niflumic acid may decrease the excretion rate of Goserelin which could result in a higher serum level.,Niflumic acid
DB04570,Latamoxef may decrease the excretion rate of Goserelin which could result in a higher serum level.,Latamoxef
DB04743,Nimesulide may decrease the excretion rate of Goserelin which could result in a higher serum level.,Nimesulide
DB04812,Benoxaprofen may decrease the excretion rate of Goserelin which could result in a higher serum level.,Benoxaprofen
DB04817,Metamizole may decrease the excretion rate of Goserelin which could result in a higher serum level.,Metamizole
DB04828,Zomepirac may decrease the excretion rate of Goserelin which could result in a higher serum level.,Zomepirac
DB04918,Ceftobiprole may decrease the excretion rate of Goserelin which could result in a higher serum level.,Ceftobiprole
DB05095,Cimicoxib may decrease the excretion rate of Goserelin which could result in a higher serum level.,Cimicoxib
DB06590,Ceftaroline fosamil may decrease the excretion rate of Goserelin which could result in a higher serum level.,Ceftaroline fosamil
DB06725,Lornoxicam may decrease the excretion rate of Goserelin which could result in a higher serum level.,Lornoxicam
DB06736,Aceclofenac may decrease the excretion rate of Goserelin which could result in a higher serum level.,Aceclofenac
DB06737,Zaltoprofen may decrease the excretion rate of Goserelin which could result in a higher serum level.,Zaltoprofen
DB07402,Azapropazone may decrease the excretion rate of Goserelin which could result in a higher serum level.,Azapropazone
DB07477,Felbinac may decrease the excretion rate of Goserelin which could result in a higher serum level.,Felbinac
DB08439,Parecoxib may decrease the excretion rate of Goserelin which could result in a higher serum level.,Parecoxib
DB08797,Salicylamide may decrease the excretion rate of Goserelin which could result in a higher serum level.,Salicylamide
DB08940,Kebuzone may decrease the excretion rate of Goserelin which could result in a higher serum level.,Kebuzone
DB08942,Isoxicam may decrease the excretion rate of Goserelin which could result in a higher serum level.,Isoxicam
DB08951,Indoprofen may decrease the excretion rate of Goserelin which could result in a higher serum level.,Indoprofen
DB08955,Ibuproxam may decrease the excretion rate of Goserelin which could result in a higher serum level.,Ibuproxam
DB08976,Floctafenine may decrease the excretion rate of Goserelin which could result in a higher serum level.,Floctafenine
DB08981,Fenbufen may decrease the excretion rate of Goserelin which could result in a higher serum level.,Fenbufen
DB08984,Etofenamate may decrease the excretion rate of Goserelin which could result in a higher serum level.,Etofenamate
DB08991,Epirizole may decrease the excretion rate of Goserelin which could result in a higher serum level.,Epirizole
DB09008,Cefaloridine may decrease the excretion rate of Goserelin which could result in a higher serum level.,Cefaloridine
DB09062,Cefminox may decrease the excretion rate of Goserelin which could result in a higher serum level.,Cefminox
DB09084,Benzydamine may decrease the excretion rate of Goserelin which could result in a higher serum level.,Benzydamine
DB09212,Loxoprofen may decrease the excretion rate of Goserelin which could result in a higher serum level.,Loxoprofen
DB09213,Dexibuprofen may decrease the excretion rate of Goserelin which could result in a higher serum level.,Dexibuprofen
DB09214,Dexketoprofen may decrease the excretion rate of Goserelin which could result in a higher serum level.,Dexketoprofen
DB09215,Droxicam may decrease the excretion rate of Goserelin which could result in a higher serum level.,Droxicam
DB09216,Tolfenamic acid may decrease the excretion rate of Goserelin which could result in a higher serum level.,Tolfenamic acid
DB09217,Firocoxib may decrease the excretion rate of Goserelin which could result in a higher serum level.,Firocoxib
DB09218,Clonixin may decrease the excretion rate of Goserelin which could result in a higher serum level.,Clonixin
DB09285,Morniflumate may decrease the excretion rate of Goserelin which could result in a higher serum level.,Morniflumate
DB09288,Propacetamol may decrease the excretion rate of Goserelin which could result in a higher serum level.,Propacetamol
DB09295,Talniflumate may decrease the excretion rate of Goserelin which could result in a higher serum level.,Talniflumate
DB09299,Tenofovir alafenamide may decrease the excretion rate of Goserelin which could result in a higher serum level.,Tenofovir alafenamide
DB11367,Cefroxadine may decrease the excretion rate of Goserelin which could result in a higher serum level.,Cefroxadine
DB11455,Robenacoxib may decrease the excretion rate of Goserelin which could result in a higher serum level.,Robenacoxib
DB11466,Tepoxalin may decrease the excretion rate of Goserelin which could result in a higher serum level.,Tepoxalin
DB11518,Flunixin may decrease the excretion rate of Goserelin which could result in a higher serum level.,Flunixin
DB11935,Flomoxef may decrease the excretion rate of Goserelin which could result in a higher serum level.,Flomoxef
DB12151,Brincidofovir may decrease the excretion rate of Goserelin which could result in a higher serum level.,Brincidofovir
DB12445,Nitroaspirin may decrease the excretion rate of Goserelin which could result in a higher serum level.,Nitroaspirin
DB12545,Indobufen may decrease the excretion rate of Goserelin which could result in a higher serum level.,Indobufen
DB13001,Tinoridine may decrease the excretion rate of Goserelin which could result in a higher serum level.,Tinoridine
DB13167,Alclofenac may decrease the excretion rate of Goserelin which could result in a higher serum level.,Alclofenac
DB13217,Fentiazac may decrease the excretion rate of Goserelin which could result in a higher serum level.,Fentiazac
DB13232,Suxibuzone may decrease the excretion rate of Goserelin which could result in a higher serum level.,Suxibuzone
DB13266,Cefatrizine may decrease the excretion rate of Goserelin which could result in a higher serum level.,Cefatrizine
DB13286,Bumadizone may decrease the excretion rate of Goserelin which could result in a higher serum level.,Bumadizone
DB13314,Alminoprofen may decrease the excretion rate of Goserelin which could result in a higher serum level.,Alminoprofen
DB13317,Flunoxaprofen may decrease the excretion rate of Goserelin which could result in a higher serum level.,Flunoxaprofen
DB13364,Feprazone may decrease the excretion rate of Goserelin which could result in a higher serum level.,Feprazone
DB13371,Difenpiramide may decrease the excretion rate of Goserelin which could result in a higher serum level.,Difenpiramide
DB13407,Nifenazone may decrease the excretion rate of Goserelin which could result in a higher serum level.,Nifenazone
DB13432,Lonazolac may decrease the excretion rate of Goserelin which could result in a higher serum level.,Lonazolac
DB13461,Cefcapene may decrease the excretion rate of Goserelin which could result in a higher serum level.,Cefcapene
DB13470,Cefodizime may decrease the excretion rate of Goserelin which could result in a higher serum level.,Cefodizime
DB13481,Tenidap may decrease the excretion rate of Goserelin which could result in a higher serum level.,Tenidap
DB13499,Cefsulodin may decrease the excretion rate of Goserelin which could result in a higher serum level.,Cefsulodin
DB13501,Bendazac may decrease the excretion rate of Goserelin which could result in a higher serum level.,Bendazac
DB13504,Cefetamet may decrease the excretion rate of Goserelin which could result in a higher serum level.,Cefetamet
DB13514,Pranoprofen may decrease the excretion rate of Goserelin which could result in a higher serum level.,Pranoprofen
DB13524,Propyphenazone may decrease the excretion rate of Goserelin which could result in a higher serum level.,Propyphenazone
DB13527,Proglumetacin may decrease the excretion rate of Goserelin which could result in a higher serum level.,Proglumetacin
DB13538,Guacetisal may decrease the excretion rate of Goserelin which could result in a higher serum level.,Guacetisal
DB13544,Ethenzamide may decrease the excretion rate of Goserelin which could result in a higher serum level.,Ethenzamide
DB13612,Carbaspirin calcium may decrease the excretion rate of Goserelin which could result in a higher serum level.,Carbaspirin calcium
DB13629,Mofebutazone may decrease the excretion rate of Goserelin which could result in a higher serum level.,Mofebutazone
DB13638,Cefbuperazone may decrease the excretion rate of Goserelin which could result in a higher serum level.,Cefbuperazone
DB13649,Proquazone may decrease the excretion rate of Goserelin which could result in a higher serum level.,Proquazone
DB13657,Benorilate may decrease the excretion rate of Goserelin which could result in a higher serum level.,Benorilate
DB13667,Cefozopran may decrease the excretion rate of Goserelin which could result in a higher serum level.,Cefozopran
DB13682,Cefpirome may decrease the excretion rate of Goserelin which could result in a higher serum level.,Cefpirome
DB13722,Pirprofen may decrease the excretion rate of Goserelin which could result in a higher serum level.,Pirprofen
DB13778,Cefazedone may decrease the excretion rate of Goserelin which could result in a higher serum level.,Cefazedone
DB13783,Acemetacin may decrease the excretion rate of Goserelin which could result in a higher serum level.,Acemetacin
DB13821,Ceftezole may decrease the excretion rate of Goserelin which could result in a higher serum level.,Ceftezole
DB13860,Imidazole salicylate may decrease the excretion rate of Goserelin which could result in a higher serum level.,Imidazole salicylate
DB13868,Adefovir may decrease the excretion rate of Goserelin which could result in a higher serum level.,Adefovir
DB14059,SC-236 may decrease the excretion rate of Goserelin which could result in a higher serum level.,SC-236
DB14060,NS-398 may decrease the excretion rate of Goserelin which could result in a higher serum level.,NS-398
DB14126,Tenofovir may decrease the excretion rate of Goserelin which could result in a higher serum level.,Tenofovir
DB01438,Phenazopyridine may decrease the excretion rate of Goserelin which could result in a higher serum level.,Phenazopyridine
DB15066,Givosiran may decrease the excretion rate of Goserelin which could result in a higher serum level.,Givosiran
DB01601,Lopinavir may decrease the excretion rate of Goserelin which could result in a higher serum level.,Lopinavir
DB14507,Lithium citrate may decrease the excretion rate of Goserelin which could result in a higher serum level.,Lithium citrate
DB00017,Goserelin may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Salmon calcitonin
DB00035,Goserelin may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Desmopressin
DB00041,Goserelin may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Aldesleukin
DB00080,Goserelin may decrease the excretion rate of Daptomycin which could result in a higher serum level.,Daptomycin
DB00081,Goserelin may decrease the excretion rate of Tositumomab which could result in a higher serum level.,Tositumomab
DB00115,Goserelin may decrease the excretion rate of Cyanocobalamin which could result in a higher serum level.,Cyanocobalamin
DB00158,Goserelin may decrease the excretion rate of Folic acid which could result in a higher serum level.,Folic acid
DB00165,Goserelin may decrease the excretion rate of Pyridoxine which could result in a higher serum level.,Pyridoxine
DB00176,Goserelin may decrease the excretion rate of Fluvoxamine which could result in a higher serum level.,Fluvoxamine
DB00181,Goserelin may decrease the excretion rate of Baclofen which could result in a higher serum level.,Baclofen
DB00182,Goserelin may decrease the excretion rate of Amphetamine which could result in a higher serum level.,Amphetamine
DB00185,Goserelin may decrease the excretion rate of Cevimeline which could result in a higher serum level.,Cevimeline
DB00186,Goserelin may decrease the excretion rate of Lorazepam which could result in a higher serum level.,Lorazepam
DB00190,Goserelin may decrease the excretion rate of Carbidopa which could result in a higher serum level.,Carbidopa
DB00193,Goserelin may decrease the excretion rate of Tramadol which could result in a higher serum level.,Tramadol
DB00198,Goserelin may decrease the excretion rate of Oseltamivir which could result in a higher serum level.,Oseltamivir
DB00200,Goserelin may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level.,Hydroxocobalamin
DB00206,Goserelin may decrease the excretion rate of Reserpine which could result in a higher serum level.,Reserpine
DB00208,Goserelin may decrease the excretion rate of Ticlopidine which could result in a higher serum level.,Ticlopidine
DB00213,Goserelin may decrease the excretion rate of Pantoprazole which could result in a higher serum level.,Pantoprazole
DB00225,Goserelin may decrease the excretion rate of Gadodiamide which could result in a higher serum level.,Gadodiamide
DB00231,Goserelin may decrease the excretion rate of Temazepam which could result in a higher serum level.,Temazepam
DB00235,Goserelin may decrease the excretion rate of Milrinone which could result in a higher serum level.,Milrinone
DB00237,Goserelin may decrease the excretion rate of Butabarbital which could result in a higher serum level.,Butabarbital
DB00254,Goserelin may decrease the excretion rate of Doxycycline which could result in a higher serum level.,Doxycycline
DB00262,Goserelin may decrease the excretion rate of Carmustine which could result in a higher serum level.,Carmustine
DB00264,Goserelin may decrease the excretion rate of Metoprolol which could result in a higher serum level.,Metoprolol
DB00271,Goserelin may decrease the excretion rate of Diatrizoate which could result in a higher serum level.,Diatrizoate
DB00273,Goserelin may decrease the excretion rate of Topiramate which could result in a higher serum level.,Topiramate
DB00279,Goserelin may decrease the excretion rate of Liothyronine which could result in a higher serum level.,Liothyronine
DB00286,Goserelin may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.,Conjugated estrogens
DB00290,Goserelin may decrease the excretion rate of Bleomycin which could result in a higher serum level.,Bleomycin
DB00292,Goserelin may decrease the excretion rate of Etomidate which could result in a higher serum level.,Etomidate
DB00294,Goserelin may decrease the excretion rate of Etonogestrel which could result in a higher serum level.,Etonogestrel
DB00296,Goserelin may decrease the excretion rate of Ropivacaine which could result in a higher serum level.,Ropivacaine
DB00303,Goserelin may decrease the excretion rate of Ertapenem which could result in a higher serum level.,Ertapenem
DB00312,Goserelin may decrease the excretion rate of Pentobarbital which could result in a higher serum level.,Pentobarbital
DB00316,Goserelin may decrease the excretion rate of Acetaminophen which could result in a higher serum level.,Acetaminophen
DB00319,Goserelin may decrease the excretion rate of Piperacillin which could result in a higher serum level.,Piperacillin
DB00322,Goserelin may decrease the excretion rate of Floxuridine which could result in a higher serum level.,Floxuridine
DB00323,Goserelin may decrease the excretion rate of Tolcapone which could result in a higher serum level.,Tolcapone
DB00325,Goserelin may decrease the excretion rate of Nitroprusside which could result in a higher serum level.,Nitroprusside
DB00327,Goserelin may decrease the excretion rate of Hydromorphone which could result in a higher serum level.,Hydromorphone
DB00330,Goserelin may decrease the excretion rate of Ethambutol which could result in a higher serum level.,Ethambutol
DB00339,Goserelin may decrease the excretion rate of Pyrazinamide which could result in a higher serum level.,Pyrazinamide
DB00349,Goserelin may decrease the excretion rate of Clobazam which could result in a higher serum level.,Clobazam
DB00351,Goserelin may decrease the excretion rate of Megestrol acetate which could result in a higher serum level.,Megestrol acetate
DB00355,Goserelin may decrease the excretion rate of Aztreonam which could result in a higher serum level.,Aztreonam
DB00356,Goserelin may decrease the excretion rate of Chlorzoxazone which could result in a higher serum level.,Chlorzoxazone
DB00364,Goserelin may decrease the excretion rate of Sucralfate which could result in a higher serum level.,Sucralfate
DB00372,Goserelin may decrease the excretion rate of Thiethylperazine which could result in a higher serum level.,Thiethylperazine
DB00377,Goserelin may decrease the excretion rate of Palonosetron which could result in a higher serum level.,Palonosetron
DB00380,Goserelin may decrease the excretion rate of Dexrazoxane which could result in a higher serum level.,Dexrazoxane
DB00401,Goserelin may decrease the excretion rate of Nisoldipine which could result in a higher serum level.,Nisoldipine
DB00402,Goserelin may decrease the excretion rate of Eszopiclone which could result in a higher serum level.,Eszopiclone
DB00404,Goserelin may decrease the excretion rate of Alprazolam which could result in a higher serum level.,Alprazolam
DB00413,Goserelin may decrease the excretion rate of Pramipexole which could result in a higher serum level.,Pramipexole
DB00415,Goserelin may decrease the excretion rate of Ampicillin which could result in a higher serum level.,Ampicillin
DB00418,Goserelin may decrease the excretion rate of Secobarbital which could result in a higher serum level.,Secobarbital
DB00422,Goserelin may decrease the excretion rate of Methylphenidate which could result in a higher serum level.,Methylphenidate
DB00432,Goserelin may decrease the excretion rate of Trifluridine which could result in a higher serum level.,Trifluridine
DB00435,Goserelin may decrease the excretion rate of Nitric Oxide which could result in a higher serum level.,Nitric Oxide
DB00437,Goserelin may decrease the excretion rate of Allopurinol which could result in a higher serum level.,Allopurinol
DB00441,Goserelin may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,Gemcitabine
DB00476,Goserelin may decrease the excretion rate of Duloxetine which could result in a higher serum level.,Duloxetine
DB00480,Goserelin may decrease the excretion rate of Lenalidomide which could result in a higher serum level.,Lenalidomide
DB00490,Goserelin may decrease the excretion rate of Buspirone which could result in a higher serum level.,Buspirone
DB00492,Goserelin may decrease the excretion rate of Fosinopril which could result in a higher serum level.,Fosinopril
DB00499,Goserelin may decrease the excretion rate of Flutamide which could result in a higher serum level.,Flutamide
DB00501,Goserelin may decrease the excretion rate of Cimetidine which could result in a higher serum level.,Cimetidine
DB00535,Goserelin may decrease the excretion rate of Cefdinir which could result in a higher serum level.,Cefdinir
DB00548,Goserelin may decrease the excretion rate of Azelaic acid which could result in a higher serum level.,Azelaic acid
DB00553,Goserelin may decrease the excretion rate of Methoxsalen which could result in a higher serum level.,Methoxsalen
DB00558,Goserelin may decrease the excretion rate of Zanamivir which could result in a higher serum level.,Zanamivir
DB00569,Goserelin may decrease the excretion rate of Fondaparinux which could result in a higher serum level.,Fondaparinux
DB00583,Goserelin may decrease the excretion rate of Levocarnitine which could result in a higher serum level.,Levocarnitine
DB00591,Goserelin may decrease the excretion rate of Fluocinolone acetonide which could result in a higher serum level.,Fluocinolone acetonide
DB00597,Goserelin may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,Gadoteridol
DB00598,Goserelin may decrease the excretion rate of Labetalol which could result in a higher serum level.,Labetalol
DB00603,Goserelin may decrease the excretion rate of Medroxyprogesterone acetate which could result in a higher serum level.,Medroxyprogesterone acetate
DB00612,Goserelin may decrease the excretion rate of Bisoprolol which could result in a higher serum level.,Bisoprolol
DB00624,Goserelin may decrease the excretion rate of Testosterone which could result in a higher serum level.,Testosterone
DB00628,Goserelin may decrease the excretion rate of Clorazepic acid which could result in a higher serum level.,Clorazepic acid
DB00631,Goserelin may decrease the excretion rate of Clofarabine which could result in a higher serum level.,Clofarabine
DB00633,Goserelin may decrease the excretion rate of Dexmedetomidine which could result in a higher serum level.,Dexmedetomidine
DB00635,Goserelin may decrease the excretion rate of Prednisone which could result in a higher serum level.,Prednisone
DB00651,Goserelin may decrease the excretion rate of Dyphylline which could result in a higher serum level.,Dyphylline
DB00657,Goserelin may decrease the excretion rate of Mecamylamine which could result in a higher serum level.,Mecamylamine
DB00660,Goserelin may decrease the excretion rate of Metaxalone which could result in a higher serum level.,Metaxalone
DB00665,Goserelin may decrease the excretion rate of Nilutamide which could result in a higher serum level.,Nilutamide
DB00669,Goserelin may decrease the excretion rate of Sumatriptan which could result in a higher serum level.,Sumatriptan
DB00683,Goserelin may decrease the excretion rate of Midazolam which could result in a higher serum level.,Midazolam
DB00688,Goserelin may decrease the excretion rate of Mycophenolate mofetil which could result in a higher serum level.,Mycophenolate mofetil
DB00690,Goserelin may decrease the excretion rate of Flurazepam which could result in a higher serum level.,Flurazepam
DB00692,Goserelin may decrease the excretion rate of Phentolamine which could result in a higher serum level.,Phentolamine
DB00698,Goserelin may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.,Nitrofurantoin
DB00706,Goserelin may decrease the excretion rate of Tamsulosin which could result in a higher serum level.,Tamsulosin
DB00709,Goserelin may decrease the excretion rate of Lamivudine which could result in a higher serum level.,Lamivudine
DB00713,Goserelin may decrease the excretion rate of Oxacillin which could result in a higher serum level.,Oxacillin
DB00716,Goserelin may decrease the excretion rate of Nedocromil which could result in a higher serum level.,Nedocromil
DB00722,Goserelin may decrease the excretion rate of Lisinopril which could result in a higher serum level.,Lisinopril
DB00730,Goserelin may decrease the excretion rate of Thiabendazole which could result in a higher serum level.,Thiabendazole
DB00733,Goserelin may decrease the excretion rate of Pralidoxime which could result in a higher serum level.,Pralidoxime
DB00759,Goserelin may decrease the excretion rate of Tetracycline which could result in a higher serum level.,Tetracycline
DB00760,Goserelin may decrease the excretion rate of Meropenem which could result in a higher serum level.,Meropenem
DB00761,Goserelin may decrease the excretion rate of Potassium chloride which could result in a higher serum level.,Potassium chloride
DB00763,Goserelin may decrease the excretion rate of Methimazole which could result in a higher serum level.,Methimazole
DB00775,Goserelin may decrease the excretion rate of Tirofiban which could result in a higher serum level.,Tirofiban
DB00780,Goserelin may decrease the excretion rate of Phenelzine which could result in a higher serum level.,Phenelzine
DB00782,Goserelin may decrease the excretion rate of Propantheline which could result in a higher serum level.,Propantheline
DB00783,Goserelin may decrease the excretion rate of Estradiol which could result in a higher serum level.,Estradiol
DB00789,Goserelin may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,Gadopentetic acid
DB00790,Goserelin may decrease the excretion rate of Perindopril which could result in a higher serum level.,Perindopril
DB00800,Goserelin may decrease the excretion rate of Fenoldopam which could result in a higher serum level.,Fenoldopam
DB00804,Goserelin may decrease the excretion rate of Dicyclomine which could result in a higher serum level.,Dicyclomine
DB00806,Goserelin may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.,Pentoxifylline
DB00811,Goserelin may decrease the excretion rate of Ribavirin which could result in a higher serum level.,Ribavirin
DB00820,Goserelin may decrease the excretion rate of Tadalafil which could result in a higher serum level.,Tadalafil
DB00828,Goserelin may decrease the excretion rate of Fosfomycin which could result in a higher serum level.,Fosfomycin
DB00829,Goserelin may decrease the excretion rate of Diazepam which could result in a higher serum level.,Diazepam
DB00841,Goserelin may decrease the excretion rate of Dobutamine which could result in a higher serum level.,Dobutamine
DB00842,Goserelin may decrease the excretion rate of Oxazepam which could result in a higher serum level.,Oxazepam
DB00851,Goserelin may decrease the excretion rate of Dacarbazine which could result in a higher serum level.,Dacarbazine
DB00853,Goserelin may decrease the excretion rate of Temozolomide which could result in a higher serum level.,Temozolomide
DB00863,Goserelin may decrease the excretion rate of Ranitidine which could result in a higher serum level.,Ranitidine
DB00894,Goserelin may decrease the excretion rate of Testolactone which could result in a higher serum level.,Testolactone
DB00897,Goserelin may decrease the excretion rate of Triazolam which could result in a higher serum level.,Triazolam
DB00900,Goserelin may decrease the excretion rate of Didanosine which could result in a higher serum level.,Didanosine
DB00911,Goserelin may decrease the excretion rate of Tinidazole which could result in a higher serum level.,Tinidazole
DB00918,Goserelin may decrease the excretion rate of Almotriptan which could result in a higher serum level.,Almotriptan
DB00928,Goserelin may decrease the excretion rate of Azacitidine which could result in a higher serum level.,Azacitidine
DB00951,Goserelin may decrease the excretion rate of Isoniazid which could result in a higher serum level.,Isoniazid
DB00953,Goserelin may decrease the excretion rate of Rizatriptan which could result in a higher serum level.,Rizatriptan
DB00960,Goserelin may decrease the excretion rate of Pindolol which could result in a higher serum level.,Pindolol
DB00961,Goserelin may decrease the excretion rate of Mepivacaine which could result in a higher serum level.,Mepivacaine
DB00962,Goserelin may decrease the excretion rate of Zaleplon which could result in a higher serum level.,Zaleplon
DB00968,Goserelin may decrease the excretion rate of Methyldopa which could result in a higher serum level.,Methyldopa
DB00980,Goserelin may decrease the excretion rate of Ramelteon which could result in a higher serum level.,Ramelteon
DB00988,Goserelin may decrease the excretion rate of Dopamine which could result in a higher serum level.,Dopamine
DB00993,Goserelin may decrease the excretion rate of Azathioprine which could result in a higher serum level.,Azathioprine
DB00995,Goserelin may decrease the excretion rate of Auranofin which could result in a higher serum level.,Auranofin
DB01002,Goserelin may decrease the excretion rate of Levobupivacaine which could result in a higher serum level.,Levobupivacaine
DB01004,Goserelin may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,Ganciclovir
DB01010,Goserelin may decrease the excretion rate of Edrophonium which could result in a higher serum level.,Edrophonium
DB01011,Goserelin may decrease the excretion rate of Metyrapone which could result in a higher serum level.,Metyrapone
DB01018,Goserelin may decrease the excretion rate of Guanfacine which could result in a higher serum level.,Guanfacine
DB01020,Goserelin may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.,Isosorbide mononitrate
DB01022,Goserelin may decrease the excretion rate of Phylloquinone which could result in a higher serum level.,Phylloquinone
DB01024,Goserelin may decrease the excretion rate of Mycophenolic acid which could result in a higher serum level.,Mycophenolic acid
DB01030,Goserelin may decrease the excretion rate of Topotecan which could result in a higher serum level.,Topotecan
DB01032,Goserelin may decrease the excretion rate of Probenecid which could result in a higher serum level.,Probenecid
DB01039,Goserelin may decrease the excretion rate of Fenofibrate which could result in a higher serum level.,Fenofibrate
DB01043,Goserelin may decrease the excretion rate of Memantine which could result in a higher serum level.,Memantine
DB01046,Goserelin may decrease the excretion rate of Lubiprostone which could result in a higher serum level.,Lubiprostone
DB01048,Goserelin may decrease the excretion rate of Abacavir which could result in a higher serum level.,Abacavir
DB01060,Goserelin may decrease the excretion rate of Amoxicillin which could result in a higher serum level.,Amoxicillin
DB01068,Goserelin may decrease the excretion rate of Clonazepam which could result in a higher serum level.,Clonazepam
DB01093,Goserelin may decrease the excretion rate of Dimethyl sulfoxide which could result in a higher serum level.,Dimethyl sulfoxide
DB01099,Goserelin may decrease the excretion rate of Flucytosine which could result in a higher serum level.,Flucytosine
DB01101,Goserelin may decrease the excretion rate of Capecitabine which could result in a higher serum level.,Capecitabine
DB01105,Goserelin may decrease the excretion rate of Sibutramine which could result in a higher serum level.,Sibutramine
DB01129,Goserelin may decrease the excretion rate of Rabeprazole which could result in a higher serum level.,Rabeprazole
DB01133,Goserelin may decrease the excretion rate of Tiludronic acid which could result in a higher serum level.,Tiludronic acid
DB01135,Goserelin may decrease the excretion rate of Doxacurium which could result in a higher serum level.,Doxacurium
DB01148,Goserelin may decrease the excretion rate of Flavoxate which could result in a higher serum level.,Flavoxate
DB01149,Goserelin may decrease the excretion rate of Nefazodone which could result in a higher serum level.,Nefazodone
DB01156,Goserelin may decrease the excretion rate of Bupropion which could result in a higher serum level.,Bupropion
DB01157,Goserelin may decrease the excretion rate of Trimetrexate which could result in a higher serum level.,Trimetrexate
DB01170,Goserelin may decrease the excretion rate of Guanethidine which could result in a higher serum level.,Guanethidine
DB01181,Goserelin may decrease the excretion rate of Ifosfamide which could result in a higher serum level.,Ifosfamide
DB01183,Goserelin may decrease the excretion rate of Naloxone which could result in a higher serum level.,Naloxone
DB01203,Goserelin may decrease the excretion rate of Nadolol which could result in a higher serum level.,Nadolol
DB01205,Goserelin may decrease the excretion rate of Flumazenil which could result in a higher serum level.,Flumazenil
DB01213,Goserelin may decrease the excretion rate of Fomepizole which could result in a higher serum level.,Fomepizole
DB01215,Goserelin may decrease the excretion rate of Estazolam which could result in a higher serum level.,Estazolam
DB01221,Goserelin may decrease the excretion rate of Ketamine which could result in a higher serum level.,Ketamine
DB01222,Goserelin may decrease the excretion rate of Budesonide which could result in a higher serum level.,Budesonide
DB01240,Goserelin may decrease the excretion rate of Epoprostenol which could result in a higher serum level.,Epoprostenol
DB01241,Goserelin may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,Gemfibrozil
DB01249,Goserelin may decrease the excretion rate of Iodixanol which could result in a higher serum level.,Iodixanol
DB01273,Goserelin may decrease the excretion rate of Varenicline which could result in a higher serum level.,Varenicline
DB01275,Goserelin may decrease the excretion rate of Hydralazine which could result in a higher serum level.,Hydralazine
DB01359,Goserelin may decrease the excretion rate of Penbutolol which could result in a higher serum level.,Penbutolol
DB01367,Goserelin may decrease the excretion rate of Rasagiline which could result in a higher serum level.,Rasagiline
DB01394,Goserelin may decrease the excretion rate of Colchicine which could result in a higher serum level.,Colchicine
DB01409,Goserelin may decrease the excretion rate of Tiotropium which could result in a higher serum level.,Tiotropium
DB01420,Goserelin may decrease the excretion rate of Testosterone propionate which could result in a higher serum level.,Testosterone propionate
DB01427,Goserelin may decrease the excretion rate of Amrinone which could result in a higher serum level.,Amrinone
DB01428,Goserelin may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,Oxybenzone
DB01431,Goserelin may decrease the excretion rate of Allylestrenol which could result in a higher serum level.,Allylestrenol
DB01550,Goserelin may decrease the excretion rate of Fenproporex which could result in a higher serum level.,Fenproporex
DB01558,Goserelin may decrease the excretion rate of Bromazepam which could result in a higher serum level.,Bromazepam
DB01563,Goserelin may decrease the excretion rate of Chloral hydrate which could result in a higher serum level.,Chloral hydrate
DB01577,Goserelin may decrease the excretion rate of Metamfetamine which could result in a higher serum level.,Metamfetamine
DB01587,Goserelin may decrease the excretion rate of Ketazolam which could result in a higher serum level.,Ketazolam
DB01610,Goserelin may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,Valganciclovir
DB01638,Goserelin may decrease the excretion rate of Sorbitol which could result in a higher serum level.,Sorbitol
DB01656,Goserelin may decrease the excretion rate of Roflumilast which could result in a higher serum level.,Roflumilast
DB01685,Goserelin may decrease the excretion rate of Topiroxostat which could result in a higher serum level.,Topiroxostat
DB04574,Goserelin may decrease the excretion rate of Estrone sulfate which could result in a higher serum level.,Estrone sulfate
DB04871,Goserelin may decrease the excretion rate of Lorcaserin which could result in a higher serum level.,Lorcaserin
DB04895,Goserelin may decrease the excretion rate of Pegaptanib which could result in a higher serum level.,Pegaptanib
DB04896,Goserelin may decrease the excretion rate of Milnacipran which could result in a higher serum level.,Milnacipran
DB04920,Goserelin may decrease the excretion rate of Clevidipine which could result in a higher serum level.,Clevidipine
DB05018,Goserelin may decrease the excretion rate of Migalastat which could result in a higher serum level.,Migalastat
DB05541,Goserelin may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,Brivaracetam
DB05676,Goserelin may decrease the excretion rate of Apremilast which could result in a higher serum level.,Apremilast
DB06154,Goserelin may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.,Pentaerythritol tetranitrate
DB06186,Goserelin may decrease the excretion rate of Ipilimumab which could result in a higher serum level.,Ipilimumab
DB06196,Goserelin may decrease the excretion rate of Icatibant which could result in a higher serum level.,Icatibant
DB06209,Goserelin may decrease the excretion rate of Prasugrel which could result in a higher serum level.,Prasugrel
DB06211,Goserelin may decrease the excretion rate of Doripenem which could result in a higher serum level.,Doripenem
DB06228,Goserelin may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.,Rivaroxaban
DB06230,Goserelin may decrease the excretion rate of Nalmefene which could result in a higher serum level.,Nalmefene
DB06262,Goserelin may decrease the excretion rate of Droxidopa which could result in a higher serum level.,Droxidopa
DB06480,Goserelin may decrease the excretion rate of Prucalopride which could result in a higher serum level.,Prucalopride
DB06623,Goserelin may decrease the excretion rate of Flupirtine which could result in a higher serum level.,Flupirtine
DB06637,Goserelin may decrease the excretion rate of Dalfampridine which could result in a higher serum level.,Dalfampridine
DB06695,Goserelin may decrease the excretion rate of Dabigatran etexilate which could result in a higher serum level.,Dabigatran etexilate
DB06700,Goserelin may decrease the excretion rate of Desvenlafaxine which could result in a higher serum level.,Desvenlafaxine
DB06702,Goserelin may decrease the excretion rate of Fesoterodine which could result in a higher serum level.,Fesoterodine
DB06705,Goserelin may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,Gadofosveset trisodium
DB06710,Goserelin may decrease the excretion rate of Methyltestosterone which could result in a higher serum level.,Methyltestosterone
DB06767,Goserelin may decrease the excretion rate of Ammonium chloride which could result in a higher serum level.,Ammonium chloride
DB06782,Goserelin may decrease the excretion rate of Dimercaprol which could result in a higher serum level.,Dimercaprol
DB06796,Goserelin may decrease the excretion rate of Mangafodipir which could result in a higher serum level.,Mangafodipir
DB06800,Goserelin may decrease the excretion rate of Methylnaltrexone which could result in a higher serum level.,Methylnaltrexone
DB06809,Goserelin may decrease the excretion rate of Plerixafor which could result in a higher serum level.,Plerixafor
DB06813,Goserelin may decrease the excretion rate of Pralatrexate which could result in a higher serum level.,Pralatrexate
DB06823,Goserelin may decrease the excretion rate of Tiopronin which could result in a higher serum level.,Tiopronin
DB06824,Goserelin may decrease the excretion rate of Triethylenetetramine which could result in a higher serum level.,Triethylenetetramine
DB08824,Goserelin may decrease the excretion rate of Ioflupane I-123 which could result in a higher serum level.,Ioflupane I-123
DB08826,Goserelin may decrease the excretion rate of Deferiprone which could result in a higher serum level.,Deferiprone
DB08840,Goserelin may decrease the excretion rate of N-methylnicotinamide which could result in a higher serum level.,N-methylnicotinamide
DB08872,Goserelin may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,Gabapentin enacarbil
DB08877,Goserelin may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.,Ruxolitinib
DB08897,Goserelin may decrease the excretion rate of Aclidinium which could result in a higher serum level.,Aclidinium
DB08899,Goserelin may decrease the excretion rate of Enzalutamide which could result in a higher serum level.,Enzalutamide
DB08900,Goserelin may decrease the excretion rate of Teduglutide which could result in a higher serum level.,Teduglutide
DB08904,Goserelin may decrease the excretion rate of Certolizumab pegol which could result in a higher serum level.,Certolizumab pegol
DB08905,Goserelin may decrease the excretion rate of Formestane which could result in a higher serum level.,Formestane
DB08909,Goserelin may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,Glycerol phenylbutyrate
DB08910,Goserelin may decrease the excretion rate of Pomalidomide which could result in a higher serum level.,Pomalidomide
DB08911,Goserelin may decrease the excretion rate of Trametinib which could result in a higher serum level.,Trametinib
DB08918,Goserelin may decrease the excretion rate of Levomilnacipran which could result in a higher serum level.,Levomilnacipran
DB08932,Goserelin may decrease the excretion rate of Macitentan which could result in a higher serum level.,Macitentan
DB08934,Goserelin may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.,Sofosbuvir
DB08964,Goserelin may decrease the excretion rate of Gemeprost which could result in a higher serum level.,Gemeprost
DB09027,Goserelin may decrease the excretion rate of Ledipasvir which could result in a higher serum level.,Ledipasvir
DB09050,Goserelin may decrease the excretion rate of Ceftolozane which could result in a higher serum level.,Ceftolozane
DB09068,Goserelin may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,Vortioxetine
DB09071,Goserelin may decrease the excretion rate of Tasimelteon which could result in a higher serum level.,Tasimelteon
DB09075,Goserelin may decrease the excretion rate of Edoxaban which could result in a higher serum level.,Edoxaban
DB09081,Goserelin may decrease the excretion rate of Idebenone which could result in a higher serum level.,Idebenone
DB09091,Goserelin may decrease the excretion rate of Tixocortol which could result in a higher serum level.,Tixocortol
DB09103,Goserelin may decrease the excretion rate of Ancestim which could result in a higher serum level.,Ancestim
DB09104,Goserelin may decrease the excretion rate of Magnesium hydroxide which could result in a higher serum level.,Magnesium hydroxide
DB09106,Goserelin may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,Hydroxyethyl Starch
DB09111,Goserelin may decrease the excretion rate of Pentastarch which could result in a higher serum level.,Pentastarch
DB09118,Goserelin may decrease the excretion rate of Stiripentol which could result in a higher serum level.,Stiripentol
DB09121,Goserelin may decrease the excretion rate of Aurothioglucose which could result in a higher serum level.,Aurothioglucose
DB09123,Goserelin may decrease the excretion rate of Dienogest which could result in a higher serum level.,Dienogest
DB09129,Goserelin may decrease the excretion rate of Chromic chloride which could result in a higher serum level.,Chromic chloride
DB09132,Goserelin may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,Gadoteric acid
DB09133,Goserelin may decrease the excretion rate of Iothalamic acid which could result in a higher serum level.,Iothalamic acid
DB09134,Goserelin may decrease the excretion rate of Ioversol which could result in a higher serum level.,Ioversol
DB09135,Goserelin may decrease the excretion rate of Ioxilan which could result in a higher serum level.,Ioxilan
DB09136,Goserelin may decrease the excretion rate of Isosulfan blue which could result in a higher serum level.,Isosulfan blue
DB09137,Goserelin may decrease the excretion rate of Technetium Tc-99m mebrofenin which could result in a higher serum level.,Technetium Tc-99m mebrofenin
DB09139,Goserelin may decrease the excretion rate of Technetium Tc-99m oxidronate which could result in a higher serum level.,Technetium Tc-99m oxidronate
DB09148,Goserelin may decrease the excretion rate of Florbetaben (18F) which could result in a higher serum level.,Florbetaben (18F)
DB09149,Goserelin may decrease the excretion rate of Florbetapir (18F) which could result in a higher serum level.,Florbetapir (18F)
DB09156,Goserelin may decrease the excretion rate of Iopromide which could result in a higher serum level.,Iopromide
DB09163,Goserelin may decrease the excretion rate of Technetium Tc-99m exametazime which could result in a higher serum level.,Technetium Tc-99m exametazime
DB09165,Goserelin may decrease the excretion rate of Technetium Tc-99m pyrophosphate which could result in a higher serum level.,Technetium Tc-99m pyrophosphate
DB09185,Goserelin may decrease the excretion rate of Viloxazine which could result in a higher serum level.,Viloxazine
DB09194,Goserelin may decrease the excretion rate of Etoperidone which could result in a higher serum level.,Etoperidone
DB09195,Goserelin may decrease the excretion rate of Lorpiprazole which could result in a higher serum level.,Lorpiprazole
DB09204,Goserelin may decrease the excretion rate of Arotinolol which could result in a higher serum level.,Arotinolol
DB09205,Goserelin may decrease the excretion rate of Moxisylyte which could result in a higher serum level.,Moxisylyte
DB09209,Goserelin may decrease the excretion rate of Pholcodine which could result in a higher serum level.,Pholcodine
DB09210,Goserelin may decrease the excretion rate of Piracetam which could result in a higher serum level.,Piracetam
DB09219,Goserelin may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,Bisoxatin
DB09220,Goserelin may decrease the excretion rate of Nicorandil which could result in a higher serum level.,Nicorandil
DB09223,Goserelin may decrease the excretion rate of Blonanserin which could result in a higher serum level.,Blonanserin
DB09241,Goserelin may decrease the excretion rate of Methylene blue which could result in a higher serum level.,Methylene blue
DB09244,Goserelin may decrease the excretion rate of Pirlindole which could result in a higher serum level.,Pirlindole
DB09245,Goserelin may decrease the excretion rate of Toloxatone which could result in a higher serum level.,Toloxatone
DB09255,Goserelin may decrease the excretion rate of Dextran which could result in a higher serum level.,Dextran
DB09256,Goserelin may decrease the excretion rate of Tegafur which could result in a higher serum level.,Tegafur
DB09257,Goserelin may decrease the excretion rate of Gimeracil which could result in a higher serum level.,Gimeracil
DB09262,Goserelin may decrease the excretion rate of Imidafenacin which could result in a higher serum level.,Imidafenacin
DB09264,Goserelin may decrease the excretion rate of Idarucizumab which could result in a higher serum level.,Idarucizumab
DB09268,Goserelin may decrease the excretion rate of Picosulfuric acid which could result in a higher serum level.,Picosulfuric acid
DB09276,Goserelin may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level.,Sodium aurothiomalate
DB09281,Goserelin may decrease the excretion rate of Magnesium trisilicate which could result in a higher serum level.,Magnesium trisilicate
DB09292,Goserelin may decrease the excretion rate of Sacubitril which could result in a higher serum level.,Sacubitril
DB09301,Goserelin may decrease the excretion rate of Chondroitin sulfate which could result in a higher serum level.,Chondroitin sulfate
DB09317,"Goserelin may decrease the excretion rate of Synthetic Conjugated Estrogens, A which could result in a higher serum level.","Synthetic Conjugated Estrogens, A"
DB09318,"Goserelin may decrease the excretion rate of Synthetic Conjugated Estrogens, B which could result in a higher serum level.","Synthetic Conjugated Estrogens, B"
DB09320,Goserelin may decrease the excretion rate of Procaine benzylpenicillin which could result in a higher serum level.,Procaine benzylpenicillin
DB09324,Goserelin may decrease the excretion rate of Sulbactam which could result in a higher serum level.,Sulbactam
DB09325,Goserelin may decrease the excretion rate of Sodium fluoride which could result in a higher serum level.,Sodium fluoride
DB09329,"Goserelin may decrease the excretion rate of Antihemophilic Factor (Recombinant), PEGylated which could result in a higher serum level.","Antihemophilic Factor (Recombinant), PEGylated"
DB09344,Goserelin may decrease the excretion rate of Invert sugar which could result in a higher serum level.,Invert sugar
DB09357,Goserelin may decrease the excretion rate of Dexpanthenol which could result in a higher serum level.,Dexpanthenol
DB09394,Goserelin may decrease the excretion rate of Phosphoric acid which could result in a higher serum level.,Phosphoric acid
DB09395,Goserelin may decrease the excretion rate of Sodium acetate which could result in a higher serum level.,Sodium acetate
DB09407,Goserelin may decrease the excretion rate of Magnesium chloride which could result in a higher serum level.,Magnesium chloride
DB09418,Goserelin may decrease the excretion rate of Potassium perchlorate which could result in a higher serum level.,Potassium perchlorate
DB09472,Goserelin may decrease the excretion rate of Sodium sulfate which could result in a higher serum level.,Sodium sulfate
DB09477,Goserelin may decrease the excretion rate of Enalaprilat which could result in a higher serum level.,Enalaprilat
DB09481,Goserelin may decrease the excretion rate of Magnesium carbonate which could result in a higher serum level.,Magnesium carbonate
DB09496,Goserelin may decrease the excretion rate of Octinoxate which could result in a higher serum level.,Octinoxate
DB09502,Goserelin may decrease the excretion rate of Fludeoxyglucose (18F) which could result in a higher serum level.,Fludeoxyglucose (18F)
DB09546,Goserelin may decrease the excretion rate of Iobenguane sulfate I-123 which could result in a higher serum level.,Iobenguane sulfate I-123
DB09570,Goserelin may decrease the excretion rate of Ixazomib which could result in a higher serum level.,Ixazomib
DB11077,Goserelin may decrease the excretion rate of Polyethylene glycol 400 which could result in a higher serum level.,Polyethylene glycol 400
DB11090,Goserelin may decrease the excretion rate of Potassium nitrate which could result in a higher serum level.,Potassium nitrate
DB11098,Goserelin may decrease the excretion rate of Potassium bicarbonate which could result in a higher serum level.,Potassium bicarbonate
DB11102,Goserelin may decrease the excretion rate of N-acetyltyrosine which could result in a higher serum level.,N-acetyltyrosine
DB11114,Goserelin may decrease the excretion rate of Eucalyptus oil which could result in a higher serum level.,Eucalyptus oil
DB11127,Goserelin may decrease the excretion rate of Selenious acid which could result in a higher serum level.,Selenious acid
DB11130,Goserelin may decrease the excretion rate of Opium which could result in a higher serum level.,Opium
DB11135,Goserelin may decrease the excretion rate of Selenium which could result in a higher serum level.,Selenium
DB11136,Goserelin may decrease the excretion rate of Chromium which could result in a higher serum level.,Chromium
DB11145,Goserelin may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,Oxyquinoline
DB11156,Goserelin may decrease the excretion rate of Pyrantel which could result in a higher serum level.,Pyrantel
DB11164,Goserelin may decrease the excretion rate of Bicisate which could result in a higher serum level.,Bicisate
DB11251,Goserelin may decrease the excretion rate of Tocopherol which could result in a higher serum level.,Tocopherol
DB11278,Goserelin may decrease the excretion rate of DL-Methylephedrine which could result in a higher serum level.,DL-Methylephedrine
DB11328,Goserelin may decrease the excretion rate of Tetradecyl hydrogen sulfate (ester) which could result in a higher serum level.,Tetradecyl hydrogen sulfate (ester)
DB11338,Goserelin may decrease the excretion rate of Clove oil which could result in a higher serum level.,Clove oil
DB11358,Goserelin may decrease the excretion rate of Evening primrose oil which could result in a higher serum level.,Evening primrose oil
DB11364,Goserelin may decrease the excretion rate of Pidotimod which could result in a higher serum level.,Pidotimod
DB11560,Goserelin may decrease the excretion rate of Lesinurad which could result in a higher serum level.,Lesinurad
DB11577,Goserelin may decrease the excretion rate of Indigotindisulfonic acid which could result in a higher serum level.,Indigotindisulfonic acid
DB11587,Goserelin may decrease the excretion rate of Etafedrine which could result in a higher serum level.,Etafedrine
DB11598,Goserelin may decrease the excretion rate of Antithrombin III human which could result in a higher serum level.,Antithrombin III human
DB11691,Goserelin may decrease the excretion rate of Naldemedine which could result in a higher serum level.,Naldemedine
DB11699,Goserelin may decrease the excretion rate of Tropisetron which could result in a higher serum level.,Tropisetron
DB11817,Goserelin may decrease the excretion rate of Baricitinib which could result in a higher serum level.,Baricitinib
DB11901,Goserelin may decrease the excretion rate of Apalutamide which could result in a higher serum level.,Apalutamide
DB11915,Goserelin may decrease the excretion rate of Valbenazine which could result in a higher serum level.,Valbenazine
DB11989,Goserelin may decrease the excretion rate of Benznidazole which could result in a higher serum level.,Benznidazole
DB12007,Goserelin may decrease the excretion rate of Isoflavone which could result in a higher serum level.,Isoflavone
DB12107,Goserelin may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,Vaborbactam
DB12278,Goserelin may decrease the excretion rate of Propiverine which could result in a higher serum level.,Propiverine
DB12783,Goserelin may decrease the excretion rate of Benserazide which could result in a higher serum level.,Benserazide
DB13025,Goserelin may decrease the excretion rate of Tiapride which could result in a higher serum level.,Tiapride
DB13139,Goserelin may decrease the excretion rate of Levosalbutamol which could result in a higher serum level.,Levosalbutamol
DB13156,Goserelin may decrease the excretion rate of Inosine pranobex which could result in a higher serum level.,Inosine pranobex
DB13178,Goserelin may decrease the excretion rate of Inositol which could result in a higher serum level.,Inositol
DB13185,Goserelin may decrease the excretion rate of Oxabolone cipionate which could result in a higher serum level.,Oxabolone cipionate
DB13191,Goserelin may decrease the excretion rate of Phosphocreatine which could result in a higher serum level.,Phosphocreatine
DB13269,Goserelin may decrease the excretion rate of Dichlorobenzyl alcohol which could result in a higher serum level.,Dichlorobenzyl alcohol
DB13293,Goserelin may decrease the excretion rate of Ipecac which could result in a higher serum level.,Ipecac
DB13595,Goserelin may decrease the excretion rate of Almasilate which could result in a higher serum level.,Almasilate
DB13873,Goserelin may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.,Fenofibric acid
DB13884,Goserelin may decrease the excretion rate of Albutrepenonacog alfa which could result in a higher serum level.,Albutrepenonacog alfa
DB13909,Goserelin may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,Bismuth subgallate
DB13943,Goserelin may decrease the excretion rate of Testosterone cypionate which could result in a higher serum level.,Testosterone cypionate
DB13944,Goserelin may decrease the excretion rate of Testosterone enanthate which could result in a higher serum level.,Testosterone enanthate
DB13946,Goserelin may decrease the excretion rate of Testosterone undecanoate which could result in a higher serum level.,Testosterone undecanoate
DB13952,Goserelin may decrease the excretion rate of Estradiol acetate which could result in a higher serum level.,Estradiol acetate
DB13954,Goserelin may decrease the excretion rate of Estradiol cypionate which could result in a higher serum level.,Estradiol cypionate
DB13955,Goserelin may decrease the excretion rate of Estradiol dienanthate which could result in a higher serum level.,Estradiol dienanthate
DB13956,Goserelin may decrease the excretion rate of Estradiol valerate which could result in a higher serum level.,Estradiol valerate
DB13967,Goserelin may decrease the excretion rate of Patent Blue which could result in a higher serum level.,Patent Blue
DB14006,Goserelin may decrease the excretion rate of Choline salicylate which could result in a higher serum level.,Choline salicylate
DB14007,Goserelin may decrease the excretion rate of Pentetic acid which could result in a higher serum level.,Pentetic acid
DB14498,Goserelin may decrease the excretion rate of Potassium acetate which could result in a higher serum level.,Potassium acetate
DB14499,Goserelin may decrease the excretion rate of Potassium sulfate which could result in a higher serum level.,Potassium sulfate
DB14526,Goserelin may decrease the excretion rate of Chromic citrate which could result in a higher serum level.,Chromic citrate
DB14527,Goserelin may decrease the excretion rate of Chromic nitrate which could result in a higher serum level.,Chromic nitrate
DB14528,Goserelin may decrease the excretion rate of Chromium gluconate which could result in a higher serum level.,Chromium gluconate
DB14529,Goserelin may decrease the excretion rate of Chromium nicotinate which could result in a higher serum level.,Chromium nicotinate
DB14530,Goserelin may decrease the excretion rate of Chromous sulfate which could result in a higher serum level.,Chromous sulfate
DB14754,Goserelin may decrease the excretion rate of Solriamfetol which could result in a higher serum level.,Solriamfetol
DB06815,Goserelin may decrease the excretion rate of Pyrithione which could result in a higher serum level.,Pyrithione
DB11121,Goserelin may decrease the excretion rate of Chloroxylenol which could result in a higher serum level.,Chloroxylenol
DB11085,Goserelin may decrease the excretion rate of Resorcinol which could result in a higher serum level.,Resorcinol
DB00661,Goserelin may decrease the excretion rate of Verapamil which could result in a higher serum level.,Verapamil
DB15593,Goserelin may decrease the excretion rate of Golodirsen which could result in a higher serum level.,Golodirsen
DB00440,Goserelin may decrease the excretion rate of Trimethoprim which could result in a higher serum level.,Trimethoprim
DB00318,Goserelin may decrease the excretion rate of Codeine which could result in a higher serum level.,Codeine
DB00454,Goserelin may decrease the excretion rate of Meperidine which could result in a higher serum level.,Meperidine
DB00813,Goserelin may decrease the excretion rate of Fentanyl which could result in a higher serum level.,Fentanyl
DB00879,Goserelin may decrease the excretion rate of Emtricitabine which could result in a higher serum level.,Emtricitabine
DB08996,Goserelin may decrease the excretion rate of Dimetacrine which could result in a higher serum level.,Dimetacrine
DB14506,Goserelin may decrease the excretion rate of Lithium hydroxide which could result in a higher serum level.,Lithium hydroxide
DB00452,Framycetin may decrease the excretion rate of Goserelin which could result in a higher serum level.,Framycetin
DB00479,Amikacin may decrease the excretion rate of Goserelin which could result in a higher serum level.,Amikacin
DB00684,Tobramycin may decrease the excretion rate of Goserelin which could result in a higher serum level.,Tobramycin
DB00798,Gentamicin may decrease the excretion rate of Goserelin which could result in a higher serum level.,Gentamicin
DB00955,Netilmicin may decrease the excretion rate of Goserelin which could result in a higher serum level.,Netilmicin
DB00994,Neomycin may decrease the excretion rate of Goserelin which could result in a higher serum level.,Neomycin
DB01082,Streptomycin may decrease the excretion rate of Goserelin which could result in a higher serum level.,Streptomycin
DB01172,Kanamycin may decrease the excretion rate of Goserelin which could result in a higher serum level.,Kanamycin
DB01421,Paromomycin may decrease the excretion rate of Goserelin which could result in a higher serum level.,Paromomycin
DB03615,Ribostamycin may decrease the excretion rate of Goserelin which could result in a higher serum level.,Ribostamycin
DB04263,Geneticin may decrease the excretion rate of Goserelin which could result in a higher serum level.,Geneticin
DB04626,Apramycin may decrease the excretion rate of Goserelin which could result in a higher serum level.,Apramycin
DB04729,Gentamicin C1a may decrease the excretion rate of Goserelin which could result in a higher serum level.,Gentamicin C1a
DB04808,Neamine may decrease the excretion rate of Goserelin which could result in a higher serum level.,Neamine
DB06696,Arbekacin may decrease the excretion rate of Goserelin which could result in a higher serum level.,Arbekacin
DB08437,Puromycin may decrease the excretion rate of Goserelin which could result in a higher serum level.,Puromycin
DB11512,Dihydrostreptomycin may decrease the excretion rate of Goserelin which could result in a higher serum level.,Dihydrostreptomycin
DB11520,Hygromycin B may decrease the excretion rate of Goserelin which could result in a higher serum level.,Hygromycin B
DB12604,Sisomicin may decrease the excretion rate of Goserelin which could result in a higher serum level.,Sisomicin
DB13270,Dibekacin may decrease the excretion rate of Goserelin which could result in a higher serum level.,Dibekacin
DB13274,Micronomicin may decrease the excretion rate of Goserelin which could result in a higher serum level.,Micronomicin
DB13540,Isepamicin may decrease the excretion rate of Goserelin which could result in a higher serum level.,Isepamicin
DB13673,Bekanamycin may decrease the excretion rate of Goserelin which could result in a higher serum level.,Bekanamycin
DB00552,Goserelin may decrease the excretion rate of Pentostatin which could result in a higher serum level.,Pentostatin
DB13145,Goserelin may decrease the excretion rate of Nedaplatin which could result in a higher serum level.,Nedaplatin
DB00314,Goserelin may decrease the excretion rate of Capreomycin which could result in a higher serum level.,Capreomycin
DB00390,Goserelin may decrease the excretion rate of Digoxin which could result in a higher serum level.,Digoxin
DB00512,Goserelin may decrease the excretion rate of Vancomycin which could result in a higher serum level.,Vancomycin
DB00515,Goserelin may decrease the excretion rate of Cisplatin which could result in a higher serum level.,Cisplatin
DB00564,Goserelin may decrease the excretion rate of Carbamazepine which could result in a higher serum level.,Carbamazepine
DB00642,Goserelin may decrease the excretion rate of Pemetrexed which could result in a higher serum level.,Pemetrexed
DB00682,Goserelin may decrease the excretion rate of Warfarin which could result in a higher serum level.,Warfarin
DB00982,Goserelin may decrease the excretion rate of Isotretinoin which could result in a higher serum level.,Isotretinoin
DB12615,Goserelin may decrease the excretion rate of Plazomicin which could result in a higher serum level.,Plazomicin
DB14509,Goserelin may decrease the excretion rate of Lithium carbonate which could result in a higher serum level.,Lithium carbonate
DB00524,Goserelin may increase the excretion rate of Metolazone which could result in a lower serum level and potentially a reduction in efficacy.,Metolazone
DB00695,Goserelin may increase the excretion rate of Furosemide which could result in a lower serum level and potentially a reduction in efficacy.,Furosemide
DB00887,Goserelin may increase the excretion rate of Bumetanide which could result in a lower serum level and potentially a reduction in efficacy.,Bumetanide
DB09338,Goserelin may increase the excretion rate of Mersalyl which could result in a lower serum level and potentially a reduction in efficacy.,Mersalyl
DB00214,Torasemide may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.,Torasemide
DB00232,Methyclothiazide may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.,Methyclothiazide
DB00310,Chlorthalidone may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.,Chlorthalidone
DB00311,Ethoxzolamide may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.,Ethoxzolamide
DB00421,Spironolactone may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.,Spironolactone
DB00436,Bendroflumethiazide may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.,Bendroflumethiazide
DB00562,Benzthiazide may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.,Benzthiazide
DB00594,Amiloride may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.,Amiloride
DB00606,Cyclothiazide may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.,Cyclothiazide
DB00700,Eplerenone may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.,Eplerenone
DB00703,Methazolamide may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.,Methazolamide
DB00774,Hydroflumethiazide may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.,Hydroflumethiazide
DB00819,Acetazolamide may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.,Acetazolamide
DB00872,Conivaptan may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.,Conivaptan
DB00880,Chlorothiazide may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.,Chlorothiazide
DB01021,Trichlormethiazide may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.,Trichlormethiazide
DB01119,Diazoxide may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.,Diazoxide
DB01144,Diclofenamide may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.,Diclofenamide
DB01324,Polythiazide may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.,Polythiazide
DB01325,Quinethazone may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.,Quinethazone
DB01395,Drospirenone may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.,Drospirenone
DB01412,Theobromine may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.,Theobromine
DB02925,Piretanide may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.,Piretanide
DB04831,Tienilic acid may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.,Tienilic acid
DB05034,Ularitide may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.,Ularitide
DB06212,Tolvaptan may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.,Tolvaptan
DB06370,Indisulam may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.,Indisulam
DB08961,Azosemide may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.,Azosemide
DB09015,Canrenoic acid may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.,Canrenoic acid
DB09125,Potassium citrate may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.,Potassium citrate
DB09401,Isosorbide may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.,Isosorbide
DB12221,Canrenone may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.,Canrenone
DB12670,Rolofylline may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.,Rolofylline
DB12704,Spiradoline may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.,Spiradoline
DB13284,Meticrane may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.,Meticrane
DB13316,Ibopamine may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.,Ibopamine
DB13405,Mefruside may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.,Mefruside
DB13430,Mebutizide may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.,Mebutizide
DB13532,Cyclopenthiazide may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.,Cyclopenthiazide
DB13617,Clorexolone may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.,Clorexolone
DB13663,Clofenamide may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.,Clofenamide
DB13708,Fenquizone may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.,Fenquizone
DB13792,Clopamide may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.,Clopamide
DB13801,Muzolimine may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.,Muzolimine
DB13803,Xipamide may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.,Xipamide
DB13989,Epitizide may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.,Epitizide
DB14018,Bromotheophylline may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.,Bromotheophylline
DB14500,Potassium may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.,Potassium
DB00331,The therapeutic efficacy of Metformin can be decreased when used in combination with Goserelin.,Metformin
DB00656,The risk or severity of QTc prolongation can be increased when Trazodone is combined with Goserelin.,Trazodone
DB11986,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Entrectinib.,Entrectinib
DB11642,Goserelin may increase the QTc-prolonging activities of Pitolisant.,Pitolisant
DB12825,Lefamulin may increase the QTc-prolonging activities of Goserelin.,Lefamulin
DB00557,The risk or severity of QTc prolongation can be increased when Hydroxyzine is combined with Goserelin.,Hydroxyzine
DB00246,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Ziprasidone.,Ziprasidone
DB00502,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Haloperidol.,Haloperidol
DB00472,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Fluoxetine.,Fluoxetine
DB06605,Apixaban may increase the anticoagulant activities of Reteplase.,Apixaban
DB06695,Dabigatran etexilate may increase the anticoagulant activities of Reteplase.,Dabigatran etexilate
DB01254,The risk or severity of bleeding and hemorrhage can be increased when Dasatinib is combined with Reteplase.,Dasatinib
DB01609,The risk or severity of gastrointestinal bleeding can be increased when Reteplase is combined with Deferasirox.,Deferasirox
DB01586,The risk or severity of bleeding and bruising can be increased when Reteplase is combined with Ursodeoxycholic acid.,Ursodeoxycholic acid
DB02123,The risk or severity of bleeding and bruising can be increased when Reteplase is combined with Glycochenodeoxycholic Acid.,Glycochenodeoxycholic Acid
DB02659,The risk or severity of bleeding and bruising can be increased when Reteplase is combined with Cholic Acid.,Cholic Acid
DB02691,The risk or severity of bleeding and bruising can be increased when Reteplase is combined with Glycocholic acid.,Glycocholic acid
DB03619,The risk or severity of bleeding and bruising can be increased when Reteplase is combined with Deoxycholic acid.,Deoxycholic acid
DB04348,The risk or severity of bleeding and bruising can be increased when Reteplase is combined with Taurocholic acid.,Taurocholic acid
DB05990,The risk or severity of bleeding and bruising can be increased when Reteplase is combined with Obeticholic acid.,Obeticholic acid
DB06777,The risk or severity of bleeding and bruising can be increased when Reteplase is combined with Chenodeoxycholic acid.,Chenodeoxycholic acid
DB08833,The risk or severity of bleeding and bruising can be increased when Reteplase is combined with Taurochenodeoxycholic acid.,Taurochenodeoxycholic acid
DB08834,The risk or severity of bleeding and bruising can be increased when Reteplase is combined with Tauroursodeoxycholic acid.,Tauroursodeoxycholic acid
DB08857,The risk or severity of bleeding and bruising can be increased when Reteplase is combined with Bamet-UD2.,Bamet-UD2
DB11622,The risk or severity of bleeding and bruising can be increased when Reteplase is combined with Dehydrocholic acid.,Dehydrocholic acid
DB11789,The risk or severity of bleeding and bruising can be increased when Reteplase is combined with Hyodeoxycholic Acid.,Hyodeoxycholic Acid
DB09075,The risk or severity of bleeding can be increased when Edoxaban is combined with Reteplase.,Edoxaban
DB09053,The risk or severity of bleeding and hemorrhage can be increased when Ibrutinib is combined with Reteplase.,Ibrutinib
DB08935,The risk or severity of bleeding and hemorrhage can be increased when Reteplase is combined with Obinutuzumab.,Obinutuzumab
DB06228,Reteplase may increase the anticoagulant activities of Rivaroxaban.,Rivaroxaban
DB06206,The risk or severity of bleeding and hemorrhage can be increased when Reteplase is combined with Sugammadex.,Sugammadex
DB09070,Tibolone may increase the anticoagulant activities of Reteplase.,Tibolone
DB00932,The risk or severity of bleeding and hemorrhage can be increased when Tipranavir is combined with Reteplase.,Tipranavir
DB00013,Urokinase may increase the anticoagulant activities of Reteplase.,Urokinase
DB00163,Vitamin E may increase the anticoagulant activities of Reteplase.,Vitamin E
DB09030,The risk or severity of bleeding and hemorrhage can be increased when Vorapaxar is combined with Reteplase.,Vorapaxar
DB06692,The therapeutic efficacy of Reteplase can be decreased when used in combination with Aprotinin.,Aprotinin
DB01381,The therapeutic efficacy of Reteplase can be increased when used in combination with Ginkgo biloba.,Ginkgo biloba
DB01181,The risk or severity of bleeding can be increased when Ifosfamide is combined with Reteplase.,Ifosfamide
DB00468,The therapeutic efficacy of Reteplase can be increased when used in combination with Quinine.,Quinine
DB00908,The therapeutic efficacy of Reteplase can be increased when used in combination with Quinidine.,Quinidine
DB00675,The risk or severity of bleeding can be increased when Tamoxifen is combined with Reteplase.,Tamoxifen
DB00539,The risk or severity of bleeding can be increased when Toremifene is combined with Reteplase.,Toremifene
DB00806,The therapeutic efficacy of Reteplase can be increased when used in combination with Pentoxifylline.,Pentoxifylline
DB00686,Pentosan polysulfate may increase the anticoagulant activities of Reteplase.,Pentosan polysulfate
DB00583,The therapeutic efficacy of Reteplase can be increased when used in combination with Levocarnitine.,Levocarnitine
DB00255,Diethylstilbestrol may decrease the anticoagulant activities of Reteplase.,Diethylstilbestrol
DB00269,Chlorotrianisene may decrease the anticoagulant activities of Reteplase.,Chlorotrianisene
DB00286,Conjugated estrogens may decrease the anticoagulant activities of Reteplase.,Conjugated estrogens
DB00783,Estradiol may decrease the anticoagulant activities of Reteplase.,Estradiol
DB00977,Ethinylestradiol may decrease the anticoagulant activities of Reteplase.,Ethinylestradiol
DB01357,Mestranol may decrease the anticoagulant activities of Reteplase.,Mestranol
DB04573,Estriol may decrease the anticoagulant activities of Reteplase.,Estriol
DB04574,Estrone sulfate may decrease the anticoagulant activities of Reteplase.,Estrone sulfate
DB04575,Quinestrol may decrease the anticoagulant activities of Reteplase.,Quinestrol
DB07931,Hexestrol may decrease the anticoagulant activities of Reteplase.,Hexestrol
DB09317,"Synthetic Conjugated Estrogens, A may decrease the anticoagulant activities of Reteplase.","Synthetic Conjugated Estrogens, A"
DB09318,"Synthetic Conjugated Estrogens, B may decrease the anticoagulant activities of Reteplase.","Synthetic Conjugated Estrogens, B"
DB09369,Polyestradiol phosphate may decrease the anticoagulant activities of Reteplase.,Polyestradiol phosphate
DB09381,Esterified estrogens may decrease the anticoagulant activities of Reteplase.,Esterified estrogens
DB11478,Zeranol may decrease the anticoagulant activities of Reteplase.,Zeranol
DB11674,Equol may decrease the anticoagulant activities of Reteplase.,Equol
DB12487,Promestriene may decrease the anticoagulant activities of Reteplase.,Promestriene
DB13143,Methallenestril may decrease the anticoagulant activities of Reteplase.,Methallenestril
DB13386,Epimestrol may decrease the anticoagulant activities of Reteplase.,Epimestrol
DB13418,Moxestrol may decrease the anticoagulant activities of Reteplase.,Moxestrol
DB13952,Estradiol acetate may decrease the anticoagulant activities of Reteplase.,Estradiol acetate
DB13953,Estradiol benzoate may decrease the anticoagulant activities of Reteplase.,Estradiol benzoate
DB13954,Estradiol cypionate may decrease the anticoagulant activities of Reteplase.,Estradiol cypionate
DB13956,Estradiol valerate may decrease the anticoagulant activities of Reteplase.,Estradiol valerate
DB15334,Biochanin A may decrease the anticoagulant activities of Reteplase.,Biochanin A
DB15335,Formononetin may decrease the anticoagulant activities of Reteplase.,Formononetin
DB00159,The risk or severity of bleeding and hemorrhage can be increased when Icosapent is combined with Reteplase.,Icosapent
DB00244,The risk or severity of bleeding and hemorrhage can be increased when Mesalazine is combined with Reteplase.,Mesalazine
DB00328,The risk or severity of bleeding and hemorrhage can be increased when Indomethacin is combined with Reteplase.,Indomethacin
DB00461,The risk or severity of bleeding and hemorrhage can be increased when Nabumetone is combined with Reteplase.,Nabumetone
DB00465,The risk or severity of bleeding and hemorrhage can be increased when Ketorolac is combined with Reteplase.,Ketorolac
DB00469,The risk or severity of bleeding and hemorrhage can be increased when Tenoxicam is combined with Reteplase.,Tenoxicam
DB00482,The risk or severity of bleeding and hemorrhage can be increased when Celecoxib is combined with Reteplase.,Celecoxib
DB00500,The risk or severity of bleeding and hemorrhage can be increased when Tolmetin is combined with Reteplase.,Tolmetin
DB00533,The risk or severity of bleeding and hemorrhage can be increased when Rofecoxib is combined with Reteplase.,Rofecoxib
DB00554,The risk or severity of bleeding and hemorrhage can be increased when Piroxicam is combined with Reteplase.,Piroxicam
DB00573,The risk or severity of bleeding and hemorrhage can be increased when Fenoprofen is combined with Reteplase.,Fenoprofen
DB00580,The risk or severity of bleeding and hemorrhage can be increased when Valdecoxib is combined with Reteplase.,Valdecoxib
DB00586,The risk or severity of bleeding and hemorrhage can be increased when Diclofenac is combined with Reteplase.,Diclofenac
DB00605,The risk or severity of bleeding and hemorrhage can be increased when Sulindac is combined with Reteplase.,Sulindac
DB00712,The risk or severity of bleeding and hemorrhage can be increased when Flurbiprofen is combined with Reteplase.,Flurbiprofen
DB00749,The risk or severity of bleeding and hemorrhage can be increased when Etodolac is combined with Reteplase.,Etodolac
DB00784,The risk or severity of bleeding and hemorrhage can be increased when Mefenamic acid is combined with Reteplase.,Mefenamic acid
DB00788,The risk or severity of bleeding and hemorrhage can be increased when Naproxen is combined with Reteplase.,Naproxen
DB00795,The risk or severity of bleeding and hemorrhage can be increased when Sulfasalazine is combined with Reteplase.,Sulfasalazine
DB00812,The risk or severity of bleeding and hemorrhage can be increased when Phenylbutazone is combined with Reteplase.,Phenylbutazone
DB00814,The risk or severity of bleeding and hemorrhage can be increased when Meloxicam is combined with Reteplase.,Meloxicam
DB00821,The risk or severity of bleeding and hemorrhage can be increased when Carprofen is combined with Reteplase.,Carprofen
DB00861,The risk or severity of bleeding and hemorrhage can be increased when Diflunisal is combined with Reteplase.,Diflunisal
DB00936,The risk or severity of bleeding and hemorrhage can be increased when Salicylic acid is combined with Reteplase.,Salicylic acid
DB00939,The risk or severity of bleeding and hemorrhage can be increased when Meclofenamic acid is combined with Reteplase.,Meclofenamic acid
DB00991,The risk or severity of bleeding and hemorrhage can be increased when Oxaprozin is combined with Reteplase.,Oxaprozin
DB01009,The risk or severity of bleeding and hemorrhage can be increased when Ketoprofen is combined with Reteplase.,Ketoprofen
DB01014,The risk or severity of bleeding and hemorrhage can be increased when Balsalazide is combined with Reteplase.,Balsalazide
DB01250,The risk or severity of bleeding and hemorrhage can be increased when Olsalazine is combined with Reteplase.,Olsalazine
DB01283,The risk or severity of bleeding and hemorrhage can be increased when Lumiracoxib is combined with Reteplase.,Lumiracoxib
DB01397,The risk or severity of bleeding and hemorrhage can be increased when Magnesium salicylate is combined with Reteplase.,Magnesium salicylate
DB01399,The risk or severity of bleeding and hemorrhage can be increased when Salsalate is combined with Reteplase.,Salsalate
DB01401,The risk or severity of bleeding and hemorrhage can be increased when Choline magnesium trisalicylate is combined with Reteplase.,Choline magnesium trisalicylate
DB01419,The risk or severity of bleeding and hemorrhage can be increased when Antrafenine is combined with Reteplase.,Antrafenine
DB01424,The risk or severity of bleeding and hemorrhage can be increased when Aminophenazone is combined with Reteplase.,Aminophenazone
DB01435,The risk or severity of bleeding and hemorrhage can be increased when Antipyrine is combined with Reteplase.,Antipyrine
DB01600,The risk or severity of bleeding and hemorrhage can be increased when Tiaprofenic acid is combined with Reteplase.,Tiaprofenic acid
DB01628,The risk or severity of bleeding and hemorrhage can be increased when Etoricoxib is combined with Reteplase.,Etoricoxib
DB02224,The risk or severity of bleeding and hemorrhage can be increased when Taxifolin is combined with Reteplase.,Taxifolin
DB03585,The risk or severity of bleeding and hemorrhage can be increased when Oxyphenbutazone is combined with Reteplase.,Oxyphenbutazone
DB04552,The risk or severity of bleeding and hemorrhage can be increased when Niflumic acid is combined with Reteplase.,Niflumic acid
DB04725,The risk or severity of bleeding and hemorrhage can be increased when Licofelone is combined with Reteplase.,Licofelone
DB04812,The risk or severity of bleeding and hemorrhage can be increased when Benoxaprofen is combined with Reteplase.,Benoxaprofen
DB04817,The risk or severity of bleeding and hemorrhage can be increased when Metamizole is combined with Reteplase.,Metamizole
DB04828,The risk or severity of bleeding and hemorrhage can be increased when Zomepirac is combined with Reteplase.,Zomepirac
DB05095,The risk or severity of bleeding and hemorrhage can be increased when Cimicoxib is combined with Reteplase.,Cimicoxib
DB06725,The risk or severity of bleeding and hemorrhage can be increased when Lornoxicam is combined with Reteplase.,Lornoxicam
DB06736,The risk or severity of bleeding and hemorrhage can be increased when Aceclofenac is combined with Reteplase.,Aceclofenac
DB06737,The risk or severity of bleeding and hemorrhage can be increased when Zaltoprofen is combined with Reteplase.,Zaltoprofen
DB07402,The risk or severity of bleeding and hemorrhage can be increased when Azapropazone is combined with Reteplase.,Azapropazone
DB07477,The risk or severity of bleeding and hemorrhage can be increased when Felbinac is combined with Reteplase.,Felbinac
DB08439,The risk or severity of bleeding and hemorrhage can be increased when Parecoxib is combined with Reteplase.,Parecoxib
DB08797,The risk or severity of bleeding and hemorrhage can be increased when Salicylamide is combined with Reteplase.,Salicylamide
DB08940,The risk or severity of bleeding and hemorrhage can be increased when Kebuzone is combined with Reteplase.,Kebuzone
DB08942,The risk or severity of bleeding and hemorrhage can be increased when Isoxicam is combined with Reteplase.,Isoxicam
DB08951,The risk or severity of bleeding and hemorrhage can be increased when Indoprofen is combined with Reteplase.,Indoprofen
DB08955,The risk or severity of bleeding and hemorrhage can be increased when Ibuproxam is combined with Reteplase.,Ibuproxam
DB08976,The risk or severity of bleeding and hemorrhage can be increased when Floctafenine is combined with Reteplase.,Floctafenine
DB08981,The risk or severity of bleeding and hemorrhage can be increased when Fenbufen is combined with Reteplase.,Fenbufen
DB08984,The risk or severity of bleeding and hemorrhage can be increased when Etofenamate is combined with Reteplase.,Etofenamate
DB08991,The risk or severity of bleeding and hemorrhage can be increased when Epirizole is combined with Reteplase.,Epirizole
DB09084,The risk or severity of bleeding and hemorrhage can be increased when Benzydamine is combined with Reteplase.,Benzydamine
DB09212,The risk or severity of bleeding and hemorrhage can be increased when Loxoprofen is combined with Reteplase.,Loxoprofen
DB09214,The risk or severity of bleeding and hemorrhage can be increased when Dexketoprofen is combined with Reteplase.,Dexketoprofen
DB09215,The risk or severity of bleeding and hemorrhage can be increased when Droxicam is combined with Reteplase.,Droxicam
DB09216,The risk or severity of bleeding and hemorrhage can be increased when Tolfenamic acid is combined with Reteplase.,Tolfenamic acid
DB09217,The risk or severity of bleeding and hemorrhage can be increased when Firocoxib is combined with Reteplase.,Firocoxib
DB09218,The risk or severity of bleeding and hemorrhage can be increased when Clonixin is combined with Reteplase.,Clonixin
DB09285,The risk or severity of bleeding and hemorrhage can be increased when Morniflumate is combined with Reteplase.,Morniflumate
DB09288,The risk or severity of bleeding and hemorrhage can be increased when Propacetamol is combined with Reteplase.,Propacetamol
DB09295,The risk or severity of bleeding and hemorrhage can be increased when Talniflumate is combined with Reteplase.,Talniflumate
DB11455,The risk or severity of bleeding and hemorrhage can be increased when Robenacoxib is combined with Reteplase.,Robenacoxib
DB11466,The risk or severity of bleeding and hemorrhage can be increased when Tepoxalin is combined with Reteplase.,Tepoxalin
DB11518,The risk or severity of bleeding and hemorrhage can be increased when Flunixin is combined with Reteplase.,Flunixin
DB12399,The risk or severity of bleeding and hemorrhage can be increased when Polmacoxib is combined with Reteplase.,Polmacoxib
DB12480,The risk or severity of bleeding and hemorrhage can be increased when Betulinic Acid is combined with Reteplase.,Betulinic Acid
DB12610,The risk or severity of bleeding and hemorrhage can be increased when Ebselen is combined with Reteplase.,Ebselen
DB13001,The risk or severity of bleeding and hemorrhage can be increased when Tinoridine is combined with Reteplase.,Tinoridine
DB13167,The risk or severity of bleeding and hemorrhage can be increased when Alclofenac is combined with Reteplase.,Alclofenac
DB13217,The risk or severity of bleeding and hemorrhage can be increased when Fentiazac is combined with Reteplase.,Fentiazac
DB13232,The risk or severity of bleeding and hemorrhage can be increased when Suxibuzone is combined with Reteplase.,Suxibuzone
DB13286,The risk or severity of bleeding and hemorrhage can be increased when Bumadizone is combined with Reteplase.,Bumadizone
DB13314,The risk or severity of bleeding and hemorrhage can be increased when Alminoprofen is combined with Reteplase.,Alminoprofen
DB13317,The risk or severity of bleeding and hemorrhage can be increased when Flunoxaprofen is combined with Reteplase.,Flunoxaprofen
DB13364,The risk or severity of bleeding and hemorrhage can be increased when Feprazone is combined with Reteplase.,Feprazone
DB13371,The risk or severity of bleeding and hemorrhage can be increased when Difenpiramide is combined with Reteplase.,Difenpiramide
DB13407,The risk or severity of bleeding and hemorrhage can be increased when Nifenazone is combined with Reteplase.,Nifenazone
DB13432,The risk or severity of bleeding and hemorrhage can be increased when Lonazolac is combined with Reteplase.,Lonazolac
DB13481,The risk or severity of bleeding and hemorrhage can be increased when Tenidap is combined with Reteplase.,Tenidap
DB13501,The risk or severity of bleeding and hemorrhage can be increased when Bendazac is combined with Reteplase.,Bendazac
DB13514,The risk or severity of bleeding and hemorrhage can be increased when Pranoprofen is combined with Reteplase.,Pranoprofen
DB13524,The risk or severity of bleeding and hemorrhage can be increased when Propyphenazone is combined with Reteplase.,Propyphenazone
DB13527,The risk or severity of bleeding and hemorrhage can be increased when Proglumetacin is combined with Reteplase.,Proglumetacin
DB13538,The risk or severity of bleeding and hemorrhage can be increased when Guacetisal is combined with Reteplase.,Guacetisal
DB13544,The risk or severity of bleeding and hemorrhage can be increased when Ethenzamide is combined with Reteplase.,Ethenzamide
DB13612,The risk or severity of bleeding and hemorrhage can be increased when Carbaspirin calcium is combined with Reteplase.,Carbaspirin calcium
DB13629,The risk or severity of bleeding and hemorrhage can be increased when Mofebutazone is combined with Reteplase.,Mofebutazone
DB13649,The risk or severity of bleeding and hemorrhage can be increased when Proquazone is combined with Reteplase.,Proquazone
DB13657,The risk or severity of bleeding and hemorrhage can be increased when Benorilate is combined with Reteplase.,Benorilate
DB13722,The risk or severity of bleeding and hemorrhage can be increased when Pirprofen is combined with Reteplase.,Pirprofen
DB13860,The risk or severity of bleeding and hemorrhage can be increased when Imidazole salicylate is combined with Reteplase.,Imidazole salicylate
DB14059,The risk or severity of bleeding and hemorrhage can be increased when SC-236 is combined with Reteplase.,SC-236
DB14060,The risk or severity of bleeding and hemorrhage can be increased when NS-398 is combined with Reteplase.,NS-398
DB14938,The risk or severity of bleeding and hemorrhage can be increased when Flurbiprofen axetil is combined with Reteplase.,Flurbiprofen axetil
DB04865,The risk or severity of bleeding can be increased when Reteplase is combined with Omacetaxine mepesuccinate.,Omacetaxine mepesuccinate
DB11133,Omega-3 fatty acids may increase the anticoagulant activities of Reteplase.,Omega-3 fatty acids
DB00081,The risk or severity of bleeding and hemorrhage can be increased when Reteplase is combined with Tositumomab.,Tositumomab
DB09211,The risk or severity of adverse effects can be increased when Limaprost is combined with Reteplase.,Limaprost
DB00048,The risk or severity of adverse effects can be increased when Reteplase is combined with Collagenase clostridium histolyticum.,Collagenase clostridium histolyticum
DB00389,Carbimazole may increase the anticoagulant activities of Reteplase.,Carbimazole
DB00550,Propylthiouracil may increase the anticoagulant activities of Reteplase.,Propylthiouracil
DB00763,Methimazole may increase the anticoagulant activities of Reteplase.,Methimazole
DB03374,"3,5-Diiodotyrosine may increase the anticoagulant activities of Reteplase.","3,5-Diiodotyrosine"
DB06715,Potassium Iodide may increase the anticoagulant activities of Reteplase.,Potassium Iodide
DB07637,Dibromotyrosine may increase the anticoagulant activities of Reteplase.,Dibromotyrosine
DB09418,Potassium perchlorate may increase the anticoagulant activities of Reteplase.,Potassium perchlorate
DB13644,Methylthiouracil may increase the anticoagulant activities of Reteplase.,Methylthiouracil
DB13804,Benzylthiouracil may increase the anticoagulant activities of Reteplase.,Benzylthiouracil
DB00834,The therapeutic efficacy of Reteplase can be decreased when used in combination with Mifepristone.,Mifepristone
DB04066,The therapeutic efficacy of Reteplase can be decreased when used in combination with p-Coumaric acid.,p-Coumaric acid
DB04682,The therapeutic efficacy of Reteplase can be decreased when used in combination with Octylphenoxy polyethoxyethanol.,Octylphenoxy polyethoxyethanol
DB05830,The therapeutic efficacy of Reteplase can be decreased when used in combination with Trestolone.,Trestolone
DB06266,The therapeutic efficacy of Reteplase can be decreased when used in combination with Lonidamine.,Lonidamine
DB08867,The therapeutic efficacy of Reteplase can be decreased when used in combination with Ulipristal.,Ulipristal
DB09401,The therapeutic efficacy of Reteplase can be decreased when used in combination with Isosorbide.,Isosorbide
DB11507,The therapeutic efficacy of Reteplase can be decreased when used in combination with Cloprostenol.,Cloprostenol
DB12025,The therapeutic efficacy of Reteplase can be decreased when used in combination with Triptolide.,Triptolide
DB13044,The therapeutic efficacy of Reteplase can be decreased when used in combination with Gossypol.,Gossypol
DB13310,The therapeutic efficacy of Reteplase can be decreased when used in combination with Ormeloxifene.,Ormeloxifene
DB00294,Etonogestrel may decrease the anticoagulant activities of Reteplase.,Etonogestrel
DB00304,Desogestrel may decrease the anticoagulant activities of Reteplase.,Desogestrel
DB00351,Megestrol acetate may decrease the anticoagulant activities of Reteplase.,Megestrol acetate
DB00367,Levonorgestrel may decrease the anticoagulant activities of Reteplase.,Levonorgestrel
DB00378,Dydrogesterone may decrease the anticoagulant activities of Reteplase.,Dydrogesterone
DB00396,Progesterone may decrease the anticoagulant activities of Reteplase.,Progesterone
DB00603,Medroxyprogesterone acetate may decrease the anticoagulant activities of Reteplase.,Medroxyprogesterone acetate
DB00717,Norethisterone may decrease the anticoagulant activities of Reteplase.,Norethisterone
DB00823,Ethynodiol diacetate may decrease the anticoagulant activities of Reteplase.,Ethynodiol diacetate
DB00957,Norgestimate may decrease the anticoagulant activities of Reteplase.,Norgestimate
DB01395,Drospirenone may decrease the anticoagulant activities of Reteplase.,Drospirenone
DB01431,Allylestrenol may decrease the anticoagulant activities of Reteplase.,Allylestrenol
DB04839,Cyproterone acetate may decrease the anticoagulant activities of Reteplase.,Cyproterone acetate
DB06713,Norelgestromin may decrease the anticoagulant activities of Reteplase.,Norelgestromin
DB06730,Gestodene may decrease the anticoagulant activities of Reteplase.,Gestodene
DB06789,Hydroxyprogesterone caproate may decrease the anticoagulant activities of Reteplase.,Hydroxyprogesterone caproate
DB09123,Dienogest may decrease the anticoagulant activities of Reteplase.,Dienogest
DB09124,Medrogestone may decrease the anticoagulant activities of Reteplase.,Medrogestone
DB09371,Norethynodrel may decrease the anticoagulant activities of Reteplase.,Norethynodrel
DB09389,Norgestrel may decrease the anticoagulant activities of Reteplase.,Norgestrel
DB11372,Altrenogest may decrease the anticoagulant activities of Reteplase.,Altrenogest
DB11619,Gestrinone may decrease the anticoagulant activities of Reteplase.,Gestrinone
DB11636,Nomegestrol may decrease the anticoagulant activities of Reteplase.,Nomegestrol
DB12474,Lynestrenol may decrease the anticoagulant activities of Reteplase.,Lynestrenol
DB13230,Gestonorone may decrease the anticoagulant activities of Reteplase.,Gestonorone
DB13528,Chlormadinone may decrease the anticoagulant activities of Reteplase.,Chlormadinone
DB13533,Methylestrenolone may decrease the anticoagulant activities of Reteplase.,Methylestrenolone
DB13563,Norgestrienone may decrease the anticoagulant activities of Reteplase.,Norgestrienone
DB13602,Promegestone may decrease the anticoagulant activities of Reteplase.,Promegestone
DB13685,Quingestanol may decrease the anticoagulant activities of Reteplase.,Quingestanol
DB13857,Demegestone may decrease the anticoagulant activities of Reteplase.,Demegestone
DB13866,Etynodiol may decrease the anticoagulant activities of Reteplase.,Etynodiol
DB13981,Nomegestrol acetate may decrease the anticoagulant activities of Reteplase.,Nomegestrol acetate
DB14570,Hydroxyprogesterone may decrease the anticoagulant activities of Reteplase.,Hydroxyprogesterone
DB14678,Norethindrone enanthate may decrease the anticoagulant activities of Reteplase.,Norethindrone enanthate
DB14679,Quingestanol acetate may decrease the anticoagulant activities of Reteplase.,Quingestanol acetate
DB00233,The risk or severity of bleeding can be increased when Aminosalicylic acid is combined with Reteplase.,Aminosalicylic acid
DB01294,The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Reteplase.,Bismuth subsalicylate
DB06251,The risk or severity of bleeding can be increased when Dersalazine is combined with Reteplase.,Dersalazine
DB06807,The risk or severity of bleeding can be increased when Phenyl aminosalicylate is combined with Reteplase.,Phenyl aminosalicylate
DB09543,The risk or severity of bleeding can be increased when Methyl salicylate is combined with Reteplase.,Methyl salicylate
DB11079,The risk or severity of bleeding can be increased when Trolamine salicylate is combined with Reteplase.,Trolamine salicylate
DB13509,The risk or severity of bleeding can be increased when Aloxiprin is combined with Reteplase.,Aloxiprin
DB14006,The risk or severity of bleeding can be increased when Choline salicylate is combined with Reteplase.,Choline salicylate
DB14026,The risk or severity of bleeding can be increased when Thiosalicylic acid is combined with Reteplase.,Thiosalicylic acid
DB00054,The risk or severity of bleeding can be increased when Abciximab is combined with Reteplase.,Abciximab
DB00063,The risk or severity of bleeding can be increased when Eptifibatide is combined with Reteplase.,Eptifibatide
DB00208,The risk or severity of bleeding can be increased when Ticlopidine is combined with Reteplase.,Ticlopidine
DB00261,The risk or severity of bleeding can be increased when Anagrelide is combined with Reteplase.,Anagrelide
DB00758,The risk or severity of bleeding can be increased when Clopidogrel is combined with Reteplase.,Clopidogrel
DB00775,The risk or severity of bleeding can be increased when Tirofiban is combined with Reteplase.,Tirofiban
DB00975,The risk or severity of bleeding can be increased when Dipyridamole is combined with Reteplase.,Dipyridamole
DB01088,The risk or severity of bleeding can be increased when Iloprost is combined with Reteplase.,Iloprost
DB01138,The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Reteplase.,Sulfinpyrazone
DB01166,The risk or severity of bleeding can be increased when Cilostazol is combined with Reteplase.,Cilostazol
DB01207,The risk or severity of bleeding can be increased when Ridogrel is combined with Reteplase.,Ridogrel
DB01236,The risk or severity of bleeding can be increased when Sevoflurane is combined with Reteplase.,Sevoflurane
DB01240,The risk or severity of bleeding can be increased when Epoprostenol is combined with Reteplase.,Epoprostenol
DB02709,The risk or severity of bleeding can be increased when Resveratrol is combined with Reteplase.,Resveratrol
DB04743,The risk or severity of bleeding can be increased when Nimesulide is combined with Reteplase.,Nimesulide
DB04905,The risk or severity of bleeding can be increased when Tesmilifene is combined with Reteplase.,Tesmilifene
DB04932,The risk or severity of bleeding can be increased when Defibrotide is combined with Reteplase.,Defibrotide
DB05229,The risk or severity of bleeding can be increased when Beraprost is combined with Reteplase.,Beraprost
DB05266,The risk or severity of bleeding can be increased when Ibudilast is combined with Reteplase.,Ibudilast
DB05767,The risk or severity of bleeding can be increased when Andrographolide is combined with Reteplase.,Andrographolide
DB06081,The risk or severity of bleeding can be increased when Caplacizumab is combined with Reteplase.,Caplacizumab
DB06209,The risk or severity of bleeding can be increased when Prasugrel is combined with Reteplase.,Prasugrel
DB06441,The risk or severity of bleeding can be increased when Cangrelor is combined with Reteplase.,Cangrelor
DB07615,The risk or severity of bleeding can be increased when Tranilast is combined with Reteplase.,Tranilast
DB08814,The risk or severity of bleeding can be increased when Triflusal is combined with Reteplase.,Triflusal
DB08816,The risk or severity of bleeding can be increased when Ticagrelor is combined with Reteplase.,Ticagrelor
DB08887,The risk or severity of bleeding can be increased when Icosapent ethyl is combined with Reteplase.,Icosapent ethyl
DB09283,The risk or severity of bleeding can be increased when Trapidil is combined with Reteplase.,Trapidil
DB12092,The risk or severity of bleeding can be increased when Naftopidil is combined with Reteplase.,Naftopidil
DB12163,The risk or severity of bleeding can be increased when Sarpogrelate is combined with Reteplase.,Sarpogrelate
DB12321,The risk or severity of bleeding can be increased when Ifetroban is combined with Reteplase.,Ifetroban
DB12445,The risk or severity of bleeding can be increased when Nitroaspirin is combined with Reteplase.,Nitroaspirin
DB12465,The risk or severity of bleeding can be increased when Ketanserin is combined with Reteplase.,Ketanserin
DB12545,The risk or severity of bleeding can be increased when Indobufen is combined with Reteplase.,Indobufen
DB12749,The risk or severity of bleeding can be increased when Butylphthalide is combined with Reteplase.,Butylphthalide
DB12771,The risk or severity of bleeding can be increased when Hydroxytyrosol is combined with Reteplase.,Hydroxytyrosol
DB13036,The risk or severity of bleeding can be increased when Ramatroban is combined with Reteplase.,Ramatroban
